{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/nemotron-nano-30b-reasoning/e3_page_window_distract/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T14:34:10.355916"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nThe carrying amount of AVGO’s 5.000 % senior notes maturing in April 2030 was essentially unchanged—about $606 million in fiscal 2022, 2023 and 2024—so the company’s direct exposure to that tranche remained flat. This stability shows that AVGO is not using the 5 % 2030 notes to adjust its overall leverage; instead it is managing debt by issuing new senior obligations and repaying larger, higher‑cost facilities, preserving a small legacy fixed‑rate slice while reshaping the broader debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer is factually incorrect in its core quantitative claim: it states that AVGO's exposure to the 5.000% notes due April 2030 was 'about $606 million' in all three fiscal years (2022, 2023, 2024), while the ground truth shows a decrease from $1,086 million in 2022 to $606 million in 2023 and 2024. This misrepresents the evolution of the debt exposure. (2) The numbers are significantly inaccurate—specifically, the 2022 value is off by $480 million. The LLM claims stability, but the truth is a substantial reduction in exposure from 2022 to 2023. This error invalidates the conclusion about debt strategy. (3) The reasoning is flawed due to incorrect data input: the model fails to recognize the multi-hop progression (a decrease over time) and instead assumes flat exposure, leading to an incorrect interpretation of AVGO’s debt management strategy. The actual reduction indicates active debt retirement, whereas the LLM suggests strategic preservation of a 'legacy fixed-rate slice,' which contradicts the observed reduction. (4) While the answer addresses the right company (AVGO), debt instrument (5.000% notes due April 2030), and time frame (2022–2024), and attempts to interpret strategy, the severe quantitative inaccuracy undermines both qualitative reasoning and overall correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 394,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife consistently reinsured roughly 59 % of the closed‑block through a modified‑coinsurance agreement (59.25 % in 2022, 59 % in 2023 and again in 2024).  Even after the 2023 risk‑transfer transaction that added a 100 % quota‑share for the general‑account portion, the company kept the modified‑coinsurance share near 59 %, underscoring a long‑term strategy of preserving capital and stabilizing the closed‑block’s risk profile and dividend expectations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the consistent percentage of the closed block reinsured via modified coinsurance: 59.25% in 2022 and 59% in both 2023 and 2024, matching the ground truth. This demonstrates strong quantitative accuracy. However, the LLM introduces a claim not present in the original answer or supported by the provided context: that a '2023 risk-transfer transaction' added a '100% quota-share for the general-account portion.' This detail is absent from the ground truth and cannot be verified from the given information, making it a significant qualitative error. 2) All numeric values related to the modified coinsurance percentages are accurate and properly attributed across years. The dollar amounts for net ceded reinsurance recoverables ($6.3B in 2021 referenced in 2022 filing, $17.6B in 2024) are not mentioned in the LLM answer, representing a notable omission of contextual financial growth that underscores the strategic consistency. 3) The multi-hop reasoning is partially sound—the model correctly infers that stable risk transfer suggests a deliberate long-term strategy focused on capital preservation and risk stabilization. However, the unsupported addition of a quota-share transaction undermines the reasoning integrity, as it introduces an external event not in the source data. 4) Despite the factual error about the quota-share, the core conclusion about MetLife’s sustained reinsurance strategy aligns semantically with the ground truth. The answer remains contextually relevant and captures the essence of strategic consistency, but the invented detail reduces qualitative accuracy. Thus, correctness is reduced to 7 due to partial inaccuracy in reasoning, even though key facts and numbers are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 474,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nThe collateral that the Corporation posts under master‑netting arrangements—recorded in the “Investments, advances and long‑term receivables” line items—fell sharply from **$1.49 billion in 2022 to $0.80 billion in 2023 and then to $0.49 billion in 2024**.  This steady decline shows that ExxonMobil is relying less on external collateral to support its derivative positions, indicating a reduction in net derivative exposure or improved credit‑risk mitigation in its derivative book.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $1.49 billion in 2022 (matches $1,494 million), $0.80 billion in 2023 (matches $800 million), and $0.49 billion in 2024 (matches $491 million); minor rounding is acceptable and common in financial reporting. (2) The answer addresses both parts of the multi-part question: it quantifies the change in collateral from 2022 to 2024 and interprets the trend regarding derivative exposure management. (3) Entities are correct—ExxonMobil (referred to as 'the Corporation', consistent with 10-K language), correct metric ('collateral under master netting arrangements'), and correct financial line item ('Investments, advances and long-term receivables'). (4) The reasoning is sound: the three-year decline is correctly identified, and the interpretation—that this suggests reduced reliance on external collateral, implying lower net derivative exposure or improved risk mitigation—aligns perfectly with the ground truth's conclusion about 'strategic reduction in derivative exposure or improved offsetting mechanisms.' No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 333,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nThe 3.625 % senior notes due October 2024 carried a carrying value of about **$622 million at the end of fiscal 2022 (and remained $622 million through fiscal 2023)**, but by the end of fiscal 2024 the balance had fallen to **$0**.  This decline shows that AVGO intentionally retired the note—using cash from its October 2024 $5 billion senior‑note issuance and proceeds from the VMware merger—thereby eliminating a near‑term maturity, lowering interest expense, and streamlining its overall debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the principal amounts for the 3.625% notes due October 2024: $622 million in both 2022 and 2023, and $0 in 2024, matching the ground truth exactly. These numbers are accurate and properly attributed to the correct fiscal years. (2) Quantitative accuracy is perfect—no errors in dollar amounts, percentages, or dates. The format variation (e.g., $622 million vs $622M) is acceptable and semantically equivalent. (3) The reasoning is mostly sound: the LLM correctly infers that the debt was retired by 2024, aligning with the ground truth's conclusion of repayment or refinancing. However, the LLM adds specific details not present in the ground truth—namely, that the retirement was funded by a $5 billion senior-note issuance in October 2024 and proceeds from the VMware merger. While plausible, these details are not supported by the provided ground truth and represent an overreach in inference, slightly undermining qualitative accuracy. (4) Contextual relevance is high—the answer directly addresses the evolution of AVGO's exposure and interprets the strategic implications. The core facts are correct, and the interpretation aligns with the ground truth, though the unsupported funding sources prevent a perfect score. Thus, correctness is rated 8 due to minor over-speculation in reasoning, despite full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 382,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nFrom 2022 to 2024 the Marine Systems segment’s surface‑ship revenue rose steadily—$2.56 billion in 2022, $2.698 billion in 2023 and $2.819 billion in 2024—reflecting a roughly 10 % cumulative increase over the three‑year span.  This upward trajectory, together with a growing backlog of destroyers, auxiliary ships and submarine‑payload‑module production and the company’s $1.8 billion investment in expanded shipyard facilities, signals that General Dynamics is consolidating its role as a premier U.S. naval shipbuilder and positioning itself to capture the next wave of Navy shipbuilding growth through 2030+.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the revenue figures for surface ships: $2,561 million in 2022, $2,698 million in 2023, and $2,819 million in 2024, matching the ground truth exactly (with acceptable format variation: $2.56 billion ≈ $2,561 million, etc.). The implied 10% cumulative growth is approximately correct: ((2,819 - 2,561) / 2,561) ≈ 10.07%. 2) All numeric values are accurate and correctly formatted; calculations are sound. 3) The reasoning is strong: the LLM correctly infers strategic positioning in naval shipbuilding from revenue growth and adds context not in the original answer (e.g., backlog, $1.8B investment, future outlook), which is factually plausible and enhances the analysis without contradicting the ground truth. However, these additional details (backlog, investment) are not present in the original ground truth from the knowledge graph, so while reasonable, they represent an expansion beyond the verified data. 4) The core answer fully addresses both parts of the question—revenue evolution and what it indicates—and conveys the same central message: sustained growth indicating strategic emphasis in naval shipbuilding. The added context improves relevance and depth without sacrificing accuracy. Thus, the answer is highly accurate, with only minor over-enrichment beyond the ground truth, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 383,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nThe dividend paid on Mastercard’s Class A shares rose each year – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 – reflecting a steady, incremental increase over the three‑year period. Class A shares have always carried “one vote per share,” and the voting‑rights structure was unchanged; however, the shareholder mix shifted slightly, with the Mastercard Foundation’s voting stake falling from roughly 10.5 % in 2023 to 9.4 % in 2024 while public investors’ voting power rose from about 89.5 % to 90.6 % of the total vote (see the equity‑ownership/voting‑power tables in the 2023 and 2024 filings). This gradual diffusion of ownership does not alter the one‑vote‑per‑share rule, indicating that Mastercard’s governance framework remains stable, with only a slow, expected transition away from concentrated control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The dividend amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) are not supported by the original answer, which states only that A Class shares had 'standard dividend rights' with no changes over time—no specific dividend payouts are mentioned. These precise figures are fabricated or hallucinated. (2) The claim about the Mastercard Foundation's voting stake decreasing from 10.5% to 9.4% and public investors increasing their share is not present in the ground truth and introduces entity-level inaccuracies (e.g., 'Mastercard Foundation' is not referenced in the original). (3) While the LLM correctly identifies that A Class shares have 'one vote per share' and that voting rights were unchanged, this is the only accurate point. (4) The reasoning about 'gradual diffusion of ownership' and 'slow transition away from concentrated control' is based on incorrect data and thus invalidates the conclusion, even though the final statement about governance stability aligns with the original. (5) The original emphasizes consistency and lack of change as the basis for stability; the LLM invents a narrative of ownership shift to reach a similar conclusion, which is not justified by the source. Therefore, despite some correct terminology and a superficially plausible structure, the answer fails on quantitative accuracy and entity fidelity, undermining its correctness. The contextual relevance is moderate because it addresses the right topic and attempts multi-hop synthesis, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 443,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nSurface‑ship revenue grew from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, delivering roughly **5 % year‑over‑year growth** in each period. This upward trend signals that General Dynamics is capturing an expanding share of the Navy’s surface‑warfare portfolio—backed by a multi‑year backlog of destroyers, auxiliary vessels and replenishment ships—affirming its strong positioning in the nation’s naval defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trend in General Dynamics' surface-ship revenue from 2022 to 2024 with values very close to the ground truth. The reported figures are $2.56B (2022), $2.70B (2023), and $2.82B (2024), which align closely with the ground truth of $2,561M, $2,698M, and $2,819M. These are within rounding differences and acceptable format variations (e.g., $2.70B ≈ $2,700M vs. $2,698M). The year-over-year growth is stated as 'roughly 5%' for each period. Actual YoY growth: (2,698 - 2,561)/2,561 ≈ 5.35% and (2,819 - 2,698)/2,698 ≈ 4.48%. The LLM rounds both to ~5%, which is a reasonable approximation but slightly overstates the second year's growth. 2) Quantitatively, the numbers are accurate within acceptable rounding and formatting norms. The minor discrepancy in 2023 ($2,700M vs. $2,698M) and 2024 ($2,820M vs. $2,819M) is negligible and common in financial reporting. The growth percentage is simplified but not misleading. 3) The reasoning is sound: the LLM correctly infers that consistent revenue growth indicates stronger positioning in naval defense programs, supported by contract backlog—this aligns with and extends the ground truth logically. It adds contextual detail (e.g., destroyers, auxiliary vessels) that enriches the answer without contradicting facts. 4) The answer is semantically equivalent and fully addresses both parts of the question: revenue evolution and implications for company positioning. The added detail about the Navy’s surface-warfare portfolio enhances relevance. Scores reflect high accuracy with a minor deduction in quantitative accuracy due to slight over-rounding of growth rates and revenue figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 456,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nLinde continued to describe the “majority of Linde’s business [as] conducted through long‑term contracts” in each of the 2022, 2023 and 2024 Form 10‑K filings, indicating that this contractual model was not a new shift but a sustained strategic pillar.  Because those contracts allow Linde to pass energy‑and‑feedstock cost changes directly to customers, the company’s cash‑flow‑from‑operations remained remarkably stable—rising only modestly from $9.3 bn in 2023 to $9.4 bn in 2024—even as energy markets fluctuated.  This consistency underscores how Linde’s long‑term agreements underpin predictable cash generation amid volatile energy prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained its reliance on long-term contracts across 2022, 2023, and 2024, which is consistent with the original answer’s claim of sustained strategy. (2) The quantitative data about cash flow from operations—$9.3B in 2023 rising to $9.4B in 2024—is factually accurate and supports the narrative of stability amid energy market fluctuations. While the original answer does not include these specific cash flow figures, their inclusion adds value and does not contradict the ground truth; rather, they enhance the reasoning. (3) The multi-hop reasoning is sound: the model connects long-term contracts → cost pass-through → stable cash flows → strategic emphasis on predictability, which mirrors the original’s logic about financial resilience. (4) All entities (Linde, Form 10-K filings, industrial gas, energy markets) are correctly identified and contextualized. The only minor limitation is that the original emphasizes the 'deliberate and stable approach to risk management' more explicitly, which the LLM implies but doesn’t fully articulate. However, the core facts, synthesis, and implications are correctly conveyed. Wording differs but semantic meaning matches. No calculation errors. Format variations are acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 372,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting items—such as goodwill impairments and other one‑time adjustments—from the NOPAT component of its ROIC calculation across 2022, 2023 and 2024. By repeatedly stating that ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance,” the company signals a stable, disciplined approach to measuring core profitability and capital efficiency, isolating the recurring operating returns that management believes better reflect sustainable performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability over the three-year period. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts), but the years (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes that consistent exclusion reflects a disciplined, institutionalized approach to measuring core performance, linking repeated disclosures to a stable financial framework. (4) The LLM enhances the original answer with specific examples (e.g., goodwill impairments) and quotes management language, adding contextual depth without introducing error. All entities—GD, ROIC, NOPAT, non-economic accounting changes—are correctly identified and logically connected. The answer fully addresses both parts of the question: the evolution (consistency over time) and what it reveals (focus on core operational performance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 322,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth Group’s service‑level guarantee obligations produced no material financial impact—​the company recorded no accruals, payments, or charges for such guarantees in any of the three years. This consistent immateriality demonstrates that the firm’s risk‑management controls and contractual performance are stable, with service‑level guarantees posing negligible financial risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UnitedHealth Group had no material financial impact from service level guarantee obligations in 2022, 2023, and 2024, with no accruals, payments, or charges recorded—matching the original answer's claim of immateriality across all three years. (2) There are no numerical discrepancies; while no specific dollar amounts are given, the qualitative assessment of 'no material impact' and 'no accruals, payments, or charges' aligns precisely with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes consistent disclosures across three years and infers that this pattern reflects effective risk management and contractual performance, which is a valid conclusion supported by the data. (4) All entities—UnitedHealth Group, service level guarantees, risk management, and the 2022–2024 timeframe—are correctly identified and contextualized. The answer is concise, factually accurate, and fully addresses both parts of the question: the evolution of obligations (consistently immaterial) and the implication for risk management (effective and stable).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 334,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose steadily from **$2.56 billion in 2022 → $2.70 billion in 2023 → $2.82 billion in 2024**, reflecting a consistent double‑digit increase in each fiscal year. This upward trajectory signals that the company is deliberately expanding its naval‑defense footprint—leveraging growing backlogs for destroyers (e.g., Flight‑III DDG‑51), auxiliary ships, and submarine programs—to position itself as a core supplier of next‑generation surface combatants and support vessels for the U.S. Navy and its allies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the overall upward trend in General Dynamics' surface-ship revenue from 2022 to 2024 and correctly infers strategic expansion in naval defense, which aligns with the ground truth. However, the 2022 revenue figure is incorrect: LLM states $2.56 billion ($2,560 million), while the ground truth is $2,328 million—a significant discrepancy of $232 million. The 2023 and 2024 figures are accurate: $2.70 billion = $2,700 million (ground truth: $2,698 million, acceptable rounding), and $2.82 billion = $2,820 million (ground truth: $2,819 million, also acceptable). 2) Quantitative accuracy is compromised primarily by the erroneous 2022 value. The claim of 'double-digit increase in each fiscal year' is misleading—actual YoY growth from 2022 to 2023 is about 15.9% using ground truth numbers, but with the inflated 2022 baseline, the implied growth is understated. 3) Qualitatively, the reasoning is sound: the LLM correctly attributes growth to demand for DDG-51 destroyers and auxiliary vessels and links it to strategic positioning in naval defense, which is consistent with General Dynamics' Marine Systems segment focus. 4) Contextual relevance is high—the answer addresses both revenue evolution and strategic implications, synthesizing financial data with strategic analysis. Despite the 2022 error, the overall trajectory and interpretation remain directionally correct, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 397,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nFrom 2022 through 2024 GE treated its captive industrial insurer, **Electric Insurance Company (EIC)**, as a **held‑for‑sale** business.  After classifying EIC in the fourth quarter of 2022, the company carried a **valuation allowance of $124 million** and reported essentially zero net assets (‑$ ) with insurance liabilities of about **$376 million**, reflecting only modest residual financial exposure.  In the **second quarter of 2024** GE **completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash**, thereby divesting the entity and removing its remaining liabilities from GE’s balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key financial figures and timing. While it correctly identifies that EIC was classified as 'held for sale' and eventually sold to Riverstone International Holdings Inc. for $120 million in cash in 2024, it misstates the timeline and critical financial data. The original answer states that EIC was classified as 'held for sale' in 2023 (not Q4 2022), and the $109 million loss was recorded in 2023, not a $124 million valuation allowance in 2022. Additionally, the LLM claims 'zero net assets' and '‑$' which contradicts the ground truth that EIC had $541 million in assets and $378 million in liabilities as of December 31, 2023 (net assets of $163 million). The liabilities are approximately correct ($376M vs $378M), but the net asset portrayal is misleading. (2) Quantitative accuracy is low: the $124 million valuation allowance is incorrect (should be $109 million loss in 2023), and the claim of 'essentially zero net assets' is false given the $163 million net asset value in the ground truth. The sale price ($120M) and buyer (Riverstone) are correct. (3) The multi-hop reasoning is partially sound—LLM correctly traces the evolution from ownership to divestiture and identifies the buyer—but misrepresents the financial state during the held-for-sale period and the timing of classification. It incorrectly implies the classification occurred in 2022, while the ground truth shows it was in 2023. (4) Contextual relevance is high as the answer addresses classification, financial exposure, and divestiture. However, due to significant numerical and temporal errors, the correctness score is moderate. The answer captures the general trajectory but fails on key details necessary for financial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 488,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips moved from a one‑time, CVE‑share‑sale‑driven repurchase (the remaining 91 million CVE shares were sold in Q1 2022 and the proceeds were used to buy back ~48 million shares that year) to a multi‑year, board‑approved $45 billion (later expanded to $65 billion) share‑buyback program that is now funded primarily by operating cash flow and the enlarged authorization.  This progression shows that the company’s capital‑allocation strategy shifted from opportunistic use of CVE proceeds to a disciplined, sustained focus on returning cash to shareholders through regular, sizable share repurchases while maintaining flexibility for future investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core narrative of ConocoPhillips' capital allocation strategy evolution—monetizing CVE shares and using proceeds for share repurchases, then transitioning to a sustained buyback program funded by operating cash flow. However, there are key quantitative inaccuracies. The ground truth states that 383 million shares were repurchased by end-2023 at a cost of $29 billion, and 433 million total by end-2024 at $34.3 billion. The LLM incorrectly claims that ~48 million shares were repurchased in 2022 specifically from CVE proceeds, which is not supported by the original answer. The original does not break down annual repurchase volumes per year, only cumulative figures. (2) The $45 billion authorization and $20 billion increase (to $65 billion total) are correctly reported. However, the LLM implies a direct link between the CVE sale in Q1 2022 and repurchasing ~48 million shares that year, which is a misinterpretation—the original answer does not specify annual repurchase volumes or attribute them solely to CVE proceeds. (3) The multi-hop reasoning is generally sound: the model correctly infers a strategic shift from asset monetization to sustained capital return. It synthesizes the CVE sale, share repurchase program, expansion, and strategic implications across years. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies—especially the unsupported claim of ~48 million shares repurchased in 2022—reduce the correctness and quantitative accuracy scores. The answer is semantically close but not factually precise on key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 446,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nMetLife has kept the same 59 percent share of the closed block reinsured under its modified‑coinsurance arrangement from 2022 through 2024.  The key change is in the accounting: the 2022 filing treated the arrangement as a simple deposit‑method offset, whereas the 2023‑2024 filings record a net cost of reinsurance that is amortized in line with DAC and other policy‑related balances.  This evolution shows that MetLife is maintaining a stable, long‑term risk‑transfer ratio for the closed block but is increasingly formalizing and matching the expense of that risk transfer to the underlying liabilities, reflecting a disciplined, capital‑preserving strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct on the percentage of the closed block reinsured, stating approximately 59% across 2022–2024, which aligns with the ground truth (59.25% in 2022, 59% in 2023 and 2024). However, it incorrectly claims a change in accounting treatment, stating that 2022 used a 'simple deposit-method offset' while 2023–2024 shifted to amortizing a net cost of reinsurance. This is factually wrong — the ground truth confirms consistent use of the deposit method with the right of offset across all three years. (2) Quantitatively, the percentages are mostly accurate (rounding 59.25% to 59% is acceptable), but the introduction of a non-existent accounting evolution undermines numerical and conceptual accuracy. There are no calculations in the response, but the misrepresentation of accounting metrics (e.g., 'net cost of reinsurance', 'amortized in line with DAC') introduces false qualitative and quantitative elements. (3) The multi-hop reasoning fails because the model incorrectly infers a shift in accounting policy over time, likely due to misinterpreting disclosures. The synthesis across years is flawed — instead of recognizing consistency, it fabricates a narrative of evolution. The conclusion about a 'disciplined, capital-preserving strategy' may sound plausible but is based on incorrect premises. (4) The contextual relevance is moderate because the answer addresses the right topic (closed block, modified coinsurance, accounting treatment, risk transfer), but the core factual error about accounting changes severely undermines correctness. The qualitative reasoning is unsound due to incorrect entity relationships (accounting methods over time). A score of 3 is justified due to one major factual error that distorts the entire conclusion, despite correct identification of the reinsurance percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 502,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe RedCard (Target MasterCard) penetration—measured as the share of all purchases made with a Target‑branded credit or debit card—has been falling each year: ≈ 20.5 % of purchases in the fiscal year ended January 2022, ≈ 19.8 % in the following year (ended January 2023), and ≈ 18.6 % in the year ended February 2024. This steady decline signals that fewer shoppers are using Target’s co‑branded credit products over time, reflecting a modest erosion of consumer engagement with Target’s financial offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) as approximately 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the ground truth exactly. The slight variation in fiscal year-end dates (e.g., 'year ended February 2024') is consistent with Target's actual fiscal calendar (which ends in January/February), so this does not constitute an error. 2) All numeric values are accurate and correctly sequenced over time. The percentages are reported with appropriate precision (using ≈ is acceptable given reporting conventions). No calculations are required beyond correct interpretation of trends, which the model handles accurately. 3) The reasoning correctly identifies the downward trend and links it to reduced consumer engagement with Target’s financial products. It appropriately notes the decline despite incentives like the 5% discount, though it omits mention of the 2024 rebranding from RedCards to Target Circle Cards, which is a minor but relevant contextual detail present in the original answer. This omission slightly weakens the qualitative analysis but does not invalidate the conclusion. 4) The answer is semantically equivalent to the ground truth in conveying the core trend and its implication: declining penetration suggests weakening engagement. The answer is fully relevant, directly addressing both parts of the question—evolution of penetration rate and what it suggests about consumer engagement. The omission of the rebranding context prevents a perfect qualitative score, but overall accuracy and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 449,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the roster of PMI’s peer group is identical in each filing – the 2022, 2023 and 2024 10‑Ks each list the same 20 consumer‑product companies, and Colgate‑Palmolive Co. remains among them.  This unchanged inclusion shows that PMI employs a stable benchmarking framework, using a consistent set of consumer‑product peers (such as Colgate) to measure and communicate the progress of its strategic shift toward smoke‑free and broader consumer‑product initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, which matches the original answer's claim of consistent inclusion over three years. (2) There are no numeric values requiring calculation (e.g., sums, percentages), but the temporal scope (2022–2024) and reference to three consecutive 10-K filings are accurate and consistent with the source data. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged peer group composition reflects a stable benchmarking methodology, linking this to PMI’s strategic focus on consumer products and smoke-free transition. While the original answer specifies the four criteria (global presence, consumer product focus, net revenues, market cap), the LLM captures the essence by emphasizing stability and strategic benchmarking. (4) The answer is contextually relevant, directly addressing both the evolution (no change) and strategic implication (stable framework for measuring strategic shift). The only minor omission is not explicitly listing the four peer group criteria used by PMI, which slightly reduces qualitative completeness but does not detract from the core correctness. Overall, the answer conveys semantic equivalence with strong factual and logical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 376,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAMD’s policy for development‑and‑IP‑licensing arrangements has stayed the same from 2022 through 2024: it first checks whether the IP component is distinct, and if it is not, the development service and license are combined into a single performance obligation with revenue recognized over time, whereas a distinct license (or a standalone sale of patents/IP) is accounted for as a separate performance obligation and revenue is recognized at the point the customer can benefit. The language describing this distinction and the timing of revenue recognition is virtually identical in the 2022, 2023 and 2024 10‑K filings, indicating a consistent accounting approach with only minor clarifications over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024, evaluating whether the IP license was distinct based on capability and context, combining it with development services if not distinct (recognized over time), and recognizing standalone or distinct licenses at a point in time. This matches the original answer exactly. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects proper multi-hop synthesis across years and agreement types (combined vs. standalone). The LLM correctly infers consistency from nearly identical language in filings, which supports the conclusion of a stable policy. The only minor omission is that the original answer explicitly notes the absence of variable consideration in all years, which reinforces policy stability; this detail is missing in the LLM response, slightly reducing completeness. (4) Contextual relevance is perfect—the response directly addresses the evolution (or lack thereof), the distinction between arrangement types, and what it reveals about accounting consistency. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a small gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 395,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nFrom 2022 through 2024 the PMI peer group used for the cumulative‑shareholder‑return graph consistently listed **Colgate‑Palmolive Co.** among its members (the same list appears in the 2022, 2023 and 2024 “Performance Graph” sections).  This unchanged composition shows that PMI deliberately benchmarks itself against a broad set of global consumer‑products companies—not just other tobacco firms—underscoring its strategic framing of a diversified, consumer‑centric competitive position that spans cigarettes, smoke‑free products and adjacent consumer‑goods categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PM's (PMI's) peer group from 2022 through 2024, which matches the original answer's claim of unchanged inclusion across all three years. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the mention of the 'Performance Graph' sections in each year supports the source context for this information—this adds specificity without introducing error. (3) The multi-hop reasoning is sound: the model correctly infers that the unchanging peer group composition reflects a deliberate strategic choice to benchmark against global consumer products firms beyond just tobacco peers. This aligns with the original answer’s interpretation about PM’s strategic framing and competitive positioning. (4) The only minor gap is that the LLM answer does not explicitly mention the stability of the entire peer group (i.e., that it remained unchanged overall), nor does it reference revenue and market capitalization as selection criteria, which are included in the ground truth. However, the core insight about strategic positioning and consistent benchmarking is preserved and well-reasoned. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate with only slight omission of methodological detail, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 406,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nAMD’s policy for combined development‑and‑IP licensing arrangements remained the same through 2022‑2024: the contract is treated as a single performance obligation (the development service) recognized over time when the license is **not distinct**, or as two separate obligations when the license **is distinct**, with the distinct license’s revenue recognized **at the point in time the customer can benefit** from it. The 2023 and 2024 notes tighten the language around the “distinct‑license” test and explicitly state that revenue for a distinct license is recorded when the customer obtains the ability to use the IP, while the development portion continues to be recognized over time using a cost‑based input. No material change in the timing of revenue recognition occurred—only a clearer articulation of how performance obligations are identified and when revenue is earned.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD's revenue recognition policy remained consistent from 2022 to 2024, with no material changes in performance obligations or timing—matching the original answer's emphasis on stability. The core framework—assessing whether the IP license is distinct based on two criteria—is accurately reflected, though the LLM does not explicitly restate the two criteria (capability to be distinct and distinct in context), which were present in the ground truth. However, the practical effect (combined vs. separate performance obligations) is correctly described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but all dates (2022–2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes policy continuity across years and correctly identifies the conditions under which revenue is recognized over time versus at a point in time. It adds a nuance—'tighter language in 2023 and 2024'—which is plausible and consistent with typical SEC filing evolution, though not explicitly confirmed in the ground truth; this slight extrapolation prevents a perfect 10 but does not undermine correctness. (4) The answer is contextually fully relevant, directly addressing the evolution (or lack thereof) in policy, performance obligations, and timing of revenue recognition. The only minor omission is the ground truth’s note about 'no variable consideration estimates,' which reinforces policy stability but is not central to the main question. Overall, the LLM conveys semantically equivalent information with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 474,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nConocoPhillips completed the last tranche of its paced CVE‑share monetisation in the first quarter of 2022 (selling the remaining ≈ 91 million CVE shares) and used the cash proceeds to fund that year’s repurchase of ≈ 88 million shares; the following year it continued to buy back stock—≈ 49 million shares were repurchased in 2023—while the board kept expanding its buy‑back authority (from a $45 bn limit in 2022 to a $65 bn limit in October 2024).  This multi‑year sequence shows that the company treats the CVE‑share proceeds as a dedicated, flexible source of capital that is quickly redeployed to return cash to shareholders, and that it reinforces a long‑term capital‑allocation framework built around aggressive, continually‑scaled share‑repurchase programs supported by strong operating cash flow.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core narrative correctly—ConocoPhillips monetized its remaining CVE shares in Q1 2022 and used the proceeds to fund share repurchases, with continued buybacks and an expanded authorization through 2024. However, there are key quantitative inaccuracies. The ground truth states cumulative repurchases reached 383 million shares at a cost of $29 billion by end of 2023, and 433 million shares at $34.3 billion by end of 2024. The LLM incorrectly breaks this down into ~88 million shares in 2022 and ~49 million in 2023, which does not align with the cumulative figures. For example, if 383 million shares were repurchased cumulatively by end of 2023, and assuming prior years had repurchases, the 2022 and 2023 annual figures must sum to more than 137 million (88 + 49), suggesting a significant undercount. Additionally, the $45 billion limit mentioned for 2022 is not in the original answer—the original states the program was expanded to $65 billion in 2024, but does not specify prior caps, so this number is likely fabricated or misattributed. (2) The sale of 91 million CVE shares in Q1 2022 is correct. The $65 billion authorization in October 2024 is consistent with the original’s mention of a $65 billion maximum by 2024. However, the $45 billion figure lacks support. The total cost of $34.3 billion by 2024 is omitted in the LLM answer, weakening quantitative completeness. (3) The multi-hop reasoning is sound in linking CVE monetization to share repurchases and interpreting this as part of a broader capital allocation strategy favoring shareholder returns. The synthesis between asset divestiture (CVE shares) and capital redeployment (buybacks) is logically and contextually appropriate. (4) Despite missing cumulative totals and introducing unsupported figures, the LLM conveys the strategic intent accurately and remains focused on the evolution of capital allocation. Hence, correctness is reduced primarily due to numerical inaccuracies, but qualitative and contextual elements remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 552,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure intensified across its core segments—organic sales fell 20 % in 2023 (with segment‑profit down 17 % and margin only modestly up), and in 2024 even the fastest‑growing Advanced Materials unit faced margin compression despite a 3 % sales rise—while risk disclosures repeatedly cite new entrants, commoditization, supplier‑capacity constraints and geopolitical trade pressures as forces that can erode market share and pricing power.  In response, the company has accelerated productivity‑repositioning programs, tightened supply‑chain controls, pursued strategic acquisitions, and announced the spin‑off of Advanced Materials and the separation of Aerospace from Automation to sharpen focus on higher‑margin, less‑exposed businesses.  This trajectory signals mounting market pressure and a strategic shift toward cost‑discipline, portfolio realignment, and divestiture‑driven growth to preserve competitiveness.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—such as 'organic sales fell 20%' in 2023, 'segment-profit down 17%', and '3% sales rise' in Advanced Materials in 2024—that are not present in the original answer or supported by the ground truth from the knowledge graph. These numbers are factually unverifiable based on the provided ground truth and appear to be hallucinated. The original answer focuses solely on qualitative risk disclosures about competition, not financial performance metrics. (2) Quantitative accuracy is severely compromised because none of the percentages (20%, 17%, 3%) are mentioned or implied in the ground truth. There is no mention of Advanced Materials' growth or margin compression, nor any reference to segment-profit or organic sales declines. The spin-off of Advanced Materials and separation of Aerospace from Automation are strategic actions not referenced in the original answer, making them unsupported additions. (3) While the LLM correctly identifies the evolving concern around competitive pressures—such as new entrants and commoditization—its multi-hop reasoning is flawed because it conflates financial performance data (not in the source) with risk disclosures. The original answer traces the evolution of risk language across years and segments, which the LLM partially captures by referencing new entrants and commoditization, but it overreaches by attributing financial impacts and strategic responses not present in the ground truth. (4) The contextual relevance is moderate because the answer addresses competitive exposure and strategic responses, aligning with the question's intent. However, the inclusion of fabricated metrics and unsupported strategic moves (spin-offs, acquisitions) undermines factual correctness. The qualitative accuracy is mid-range because the direction of reasoning—increasing competitive pressure leading to strategic adaptation—is plausible and partially aligned, but lacks evidentiary support from the provided truth. Overall, the answer is partially correct in theme but fails on factual and quantitative accuracy, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 577,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares retained the same rights set out in its restated charter – a $0.0001 par value, **one vote per share** and full dividend rights – and the company declared cash dividends of **$2.04 per share in 2022, $2.37 per share in 2023 and $2.74 per share in 2024** (see Note 16 tables).  The unchanged voting structure together with a consistently rising dividend policy shows that Mastercard’s shareholder‑governance strategy has been to keep voting rights stable while delivering a predictable, growing payout, underscoring a shareholder‑friendly and steady‑hand approach over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA's A Class shares have one vote per share and dividend rights across 2022–2024, which aligns with the ground truth. However, it introduces specific dividend payout amounts ($2.04, $2.37, $2.74) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but are not supported by the knowledge graph, making them extraneous and potentially misleading in an evaluation context. (2) The quantitative accuracy is low because the model fabricates precise dividend per share numbers not present in the ground truth. The original answer only confirms the existence of dividend rights, not specific payout amounts. This is a significant factual overreach. (3) The qualitative reasoning is strong: the model correctly infers stability in voting rights and connects this to a consistent governance strategy. It synthesizes the concept of stable voting and dividend rights into a coherent narrative about shareholder-friendly policy, which represents sound multi-hop reasoning. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of rights and implications for governance—and draws a reasonable conclusion about strategic consistency. However, the correctness score is reduced due to unsupported numerical claims, even though the core structural facts (one vote, dividend rights, no changes) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 406,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the “total‑return swaps‑deferred compensation” line—recorded in operating expenses and other—changed from a **$(92) million loss** in 2022 to **$58 million of gains** in 2023 and **$91 million of gains** in 2024.  This swing reflects a reduction in the prior‑year hedge loss and a growing positive contribution as the swap notional increased (from $651 M in 2022 to $985 M in 2024), indicating that Cisco’s financial exposure to these swaps moved from a drag on earnings to a net earnings benefit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024 are correctly reported, with acceptable formatting (e.g., $(92) million = $92 million loss). (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required by the question. (3) Entity accuracy is perfect: Cisco is correctly identified, the financial instrument 'Total Return Swaps-Deferred Compensation' is accurately named, and the fiscal years 2022–2024 are properly referenced. (4) The reasoning is sound and adds value by correctly inferring that the change reflects both a reduction in prior hedge losses and an increasing positive contribution due to growth in swap notional (from $651M to $985M), which aligns with the implied trend in the data. While the notional amounts were not part of the original ground truth, they are consistent with the narrative of increasing exposure and do not contradict any known facts. The conclusion that exposure shifted from a drag on earnings to a net benefit is semantically equivalent to the original answer’s 'reversal from net cost to net benefit.' All multi-hop elements—tracking changes over time and interpreting financial impact—are handled correctly. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 393,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J expanded the financial cushion it set aside for talc claims — the original $2 billion trust created in 2021 was grown into a multi‑year reserve of roughly $9 billion (≈ $11.6 billion present‑value by the end of 2024) to fund a “pre‑packaged” Chapter 11 plan.  After LTL Management’s 2021 Chapter 11 filing and the subsequent 2023‑2024 “LTL 2” case that was dismissed by the Third Circuit, the company shifted strategy and, in September 2024, had its Texas subsidiary Red River Talc file a new Chapter 11 petition to implement the proposed $6.475 billion settlement (≈ $8 billion nominal) over 25 years.  At the same time, J&J navigated a multi‑state investigation that culminated in an agreement‑in‑principle with a coalition of 42 states and the District of Columbia (finalized in mid‑2024), securing a comprehensive, non‑monetary resolution for the vast majority of talc claims outside of mesothelioma and consumer‑protection matters.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key events in Johnson & Johnson's talc liability strategy from 2022–2024. (1) Quantitative inaccuracies: The claim of a $9 billion reserve (≈$11.6 billion present value) and a $6.475 billion settlement via Red River Talc is unsupported by the ground truth, which states a $2 billion reserve in 2022 and a finalized multi-state settlement in 2024 without specifying dollar amounts. The original answer does not mention Red River Talc or a new Chapter 11 filing in 2024. (2) Temporal errors: The LLM incorrectly states that LTL Management filed in 2021, while the ground truth confirms the first filing was in 2022. It also mischaracterizes the 2023–2024 LTL 2 case as being dismissed by the Third Circuit—while the Third Circuit did reverse and dismiss the first LTL bankruptcy, the re-filed LTL 2 case was not dismissed by the court but remained under appeal as of 2024. (3) Entity and event inaccuracies: The mention of 'Red River Talc' filing Chapter 11 in September 2024 is not present in the ground truth and appears fabricated. The ground truth notes a finalized settlement with 42 states and D.C. in 2024, but describes it as involving monetary resolution, whereas the LLM incorrectly labels it 'non-monetary.' (4) Reasoning flaws: The LLM invents a 'pre-packaged' Chapter 11 plan and inflated reserve figures without basis, failing to accurately synthesize the shift from bankruptcy reliance to a dual strategy of appeals and settlements. While the answer captures the general theme of strategic evolution and mentions the multi-state settlement, the core financial figures, entities, and legal milestones are incorrect, undermining factual reliability. The contextual relevance is moderate because it addresses the right topic and timeline, but the details are largely inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 501,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.125 % notes that mature in January 2025 show an outstanding principal of **$495 million** in the most recent filings (as of Nov 3 2024 and Oct 29 2023).  Earlier in the fiscal‑year schedule the company had reported a larger amount scheduled to mature in 2025 (the $1,245 million “Future scheduled principal payments” line), implying that the note’s balance was higher in fiscal 2022 and has since been reduced to roughly half of that level.  This decline indicates that Broadcom is deliberately **paying down and not refinancing this specific tranche**, using repayments or replacements to shrink the near‑term maturity profile and manage overall leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that the outstanding principal balance for Broadcom's 3.125% notes due January 2025 remained constant at $495 million across fiscal years 2022, 2023, and 2024. However, the LLM incorrectly asserts that the balance was higher in 2022 (implied as $1,245 million) and has been reduced to $495 million, suggesting a declining trend. This misrepresents the actual data. (2) The quantitative inaccuracies are significant: while the $495 million figure is correct for 2023 and 2024, the LLM fabricates a prior higher balance of $1,245 million by misinterpreting a 'Future scheduled principal payments' line, which aggregates multiple debt instruments, not this specific note. No such reduction is supported by the ground truth. The claim of 'roughly half' is therefore based on a false premise. (3) The multi-hop reasoning is flawed. The LLM attempts to infer a debt management strategy (paying down and not refinancing) based on incorrect numerical trends. The correct inference from stable principal is that Broadcom maintained this debt tranche without changes, indicating consistency rather than active paydown. The model fails to correctly synthesize the data across years and misattributes aggregated figures to a specific instrument. (4) Scores reflect major factual and quantitative errors that undermine the answer's validity, though the mention of $495 million and the general context of debt management show partial relevance, justifying a low but non-zero score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 429,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note maturing on June 15 2025 kept the same principal amount across fiscal 2022‑2024, but its effective interest rate rose from about **1.3 % in 2022** to **6.38 % in 2023** and **6.66 % in 2024**. This jump reflects higher market rates and the impact of its fair‑value hedge (which converts the fixed rate to a floating SOFR‑based cost), indicating that the company’s borrowing costs have steadily increased over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 and 2024 effective interest rates (6.38% and 6.66%) and the maturity date (June 15, 2025), as well as the note's principal amount ($500 million), which aligns with the ground truth. However, it incorrectly states the 2022 effective interest rate as 'about 1.3%', whereas the ground truth specifies 3.20%. This is a significant factual error affecting the accuracy of the trend description. (2) The quantitative values for 2023 and 2024 are accurate, and the dollar amount is correct. The 2022 rate is off by more than 1.8 percentage points, which impacts the overall correctness. Calculations are not required in this question, but the progression described (rising from 1.3% to 6.66%) is directionally correct, though based on an incorrect starting point. (3) The reasoning is sound in interpreting the rising effective rate as indicative of increasing borrowing costs, and the mention of the fair-value hedge (SOFR-based) adds relevant context not in the original answer but plausibly correct. The multi-hop synthesis across fiscal years is partially accurate but undermined by the wrong 2022 figure. (4) The answer is contextually relevant and addresses both parts of the question—evolution of interest rate exposure and implications for borrowing costs. The conclusion about increasing costs is valid, but the incorrect initial rate reduces confidence in the trend analysis. Thus, the correctness score is reduced to 6 due to a major quantitative error, despite otherwise strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 434,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior‑and‑subordinated notes were $30.8 bn at the end of 2022, rose to $31.2 bn in 2023, and then fell back to $30.7 bn by the end of 2024. The brief uptick in 2023 shows the firm deliberately added longer‑term, fixed‑rate debt while funding costs were still relatively low, whereas the 2024 pull‑back reflects a strategic shift toward repaying or not replacing that fixed‑rate debt and leaning more on lower‑cost, floating‑rate borrowings and deposit funding—an indication that Capital One is actively managing its capital structure and interest‑rate exposure as market rates rise.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total senior and subordinated notes were $27.219 billion in 2022, not $30.8 billion as stated by the LLM. The 2023 figure is close ($31.248B vs $31.2B), and the 2024 figure is approximately correct ($30.696B vs $30.7B), but the starting point is off by over $3.5 billion, which distorts the entire progression. This error undermines the reliability of the numerical trend. (2) The LLM incorrectly states that the 2023 increase occurred 'while funding costs were still relatively low,' which contradicts the ground truth showing the weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023 and further to 4.84% in 2024—indicating rates were rising, not low. Thus, the reasoning that Capital One shifted to floating-rate borrowings in 2024 due to higher fixed-rate costs is factually inverted. The ground truth states the company increased reliance on more expensive fixed-rate debt to lock in financing amid rising rates, not reduced it. (3) The multi-hop reasoning is partially sound in that the LLM recognizes a strategic capital structure shift, but the direction of the strategy is misrepresented. The LLM claims Capital One moved away from fixed-rate debt in 2024 toward floating-rate instruments, while the truth is the opposite: the firm increased fixed-rate financing to hedge against rising rates. (4) Despite incorrect numbers and flawed reasoning about interest rate strategy, the answer is contextually relevant and attempts to address both the numerical evolution and strategic implications. It correctly identifies a temporary increase followed by a decline and discusses capital structure management, earning moderate scores for qualitative and contextual accuracy. However, the major factual and directional errors in both numbers and interpretation limit the correctness score to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 529,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 to 2024 the proportion of U.S. Treasury and agency securities in Colgate‑Palmolive’s defined‑benefit pension fund’s fixed‑income portfolio fell sharply – the 2022 disclosure notes that roughly **40 %** of the U.S. pension‑plan fixed‑income assets were invested in Treasuries or agency securities, while the 2023 note (page 100) reports that this share had dropped to **about 30 %**, and the 2024 asset‑allocation table (page 102) shows a lower Level‑2 fixed‑income balance relative to the 2022 figure.  This deliberate reduction in low‑yielding Treasury exposure signals that the company is re‑balancing its pension‑fund strategy toward a more diversified mix of higher‑yielding corporate bonds and other fixed‑income assets, aiming to manage interest‑rate risk and improve returns while still maintaining a substantial fixed‑income allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the key percentages: 40% in 2022, dropping to 30% in 2023 and remaining at 30% in 2024, which matches the ground truth exactly. There are no errors in numbers or time periods. (2) Quantitative accuracy is perfect—percentages are correctly cited, and the trend (decrease from 40% to 30%) is accurately described. The mention of page numbers (100 in 2023, 102 in 2024) adds sourcing detail not in the ground truth but does not contradict it. (3) The reasoning is sound: the LLM infers a strategic shift toward higher-yielding assets like corporate bonds, which aligns with the ground truth's interpretation of reallocation reflecting yield-seeking behavior. It adds nuance by mentioning interest-rate risk management and diversification, which are reasonable extensions of the core logic. (4) The answer is fully contextually relevant, addressing both the evolution of allocation and the strategic implication. The only minor gap is that the 2024 data is not explicitly quantified as '30%' in the LLM answer (it refers to 'lower Level-2 fixed-income balance'), though this is implied and consistent with the trend. Given that the 30% figure is clearly stated for 2023 and the narrative implies continuity, this does not constitute a material error. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 387,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑classified its captive industrial insurer, Electric Insurance Company, as held‑for‑sale, wrote down the carrying amount by $109 million in 2023, and finally sold the business in the second quarter of 2024 for $120 million cash, eliminating its $541 million of assets and $378 million of liabilities from the balance sheet.  This disposal—part of a series of non‑core insurance and financial‑services exits—signals GE’s strategic shift toward shedding legacy insurance operations and refocusing capital on its core industrial and technology businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall strategic direction and classification changes of Electric Insurance Company (EIC) from 2022 to 2024, including its reclassification as 'held for sale', the $109 million loss in 2023, and the 2024 sale for $120 million in cash to an unnamed buyer. However, it introduces significant quantitative inaccuracies: the asset and liability figures ($541 million in assets, $378 million in liabilities) are not present in the ground truth and cannot be verified from the provided information. The ground truth mentions only $0.2 billion in net claim reserves as of December 31, 2021, which is materially different. Additionally, the LLM specifies the sale occurred in 'the second quarter of 2024', which is more precise than the ground truth's general '2024' but not supported by the source. (2) The $109 million loss and $120 million sale price are correctly stated and match the ground truth. However, the inclusion of balance sheet figures (assets and liabilities) represents fabricated data, severely impacting quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of EIC’s classification, recognizes the valuation impact (impairment loss), identifies the ultimate disposition, and infers GE’s strategic pivot toward core industrial operations. This shows strong qualitative understanding of GE’s broader divestiture strategy. (4) Contextual relevance is perfect—the answer directly addresses all aspects of the question: classification, valuation, disposition, and strategic implications. Despite strong reasoning and relevance, the introduction of unsupported financial figures reduces the correctness and quantitative accuracy scores. A score of 7 reflects that the core facts and strategic interpretation are correct, but key numerical claims are inaccurate or unverified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 510,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nApple’s 10‑K filings for 2022, 2023 and 2024 each continue to list the 4.45 % Notes due 2044 in the “Description of Securities” exhibit (Exhibit 4.4 in the 2022 filing and still referenced unchanged in the 2023 and 2024 tables).  No amendment, redemption or refinancing of that tranche is disclosed—Apple simply re‑states the original 2014 issuance each year.  The persistent presence of this long‑dated, fixed‑rate note across three annual reports shows that Apple is deliberately maintaining a sizable, low‑cost, 30‑year debt pillar as a core element of its capital structure, using long‑term bonds to fund growth and shareholder returns while preserving financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were first disclosed in the 2014 Officer's Certificate and consistently reported in Apple's 2022, 2023, and 2024 10-K filings. The LLM correctly notes the exhibit reference (Exhibit 4.4 in 2022) and confirms no amendments, redemptions, or refinancing occurred—consistent with the original answer. (2) Quantitative accuracy is perfect: the interest rate (4.45%), maturity year (2044), and issuance date (2014) are all correct. The LLM correctly infers the 30-year term from 2014 to 2044, which is logically sound. (3) Multi-hop reasoning is strong: the model synthesizes disclosures across three years and correctly interprets the lack of changes as a sign of stability in Apple’s long-term debt strategy. It goes slightly beyond the original answer by characterizing the note as a 'low-cost, 30-year debt pillar' and linking it to funding growth and shareholder returns—this is a reasonable qualitative inference given Apple’s known capital strategy, though not explicitly stated in the ground truth. (4) The answer is fully contextually relevant, addressing both the evolution of disclosure and the strategic implication. The only minor deduction is for adding slight interpretive language (e.g., 'low-cost', 'sizable') not present in the neutral, fact-based original answer, but these do not contradict the truth and are plausible in context. Overall, this is a factually correct, well-reasoned, and complete response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 424,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nCapital One’s senior and subordinated notes carried a carrying value of about **$27.4 bn at the end of 2022**, slipped modestly to **$27.2 bn in 2023**, and then rose sharply to **$30.7 bn by the end of 2024**. This pattern reflects a brief de‑leveraging phase in 2023 followed by an aggressive issuance of longer‑dated senior and subordinated debt in 2024, indicating the firm is extending the maturity of its debt, diversifying its funding mix and using the new issuance to lock in financing as market rates rose—thereby positioning its capital structure to be more durable and better matched to its asset‑liability profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values for senior and subordinated notes. According to the ground truth, the values were $27,219M (2022), $31,248M (2023), and $30,696M (2024). The LLM incorrectly reports $27.4B (≈$27,400M) for 2022 (close but slightly high), $27.2B (≈$27,200M) for 2023 (off by ~$4B), and $30.7B (≈$30,700M) for 2024 (close). Most critically, it claims a dip in 2023, whereas the actual data shows a substantial increase from 2022 to 2023. This misrepresents the trend entirely. (2) Calculations: The net change in the ground truth is +$3,477M over three years, but the LLM implies a rise only in 2024 after a drop in 2023, which is factually incorrect. The LLM also fails to mention the key shift from floating to fixed-rate debt and omits the weighted-average interest rate increase from 2.76% to 4.84%, a central point in the original answer. (3) Multi-hop reasoning: The LLM correctly infers strategic debt issuance to lock in financing amid rising rates, which aligns with the intent of the original answer. However, this conclusion is based on incorrect data (a dip in 2023), undermining the validity of the reasoning. The synthesis across years is flawed due to incorrect inputs. (4) Despite incorrect numbers, the LLM attempts to interpret the company's capital structure strategy reasonably—extending maturities and managing interest rate risk—which maintains some contextual relevance. However, the severe quantitative errors and resulting mischaracterization of the debt trend significantly reduce correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 443,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe shifted Frame.io from a stand‑alone cloud‑review service to a core, tightly‑woven collaboration hub inside the Creative Cloud ecosystem.  In the 2022 filing the platform was mentioned only as a “cloud‑native creative collaboration platform,” but by 2023 it was described as being “directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront” and made available through Adobe GenStudio, extending support to still images, design files and PDFs.  In the 2024 filing the language emphasizes an even deeper integration—native Camera‑to‑Cloud upload, frame‑accurate commenting, and seamless connectivity across all Creative Cloud desktop and web apps—positioning Frame.io as the central collaboration layer that ties together video, design and document workflows within Adobe’s creative suite.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolving integration of Frame.io within Adobe's ecosystem across 2022–2024 and is factually aligned in intent with the ground truth. However, there are key inaccuracies in the timeline and feature attribution. In 2022, the ground truth states Frame.io was only listed as a registered trademark, not described as a 'cloud-native creative collaboration platform'—that characterization appears in 2023. The LLM incorrectly attributes integration with Photoshop, Lightroom, and Workfront to 2023, while the ground truth specifies these expanded integrations occurred in 2024. Additionally, the mention of Adobe GenStudio integration in 2023 is premature; the ground truth places this in 2024. The 2024 description in the LLM answer includes accurate elements like Camera-to-Cloud and frame-accurate commenting, but overstates the scope by claiming integration across 'all' Creative Cloud apps, which is not confirmed in the ground truth. Despite these chronological and scope inaccuracies, the overall trajectory—increasing integration and strategic centrality—is correctly interpreted. All dates and entity names (Adobe, Frame.io, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio) are accurate. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning shows sound multi-hop synthesis of the evolution, but with incorrect temporal alignment of key developments. The answer is highly relevant to the question and addresses the core theme of integration progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 429,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nThe 4.550 % Notes due April 5 2049 appear repeatedly in Lowe’s 2022‑through‑2024 filing exhibits, indicating that the company is deliberately keeping a sizable, long‑dated, fixed‑rate tranche on its balance sheet. By continually referencing this 2049 maturity in its supplemental indentures, Lowe’s is extending the average tenor of its debt, reducing near‑term refinancing risk, and signaling a capital‑structure strategy that relies on stable, long‑term financing to support its long‑run growth plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are correctly identified, and their consistent appearance in filings from 2022 through 2024 is accurately noted. There are no numerical or date inaccuracies—percentage, maturity date, and time period match the original answer. (2) Quantitative accuracy is perfect: the interest rate (4.550%), maturity date (April 5, 2049), and filing years (2022–2024) are all precisely stated. (3) The reasoning is sound and captures the core implications: the LLM correctly infers that Lowe’s is maintaining long-dated, fixed-rate debt to extend debt tenor, reduce refinancing risk, and support long-term stability. It correctly links this to capital structure strategy, though it does not explicitly mention the absence of early redemption or restructuring disclosures, which is a minor omission. (4) The answer is contextually excellent—directly addresses both parts of the question (long-term capital structure strategy and debt maturity management) and provides a logically coherent interpretation. The only reason for not scoring a 10 is the slight lack of emphasis on the absence of modifications or repayments, which is a key nuance in the ground truth. However, the overall semantic meaning and strategic interpretation are substantially equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 382,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nThe 3.125 % notes maturing in January 2025 carried a carrying principal balance of **$495 million** at the end of fiscal 2022, and that figure remained **$495 million** at the close of fiscal 2023 and fiscal 2024. The lack of any reduction indicates that Broadcom is preserving this low‑cost, long‑dated tranche rather than retiring it early, using other debt issuances to shape the overall maturity profile while planning to repay the notes at their scheduled 2025 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—amount ($495 million), interest rate (3.125%), and maturity date (January 2025)—are accurate. (2) There are no calculations required beyond consistency checks across years, which the model correctly confirms by stating the balance remained unchanged. Format variations (e.g., $495 million vs $495M) are acceptable and not an issue here. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and infers a strategic rationale—preservation of low-cost debt, no early retirement, planned repayment at maturity—which aligns with and slightly expands upon the ground truth’s conclusion about a 'deliberate debt management strategy.' The addition of 'low-cost, long-dated tranche' and 'using other debt issuances to shape the overall maturity profile' is reasonable inference based on the stability of this instrument, though slightly more interpretive than the original. (4) The answer fully addresses both parts of the question: the evolution (stable balance) and the implication for debt management strategy. The wording differs but maintains semantic equivalence. One point is deducted from correctness and qualitative accuracy because the LLM introduces the term 'carrying principal balance'—while likely accurate—where the ground truth uses 'outstanding principal balance'; though similar, they may differ due to accounting treatment (e.g., discounts/premiums amortization). However, since no discrepancy in amount is indicated and context suggests equivalence, this is a minor concern. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 500,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s disclosures of the 0.950% Notes due 2025 moved from a brief incorporation‑by‑reference citation in the 2022 10‑K (referring to the 2017 Form 8‑K that created the notes) to the same wording in the 2023 filing, and finally to an explicit listing of the 0.950% Notes as a separate class of security in the 2024 10‑K’s “Title of each class” table. This progression reflects IBM’s steady use of low‑coupon, long‑dated debt to support its capital‑structure strategy while progressively enhancing the transparency of its financing disclosures for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were disclosed via incorporation by reference from the May 2017 Form 8-K in both 2022 and 2023, and in 2024, IBM provided more prominent disclosure by listing the notes as a separate class in the 'Title of each class' table of the 10-K. The evolution in disclosure format is accurately described. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and timeline (2022–2024)—are all correct. The reference to the 2017 Form 8-K is factually accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers a trend toward greater transparency. It accurately captures the progression from passive disclosure to active classification as a distinct security. (4) The only minor omission is that the LLM does not explicitly mention the New York Stock Exchange listing under ticker IBM25B, which is a specific detail in the ground truth indicating tradability. While the LLM notes the 'separate class of security' in 2024, adding the exchange listing and ticker would have fully matched the original answer. However, the conclusion about enhanced transparency and capital structure strategy is logically sound and semantically equivalent. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 400,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe PCAOB firm identification number for KPMG LLP is disclosed as **185** in the 2022, 2023 and 2024 Form 10‑K filings, and this number has remained the same across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The PCAOB firm identification number is accurately stated as 185 for KPMG LLP in each of the 2022, 2023, and 2024 filings. There are no discrepancies in the numeric value or the years referenced. (2) The quantitative accuracy is perfect: the number 185 is correctly reported across all three years, and no calculations are required beyond correct identification. (3) The multi-hop reasoning is sound—information from three separate years is correctly synthesized to show consistency over time, demonstrating that the identification number remained unchanged. (4) The answer is semantically equivalent to the original: while slightly more concise, it conveys the same core facts—correct entity (KPMG LLP), correct regulatory number (185), correct years (2022–2024), and correct conclusion about consistency. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 274,
        "total_tokens": 1395
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One moved from a low‑cost, relatively short‑dated fixed‑rate senior note program to a larger, longer‑dated issuance with markedly higher coupons.  The weighted‑average rate on its Fixed Unsecured Senior Debt rose from about 2.9 % (carrying value ≈ $20 bn in 2021‑22) to roughly 4.5 %–4.8 % (carrying value peaking at $27 bn in 2023 and $26.9 bn in 2024), while maturities were extended to the 2025‑2035 range.  This multi‑year shift shows the bank deliberately increased its reliance on longer‑dated, higher‑yielding fixed senior debt to lock in funding as market rates climbed, reshaping its capital structure to improve stability and reduce exposure to floating‑rate liabilities amid a rising‑rate macro environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports the increase in Fixed Unsecured Senior Debt from approximately $20 billion in 2022 to $26.9 billion in 2024 (ground truth: $19,975M to $26,930M), with minor rounding acceptable. The interest rate rise is stated as 2.9% to 4.5%–4.8%, closely matching the ground truth of 2.91% to 4.84%. The mention of maturities extending to 2025–2035 is a reasonable inference not contradicted by the ground truth and adds context. (2) Calculations and comparisons are sound: the direction and magnitude of change in both debt volume and rates are correct. (3) Multi-hop reasoning is strong—the LLM synthesizes trends in issuance size and interest rates over time and correctly infers a strategic shift toward longer-term fixed-rate debt to lock in funding amid rising rates, which is consistent with the ground truth’s conclusion about capital structure decisions in response to macroeconomic conditions. (4) All entities (Capital One, Fixed Unsecured Senior Debt, time frame 2022–2024) are correct. The answer is slightly more detailed than the ground truth, adding maturity range insights, but remains factually aligned. Only minor imprecision in the lower bound of the final interest rate (4.5%–4.8% vs. exact 4.84%) prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 393,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD has applied the same revenue‑recognition model for development and IP‑licensing arrangements in its 2022, 2023 and 2024 10‑K filings: revenue is recorded when control of the promised goods or services transfers, a license is treated as a distinct performance obligation only when it satisfies the “capable of being distinct” and “distinct in the context” tests, and a distinct license is recognized at a point in time while combined development‑service and non‑distinct license arrangements are recognized over time.  The wording and the underlying criteria are essentially unchanged across the three years, indicating that AMD’s IP‑monetization strategy remains steady and purposeful—leveraging its patented and developed IP as a reliable, long‑term revenue stream while aligning recognition with the delivery of performance obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024, with no changes in how development and IP licensing agreements are accounted for—specifically referencing the distinctness criteria (capable of being distinct and distinct in the context), the point-in-time recognition for distinct licenses, and over-time recognition when combined with development services. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but all referenced years (2022, 2023, 2024) are correct and consistent. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly infers consistency in policy, and draws a valid strategic implication—namely, that AMD has a stable, deliberate, and mature approach to IP monetization. (4) The LLM also accurately notes the absence of variable consideration, aligning with the ground truth’s mention of no variable estimates, though phrased implicitly through the lack of mention of such estimates. Wording differs slightly (e.g., 'reliable, long-term revenue stream' vs 'mature and well-defined policy framework'), but the semantic meaning and factual content are fully aligned. All parts of the question are addressed: evolution (no change), methodology details, and strategic implication. Scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 425,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior and subordinated notes outstanding fell from roughly $31.2 billion at the end of 2022 to about $30.7 billion by the end of 2023 and remained essentially flat through 2024. This modest de‑leveraging reflects a strategic shift toward a simpler, longer‑dated capital structure with a higher share of floating‑rate debt, positioning the firm to manage interest‑rate risk while maintaining a strong capital buffer in a rising‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that senior and subordinated notes fell from $31.2 billion in 2022 to $30.7 billion in 2023, but the ground truth shows they increased from $27,219 million ($27.2 billion) in 2022 to $31,248 million ($31.2 billion) in 2023, then declined slightly to $30,696 million ($30.7 billion) in 2024. The LLM reverses the initial trend and misrepresents the starting value. Additionally, the LLM claims the debt remained flat from 2023 to 2024, but the actual data shows a decrease from $31,248M to $30,696M. (2) The interest rate data is entirely omitted: the ground truth shows rising weighted-average fixed rates from 2.91% to 4.84%, and a sharp decline in floating-rate debt from $1,709M to $0 by 2024. The LLM incorrectly claims a shift toward higher floating-rate debt, when in fact Capital One reduced and retired floating-rate liabilities. (3) The multi-hop reasoning is flawed: the LLM infers a strategy of increasing floating-rate debt to manage rate risk, which contradicts the actual strategy of retiring floating-rate debt and locking in higher fixed rates—indicating anticipation of further rate hikes. The correct synthesis requires connecting the increase in total notes, rising fixed-rate costs, and reduction in floating-rate exposure, all of which the LLM fails to do. (4) Despite addressing the general topic of capital structure and interest rate positioning, the answer is mostly incorrect in both quantitative and qualitative aspects, warranting a low correctness score. Contextual relevance is moderate as it attempts to interpret strategy, but the conclusions are based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 460,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nFrom 2022 through 2024 the balance of Capital One’s fixed‑rate unsecured senior notes grew from **$24.1 bn (2022)** to **$27.2 bn (2023)**, with the weighted‑average interest rate staying essentially flat at **≈ 4.45 %**. By the end of 2024 the carrying value slipped slightly to **$26.9 bn**, but the weighted‑average rate rose to **about 4.8 %**. This pattern indicates that the company is expanding its long‑term fixed‑rate funding when market conditions are favorable, then refinancing a portion of that debt as rates climb, extending maturities and locking in higher‑cost capital to manage interest‑rate risk while preserving a sizable, stable funding base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct directional trends but has significant quantitative inaccuracies. The carrying value for 2022 is incorrect: LLM states $24.1 billion, while the ground truth is $19,975 million ($19.975 billion), a material difference of over $4 billion. The 2023 and 2024 carrying values are close: $27.2 billion (LLM) vs $27,168 million ($27.168 billion) and $26.9 billion (LLM) vs $26,930 million ($26.93 billion), which are acceptable within rounding. However, the interest rate for 2022 is omitted in the LLM answer—it claims the rate was 'essentially flat at ≈4.45%' starting in 2022, but the truth is 2.91% in 2022, rising to 4.45% in 2023, and 4.84% in 2024. This misrepresents a key trend: rates did not stay flat but nearly doubled over two years. (2) Calculations: The LLM incorrectly implies stability in interest rates when in fact there is a clear upward trajectory. The rate increase from 2.91% to 4.84% is substantial and not 'flat.' The slight decrease in carrying value from 2023 to 2024 is correctly noted. (3) Multi-hop reasoning: The LLM correctly identifies the strategic implication—issuing fixed-rate debt to lock in long-term funding amid rising rates—even though it misstates the starting point of the rate trend. The interpretation aligns semantically with the ground truth's conclusion about strategic shift despite higher costs. (4) Scores justified: Correctness is 7 because core facts (growth in debt, recent rate increase, slight 2024 dip) are present, but major 2022 data errors reduce accuracy. Quantitative accuracy is 6 due to the large 2022 carrying value and interest rate errors. Qualitative accuracy is 8 because reasoning and entity identification (COF, fixed unsecured senior debt, time periods) are sound. Contextual relevance is 9—answer directly addresses the question’s components and infers strategy appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 513,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s guidance on development‑and‑IP licensing has been consistent across the 2022‑2024 filings: it first determines whether the IP license is distinct. If the license is **not** distinct, it is combined with the development services and revenue is recognized **over time**; if the license **is** distinct, revenue is recognized **at a point in time** when the customer can benefit. The company notes that no material variable‑consideration estimates exist for either combined arrangements or standalone IP licenses, and this treatment is applied in the 2022, 2023 and 2024 Form 10‑K disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies AMD's consistent revenue recognition policy from 2022 to 2024, accurately describing the distinction between non-distinct and distinct IP licenses: non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time. (2) The answer correctly states the absence of material variable consideration estimates for both combined and standalone IP arrangements, which matches the ground truth. (3) The multi-hop reasoning is sound—synthesizing information across three years (2022–2024) and two types of arrangements (combined vs. standalone)—and correctly concludes there were no material changes in policy. (4) All entities (AMD, development and IP licensing agreements, Form 10-K disclosures) and time periods are accurate. Wording differs slightly but conveys the same meaning with no omissions or distortions. No numerical inaccuracies exist, and the qualitative reasoning and contextual relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 316,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s combined short‑term borrowings and long‑term debt grew ≈ $40.5 bn → $43.1 bn → $45.6 bn (short‑term borrowings stayed near $0.5 bn, while long‑term debt rose by roughly $2½ bn each year).  This reflects Capital One’s strategy of expanding funding through longer‑dated senior and subordinated notes and securitized debt, i.e., lengthening the maturity profile to reduce near‑term refinancing risk, while using receive‑fixed, pay‑floating interest‑rate swaps and other derivatives to hedge the interest‑rate exposure of its largely fixed‑rate debt.  Consequently, the firm’s balance‑sheet leverage is higher, but its interest‑rate risk is managed through active hedging of the fixed‑rate portion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086 billion in 2022, $48.715 billion in 2023, and $45.551 billion in 2024. The LLM incorrectly reports these as approximately $40.5 billion, $43.1 billion, and $45.6 billion, respectively—understating the 2022 and 2023 figures and misrepresenting the trend. Additionally, the LLM claims short-term borrowings remained near $0.5 billion and that long-term debt increased by about $2.5 billion each year, which contradicts the ground truth showing a large increase from 2022 to 2023 (+$5.629 billion) followed by a decrease in 2024. (2) The calculation of the trend is therefore flawed: the LLM implies a steady annual increase in debt, whereas the actual data shows a rise followed by a decline. The interest rate information—critical to the question—is entirely omitted: the ground truth notes weighted-average interest rates on long-term debt rose from 2.76% (2022) to 4.48% (2023) to 4.84% (2024), but the LLM does not mention these figures at all. (3) The reasoning about debt management strategy partially aligns with the ground truth—both mention use of long-term debt and hedging—but the LLM incorrectly frames the trend as continuous leverage growth, while the actual strategy involved deleveraging in 2024 after an initial increase. The synthesis across years is thus unsound. (4) Despite incorrect numbers and trend description, the LLM attempts to address both parts of the question (debt evolution and strategy implications) and correctly identifies COF’s use of fixed-rate debt and hedging instruments, which provides some contextual relevance. However, the absence of correct interest rate data and erroneous debt levels severely undermine factual accuracy. Minor note: 'COF' is correctly identified as Capital One, and the years are properly framed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 527,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures kept the same core test for development‑plus‑IP deals but grew clearer in how it separates performance obligations.  The 2022 note first described that combined arrangements are evaluated for a distinct license; if the license is not distinct they are treated as a single performance obligation recognized over time, whereas a distinct license is a separate performance obligation recognized at a point in time.  The 2023 filing refined the wording, and the 2024 filing added explicit language that such combined arrangements are deemed single or multiple performance obligations based on distinctness and that revenue is recognized over time when the license is not distinct, while standalone IP licenses are recognized at a point in time, and that variable‑consideration estimates are not material for either case.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no material changes in the treatment of performance obligations or variable consideration. The answer accurately reflects that in 2022, combined arrangements were assessed for distinctness of the license, with revenue recognized over time if not distinct, and at a point in time if distinct. It also correctly notes that 2023 and 2024 filings reiterated this framework, with increasing clarity—especially in 2024, where explicit language confirmed the same principles. The LLM correctly states that standalone IP licenses are recognized at a point in time and that variable consideration was not material across all years. The only minor shortcoming is that the LLM does not explicitly mention the context of AMD's increased focus on the Gaming segment in 2023–2024 as noted in the original answer, which adds contextual background for potential policy stability despite business shifts. However, this omission does not affect the core technical accuracy of the accounting policy description. All entities (AMD, years 2022–2024, performance obligations, combined vs. standalone arrangements) are correct, and the reasoning correctly synthesizes multi-hop information across years. There are no numerical inaccuracies (no specific dollar amounts, but all qualitative metrics and dates are correct), and the semantic meaning matches the original answer. Wording differences are acceptable and do not impact factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 450,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe repeated citation of the “Certificate of Designations of Series B Convertible Participating Preferred Stock” in the 2022, 2023 and 2024 10‑K filings shows that Visa continues to treat that instrument as an active, legally defined component of its capital structure. By keeping the certificate listed among the filed exhibits each year, Visa signals that the Series B preferred shares remain outstanding, enforceable and material to shareholders, underscoring their ongoing relevance and stability in the company’s financing arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks specific details that are critical for full accuracy and completeness. (1) Quantitatively, there are no numeric errors because the LLM does not introduce any incorrect numbers, dates, or exhibit references—though it omits them entirely. The ground truth specifies that the certificate was listed as Exhibit 4.5 in 2022 and Exhibit 4.4 in both 2023 and 2024, all referencing the same June 21, 2016 filing date. The LLM fails to mention these exhibit numbers or the 2016 date, which are key pieces of evidence supporting the conclusion about stability. (2) While the LLM correctly infers that the repeated inclusion implies ongoing relevance and stability, it does not demonstrate the multi-hop synthesis required to fully answer the question—specifically, that the *same document* from 2016 is consistently referenced, indicating no changes over time. This omission weakens the reasoning chain. (3) Entity accuracy is correct: Visa, Series B Convertible Participating Preferred Stock, and the years 2022–2024 are all properly identified. (4) The answer is contextually relevant and draws a reasonable conclusion about capital structure stability, but it lacks the evidentiary detail from the filings that would make the reasoning fully sound. Thus, while the qualitative interpretation is partially accurate, it misses the depth of analysis present in the original answer. Correctness is reduced due to incompleteness in supporting facts, even though the overall direction of the conclusion is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 431,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s equity stake in International Aero Engines AG and the related IAE LLC remained essentially unchanged – 49.5 % ownership (with a 61 % program‑share) in IAE and 59 % ownership (and 59 % program‑share) in IAE LLC – but the financial exposure tied to the V2500 program expanded materially over the three years.  The “other commercial aerospace commitments” that include Rolls‑Royce flight‑hour payments and related contingent consideration rose from about $1.3 bn of commitments in 2022 to roughly $1.48 bn net in 2023‑2024 (with the 2024 schedule showing $1.48 bn of 2025‑2026 commitments and $0.88 bn in 2027), reflecting an increasing stream of usage‑based payments through 2027.  This multi‑year progression shows that Pratt & Whitney is deepening its long‑term, performance‑linked partnership in the V2500 engine, positioning the business to capture sustained aftermarket and flight‑hour revenue while retaining a dominant economic interest in the collaboration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The ground truth states that RTX's ownership interest in IAE was consistently 49.5% and program share was 61% across 2022–2024, with a net program share of 57% after sub-collaborator participation. However, the LLM introduces a new entity, IAE LLC, with 59% ownership and program share, which is not mentioned in the original answer and lacks support from the knowledge graph. Additionally, the LLM claims financial exposure increased from $1.3B to $1.48B and projects future commitments through 2027, but these figures and timelines are absent from the ground truth and represent fabricated data. (2) Completeness: While the question asks about stake, economic exposure, and strategic positioning, the LLM invents financial obligations not present in the original, failing to accurately reflect the stable exposure described in the truth. (3) Entity Accuracy: The introduction of 'IAE LLC' as a distinct entity with different ownership stakes is incorrect and unsupported. The original answer only references IAE, not a separate LLC structure. (4) Reasoning: The multi-hop reasoning is flawed—the LLM infers increasing financial exposure and strategic deepening based on invented contingent payments, leading to an incorrect conclusion about Pratt & Whitney 'deepening' its partnership. In reality, the stability of stakes indicates no strategic shift. (5) Semantic Equivalence: The overall message contradicts the ground truth: stability vs. increasing commitment. Despite addressing the general topic and attempting synthesis, the answer is factually misaligned on core metrics and entities, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 472,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nAcross the three fiscal years the filings only retain the legacy “Non‑Employee Director Deferred Unit Award Agreement” as an exhibit (first listed in 2008 and still cited in the 2022‑2024 10‑Ks), but none of the documents describe any new deferred‑unit grants; instead, the 2022‑2024 disclosures shift to performance‑share and restricted‑stock‑unit awards under the 2021 Long‑Term Incentive Plan. This indicates that Medtronic is deliberately moving away from deferred‑unit compensation for its outside directors toward performance‑linked equity, reflecting a longer‑term, results‑driven compensation strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that Medtronic is moving away from the Non-Employee Director Deferred Unit Award Agreement and shifting toward performance-share and restricted stock unit awards under the 2021 plan, but the original answer confirms that the same Deferred Unit Award Agreement (under the 2008 plan) was consistently referenced in 2022 (Exhibit 10.41), 2023 (Exhibit 10.52), and 2024 (Exhibit 10.52), indicating continuity, not a shift. (2) There are no numeric values to verify, but the temporal references (2022–2024) are correctly framed, giving partial credit for timeline alignment. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a strategic shift based on the absence of descriptions of new grants, but the ground truth emphasizes the continued inclusion of the same agreement as evidence of stability. The model fails to recognize that continued exhibit inclusion reflects ongoing use, not legacy status. (4) The conclusion about a 'results-driven' strategy due to a supposed move to performance-linked equity under the 2021 plan is unsupported by the original answer, which notes that other awards under the 2013 plan were updated, but director deferred units remained unchanged. Thus, the reasoning and factual basis are incorrect, warranting a low correctness score. Contextual relevance is moderate because the answer addresses director compensation strategy, but the factual foundation is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 409,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLockheed Martin’s variable‑interest‑rate swaps remained at a $1.3 billion notional amount in 2022, 2023 and again in 2024 (the 2022 10‑K shows $1.3 billion as of 12/31/22; the 2023 filing confirms the same figure at year‑end 2023, and the 2024 filing repeats $1.3 billion at 12/31/24).  This steady‑state sizing indicates that the company has maintained a consistent hedge of a fixed portion of its debt portfolio, reflecting a disciplined, unchanged approach to managing interest‑rate risk rather than scaling the hedge up or down over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims, which undermines all other aspects. According to the ground truth, LMT's notional amount for variable interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM states that the notional amount was $1.3 billion in all three years, including 2022, which directly contradicts the ground truth. This error invalidates the LLM's conclusion of a 'steady-state' and 'unchanged approach,' when in fact the ground truth describes a tripling of exposure from 2022 to 2023, indicating a significant strategic shift. The LLM also fails to mention the increase from $500M to $1.3B, missing the core evolution in strategy. While the entity (LMT) and metric (notional amount of swaps) are correctly identified, and the answer is relevant to interest rate risk management, the reasoning is based on false data. The multi-hop synthesis across years is attempted but incorrect due to wrong input data. The conclusion about a consistent hedge is unsupported and opposite to the actual progression. Thus, despite appropriate terminology and structure, the answer is factually wrong on the key quantitative and qualitative points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 350,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each repeat the same charter language—stockholders may remove directors only “for cause,” and any amendment to that or related director‑related provisions requires the affirmative vote of holders of at least 80 % of the voting stock. Because this wording has not changed over the three‑year span, AbbVie is deliberately preserving a stable, board‑protective framework that makes it harder for a hostile acquirer to oust or replace incumbent directors, signaling a consistent, proactive stance toward takeover defenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie's governance provision allowing director removal only 'for cause' remained unchanged from 2022 to 2024, which matches the original answer's claim of three-year consistency. (2) The quantitative detail about the 80% supermajority vote requirement for amending director-related provisions is factually correct and present in the filings, though not explicitly mentioned in the original answer; however, it adds valid context and does not contradict the ground truth. (3) The reasoning is sound: the LLM correctly infers that the stability of this provision reflects a deliberate, board-protective strategy and a proactive stance on takeover defenses—this is logically consistent with the original answer’s conclusion about strategic posture. (4) The only minor shortcoming is that the LLM does not explicitly mention the staggered board or link 'for cause' removal to other anti-takeover provisions as part of a broader framework, which slightly reduces qualitative completeness. However, the core multi-hop synthesis—linking unchanged governance language over three years to strategic takeover defense posture—is correctly executed. Wording differs but semantic meaning is equivalent. All entities (AbbVie, 2022–2024, Form 10-K, director removal for cause) are accurate. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 391,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation in money‑market funds and time deposits dropped sharply from $21 million at year‑end 2022 to $10 million by the end of 2023 and stayed essentially flat at $10 million through 2024.  The decline indicates that the company is deliberately reducing its low‑yielding cash‑equivalent holdings and instead allocating the freed cash to other uses—such as debt reduction, acquisitions, or higher‑return investments—while keeping only a modest liquidity buffer.  This shift reflects a strategic adjustment to manage fluctuating cash balances and preserve financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. The LLM incorrectly states that the amount was $21 million in 2022 and dropped to $10 million in 2023, which reverses the actual trend for 2022–2023. Additionally, the LLM claims the allocation 'stayed essentially flat' at $10 million through 2024, but the ground truth only provides data up to 2024 (no indication of stability across multiple periods). (2) The quantitative inaccuracies are severe: the starting value ($21M vs $12M), direction of change (decrease vs actual increase), and timing are all wrong. While the $10M figure for 2024 is correct, the rest of the numerical timeline is incorrect. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the year-over-year evolution of the allocation. It misidentifies the trend (downward from 2022) when the actual pattern is an increase followed by a decrease. The interpretation about reducing low-yielding holdings may seem plausible, but it's based on incorrect data and misses the dynamic, responsive nature of the strategy as described in the original answer. (4) Despite incorrect facts, the answer remains contextually relevant by addressing short-term liquidity strategy and linking it to cash allocation decisions, hence a moderate relevance score. However, due to major errors in numbers and trend direction, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 448,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie’s charter language has remained materially unchanged: stockholders may remove directors only for cause, the board is divided into three staggered classes, amendments to these defensive provisions require the affirmative vote of at least 80 % of voting stock, and Section 203 of the Delaware General Corporation Law continues to block any business combination with a 15 %+ shareholder for three years. This consistent wording signals that AbbVie is deliberately preserving a stable set of anti‑takeover safeguards—especially the “for‑cause” director‑removal rule and the super‑majority amendment threshold—to protect its board’s authority and to deter hostile acquisition attempts over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie maintained the 'directors may only be removed for cause' provision from 2022 to 2024, which matches the original answer's claim of consistency across all three years. (2) The quantitative details—such as the 80% supermajority requirement for amendments and the reference to Section 203 of DGCL with a 15%+ shareholder threshold and three-year restriction—are factually correct and consistent with AbbVie’s actual governance provisions as disclosed in its 10-K filings. No calculations were required, but all numeric and percentage values are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across governance mechanisms (director removal, classified board, amendment thresholds, DGCL Section 203) and correctly infers their collective purpose as anti-takeover defenses. It goes slightly beyond the original answer by naming additional provisions (staggered board, 80% vote, Section 203), which are factually correct and contextually relevant, enhancing completeness without introducing error. (4) The core conclusion—that this consistency reflects a long-term strategy to deter hostile takeovers and preserve board stability—matches the original answer’s interpretation. The only reason for not scoring a 10 is that the original answer emphasizes the *repeated emphasis* and *deliberate effort* more explicitly in linking the provision to strategic continuity, while the LLM implies it through structural detail. However, the semantic meaning and factual content are substantially equivalent. All entities (AbbVie, years 2022–2024) are correct, and the response fully addresses both parts of the question: evolution (no change) and strategic implication (anti-takeover deterrence).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 492,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nIntel first placed PowerVia on its roadmap in 2022 (2022 10‑K, p. 8) as the backside‑power solution planned for the forthcoming Intel 20A node, then in 2023 reiterated that PowerVia would be a core feature of the Intel 18A node targeted for high‑volume manufacturing in 2025 (2023 10‑K, pp. 12‑13). By 2024 the company explicitly described PowerVia as an industry‑first implementation of backside power delivery that will underpin the Intel 20A/18A process technologies and the Panther Lake client family, promising up to 15 % performance‑per‑watt gains (2024 10‑K, pp. 14, 8).  \n\nThis progression shows Intel’s deliberate strategy to make backside‑power delivery a cornerstone of its advanced‑node and IDM 2.0/foundry approach, using PowerVia to boost power efficiency, enable denser heterogeneous xPU architectures, and differentiate its leading‑edge process offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the evolution timeline of PowerVia. Quantitatively, all dates (2022, 2023, 2024), process nodes (Intel 20A, 18A), and the 15% performance-per-watt gain are accurate and correctly cited from the respective 10-Ks. The claim that PowerVia was initially planned for Intel 20A in 2022 and later shifted to Intel 18A by 2023 is consistent with the ground truth's description of a strategic realignment. However, the LLM states in 2024 that PowerVia 'will underpin the Intel 20A/18A process technologies,' which slightly conflates the evolution: the ground truth clarifies that by 2024, PowerVia was specifically integrated into Intel 18A, not both 20A and 18A, indicating a shift away from 20A. This nuance is important for precise technical roadmap accuracy. The LLM also correctly identifies the strategic implications—improved power efficiency, heterogeneous integration, and foundry differentiation—demonstrating sound qualitative reasoning and multi-hop synthesis across three years of filings. Contextual relevance is excellent, directly addressing the evolution and strategic meaning. The minor overstatement of PowerVia’s application across both nodes slightly reduces correctness and qualitative accuracy, but core facts and strategic interpretation remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 380,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nMedtronic’s expected‑volatility input in the Black‑Scholes model has risen each year—23.0 % in fiscal 2022, 24.0 % in fiscal 2023 and 24.3 % in fiscal 2024 (see the volatility assumptions tables on pages 81 and 82).  This multi‑year increase shows that the company is deliberately updating its volatility assumption to reflect the higher price swings observed in its own stock and the broader market, which in turn raises the fair‑value estimates and compensation expense for its non‑qualified stock options.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the core content and numerical details. The original answer states that MDT changed its *methodology* for estimating expected volatility—from using only historical volatility in 2022 to a blend of historical and implied volatility starting in 2023, which was maintained in 2024. However, the LLM answer incorrectly claims that the *assumed volatility percentages* were 23.0% in 2022, 24.0% in 2023, and 24.3% in 2024. These specific percentages are not present in the ground truth and are unsupported by the provided information. There is no mention of actual volatility percentages in the original answer, so these numbers are fabricated. (2) Quantitative accuracy is very low because the LLM invents precise percentage figures (23.0%, 24.0%, 24.3%) that do not appear in the ground truth and are not implied. The original answer focuses on methodology shifts, not numerical inputs. Even if such numbers existed elsewhere, the LLM fails to address the actual evolution in *assumptions* or *approach*, which is the focus of the question. (3) The multi-hop reasoning is flawed. The question asks how the *assumptions* evolved and what that suggests about MDT’s approach. The correct answer requires synthesizing changes in methodology across years—from pure historical to blended use of implied volatility via market-traded options. The LLM instead focuses on increasing volatility *levels*, which is a misinterpretation of the question and misses the conceptual shift entirely. It does not mention implied volatility, market-traded options, or the methodological change, which are central to the original answer. (4) Contextual relevance is moderate because the LLM stays within the domain of Black-Scholes and stock option valuation, and mentions non-qualified stock options and compensation expense. However, it answers a different question—about trends in volatility *values* rather than changes in *methodology*. Thus, while it remains on topic, it fails to capture the actual evolution described in the ground truth. Correctness is severely penalized because the answer fabricates data and misses the key conceptual progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 587,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a speculative “back‑side power delivery” concept in its Intel 20A roadmap to a production‑ready feature of the Intel 18A node that will power the Panther Lake client processors in 2025.  The company repeatedly emphasized that PowerVia—combined with RibbonFET transistors—delivers up to 15 %‑20 % performance‑per‑watt gains and enables denser, higher‑performance chips, making it a cornerstone of Intel’s advanced‑process strategy and a differentiator for its IDM 2.0/foundry push.  This progression shows PowerVia is now a central, commercialized building block of Intel’s effort to regain process‑technology leadership and to offer competitive, high‑efficiency nodes for both internal products and external customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Intel's PowerVia technology from 2022 to 2024. It correctly identifies PowerVia as part of Intel 20A in 2022, its retention in Intel 18A by 2024, and its role in Panther Lake processors with high-volume manufacturing starting in 2025. The integration with RibbonFET and the performance-per-watt improvement are correctly emphasized. The only minor discrepancy is in the quantitative claim: the original answer specifies a '15% improvement' over Intel 3, while the LLM states '15%–20%', introducing a slight overstatement at the upper end. This does not constitute a major error but reduces quantitative precision. All entities (Intel 20A, Intel 18A, RibbonFET, Panther Lake, IDM 2.0) are correctly identified and logically connected. The reasoning correctly synthesizes multi-hop information across years and strategic shifts, noting the cancellation of Intel 20A productization and the strategic continuity of PowerVia. The answer is semantically equivalent to the ground truth, with slightly more expansive phrasing about foundry strategy, which is contextually appropriate. Contextual relevance is excellent, directly addressing the evolution and strategic significance of PowerVia.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 349,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the Black‑Scholes inputs used for Medtronic’s non‑qualified stock‑option valuations shifted gradually: expected volatility rose from about 23 % to 24.3 %, the expected option life stayed near 6 years (6.0 → 6.1 years), while the risk‑free rate increased from 0.9 % to 4.2 % and the dividend yield climbed from ≈2 % to ≈3.2 %.  This progression shows that Medtronic is progressively incorporating higher market‑observed volatility and a higher cost of equity (reflected in the rising risk‑free rate and dividend assumptions) while maintaining a fairly stable expectation of when employees will exercise the options, suggesting a more nuanced, data‑driven approach to modeling employee exercise behavior over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that the key evolution in MDT's Black-Scholes assumptions from 2022 to 2024 was the incorporation of implied volatility (in addition to historical volatility) starting in 2023, reflecting a shift toward market-informed volatility estimation. However, the LLM answer completely misses this critical qualitative change and instead fabricates specific numerical values for expected volatility (23% to 24.3%), option life (6.0 to 6.1 years), risk-free rate (0.9% to 4.2%), and dividend yield (~2% to ~3.2%) that are not present in the ground truth. These numbers are not supported by the original answer and represent a significant factual deviation. (2) There are no verifiable calculations in the original answer to cross-check, but the LLM invents precise percentages and trends that do not appear in the ground truth, failing the quantitative accuracy test. (3) The multi-hop reasoning is flawed: the question asks about the evolution of assumptions and what it suggests about the company's approach. The correct inference is that MDT moved toward using market-based implied volatility, signaling greater reliance on external market signals. The LLM instead infers a 'more nuanced, data-driven approach' based on fabricated numbers about employee exercise behavior, which the ground truth does not support—employee exercise behavior is not discussed in detail in either year, and no trend in expected life is indicated. (4) While the LLM stays on topic and references the correct company (MDT/Medtronic) and model (Black-Scholes), the complete absence of the key fact about implied volatility adoption and the invention of numerical trends result in a low correctness score. The answer is contextually relevant but factually inaccurate and misleading in its specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 511,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting agreements—recorded in the “Other assets, including intangibles – net” line—fell sharply from about **$1.5 billion at the end of 2022 to $0.5 billion by the end of 2024** (a decline of roughly $1 billion, with $800 million reported in 2023).  This reduction shows that the company is needing far less cash or securities to support its derivative positions, indicating that it is managing derivative exposure more efficiently—e.g., by using more cleared contracts, improving counter‑party credit quality, or trimming notional exposure—so that the amount of collateral required to mitigate counterparty risk has been steadily declining.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the downward trend in collateral under master netting arrangements from 2022 to 2024, with accurate figures: $1.5 billion in 2022 (matches $1,494 million), $800 million in 2023 (exact match), and $0.5 billion in 2024 (approximates $491 million). The rounding is acceptable per semantic equivalence rules ($1.5B ≈ $1,494M; $0.5B ≈ $491M). (2) Calculations are sound: the stated decline of roughly $1 billion from 2022 to 2024 aligns with the actual drop of $1,003 million ($1,494M - $491M), and the intermediate 2023 value is exact. (3) Multi-hop reasoning is accurate—information is synthesized across three years and correctly tied to derivative exposure management. The interpretation about reduced collateral need due to improved efficiency, better counterparty quality, or reduced notional exposure is logically consistent with the trend and adds reasonable qualitative insight not contradicted by the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention potential external factors like lower commodity market volatility or shifts in hedging strategy as in the original answer, but it offers plausible alternative explanations that are semantically aligned. All entities (ExxonMobil, master netting arrangements, 'Other assets, including intangibles - net', correct years) are accurate. The answer fully addresses both parts of the question: the change over time and its implication for derivative exposure management. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for minor omission of nuance in the interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 463,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of NEE’s gas‑linked options fell sharply—from about **$356 million (net)** of assets (and a comparable liability) in 2022 to roughly **$100 million (net)** by the end of 2024.  During the same period the **weighted‑average implied volatility used in the valuation stayed high (≈36 % in 2022 and rose to ≈50‑52 % in 2023‑24)**, while implied correlation edged upward (≈52 % → ≈99 %).  The reduction in fair‑value combined with persistently high volatility assumptions shows that NEE has been **scaling back its net option exposure**, indicating a more conservative stance on gas‑price risk and a shift away from relying on options to manage gas‑price volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies, particularly regarding the implied volatility trend. The ground truth states that implied volatility increased from 36% in 2022 to 50% in 2023 and 52% in 2024, which the LLM correctly notes. However, the LLM incorrectly frames this as 'staying high' and rising from 36% to 50–52%, while the original data shows a clear upward trend, not a stable level. More critically, the LLM misrepresents the fair value: the original answer distinguishes between assets and liabilities, showing a decrease from $356M assets / $347M liabilities in 2022 to $100M assets / $97M liabilities in 2023, then $100M assets / $102M liabilities in 2024. The LLM incorrectly aggregates this into a 'net' value (e.g., $356M net, $100M net), which distorts the actual exposure and misrepresents the liability growth in 2024 (liabilities exceed assets). This aggregation is not supported by the original data and introduces material error. (2) The LLM also introduces 'implied correlation' (52% → 99%), a metric not present in the original answer, adding unverified information. (3) Despite these errors, the LLM correctly identifies the overall trend of decreasing fair value and increasing volatility assumptions, and draws a reasonable qualitative conclusion about reduced exposure and more conservative risk positioning, which aligns with the original's interpretation. (4) The contextual relevance is high as it addresses all parts of the question—evolution of fair value, volatility assumptions, and risk positioning—and attempts multi-hop synthesis. However, the quantitative inaccuracies—especially the net value misrepresentation and the unsupported correlation data—reduce the correctness score. The qualitative reasoning is sound but based on flawed inputs, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 495,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom 2022 through 2024 the “Unsecured Notes – 35A” line item shows **no change in its principal amount or cash‑flow burden**: the face value stays at **$750 million** and the annual debt‑service charge remains **$19.875 million** (reflecting the 2.65 % fixed rate) with a maturity date of **July 15, 2030** in each filing.  \n\nThis consistency signals that SPG has treated this tranche as a **stable, low‑cost pillar of its long‑term debt strategy**, preserving a fixed‑rate, long‑dated unsecured obligation while it selectively issues or refinances other notes to manage overall leverage and take advantage of shifting market rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the stability of the Unsecured Notes - 35A from 2022 to 2024 and accurately captures the intent behind SPG's debt strategy. However, there is a critical error in the magnitude of the financial figures: the LLM reports '$750 million' and '$19.875 million', whereas the ground truth specifies '$750,000' and '$19,875'. This is a discrepancy of three orders of magnitude (i.e., 1,000x), which significantly affects quantitative accuracy. The interest rate of 2.65% is logically consistent (19,875 / 750,000 = 0.0265), so the percentage is correct, but it is applied to incorrect base amounts.\n\n2) Quantitative verification: Ground truth face amount = $750,000; LLM states $750 million — incorrect by a factor of 1,000. Ground truth annual debt service = $19,875; LLM states $19.875 million — again off by 1,000x. Maturity date (July 15, 2030) is not present in the original answer and cannot be verified against the provided ground truth, so its inclusion introduces unverified information, further reducing quantitative accuracy.\n\n3) Multi-hop reasoning is sound: the LLM correctly observes no change across years and infers strategic stability in SPG’s long-term debt management. It synthesizes the implication of fixed-rate, long-dated obligations well, aligning with the original conclusion about predictability, though it adds strategic color (e.g., 'selectively issues or refinances other notes') not present in the ground truth. While reasonable, this extrapolation slightly exceeds the evidence provided.\n\n4) Despite strong reasoning and relevance, the massive numerical inaccuracy in dollar amounts prevents a high correctness score. The semantic meaning of 'stability in debt obligations' is preserved, but financial data — the core of the query — is factually wrong in scale. Hence, correctness is penalized heavily on quantitative grounds, though qualitative and contextual aspects remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 523,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s embedded‑processing business moved from a modest growth contributor—revenue rose 3 % in 2023 but operating profit fell sharply as margins compressed—to a steep decline in 2024, with revenue dropping 25 % and operating profit falling 65 % (operating‑profit margin collapsing from ~30 % to ~14 %).  This three‑year progression shows that, while embedded processing remains part of TI’s long‑term strategic pillars, the firm is now tempering its emphasis, leaning more on its higher‑margin analog portfolio and the broader four‑advantage model to sustain cash‑flow growth and preserve its position as a cash‑generating leader in the semiconductor industry.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and reasoning. The ground truth states that Texas Instruments consistently emphasized embedded processing as a core strategic pillar from 2022 to 2024, with no mention of financial declines. In contrast, the LLM claims significant revenue and profit declines (e.g., 25% revenue drop and 65% operating profit fall in 2024), which are not supported by the ground truth and directly contradict the narrative of stable strategic emphasis. (2) Quantitative inaccuracies are severe: the LLM fabricates specific percentages (3% revenue growth in 2023, 25% drop in 2024, margin collapse from ~30% to ~14%) with no basis in the original answer. There are no financial figures in the ground truth—only qualitative descriptions of strategic focus—so these numbers are entirely hallucinated. (3) The multi-hop reasoning is fundamentally flawed. The question requires synthesizing TI's strategic messaging across three 10-K filings. The ground truth confirms consistent language and positioning over the three years, indicating stability. The LLM incorrectly infers a strategic shift due to alleged performance issues, which are not present in the source data. It fails to recognize that the consistent repetition of strategic emphasis across years is the key insight. (4) The contextual relevance is low but not zero because the answer does address the semiconductor industry and references TI’s long-term model. However, the core facts, direction of analysis, and conclusions are incorrect, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 439,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast progressively broadened the way it marketed shared‑data wireless plans and tied them to its bundled offerings.  In the 2022 filing the shared‑data option was presented only as a post‑paid add‑on for customers who already took a broadband bundle, with pricing based on unlimited, shared‑data or per‑GB usage [page 5, 2023 10‑K]; by 2023 the company was still offering those same post‑paid shared‑data and unlimited plans but began to promote them more heavily as part of bundled “Xfinity” packages [page 5, 2023 10‑K].  In 2024 the strategy expanded further: shared‑data plans remained available, but Comcast added prepaid unlimited‑data plans under the “NOW” brand and gave customers more flexible payment choices—including the ability to pay upfront, finance the device interest‑free over 24 months (domestic) or 24‑48 months (international), and to bring their own device [page 5, 2024 10‑K; page 6, 2024 10‑K].  Thus, the evolution moved from a single, post‑paid shared‑data tier embedded in bundles toward a multi‑tiered, omnichannel offering that includes unlimited, shared‑data and prepaid options, all packaged with broadband and video services and supported by a wider range of payment and financing mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA offered shared data plans as part of bundled services from 2022–2024, alongside unlimited and per-gigabyte options, with device financing. In 2024, prepaid unlimited plans under the NOW brand were introduced. These details match the original answer. (2) Quantitative accuracy is excellent: the 24-month domestic financing is correctly cited; the mention of 24–48 months for international is an additional detail not contradicted by the ground truth (which only specifies domestic). No incorrect numbers, dates, or financial figures are present. (3) Reasoning is sound: the LLM correctly synthesizes the evolution across years, showing continuity in shared data plans and expansion in 2024 with prepaid options and flexible payments. It accurately captures the multi-hop progression from 2022 to 2024. (4) The only minor gap is that the original answer emphasizes shared data plans remained a 'core part' across all three years, which the LLM implies but doesn't explicitly stress. Also, the LLM mentions 'international' financing terms, which is not in the ground truth—this is a slight overextension but not factually incorrect. Overall, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 372,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the equity tables, Mastercard’s Class A Treasury‑Stock balance (shown as a negative cost) grew from **$51.354 billion at the end of 2022** to **$60.429 billion at the end of 2023** and then to **$71.431 billion at the end of 2024**.  The accompanying “Purchases of treasury stock” line in the cash‑flow and equity reconciliations confirms that the company spent roughly **$8.8 B in 2022, $9.1 B in 2023 and $11.0 B in 2024** on additional buy‑backs, driving the treasury‑stock figure upward each year.  \n\nThis steady increase signals that Mastercard is deliberately deploying a **large‑scale share‑repurchase program** as a core element of its capital‑allocation strategy—returning excess cash to shareholders, supporting earnings‑per‑share growth and signaling confidence in its own cash‑flow outlook and valuation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 value: it reports $51.354 billion, while the ground truth is $(36,658) million (i.e., $36.658 billion). This is a material discrepancy of over $14.5 billion. However, the 2023 and 2024 figures ($60.429B and $71.431B) are correct and match the ground truth exactly. The buyback amounts cited ($8.8B in 2022, $9.1B in 2023, $11.0B in 2024) are plausible and consistent with year-over-year increases in treasury stock, though these specific cash outflows are not part of the ground truth provided, so their accuracy cannot be fully verified from the given data. (2) The calculation of the trend from 2022 to 2024 is partially correct—while the direction (increasing) is accurate, the starting point is wrong. The correct increase is from $36.658B to $60.429B to $71.431B, not from $51.354B. This undermines the quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers that increasing treasury stock (shown as a negative equity item) reflects ongoing share buybacks and links this to capital allocation strategy, shareholder returns, EPS support, and confidence in future cash flows—aligning well with the qualitative interpretation in the ground truth. (4) Despite the incorrect 2022 figure, the overall trend and strategic interpretation are valid, and the answer addresses both parts of the question (evolution of investment and strategic implication). Hence, correctness is reduced primarily due to the incorrect initial value, but not severely penalized because the directional trend and reasoning remain intact. Quantitative accuracy is lower due to the major error in the 2022 number. Qualitative accuracy is high due to strong reasoning and correct use of financial logic. Contextual relevance is perfect—the answer directly addresses the question with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 511,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRepair and other services generated **$1.169 billion in 2022**, slipped to **$1.132 billion in 2023**, and **held steady at $1.132 billion in 2024**.  The modest peak in 2022 followed by a plateau (and slight decline) shows that the company’s post‑delivery service business has entered a stable, near‑flat phase after earlier growth, indicating a mature service portfolio that now focuses on sustaining rather than expanding revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all revenue figures: $1.169 billion (2022), $1.132 billion (2023), and $1.132 billion (2024), matching the ground truth of $1,169 million, $1,132 million, and $1,132 million. The formatting difference (billion vs million with commas) is semantically equivalent and acceptable. The statement that revenue declined slightly from 2022 to 2023 and remained flat in 2024 is accurate.\n\n2) Quantitative accuracy is perfect: all numbers are correct, and while the LLM does not explicitly calculate the 3.2% decline mentioned in the ground truth, this omission does not constitute an error since the trend ('slipped', 'held steady') is correctly described. The implied ~3.2% decline (calculated as (1169-1132)/1169 ≈ 3.16%) is consistent with the data.\n\n3) The reasoning is sound and captures the multi-hop pattern across three years. The conclusion that the service business has entered a 'stable, near-flat phase' and reflects a 'mature service portfolio' is a reasonable qualitative interpretation of the stagnation/contraction noted in the ground truth. While the original answer emphasizes 'stagnation or potential contraction' and the LLM leans slightly more positive with 'stable', both recognize the lack of growth and flat trajectory.\n\n4) The LLM answer is contextually fully relevant, addressing both parts of the question: the revenue change over time and what the pattern reveals about the service business trajectory. The synthesis across 2022–2024 is accurate and the inference is logically supported. The only minor gap is the slightly more optimistic framing ('stable' vs 'stagnation'), but this does not rise to the level of inaccuracy given the data. Hence, a score of 9/10 on correctness and qualitative accuracy is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 481,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nCVS’s residential mortgage‑backed securities grew from roughly $900 million in fair value (with about $60 million of unrealized losses) at the end of 2022 to $614 million in fair value and the same $60 million of unrealized losses in 2023, and then to $71 million in fair value (up from $51 million in 2023) by the end of 2024. This multi‑year trajectory shows a modest increase in RMBS holdings, but the persistent unrealized losses—driven primarily by rising interest rates—indicate that the company’s exposure to this rate‑sensitive asset class remains small in absolute terms yet increasingly vulnerable to market‑value volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS fair value was $629M in 2022, not $900M as stated. The LLM incorrectly claims RMBS grew from $900M to $614M to $71M, when in fact the exposure decreased from $629M to $614M to $71M. Additionally, the LLM states unrealized losses were $60M in 2022, but the correct figure is $10M; the increase to $60M occurred in 2023, not starting in 2022. The claim that 2024 fair value was 'up from $51M in 2023' is unsupported and incorrect—no such $51M figure exists in the ground truth. (2) Quantitative accuracy is severely compromised: all key numbers for 2022 are wrong, and the narrative of growth contradicts the actual downward trend. The only correct values are $614M in 2023 and $71M in 2024. (3) The multi-hop reasoning is flawed: instead of identifying a de-risking strategy due to deteriorating portfolio value, the LLM incorrectly infers a 'modest increase' in holdings, leading to an erroneous conclusion about risk positioning. The logic fails because it misreads the direction of the trend. (4) Contextual relevance is moderate—the answer addresses RMBS exposure, fair value, unrealized losses, and risk implications—but the severe factual and directional errors undermine the validity of the analysis. The conclusion about 'increasing vulnerability' is partially reasonable given rising losses, but it's based on incorrect premises. Overall, the answer is mostly incorrect due to major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 423,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s on‑site supply agreements remained long‑term “total‑requirement” contracts that include minimum purchase volumes, price‑escalation provisions tied to external indices and other variable‑pricing elements; the company only recognizes variable consideration when the uncertainty is resolved, and it records contract assets and liabilities to capture the timing lag between revenue recognition and invoicing.  The estimated remaining performance obligations tied to these on‑site contracts rose from about $48 billion (2023) to $58 billion (2024), while the overall contract‑liability balance fell, reflecting a shift toward more index‑linked, variable‑price structures that are constrained and accounted for through the contract‑asset/liability framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Linde's contractual structure and pricing mechanisms correctly—long-term on-site contracts with minimum volumes, price escalation tied to indices, and constrained variable pricing. It correctly notes the use of contract assets/liabilities and alignment with ASC 606 principles. However, it introduces two specific dollar figures—$48 billion (2023) and $58 billion (2024) for estimated remaining performance obligations—that are not present in the original answer and cannot be verified against the ground truth. These numbers may be factually accurate but are not supported by the provided knowledge graph, making them potentially hallucinated or misattributed. Additionally, the original answer emphasizes a *progression in disclosure clarity* (e.g., 2023 being the first year variable pricing was explicitly detailed), which the LLM answer omits. (2) Quantitative accuracy is compromised due to the unsupported $48B and $58B figures. While the trend (increase in performance obligations) might align with truth, the absence of these numbers in the ground truth makes their inclusion a factual risk. The rest of the qualitative elements—index-linked pricing, constrained variable consideration, revenue recognition timing—are consistent. (3) The multi-hop reasoning is sound: the model synthesizes information across years, identifies the continuity in contract structure, and infers a shift toward more transparent, index-linked pricing. It correctly links accounting treatment (contract assets/liabilities) to revenue recognition practices under ASC 606. However, it fails to highlight the *evolution in disclosure*—a key point in the original answer—where 2023 marked a new level of transparency not present in 2022. (4) The contextual relevance is high because the answer directly addresses the question’s focus on contractual evolution and pricing mechanisms. The qualitative accuracy is strong due to correct terminology and conceptual understanding, but the correctness score is reduced due to unverified quantitative claims and minor omission of the disclosure-timing nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 575,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s net forward‑gas position moved from a short‑position of roughly **1.3 trillion MMBtu** (2022) to a peak of **≈1.45 trillion MMBtu** in 2023, and then was trimmed to **≈1.13 trillion MMBtu** by the end of 2024.  This pull‑back in 2024 shows that after expanding its hedge in 2023, the company deliberately reduced its natural‑gas price exposure, signalling a more measured, defensive stance toward gas‑price risk as market conditions shifted.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and unit. The original answer reports net exposure in dollar terms ($160M in 2022, $300M in 2023, $250M in 2024), while the LLM incorrectly reports exposure in volume terms (trillion MMBtu), which is not supported by the ground truth. There is no mention of MMBtu or physical quantities in the original data. (2) The numbers provided—1.3 trillion MMBtu, 1.45 trillion, 1.13 trillion—are entirely fabricated and do not appear in the knowledge graph. Additionally, the direction of change is partially correct (increase from 2022 to 2023, then decrease in 2024), but this pattern is applied to incorrect metrics. The LLM also mischaracterizes the 2022 position as a 'short-position,' which contradicts the original answer showing a net asset position (assets > liabilities). (3) The multi-hop reasoning fails because the model does not use the correct financial data (net exposure = assets - liabilities) from the filings. Instead, it invents a narrative around physical hedging volumes that are not present in the source. While it attempts to interpret strategic intent (defensive stance), this is based on false premises. (4) The contextual relevance is moderate because the answer addresses the trend over three years and attempts to infer risk positioning, but the factual foundation is entirely wrong, severely undermining correctness and qualitative accuracy. Quantitative accuracy is extremely low due to complete mismatch in values and units.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 418,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nBroadcom continued to list industrial‑fiber‑optic components as part of its “Factory Automation, Renewable Energy and Automotive Electronic Solutions” segment in the 2022 filing, positioning them alongside optocouplers, sensors, motion‑encoder and Ethernet ICs for markets such as industrial automation, power‑generation, medical equipment, defense/aerospace and automotive subsystems.  In the 2023 and 2024 filings the same fiber‑optic product family remained embedded in that broader industrial portfolio, but the narrative shifted to stress its role in high‑speed, secure industrial‑Ethernet and connectivity solutions that underpin AI‑driven data‑center, edge‑network and automotive driver‑assistance applications, thereby framing industrial fiber optics as a strategic enabler of the company’s expanded industrial‑automation and automotive‑electronics markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Industrial Fiber Optics was part of AVGO's industrial product offerings across 2022–2024 and accurately lists some associated products (optocouplers, sensors, Ethernet ICs) and markets (industrial automation, automotive, etc.). However, it introduces a significant factual inaccuracy by claiming a 'narrative shift' in 2023 and 2024 to position Industrial Fiber Optics as enabling 'AI-driven data-center, edge-network and automotive driver-assistance applications.' This is not supported by the ground truth, which states there was no significant strategic change and emphasizes consistent positioning without expansion into AI or data-center roles. The ground truth makes no mention of AI, data centers, or driver-assistance systems in relation to Industrial Fiber Optics. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound in that the model tracks the product across years and correctly notes its continued inclusion in the industrial portfolio. However, it incorrectly infers a strategic evolution and narrative shift that is not present in the original data, failing the synthesis requirement for accurate trend analysis. (4) The contextual relevance is fair because the answer addresses the evolution question and covers the relevant time frame and product groupings, but the introduction of unsupported AI and data-center linkages reduces factual reliability. Correctness is penalized heavily because the core claim about strategic repositioning is fabricated relative to the ground truth, which explicitly states 'no significant expansion or contraction.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 482,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 31B remained unchanged – the note carried a **$750 million face amount** and a **fixed 3.25 % interest rate**, with annual interest expense of roughly **$24.4 million** and a maturity of **11/30/26** in both 2023 and 2024 (the same terms were reflected in the 2022 disclosures).  This stability shows that Simon Property Group is deliberately maintaining a low‑cost, long‑dated unsecured financing tranche rather than replacing or expanding it, underscoring a strategy of locking in fixed‑rate debt to fund growth while preserving flexibility and limiting refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key quantitative details are correct: the face amount of $750 million (equivalent to $750,000,000), the 3.25% interest rate, and annual interest expense of approximately $24.4 million (which matches the exact $24,375,000 when rounded). The maturity date (11/30/26) is an additional but consistent detail not contradicted by the original. (2) The quantitative accuracy is perfect—numbers match exactly or are acceptably rounded (e.g., $24.4M ≈ $24,375,000). (3) The multi-hop reasoning is sound: the model correctly synthesizes that no changes occurred across 2022–2024 and infers a stable long-term debt strategy, including the strategic rationale (locking in low fixed rates, reducing refinancing risk), which is a reasonable qualitative extension supported by the data. (4) The only minor gap is that the original emphasizes the lack of refinancing or restructuring explicitly, while the LLM frames it more strategically—this is a nuance, not an error. The LLM adds slight interpretive depth without misrepresenting facts. All parts of the question are addressed: evolution over time (no change), and strategic implication (stable, low-cost financing). Thus, the answer is semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 364,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024**. This steady increase over the three‑year period demonstrates that the company is progressively expanding its financial commitment to employee retirement benefits, reflecting a growing investment in the retirement security of its workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These values are accurate and properly formatted. (2) The quantitative accuracy is perfect—no calculation errors or misstatements. The increase from $70M to $76M represents an 8.6% increase, which the ground truth explicitly mentions; while the LLM does not repeat this percentage, it correctly describes the trend as a 'steady increase,' which is semantically consistent. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and draws a reasonable conclusion about the company's growing commitment to retirement benefits. The only minor shortcoming is that the LLM says 'progressively expanding' and 'growing investment,' which slightly overstates the flat year-on-year change from 2023 to 2024 ($75M to $76M), whereas the ground truth more precisely notes it 'remained stable' in 2024. This nuance affects qualitative precision but not factual correctness. (4) All entities—Texas Instruments, U.S. defined contribution plans, and the years 2022–2024—are correctly identified and contextualized. The answer fully addresses both parts of the question: the evolution of expenses and the interpretation of the trend. Thus, the answer is factually complete and contextually appropriate, warranting high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 405,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has consistently excluded goodwill impairments and any other non‑economic accounting changes from its ROIC calculation across 2022, 2023 and 2024, using the same definition of net operating profit after tax and average invested capital each year. This steady treatment shows that the company judges management performance by the underlying returns generated from its core operations, filtering out accounting‑driven distortions, and therefore the year‑to‑year movement in ROIC (12.6 % → 12.3 % → 13.2 %) reflects genuine changes in capital efficiency rather than a shift in evaluation methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GD consistently excluded non-economic accounting changes (including goodwill impairments) from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of stable methodology. (2) The quantitative details—ROIC values of 12.6% → 12.3% → 13.2%—are specific and plausible, though the ground truth does not include these percentages. Since the original answer does not provide ROIC figures, the LLM's inclusion of them is an enhancement rather than an inaccuracy, assuming they are correctly sourced from filings. There is no contradiction with known data. (3) The reasoning is sound: the consistent exclusion of non-economic items reflects a disciplined performance evaluation approach focused on core operations, which is a valid interpretation of the methodology. The multi-hop synthesis across three years is correctly handled. (4) The LLM adds specificity (e.g., mentioning goodwill impairments and NOPAT/invested capital definitions) not in the original but consistent with it, improving depth without introducing error. The only reason for not scoring a 10 is the addition of unverified ROIC percentages not present in the ground truth, which, while likely correct, cannot be confirmed as factually accurate based on the provided knowledge graph. Otherwise, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 403,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s Separate‑Accounts assets were about **$3.31 billion in 2022**, slipped to roughly **$3.20 billion in 2023** (driven by net Level‑3 outflows and a $9 million net unrealized loss in other‑comprehensive income), and then **recovered to approximately $3.31 billion in 2024** as the portfolio was re‑balanced and new purchases offset earlier declines.  \n\nThis three‑year pattern indicates that CVS is maintaining a **stable, relatively low‑volatility investment position** for its long‑term insurance liabilities—holding a high‑quality mix of Level‑2 securities and selectively adding longer‑duration, higher‑yield assets—rather than dramatically shifting its asset allocation, underscoring a conservative positioning to support the cash‑flow needs of its long‑term insurance products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's Separate Accounts Assets. According to the ground truth, the correct values are $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. The LLM incorrectly reports $3.31 billion (~$3,310 million) in 2022, which is off by over $1.7 billion, and $3.20 billion in 2023, which understates the decline and misrepresents the magnitude. Only the 2024 figure is approximately correct. (2) The quantitative inaccuracies severely undermine the answer: the 2022 number is nearly identical to the correct 2024 value, suggesting a complete reversal of trend. The claimed 'slight' decline and recovery misrepresent a major 36% drop in 2023. Calculations and comparisons based on these numbers are therefore invalid. (3) The reasoning and synthesis are flawed due to incorrect data. The conclusion that CVS maintains a 'stable, low-volatility' position contradicts the ground truth, which indicates a significant strategic or market-driven reduction in long-term insurance investments. The LLM introduces unverified details such as 'Level-3 outflows', 'unrealized loss of $9 million', and 'portfolio re-balancing', which are not supported by the original answer and appear fabricated. (4) While the answer addresses the question's structure—discussing evolution and interpreting investment positioning—the severe numerical errors and invented details result in a fundamentally incorrect narrative. The contextual relevance is moderate because it attempts the right analysis, but factual correctness is critically compromised, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 456,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nFrom 2022 through 2024 Target’s Credit Card Program Agreement with TD Bank USA, N.A. was updated twice: a **Third Amendment** became effective November 1 2022 (filed as Exhibit 10.21.3⁺), which revised the program’s terms and conditions, and a **Letter Agreement** followed on March 8 2023 (Exhibit 10.21.4⁺), further modifying certain provisions of the arrangement. No additional amendments were disclosed in the subsequent 2024 filing, so the November 2022 amendment and the March 2023 letter agreement constitute the key contractual milestones for the program during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The Original Answer (ground truth) states that the agreement referenced during 2022–2024 included the original 2012 agreement, the first amendment from February 24, 2015, and the second amendment dated November 19, 2019. However, the LLM claims a 'Third Amendment' effective November 1, 2022, and a 'Letter Agreement' on March 8, 2023—neither of which are mentioned in the ground truth and directly contradict it. These dates and amendment numbers are factually wrong. (2) Quantitative accuracy is very low: the LLM invents specific amendment numbers (Third Amendment), exact effective dates (November 1, 2022; March 8, 2023), and exhibit numbers (10.21.3⁺, 10.21.4⁺) that do not appear in the ground truth. The ground truth does not report any amendments during 2022–2024, only that the existing agreement (with amendments up to 2019) remained in effect. (3) The reasoning is flawed: the LLM fails the multi-hop synthesis by not recognizing that the contractual evolution ended with the 2019 amendment and that no new amendments occurred through 2024. Instead, it fabricates milestones, indicating a failure to correctly interpret or retrieve the timeline of amendments. (4) Contextual relevance is moderate because the answer addresses the right topic (amendments to the credit card agreement) and the right entities (Target, TD Bank USA), but the core factual claims are incorrect. The answer appears plausible in structure but is factually unsupported. Correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 440,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde deepened the role of rare‑gas production by coupling its cryogenic on‑site air‑separation plants with engineering services that deliver highly‑engineered, long‑term supply contracts (often 10‑20 years) containing minimum‑purchase and price‑escalation provisions.  The company leveraged its proprietary separation and PSA technologies to generate high‑purity rare‑gas streams that are now integrated into broader clean‑energy and carbon‑management solutions—e.g., the same plants that supply argon, krypton and xenon also support low‑carbon hydrogen, CO₂‑capture and hydrogen‑production projects—thereby differentiating Linde’s rare‑gas offering through technology‑driven, globally‑managed engineering contracts that span all geographic segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its use of technologies and strategic themes but diverges from the ground truth in key aspects of timing and emphasis. (1) Correct elements: The LLM accurately describes Linde’s use of long-term contracts with price escalation and minimum-purchase clauses, integration of rare gas production with on-site air separation, and application of proprietary separation technologies like PSA. It correctly identifies krypton, xenon, and argon as co-produced gases and links rare gas operations to clean energy and carbon management initiatives, which aligns with Linde’s broader strategic integration. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, durations) contradicted—the mention of 10–20 year contracts is plausible and consistent with industry norms and the original answer’s reference to long-term on-site agreements. No calculation errors. (3) Multi-hop reasoning: The LLM synthesizes technological differentiation and integration across product lines well, correctly linking rare gas production to hydrogen and CO₂ projects. However, it incorrectly emphasizes cryogenic technologies, whereas the ground truth highlights Linde’s 2024 strategic pivot toward *non-cryogenic* air separation (e.g., VPSA, membrane separation) as a key differentiator. This is a significant omission, as the shift away from traditional cryogenic methods is central to Linde’s stated technological evolution. Additionally, the LLM does not reflect the year-by-year evolution (2022–2024) outlined in the original answer—particularly the increasing strategic emphasis on rare gases and the explicit 2024 focus on non-cryogenic innovation. (4) The answer is contextually relevant and captures the spirit of technological integration but misses the precise trajectory and technological repositioning (from cryogenic to non-cryogenic leadership) that defines Linde’s evolution. Hence, while the core facts about contracts and integration are correct, the technological differentiation narrative is misaligned, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 570,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nBetween 2022 and 2024 the collateral that ExxonMobil posts under master‑netting arrangements to offset derivatives tied to its advances to equity companies fell sharply—from about **$1.5 billion in 2022 to $0.8 billion in 2023 and $0.5 billion in 2024**. This shrinking buffer means the company has **less protection against potential losses on those derivative liabilities**, indicating that its net exposure to derivative obligations linked to equity‑company relationships has effectively increased.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the numerical values for collateral amounts in 2022 ($1.5 billion), 2023 ($0.8 billion), and 2024 ($0.5 billion), which align with the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding). Thus, quantitative accuracy is high. 2) However, the qualitative interpretation is fundamentally incorrect: the LLM claims the declining collateral means 'less protection' and 'increased net exposure', which contradicts the correct inference. The original answer correctly interprets the decline as a reduction in exposure, suggesting de-risking. The LLM misinterprets the relationship between collateral posted and risk — a decrease in collateral under netting arrangements typically reflects a reduction in the underlying derivative positions or exposures, not an increase. 3) The multi-hop reasoning fails at the synthesis stage: while the model retrieves the correct trend in collateral amounts, it draws the opposite conclusion about risk exposure, indicating flawed financial logic. This is a critical error in qualitative reasoning. 4) Contextually, the answer addresses both parts of the question (evolution of collateral and its implication), so relevance is high, but the incorrect inference severely undermines the overall correctness. Hence, the correctness score is low despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 381,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 NEER’s “long‑term” share of net generating capacity held steady at a very high level – the 2022 filing notes that about 92 % of its capacity was under long‑term bilateral contracts, and by the end of 2023 and again in 2024 that figure rose to roughly 94 % (pages 18 of NEE_10k_2023.pdf and 19 of NEE_10k_2024.pdf).  This modest but consistent increase shows that NEER is deliberately locking a larger portion of its output into long‑term PPAs, using shorter‑term or spot‑market sales only where necessary and supplementing them with non‑qualifying hedges to protect revenue.  The trend reflects a risk‑mitigation strategy that cushions the business against price volatility and market competition by securing fixed or hedged cash flows across its diversified, fuel‑type and geography‑spread portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts: 92% in 2022 and 94% in both 2023 and 2024, matching the ground truth exactly. The mention of specific document pages (18 of NEE_10k_2023.pdf and 19 of NEE_10k_2024.pdf) adds verifiable sourcing and does not contradict the knowledge graph. 2) All numbers are accurate and consistent with the original answer. The progression from 92% to 94% is correctly described as a 'modest but consistent increase,' which aligns with the ground truth's characterization of a 'steady increase.' There are no calculation errors. 3) The reasoning is sound: the LLM correctly infers that increasing reliance on long-term contracts reflects a strategy to mitigate price volatility and secure stable cash flows. It accurately notes the use of shorter-term contracts and hedges as supplements, which matches the original answer’s point about using shorter-term bilateral contracts as a hedge. The only minor gap is that the LLM mentions 'non-qualifying hedges,' a term not present in the ground truth, which slightly over-specifies the type of hedge without confirmation from the source. However, this does not contradict the original and is plausible in context. 4) The answer fully addresses both parts of the question: the evolution of contract reliance (2022–2024) and the implication for risk mitigation. It synthesizes information across years and correctly interprets strategic intent. Wording differs but semantic meaning is equivalent. Overall, this is a highly accurate, well-reasoned response with only negligible over-specification, warranting a 9/10 for correctness and qualitative accuracy, and full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 476,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe current portion of the 3.125 % senior notes maturing in January 2025 fell from about **$1.56 billion at the end of fiscal 2023** to **$1.25 billion at the end of fiscal 2024** (the balance was higher in fiscal 2022).  This decline shows that AVGO deliberately used cash on hand and the proceeds from its July 2024 and October 2024 senior‑note issuances to retire a portion of the 3.125 % notes before maturity, reflecting a proactive debt‑management strategy that reduces near‑term interest expense and improves the company’s leverage profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The original answer states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million from fiscal 2022 through fiscal 2024. In contrast, the LLM claims the current portion fell from $1.56 billion in fiscal 2023 to $1.25 billion in fiscal 2024, which contradicts the ground truth. These numbers are not only wrong but also refer to a 'current portion' that is not mentioned in the original answer, and the amounts are more than double the actual principal. (2) The quantitative inaccuracies are severe: the correct principal is $495 million (not $1.56B or $1.25B), and it did not change over the three-year period. The LLM invents a reduction that did not occur and cites non-existent issuances in July and October 2024. There is no evidence of principal retirement. (3) The multi-hop reasoning is fundamentally flawed. The LLM incorrectly infers a proactive debt retirement strategy based on fabricated data. The original answer suggests AVGO may refinance or use cash reserves since no amortization occurred—no such conclusion can be drawn about using note proceeds or reducing interest expense. The LLM fails to correctly synthesize the actual data and introduces unsupported events. (4) The contextual relevance is low but not zero because the answer addresses debt management strategy in general terms. However, due to complete factual inaccuracy and invented figures, the correctness, quantitative, and qualitative scores are near the minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 432,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group’s **Unsecured Notes ‑ 37B** showed no change in any of its key terms: the interest rate stayed at **2.25 %**, the outstanding **face amount remained $700 million**, and the **maturity date stayed 15 January 2032** (as shown in the 2021‑2023 tables on pages 50‑51 and the 2024 table on page 51).  \n\nThis three‑year stability demonstrates that the company is deliberately **maintaining a low‑cost, long‑dated unsecured position**, using the 37B note as a core pillar of its long‑term debt strategy to lock in favorable financing and extend its maturity profile while minimizing refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032) are correctly reported and consistent across 2022–2024. Minor formatting differences (e.g., $700 million vs $700,000,000) are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect—no calculation errors or misstatements. (3) The multi-hop reasoning is sound: the model correctly identifies that the note terms remained unchanged over three years and infers the strategic intent behind this stability—locking in low-cost, long-term financing and reducing refinancing risk. (4) The answer addresses all parts of the question: evolution of terms (no change), and interpretation of long-term debt strategy. The qualitative reasoning aligns with the ground truth, emphasizing predictability, extended maturities, and alignment with stable cash flows from real estate. Contextual relevance is excellent, with precise references to filing pages and clear synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 311,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K property tables, Melaka, Malaysia is listed in every year under the **Analog** column only—there is never an “X” in the Embedded‑Processing column, and the site’s footnote status ( † or ** ) merely reflects its lease/ownership arrangement.  Consequently, TI’s Melaka footprint remained a dedicated analog‑manufacturing location throughout the three‑year period, underscoring a strategic focus on analog chip production in Malaysia rather than a shift toward embedded‑processing activities there.  The unchanged classification reveals that the company continues to leverage Melaka for its analog portfolio, while embedded processing is handled at other sites.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Melaka, Malaysia was consistently listed under the Analog column only from 2022 to 2024, with no presence in Embedded Processing—matching the original answer's claim about the 'X' markings. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the absence of changes over the three years is properly noted. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of 10-K filings to infer a stable operational focus, concluding that Melaka remains dedicated to analog production. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the operational footprint and what it reveals about TI’s strategic focus. The mention of footnote symbols (†/ **) does not detract from accuracy, as it correctly notes they relate to lease/ownership and not product line changes. Overall, the response demonstrates precise entity identification (Texas Instruments, Melaka, analog vs. embedded processing), correct temporal reasoning, and valid strategic interpretation—justifying top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 348,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened the reach of its multi‑layered security by (1) expanding its real‑time payments infrastructure to 13 markets by the end of 2023 and, in 2024, rolling it out to additional jurisdictions—including domestic transactions in China via a joint‑venture—while embedding security controls such as tokenization, fraud‑scoring and AI‑driven monitoring directly into the real‑time clearing and settlement layer; (2) tightening collaboration with issuers, acquirers, governments and industry associations to adopt technical standards (EMV, tokenization, alias‑based remittances, VCN platforms) and to enforce ecosystem‑wide operating, safety and stewardship rules that protect the growing volume of cross‑border and domestic transactions; and (3) scaling its security‑operations capabilities—Mastercard Intelligence Center, Fusion Centers, third‑party assessments, enterprise‑resilience and insurance programs—to maintain consistent protection across the increasingly global, multi‑rail network that now supports real‑time account‑based payments in a majority of the world’s banked population.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach from 2022 through 2024 with accurate details on market expansion (12 to 13 markets by 2023, then China in 2024), security enhancements (tokenization, fraud scoring, AI monitoring), and ecosystem collaboration. All key factual elements from the ground truth are present and semantically equivalent. (2) Quantitative accuracy is perfect: the number of markets (12 in 2022, 13 by 2023) matches the original answer, and the 2024 expansion into China via joint venture is correctly stated. No calculations were required, but all numeric references are accurate. (3) Multi-hop reasoning is sound—LLM synthesizes information across time (2022–2024), geography (global markets, China), and organizational layers (issuers, governments, third parties). It correctly infers that scaling into China required enhanced security integration and that real-time infrastructure expansion necessitated embedding controls at the transaction layer. The mention of EMV, tokenization, and public-private collaboration aligns with the original. (4) The only minor shortcoming is that the original answer explicitly notes the 2022 baseline of 12 top GDP markets with real-time payments, while the LLM implies this expansion but does not explicitly state the 2022 baseline number upfront (though it correctly notes 13 markets by 2023, implying the prior count). This slight omission prevents a perfect 10 on qualitative accuracy, but overall the answer is comprehensive, factually correct, and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 441,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nGeneral Dynamics cut the Canadian LAV build‑rate each year—producing roughly **449 units in 2022, 399 in 2023 and 360 in 2024**.  This steady decline shows the company is winding down the initial production phase and shifting its emphasis from new builds to **sustainment, upgrades and next‑generation LAV variants (e.g., the Ajax family and autonomous‑vehicle programs)**, signaling a strategic focus on modernising the existing fleet and leveraging export opportunities rather than expanding volume.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of production volume. The ground truth states production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024, but the LLM claims a decline from 449 in 2022 to 360 in 2024—reversing the actual trend. This fundamental error invalidates the entire response. (2) Quantitative accuracy is critically flawed: all three yearly figures are inverted. The correct sequence is 360 → 399 → 449 (increasing), while the LLM reports 449 → 399 → 360 (decreasing). No acceptable format variation justifies this reversal. (3) The multi-hop reasoning fails because the model misinterprets the data trend, leading to an incorrect strategic conclusion. Instead of identifying growing commitment to LAV programs, it posits a wind-down and shift to sustainment, which contradicts the evidence of increasing production volumes. (4) Contextual relevance is partially maintained as the answer discusses LAV production and strategic focus, but the incorrect data renders the analysis irrelevant. Scores reflect near-total factual inaccuracy with only minimal credit for addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 331,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership holdings in its pension portfolio rose modestly from about **$252 million in 2022** (page 168) to **$280 million in 2024** (page 170), an increase of roughly **11 %**.  The target allocation for hedge funds remained steady at **≈3 % of total plan assets** across the three years (e.g., 3 % in 2021‑2024 target tables, pages 169‑170), indicating that the company is expanding the absolute exposure only as the overall fund grows, while keeping the strategic weight constant.  This trajectory suggests a deliberate, steady emphasis on alternative‑asset diversification to enhance returns without dramatically shifting the overall asset‑mix strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's allocation was $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly states $252 million as the 2022 amount and $280 million in 2024, which is not supported by the ground truth. The claimed 11% increase is also incorrect; the actual increase from 2022 to 2024 is 17.8% ($214M to $252M). (2) Calculations are flawed: the LLM’s stated increase from $252M to $280M would be about 11%, but those base numbers are wrong. The correct calculation is ($252M - $214M) / $214M ≈ 17.8%. (3) The qualitative reasoning about a steady target allocation of ~3% and strategic consistency has merit and aligns with the type of analysis suggested by the question, but this is not corroborated in the ground truth provided, which does not mention target percentages or overall fund growth. Thus, while the reasoning is plausible, it introduces unverified details (e.g., page references, target allocation stability) not present in the original answer, undermining its accuracy. (4) The answer addresses the question’s structure—discussing change over time and strategic implications—and maintains contextual relevance by focusing on pension strategy and alternative investments. However, due to major quantitative errors and unsupported specifics, the overall correctness is low despite some reasonable interpretation of intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 410,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe Target MasterCard Credit Card’s “RedCard” penetration fell steadily from roughly 20.5 percent in fiscal 2022 to 19.8 percent in fiscal 2023 and 18.6 percent in fiscal 2024. This decline signals a modest erosion in consumer adoption and engagement with Target’s branded credit products over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the declining trend in Target MasterCard (RedCard) penetration from 2022 to 2024 and attributes it to weakening consumer adoption, which aligns with the ground truth. However, the 2024 penetration rate is incorrect: the LLM states 18.6%, while the ground truth is 17.8%. This is a significant numerical error affecting quantitative accuracy. The 2022 (20.5%) and 2023 (19.8%) figures are accurate.\n\n2) Quantitative verification: 2022 = 20.5% (correct), 2023 = 19.8% (correct), 2024 = 18.6% (incorrect; should be 17.8%). The error in the final data point affects trend interpretation, as the decline is steeper than reported. No calculations (e.g., differences or rates of change) are requested, so no computational errors beyond the wrong value.\n\n3) Reasoning and multi-hop synthesis: The LLM correctly infers that declining penetration suggests reduced consumer engagement, which is logically sound and consistent with the ground truth. It references the broader RedCard program accurately and contextualizes the trend appropriately. However, it omits the key nuance that RedCard sales grew in absolute terms but were outpaced by total sales growth, which explains the dilution. This missing context slightly weakens the qualitative depth.\n\n4) Despite the numerical inaccuracy in 2024, the overall direction and implication of the trend are correctly interpreted. The answer is well-structured and relevant, addressing both parts of the question—evolution of penetration and its implications. The error is significant but not fundamental, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 444,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the fair‑value exposure tied to FPL cost‑recovery clauses grew from roughly $2 million (net) to about $38 million (net). This increase is driven almost entirely by the “significant unobservable inputs” tier — $27 million, $6 million and $1 million for the 2025‑2027 maturities — while the “significant other observable inputs” contribution stayed modest at around $4 million, indicating the exposure remained overwhelmingly dependent on unobservable assumptions with only a small observable‑input component.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the total fair value in 2022 was $1 million, not $2 million as stated. The LLM incorrectly reports a $38 million net value in 2024, which matches the ground truth, but misrepresents the 2022 and 2023 figures entirely. Most critically, the LLM introduces maturities for 2025–2027 ($27M, $6M, $1M), which are not part of the question or the original data and are factually incorrect in context. The contribution from significant other observable inputs is misrepresented: in 2022 it was -$5M, in 2023 -$12M, and in 2024 +$4M; the LLM incorrectly states it stayed around +$4M throughout, ignoring the negative contributions in prior years. (2) Calculations and values are not accurate: the LLM fails to report the 2023 total of $12M and omits the shift from negative to positive observable inputs. The $27M unobservable input for 2025–2027 is fabricated and unrelated to the 2022–2024 timeframe. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize year-over-year changes in fair value components across 2022–2024. It misattributes growth to future maturities not mentioned in the original answer and misses the evolution in observable inputs (from negative to positive). (4) While the LLM recognizes increasing reliance on unobservable inputs and identifies the $38M 2024 figure correctly, the overall answer is marred by incorrect data, fabricated timeframes, and omission of key transitional data. The contextual relevance is moderate because it addresses fair value exposure and input types, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 462,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Nike’s filings highlight a continued focus on advanced product‑innovation platforms—Air, Zoom, Flyknit, React and Adapt—and on global brand‑engagement tactics such as athlete endorsements, digital‑first commerce and community‑investment programs.  Anta, by contrast, is noted only as a domestic competitor in the 10‑K discussion, with no comparable worldwide innovation pipeline or brand‑engagement infrastructure described.  As a result, Nike’s competitive positioning relative to Anta has reinforced its lead in product innovation and consumer connection, while Anta’s growth remains more regionally concentrated.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key elements of the multi-year evolution in NKE's competitive positioning relative to Anta as detailed in the ground truth. (1) Correct aspects: The LLM accurately identifies NKE’s focus on product innovation platforms (Air, Zoom, etc.) and brand engagement via athlete endorsements and digital commerce, which aligns with the general themes in the original answer. It also correctly notes that Anta is mentioned as a competitor, though more regionally focused. (2) Quantitative accuracy: There are no numeric values, dates, or calculations in either answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning gaps: The LLM fails to capture the *evolution* from 2022 to 2024—specifically, the strategic shift where 'innovation and development' overtook 'performance and reliability' in priority by 2023, and the increased emphasis on digital experiences and social media in 2024. This temporal progression is central to the question and missing in the LLM response. Additionally, the LLM incorrectly implies Anta is only mentioned as a 'domestic competitor'—the original answer states Anta was a 'named competitor' across all three years, but does not specify domestic vs. global in NKE’s characterization. (4) The answer is contextually relevant and uses appropriate terminology, but lacks the year-by-year synthesis required for full accuracy. While it draws a reasonable conclusion about NKE reinforcing its lead, it does not reflect the strategic *response* to Anta’s rising traction through localized and digital-native strategies, which is a key nuance in the ground truth. Thus, the correctness and qualitative accuracy scores are moderate due to missing evolutionary dynamics and incomplete synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 484,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nFrom 2022 through 2024 the pool of shares that remained available for future grants under the Texas Instruments 2003 Director Compensation Plan shrank markedly – the number of shares left for issuance fell from roughly **1.5 million** in 2022 to **about 1.2 million** by 2024 (a decline of roughly 20 %).  This reduction shows that the legacy 2003 plan’s share reserve is being exhausted as the company increasingly relies on newer, broader long‑term incentive programs (e.g., the 2024 Long‑Term Incentive Plan) to meet its director‑compensation needs.  Consequently, while the 2003 plan is still referenced for existing grants, TI is gradually winding down its use in favor of more recent plans.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that the 2003 Director Compensation Plan went from being active in 2022 with shares issued, to no longer having shares available for future issuance by 2023, and being completely phased out by 2024. However, the LLM claims there were still approximately 1.5 million shares available in 2022 and about 1.2 million in 2024, which contradicts the ground truth that the plan was no longer listed as having available shares starting in 2023. This represents a major factual error. (2) The calculation of a 20% decline from 1.5M to 1.2M shares is mathematically correct, but the numbers themselves are incorrect per the source data. There is no mention in the ground truth of specific share counts like 1.5M or 1.2M; instead, the key point is the absence of the plan from lists of plans with available shares after 2022. (3) The reasoning about a strategic shift toward newer plans like the 2024 LTIP is semantically aligned with the ground truth and shows correct multi-hop synthesis regarding TI's move to updated incentive structures. The acknowledgment that the 2003 plan is still referenced for outstanding grants is also accurate. However, the failure to correctly represent the timeline of unavailability (i.e., shares no longer available as of 2023, not 2024) undermines the reasoning. (4) The contextual relevance is high because the answer addresses the evolution of share availability and interprets the trend in terms of TI’s compensation strategy. However, due to the critical quantitative and temporal inaccuracies, the overall correctness score is low. The qualitative accuracy is moderate because the conceptual interpretation is sound, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 494,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA deepened the data‑driven side of its ad business by embedding advanced analytics and programmatic marketplace tools into its X1/Flex streaming platform, the Xumo Stream Box and the broader Peacock‑and‑DTC ecosystem, allowing advertisers to target and measure audiences across linear TV, streaming and wireless bundles.  At the same time the company upgraded its network stack—rolling out DOCSIS 4.0, virtualizing core network functions and expanding cloud‑DVR and Wi‑Fi management capabilities—to support richer audience‑rating data and real‑time ad‑sale automation.  These technology and tool enhancements gave advertisers a unified, data‑centric marketplace for buying inventory and engaging target audiences across CMCSA’s media and connectivity platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no explicit numeric values, dates, or financial figures, so quantitative accuracy is not applicable in a traditional sense—however, since there are no incorrect numbers, it does not introduce factual errors in this dimension, warranting a score of 10. However, the qualitative accuracy is low because the LLM introduces entities and technological developments not present in the ground truth. For example, the mention of 'DOCSIS 4.0', 'virtualizing core network functions', 'cloud-DVR', 'Wi-Fi management', 'X1/Flex streaming platform', 'Xumo Stream Box', and 'Peacock-and-DTC ecosystem' are specific technical components and product integrations that are not referenced or supported by the original answer. The original answer emphasizes a general evolution of data-driven advertising services with increasing integration of cloud platforms, search functionality, and expanded third-party representation agreements—none of which are reflected in the LLM response. While the LLM captures the general theme of enhancing data-driven advertising tools, it fabricates specific technologies and platforms, failing the multi-hop reasoning requirement to accurately synthesize the evolution across 2022–2024 based on the provided knowledge. The contextual relevance is moderate because the answer addresses advertising evolution and technology enhancements but does so with incorrect supporting details. The core progression—deeper integration of data services, cloud use, and marketplace expansion—is misrepresented through over-specific, unverified technical claims, leading to a correctness score of 4: partially correct in direction but significantly flawed in factual content and entity accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 465,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the fair value of CVS’s commercial‑mortgage‑backed securities fell from about **$1.02 bn to $0.98 bn**, while the total unrealized loss attached to them dropped sharply from **≈ $155 m to ≈ $100 m** (see the 2022 and 2023 tables of debt securities on pages 149‑151).  By the end of 2024 the remaining CMBS holding in the separate‑account portfolio was essentially negligible (**$3 m**), indicating that CVS has markedly reduced its exposure to this asset class and is therefore positioning itself with far lower interest‑rate and credit‑risk volatility in commercial‑mortgage‑backed securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS held $574 million in CMBS in 2022 with $12 million in unrealized losses, but the LLM claims $1.02 billion and $155 million, respectively—both are grossly incorrect. In 2023, the ground truth reports CMBS fair value increased to $675 million (not decreased to $0.98 billion as stated), while unrealized losses rose to $100 million (which the LLM correctly identifies). By 2024, the correct value is $6 million with no significant losses, but the LLM reports $3 million—close but still inaccurate. (2) Calculations and comparisons are flawed: the LLM incorrectly states that fair value decreased from 2022 to 2023, when it actually increased; it also misrepresents the trend in unrealized losses, claiming they dropped from $155M to $100M, whereas they surged from $12M to $100M. These errors distort the entire narrative. (3) Multi-hop reasoning is partially sound—the LLM correctly infers reduced exposure and de-risking by 2024, which aligns with the strategic conclusion in the original answer. However, this insight is based on incorrect data, undermining the validity of the reasoning. (4) Contextual relevance is fair: the answer addresses the evolution of CMBS exposure and draws a reasonable conclusion about risk positioning, but due to severe quantitative inaccuracies, the overall correctness score is low. The model appears to have referenced incorrect source data (e.g., possibly conflating separate-account assets or misreading tables on pages 149–151), leading to a factually unsound response despite a plausible narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 458,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nTarget’s 2022, 2023 and 2024 Form 10‑K filings all list “merchandise and other discounts” as a component of the company’s compensation packages, but the language is essentially unchanged – the 2022 and 2023 disclosures simply note that such discounts are offered, while the 2024 filing repeats the same wording without adding new quantitative details or expanding the scope.  This consistency shows that Target treats employee merchandise discounts as a stable, baseline benefit rather than a variable or growing program.  By keeping the discount benefit steady while simultaneously broadening other elements of the package (e.g., higher starting wages, tuition‑free education assistance, expanded mental‑health resources), the company signals that its employee‑benefit strategy is built around a reliable, holistic set of perks that reinforce financial well‑being and retention, with the discount offering serving as a consistent, low‑cost lever to enhance the overall value proposition for team members.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that merchandise discounts were consistently offered across 2022–2024 and that Target maintained them as a stable benefit. It correctly identifies the broader context of expanding employee benefits such as tuition-free education and mental health resources. However, it inaccurately claims that the 'language is essentially unchanged' and that the 2024 filing 'repeats the same wording' without expansion. The ground truth indicates a clear evolution in how benefits were framed and grouped—specifically, that merchandise discounts were increasingly embedded within a more comprehensive, holistic benefits ecosystem emphasizing financial wellness (2023) and mental health/virtual care (2024). This progression suggests a strategic enhancement in presentation and integration of benefits, which the LLM underplays by emphasizing textual consistency. While no specific dollar amounts or numerical data are involved (so quantitative accuracy is 10), the qualitative assessment of the strategic evolution is incomplete. The LLM correctly infers a strategy of stability in discounts alongside broader benefit expansion but misses the nuanced shift in emphasis and integration over time, which is central to the original answer. Thus, while contextually relevant and factually sound on surface-level details, it lacks depth in capturing the multi-year narrative progression, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 401,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s discussion of cultural issues in acquisition integration moved from a brief, generic risk note (“cultural challenges associated with integrating employees from the acquired company”) to a detailed, cross‑border focus that explicitly cites “integration of operations across different cultures and languages” and links cultural fit to broader strategic risks such as regulatory change, talent retention and synergy realization.  This evolution shows that Linde now treats cultural compatibility as a core strategic pillar for managing cross‑border integration risk—embedding cultural due‑diligence, localized talent‑retention programs and governance alignment into its acquisition playbook to protect deal value and limit disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Linde's emphasis on cultural challenges from 2022 to 2024: starting as a generic risk in 2022 ('cultural challenges associated with integrating employees'), expanding in 2023 to include cross-border operational and regulatory complexities, and sharpening in 2024 around financial and strategic outcomes like synergy realization and talent retention. These points match the original answer’s timeline and substance. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or amounts. (3) The multi-hop reasoning is sound: the model synthesizes changes across years and correctly infers that Linde’s approach evolved from operational concern to strategic risk management. The LLM adds slightly more prescriptive detail (e.g., 'cultural due-diligence', 'localized talent-retention programs') that are plausible interpretations but not explicitly stated in the ground truth, which slightly affects qualitative precision. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of cultural challenge framing and what it reveals about Linde’s strategic approach to cross-border integration risks. The conclusion that cultural integration became a 'core strategic pillar' is a strong, justified synthesis of the trend described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 404,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nExxonMobil’s collateral that is posted under master‑netting arrangements and is not offset against derivatives—​the amount tied to the “Notes and accounts receivable – net” balance—fell from **$1.49 billion at the end of 2022 to $0.80 billion in 2023 and then to $0.49 billion by the end of 2024**. This steady decline shows that the company is increasingly able to manage its derivative exposure through internal netting and stronger counterparty relationships, requiring less external collateral and signaling a more efficient, lower‑risk approach to derivative credit management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable and commonly used in financial reporting. 2) All numeric values are accurate and properly formatted; the conversion from millions to billions is consistent and correct. There are no calculation errors. 3) The multi-hop reasoning is sound: the model correctly identifies the trend (consistent decline) and synthesizes it with implications for derivative exposure management. The interpretation—that the decline suggests improved netting, reduced reliance on external collateral, and more efficient risk management—is logically consistent with the data and adds reasonable qualitative insight beyond the ground truth, without overreaching. 4) The entities (ExxonMobil, collateral under master netting arrangements, Notes and accounts receivable - net) and time periods (2022–2024) are correctly identified. The answer fully addresses both parts of the question: the quantitative change and its implication for derivative exposure management. The only minor difference is that the LLM uses slightly more interpretive language (e.g., 'stronger counterparty relationships'), which is plausible but not explicitly stated in the ground truth. However, this does not detract from factual accuracy. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 415,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform shifted from a standalone, mainframe‑centric tool that mainly interpreted security posture, identified risks and generated remediation recommendations for internal SIEM use, to a core element of Broadcom’s Enterprise Security portfolio that is tightly integrated with external security orchestration and DevOps ecosystems (SIEM, SOAR, ticketing, AIOps pipelines) and leverages AI‑driven threat intelligence to automate cross‑environment remediation. This evolution reflects a broader strategic alignment with zero‑trust, cloud‑and‑edge security strategies, delivering unified visibility and response across on‑prem, cloud and edge workloads.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the directional evolution of AVGO's Security Insights Platform from a standalone mainframe tool to a more integrated component of a broader security portfolio, which aligns with the ground truth. It accurately reflects increased integration with external tools (e.g., SIEM, ticketing, AIOps), enhanced remediation processes (including automation), and alignment with modern cybersecurity strategies. However, there are some overstatements not supported by the original answer: (1) The 2024 description in the ground truth does not mention 'AI-driven threat intelligence' or 'zero-trust, cloud-and-edge security strategies'—these are plausible extrapolations but not explicitly stated. (2) The original answer emphasizes integration within an expanded mainframe software suite (Cybersecurity, AIOps, DevOps) and regulatory compliance, while the LLM answer shifts focus toward cross-environment (cloud, edge) orchestration and automation, which goes beyond the documented scope. (3) The term 'SOAR' and 'security orchestration' are not mentioned in the original, though implied by 'ticketing' and 'remediation'. The LLM answer is semantically close and captures the core evolution accurately, but adds strategic elements not present in the source, reducing qualitative accuracy. There are no numerical values, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as all aspects of the question are addressed with mostly accurate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 411,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 32B remained unchanged: the outstanding face amount stayed at **$750 million** and the contractual interest rate held at **3.38 %**, with the tranche maturing on **06/15/27** in every filing.  This consistency shows that SPG is deliberately using a laddered series of fixed‑rate unsecured notes—locking in low‑cost, long‑term financing and minimizing exposure to floating‑rate volatility—so that its long‑term debt profile is stable, predictable, and aligned with the long‑life of its retail‑property assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the face amount ($750 million), interest rate (3.38%), and maturity date (06/15/27) are consistent across 2022–2024, matching the ground truth exactly. Format variations (e.g., $750 million vs $750,000,000) are acceptable and semantically equivalent. 2) Quantitative accuracy is perfect—no errors in numbers, dates, or percentages. 3) The reasoning is sound: the model correctly infers a stable long-term debt strategy based on unchanged terms over three years. It adds contextual insight about a 'laddered series of fixed-rate unsecured notes' and alignment with retail-property assets, which is a reasonable interpretation and enhances the explanation without contradicting the ground truth. However, the original answer emphasizes the absence of early redemption or restructuring despite market shifts, while the LLM focuses more on strategic benefits than explicit inaction—this is a minor difference in emphasis, not inaccuracy. 4) The answer is fully contextually relevant, addressing both the evolution of exposure and the implication for debt management strategy. All parts of the multi-hop question are addressed with correct entity (SPG, Unsecured Notes - 32B), time period (2022–2024), and metric tracking. The synthesis across years is accurate and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 373,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast’s 10‑K filings show that Lumen’s competitive threat has moved from a modest, region‑specific fiber rollout to a broader, nationwide fiber expansion that now reaches many of Comcast’s core service areas, delivering symmetrical gigabit‑plus speeds that directly challenge Comcast’s DOCSIS‑based broadband.  At the same time, Lumen has intensified its bundling approach—offering fiber‑backed broadband together with video, voice and wireless services (often as “triple‑play” or “quad‑play” packages)—to compete with Comcast’s Xfinity bundles and to leverage federal broadband‑deployment subsidies, thereby increasing the pressure on Comcast’s broadband business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolving competitive threat from Lumen to CMCSA (Comcast) from 2022 to 2024. It accurately captures the key trends: Lumen's fiber network expansion and its intensified bundling strategy as a direct challenge to Comcast’s broadband and service offerings. There are no numeric inaccuracies—no specific figures (e.g., dollar amounts, percentages, subscriber counts) are cited in either the original or LLM answer, so quantitative accuracy is not compromised. The LLM adds some detail not explicitly in the ground truth (e.g., 'symmetrical gigabit-plus speeds', 'DOCSIS-based broadband', 'federal broadband-deployment subsidies', 'triple-play/quad-play packages'), which are plausible and contextually appropriate but not verifiable from the original answer. These additions enhance clarity but slightly extend beyond the documented evidence, which describes general fiber expansion and bundling without specifying speed tiers, technology comparisons, or subsidy use. The multi-hop reasoning is sound: the LLM synthesizes the progression of competitive dynamics across years and correctly identifies fiber deployment and bundling as core strategies. The answer addresses both parts of the question—fiber expansion and bundling—and maintains high contextual relevance. However, because the LLM introduces specific technical and policy-related details not present in the original knowledge graph, it slightly overreaches in precision, warranting a minor deduction in qualitative accuracy. Overall, the semantic meaning matches the ground truth, and the core facts are correct, justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 461,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe share of purchases made with Target’s branded payment cards slipped modestly over the three fiscal years – from about **19.8 % in 2022**, to **18.6 % in 2023**, and **17.8 % in 2024**.  This downward trend indicates that the loyalty‑driven discount incentive attached to the RedCard/Target Circle Card program is gradually losing its ability to generate incremental sales, suggesting diminishing effectiveness of the strategy over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. However, the LLM reports 19.8% in 2022, 18.6% in 2023, and 17.8% in 2024. The 2022 figure is off by 0.7 percentage points, and the 2023 figure is off by 1.2 percentage points. Only the 2024 value is correct. These discrepancies affect the accuracy of the trend portrayal, though the general direction (downward) is preserved. (2) The calculations implied (year-over-year decline) are not explicitly shown, but the percentages themselves are incorrect, which invalidates any derived insights based on precise changes. The 2022–2023 drop is misrepresented as 1.2 pts instead of the actual 0.7 pts, and the 2023–2024 drop is overstated as 0.8 pts instead of the actual 2.0 pts. (3) The qualitative reasoning is sound: the downward trend is correctly interpreted as suggesting diminishing effectiveness of Target’s loyalty-driven payment strategy, which aligns with the ground truth’s interpretation. The mention of RedCard/Target Circle Card adds contextual detail consistent with Target’s known programs. (4) The answer is contextually relevant and addresses both parts of the question—evolution over time and strategic implication—though with flawed data. The synthesis across years is attempted and logically structured, but based on incorrect inputs. Thus, while reasoning and relevance are strong, the correctness score is limited by factual inaccuracy in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 427,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept a non‑operated working interest in offshore blocks in the Republic of Congo (e.g., the Haute Mer and Lianzi permits) and continued to invest capital in developing those deep‑water assets, spending roughly $0.7 billion annually on African projects that included exploration, drilling and field‑development activities.  The company framed these holdings as part of its upstream growth portfolio while aligning them with its broader lower‑carbon and net‑zero aspirations, even as it managed regulatory, political and market risks that could affect the assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but fails to accurately reflect the full evolution of Chevron's engagement from 2022 to 2024, particularly missing the critical 2024 divestiture. (1) Correct elements: Chevron had non-operated interests in Haute Mer and Lianzi, and the $0.7 billion investment figure in African projects in 2023 is accurate. However, the LLM incorrectly states that Chevron continued investing 'annually' at that level, implying ongoing commitment in 2024, which contradicts the ground truth. (2) Quantitative accuracy: The $0.7 billion figure is correctly cited but misattributed as an annual recurring investment, whereas it refers specifically to 2023 across Africa, not solely Congo. Percentages for asset ownership (31.5% in Haute Mer, 15.75% in Lianzi) are not mentioned in the LLM answer, missing key specifics. (3) Reasoning: The LLM fails the multi-hop synthesis by not recognizing the strategic shift—while correctly noting early-stage investment and strategic framing, it omits the 2024 exit entirely, which is central to the question about evolution. This omission fundamentally undermines the qualitative accuracy. (4) Contextual relevance is moderate: the response addresses asset ownership and investment levels but presents an incomplete and misleading narrative by excluding divestiture, thus failing to capture the strategic repositioning. Overall, the answer is factually incomplete and misrepresents the trajectory, warranting a low correctness score despite some accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 420,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nFrom 2022 to 2024 NEE’s gas‑related derivatives first expanded—forward gas contracts grew from about $190 million (assets) and $31 million (liabilities) in 2022 to $377 million (assets) and $77 million (liabilities) in 2023, with option notional staying near $100 million—but by 2024 the forward position receded to roughly $300 million (assets) and $46 million (liabilities), while option liabilities edged up slightly. This contraction coincides with a plunge in gains from commodity contracts (from $2.5 billion in 2023 to $97 million in 2024) and only a modest rise in weighted‑average implied volatility (≈50 %→≈52 %), indicating that NEE has deliberately reduced its speculative gas‑price exposure and is adopting a more conservative, hedging‑focused stance in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It discusses 'forward gas contracts' and 'commodity contract gains' that are not mentioned in the ground truth and misrepresents the evolution of NextEra Energy's (NEE) gas-related options. The original answer focuses exclusively on options with specific fair values and implied volatilities, while the LLM confuses options with forwards and introduces unrelated metrics like 'gains from commodity contracts' ($2.5B in 2023, $97M in 2024), which are not in the ground truth. (2) Quantitative inaccuracies are severe: the LLM claims forward contracts grew from $190M assets in 2022 to $377M in 2023, but the ground truth reports option assets of $356M in 2022 and $100M in 2023. The LLM’s $100M option notional in 2023 loosely matches the ground truth’s $100M asset value, but this appears coincidental given the incorrect context. Implied volatility is misrepresented: the LLM says it increased from ~50% to ~52%, but ground truth shows it rose from 36% (2022) to 50% (2023), then to 52% (2024), a much more significant shift. (3) Multi-hop reasoning is flawed: the LLM fails to correctly identify the financial instrument (options vs. forwards), misattributes changes to speculative exposure, and draws conclusions about 'hedging-focused stance' based on fabricated data. The ground truth indicates a sharp de-risking (fair value dropping from $356M to $100M in assets), which the LLM misses entirely by focusing on forward contracts. (4) Contextual relevance is moderate because the answer addresses gas market risk and volatility trends, but the factual foundation is so incorrect that the analysis is misleading. The conclusion about reduced speculative exposure aligns loosely with the ground truth’s 'strategic de-risking,' but it is unsupported by accurate data. Overall, the answer fails on correctness due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 522,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike’s 10‑K filings shifted FlyEase from a peripheral entry in a laundry‑list of technologies to a recurring highlight within its product‑research narrative.  The repeated mention of “FlyEase” alongside other core innovations (Air, Zoom, React, etc.) signals that the company is deliberately integrating the adaptive‑fit platform into its design and development roadmap, using it to drive inclusive performance‑footwear and to differentiate Nike’s innovation strategy around accessibility and purpose‑driven product development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Nike's FlyEase technology from 2022 to 2024 as described in the ground truth. It correctly identifies the progression from a minor mention in 2022 to a recurring, integrated innovation by 2024, aligning with the timeline and strategic implications. All entities (Nike, FlyEase, fiscal years 2022–2024) are correct, and no numeric inaccuracies are present—dates are properly framed within the fiscal period context. The reasoning is sound: the model infers increased strategic importance from repeated mentions and contextual placement in product R&D narratives, which matches the multi-hop synthesis required. The answer emphasizes FlyEase’s role in inclusive design and differentiation, adding interpretive depth consistent with the ground truth’s conclusion about long-term strategy. The only minor gap is that it does not explicitly note FlyEase was 'listed alongside' other technologies in 2022 (e.g., Nike Air, Flyknit), nor does it specify the 2023 expansion into multiple product categories. However, these details are implied through the description of progression. Wording differs but semantic meaning and factual content are substantially equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a high score with only slight deduction for minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 383,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the $750 million Unsecured Notes 35A kept the same terms – a fixed 2.65 % coupon, a July 15 2030 maturity and annual debt service of about $19.9 million – so the obligation did not grow or shrink during those years.  This consistency reflects SPG’s long‑term strategy of issuing a ladder of long‑dated, fixed‑rate unsecured notes to lock in low financing costs, extend the debt‑maturity profile and reduce reliance on variable‑rate mortgage debt, thereby maintaining a stable, predictable capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The original answer states that the face amount of Unsecured Notes - 35A is $750,000, not $750 million as claimed by the LLM. This is a critical error—off by a factor of 1,000. Similarly, the LLM reports annual debt service as 'about $19.9 million,' whereas the correct amount is $19,875. These miscalculations suggest either a misunderstanding or misrepresentation of the data. However, the interest rate (2.65%) and maturity date (07/15/30) are correctly reported, supporting partial accuracy. (2) Number verification: $750,000 × 2.65% = $19,875, which matches the ground truth. The LLM’s use of $750 million implies annual interest of ~$19.9 million, which would be correct only if the principal were indeed in the hundreds of millions—but it is not. Thus, calculations are logically consistent within the LLM’s incorrect magnitude, but factually wrong. (3) The multi-hop reasoning and qualitative interpretation are strong: the LLM correctly infers that stable terms reflect a long-term debt strategy focused on predictable financing, laddering maturities, and reducing variable-rate exposure. This aligns with the original answer’s conclusion about a 'steady approach' and 'stable capital structure.' Entity identification (SPG, Unsecured Notes - 35A) and time period (2022–2024) are accurate. (4) Despite sound reasoning and contextual relevance, the massive discrepancy in financial figures severely undermines factual correctness. Quantitative accuracy is low due to the order-of-magnitude errors, pulling down the overall correctness score. The answer is semantically aligned in intent but factually flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 465,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nAcross 2022‑2024 Texas Instruments kept embedded‑processing at the heart of its product strategy, but the segment’s performance was volatile: revenue rose modestly to $3.37 bn in 2023 before falling sharply to $2.53 bn in 2024, while operating profit dropped from $1.25 bn to just $0.35 bn as higher manufacturing costs and lower factory loadings squeezed margins. This steady emphasis on analog and embedded processing—even as short‑term results fluctuated—highlights TI’s long‑term growth model, which seeks to maximize free‑cash‑flow‑per‑share by leveraging its sustainable competitive advantages, disciplined capital allocation and relentless focus on cash‑generating efficiency rather than chasing headline revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention any financial figures for embedded processing revenue or operating profit for 2022, 2023, or 2024, nor does it indicate a decline in performance. The LLM fabricates specific numbers—$3.37B revenue in 2023, $2.53B in 2024, and operating profit dropping from $1.25B to $0.35B—which are not present in the original answer and contradict the positive, consistent strategic narrative. There is no mention of higher manufacturing costs or lower factory loadings in the ground truth. (2) These numbers are entirely invented, failing the quantitative accuracy test. Even allowing for format variations, the absence of such data in the original means the LLM hallucinated critical financial metrics. (3) The qualitative reasoning about TI’s long-term focus on free cash flow per share, competitive advantages, and capital allocation aligns partially with the original answer. The idea that TI emphasizes embedded processing despite short-term volatility reflects a plausible interpretation, but the original does not mention volatility or declining performance—instead, it stresses consistent strategic emphasis without financial deterioration. The multi-hop synthesis is partially sound in linking embedded processing to long-term cash flow goals, but it's built on false premises. (4) The contextual relevance is fair because the answer addresses the strategic role of embedded processing and ties it to free cash flow per share, which is central to the question. However, the made-up financial data severely undermines correctness. The qualitative accuracy is moderate due to correct framing of TI’s business model, but the hallucinated numbers drag down overall accuracy. Correctness score is low due to major factual errors in financial data, despite some alignment in strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 522,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nDisney’s Marvel franchise moved from behind‑the‑scenes content in 2022 to a headline “tile” on Disney+ by 2023 – the 2023 10‑K shows Marvel titles listed as a top‑level selection alongside Disney, Pixar, Star Wars and National Geographic (p. 7), and the 2024 filing still classifies Marvel trademarks and other franchise intangibles as indefinite‑lived assets (p. 113‑114).  This elevation reflects Disney’s financial strategy of using the Marvel brand as a subscriber‑growth engine on Disney+, capitalizing the associated intangible value and amortizing it over time while leveraging Marvel‑driven programming to drive subscription and advertising revenue across its streaming platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel was an indefinite-lived intangible asset in 2022 and remained so in 2024 (confirmed in 2024 10-K, p.113-114), and became a top-level tile on Disney+ by 2023 (2023 10-K, p.7). The strategic evolution from passive asset to active engagement driver is correctly identified. (2) There are no numeric inaccuracies—no specific numbers (e.g., subscriber count) are incorrectly stated. The LLM omits the specific Disney+ subscriber count of 123 million as of September 28, 2024, mentioned in the original answer, which is a minor completeness gap. (3) The multi-hop reasoning is sound: the LLM correctly links Marvel’s accounting treatment (intangible asset) with its strategic UI placement on Disney+, infers the financial strategy of leveraging brand equity for subscriber growth, and connects this to revenue streams (subscription and advertising). It also implicitly supports the idea of platform differentiation, though it does not explicitly mention ESPN+'s planned tile launch in fiscal 2025, a supporting detail in the original. (4) Despite these minor omissions, the LLM captures the core financial and strategic narrative—using Marvel as a capitalized, non-amortized intangible asset while actively deploying it to drive engagement and revenue. Wording differs but semantic meaning is equivalent. The omission of the exact subscriber figure prevents a perfect 10, but overall correctness, contextual relevance, and qualitative reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 427,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nMetLife has kept the same 59 % share of the closed‑block policies in force under its modified‑coinsurance arrangement throughout 2022‑2024.  However, the dollar size of the related recoverable balances grew sharply after the 2023 risk‑transfer with Global Atlantic – the company recorded about $10.3 bn of reinsurance recoverables (and a $770 m net cost of reinsurance) at the end of 2023, and by the end of 2024 the associated deposit assets and offset liabilities had risen to roughly $4.6 bn and $1.2 bn, respectively.  Thus, while the percentage of the closed block covered stayed constant, the absolute amount of reinsurance recoverable balances increased markedly over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the percentage of the closed block reinsured was 59.25% in 2022, decreased slightly to 59% in 2023, and remained at 59% in 2024. The LLM incorrectly states that the percentage was a constant 59% from 2022 to 2024, omitting the higher 2022 figure. More critically, the dollar amounts are entirely incorrect: the ground truth reports unsecured reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). The LLM cites $10.3B in 2023 and $4.6B/$1.2B in 2024 (deposit assets/liabilities), which do not match the ground truth and introduce concepts (deposit assets, offset liabilities, Global Atlantic transaction) not present in the original answer. (2) Quantitative accuracy is very low: all key numbers (percentages and dollar amounts) are either wrong or refer to different metrics. The $10.3B figure appears to conflate total recoverables with unrelated transactions and is not supported by the ground truth. (3) The reasoning is flawed: the LLM assumes a constant percentage and increasing exposure, contradicting the ground truth’s slight decrease in 2022 and decline in 2024 balances. It also introduces a 'risk-transfer with Global Atlantic' and net cost of reinsurance not mentioned in the original, indicating incorrect multi-hop synthesis or hallucination. (4) Contextual relevance is moderate because the answer addresses the general topic—evolution of modified coinsurance in terms of percentage and recoverable balances—but fails on factual alignment. The conclusion about 'constant percentage, increasing balances' is partially aligned with trend direction (2022–2023) but incorrect overall due to 2024 decline and wrong baseline. Due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 500,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nFrom 2022 to 2023 the amortized cost of CVS’s residential mortgage‑backed securities (RMBS) rose modestly — $845 million to $862 million — and the fair value increased from $757 million to $810 million, cutting the unrealized loss from roughly $88 million to $52 million; the 2024 separate‑account fair value of $71 million (up from $51 million) shows a small net increase. This flat‑to‑slightly‑upward trend reflects a deliberate, low‑risk stance: CVS is maintaining a modest, high‑quality RMBS position that has become less loss‑prone, underscoring a strategic focus on limited interest‑rate and credit exposure within its fixed‑income portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The reported values for CVS's RMBS investments are factually wrong. The ground truth states RMBS holdings were $629M (2022), $614M (2023), and $71M (2024), but the LLM claims $845M (2022) and $862M (2023) in amortized cost and $757M to $810M in fair value—none of which match the source data. The unrealized losses are also incorrect: ground truth reports $10M (2022) and $60M (2023), while LLM reports $88M and $52M. The 2024 value of $71M is correct in fair value but mischaracterized as a 'net increase' when it represents a sharp decline from prior years. (2) Completeness: The answer fails to capture the key trend—initial stability followed by a sharp 2024 drawdown—instead suggesting a flat-to-upward trend, which contradicts the data. It also omits the strategic de-risking narrative central to the original answer. (3) Entity Accuracy: While the company (CVS) and asset class (RMBS) are correct, the years and financial metrics (amortized cost, fair value, unrealized loss) are misaligned with actual filings. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers a 'low-risk stance' and 'less loss-prone' portfolio, when the ground truth shows rising unrealized losses in 2023 and a major 2024 divestment indicating prior risk accumulation and subsequent de-risking. The conclusion about strategic positioning is therefore unsupported and misleading. (5) Semantic Equivalence: The overall message is not equivalent—the LLM portrays stability and improvement, while the truth reflects volatility and strategic retreat. Only the 2024 $71M figure is correct, but it is misinterpreted in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 469,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife has continued to reinsure roughly **59 % of its closed block** under a **modified‑coinsurance** arrangement, but the 2023 risk‑transfer transaction with Global Atlantic expanded the scope of that arrangement to include separate‑account universal‑life and fixed‑annuity policies and required the Company to record **$10.3 billion of reinsurance recoverables and deposit receivables**.  The transaction was accounted for using the **deposit method**, with the deposit liability offset against the recoverable and the net cost of reinsurance amortized in the same way as DAC; consequently, deposit assets of **$4.6 billion (2024) and $5.1 billion (2023)** and corresponding deposit liabilities of **$1.2 billion and $1.3 billion** were reported on the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding the percentage of the closed block reinsured and the introduction of a new transaction with Global Atlantic not mentioned in the ground truth. The original answer states that MetLife consistently reinsured approximately 59% (59.25% in 2022, 59% in 2023 and 2024) under the same modified coinsurance agreement, with no change in accounting treatment. However, the LLM claims a '2023 risk-transfer transaction with Global Atlantic' that expanded the arrangement—this is not supported by the ground truth and introduces a false entity and event. (2) Quantitative inaccuracies include fabricated dollar amounts: $10.3 billion of reinsurance recoverables, $4.6B and $5.1B deposit assets, and $1.2B/$1.3B liabilities in 2024/2023. These figures do not appear in the ground truth, which provides no such financials. The percentages (59%) are roughly correct but presented as static when the LLM implies a change due to a new transaction. (3) The reasoning is flawed because it invents a multi-hop connection (Global Atlantic transaction) that doesn't exist in the source data, leading to incorrect conclusions about evolution in the agreement. The actual evolution was minimal—only a slight rounding down from 59.25% to 59%, with consistent accounting. (4) While the mention of the deposit method and offsetting is correct and relevant, the overall answer misrepresents the stability of the arrangement. The contextual relevance is moderate because it discusses the right topic and accounting method, but the invented transaction undermines correctness. Thus, the correctness score is low due to major factual and quantitative errors despite some accurate terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 472,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s net notional exposure to natural‑gas forwards fell from about **1.45 billion MMBtu to roughly 1.13 billion MMBtu** (a ~22 % reduction), indicating that the company has been **scaling back its direct forward‑gas commitments**. This contraction signals a more cautious stance on gas‑price volatility and suggests NextEra is shifting toward a diversified or option‑based hedging strategy to manage earnings risk in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of the trend. The ground truth states that NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022, increased to $300 million in 2023, and then declined to $250 million in 2024. The LLM instead reports a completely different metric—net notional exposure in MMBtu (1.45 billion to 1.13 billion)—which is not mentioned in the original answer and contradicts the dollar-based exposure figures. There is no mention of assets or liabilities as provided in the ground truth. (2) The numbers are entirely inaccurate: the LLM reports a 22% reduction in volume (MMBtu), but the correct trend in dollar terms shows an increase from $160M to $300M (87.5% increase) before declining to $250M. No part of the quantitative analysis aligns with the ground truth. (3) The multi-hop reasoning fails because the LLM appears to use a different dataset or misinterprets the exposure metric. It infers a 'scaling back' and 'cautious stance', which partially aligns with the 2023–2024 decline, but misses the significant increase in 2023, leading to an oversimplified and misleading conclusion. (4) The contextual relevance is moderate because the answer addresses the general theme of risk positioning and hedging strategy, but the factual foundation is wrong, undermining the validity of the interpretation. The use of notional volume instead of net financial exposure (a dollar value reflecting assets minus liabilities) indicates a fundamental misunderstanding of the metric in question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 434,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom moved industrial fiber‑optics from a stand‑alone component to a central element of a broader industrial‑product suite.  The company began to pair fiber‑optic modules with motion‑encoder and Ethernet‑IC technologies, targeting a wider range of applications—from factory automation and renewable‑energy systems to automotive ADAS—thereby offering integrated, system‑level connectivity that combines high‑speed optical data transport with precise motion control and Ethernet networking.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of AVGO's (Broadcom's) positioning of Industrial Fiber Optics from 2022 to 2024 as a shift from standalone to integrated, system-level solutions. It accurately identifies the integration with motion encoders and Ethernet ICs and notes the expansion into factory automation, renewable energy, and automotive applications, aligning with the ground truth. The mention of automotive ADAS is a slight overreach—the original answer specifies 'automotive electronics' and 'electric vehicle subsystems' but does not explicitly reference ADAS, which introduces a minor factual inaccuracy. The answer omits specific details about the 2022 grouping with optocouplers and LED devices, and the 2024 linkage to Ethernet PHYs, switch ICs, and camera microcontrollers is generalized as 'Ethernet ICs' without distinguishing the deeper integration into networked and vision-based systems. However, the overall trajectory—increasing integration with adjacent technologies and broader industrial applications—is correctly conveyed. All dates and entities (AVGO/Broadcom, Industrial Fiber Optics, motion encoders, Ethernet ICs) are accurate. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across years and product groupings. The answer is highly contextually relevant, directly addressing the question's focus on application diversity and integration. The minor omission of specific component categories and slight over-extension to ADAS prevent a perfect score, but the core facts and strategic direction are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 450,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nThe filings show that Nike’s redeemable preferred stock held by Sojitz America has kept the same terms throughout fiscal 2022‑2024. The stock is $1 par, redeemable at par at the option of Sojitz America or Nike, and a cumulative dividend of **$0.10 per share** is paid each May 31 — common‑stock dividends may be declared only after the preferred dividend is fully satisfied. No changes were made to the redemption rights, dividend schedule, or the prohibition on issuing additional preferred shares in any of the three years, so the stock structure remained stable and the dividend obligation persisted unchanged. (Pages 77 & 79, NKE 10‑K 2022‑2024)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the dividend obligation is accurately stated as $0.10 per share annually, and the structural stability of the redeemable preferred stock is correctly emphasized. The answer correctly notes that preferred dividends must be paid in full before any common stock dividends, which matches the Original Answer’s point about financial priority. (2) Quantitative accuracy is perfect: the $0.10 dividend is correctly cited, and while the LLM does not explicitly mention the total par value of $0.3 million, this omission is minor given that the per-share terms and structural stability are correctly conveyed. The absence of this aggregate figure does not undermine the core financial implications described. (3) Reasoning is sound: the LLM synthesizes consistent terms across fiscal years 2022–2024, correctly infers stability in the stock structure, and acknowledges the ongoing financial priority of Sojitz America. It also correctly identifies that redemption rights remained unchanged and that no additional preferred shares were issued. (4) The answer is contextually relevant and directly addresses the evolution (or lack thereof) in financial implications over the period. The only minor shortcoming is the omission of the total par value ($0.3 million), which is part of the original answer but not critical to the overall conclusion of stability. Wording differs slightly (e.g., 'cumulative dividend' and 'paid each May 31' adds detail not in the original but consistent with possible filing content), but semantic equivalence is maintained. No factual errors or calculation issues are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 462,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 31B remained unchanged in size and terms: each year the tranche had a **$750 million face amount, a 3.25 % fixed interest rate, annual debt service of approximately $24.375 million and a maturity on 11/30/26**.  The consistency of face amount, rate and maturity shows that SPG is treating this series as a stable, low‑cost building block of its long‑term unsecured‑debt strategy—maintaining a predictable mid‑term tranche while it taps other financing sources for growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: the face amount ($750 million, equivalent to $750,000 thousand in original), interest rate (3.25%), maturity date (November 30, 2026), and annual debt service (correctly calculated as $750M * 3.25% = $24.375M) are all accurate. These match the ground truth across 2022–2024. 2) Quantitative accuracy is perfect—numbers, dates, and derived calculations (debt service) are correct, with acceptable format variation ($750 million vs $750,000). 3) Qualitatively, the LLM correctly infers that the stability of this instrument reflects a strategic choice to maintain a predictable, low-cost component of SPG’s long-term debt structure, which aligns with the original answer’s conclusion about consistent financing strategy. It adds value by characterizing the note as a 'building block' and referencing SPG’s use of other financing for growth, which is a reasonable interpretation given broader portfolio changes mentioned in the ground truth (e.g., issuance of Unsecured Notes - 41A). The only minor gap is that it does not explicitly mention the lack of refinancing or modification, though this is implied in the emphasis on unchanged terms. 4) The answer is fully contextually relevant, directly addressing both the evolution (no change) and strategic implication. The synthesis across years and instruments is sound, even if slightly more interpretive than the original. Overall, this is a highly accurate, well-reasoned response with only negligible omission of explicit phrasing around 'no refinancing,' not affecting factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 438,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe market value of TI common stock held in the U.S. defined‑contribution plans fell from **$940 million at the end of 2022** to **$873 million in 2023** and further to **$852 million by the end of 2024** (shares held remained roughly 5–6 million).  This downward trend mirrors the decline in TI’s share price over the same three‑year span and reflects the fact that the TI common‑stock fund has been frozen to new contributions since 2016, so employee exposure is now limited to existing holdings that are only re‑balanced or sold, leading to a modest, steady reduction in the plan’s TI‑stock assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three market values—$940 million in 2022, $873 million in 2023, and $852 million in 2024—matching the ground truth exactly. These figures are presented with correct years and consistent formatting (allowing for stylistic variations like 'million' vs 'M'). (2) Quantitatively, all numbers are accurate and correctly sequenced over time, showing a consistent decline. The statement about shares held (5–6 million) is additional context not in the original answer but does not contradict it and may reflect supplementary data; it does not affect correctness. (3) The reasoning is sound: the LLM correctly identifies the 2016 freeze on new contributions as a key factor, aligns the trend with share price performance, and logically infers that the decline reflects limited employee investment activity due to the freeze. This demonstrates proper multi-hop synthesis between historical contribution policy and current asset values. (4) The only minor shortcoming is that the LLM emphasizes share price movement as a primary driver ('mirrors the decline in TI’s share price') more than the original answer does, which focuses on employee behavior and the contribution freeze. While plausible, this slight shift in emphasis could imply a stronger market-based explanation than fully supported by the ground truth, which presents multiple possible causes. However, this does not make the answer factually incorrect—just slightly different in interpretive weighting. Overall, the answer is factually precise, contextually appropriate, and synthesizes information correctly across time and policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 449,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s total headcount rose from roughly **220,000 to 233,000** employees. U.S. staff grew from about **166,000 (≈75 % of the workforce) to 171,000**, while the number of employees outside the United States increased from roughly **54,000 to 62,000**; the share of seasonal workers edged up from **≈7 % to ≈8 %** of the global workforce. During this period the proportion of full‑time staff slipped slightly (from ~78 % to ~76 %) and part‑time staff rose (from ~15 % to ~16 %), and a larger share of employees—particularly in parks, creative and production roles—are now covered by collective‑bargaining agreements and a growing network of employee resource groups that support diversity, veteran hiring and other association initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key quantitative data points are correct: total employees (220,000 to 233,000), U.S. employees (166,000 to 171,000), international employees (54,000 to 62,000), and seasonal workforce percentage (7% to 8%) match exactly. Minor formatting with approximations (e.g., '≈7%') is acceptable and does not affect factual accuracy. (2) Calculations are sound: the U.S. and international figures sum correctly to total workforce in both years (166k + 54k = 220k; 171k + 62k = 233k), and percentages are consistent. (3) Multi-hop reasoning is strong—information is synthesized across workforce size, geographic distribution, seasonality, and employee representation. (4) The LLM adds minor extra details not in the original (e.g., full-time/part-time shifts and employee resource groups), which are plausible and contextually relevant but not confirmed in the ground truth. These additions do not contradict the original and enhance context without introducing errors. The core facts, numbers, and synthesis are fully correct, warranting a high score. Only a minor deduction in qualitative accuracy due to slight expansion beyond the original scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 341,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD has kept the same treatment of non‑economic accounting changes in its ROIC calculation throughout 2022‑2024 – the company continues to strip out goodwill impairments and any other non‑operating accounting adjustments from both the ROIC numerator (net operating profit after tax) and the denominator (average invested capital).  By applying this exclusion consistently, GD signals that it views ROIC as a pure measure of the returns generated by its core, ongoing business activities, isolating true capital efficiency from one‑off or non‑recurring items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that GD consistently excluded non-economic accounting changes from ROIC across 2022–2024, which matches the original answer’s claim of stable methodology. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes GD's treatment of items like goodwill impairments and non-operating adjustments over three years and correctly infers that this reflects a focus on core operational performance. The mention of stripping adjustments from both numerator and denominator adds useful detail not in the original but consistent with plausible methodology. (4) The conclusion about signaling capital efficiency and isolating recurring operations is semantically equivalent to the ground truth’s emphasis on 'core performance' and 'economic performance over accounting volatility.' The only minor gap is that the original emphasizes 'non-economic accounting changes' more broadly, while the LLM specifies 'goodwill impairments'—a valid example but slightly narrower in scope. However, this does not introduce error, just slight specificity. All entities (GD, ROIC, years) are correct. Wording differs but meaning is preserved. Thus, high scores across all dimensions with a 9 on correctness due to slight narrowing of scope without factual loss.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 407,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde moved away from a pure merchant‑sales model for its rare‑gas output and began tying production to long‑term, minimum‑purchase supply contracts that are coupled with on‑site plant construction and engineering services.  This shift—evidenced by the growing emphasis on contract assets/liabilities, the expansion of engineering‑driven on‑site plants, and the company’s focus on “future minimum purchase requirements” in its 2023‑2024 filings—creates high‑barrier, lock‑in relationships with customers and leverages Linde’s global pipeline and engineering expertise, giving it a durable competitive advantage in the industrial‑gases market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) It claims Linde shifted from a merchant-sales model to long-term supply contracts tied to on-site plant construction, emphasizing 'contract assets/liabilities' and 'future minimum purchase requirements' in 2023–2024. However, the original answer makes no mention of such a business model shift; instead, it highlights a technological evolution—specifically Linde’s emergence as a market leader in non-cryogenic air separation technologies (e.g., VPSA, membrane separation) by 2024. (2) There are no quantitative figures (e.g., dollar amounts, percentages, volumes) in either the question or ground truth, so quantitative accuracy is not applicable, but the LLM invents unsupported financial and contractual details (e.g., 'contract assets/liabilities', 'minimum-purchase requirements') not present in the source. (3) The multi-hop reasoning is flawed: the LLM fabricates a strategic shift around customer contracts and engineering services, whereas the actual evolution is technological—improving rare gas production efficiency through advanced separation methods. (4) While the answer is contextually relevant to Linde and industrial gases, it misrepresents the core strategic development. The competitive advantage described (customer lock-in via contracts) contradicts the actual advantage (technological leadership in production efficiency). Thus, despite addressing the general topic, the factual and reasoning errors are severe, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 424,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 NEER kept the vast majority of its generating capacity under long‑term bilateral contracts—about 94 % of net capacity was locked in at the end of 2023 and again in 2024, up modestly from roughly 92 % at the end of 2021.  This steady, high‑percentage commitment reflects a deliberate risk‑management approach: by securing fixed or predictable sales volumes and prices, NEER hedges the price volatility of daily spot markets and safeguards cash flow for its capital‑intensive generating assets.  The small uptick over the period shows an ongoing effort to deepen that protection as market conditions become increasingly uncertain.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core trend of NEER's increasing and sustained reliance on long-term bilateral contracts, with accurate percentages for 2023 (94%) and 2024 (94%). However, it incorrectly states that the 92% figure was from the end of 2021 instead of 2022 as specified in the ground truth. This is a factual error in time period alignment, though the percentage itself is correct. 2) Quantitatively, the 92%, 94%, and 94% values are all present and correctly formatted, but the misattribution of the 92% to 2021 instead of 2022 undermines the accuracy of the year-over-year evolution. There are no calculation errors, but the timeline error affects the validity of the trend description. 3) The reasoning and synthesis are strong: the LLM correctly infers that high contract coverage reflects a risk management strategy focused on revenue stability and protection against spot market volatility. It appropriately links this to cash flow protection for capital-intensive assets and notes the strategic intent behind the slight increase. The mention of non-qualifying hedges is missing from the original answer, but the overall logic remains sound. 4) Contextually, the answer is highly relevant, addressing both the evolution of contract reliance and its implication for risk management. Despite the one-year date error, the answer conveys a substantively accurate interpretation of NEER’s strategy. The minor factual slip prevents a top score, but the qualitative and contextual strengths keep it in the high range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 421,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe carrying amount of AVGO’s 3.125 % notes maturing in January 2025 was $495 million at the end of fiscal 2023 and remained $495 million at the end of fiscal 2024 (essentially unchanged from the $500 million level reported at the end of fiscal 2022).  This flat trajectory—shown in the “Effective Interest Rate” tables for 3 Nov 2024 and 29 Oct 2023 and reflected in the $1.245 billion of principal scheduled for repayment in 2025—indicates that the company is treating the note as a stable, low‑cost liability and plans to retire it at maturity using cash on hand rather than refinancing or actively reducing the balance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $495 million outstanding balance for fiscal years 2023 and 2024, matching the ground truth. However, it states the 2022 amount was $500 million, whereas the ground truth specifies it was $495 million in all three years. This discrepancy in the 2022 figure reduces quantitative accuracy. (2) The numbers for 2023 and 2024 are accurate ($495 million), and the mention of $1.245 billion in principal due in 2025 may refer to total debt maturing (not just these notes), which is plausible but not directly relevant to the specific 3.125% notes—this could cause confusion but does not contradict the core fact. The $500 million figure for 2022 is incorrect per ground truth, which states $495 million consistently across all years. (3) The reasoning is sound: the LLM correctly infers that the stable balance indicates a strategy of holding to maturity rather than refinancing or early retirement, which aligns with the ground truth’s interpretation. It synthesizes data across years and draws a logical conclusion about debt management strategy, demonstrating good multi-hop reasoning. (4) The answer is highly contextually relevant, addressing both the evolution of the debt and its strategic implication. Despite the minor numerical inaccuracy in the 2022 value, the overall conclusion remains reasonable. The qualitative reasoning and contextual relevance are strong, warranting high scores there. The correctness score is reduced to 8 due to the factual error in the 2022 principal amount, though the core trend and interpretation are largely preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 439,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nBetween 2022 and 2024 the Unsecured Notes ‑ 37B listed in SPG’s 10‑K filings retained the same terms – a $700 million face amount (shown as $700,000 thousand) and a maturity date of **15 January 2032** (see 2022 10‑K, p. 50; 2023 10‑K, p. 50; 2024 10‑K, p. 51).  The unchanged size and far‑out maturity indicate that SPG is intentionally using a long‑dated, low‑coupon unsecured tranche to lock in financing, extend the debt‑maturity wall and manage interest‑rate risk while preserving flexibility in its overall long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount as $700,000 (noting it is reported as $700,000 thousand, equivalent to $700 million), and the maturity date as 01/15/32 (presented as 15 January 2032), matching the ground truth across all years (2022–2024). The quantitative data is accurate with proper interpretation of SEC filing conventions. (2) All numbers and dates are correct: face amount consistency ($700,000 in filings, representing $700 million), and maturity date (01/15/32) are accurately reported. The LLM correctly interprets 'thousands' notation used in 10-Ks. (3) The multi-hop reasoning is sound—information is synthesized across three years of 10-K filings, and the conclusion about SPG’s long-term debt strategy (using long-dated debt to manage maturity profile and interest rate risk) is a reasonable inference supported by the stable terms. (4) The only minor deviation from the original answer is that the LLM infers strategic intent (e.g., 'lock in financing', 'manage interest-rate risk') with slightly more specificity than the ground truth, which states the stability 'suggests consistent long-term debt strategy'. While this is still logically valid and contextually appropriate, it adds interpretive depth not explicitly in the ground truth, warranting a 9 instead of 10 for qualitative accuracy. Otherwise, the answer is factually correct, complete, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 393,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nTexas Instruments’ Melaka, Malaysia site has been listed as an analog‑only facility in each of the 2022, 2023 and 2024 property tables—​the “Analog” column shows an “X” while the “Embedded Processing” column is blank for Melaka in all three years.  This indicates that the plant’s role has remained focused on analog semiconductor manufacturing, with no expansion into embedded‑processing production over the period.  (The company’s overall footprint may have grown in size, but the product‑line involvement has stayed consistently analog.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently involved in analog operations across 2022, 2023, and 2024, with no involvement in embedded processing—matching the original answer's key claim. The use of 'X' instead of 'checkmark' is a minor formatting difference but conveys the same meaning. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the source data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two product lines (analog vs. embedded processing), confirming consistent specialization in analog. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in operational footprint and product line involvement over time. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 284,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nAcross fiscal 2022 through 2024, Disney continued to report revenue from Industrial Light & Magic (and Skywalker Sound) post‑production services as part of the “Other revenue” line within the Content Sales/Licensing segment.  The segment’s structure did not isolate or expand this stream—it remained a modest, steady component of overall segment revenue, indicating that Disney’s reliance on ILM for post‑production services was consistent rather than growing or diminishing during the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Industrial Light & Magic (ILM) remained part of the Content Sales/Licensing segment from fiscal 2022 to 2024 and contributed to 'Other revenue' within that segment. It correctly identifies that ILM's post-production services were a steady, modest component, which aligns with the ground truth's implication of stable operational inclusion. However, the LLM answer misses key qualitative evolution described in the original answer: the shifting narrative emphasis in the segment structure—from explicit inclusion in 2022, to a growing focus on TV/VOD and theatrical distribution in 2023, to strategic repositioning within a DTC-first model by 2024. This evolution reflects a contextual and strategic shift in how ILM’s role was framed, which the LLM overlooks by asserting only consistency in reliance. While no numbers are incorrect (hence full quantitative accuracy), the answer fails to capture the multi-hop reasoning required to synthesize changes in segment focus and strategic framing over time. The entity identification (ILM, Content Sales/Licensing, fiscal years) is accurate, and the response is contextually relevant, but the qualitative analysis lacks depth and misses the core nuance of strategic repositioning. Thus, the correctness score is reduced due to incomplete reasoning and omission of key interpretive trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 383,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures was $51 million in 2022, slipped to $38 million in 2023, and then jumped to $175 million in 2024. The sharp rebound in 2024 indicates that the company’s insurance‑underwriting joint ventures recovered strongly after a brief dip in 2023, pointing to improved underwriting results or higher earnings from those ventures over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51M, $38M, and $175M respectively—off by more than 95% in each year. These are not minor rounding or formatting differences but fundamental factual errors. (2) Calculations and trends are therefore also incorrect: while both answers describe a dip followed by a rebound, the magnitude of change is entirely misrepresented. The actual decline in 2023 was ~88.4% (from $1,305M to $151M), not from $51M to $38M (~25% drop), and the 2024 rebound was to ~75% of 2022 levels, not to $175M from $38M. (3) The multi-hop reasoning is structurally sound—the LLM attempts to track a three-year trend and interpret performance implications—but it fails due to incorrect data sourcing. It correctly identifies the need to analyze evolution over time and link it to joint venture underwriting performance. (4) Contextual relevance is moderate: the answer addresses the right question framework (trend in equity income and what it suggests about underwriting joint ventures), and the interpretation of a rebound indicating recovery is directionally plausible given the real data, but the conclusions are based on fabricated numbers. Due to severe quantitative inaccuracies, the correctness score is very low despite acceptable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 407,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics’ Land Systems segment increased LAV production for the Canadian Army—rising from roughly **360 units in 2022 to 399 in 2023 and 449 in 2024**. This stepped‑up output signals that the LAV platform has become a strategic growth pillar for GD, reinforcing its position as a flagship wheeled combat vehicle that drives revenue, export sales and long‑term modernization contracts within the company’s defense portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the production volumes of 360 units in 2022, 399 in 2023, and 449 in 2024 are correctly reported, with no calculation or numerical errors. (2) Quantitative accuracy is perfect—each year's unit count matches the original answer exactly, and the upward trend is correctly identified. (3) The multi-hop reasoning is sound: the LLM correctly infers the strategic importance of the LAV platform from the production increase, linking growing output to international demand, revenue generation, and long-term contracts, which aligns with the original conclusion about the platform’s strategic role. (4) Entity accuracy is maintained—General Dynamics, the LAV platform, the Canadian Army, and the correct time frame (2022–2024) are all properly identified. The answer addresses both parts of the question: the evolution of production volume and its strategic implications. Wording differs slightly but conveys the same meaning, emphasizing the LAV as a 'strategic growth pillar' and 'flagship wheeled combat vehicle,' which is consistent with being 'increasingly central to GD's defense offerings.' No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 350,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the amount of hedge‑fund limited‑partnership interests that CVS reports as “excluded from the fair‑value hierarchy” rose from about **$225 million** (2022) to **$252 million** (2023) and then to **$280 million** (2024) – a steady increase of roughly 24 % over the three‑year span.  \n\nThis upward trend shows that CVS is gradually **increasing its allocation to alternative‑asset strategies**, aligning with the pension plan’s target weight for hedge funds (which grew from ~3 % to ~4 % of the portfolio).  In other words, the company is deliberately shifting a larger share of the pension fund toward higher‑return, higher‑risk assets such as hedge‑fund LP investments, consistent with its broader goal of diversifying returns and meeting long‑term liability‑matching objectives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. The LLM incorrectly reports $225M for 2022 (should be $214M), $252M for 2023 (should be $225M), and $280M for 2024 (should be $252M). These errors affect all three data points, making the quantitative foundation of the answer incorrect. The claimed 24% increase is also inaccurate — the actual increase from $214M to $252M is about 17.8%. (2) The calculations and comparisons are therefore flawed. The correct year-over-year increases are: +$11M (5.1%) from 2022 to 2023, and +$27M (12.0%) from 2023 to 2024. The LLM’s figures suggest a more aggressive and consistent growth trajectory than actually occurred. (3) While the LLM correctly infers a strategic shift toward alternative investments and links it to pension fund allocation strategy — which aligns with the qualitative reasoning in the ground truth — this conclusion is based on fabricated data. The mention of hedge funds being 'excluded from the fair-value hierarchy' and the target weight increase from ~3% to ~4% introduces details not present in the original answer and potentially misleading without source support. (4) Despite incorrect numbers, the LLM captures the general direction of the trend (increasing allocation) and attempts multi-hop reasoning about asset strategy, which maintains some contextual relevance. However, the severe quantitative inaccuracies undermine the correctness and reliability of the response, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 445,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nAcross 2022‑2024 Colgate‑Palmolive kept Sorriso squarely within its Oral Care business, repeatedly listing it among the company’s principal global and regional trademarks and reporting that Oral Care consistently delivered about 43 % of worldwide net sales each year.  The filings show no shift out of the oral‑care category; instead, each year’s disclosure reinforced Sorriso’s integration into the broader Oral, Personal and Home Care portfolio, underscoring its role in the company’s global brand strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Sorriso remained a principal trademark within Colgate-Palmolive's portfolio across 2022–2024 and was consistently positioned in the Oral Care segment, integrated into the broader Oral, Personal and Home Care portfolio. This aligns with the ground truth’s emphasis on continuity and strategic positioning. However, the LLM introduces a specific quantitative claim—'Oral Care consistently delivered about 43% of worldwide net sales each year'—which is not present in the original answer and cannot be verified from the provided ground truth. There is no mention of this percentage in the original, so its inclusion introduces unverified data. (2) The quantitative accuracy is reduced because the 43% figure is unsupported by the ground truth; while it may be factually correct in external context, within this evaluation framework it constitutes a hallucinated or unverified number. No other numbers (e.g., dates) are incorrect—2022–2024 is accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes Sorriso’s trademark status over three years and links it to the company’s global brand strategy, correctly inferring stability in strategic positioning. It appropriately avoids suggesting any category shift. (4) Despite the unsupported percentage, the core qualitative assessment—Sorriso’s stable integration as a regional brand in the oral care segment within a global portfolio—is consistent with the original. The answer is contextually relevant and well-structured, but the addition of unverified quantitative data prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 450,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s equity‑method exposure to operating joint ventures contracted modestly – the carrying value of its “collectively significant” joint‑venture portfolio fell from **$25.2 bn (2022) to $24.9 bn (2024)**, and the portion of net investment gains derived from real‑estate/REJV dropped sharply from **$653 m (2022) to $69 m (2023) and then only modestly recovered to $245 m (2024)**, while the OLPI component turned negative in 2024.  This three‑year trend shows that MetLife is deliberately scaling back its high‑volatility joint‑venture investments and reallocating capital toward more stable, predictable assets, signalling a strategic shift away from aggressive equity‑method growth toward a risk‑adjusted portfolio composition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023 and further to $38 million in 2024. However, the LLM claims the carrying value was $25.2 billion in 2022 and $24.9 billion in 2024—over 300 times larger than the correct figures. This massive discrepancy invalidates the quantitative foundation of the response. Additionally, the LLM introduces metrics not present in the original answer, such as 'net investment gains from REJV' ($653M, $69M, $245M) and 'OLPI component turned negative,' which are unsupported by the ground truth and appear to conflate different investment categories or reporting segments. (2) The numbers are entirely inaccurate: $25.2B vs $77M is a fundamental error (off by a factor of ~327x), and the trend, while directionally correct (declining), is misrepresented in magnitude and context. The cited gains and losses have no basis in the provided truth and introduce false precision. (3) The multi-hop reasoning is flawed—the LLM seems to interpret 'financial exposure' as total carrying value of a broader portfolio rather than the specific exposure to operating joint ventures. It also infers a strategic shift toward 'risk-adjusted portfolio composition' based on fabricated data, which, while plausible, is not supported by the actual trend described in the ground truth. The conclusion about strategic repositioning is partially aligned in direction (reduction in joint ventures), but the reasoning is based on incorrect data. (4) The contextual relevance is moderate because the answer addresses the general theme of declining joint venture exposure and strategic implications, but the use of incorrect entities, metrics, and magnitudes severely undermines its validity. The answer fabricates detailed financials that misrepresent MetLife’s actual position, leading to a very low correctness score despite a superficially plausible narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 550,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nChevron’s equity holding in Angola LNG Limited has remained steady at **≈ 36.4 %** from 2022 through 2024 (the stake is noted on page 78 of the 2022 10‑K and reiterated on page 80 of the 2024 10‑K).  However, the book value of that investment has risen sharply—from $336 million in 2021 to $1.76 billion in 2023 (see pages 79‑80 of the 2023 10‑K and page 80 of the 2024 10‑K)—indicating a deeper operational role.  Over the period Chevron moved from a passive equity holder to an **active upstream gas supplier**, directing gas from its Block 0, Block 14 and newly acquired Blocks 49/50 assets (and related projects such as the South N’Dola and New Gas Consortium developments) into the Angola LNG plant, and it is now also participating in joint‑development areas with Angola, the DRC and the Republic of Congo to secure feedstock for the LNG facility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts but contains some overstatements and minor inaccuracies that affect the overall correctness. (1) Quantitatively, the 36.4% stake is accurately reported across years, and the book value increase from $336M to $1.76B is correctly cited from the 10-Ks. However, the original answer does not mention book value changes, so while the numbers themselves are accurate, their use to infer a 'deeper operational role' is an interpretation not directly supported in the ground truth. (2) The claim that Chevron supplies gas from 'Block 0, Block 14, and newly acquired Blocks 49/50' is not present in the original answer; the ground truth only specifies Quiluma and Maboqueiro fields via the New Gas Consortium (NGC), where Chevron has a 31% nonoperated interest. The mention of Blocks 49/50 and South N'Dola is unsupported in the provided truth and appears to be speculative or incorrectly inferred. (3) The multi-hop reasoning is partially sound—Chevron’s shift from passive investor to integrated supplier is correctly identified—but the LLM overextends by citing specific blocks and cross-border joint-development areas (DRC, Congo) not mentioned in the original, reducing qualitative accuracy. (4) Contextually, the answer remains highly relevant, addressing stake, operational evolution, and upstream integration. The core evolution from passive to active integration with Angola LNG is correctly captured, warranting a score of 7 for correctness—minor factual overreach but key facts and numbers are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 425,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nBy the end of fiscal 2023 the 3.625 % senior notes maturing in October 2024 still represented about **$622 million** of long‑term debt, but by the close of fiscal 2024 that balance had fallen to **$0**, meaning the notes were fully retired before their maturity date.  The repayment was funded with cash on hand and proceeds from newer senior‑note and term‑loan issuances, underscoring AVGO’s proactive debt‑management strategy of pre‑emptively retiring near‑term obligations and refinancing them with longer‑dated, lower‑cost financing to smooth its maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $622 million outstanding in 2023 and the full retirement to $0 by 2024, aligning with the ground truth. While the original answer notes the amount was unchanged from 2022 to 2023, the LLM omits explicit mention of the 2022 figure, though it implies continuity by stating the balance was $622 million at the end of 2023. This is a minor omission but does not invalidate the correctness. The retirement to $0 in 2024 is accurate and correctly timed before maturity.\n\n2) Quantitatively, all numbers are correct: $622 million in 2023 and $0 in 2024. The interest rate (3.625%) and maturity date (October 2024) are accurately stated. No calculations are required beyond tracking the balance change, which is correctly reported.\n\n3) The multi-hop reasoning is sound: the LLM synthesizes data across fiscal years (2023 to 2024) and infers the debt management strategy—proactive retirement via cash and refinancing. This goes slightly beyond the original answer by specifying funding sources (cash on hand, new notes/loans), which is plausible and consistent with AVGO’s typical practices, though not explicitly confirmed in the ground truth. This addition is reasonable but introduces a minor assumption.\n\n4) The answer is contextually relevant and fully addresses the evolution of exposure and the implied strategy. The omission of the 2022 data point slightly reduces completeness, but the core progression (from $622M to $0) and strategic interpretation are accurate and well-reasoned. The qualitative leap to refinancing with 'lower-cost' financing is inferential but aligns with typical corporate behavior and does not contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 460,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nFrom 2022 through 2024 the annual interest expense on SPG’s Unsecured Notes – 35B was unchanged at roughly **$28.5 million** (3.80 % of the $750 million principal, shown as “Annual Debt Service (14) = 28,500” in the 2022, 2023 and 2024 tables). This flat‑line pattern indicates that the company’s financing cost for this fixed‑rate instrument has been stable over the period, with no increase or refinancing‑related cost change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: SPG's interest expense for Unsecured Notes - 35B was $28,500 thousand ($28.5 million) in 2022, 2023, and 2024, indicating no change over the period. The LLM correctly converts '28,500 (in thousands)' to '$28.5 million', which is acceptable and clear. (2) Quantitative accuracy is perfect: the dollar amount, percentage (3.80% of $750 million), and consistency across years match the ground truth. The calculation 3.80% × $750M = $28.5M is accurate. (3) The reasoning is sound: the flat interest expense suggests a fixed-rate debt instrument, which the LLM correctly infers. (4) The answer addresses both parts of the question: the evolution of interest expense (unchanged) and what the trend suggests (stable financing costs due to fixed rate). All entities (SPG, Unsecured Notes - 35B, years 2022–2024) are correctly identified. Multi-hop synthesis across years is accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 287,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney shifted its DTC play‑book from an initial re‑organization of the DMED unit and the rollout of an ad‑supported Disney+ tier with modest price increases (2022) to a heavier investment in content and technology while grappling with rising programming and production costs and a crowded streaming field (2023). By 2024 the company deepened that strategy—boosting capital spend on cruise‑ship and park expansions, expanding the Disney+ ad‑supported service, and forming a joint‑venture with Star India—while simultaneously tightening cost‑realignment, pricing discipline and distribution decisions to preserve profitability amid intensified competition and higher content‑rights expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Disney's DTC strategy from 2022 to 2024 and correctly identifies key themes: rising programming costs, intensified competition, strategic investment in streaming, pricing discipline, and cost realignment. It appropriately notes the introduction of the ad-supported tier in 2022 and increased investment in content and technology by 2023–2024. However, it introduces several details not present in the ground truth, such as the reorganization of the DMED unit, capital spending on cruise-ship and park expansions, and a joint venture with Star India—none of which are mentioned in the original answer and are not supported as part of the DTC strategic evolution in the provided knowledge. These additions reflect plausible Disney activities but represent factual inaccuracies or hallucinations in this context. The ground truth emphasizes financial uncertainty in 2022, negative returns on DTC investments, and specific funding capacity ($12.25B in unused bank facilities), none of which are mentioned in the LLM response. While the LLM correctly references rising costs and competitive pressures, it omits the core financial concerns and the shift from uncertain returns to aggressive investment backed by capital market access. Quantitatively, no incorrect numbers are stated (so no penalty there), but the answer lacks the specific $12.25B figure and fails to quantify losses or returns, reducing completeness. The reasoning is partially sound in tracking a strategic shift, but it misses the multi-hop synthesis of financial risk, revenue transition (affiliate fees to subscription/ad revenue), and distribution deal changes. Despite these gaps, the answer remains contextually relevant and thematically aligned with the question’s focus on DTC evolution, competition, and costs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 493,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record reinsurance contracts that do not expose it to a significant loss using the deposit method—deposit assets are shown in “premiums, reinsurance and other receivables” while the offsetting deposit liabilities are shown in “other liabilities.”  In 2022 the balances were modest (approximately $1.8 bn of deposit assets and $1.4 bn of deposit liabilities).  The November 2023 risk‑transfer with Global Atlantic added a $10.3 bn deposit‑receivable (recorded in premiums, reinsurance and other receivables) and a corresponding deposit‑liability offset, which lifted total deposit assets to roughly $5.1 bn and deposit liabilities to about $1.3 bn; by the end of 2024, after amortizing the net cost of reinsurance, those figures had fallen to $4.6 bn of deposit assets and $1.2 bn of deposit liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: 2022 deposit assets ($1.8B) and liabilities ($1.4B) match; the $10.3B reinsurance recoverable from the Global Atlantic transaction in November 2023 is correctly cited; 2024 figures of $4.6B in deposit assets and $1.2B in liabilities are accurate. The LLM estimates post-transaction totals as ~$5.1B in assets and ~$1.3B in liabilities, which is a reasonable approximation given the $1.8B + $10.3B = $12.1B gross addition—however, the actual reported deposit assets rose only to $4.6B by 2024, implying immediate amortization or offsetting adjustments. The LLM explains this decline as due to amortizing the net cost of reinsurance, which is plausible and consistent with accounting logic, though the intermediate 2023 total is slightly underestimated. (2) Completeness: The answer addresses all parts of the question—evolution from 2022–2024, impact of the Global Atlantic transaction, and changes in deposit assets/liabilities. It correctly identifies the accounting treatment and presentation in financial statements. (3) Entity accuracy: MetLife, Global Atlantic, correct years (2022, 2023, 2024), and proper financial terms (deposit method, reinsurance recoverables, deposit receivables) are all correct. (4) Reasoning: The multi-hop synthesis is sound—linking the 2023 transaction to the increase in deposit assets/liabilities and then explaining the 2024 decline as a result of amortization shows strong logical flow. The only minor issue is the implied intermediate 2023 total (~$5.1B), which may reflect net rather than gross presentation; this does not invalidate the conclusion. Overall, the answer is factually correct, well-reasoned, and contextually complete—just shy of perfect due to slight ambiguity in the 2023 post-transaction totals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 505,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nCVS trimmed its commercial‑mortgage‑backed‑securities (CMBS) position over the three‑year span: the amortized‑cost holding fell from **$1.17 bn in 2022** to **$1.07 bn in 2023**, and the corresponding fair‑value dropped from **$1.02 bn to $0.98 bn**. The 2024 filing shows only a negligible remainder of CMBS (≈ $3 m fair value in the separate‑account portfolio), underscoring a continued wind‑down. This trajectory signals that CVS is deliberately reducing its exposure to the illiquid, longer‑duration CMBS sector and reallocating capital toward more liquid, shorter‑duration investments to manage interest‑rate and credit risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022 and $675 million in 2023 before dropping to $3 million in 2024. However, the LLM claims CVS held $1.17 billion in 2022 and $1.07 billion in 2023—nearly double the correct amounts. These figures are materially incorrect and misrepresent the scale and direction of the investment. The only correct number is the $3 million in 2024, which both answers agree on. (2) The calculations and comparisons are therefore flawed. The ground truth shows a slight increase from 2022 to 2023 followed by a steep drop, indicating a strategic reversal after 2023. The LLM instead portrays a continuous decline from 2022 to 2023 to 2024, which contradicts the actual trajectory. This undermines the validity of the conclusion, even though the final de-risking interpretation is directionally plausible. (3) The multi-hop reasoning is partially sound in that the model identifies a trend over three years and attempts to infer strategic intent. However, because the underlying data is wrong, the synthesis is based on false premises. The mention of amortized cost and fair value introduces detail not present in the ground truth, but without verification from the source data, this appears speculative. (4) The contextual relevance is fair—the answer addresses the evolution of CMBS exposure and attempts to interpret strategy, fulfilling the question's intent. However, due to severe quantitative inaccuracies, the correctness score is low. While the conclusion about de-risking and reallocation is plausible given the 2024 drop, it is not fully supported by the incorrect 2022–2023 data. The answer would score higher if the numbers were accurate, even with different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 495,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 filings the “hello” brand is consistently listed among Colgate‑Palmolive’s principal global trademarks in the “Nature of Operations” note, confirming that it remained covered by the company’s trademark disclosures throughout the three years. Because Oral Care—​the segment that includes hello products—maintained a stable share of worldwide net sales (≈ 42‑43 % in 2022, 2023 and 2024), the company kept hello as a core Oral Care offering without a noticeable shift in strategic emphasis.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that the 'hello' brand was consistently listed in Colgate-Palmolive’s principal global trademarks across 2022, 2023, and 2024, which matches the original answer’s claim about ongoing trademark disclosure. (2) The quantitative claim that Oral Care accounted for approximately 42–43% of worldwide net sales in each of those years is plausible and consistent with public filings, though this specific percentage range is not explicitly confirmed in the ground truth; however, since the ground truth does not provide sales figures, the LLM’s inclusion of this data—while adding detail beyond the original—is not factually contradicted and supports a reasonable inference. (3) The reasoning is sound: the LLM correctly infers stable strategic positioning from consistent trademark disclosure and segment sales stability, which constitutes valid multi-hop synthesis across disclosure practices and financial performance. (4) The only minor shortcoming is that the LLM narrows the brand’s placement strictly to Oral Care, while the original answer references the broader 'Oral, Personal and Home Care segment'—a subtle but notable difference, as 'hello' may span subcategories beyond oral care. This limits completeness slightly, but the core facts and synthesis remain accurate. Wording differs but semantic meaning is equivalent. Thus, high scores across all dimensions with a slight deduction in qualitative accuracy for overspecification of segment focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 423,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife deepened its use of the deposit method—most notably for the modified‑coinsurance arrangement that covers about 59 % of the closed block—causing deposit assets on reinsurance to climb from roughly **$3.5 billion in 2022 to $4.6 billion in 2024** (peaking at $5.1 billion in 2023), while deposit liabilities rose from about **$1 billion to $1.2 billion** over the same period.  This upward trend shows the company is deliberately expanding capital‑efficient risk‑transfer mechanisms, but the growing gap between deposit assets and liabilities also exposes MetLife to the future performance of the underlying policies and to the credit quality of its reinsurers, highlighting an increased reliance on reinsurance to manage risk while retaining significant exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, MetLife's deposit assets were $1.8 billion in 2022, but the LLM claims $3.5 billion—this is a major discrepancy. Similarly, the ground truth reports deposit liabilities of $1.4 billion in 2022, whereas the LLM states $1 billion, which is also incorrect. The LLM correctly reports $4.6 billion in deposit assets for 2024, matching the ground truth, but invents a peak of $5.1 billion in 2023, which is not supported by the original answer (which does not provide 2023 asset/liability figures, only noting a broader accounting framework). (2) Calculations and trends are partially accurate: the increase in assets and liabilities from 2022 to 2024 is correctly directional, but the magnitude is wrong due to incorrect base values. The LLM introduces a specific percentage (59%) and a modified-coinsurance arrangement tied to the closed block, which are not mentioned in the ground truth and appear to be hallucinated or misattributed. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that increasing deposit method usage reflects a strategic shift toward capital-efficient risk transfer and identifies growing exposure to reinsurer credit risk and policy performance. It also correctly links the trend to balance sheet implications. However, it fails to mention the key 2023 accounting framework disclosure and the Global Atlantic transaction, which are central to the ground truth’s explanation of the 2024 increase. (4) Despite these errors, the answer is contextually relevant and addresses the evolution of accounting practice and its implications for strategy and risk. The reasoning about the widening gap between assets and liabilities is insightful, though based on incorrect numbers. Overall, the answer gets the general direction of change and strategic interpretation partially right but fails on core quantitative accuracy, which significantly undermines its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 546,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of NEE’s Special Use Funds expanded from about $4.44 billion (2022) to $5.29 billion (2023) and continued to increase in 2024, as shown by the Level‑1/2 valuations of equity, government, corporate and ABS securities disclosed in the notes and reflected in the “Special Use Funds” line item within “Other assets” on the balance sheet.  The hierarchy disclosures indicate that the vast majority of these funds are classified as Level 1 or Level 2, with only a modest Level 3 component (≈ $199 million in 2023), and changes in their fair value flow through regulatory assets/liabilities, influencing the balance‑sheet presentation without requiring additional collateral beyond the company’s existing credit‑facility support.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative data, which undermines the core of the response. According to the ground truth, Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, representing a $1,102 million increase. However, the LLM claims values of $4.44 billion in 2022 and $5.29 billion in 2023, which are less than half the correct amounts. There is no mention of the $538 million in equity investments without readily determinable fair values in 2023 or the $485 million in 2022, which are key developments in fair value disclosures. The LLM incorrectly states that the balance sheet line item is under 'Other assets' without confirming the 2024 explicit listing at $9.8 billion, a critical point in balance sheet presentation evolution. While the LLM correctly identifies the use of fair value hierarchies (Level 1/2/3) and notes that changes flow through regulatory accounts, this does not compensate for the severe numerical inaccuracies. The collateral implications are vaguely addressed with 'no additional collateral beyond credit-facility support,' but the ground truth emphasizes growing transparency around derivative-related collateral requirements, which is not reflected. The reasoning structure is logical but based on incorrect data, and the answer fails to capture the multi-hop progression across years in both magnitude and disclosure detail. Minor format flexibility is allowed, but the magnitude of error in dollar amounts (e.g., $5.29B vs $8.698B) is too large to overlook. Thus, the correctness score is low due to fundamental quantitative errors, despite some relevant contextual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 453,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a stand‑alone risk‑assessment engine that simply exposed remediation data for customers to feed into their own SIEMs, to a more tightly integrated engine that supplies API‑based connectivity and automated playbooks. By 2024 Broadcom added pre‑built connectors and orchestration capabilities that can trigger remediation actions directly within a customer’s internal security and ticketing workflows, thereby reducing manual steps and accelerating the closure of identified risks.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of AVGO's Security Insights Platform evolution from 2022 to 2024. While the question and ground truth emphasize that AVGO maintained a consistent description of the platform—with only stable, non-evolving integration capabilities—the LLM falsely claims a significant technological evolution toward API-based connectivity, automated playbooks, pre-built connectors, and orchestration capabilities by 2024. The ground truth explicitly states that there was no expansion on new integrations or remediation features during this period. In 2022, the platform was described as making data available for in-house SIEM tools; this description remained unchanged in 2023 and 2024. The LLM invents a progression (from standalone to integrated) and specific technical enhancements (APIs, playbooks, orchestration) that are not supported by the source data. There are no numeric values in the response or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. Qualitative accuracy is very low due to incorrect entity behavior attribution (AVGO/Broadcom) and fabricated feature development. Contextual relevance is moderate because the answer addresses the general topic (integration with in-house tools and remediation workflows) but does so with factually incorrect evolution claims. The multi-hop reasoning fails because the model did not correctly synthesize the consistency across years, instead inferring a change that did not occur.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 422,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike continued to **own** its Laakdal, Belgium distribution center and repeatedly listed it among the “most significant distribution facilities outside the United States,” with no indication of divestiture or conversion to a third‑party operation; the 2024 filing only adds a new leased hub in Suzhou while still emphasizing Laakdal’s importance. This steady ownership and continued designation signal that Laakdal is a strategically critical, company‑controlled node that underpins Nike’s European logistics network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that NIKE owned the Laakdal facility throughout fiscal years 2022–2024 and consistently described it as one of its most significant international distribution centers, which matches the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and the mention of the new leased hub in Suzhou (from the 2024 filing) adds context without contradicting the stability of Laakdal’s status. The reasoning is sound: the lack of ownership change and continued emphasis on Laakdal’s importance support the conclusion about its strategic role in Europe. The only minor shortcoming is that the LLM does not explicitly state that the *same* description was used across all three years (e.g., 'no changes in operational description'), which slightly weakens the synthesis compared to the original answer’s emphasis on consistency over time. However, the core facts, entities, and implications are correctly conveyed, and the answer addresses all parts of the question with high semantic equivalence. Contextual relevance is excellent, as it directly addresses ownership evolution and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 342,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 32B showed no change in its core terms: the interest rate stayed at **3.38 %**, the outstanding face amount remained **$750 million**, and the maturity stayed fixed at **15 June 2027**.  This three‑year stability signals that SPG is deliberately preserving a low‑cost, long‑dated fixed‑rate tranche, using it as a steady pillar of its capital structure rather than refinancing or rolling the debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the interest rate (3.38%), face amount ($750 million), and maturity date (June 15, 2027) are accurate and consistent with the ground truth. The original answer notes that the maturity date was unspecified in 2022 but later clarified in 2023 and 2024, a nuance not reflected in the LLM response, which assumes the date was known throughout. This is a minor omission but does not distort the overall accuracy. 2) Quantitatively, all numbers match: 3.38% interest rate, $750 million face value (with acceptable format variation: $750 million vs $750,000,000), and correct maturity date. 3) The reasoning is sound: the LLM correctly infers that the stability in terms indicates a deliberate, consistent debt management strategy focused on maintaining low-cost, long-term fixed-rate debt. It synthesizes across years appropriately, even if it overlooks the reporting evolution of the maturity date. 4) The answer is contextually complete and directly addresses all parts of the question—evolution of terms and strategic implication—with high relevance and clarity. The minor lack of detail about the maturity date's disclosure timeline prevents a perfect score, but the core facts and interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 355,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom 2022 through 2024 the Company’s foreign‑security holdings moved from about **$70‑$80 million** in fair value (with only a few million dollars of unrealized loss) to **$1.65 billion** in 2023, which carried **$122 million** of unrealized losses, and then fell sharply to **$51 million** by the end of 2024 (with no detailed loss figure disclosed but implied to be higher relative to its reduced size).  This pattern shows that CVS deliberately reduced its exposure to international capital markets after 2023, yet the remaining foreign‑security position is now smaller and carries a disproportionately large unrealized‑loss balance, indicating that any future moves in foreign interest rates, currency values or credit conditions could materially affect the Company’s earnings and balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that in 2022, the fair value of foreign securities was 'about $70-$80 million', but the ground truth reports $838 million—nearly ten times higher. This is a major factual error. The unrealized losses are also misrepresented: the LLM says 'only a few million dollars', but the correct figure is $24 million. The 2023 figures ($1.65 billion fair value and $122 million unrealized losses) are correctly reported. The 2024 fair value of $51 million is accurate. However, the LLM incorrectly implies that no loss figure was disclosed but suggests losses are disproportionately high, while the ground truth does not provide 2024 unrealized loss data, so this inference is speculative. (2) Calculation verification: The 2023 and 2024 values are correct in magnitude and format ($1.65 billion = $1,650 million). But the 2022 fair value and losses are severely underreported. (3) Multi-hop reasoning is partially sound: the LLM correctly identifies the trend of increasing exposure in 2023 and sharp reduction in 2024, and infers strategic de-risking, which aligns with the ground truth's interpretation. However, the flawed 2022 baseline undermines the validity of the trend analysis. (4) Despite the reasoning being logically structured and contextually relevant, the severe inaccuracy in 2022 data reduces overall correctness. The answer captures the directional trend and strategic implication but fails on key factual inputs, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 423,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife shifted from using internally‑developed credit designations for newly acquired non‑agency RMBS and CMBS only as a temporary measure—assigning them until the NAIC could evaluate the securities—and began reporting essentially all such assets with the NAIC’s designated categories once those designations became available.  The tables for 2023 and 2024 show the NAIC designations for RMBS and CMBS expanding to cover the full amount of those holdings, while the footnote disclosures indicate that internal designations were used only “until a NAIC designation becomes available.”  This multi‑year pattern reveals that MetLife’s credit‑quality assessment has become increasingly dependent on the NAIC’s modeling methodology, with internal designations playing a diminishing, placeholder role.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall trend correctly: MetLife's use of internally developed designations for non-agency RMBS and CMBS decreased over time as NAIC designations became more widely adopted, with internal ratings serving as temporary placeholders. This aligns with the ground truth's core message of a gradual shift toward reliance on NAIC methodology. However, the LLM answer omits key quantitative details that are central to the multi-year pattern described in the original answer. Specifically, it fails to mention the $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and the $1.6 billion (4.9%) increase in 2024—data points that ground the conclusion about slowing growth and increasing NAIC designation coverage. These numbers are critical for supporting the inference about reduced reliance on internal designations. While the LLM correctly identifies the transitional role of internal designations and the expanding use of NAIC categories, it does not reference or analyze the changing growth rates in Level 3 securities, which are essential evidence in the original reasoning. The qualitative reasoning is sound and contextually relevant, showing understanding of the NAIC's role and the placeholder function of internal ratings. Entity accuracy (MetLife, RMBS, CMBS, NAIC, Level 3 securities) and time frame (2022–2024) are correct. The answer is semantically close but lacks the numerical foundation needed for full factual accuracy, particularly in a financial context where trends are supported by specific figures. Thus, while the direction of the conclusion is correct, the absence of key data limits its quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 462,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron allocated roughly $0.7 billion of its Africa capital budget to offshore development and natural‑gas projects in the Republic of Congo, preserving its equity stakes in the Haute Mer permit area and the Lianzi block. In early 2025 (planned during 2024) the company announced the sale of its 31.5 % non‑operated interest in Haute Mer and its 15.75 % stake in Lianzi, signalling a strategic divestiture that reduced its Congo exposure and shifted the capital toward lower‑carbon investments and other upstream growth areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the $0.7 billion allocation to Africa in 2023 for offshore and natural gas projects, it incorrectly attributes this entire amount specifically to the Republic of Congo, whereas the ground truth clarifies that the Republic of Congo was only one of several countries (including Nigeria and Angola) included in that regional budget. This misrepresents the capital allocation. Additionally, the LLM claims Chevron 'preserved its equity stakes' through 2024, which directly contradicts the ground truth: Chevron sold its 31.5% nonoperated interest in Haute Mer and 15.75% in Lianzi in 2024, not in early 2025. The timing is incorrect—the divestiture occurred in 2024, not as a future plan announced in 2024 for 2025. (2) Quantitatively, the $0.7 billion figure and the percentages (31.5% and 15.75%) are accurate, but their contextual application is flawed. The dollar amount is misallocated solely to Congo, and the sale date is shifted incorrectly to 2025. (3) The multi-hop reasoning is partially sound—Chevron’s broader African investment and eventual exit from Congo are recognized—but the synthesis fails on timing and geographic specificity. The model incorrectly infers continued ownership into 2025 when the exit was completed in 2024. (4) Contextual relevance is high because the answer addresses capital allocation and asset ownership changes as asked, but factual correctness is undermined by key errors in scope, timing, and operational status. Hence, the correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 443,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept Embedded‑Processing products as a central element of its **“broad portfolio”** advantage, but the way that pillar is used has shifted from growth‑oriented expansion to a focus on **cost‑control and supply‑chain resilience**.  The segment’s revenue and operating‑profit margins fell sharply in 2023‑24, yet the company leans on its **manufacturing‑technology advantage** (lower‑cost, high‑volume 300 mm fab), its **market‑channel reach** (selling into industrial and automotive designs), and the **longevity/diversity** of its product mix to protect cash flow and fund capacity investments.  In short, Embedded Processing now contributes to the four sustainable competitive advantages more through **operational efficiency and risk‑spreading** than through top‑line growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces unsupported claims not present in the ground truth. (1) The original answer states that Texas Instruments consistently emphasized Embedded Processing Products as a stable strategic pillar from 2022 to 2024, with evolving but reinforcing language each year—there is no mention of a strategic shift toward cost-control or supply-chain resilience. The LLM incorrectly asserts that the focus shifted from growth to operational efficiency, which contradicts the ground truth of consistent strategic emphasis. (2) The LLM claims that 'revenue and operating-profit margins fell sharply in 2023-24'—this is a significant factual error with no support in the original answer, which contains no financial performance data. There are no numbers in the ground truth, so introducing specific financial declines constitutes fabrication. (3) The multi-hop reasoning is flawed: while the LLM attempts to link embedded processing to TI’s four sustainable advantages, it misrepresents how the product line contributes, inventing a narrative about manufacturing technology and risk-spreading that is not in the source. The original answer emphasizes customer reach, design engagement, and long-term returns—not cost leadership or margin protection. (4) Despite being off-base factually, the answer is contextually relevant in that it addresses the strategic role of embedded processing within TI’s competitive advantages, and attempts to trace evolution across years. However, the invented details and incorrect characterization of strategic shifts severely undermine accuracy. Minor note: 'Embedded‑Processing' with a hyphen is a formatting variance but acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 460,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Cisco’s $500 million, 3.50 % senior note due 2025 moved from a low‑cost, effectively‑3.2 % fixed‑rate liability (with only a modest $10 fair‑value‑hedge gain in 2022) to an effective rate of roughly 6.6 % by 2024, as the $0.5 billion interest‑rate swap that hedged the note was largely unwound and floating‑rate markets rose. This shift shows that the company’s borrowing costs have increased markedly over the three‑year period, driven by higher market interest rates and the reduction of hedge protection on that senior debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key trend of rising effective interest rates on Cisco's $500 million 3.50% Senior Note from fiscal 2022 to 2024, aligning with the ground truth that borrowing costs increased significantly. However, there are minor quantitative discrepancies: the ground truth specifies exact effective rates of 3.20% (2022), 6.38% (2023), and 6.66% (2024), while the LLM rounds these to '3.2%' and 'roughly 6.6%', omitting the 2023 figure entirely. Additionally, the mention of a '$0.5 billion interest-rate swap' and '$10 fair-value-hedge gain' introduces specific figures not present in the original answer, which may be accurate but are unverifiable against the provided ground truth. (2) The dollar amount ($500 million) and maturity (2025) are correct. The progression from 3.20% to 6.66% is accurately reflected in direction and magnitude, though lack of precise year-by-year breakdown reduces quantitative precision. (3) The reasoning is strong: the LLM correctly infers that the increase in effective rate is due to a combination of rising market rates and the unwinding of hedge protection, which is a plausible and logical explanation consistent with financial principles and implies correct multi-hop synthesis between interest rate exposure, hedging activity, and cost of borrowing. (4) Despite minor omissions and unverified details, the core facts—increasing effective interest rate on a fixed coupon note due to market and hedging factors—are correct, and the conclusion about rising borrowing costs is fully supported. Hence, the answer is largely accurate with minor flaws in numerical precision, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 462,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s capital‑planning and shareholder‑return decisions are “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations governing capital and capital planning” and that any material reduction in credit ratings or failure to meet “well‑capitalized” and “well‑managed” standards could restrict its ability to pay dividends or repurchase shares.  This multi‑year language shows that regulatory capital adequacy, liquidity and supervisory expectations are the primary constraints on the firm’s strategic flexibility, forcing capital actions to be contingent on maintaining prescribed capital ratios, stress‑test results and regulator‑approved capital plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns from 2022 to 2024. It correctly identifies the consistent regulatory constraints tied to capital adequacy, 'well-capitalized' and 'well-managed' standards, and the impact on dividend and share repurchase flexibility. The answer accurately reflects that these limitations are contingent on regulatory approval, stress-test results, and capital ratios, which aligns with the ground truth's emphasis on regulatory constraints and strategic flexibility. Quantitatively, there are no numbers, dates, or financial figures in dispute—only qualitative disclosures, which are correctly represented. The LLM synthesizes the multi-year trend effectively, noting sustained regulatory pressure. However, it omits the specific mention of Delaware law and the failure to pay preferred dividends, which were explicitly noted in the 2023 and 2024 filings per the original answer. Additionally, while the LLM mentions liquidity risk implicitly through 'liquidity management' in the context of capital standards, it does not explicitly highlight the increasing emphasis on liquidity management in 2024 as stated in the ground truth. These are minor but relevant nuances in the progression of risk factor language. Despite these omissions, the overall reasoning, entity accuracy (BNY Mellon, U.S. banking laws, capital planning), and contextual relevance are excellent, and the answer conveys semantically equivalent information with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 434,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nThe “Repair and other services” line fell from **$1,169 million in 2022 to $1,132 million in 2023**, then held steady at **$1,132 million in 2024**. This dip followed the company’s strategic shift toward higher‑priority submarine and ship‑building programs, after which the repair business settled into a stable, low‑growth level rather than expanding. Consequently, the pattern signals that the segment is now being treated as a **steady‑state, cash‑generating unit** rather than a growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for Repair and other services: $1,169 million in 2022, $1,132 million in 2023, and flat at $1,132 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting (e.g., 'million' vs 'M'). (2) Quantitative accuracy is perfect—decline of $37 million from 2022 to 2023 is correctly implied, and no change in 2024 is accurately stated. (3) The reasoning is largely sound: the LLM correctly infers a strategic shift toward submarine and shipbuilding programs as a cause for the flat performance, aligning with the ground truth mention of resource reallocation to higher-priority programs. It adds a plausible interpretation that the segment is now a 'steady-state, cash-generating unit,' which is a reasonable inference from stagnation amid growth elsewhere, though slightly more interpretive than the original. However, it omits mention of possible contributing factors like market saturation or operational constraints, which were in the original answer, making the explanation slightly less complete. (4) Despite this minor omission, the LLM captures the core implications about stability and strategic focus. The answer is contextually relevant, directly addressing all parts of the multi-hop question: change from 2022–2023, flat trend in 2024, and what the pattern suggests. Thus, high scores across all dimensions with only a slight deduction in qualitative accuracy for incomplete reasoning coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 419,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s equity‑method stakes in health‑care operating businesses expanded sharply—from roughly **$1.3 billion in 2022 to $1.4 billion in 2023 and then to about $3.8 billion in 2024**—while its broader venture‑related equity securities remained large and relatively stable, moving from **$3.7 billion in 2022 to $4.9 billion in 2023‑24**.  This progression shows a clear strategic shift toward deepening investments in health‑care‑focused equity‑method assets, even as the company continues to maintain a multi‑billion‑dollar venture portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct, with only a minor discrepancy in the equity method investment value for 2022. The ground truth states that equity method investments were $1.4 billion in 2022 (and remained flat in 2023), but the LLM reports $1.3 billion in 2022. All other numbers are accurate: the $1.4 billion in 2023 and $3.8 billion in 2024 for equity method investments, and the $3.7 billion in 2022 and $4.9 billion in 2023–2024 for equity securities are correctly reported. (2) The quantitative values for the broader equity securities portfolio are fully accurate—$3.7B (2022), $4.9B (2023), and $4.9B (2024)—and correctly described as stable after growth. The equity method investment increase from $1.4B to $3.8B in 2024 is correctly highlighted, showing a significant jump. Only the 2022 equity method figure is off by $0.1B, which is minor but notable. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes trends across three years and two types of investments, identifying the strategic shift toward deeper, integrated equity method investments in 2024 while maintaining a stable venture portfolio. The conclusion about strategic emphasis aligns with the ground truth. (4) The correctness score is 9 due to the small error in the 2022 equity method investment value; otherwise, the answer is complete, contextually relevant, and semantically equivalent to the original. Quantitative accuracy is slightly reduced for the same reason, but qualitative and contextual scores remain perfect due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 431,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, Colgate‑Palmolive Co. is listed as a member of PMI’s peer group in each year’s performance‑graph table, and the composition of that peer group is unchanged in all three years. This multi‑year consistency reveals that PMI’s strategic benchmarking framework relies on a rigorously defined, stable peer set—selected by global presence, consumer‑product focus and comparable size—so that it can compare total‑shareholder‑return performance over time with a consistent reference group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PMI's peer group across 2022, 2023, and 2024 with no changes in composition, which matches the original answer's claim of year-over-year consistency. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and no incorrect dates or figures are present—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly infers that the unchanging peer group reflects a stable strategic benchmarking framework, citing global presence, consumer-product focus, and comparable size—consistent with the ground truth’s stated criteria (global presence, consumer products focus, net revenues, market cap). The only minor omission is not explicitly mentioning the exclusion of direct tobacco peers, which adds strategic nuance to PMI’s framework. This slightly reduces qualitative accuracy but does not undermine the core correctness. (4) The answer is highly contextually relevant, directly addressing both the evolution (or lack thereof) in classification and the implications for PMI’s benchmarking strategy. Wording differs but semantic meaning is equivalent. Overall, this is a strong, accurate response with only a slight gap in completeness regarding PMI’s rationale for excluding tobacco peers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 392,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior grew in step with its expanding credit‑product portfolio and deeper reliance on third‑party lenders, payment processors and other partners.  The 2022 filing warned of default risk and generic fraud threats; the 2023 filing added details on new BNPL and merchant‑financing receivables sales and the risks of depending on unaffiliated banks; and the 2024 filing explicitly states that fraud‑detection measures are “complex, require continuous improvement, and may not be effective” as the company adds more credit products and third‑party relationships.  Consequently, while PayPal continues to employ buyer‑/seller‑protection and risk‑modeling controls, the trend indicates that its fraud‑mitigation effectiveness is being stretched and may be less able to keep loss rates in check as the business scales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to credit product expansion and third-party risk. (1) All factual elements are correct: the 2022 focus on fraud threats and default risk, the 2023 expansion into BNPL and receivables sales (though the €40 billion figure is omitted, it is not misrepresented), and the 2024 acknowledgment of limitations in fraud detection systems. (2) Quantitative accuracy is strong—no incorrect numbers are stated, and while the €40 billion receivables agreement is not mentioned, its absence does not introduce inaccuracy, only a minor omission. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes risk trends across years, links credit expansion and third-party dependencies to increasing fraud exposure, and infers that mitigation efforts are being outpaced. (4) The answer conveys semantic equivalence to the ground truth, concluding that fraud-mitigation effectiveness is under strain despite ongoing controls. The only minor shortcoming is the lack of specific mention of regulatory uncertainty around loan receivables post-sale in 2024, which slightly reduces completeness. However, the core trend and implications are accurately captured, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 369,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s natural‑gas option notional first rose sharply—Southern Company’s options increased from 214 mmBtu in 2022 to 339 mmBtu in 2023, while Southern Company Gas’s options grew from 93 mmBtu to 102 mmBtu—and then pulled back in 2024 to 176 mmBtu and 83 mmBtu, respectively. This three‑year trajectory reflects a tactical scaling of option hedges: the firm expanded option coverage during the volatile 2023 price swing to lock in downside protection, then reduced the notional as market turbulence eased, illustrating a risk‑management strategy that adjusts hedge size in response to evolving natural‑gas price volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Southern Company's natural gas options were 253 million mmBtu in 2022, not 214 mmBtu as stated in the LLM answer. The 2023 value (339 million mmBtu) is correct, and the 2024 value (176 million mmBtu) is also correct for the parent company. However, the LLM introduces 'Southern Company Gas' with values of 93 mmBtu (2022), 102 mmBtu (2023), and 83 mmBtu (2024), which are not present in the original answer and represent a factual addition not supported by the ground truth. These figures suggest a breakdown between Southern Company and its subsidiary, but the original answer does not make this distinction, nor does it provide such granular data. (2) The calculation of trends is partially correct: the increase from 2022 to 2023 and decrease in 2024 aligns with the ground truth, but the baseline 2022 number is wrong. The LLM's total for 2022 (214 + 93 = 307 mmBtu) and 2024 (176 + 83 = 259 mmBtu) do not match the ground truth trajectory of 253 → 339 → 176. This misrepresents the magnitude and direction of change. (3) The multi-hop reasoning is sound in interpreting the trend as a tactical response to volatility—increasing hedges during volatile periods and reducing them afterward—which aligns with the original answer’s conclusion about dynamic risk management. The logic and synthesis of intent are qualitatively accurate. (4) Contextual relevance is high, as the answer directly addresses the evolution of hedging strategy and infers strategic intent correctly. However, the incorrect numerical foundation undermines factual correctness, especially in financial reporting contexts where precision is critical. The introduction of unverified subsidiary-level data reduces quantitative accuracy significantly despite reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 504,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose modestly—$70 million in 2022, $75 million in 2023 and $76 million in 2024.  This upward trend reflects a deliberate long‑term shift toward emphasizing defined‑contribution benefits (particularly the enhanced matching DC plan) while keeping the non‑qualified defined‑benefit pension plan closed and unfunded, signaling that the company is moving away from legacy defined‑benefit liabilities and toward DC‑based retirement compensation as its primary employee‑benefit strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect—each dollar amount and year is correct, and the trend of steady increase is accurately described. (3) The reasoning is sound and captures the multi-hop synthesis: the company has closed its defined benefit plan to new participants (since 1997, implied in original answer) and is increasingly focusing on defined contribution plans. The LLM correctly infers a strategic shift away from legacy defined-benefit liabilities toward DC-based retirement compensation. It accurately links the rising DC expenses to a long-term benefit strategy, even though the phrase 'since 1997' is omitted. (4) The only minor shortcoming is that the LLM does not explicitly mention that the defined benefit plan was closed to new participants in 1997, which provides important historical context for the current strategy. However, it correctly implies this by referencing the plan as closed. The answer is semantically equivalent in intent and meaning, with strong contextual relevance and factual precision. Thus, correctness is high but not perfect due to the missing 1997 closure context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 382,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nGM kept its long‑term expected return on U.S. pension‑plan assets steady at **6.3 % in 2022 and 2023**, and then **raised it to 6.5 % for 2024** after the 2024 investment‑policy study. This upward shift signals a more optimistic view of future market performance and a modest increase in risk tolerance—evidenced by a slight tilt toward higher‑return asset classes such as equities and alternative‑return strategies to meet the plans’ funding goals.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2022 rate of return. The ground truth states that GM's weighted-average long-term rate of return was 5.4% in 2022, but the LLM claims it was 6.3% in 2022 (and unchanged in 2023). This misrepresents the trend: the correct evolution is an increase from 5.4% (2022) to 6.3% (2023) to 6.5% (2024), whereas the LLM implies stability at 6.3% before a small rise in 2024. This undermines the quantitative accuracy significantly. (2) The 2023 and 2024 figures (6.3% and 6.5%) are correct and match the ground truth. The mention of an 'investment-policy study' aligns with typical pension assumption updates, though not explicitly stated in the original answer. However, the core error in the 2022 figure invalidates the stated trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that an increase in expected return suggests greater optimism and risk tolerance, which is consistent with the ground truth. It appropriately links the rate change to strategic asset allocation (e.g., equities and alternatives), adding plausible context. However, because the starting point (2022) is wrong, the synthesis of the trend across years is flawed. (4) Despite the major quantitative error, the answer is contextually relevant and addresses both parts of the question—evolution of assumptions and implications for risk/return expectations. The qualitative reasoning is reasonable given the numbers it uses, but the factual foundation is incorrect for 2022. Hence, correctness is penalized heavily due to the incorrect percentage in the first year, which distorts the entire trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 458,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nCisco’s total‑return swaps that economically hedge its deferred‑compensation obligations moved from a **$92 million loss in fiscal 2022** to **gains of $58 million in fiscal 2023 and $91 million in fiscal 2024**, while the notional amount of the swaps expanded from roughly **$650 million to $985 million** over the same period.  This shift shows that the company’s hedging program has become increasingly effective at offsetting the volatility of deferred‑compensation expense, allowing Cisco to manage compensation‑related risk more proactively and smooth earnings against fluctuations in the underlying compensation liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: a $92 million loss in fiscal 2022, a $58 million gain in 2023, and a $91 million gain in 2024. These match the original answer exactly, satisfying quantitative accuracy. However, the LLM introduces an additional detail—the notional amount of swaps increasing from $650 million to $985 million—which is not present in the ground truth. While this may be factually correct in external sources, it is not part of the verified knowledge graph and thus introduces unverified information, slightly reducing qualitative accuracy. (2) All numbers are accurate and correctly attributed to the right fiscal years. Format variations (e.g., $92 million vs $92M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of gains/losses over time and draws a logical conclusion about risk management and compensation strategy. The inference about improved hedging effectiveness aligns with the original answer’s interpretation of a 'notable turnaround' and 'strategic adjustments.' (4) The answer is highly contextually relevant, addressing both the quantitative evolution and the strategic implications. The only deviation is the inclusion of notional amounts, which, while plausible, are not in the ground truth and thus prevent a perfect qualitative score. Overall, the answer is factually correct on all verified points and provides a coherent, well-reasoned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 420,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nPayPal continued to record transaction revenue on a gross basis and to bear full margin risk on every payment, expense‑recognizing the fees it pays to third‑party processors as transaction expense.  Its pricing is managed through volume‑based tiers and incentive adjustments that are accounted for as reductions of revenue rather than as separate costs, and while the volume of processor‑related transactions grew, the underlying margin‑risk profile remained essentially stable from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and overall message. It accurately conveys that PayPal bore full margin risk across 2022–2024, recognized fees paid to third-party processors as transaction expenses, and maintained pricing control through volume-based tiers. The statement that pricing adjustments are accounted for as revenue reductions (not separate costs) is consistent with the original answer’s point about tiered pricing not constituting a future material right. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (PayPal, third-party processors, transaction expenses) and timeframes (2022–2024) are correctly referenced. However, the LLM answer omits specific year-by-year evolution details emphasized in the original answer: notably, the 2022 emphasis on pricing discretion independent of costs, the 2023 clarification on material rights, and the 2024 confirmation despite new segment reporting. While the core reasoning and conclusion about stable margin risk are valid, this lack of granular progression slightly weakens the multi-hop synthesis expected in a full response. Thus, qualitative accuracy is high but not complete. Contextual relevance is excellent—the answer directly addresses the question’s focus on margin risk evolution, pricing control, third-party processors, and expense recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 390,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s natural‑gas output from the Angola LNG project was essentially flat from 2022 through 2024 – roughly 52 million cubic feet per day in 2022 and about 48 million cubic feet per day in both 2023 and 2024. This steady, modest production underscores the company’s strategy of relying on established, long‑term LNG partnerships to secure a reliable supply slice within its global LNG portfolio rather than pursuing aggressive capacity expansion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that Chevron's natural gas consumption in Angola LNG operations was 592 million cubic feet per day (MMcf/d) in 2022, rising to 596 MMcf/d in 2023, and 609 MMcf/d in 2024 — indicating a steady increase. In contrast, the LLM claims volumes were around 52 MMcf/d in 2022 and 48 MMcf/d in 2023 and 2024, which is not only wrong but off by an order of magnitude (roughly 10x lower). These numbers do not align with the ground truth in any way, suggesting a fundamental data error or confusion with another asset or metric. (2) Quantitative accuracy is extremely low: all three years' values are incorrect, and the trend (flat or slightly declining) contradicts the actual upward trajectory. The correct values show a cumulative increase of 17 MMcf/d from 2022 to 2024; the LLM reports a decrease of 4 MMcf/d, which is both directionally and numerically wrong. (3) The qualitative reasoning fails because it draws conclusions from false data. The claim that 'steady, modest production' reflects a strategy of relying on stable partnerships may sound plausible, but it contradicts the ground truth, which shows increasing volumes signaling active operational growth and strategic emphasis on LNG in Angola. The original answer correctly ties rising volumes to Chevron’s broader LNG market positioning, especially amid divestitures elsewhere — a nuance entirely missed due to incorrect data. (4) Contextual relevance is moderate because the answer addresses the right topic (Chevron, Angola LNG, production trends, strategic implications), uses appropriate terminology, and attempts multi-hop reasoning by linking volume trends to corporate strategy. However, because the underlying data is so inaccurate, the conclusions are invalid. The model appears to fabricate numbers rather than retrieve or synthesize actual figures, leading to a highly misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 531,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nThe company’s reporting of scheduled payments under outdoor‑lighting contracts shifted from a brief, aggregate reference in the 2022 filing (where they were folded into a generic “operating‑lease obligations” line) to a dedicated, year‑by‑year maturity schedule in the 2023 and 2024 disclosures that lists specific cash‑flow amounts for each future year (e.g., $239 M in 2025, $212 M in 2026, $190 M in 2027, etc.) and a total present‑value of about $1.5 B.  This increasing level of detail and the growing dollar magnitude of the obligations reveal that these contracts have become a material, structurally important source of lease‑related revenue for Southern Power, prompting the firm to give them separate, more granular disclosure over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, outdoor lighting contracts were considered immaterial and not separately disclosed, but the LLM claims they were included in a 'generic operating-lease obligations line'—a detail not supported by the original. More critically, the LLM introduces specific dollar figures such as $239M in 2025, $212M in 2026, $190M in 2027, and a total present value of $1.5B, which are entirely absent from the ground truth and cannot be verified. These numbers are central to the LLM's argument about growing materiality but are fabricated. (2) There are no calculations in the ground truth to verify, but the introduction of precise future cash flows and a present-value estimate implies a level of disclosure that did not occur according to the original answer. The ground truth emphasizes qualitative changes in disclosure treatment (e.g., inclusion in maturity analyses, integration with PPAs), not granular year-by-year cash flow reporting. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increased disclosure granularity reflects growing materiality—but it misrepresents the nature and extent of the disclosures in each year. The evolution described (from aggregate to detailed) is conceptually aligned with the ground truth, but the specifics are exaggerated or invented. (4) While the overall direction of reasoning (increased importance leading to better disclosure) matches the original, the reliance on false quantitative data severely undermines factual correctness. The contextual relevance is high because the answer addresses the evolution of reporting and its implications, but the qualitative accuracy is reduced due to incorrect characterization of the disclosures. Correctness score is low due to unsupported numbers, which are central to the argument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 523,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Melaka, Malaysia site is repeatedly shown in the property tables under the **Analog** column (marked “X”) and never appears in the Embedded‑Processing column.  The disclosures for each year describe the facility only as part of TI’s analog‑chip manufacturing network (with the same “**” notation indicating leased/owned portions), and there is no mention of any re‑assignment or expansion of its role into embedded‑processing activities.  Consequently, TI’s operational footprint in Melaka remained focused on analog production throughout 2022, 2023 and 2024, with no documented shift or added involvement in the embedded‑processing segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in the Embedded Processing segment—this matches the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the use of 'repeatedly shown' and 'each year' confirms consistency across all three years as required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings, noting the consistent presence in Analog and absence in Embedded Processing, and draws the correct conclusion of no expansion or shift. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) of TI's operational footprint in Melaka with respect to the two business segments. Minor wording differences (e.g., 'focused on analog production' vs 'limited to Analog operations') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 326,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nThe $700 million 1.600% senior notes kept their original principal through 2022‑2024, with interest still paid semi‑annually on 15 April and 15 October and the earliest par‑call date unchanged at 15 March 2026; the only variations were modest reductions in the recorded amount due to discount amortisation, not actual repayments.  This demonstrates the company’s strategy of retaining a low‑cost, long‑dated debt tranche while using cash and revolving‑credit facilities to retire higher‑coupon maturities and extend the overall maturity profile of its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the principal amount of $700 million is accurately stated, the interest payment dates (April 15 and October 15) and par call date (March 15, 2026) match exactly. While the ground truth mentions adjustments to principal decreasing from (2.6) in 2023 to (1.5) in 2024—likely referring to amortization or discount adjustments—the LLM correctly interprets this as 'modest reductions in the recorded amount due to discount amortisation', which is a semantically valid explanation. (2) The LLM does not explicitly quantify the adjustment values ((2.6) and (1.5)), which were present in the original answer, representing a minor omission. However, this does not affect the core financial understanding, as the trend of decreasing adjustments is captured qualitatively. (3) The reasoning is sound: the LLM correctly infers that the stability in principal, interest schedule, and call date indicates a deliberate debt management strategy focused on preserving low-cost debt while retiring higher-cost obligations elsewhere. This goes beyond repetition of facts and offers a plausible strategic interpretation consistent with the data. (4) Contextual relevance is excellent—the response directly addresses all parts of the multi-year evolution (principal, interest, call date) and synthesizes them into a coherent view of AMT’s debt strategy. The only reason for not scoring a 10 is the lack of explicit mention of the numerical adjustment values, but the conceptual treatment is accurate. Thus, the answer earns a 9 for correctness and qualitative accuracy, a 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 469,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco’s 5.90% senior note due 2039 has remained on the books at a $2 billion principal with a stable 6.11% effective interest rate from fiscal 2022 through 2024.  During that time the company’s total long‑term debt grew from roughly $8.5 billion to $20.3 billion—largely because of a $13.5 billion senior‑note issuance in February 2024—so the 5.90% tranche’s share shrank to about 10% of the enlarged debt base.  This shift reflects a strategy of extending maturity and diversifying funding by issuing newer, lower‑coupon, longer‑dated notes while keeping a legacy high‑rate tranche as a stable, long‑term financing pillar.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco's 5.90% Note remained at $2,000 million (i.e., $2 billion) with a stable effective interest rate of 6.11% across fiscal years 2022–2024, which aligns with the ground truth. However, there are discrepancies in the total long-term debt figures: the ground truth reports $8,416 million in 2022 and $19,621 million in 2024, while the LLM states 'roughly $8.5 billion' and '$20.3 billion', respectively. These approximations are close but not precise, and the 2024 figure is notably off by over $700 million. Additionally, the LLM attributes the debt increase to a '$13.5 billion senior-note issuance in February 2024', a specific event not present in the ground truth, which does not mention the timing or size of any single issuance. (2) The calculation of the 5.90% note’s shrinking share to 'about 10%' is reasonable ($2B / $20.3B ≈ 9.85%), but this specific percentage was not in the original answer and introduces inferred detail. The ground truth emphasizes the shift toward long-term fixed-rate instruments broadly, not diversification via 'lower-coupon' notes, which is speculative. (3) The multi-hop reasoning is sound in linking the stable 5.90% note to a growing total debt base and inferring a strategic shift toward long-term financing. The conclusion about using the note as a 'stable, long-term financing pillar' aligns semantically with the original's interpretation of stabilizing financing costs. However, the LLM adds unverified specifics (e.g., February 2024 issuance, lower coupons) that go beyond the provided data. (4) The correctness score is 7 because core facts (note amount, interest rate, trend in long-term debt growth) are accurate, but quantitative inaccuracies in total debt figures and unsupported details about new issuances prevent a higher score. Quantitative accuracy is rated 6 due to the material overstatement of 2024 long-term debt. Qualitative accuracy is 8 because reasoning and strategic interpretation are strong and logically derived, despite some speculation. Contextual relevance is 9 as the answer directly addresses all aspects of the question with high alignment to the intended analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 588,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nBased on the 2022‑2024 10‑K filings, General Dynamics built 399 LAVs for the Canadian Army in 2022, 360 in 2023, and in 2024 it is producing 449 new LAVs plus an additional 66 LRSS‑equipped vehicles (≈515 total). This dip‑then‑increase shows the company is scaling up LAV production for Canada, reflecting a strategic focus on expanding its light‑armored‑vehicle portfolio and maintaining its market‑leading position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the production volumes and their temporal assignment. It incorrectly states that 399 LAVs were produced in 2022 and 360 in 2023, which reverses the correct order from the ground truth (360 in 2022, 399 in 2023). This misrepresentation undermines the core quantitative claim. While it correctly identifies 449 units in 2024 and the additional 66 LRSS-equipped vehicles, it erroneously labels the sum (449 + 66 = 515) as 'total' production, implying all are standard LAVs, whereas the ground truth specifies the 66 as specialized variants under a new program. (2) The calculation of total units is misleading—while 449 + 66 = 515 is mathematically correct, presenting this as 'total' LAV production without distinguishing between standard and specialized vehicles distorts the meaning. The original answer does not suggest such aggregation. (3) The reasoning is partially sound in identifying a strategic focus on LAV manufacturing, and the mention of the LRSS program aligns with the ground truth. However, the characterization of a 'dip-then-increase' is factually incorrect due to the swapped 2022 and 2023 numbers, leading to flawed trend analysis. The conclusion about scaling up is directionally correct but based on invalid data. (4) Contextually, the answer addresses both parts of the question—production evolution and strategic implications—and references relevant programs. Despite incorrect numbers, it attempts multi-hop synthesis by linking production figures to strategic intent. However, the reversal of key data points severely compromises factual correctness, warranting a low correctness and quantitative accuracy score. Qualitative reasoning is partially valid but built on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 484,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payments grew more volatile as CMS repeatedly revised the risk‑adjustment formula and expanded RADV audits, producing lower benchmarks and greater payment uncertainty.  In response, the company progressively tightened its cost structure—selectively adjusting benefits and premiums, exiting unprofitable counties, intensifying medical‑cost and operating‑expense controls, and investing in risk‑adjustment analytics and data‑driven pricing—while also focusing on improving quality star‑rating performance to protect revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024, as well as the company's strategic responses. It accurately reflects ongoing CMS methodology changes, payment uncertainty, and UnitedHealth’s operational responses such as benefit and premium adjustments, market exits, cost controls, and investments in analytics. While the original answer emphasizes consistent repetition of similar strategies across the three years (selective bidding, cost management, market withdrawals), the LLM answer synthesizes this into a coherent narrative of progressive tightening and increased investment in data analytics and pricing—semantically aligned but slightly more interpretive. The mention of 'expanded RADV audits' and 'improving quality star-rating performance' adds detail not explicitly present in the ground truth; while plausible and contextually relevant, these specific initiatives are not confirmed in the original knowledge graph and represent a minor overreach. However, no numeric or factual inaccuracies are present—there are no specific numbers (e.g., dollar amounts, percentages) to verify, and all dates (2022–2024) and entities (UnitedHealth, CMS, Medicare Advantage) are correct. The reasoning is sound and reflects multi-hop synthesis across years and strategic domains. The answer is highly contextually relevant and conveys the essential continuity of risk exposure and adaptive strategy. Minor deduction in qualitative accuracy due to unverified additions (RADV, star ratings), but overall factual core remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 447,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nFrom 2022 through 2024 the balance of PayPal’s 2.850 % fixed‑rate notes remained constant at **$1.5 billion** each year (the amount disclosed in the September 2019 issuance that matures in 2029).  While the company’s total term‑debt grew from roughly $9 billion to more than $10.5 billion, the 2.850 % tranche stayed on the books as a long‑dated, low‑cost pillar of financing that will not be retired until 2029.  This continuity shows PayPal’s long‑term debt strategy of maintaining a sizable, stable core of fixed‑rate debt to lock in favorable rates and provide financing stability, while supplementing it with newer issuances and revolving facilities for liquidity and flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: the fixed-rate 2.850% notes maintained a constant carrying value of $1.5 billion from 2022 to 2024, and these notes mature in 2029. The mention of total term debt increasing from ~$9B to ~$10.5B is consistent with broader portfolio changes noted in the context. (2) Quantitative accuracy is precise: $1.5 billion is correctly cited each year, the 2.850% rate is exact, and the 2029 maturity date matches the original. No calculations are required, but comparative statements about stability versus overall growth are factually sound. (3) Multi-hop reasoning is strong: the model correctly infers that maintaining this tranche while other debt evolved indicates a strategic choice to preserve a stable, low-cost, long-term liability structure. (4) The answer addresses both parts of the question—evolution of exposure (constant) and what it indicates about long-term strategy (intentional stability, locking in favorable rates). Wording differs slightly but achieves full semantic equivalence. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 328,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its upstream gas base in Angola—beginning with its 39.2 % interest in Block 0 and the 2024 completion of the Sanha Lean Gas Connection Project that links Blocks 0 and 14 to the Angola LNG plant—while expanding its 36.4 % stake in Angola LNG Limited and acquiring new frontier blocks (49 & 50) and a 31 % PSA interest in Block 14/23. It also sold its non‑Angolan portion of the Lianzi joint‑development area but retained the Angolan share, ensuring a growing, dedicated feed‑stock base for the LNG facility. This multi‑year progression shows Chevron’s long‑term strategy of monetising Angola’s associated gas by integrating new upstream discoveries and infrastructure directly into the Angola LNG value chain, positioning the country as a core natural‑gas export hub.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that undermine its correctness. Most critically, it incorrectly states Chevron's ownership in Angola LNG Limited as 'expanding its 36.4%' stake, implying growth, when the ground truth confirms the stake remained constant at 36.4% from 2022–2024. Additionally, the LLM claims Chevron had a '39.2% interest in Block 0' and a '31% PSA interest in Block 14/23'—details not present in the ground truth and potentially fabricated. The 'Sanha Lean Gas Connection Project' completion in 2024 is also not supported by the original answer, which instead highlights the Quiluma and Maboqueiro (Q&M) fields within the New Gas Consortium Project connecting to the LNG plant. (2) Quantitative accuracy is low: while 36.4% is correctly cited as the Angola LNG stake, the other percentages (39.2%, 31%) and project timelines (2024 completion of Sanha project) are unsupported or incorrect. The original answer does not mention Block 0 or Block 14/23 interests, nor the Sanha project, making these hallucinations. (3) The multi-hop reasoning is partially sound—the LLM correctly infers integration between upstream development and LNG monetization as a strategic theme. It also correctly identifies new exploration in Blocks 49 and 50. However, it misattributes specific projects and ownerships, failing to accurately synthesize the evolution around Q&M fields and the New Gas Consortium. The sale of the non-Angolan portion of Lianzi is mentioned but not in the ground truth, introducing unverified detail. (4) Contextual relevance is high—the answer addresses the strategic evolution of Chevron’s gas monetization and attempts to show integration into the LNG value chain. However, due to significant factual and quantitative errors, especially regarding ownership stakes and project details, the overall correctness score is low despite capturing the general strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 522,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nFrom 2022 to 2024 the fair‑value of Southern Company’s trust‑held domestic‑equity rose from about $565 million to roughly $1.1 billion, while private‑equity increased from $161 million to $181 million and then remained flat. This trend shows a deliberate shift toward greater U.S. equity exposure and a modest, stable allocation to private‑equity, reflecting a long‑term capital‑allocation strategy that prioritizes growth‑oriented equities while maintaining a cautious, diversified stance on alternative assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, domestic equity investments were $1,016 million in 2022, decreased to $829 million in 2023, and rose to $1,099 million in 2024. However, the LLM claims domestic equity started at $565 million in 2022 and rose to $1.1 billion by 2024, omitting the intermediate drop in 2023 and misstating the starting value. This misrepresents the trend. For private equity, the ground truth shows $150M (2022), $161M (2023), $181M (2024), indicating a consistent upward trajectory. The LLM incorrectly states private equity started at $161M in 2022 (overstating by $11M) and then 'remained flat' after 2024, missing the 2022–2024 progression entirely. (2) Calculations and comparisons are flawed: the LLM implies a steady rise in domestic equity, but the actual data shows a dip in 2023, which is a critical part of the trend. The claim of 'flat' private equity in 2024 contradicts the increase from $161M to $181M. (3) Multi-hop reasoning is unsound: the model fails to correctly synthesize year-over-year changes across three years, missing the strategic shift indicated by the dip and rebound in domestic equity and the consistent growth in private equity. (4) While the general theme of increasing equity exposure and diversification is partially relevant, the incorrect data leads to an inaccurate interpretation. The conclusion about 'stable allocation to private equity' contradicts the ground truth showing a clear upward trend. Thus, despite addressing the question's structure and attempting strategic interpretation, the answer is severely compromised by incorrect numbers and flawed reasoning. Contextual relevance is moderate because it discusses the right topic and strategy, but factual errors undermine validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 499,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Eliminations/Reclassifications” line subtracted $107 million, $151 million and $296 million from GM’s consolidated net‑sales/revenue, respectively – a 44 % rise from 2022 to 2023 and a further 95 % jump to 2024.  This expanding subtraction reflects increasingly extensive internal re‑classifications, such as the removal of inter‑segment sales (e.g., between Automotive, GM Financial and Cruise), the amortization of contract‑liability revenue and the accounting for cash‑flow hedge adjustments, indicating that GM is continually refining and tightening its segment‑level reporting boundaries.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105M in 2022, $107M in 2023, and $296M in 2024. However, the LLM states $107M (correct for 2023 but wrong for 2022), $151M (incorrect for 2023), and $296M (correct for 2024). The 2022 and 2023 figures are therefore wrong, with the 2023 value particularly off. (2) Calculations are also incorrect: the LLM claims a 44% rise from 2022 to 2023, but using its own numbers ($107M to $151M) this would be ~41%, and in reality the increase from $105M to $107M is only ~1.9%. The 95% jump to 2024 is roughly accurate if comparing $151M to $296M, but not from the correct $107M base. (3) Qualitatively, the reasoning is sound—identifying inter-segment sales, revenue reclassifications, and reporting refinements aligns with plausible causes and shows correct multi-hop synthesis of segment reporting dynamics. The trend interpretation (increasing adjustments indicating more complex reporting) matches the ground truth’s implication. (4) Contextually, the answer is highly relevant, addressing both the evolution of the eliminations and the implications for internal reporting. However, due to key numerical errors in two of the three years and incorrect calculations, the correctness score is limited to 6—partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 388,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 onward Netflix’s Performance Bonus Plan (PBP) was formally amended and restated in a December 9 2022 8‑K filing (Exhibit 10.5†), and that amended plan was subsequently incorporated by reference in the company’s 2023 and 2024 Form 10‑K filings (listed as Exhibit 10.5† in both years).  The PBP now operates as a distinct, documented component of Netflix’s executive compensation program, alongside the Amended and Restated Executive Severance and Retention Incentive Plan and the 2020 Stock Plan, but it is presented in the annual reports as a separate exhibit rather than being merged into any other compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and exhibit numbers are correct: the December 9, 2022 filing date for the amended and restated plan (Exhibit 10.5†) is accurately cited, and its inclusion in the 2023 and 2024 10-Ks as Exhibit 10.5† matches the original answer. The 2022 status as a historical exhibit (Exhibit 10.6† from 2014) is implied by the absence of updates and the shift to Exhibit 10.5† in 2023, though not explicitly stated. (2) The answer correctly captures the evolution: amendment in late 2022 (filed in 2023), continuity into 2024, and documentation status. (3) Qualitatively, the reasoning is sound—correctly identifying the plan's integration as a distinct but foundational component alongside other compensation plans. The only minor omission is not explicitly noting that in 2022 the plan was still referenced but as a historical exhibit (Exhibit 10.6†), which slightly weakens the multi-hop synthesis across all three years. However, the core progression—amendment in 2022 (filed 2023), stability in 2024—is accurately conveyed. (4) The answer correctly states the plan remains a separate exhibit and is not merged into other frameworks, which aligns with the 'integration' aspect of the question by clarifying it is referenced alongside newer structures like performance-based RSUs, even if not formally merged. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the ground truth with only a slight gap in completeness regarding 2022's exhibit status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 439,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nBK has continued to disclose its “Business Relationships and Related Party Transactions Policy” in the same location—Item 13 of the Form 10‑K and by reference in the Proxy’s “Corporate Governance and Board Information” section—across the 2022, 2023 and 2024 filings.  The wording of the cross‑reference is essentially unchanged, although the 2023 filing adds a brief note that any amendments to the policy are posted on the company’s website, and the 2024 filing repeats the same reference.  This steady presentation indicates that BK’s corporate‑governance disclosures concerning director independence and committee structures have been consistently applied, with only minor updates to keep the language current.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—BK, the 'Business Relationships and Related Party Transactions Policy', Item 13, and the relevant years (2022, 2023, 2024)—are correctly identified. The disclosure location (Item 13 of Form 10-K and 'Corporate Governance and Board Information' in the Proxy) matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The LLM correctly synthesizes multi-hop information across three years, noting consistent placement of the policy and its linkage to corporate governance, which reflects sound reasoning. It adds a detail not in the ground truth—that the 2023 filing notes website updates for policy amendments—but this is a minor enhancement, not a factual error. (4) The core conclusion about consistency in corporate governance disclosures related to director independence and committee structures is fully supported and semantically equivalent to the original answer. The only reason for not scoring a 10 is that the LLM omits explicit mention of the three committee names ('Audit Committee', 'Corporate Governance, Nominating and Social Responsibility Committee', and 'Human Resources and Compensation Committee'), which are included in the ground truth and relevant to the question about committee structures. Despite this omission, the overall consistency and correctness are very high, warranting a 9 for correctness and qualitative accuracy. Contextual relevance is perfect—answer directly addresses evolution over time and implications for governance consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 458,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of UnitedHealth’s held‑to‑maturity debt securities fell from **$679 million (2022) → $596 million (2023) → $508 million (2024)**, and the corresponding carrying (amortized‑cost) values declined from **$696 million → $603 million → $512 million**.  This reflects scheduled maturities and principal repayments together with the price‑decline that accompanies rising interest rates, showing that the company has been deliberately shrinking its held‑to‑maturity portfolio while maintaining a conservative valuation stance—recording amounts close to cost and relying on expected cash‑flow collection rather than market‑price fluctuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $643 million, but the LLM reports $679 million. Similarly, the carrying value in 2022 was $641 million (ground truth), while the LLM states $696 million. These discrepancies affect all years and are not minor formatting differences but material overstatements. The 2023 and 2024 values for fair value ($596M, $508M) and carrying value ($603M, $512M) match the ground truth and are correctly reported. (2) Calculations: While the LLM correctly shows a downward trend, the starting point is wrong, leading to incorrect magnitude of decline (e.g., $679M → $508M implies a $171M drop vs. actual $643M → $508M = $135M drop). This impacts interpretation of the trend’s severity. (3) Multi-hop reasoning: The LLM correctly identifies the three-year trend of decline and attributes it to maturities, repayments, and rising rates—plausible and contextually sound. It also notes the conservative valuation approach, which aligns with the idea of relying on amortized cost. However, it misses the key qualitative insight from the ground truth about the shift away from Level 3 unobservable inputs, which is a critical indicator of changing valuation assumptions and increased reliance on observable markets. This omission weakens the analysis of valuation assumptions. (4) Despite incorrect initial figures, the directional trend (decline) and general strategic interpretation (shrinking portfolio, conservative stance) are reasonable and relevant. The answer addresses both parts of the question—evolution of values and implications—but with flawed data and incomplete reasoning on valuation assumptions. Hence, correctness is partially compromised due to major quantitative errors, though qualitative logic and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 504,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nFrom 2022 through early 2023 PayPal’s BNPL portfolio was expanding and its internal risk models warned that higher default rates could raise charge‑offs and loan‑loss allowances.  In June 2023 the company executed a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, thereby transferring the bulk of that credit risk off‑balance‑sheet and sharply reducing its direct exposure.  By 2024 the remaining BNPL exposure was confined to a smaller forward‑flow portfolio, with the firm managing any residual risk through allowances and continued sales, indicating a clear shift from growing BNPL assets to an active risk‑mitigation strategy of divestiture and loss‑reserve management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables is accurately reported, including the amount (€40 billion), timing (June 2023), and geographic scope (U.K. and Europe). There are no numerical or date inaccuracies. (2) Quantitative accuracy is perfect: the figure '€40 billion' matches the original, and no calculations are required beyond correct reporting. (3) The multi-hop reasoning is sound—LLM correctly synthesizes PayPal’s increasing BNPL risk in 2022, the strategic sale in 2023 as a risk-mitigation move, and the reduced exposure in 2024 through forward-flow arrangements and reserves. It captures the evolution of risk strategy even if it doesn’t explicitly mention 'conditions' that could delay benefits (a minor omission). (4) The answer conveys semantic equivalence: while the LLM uses terms like 'off-balance-sheet' and 'forward-flow portfolio' not in the original, these are accurate characterizations. The core insight—that PayPal shifted from growing BNPL exposure to active risk mitigation via asset sales and reserves—is fully aligned. The only reason for not scoring 10 is the slight omission of the conditional nature of the 2024 benefits mentioned in the original, which adds nuance about potential delays. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 408,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s net oil‑equivalent production in Myanmar fell sharply — from roughly **17 kbbl/d in 2022 to 15 kbbl/d in 2023 and only 4 kbbl/d in 2024** — and its natural‑gas output dropped from about **94 MMcf/d in 2022 to 87 MMcf/d in 2023 and 22 MMcf/d in 2024** (see the production tables on pages 9‑11 of the 2023 and 2024 10‑Ks).  This decline reflects the company’s strategic decision to wind down its Myanmar operations, a process begun with the January 2022 announcement of an orderly exit, and to re‑allocate capital toward its core upstream assets elsewhere.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the 2022 (17 kbbl/d) and 2023 (15 kbbl/d) upstream production volumes for Chevron in Myanmar, it incorrectly claims production was 4 kbbl/d in 2024. The ground truth states Chevron completely withdrew from Myanmar in April 2024, meaning production dropped to 0, not 4 kbbl/d. Similarly, the cited natural gas figures (94 to 87 to 22 MMcf/d) are not supported by the ground truth, which does not provide gas-specific data, making these numbers unverifiable and likely fabricated or misattributed. (2) The calculation of decline is partially accurate from 2022 to 2023 but fails in 2024 due to the incorrect nonzero value. The mention of 'pages 9–11 of the 2023 and 2024 10-Ks' implies specific sourcing, but such detailed data (especially gas volumes) are not confirmed in the knowledge graph, raising concerns about hallucination. (3) The reasoning about a strategic shift is qualitatively sound—Chevron did announce an orderly exit starting in January 2022 and completed it in April 2024, reflecting portfolio optimization and risk management. The LLM correctly identifies the strategic rationale of reallocating capital to core assets, which aligns with the ground truth’s 'portfolio optimization and risk management' explanation. (4) Despite correct identification of the strategic context and partial numerical accuracy, the inclusion of unsupported 2024 production figures and gas metrics significantly undermines factual correctness. The answer is contextually relevant and addresses both parts of the question (production evolution and strategic shift), but the quantitative errors in the final year and addition of unverified gas data reduce the correctness score. Minor formatting variations (kbbl/d vs MBD) are acceptable, but reporting 4 kbbl/d instead of 0 is a major factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 514,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nThe disclosures show that the “Personal electronics” bucket—of which PC & notebooks are a component—fell from about 24 % of total TI revenue (the 2021/2022 reference) to roughly 20 % of total revenue in both 2023 and 2024.  Consequently, the share of PC & notebooks within the Personal Electronics segment declined modestly over the 2022‑2024 period.  This downward trend signals TI’s deliberate move away from the consumer‑computing market and a strategic refocus on higher‑margin industrial, automotive and other analog/embedded‑processing opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key percentages and years. According to the ground truth, the Personal Electronics segment was 24% in 2022, dropped to 15% in 2023, and rose to 20% in 2024. The LLM incorrectly states that the segment was about 24% in '2021/2022' (blending years), then claims it was roughly 20% in both 2023 and 2024—this misrepresents the 15% drop in 2023, a significant data point indicating a sharper decline. This is a critical quantitative error. (2) The LLM correctly identifies that PC & Notebooks are part of Personal Electronics and that the trend reflects a strategic shift, but misstates the trajectory: it omits the 15% low in 2023 and incorrectly implies a stabilization at 20% from 2023 onward. The calculation of relative contribution within the segment is not explicitly provided in either answer, but the LLM infers a 'modest' decline, while the ground truth suggests a more pronounced shift given the segment's overall drop to 15%. (3) The reasoning is partially sound—TI’s strategic refocus on Industrial and Automotive markets is correctly inferred and aligns with the ground truth. The entity identification (Texas Instruments, Personal Electronics, PC & Notebooks) is accurate, and the multi-hop synthesis across years is attempted, but flawed due to incorrect year-to-year comparisons. (4) Despite the incorrect figures, the LLM captures the overall directional trend and strategic implication, which maintains contextual relevance. However, the quantitative inaccuracies—especially the misstatement of 2023 data—reduce correctness significantly. The answer is not completely wrong but is partially accurate with major factual flaws in the core metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 469,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nFrom 2022 through 2024, GM’s indemnification obligations to Stellantis remained limited to a contingent guarantee of the seller’s duties under the 2017 Master Agreement, with only an immaterial accrual (a negligible amount recorded in 2023 for Takata‑related recall reimbursements) and no material liability recorded in 2022 or 2024. The company continues to be unable to estimate any reasonably possible loss from the pending emissions‑related consumer lawsuits in Europe or from any future Takata‑related indemnities, although the obligations are subject to time caps and thresholds that could result in additional payments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some key elements of GM's indemnification obligations to Stellantis but contains significant inaccuracies and omissions that affect factual correctness and completeness. (1) Quantitatively, the answer correctly states that accruals were immaterial and that no material liability was recorded in 2022 or 2024, aligning with the ground truth. However, it incorrectly attributes the immaterial accrual to 2023 for 'Takata-related recall reimbursements,' whereas the ground truth indicates the immaterial payment in 2023 was for broader indemnifications (including emissions, product liability, recalls), not specifically Takata. Furthermore, the 2024 accrual was related to European Commission and UK CMA investigations into end-of-life vehicle practices from the Opel era—this is entirely missing from the LLM answer. (2) The LLM incorrectly implies the only accrual was Takata-related in 2023, while the ground truth shows evolving disclosures: 2023 introduced indemnification for multiple legacy risks (emissions, product liability), and 2024 added a new accrual tied to regulatory investigations. The LLM reverses the emphasis—Takata is mentioned as a remote possibility in 2024, not an actual accrual. (3) Multi-hop reasoning is partially sound—linking GM’s indemnification to the 2017 sale of Opel/Vauxhall to Stellantis is contextually valid—but fails to synthesize the year-over-year evolution in disclosure specificity and emerging regulatory exposure. (4) Entity accuracy is acceptable (GM, Stellantis, Opel-era references), but the misattribution of accruals to Takata undermines qualitative accuracy. The answer is contextually relevant and addresses indemnification scope, but misses the trend of increasing disclosure and shifting risk focus. Thus, the answer is partially correct but contains key factual errors in timing, causality, and risk categorization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 509,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450 % Senior Notes due 2026 were first issued in September 2021 (Supplemental Indenture No. 12) and, as reflected in the 2022‑2024 filings, no additional tranche of that exact 2026‑maturity series was added thereafter.  Instead, the company’s later debt‑issuance activity introduced new note series with higher coupons and staggered maturities (e.g., 1.600 % 2026, 3.650 % 2027, 5.5 % 2028, etc.), showing that its debt‑management strategy shifted from relying on a single low‑cost, long‑dated issuance to a more diversified, rate‑responsive approach that spreads maturities and takes advantage of evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 1.450% Senior Notes due 2026 were issued under 'Supplemental Indenture No. 12', while the ground truth confirms they were issued under Supplemental Indenture No. 10. Second, the LLM claims no additional tranches of the same notes were issued, which may be true, but it then incorrectly infers a strategic shift based on the introduction of new note series (e.g., 1.600% 2026, 3.650% 2027, etc.), which are not mentioned or supported in the original answer. These new series and their coupon rates are unverified and appear fabricated. (2) The date of issuance (September 2021) is correct and aligns with the ground truth (September 27, 2021), and the maturity year (2026) is accurate. However, the exhibit numbers (4.25 in 2022, 4.22 in 2023, 4.21 in 2024) and their consistent referencing across years—key evidence of stability—are omitted. Instead, the LLM introduces unsupported details about other notes and a strategic shift not present in the original data. (3) The multi-hop reasoning is flawed. The original answer draws a conclusion of stability from the consistent inclusion of the same notes across three years’ filings. The LLM, however, infers a strategic evolution without evidence from the provided data, misrepresenting the pattern. There is no indication in the ground truth that the company diversified or responded to market conditions during this period—those are speculative additions. (4) The contextual relevance is moderate because the answer addresses debt management strategy and references the correct company and time frame, but the core factual inaccuracies and unsupported inferences severely undermine correctness. Quantitative and qualitative accuracy are low due to incorrect indenture number and invented financial instruments. The correctness score is low because the answer contradicts the ground truth’s central claim of stability with an unsupported narrative of strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 544,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the 2019 Long‑Term Incentive Plan remained the governing framework, but the company repeatedly updated the award documents that implement it.  Each year new forms of Performance‑Share‑Unit Agreements (2022 Exhibit 10.21, 2023 Exhibit 10.26, 2024 Exhibit 10.25) and Restricted‑Stock‑Unit Agreements (2022 Exhibit 10.22, 2023 Exhibit 10.27, 2024 Exhibit 10.29) were filed, showing a progressive rollout and refinement of deferred‑stock‑unit and performance‑share‑unit awards under the plan.  These successive filings reflect the evolution of the plan’s equity‑based compensation structure across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general idea that the 2019 Long-Term Incentive Plan remained the foundational framework and was implemented through updated award agreements from 2022 to 2024, which aligns with the original answer's theme of 'sustained and expanding reliance.' However, there are significant factual discrepancies. The LLM claims new forms of Performance Share Unit (PSU) and Restricted Stock Unit (RSU) agreements were filed each year (2022, 2023, 2024) with specific exhibit numbers, but the ground truth does not mention these exhibit numbers or annual updates for all three years. More critically, the original answer highlights a key evolution: in 2023, a new 'Deferred Stock Unit Agreement for Directors' was introduced, extending the plan to directors—this important expansion is entirely missing in the LLM response. Additionally, the original answer notes the 2024 adoption of the '2022 Form of PSU Agreement,' indicating reuse/iteration of prior forms, not necessarily new annual forms as the LLM implies. The LLM incorrectly suggests a pattern of yearly new PSU and RSU forms, which is not supported by the ground truth and introduces fabricated exhibit numbers (e.g., 2022 Exhibit 10.21, etc.), severely undermining quantitative and qualitative accuracy. While the LLM correctly identifies the continued use of the 2019 plan and references performance and restricted stock units, it fails to accurately represent the nature, timing, and strategic significance of the changes, particularly the director-level expansion and the specific forms introduced. Thus, while contextually relevant and semantically partially aligned, the answer contains material factual errors and omits key developments, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 475,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nBetween 2022 and 2024 General Dynamics progressively deepened its aerostructure focus in the Combat Systems segment, expanding OTS’s metal‑parts and propellant production capacity and launching a 2024 strategic partnership to manufacture solid‑rocket motors, while weapons‑systems revenue grew from about $2.0 bn to $2.9 bn. This three‑year ramp‑up shows a deliberate strategy to position GD as a premier supplier of next‑generation missile subsystems—particularly hypersonic and high‑performance missile components—by strengthening domestic supply‑chain resilience and embedding advanced aerostructures into its missile‑system portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Combat Systems accounted for 20% of consolidated revenue in 2023 and 19% in 2024, but the LLM claims weapons-systems revenue grew from $2.0B to $2.9B — a figure not present in the original answer and unsupported by the provided data. There is no mention of OTS (Orbital Tactical Systems?), metal-parts expansion, propellant production, solid-rocket motor partnerships, or domestic supply-chain initiatives in the ground truth. These are fabrications or hallucinations. (2) Quantitative accuracy is very low: the $2.0B to $2.9B revenue growth is incorrect and cannot be verified from the original answer, which only provides percentages of consolidated revenue (20%, then 19%) without absolute values. No revenue figures for Combat Systems are given in the ground truth, making the LLM’s precise dollar amounts entirely speculative. (3) The multi-hop reasoning is flawed. While the original answer confirms a consistent strategic focus on aerostructures for next-gen missiles across 2022–2024, the LLM invents a narrative of expansion and new partnerships not present in the source. It misrepresents slight revenue share decline as growth in absolute terms. The conclusion about positioning GD as a 'premier supplier' via supply-chain moves is unsupported. (4) Despite incorrect facts and numbers, the LLM does address the general theme of strategic focus on aerostructures in missile subsystems, which aligns with the question's intent, giving it moderate contextual relevance. However, the core factual and quantitative errors severely undermine correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 460,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly listed **Jackpot** among PMI’s “important local cigarette brands” in the Philippines, but the way the brand was framed evolved.  In 2022 it was presented simply as part of PMI’s diversified local portfolio; by 2023, after the regional segment realignment and the integration of Swedish Match, the reference was tied to the broader push to fund the company’s smoke‑free transformation, and in 2024 the brand was highlighted again as a stable cash‑generating asset that underwrites PMI’s shift toward reduced‑risk products while preserving market share in the Philippines.  This multi‑year progression shows that Jackpot is being used as a regional “cash‑cow” to subsidize PMI’s long‑term smoke‑free portfolio and to maintain a foothold in emerging markets, positioning the brand as a bridge between traditional cigarette sales and the company’s broader product‑portfolio strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Jackpot is consistently identified as a key local brand in the Philippines across 2022–2024, and PMI’s strategic emphasis on it persists despite its smoke-free transformation. The evolution in framing—from a portfolio component (2022), to a funding source amid restructuring (2023), to a cash-generating asset supporting reduced-risk products (2024)—is logically inferred and consistent with the original answer’s implication that traditional brands remain strategically relevant. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and contextually accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects Jackpot’s role to broader corporate strategy (funding IQOS/ZYN expansion, regional market retention), correctly inferring the 'cash cow' dynamic even if the term isn’t used in the original. This represents a nuanced but justified interpretation. (4) The only reason for not scoring a 10 is that the original answer does not explicitly state Jackpot is a 'cash cow' or 'subsidizes' the transformation—though this is a reasonable inference, it slightly extends beyond the documented facts. However, the core facts, timeline, entity accuracy, and strategic interpretation are all correct and relevant, making the answer semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 421,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept its upstream investment in the Republic of Congo focused on sustaining production and modest growth within its broader $10 billion lower‑carbon capital programme.  However, by the close of 2024 the company moved to streamline that exposure, announcing in January 2025 the sale of its 31.5 % non‑operated stake in the offshore Haute Mer permit and its 15.75 % interest in the Republic of Congo portion of Lianzi—an explicit asset‑disposition step that reflects a strategic reduction in capital deployment in the country.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's strategic shift in the Republic of Congo, including the key asset dispositions in January 2025 — the 31.5% nonoperated stake in Haute Mer and the 15.75% interest in Lianzi — which aligns with the ground truth. However, it introduces a significant inaccuracy by referencing a 'broader $10 billion lower-carbon capital programme' that is not mentioned or supported in the original answer, potentially misleading the reader about the context of capital deployment. Additionally, while the original answer specifies that Chevron invested approximately $0.7 billion in Africa (including Congo) in 2023, this figure is entirely omitted in the LLM response, representing a critical omission of quantitative evidence for active capital deployment. (2) The dates and percentages related to the 2025 asset sales are accurate and match the ground truth. However, the absence of the $0.7 billion investment figure from 2023 undermines quantitative completeness. The mention of a $10 billion program is unsupported and factually suspect in this context. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic reduction from ongoing operations to divestiture. It connects 2022 presence to 2025 exit logically. However, it fails to incorporate the 2023 investment data point, weakening the synthesis across all three years. Instead, it fabricates a broader program context not present in the source. (4) The contextual relevance is high as the answer addresses capital deployment and asset disposition as asked. Qualitative accuracy is good due to correct entity and timeline identification, but quantitative accuracy is reduced due to missing data and an unsupported dollar figure. Correctness score is 7 because core facts about the divestiture are correct and the overall trajectory is accurately characterized, but key financial data is omitted and replaced with extraneous, unverified information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 533,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company kept outdoor‑lighting contracts classified as operating leases for all of its electric subsidiaries throughout 2022‑2024, consistently describing the cash‑flow amounts as immaterial and applying the same stand‑alone‑selling‑price method to allocate lease revenue; the lease‑payment pattern—scheduled payments with month‑to‑month renewals and variable, energy‑based components that are excluded from the maturity tables—has not changed materially across the subsidiaries.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in several key aspects. (1) It claims that outdoor lighting contracts were consistently treated as immaterial and that there was no material change in treatment from 2022 to 2024, which directly conflicts with the original answer stating that in 2023, Southern Company began disclosing scheduled lease payments in maturity analyses, and by 2024 expanded disclosures to include initial terms and clarified revenue classification—indicating a clear evolution in accounting treatment and increased transparency. (2) The LLM asserts that the payment pattern has 'not changed materially' and that variable components are excluded from maturity tables, but the ground truth shows an explicit inclusion of scheduled payments in maturity analyses starting in 2023, implying a structural change in disclosure and possibly in accounting approach. (3) The LLM fails to mention the key 2024 clarification that lease income from PPAs is included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power—a critical multi-hop detail involving subsidiary-level revenue allocation. (4) The claim of consistent immateriality is false: while 2022 considered it immaterial, the expanded disclosures in 2023 and 2024 suggest growing materiality or at least a shift toward more rigorous reporting. (5) No numeric values are present, but the qualitative inaccuracies are severe, especially regarding the timeline of changes and subsidiary-specific disclosures. The reasoning fails to capture the progression across years and subsidiaries, showing poor multi-hop synthesis. Contextual relevance is moderate as it addresses the general topic but misses the core evolution in accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 475,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due 2025 kept a constant carrying amount of roughly $500 million in fiscal 2022‑2024, but its effective interest rate climbed from about 6.0 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024. This upward shift—driven by higher market rates, the accretion of discount and hedge‑accounting adjustments—shows that Cisco’s debt valuation is increasingly tied to floating‑rate market conditions and that the note’s borrowing cost has risen as monetary policy tightened.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the effective interest rate for fiscal year 2022. The ground truth states the effective rate was 3.20% in FY2022, but the LLM claims it was 'about 6.0%', which is significantly incorrect. The carrying amount of $500 million is correctly reported across all years, and the effective rates for FY2023 (6.38%) and FY2024 (6.66%) are accurate. (2) Quantitative accuracy is compromised due to the incorrect FY2022 rate; this error affects the validity of the trend description. While the later years' numbers are correct, the misrepresentation of the starting point undermines the quantitative integrity. (3) The reasoning about rising market rates, accretion of discount, and hedge-accounting adjustments is plausible and aligns with the kind of factors that could drive an increasing effective interest rate, showing sound qualitative understanding. The synthesis across years is logical and addresses the evolution over time, though based on an incorrect initial value. (4) Contextually, the answer is highly relevant, addressing both carrying amount and effective interest rate trends and interpreting their implications for debt valuation and market conditions. However, the significant error in the FY2022 effective rate reduces the correctness score to the mid-range despite otherwise strong structure and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 386,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s Unsecured Notes – 35A remained a $750 million, 2.65 % tranche that matures on 07/15/30 and carries an annual debt‑service charge of roughly $19.9 million (in 000s).  The absolute amount of the 35A issue did not change across the three years, but its weight in the company’s overall unsecured portfolio declined as total unsecured indebtedness grew (from about $20 bn in 2021 to $21 bn in 2023 and $26 bn in 2024).  This stable, long‑dated core note illustrates SPG’s disciplined, long‑term debt‑management approach: it uses a low‑cost, fixed‑rate, far‑out‑maturity instrument as an anchor while gradually expanding and diversifying the rest of its unsecured issuance to extend the overall maturity profile and manage liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date for Unsecured Notes - 35A across 2022–2024, matching the ground truth exactly. The annual debt-service calculation ($750M × 2.65% = $19.875M ≈ $19.9M) is accurate and properly contextualized. While the ground truth does not mention the debt-service cost, this is a valid inference and adds value without introducing error. (2) The LLM introduces additional context about total unsecured indebtedness growing from $20B in 2021 to $26B in 2024, which is not in the original answer. However, this information is plausible and supports the core insight—namely, that the 35A note’s proportion declined even as its absolute value remained constant. This enhances rather than contradicts the original reasoning. (3) The multi-hop reasoning is sound: the model correctly synthesizes the stability of the 35A note with broader portfolio changes (e.g., new issuances like 41A implied by portfolio growth), leading to a valid conclusion about SPG’s long-term debt strategy—using stable, fixed-rate debt as an anchor while actively managing the rest of the portfolio. (4) The only minor deviation is the inclusion of inferred portfolio totals not in the ground truth, but these do not affect the correctness of the 35A exposure assessment and are consistent with the strategic interpretation. Thus, the answer is factually correct, fully addresses both parts of the question, and demonstrates strong reasoning. A score of 9 is given because while all stated facts are accurate, one data point (total unsecured debt figures) extends beyond the provided ground truth, though reasonably so.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 466,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024, Embedded‑Processing remained one of TI’s four sustainable competitive advantages—providing supply‑chain control, a broad portfolio, market reach and product longevity—but the way the company leaned on it changed. In 2022 the segment delivered modest 3 % revenue growth and contributed positively to profit, underscoring its role in expanding market share and exploiting TI’s manufacturing scale. By 2023 and especially 2024, revenue fell sharply (‑25 % to ‑30 %) and operating‑profit margins collapsed (from 29.9 % to 13.9 %), so the strategic emphasis moved from using Embedded Processing as a growth engine to protecting its cost structure and leveraging the segment to reinforce the other three advantages (manufacturing efficiency, portfolio breadth and market diversification).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and strategic interpretation. (1) The original answer states that Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, using identical language each year to describe its value as part of the four sustainable competitive advantages. The LLM, however, claims a significant shift in strategy due to sharp revenue declines (‑25% to ‑30%) and collapsing margins (from 29.9% to 13.9%), which are not mentioned or supported in the ground truth. These specific financial figures (revenue growth, operating margins) are entirely fabricated or misattributed, with no basis in the provided truth. (2) Quantitative accuracy is extremely low—none of the percentages (3%, -25%, -30%, 29.9%, 13.9%) appear in the original answer, and there is no discussion of financial performance trends in the ground truth. The original focuses on qualitative consistency, not financial deterioration. (3) Qualitatively, the LLM misrepresents the evolution of the strategic emphasis: the ground truth emphasizes stability and sustained importance, while the LLM invents a narrative of decline and strategic repurposing. It incorrectly suggests that Embedded Processing shifted from a 'growth engine' to a cost-protection role, which is unsupported. The four competitive advantages are misrepresented—the original lists 'broad portfolio of analog and embedded processing products' as one of the four, not supply-chain control, market reach, etc., as the LLM claims. (4) Contextual relevance is moderate because the answer addresses the right company, time frame, and general topic (strategic role of embedded processing), but the reasoning and synthesis are flawed. The LLM fails the multi-hop requirement by not recognizing that the consistency of language across years is the key evidence of strategic continuity. Overall, the answer fabricates financial data and constructs an erroneous narrative, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 550,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast shifted its wireless offering from a narrow, bundled‑only service with limited shared‑data or per‑gigabyte choices to a far more flexible portfolio: it introduced prepaid unlimited‑data plans under the NOW brand, let customers pick from unlimited, shared‑data or per‑GB options, bring their own device or finance purchases interest‑free (24 months domestically, up to 48 months internationally), and expanded the service beyond the United States to the United Kingdom (via an MVNO deal with Virgin Media O2) and other markets, where it now offers a range of gigabyte‑based plans and longer financing terms. This evolution gave subscribers greater flexibility in plan selection and broadened the wireless service internationally.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of CMCSA's wireless shared data plan offerings from 2022 to 2024. It correctly identifies the shift from bundled-only offerings in 2022 to increased flexibility by 2023 (offering unlimited, shared data, and per-gigabyte plans), and international expansion in 2024 under the NOW brand. The mention of prepaid unlimited data plans under NOW aligns with the ground truth. The LLM adds specific details not in the original answer—such as interest-free financing (24 months domestically, up to 48 months internationally), BYOD options, and the MVNO partnership with Virgin Media O2 in the UK—which are plausible elaborations consistent with CMCSA’s strategy but not explicitly confirmed in the ground truth. These additions do not contradict the original answer and enhance context without introducing errors. All dates (2022–2024) and service evolution are correctly sequenced and semantically aligned. No calculation errors exist, as the response is qualitative. The multi-hop reasoning—linking domestic bundling, plan flexibility, and international expansion—is sound and synthesizes the required information accurately. The only minor deduction is for including unverified specifics (e.g., financing terms, Virgin Media O2 deal) not present in the ground truth, which, while reasonable, go beyond the provided knowledge. Overall, the answer is factually correct, complete, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 401,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 to 2024 PayPal’s exposure to abusive behavior moved beyond generic transaction fraud to a more product‑specific risk environment that now includes credit‑line underwriting, BNPL receivable sales and heightened reliance on third‑party lenders and funding structures; at the same time, sophisticated third‑party fraud schemes—such as synthetic‑identity account creation, misuse of credit products and large‑scale abuse of digital‑wallet channels—have expanded in both frequency and complexity. This evolution shows that managing risk in PayPal’s digital‑payments ecosystem now demands increasingly layered controls, combining advanced fraud‑detection technologies, rigorous credit‑risk modeling, and tighter governance of third‑party partnerships. Consequently, the company must continuously adapt its risk‑management framework, compliance processes and investment in detection capabilities to keep pace with these growing threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and contextually relevant, capturing the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024. (1) It correctly identifies the shift toward more sophisticated, product-specific risks involving credit products and third-party fraud schemes, aligning with the ground truth's emphasis on BNPL receivables, synthetic identities, and account takeovers. (2) There are no numeric inaccuracies; the LLM avoids making up figures and does not contradict the €40 billion receivables sale mentioned in the original—though it does not explicitly mention the €40 billion or the U.K./Europe scope, which is a minor omission. (3) The multi-hop reasoning is sound: it synthesizes the progression of fraud types (e.g., synthetic identity, account takeovers), links them to credit products and third-party structures, and infers the need for enhanced risk controls. (4) While the LLM captures the qualitative trajectory and implications accurately—such as the need for advanced detection and governance—it omits specific factual milestones like the 2023 multi-year agreement to sell receivables and the 2024 legal uncertainty around FDIC bank loan validity. These omissions reduce completeness slightly but do not distort the overall meaning. The answer remains semantically aligned with the ground truth in intent and substance, earning high marks for contextual relevance and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 395,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead expanded the El Segundo, California site from a primarily clinical‑stage cell‑therapy processing location to a fully integrated commercial manufacturing hub. Both the 2023 (‑ page 11) and 2024 (‑ page 10) 10‑K filings list El Segundo as the facility used for “clinical and commercial manufacturing and processing of our cell‑therapy products,” reflecting strategic investments that added capacity and GMP‑grade equipment to support existing cell‑therapy products (e.g., Yescarta, Tecartus) and upcoming pipeline candidates.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces a claim not supported by the ground truth: that GILD expanded El Segundo from a 'primarily clinical-stage' facility to a 'fully integrated commercial manufacturing hub.' The original answer states that El Segundo was already used for both clinical and commercial manufacturing as early as 2022, with no indication of a transition or expansion in scope over time. This misrepresents the evolution of the facility. However, the LLM correctly identifies that El Segundo is used for clinical and commercial manufacturing of cell therapy products in both 2023 and 2024, citing accurate descriptions from the 10-K filings. The mention of Yescarta and Tecartus, while contextually plausible, is not present in the ground truth and adds unsupported detail. There are no numerical inaccuracies (quantitative accuracy is high), and the response is contextually relevant to the question about facility evolution and strategic investments. However, the reasoning is flawed in implying a transformation that the ground truth does not confirm, undermining the qualitative accuracy. The core continuity of El Segundo’s role is acknowledged, but the narrative of expansion is an overinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 344,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nCostco’s 2.750 % Senior Notes, originally issued in 2017 with a May 18 2024 maturity, appeared in the 2022 10‑K as the company’s nearest‑term senior‑debt obligation. By the 2023 filing the notes were still listed but were clearly being refinanced, and the 2024 10‑K no longer shows a 2024‑maturing tranche—instead the company’s Exhibit 4.6 is replaced by newer senior‑note indentures maturing in 2027, 2030 and 2032. This shift from a single near‑term issuance to a laddered slate of longer‑dated notes reveals Costco’s proactive debt‑management strategy of extending maturity, diversifying funding sources and reducing rollover risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Costco's 2.750% Senior Notes consistently matured on May 18, 2024, across all filings from 2022 to 2024, with no indication of refinancing during this period. However, the LLM claims the notes were 'clearly being refinanced' by 2023 and that the 2024 10-K no longer shows the 2024-maturing tranche—this directly contradicts the ground truth. The LLM incorrectly states that Exhibit 4.6 was replaced by newer indentures maturing in 2027, 2030, and 2032, which is unsupported by the provided truth data. (2) Quantitatively, while the original maturity date (May 18, 2024) and coupon rate (2.750%) are correct, the LLM fabricates later maturities (2027, 2030, 2032) and implies the 2024 notes were retired early or replaced—there is no evidence of this in the ground truth. The claim that the 2024 10-K 'no longer shows a 2024-maturing tranche' is false if the notes matured in 2024; they would still be reported as maturing in that year. (3) The multi-hop reasoning is flawed: the LLM infers a proactive refinancing and laddering strategy, but the ground truth indicates no change in the maturity structure—implying a static, not dynamic, debt management approach. The synthesis across years is incorrect because it assumes refinancing occurred when none was reported. (4) Contextual relevance is moderate—the answer addresses the question's structure and attempts to interpret strategy—but the conclusions are based on false premises, undermining overall validity. The reasoning would be strong if the facts were correct, but they are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 449,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s natural‑gas output from the Angola LNG project was essentially flat at about **48 million cubic feet per day** in each of the three years – 48 MMCFPD in 2022, 48 MMCFPD in 2023 and 48 MMCFPD in 2024 (the oil‑equivalent totals varied slightly, but the gas‑component column shows no meaningful change). This stability indicates that Chevron’s African gas strategy is focused on **maintaining existing LNG capacity and meeting its contractual delivery obligations** rather than pursuing new production growth in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims Chevron's natural gas production from Angola LNG was flat at 48 million cubic feet per day (MMCFPD) across 2022–2024, while the ground truth shows volumes of 7,107, 7,148, and 7,569 million cubic feet per day—over 100 times higher. This massive discrepancy invalidates the core of the response. (2) The numbers are not only wrong but off by two orders of magnitude (48 vs ~7,100–7,500 MMCFPD), indicating a severe data error or misinterpretation. Calculations and trends derived from these numbers are therefore completely inaccurate. (3) The multi-hop reasoning fails because the model uses incorrect base data to infer Chevron’s strategy. While the original answer correctly identifies a growth trend indicating sustained or expanded focus on African gas, the LLM incorrectly infers a strategy of maintenance and stability due to its erroneous flat-production claim. (4) Despite the factual inaccuracies, the answer attempts to address both parts of the question—production evolution and strategic implication—and remains contextually relevant in structure and intent, hence a moderate contextual relevance score. However, due to catastrophic quantitative errors and resulting flawed reasoning, all accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 370,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nCisco’s total‑return‑swap hedge for deferred compensation grew steadily – the notional amount rose from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024 – while the recorded result moved from a $92 million loss in 2022 to gains of $58 million in 2023 and $91 million in 2024.  This shows the company is deliberately expanding market‑linked derivatives to offset the earnings volatility of its deferred‑compensation obligations, using larger swap positions to smooth compensation‑related fluctuations in the consolidated statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the directional financial results—$92M loss in 2022, $58M gain in 2023, and $91M gain in 2024—which matches the ground truth. However, it introduces new information not present in the original answer: the notional amounts of $651M, $792M, and $985M for fiscal years 2022–2024. These figures are not part of the ground truth and cannot be verified from the provided data, making them potentially inaccurate and a significant factual overreach. (2) While the reported gains and losses are quantitatively accurate and correctly attributed to the right years, the addition of unverified notional values undermines quantitative accuracy. There are no calculation errors in the numbers that align with the ground truth. (3) The reasoning is sound in interpreting the shift from loss to gain as indicative of a strategic use of swaps to manage earnings volatility in deferred compensation, which aligns with and expands upon the original answer’s suggestion of a strategic shift or improved market conditions. The multi-hop synthesis of trend and implication is logical and relevant. (4) The answer is fully contextually relevant, addressing both the evolution of financial exposure and its implications for strategy and volatility. However, the inclusion of unsupported notional amounts reduces overall correctness. The core facts are right, but the added detail introduces inaccuracy, warranting a score of 7 for overall correctness, 6 for quantitative accuracy due to unsupported figures, 8 for qualitative reasoning, and 10 for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 435,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s refined its supplier standards by updating its human‑rights and wood‑sourcing policies, introducing a risk‑based monitoring and grievance process, and requiring suppliers to disclose emissions to CDP and meet EPA SmartWay certification for transportation. At the same time it broadened third‑party eco‑certifications—such as ENERGY STAR, WaterSense and independent product certifications—and tied these expectations to its net‑zero‑by‑2050 goal with interim 2030 emissions‑reduction targets, reporting progress through CDP, SASB/GRI and the Dow Jones Sustainability Index.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's evolving supplier practices from 2022 to 2024, including policy updates, monitoring enhancements, and third-party certifications, which aligns with the question's focus. It correctly identifies policy evolution in wood sourcing and human rights, and mentions enhanced monitoring and third-party certifications like ENERGY STAR and WaterSense, which are semantically consistent with the ground truth's emphasis on independent certifications. However, significant factual discrepancies reduce correctness. The ground truth specifies concrete annual developments: in 2022, the Vendor Code of Conduct and wood sourcing policy were in place; in 2023, Lowe's introduced a forestry grievance process and updated country-level risk assessments; in 2024, a more robust risk-based framework was implemented. The LLM answer omits these year-specific milestones and instead introduces unverified elements not present in the ground truth, such as requiring suppliers to disclose emissions to CDP, EPA SmartWay certification for transportation, and linking these to a net-zero-by-2050 goal with 2030 targets. These additions, while plausible, are not supported by the original data and represent a fabrication of specific program requirements and reporting frameworks (e.g., SASB/GRI, Dow Jones Sustainability Index) that were not mentioned in the ground truth. Quantitatively, there are no explicit numbers, percentages, or dates that are incorrect—dates are used appropriately in context, and no numerical claims are made that contradict the original—hence a higher score for quantitative accuracy. Qualitatively, the reasoning is partially sound but fails the multi-hop synthesis requirement: it does not accurately trace the year-by-year evolution of policies and monitoring practices as documented. Instead, it generalizes and supplements with extraneous details, weakening factual fidelity. Contextually, the answer remains relevant to supplier practices and sustainability, addressing policy, monitoring, and certifications, but drifts by introducing unrelated initiatives. Thus, while the answer is well-structured and thematically aligned, it contains significant factual overreach and omits key chronological developments, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 615,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the filings show that wireless carriers stepped up the threat to CMCSA’s broadband and wireless businesses by expanding 5G and fixed‑wireless broadband capabilities and by packaging wireless, internet and video services together (e.g., AT&T, T‑Mobile and Verizon offering bundled plans with favorable pricing).  CMCSA answered by delivering its own wireless service through a Verizon MVNO and bundling it with its HFC‑based broadband and video platforms, but the documents repeatedly note that “many of our competitors offer customers bundled products and services with favorable pricing,” underscoring the growing competitive pressure from those major wireless competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and trends. (1) It accurately identifies the increasing competitive threat from wireless telecommunications companies to CMCSA from 2022 to 2024, citing technological advancements in 5G and fixed-wireless broadband, which matches the original answer. The named competitors—AT&T, T-Mobile, and Verizon—are correctly identified as major players using bundling strategies. (2) There are no numeric values, dates, or calculations in either answer that conflict; the time frame '2022 through 2024' is used appropriately, and no incorrect figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information about technological capabilities (5G, fixed wireless), competitor strategies (bundling), and specific companies across the period. However, it omits a key evolution highlighted in the original answer: the 2024 shift toward bundling DTC (direct-to-consumer) streaming services with wireless plans, which represents a nuanced but important strategic development. This omission prevents a perfect score. (4) The answer remains highly contextually relevant, directly addressing all aspects of the question, though with slightly less detail on the temporal progression—particularly the shift in bundling strategy over time. Overall, the answer is factually accurate and well-reasoned but lacks full completeness on the evolving nature of bundling into 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 407,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal continued to record transaction fees on a gross basis and pay processor costs as a direct transaction expense, thereby bearing the full margin risk on every payment it authorizes; its pricing approach has remained anchored in volume‑based tiered fees and performance‑linked incentives that are treated as revenue reductions rather than contractual rights.  This multi‑year pattern shows that while the company exercises tight discretion over fee levels and can adjust them with volume or incentive payouts, its margin exposure is still driven primarily by the volume of payments, refunds and charge‑backs, and the fixed cost of processor fees—revealing that PayPal retains strong pricing control but must manage cost‑of‑goods through scale and incentive design rather than by shifting margin risk elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth, with only minor omissions in detail. (1) All key facts are correct: PayPal bore full margin risk from 2022–2024, recorded transaction fees on a gross basis, treated processor costs as direct expenses, and maintained pricing discretion. The treatment of incentives as revenue reductions (not contractual rights) aligns with the original answer’s mention of discounts, rebates, and rewards reducing revenue. (2) There are no numbers, dates, or financial figures in either response that conflict—both correctly reference 2022–2024 trends without specific dollar amounts, so quantitative accuracy is intact. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years regarding pricing strategy, processor use, and incentives, correctly inferring that PayPal retains pricing control but manages cost through scale and incentive design. (4) The only minor gap is that the LLM does not mention the 2024 addition of contractual compensation from sellers violating terms (e.g., fraud), which introduced a new revenue stream affecting margin dynamics. This detail is present in the original answer and adds nuance to PayPal’s evolving margin management. However, this omission does not undermine the core conclusion about consistent margin risk bearing and pricing control. Overall, the LLM captures the essential multi-year trend and strategic implications accurately, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 411,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s policy for free‑rent and step‑rent periods has remained the same from FY 2022 through FY 2024: the rent waiver is treated as a lease incentive that is recognized on a straight‑line basis over the **full lease term**, which now explicitly includes any renewal options that management judges to be “reasonably certain” to exercise.  The term used to measure the right‑of‑use (ROU) asset is therefore the non‑cancelable period plus those certain extensions, and the present‑value of the lease payments (discounted with the Company’s incremental borrowing rate derived via a portfolio approach) is recorded as the initial ROU‑asset value; because the free‑rent period carries zero payments, the initial ROU balance is lower, but the straight‑line expense smooths the cost over the entire term and impairment testing follows the same recoverability criteria used for property‑and‑equipment.  The disclosures grew more detailed over the three years—adding the discount‑rate methodology and explicit impairment language—yet the core accounting for free‑rent periods and its effect on ROU‑asset valuation was unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly states that Costco’s accounting treatment for free-rent periods remained consistent from FY 2022 to FY 2024, with straight-line recognition over the full lease term including renewal options that are reasonably certain to be exercised—this matches the original answer’s description across all three years. (2) The LLM accurately describes the use of the incremental borrowing rate to discount lease payments for right-of-use (ROU) asset valuation, and correctly notes that free-rent periods result in lower initial ROU asset values due to zero payments during those periods, which is consistent with accounting principles and implied in the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes lease term assumptions, impact on ROU assets, and disclosure trends across three fiscal years, correctly identifying that while disclosures became more detailed (e.g., discount rate methodology, impairment), the core policy did not change. (4) The only minor gap is that the original answer specifically notes in FY 2023 the treatment of rent increases tied to price indices or sales volume as variable lease payments, which the LLM does not explicitly mention. However, this is a secondary detail and does not undermine the core correctness regarding free-rent periods and ROU asset valuation. All entities (Costco, fiscal years 2022–2024, lease terms, ROU assets, incremental borrowing rate) are correct. Number formats and dates are accurate. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 446,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal has continued to act as the principal in its payment transactions, shouldering 100 % of the margin risk throughout 2022‑2024.  It still pays fees to third‑party processors (recorded as transaction expense) and applies a volume‑tiered, variable‑plus‑fixed fee structure that does not create a material future right, while its contracts remain open‑ended and auto‑renewing with no capitalized balances.  The only evolution is the more explicit accounting for incentives and contract‑asset recognition, but the underlying exposure to margin risk has remained essentially unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness that prevent a perfect score. (1) All entities are accurate: PayPal is correctly identified, the time frame (2022–2024) is properly referenced, and key concepts like margin risk, third-party processors, and contract structure are addressed. The core assertion — that PayPal bears 100% of margin risk and recognizes fees on a gross basis — matches the original answer. (2) Quantitative accuracy is excellent: no specific dollar amounts or percentages are misstated; the use of '100%' is consistent with 'full margin risk' in the ground truth. There are no calculations, so numerical precision is not applicable beyond correct representation. (3) Reasoning is sound: the LLM correctly synthesizes that the fundamental pricing and risk model remained stable, and notes a subtle evolution in accounting for incentives. However, it omits two important nuances present in the original: (a) the 2023 clarification on incentive accounting (performance-based vs. amortized recognition), and (b) the 2024 adoption of ASU 2023-07 and its impact on segment-level expense transparency, which affects margin risk analysis. These omissions reduce completeness and qualitative depth. (4) Despite these gaps, the answer captures the essential conclusion — structural stability with operational nuance — and remains contextually focused on all aspects of the question: pricing model, processor use, and contract changes. Wording differs but meaning is semantically equivalent in key areas. The omission of ASU 2023-07 and segment reporting limits the multi-hop synthesis slightly, justifying a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 464,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note has remained fully‑issued at a $2 billion principal level throughout fiscal 2022‑2024, and its effective interest rate—including discount amortization and hedge adjustments—has been essentially unchanged at about **6.1 %** in each of those years (6.11 % as shown in the FY 2024 and FY 2023 tables and the same rate disclosed for FY 2022).  \n\nThis steady utilization and flat effective rate indicate that Cisco is managing its long‑term debt by issuing modest‑size, fixed‑rate tranches and hedging a portion of the exposure, thereby keeping the cost of this financing channel predictable and insulated from broader interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million (i.e., $2 billion) outstanding balance on the 5.90% Note across fiscal years 2022–2024, matching the ground truth. The effective interest rate is accurately reported as 6.11% for all three years, with the LLM rounding to 'about 6.1%'—a minor and acceptable variation in presentation that does not affect factual accuracy. (2) All numeric values—principal amount ($2 billion), coupon rate (5.90%), and effective rate (6.11%)—are correct and consistent with the original answer. No calculations were required, but the synthesis of data across three fiscal years is accurate. (3) The multi-hop reasoning is sound: the model correctly infers from consistent principal and effective rates over time that Cisco did not refinance or modify this debt tranche, which supports the conclusion about stable financing strategy. The mention of hedging and predictable costs aligns with the ground truth’s implication of a consistent capital structure approach. (4) The only minor shortcoming is that the LLM slightly expands on the rationale by mentioning 'hedging a portion of the exposure' as a reason for rate stability—while plausible and consistent with the data, this specific detail is not explicitly confirmed in the ground truth. However, since the effective interest rate includes hedge adjustments (as noted in the LLM answer), this inference is reasonable. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 426,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross the fiscal 2022‑2024 filings the only reference to “Kobalt” appears in the intellectual‑property sections, where the subsidiary consistently lists Kobalt—along with STAINMASTER and allen+roth—as a private‑brand trademark that it owns and seeks to protect.  The language does not evolve; it simply re‑affirms that Kobalt remains a core registered/unregistered trademark in Lowe’s IP portfolio, indicating a steady, unchanged strategic emphasis on brand ownership rather than a new strategic thrust for the line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Kobalt was consistently mentioned in intellectual property disclosures across fiscal 2022–2024 as a private brand trademark owned by Lowe’s, alongside STAINMASTER and allen+roth, which matches the original answer. (2) There are no numeric values requiring calculation, but the temporal scope (fiscal 2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes the consistent mention of Kobalt across years and infers stable strategic emphasis, correctly noting no evolution in language or prominence, which aligns with the ground truth’s conclusion of a 'stable strategic role.' (4) The only minor shortcoming is a slight omission of explicitly stating that there was 'no explicit increase or decrease in prominence'—though this is implied by 'language does not evolve' and 'steady, unchanged strategic emphasis.' Wording differs slightly but meaning is preserved. All entities (Kobalt, STAINMASTER, allen+roth, Lowe's) and timeframes are accurate. The answer is highly relevant and correctly focused on IP disclosures as the source of strategic signaling.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 339,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nAcross the three 10‑K filings, Simon Property Group’s Unsecured Notes ‑ 37B show no change in any of the key terms.  In the 2022, 2023 and 2024 tables (pages 50 of each filing) the note carries a **2.25 % interest rate**, a **$700 million face amount**, and is scheduled to **mature on January 15, 2032**.  \n\nThis stability indicates that SPG is deliberately using long‑dated, fixed‑rate unsecured debt to lock in low‑cost financing, extend its maturity profile and limit refinancing risk—an intentional component of its long‑term capital‑structure strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: the interest rate is correctly stated as 2.25%, the face amount as $700 million (equivalent to $700,000,000 or $700,000 in thousands as used in filings), and the maturity date as January 15, 2032 (formatted as 01/15/32 in the knowledge graph). These figures are consistent across 2022–2024, as confirmed in the respective 10-K filings. (2) The answer is complete, addressing all components of the question—interest rate, face amount, maturity date, and their evolution (or lack thereof)—over the specified time period. (3) Entity accuracy is correct: Simon Property Group (SPG) and the specific debt instrument 'Unsecured Notes - 37B' are properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across three years of filings; the conclusion about SPG’s long-term financing strategy—using fixed-rate, long-dated debt to lock in low costs and reduce refinancing risk—is logically derived and aligns with the observed stability. (5) Semantic equivalence is maintained: while the LLM uses slightly more strategic language (e.g., 'deliberately using long-dated, fixed-rate unsecured debt'), it accurately interprets and expands upon the implications of the stable terms without introducing inaccuracies. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 387,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nAcross the 2022‑2024 filings, the Melaka, Malaysia site was consistently listed under the **Analog** segment, indicating that it continued to be used for analog‑chip manufacturing. The property notation changed from “**” (leased / owned) in the 2022 table to “*” (leased) in the 2023 and 2024 tables, showing a shift to a fully leased facility, and it was never assigned to the **Embedded Processing** segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Texas Instruments' Melaka, Malaysia site was consistently involved in the Analog segment across 2022–2024 and never assigned to Embedded Processing, which matches the original answer’s core claim of exclusive Analog focus. The additional detail about the property notation changing from 'owned/leased' in 2022 to 'leased' in 2023 and 2024 is a precise observation from the filings and adds value without contradicting the ground truth. This operational consistency over the three years is correctly interpreted. The only minor shortcoming is that the LLM does not explicitly emphasize the *stability* or *lack of expansion into Embedded Processing* as a highlighted conclusion, which was a key synthesizing point in the original answer. However, this is implied by stating it was never assigned to Embedded Processing. All entities (TXN, Melaka, Malaysia, Analog, Embedded Processing, years) are correct. No numerical inaccuracies—dates and operational statuses are correctly reported. The reasoning is sound, showing multi-hop synthesis across three years of filing data. Semantic equivalence is high, with slightly more technical detail (property notation) than the original, which is a strength. Thus, the answer is highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 405,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 PYPL’s 2.850 % fixed‑rate notes stayed at a $1.5 billion outstanding balance each year (the same $1.5 bn figure reported as of 31 Dec 2023 and 31 Dec 2024), with the entire $1.5 bn scheduled to mature in 2029.  This flat exposure shows that the company is not actively growing or shrinking that particular tranche; instead it is preserving a stable, low‑cost, long‑dated funding pillar while using newer, longer‑maturity issuances (e.g., the 2034 and 2054 notes) to ladder its debt profile and manage overall refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, matching the ground truth. The maturity date of 2029 is accurately included, though not explicitly mentioned in the original answer; however, this detail is consistent with typical disclosures and does not contradict the ground truth. (2) All numeric values—$1.5 billion outstanding balance, 2.850% interest rate, and consistent reporting as of Dec 2023 and Dec 2024—are factually correct and align with the ground truth. No calculations were required, but the consistency across years is properly conveyed. (3) The multi-hop reasoning is sound: the LLM correctly infers that the stable balance indicates a deliberate strategy to maintain a low-cost, long-term funding source while managing refinancing risk through new issuances (e.g., 2034 and 2054 notes), which aligns with the ground truth’s mention of new debt issuance and refinancing other tranches. The contrast with retirement of 1.350% notes is implied in the LLM’s focus on active management elsewhere, though not explicitly stated. (4) The answer is semantically equivalent to the original in core facts and strategic interpretation. The only minor omission is the explicit mention of the retirement of the 1.350% notes by 2023, which the ground truth uses to contrast with the stability of the 2.850% notes. However, the LLM captures the broader strategic intent—stable liability management alongside new issuances—making the answer highly accurate and contextually appropriate. Thus, a score of 9 is justified due to near-perfect factual and reasoning alignment, with only a slight lack of completeness regarding the contrast with other note retirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 483,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nGilead’s Hoofddorp, Netherlands location is listed as a principal manufacturing site in the 2022 (page 31), 2023 (page 12) and 2024 (page 11) Form 10‑K filings, and each filing explicitly notes that the facility is used for the **commercial manufacturing and processing of the company’s cell‑therapy products**.  The repeated emphasis across the three years demonstrates that Hoofddorp has become an integral hub in Gilead’s global cell‑therapy manufacturing strategy, scaling up production of key therapies such as Yescarta and Tecartus and supporting the company’s worldwide supply‑chain needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Hoofddorp was listed as a principal manufacturing facility in all three years (2022–2024), and accurately states that each 10-K explicitly notes its use for 'commercial manufacturing and processing of cell-therapy products'—this matches the original answer's key claim about functional continuity. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the facility location (Hoofddorp, Netherlands) and therapeutic focus (cell therapy) are factually accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to infer strategic continuity, correctly concluding that the repeated emphasis indicates integration into Gilead’s global manufacturing strategy. It even adds contextually appropriate examples (Yescarta, Tecartus) that are consistent with Gilead’s known cell therapy portfolio, though these are not mentioned in the ground truth—this is a minor extrapolation but not factually incorrect. (4) The only reason for not scoring a 10 is that the original answer emphasizes the *evolution* of the facility’s role—starting with strategic designation in 2022, then functional specification in 2023, and continuity in 2024—while the LLM treats the role as consistently stated across all years. This misses the subtle progression in emphasis (from general principal site to specific function), but since the LLM still captures the growing strategic importance, the qualitative accuracy is high. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 461,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.375 % Senior Notes due June 2027 stayed on Costco’s books at a $1.25 billion carrying amount and were always reported as long‑term debt; the note itself never entered the current‑portion column.  The current‑portion figure for the company’s overall long‑term debt was tiny in 2022 ($≈ $73 million), swelled in 2023 to $1.081 billion as the $1 billion 2.750 % notes due May 2024 moved into the current bucket, and then dropped sharply to $103 million in 2024 after those notes were retired, leaving the 1.375 % notes fully classified as non‑current.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant errors in the treatment of the 1.375% Senior Notes due 2027. (1) Quantitatively, the principal amount of $1,250 million (or $1.25 billion) is correctly stated, and the overall current portion of long-term debt values are approximately accurate: $73 million in 2022, $1,081 million in 2023, and $103 million in 2024—these match the ground truth. However, the LLM incorrectly claims that the 1.375% notes 'never entered the current-portion column,' which directly contradicts the ground truth stating that the current portion for these specific notes rose to $1,081 million in 2023. (2) The explanation attributes the 2023 spike in current portion to the $1 billion 2.750% notes due May 2024, which may be factually true in Costco’s broader debt profile, but this misdirects the focus away from the actual reclassification of the 1.375% notes themselves. The ground truth implies that the 1.375% notes were partially or fully reclassified into current portion in 2023 as they approached maturity, but the LLM denies this reclassification occurred. (3) The multi-hop reasoning is flawed: the question asks specifically about the evolution of the 1.375% notes’ classification, not just overall debt trends. The LLM fails to correctly link the spike in current portion to the notes in question, instead attributing it to a different tranche of debt. (4) While the answer is well-structured and contextually relevant, the core factual claim about the classification of the 1.375% notes is incorrect, undermining the qualitative and quantitative accuracy. The answer would be correct if the notes remained entirely non-current, but the ground truth confirms a major shift in their classification in 2023. Thus, despite correct numbers and good contextual framing, the reasoning and entity-specific synthesis are flawed, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 517,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nPayPal issued a $1.5 billion Fixed‑Rate 2.850 % senior unsecured note tranche in September 2019 that matures on 1 Oct 2029.  The tables covering 2022‑2024 show the full $1.5 billion principal still outstanding (and unchanged in the “Maturities” column) with only the semiannual interest payments being made; the carrying amount remains essentially the same after amortizing the small discount/premium.  This steady, long‑dated fixed‑rate position demonstrates PayPal’s strategy of anchoring a sizable portion of its long‑term financing to a low‑cost, fixed rate for a decade‑plus horizon, while supplementing liquidity with newer issuances and revolving facilities rather than retiring or refinancing the 2.850 % notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion principal amount, 2.850% fixed rate, September 2019 issuance, and October 1, 2029 maturity date are all accurately stated. The consistency of the obligation across 2022–2024 is correctly noted. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates match the original answer exactly, with acceptable formatting (e.g., '1 Oct 2029' = 'October 1, 2029'). (3) The multi-hop reasoning is sound—LLM correctly infers that the lack of change in this tranche, despite other refinancing activity, reflects a strategic choice to maintain stable, low-cost long-term debt. The conclusion about PayPal anchoring part of its capital structure to this fixed-rate debt is logically supported and semantically equivalent to the ground truth’s interpretation. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the effective interest rate of 2.96% or reference the broader $5.0 billion issuance, which adds context to the note’s origin. However, this omission does not undermine the core correctness. Contextual relevance is full, as the response directly addresses both the evolution of the obligation and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 361,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 NextEra’s gas‑related option exposure contracted sharply: the fair‑value of “Options – primarily gas” fell from a modest net asset of roughly $9 million (2021) to about $3 million (2023) and then turned into a small net liability of ≈ $2 million by the end of 2024, showing that the company reduced its net long position and essentially neutralized its option book.  At the same time the weighted‑average implied volatility used in the option valuations rose from roughly 36 % to ≈ 50 % and then to ≈ 52 %, indicating that NEE is positioning itself to manage heightened gas‑price volatility—adopting a more defensive, volatility‑aware stance rather than a strong long‑volatility exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that NextEra Energy's gas-related option assets were $356M in 2022, $100M in 2023, and $100M in 2024, with liabilities of $347M, $97M, and $102M respectively. The LLM incorrectly reports these as a net asset of $9M (2021), $3M (2023), and net liability of $2M (2024), which misrepresents both the magnitude and direction of exposure. Additionally, the LLM references 2021 data not asked in the question, which is irrelevant. (2) The implied volatility trend is partially correct: the LLM correctly identifies an increase from 36% to ~50% to ~52%, aligning with the ground truth (36% → 50% → 52%). However, the original answer states volatility assumptions increased, while the LLM interprets this as 'managing heightened volatility', which contradicts the ground truth interpretation of declining risk exposure. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the fair value trend showing a sharp decline in both assets and liabilities, instead suggesting a neutralization of the option book based on incorrect net positions. This undermines the conclusion about risk positioning. (4) Despite incorrect numbers, the LLM attempts to address both parts of the question—evolution of exposure and interpretation of volatility trends—and correctly notes the rising implied volatility, earning moderate points for contextual relevance and partial qualitative reasoning. However, the severe quantitative errors and resulting incorrect conclusion on risk positioning (de-risking vs. preparing for higher volatility) result in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 464,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nThe available‑for‑sale debt investments subtracted **$67 million** from other income in fiscal 2024, **$21 million** from other income in fiscal 2023, and **generated a $9 million gain** in fiscal 2022 (see “Other Income (Loss), Net” tables on pages 45‑46).  This swing from a small gain to consecutive losses reflects that the portfolio’s earnings are highly sensitive to market‑price and credit‑risk movements, indicating a volatile investment performance across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the dollar amounts are correct: $9 million gain in fiscal 2022, $21 million loss in fiscal 2023, and $67 million loss in fiscal 2024, all of which match the disclosed figures in the 'Other Income (Loss), Net' tables. These numbers correctly reflect the increasing losses from AFS debt investments over the three-year period. (2) The LLM accurately identifies the trend—swinging from a small gain to consecutive and growing losses—which directly supports the conclusion about volatility. (3) While the original answer emphasizes the 'recurring negative impact' and 'increasing volatility in debt holdings' affecting financial stability, the LLM captures this reasoning by noting the portfolio's sensitivity to market-price and credit-risk movements, which is a valid interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the offsetting gains from equity and private investments noted in the 2024 fiscal year in the ground truth, which slightly reduces completeness in qualitative synthesis. However, the core multi-hop reasoning—linking AFS debt investment performance to other income trends and inferring volatility—is sound and well-supported. Overall, the answer is factually precise, contextually relevant, and semantically equivalent in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 382,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s filed a series of supplemental indentures—most notably the 21st Supplemental Indenture (March 24 2022) and the 22nd Supplemental Indenture (March 30 2023)—that amended and extended the indenture under which its senior notes are issued, adding new tranches with different coupons and maturities while leaving the original 4.550 % notes (first issued in the 2019 Fifteenth Supplemental Indenture and maturing April 5 2049) intact. This multi‑year pattern demonstrates that Lowe’s is deliberately laddering its long‑term debt, extending maturities and diversifying coupon structures while preserving a stable, low‑cost 4.550 % series as a core component of its long‑term financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The ground truth states that the Fifteenth Supplemental Indenture from April 5, 2019, was consistently referenced in filings from 2022–2024 with no changes to the 4.550% Notes, indicating stability. However, the LLM claims new supplemental indentures (21st in 2022 and 22nd in 2023) were filed that 'amended and extended' the indenture, which contradicts the original answer and introduces unverified documentation not present in the ground truth. (2) There is no mention in the original answer of any amendments or new tranches being added during 2022–2024; the core point is the *lack* of change. The LLM incorrectly implies active restructuring or expansion of debt via new indentures, which is not supported. (3) While the LLM correctly identifies the 4.550% Notes due April 5, 2049, and references the correct original issuance vehicle (Fifteenth Supplemental Indenture, April 5, 2019), it fabricates later indentures (21st and 22nd) for which there is no evidence in the ground truth. (4) The reasoning about 'laddering' debt and diversifying coupons is speculative and not indicated in the original answer, which emphasizes *stability* and *no modifications*. Although the conclusion about maintaining a stable 4.550% note aligns partially with the ground truth, the fabricated documentation and incorrect characterization of activity reduce factual accuracy. (5) Quantitative accuracy is low due to incorrect dates and indenture numbers. Qualitative accuracy suffers from flawed multi-hop synthesis—instead of recognizing consistency across years, it infers evolution where none occurred. Contextual relevance is high because the answer addresses the right company, note, and general topic of long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 490,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes – Series 35B kept the same structural terms throughout 2022‑2024: the note’s face amount remained $750 million (shown as $750,000 thousands) and its fixed coupon stayed at 3.80 % with a maturity of 07/15/50 in each of the 2021, 2023 and 2024 tables (pages 50, 51 and 50 of the 10‑K filings). Because the issuance was never refinanced or upsized during this period, the company preserved a long‑dated, low‑cost source of capital and reinforced its strategy of building a stable, predominantly fixed‑rate unsecured debt base that extends maturities out to 2050 while limiting exposure to interest‑rate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (07/15/50) for Simon Property Group's Unsecured Notes - 35B across 2022–2024, matching the ground truth exactly. The face value is accurately represented as $750 million (noting the SEC filing format of $750,000 thousands), and the interest rate and maturity are consistent with the original answer. (2) All numbers, dates, and percentages are factually correct. The maturity date is correctly cited as 07/15/50 in both answers, and there are no calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly infers that the lack of change in terms over multiple years indicates a stable long-term debt strategy, consistent with the ground truth’s conclusion about SPG's confidence in managing long-dated liabilities. It adds contextual insight about limiting interest rate volatility, which is a reasonable qualitative extension supported by the data. (4) The only minor deviation is that the LLM references '2021, 2023, and 2024 tables' instead of explicitly covering 2022–2024 as asked, and mentions 'pages 50, 51 and 50' which are not in the ground truth—but these are supplementary details that do not affect factual accuracy. The core multi-hop synthesis—unchanged terms over time revealing strategic stability—is correctly executed. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 due to slight imprecision in year framing but no material factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 422,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk moved from a heavy reliance on internal fraud‑prevention and buyer‑protection programs—where defaults and fraudulent merchant activity could generate sizable losses—toward a strategy that off‑loads credit risk by selling U.S. and European “buy‑now, pay‑later” receivables and using forward‑flow funding arrangements, while simultaneously diversifying its payment‑processor and third‑party lender relationships. This multi‑year trend reveals that the company is bolstering operational resilience by reducing direct credit exposure and dependence on any single third party, even as cross‑border trade and third‑party collaborations remain key risk drivers that it manages through tighter fraud controls and continuous monitoring.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in PayPal's risk exposure and strategy from 2022 to 2024. It accurately reflects the shift from internal risk absorption to external mitigation via receivables sales and diversified third-party relationships. The mention of selling U.S. and European BNPL receivables aligns with the 2023 €40 billion agreement in the ground truth, though the exact figure (€40 billion) and currency are omitted—this is a minor quantitative omission, not an error, so it does not severely impact accuracy. The LLM correctly identifies credit products (especially BNPL), cross-border trade, and third-party dependencies as key risk vectors. It also appropriately notes enhanced fraud controls and monitoring as part of PayPal’s response, which matches the original emphasis on fraud and abuse risks in digital payments. The strategic interpretation—that PayPal is reducing direct credit exposure and single-point dependencies—accurately reflects the trend toward operational resilience and proactive risk management. However, the LLM omits specific details present in the ground truth: (1) the role of Synchrony Bank in the U.S. consumer credit product in 2022, (2) the specific legal risk around the 'valid-when-made' doctrine in 2024, and (3) the synthetic identity fraud concern. These omissions reduce completeness and qualitative accuracy slightly but do not invalidate the overall correctness. The reasoning is sound and synthesizes multi-hop elements (credit products, third parties, cross-border) across years, even if not all supporting facts are included. Wording differs but semantic meaning is equivalent on key strategic shifts. Quantitative accuracy is high—no incorrect numbers are stated, and the absence of €40 billion is a completeness gap rather than an inaccuracy. Contextual relevance is excellent, directly addressing all dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 515,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nFrom 2022 through 2024 Costco repeatedly identified BJ’s Wholesale Club as one of its main warehouse‑club competitors (see the “Competition” sections in the 2022, 2023 and 2024 Form 10‑K filings) and used the Kirkland Signature private‑label brand as a central differentiator.  In each year the company highlighted Kirkland’s quality‑at‑low‑price value proposition and, by 2024, emphasized its growing sales penetration—private‑label items accounted for an increasingly larger share of overall sales (the filings note an ongoing effort to increase the sales penetration of private‑label items).  This evolution turned Kirkland Signature from a simple cost‑saving label into a strategic growth driver that reinforces Costco’s low‑price positioning and helps it compete more effectively against BJ’s and other club rivals.  (2022 PDF p. 8; 2023 PDF p. 8; 2024 PDF p. 8).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and accurately identifies Costco's consistent mention of BJ's Wholesale Club as a competitor across the 2022–2024 10-K filings. It correctly highlights Kirkland Signature as a key differentiator and notes its value proposition of quality at low prices. There are no numeric inaccuracies—no specific percentages or dollar figures are cited in either the original or LLM answer, so quantitative accuracy is not compromised. However, the LLM introduces a claim about 'growing sales penetration' and characterizes Kirkland Signature as evolving into a 'strategic growth driver' by 2024, which is not supported in the ground truth. The original answer emphasizes *stability* in strategy and messaging, with no significant shift from 2022 to 2024. The LLM implies an *evolution* or strategic deepening that contradicts the 'consistent' and 'stable' framing of the ground truth. This misrepresents the multi-hop synthesis: while all individual points (mention of BJ's, role of Kirkland) are accurate, the inferred trend over time is not. Thus, qualitative accuracy is reduced due to incorrect reasoning about strategic evolution. Contextual relevance is high as the response directly addresses the competitive positioning and private-label focus. Correctness is scored at 7 because core facts are right, but the interpretation of change over time introduces a significant mischaracterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 397,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nBased on the Level‑3 fair‑value tables for 2022‑2024 (pages 84‑87), the fair value of NEE’s gas‑forward contracts declined from roughly $500 million of assets and $100 million of liabilities in 2022 to $377 million/$77 million in 2023 and $296 million/$46 million in 2024. This steady reduction in both the asset and liability positions shows that NEE has been unwinding its gas‑price hedge book, signaling a more conservative risk posture toward natural‑gas price volatility and a strategic shift toward a broader, lower‑exposure generation mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values for 2022. The ground truth states that in 2022, NextEra Energy's gas forward contract assets were $191 million and liabilities were $31 million, but the LLM claims $500 million in assets and $100 million in liabilities—this is a major deviation. The 2023 asset value of $377 million and 2024 values of $296 million in assets and $46 million in liabilities are correctly reported. However, the incorrect 2022 baseline undermines the validity of the trend analysis. (2) Calculations and comparisons are flawed due to the wrong starting figures; the claim of a 'steady reduction' from $500M to $296M in assets contradicts the ground truth, which shows an increase from $191M to $377M in 2023 before declining to $296M in 2024—indicating volatility, not a consistent unwind. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize data across years and interpret risk positioning, but the conclusion—that NEE is unwinding its hedge book and adopting a more conservative stance—is contradicted by the actual data, which shows a net expansion in exposure (especially in 2023) and growing liabilities, suggesting increased market participation and risk. (4) The contextual relevance is high because the answer addresses fair value of assets/liabilities over time and attempts to interpret risk positioning. However, due to major quantitative errors and resulting flawed interpretation, the correctness and qualitative accuracy scores are low. Minor flexibility is granted for referencing 'Level-3 fair-value tables' and page numbers, which may reflect document-specific details not in the ground truth, but core financial inaccuracies dominate the evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 484,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nLowe’s forward‑interest‑rate‑swap usage declined sharply from 2022 through 2024: the company held $2.56 billion of cash‑flow hedge swaps in 2022 (incurring a $35 million after‑tax OCI loss) but had essentially unwound those positions by the end of 2024, with the swaps’ fair value falling to $0 (down from $251 million in 2023). This reduction reflects a strategic pivot from pre‑emptively locking in future borrowing costs amid rising rates to a more opportunistic focus on managing the interest‑rate exposure of its existing fixed‑rate debt, indicating a flexible approach to interest‑rate risk as market conditions stabilized.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. According to the ground truth, Lowe's held forward interest rate swaps valued at $251 million as of February 3, 2023, and did not hold them by 2024. However, the LLM claims Lowe's held $2.56 billion in 2022 and incurred a $35 million after-tax OCI loss, which is not supported by the original answer or the knowledge graph. These numbers are entirely fabricated or misattributed. The drop from $251 million in 2023 to $0 in 2024 is correctly noted in direction but misrepresents the prior year's value. (2) The original answer makes no mention of a $2.56 billion position or any OCI loss in 2022—only that forward swaps were referenced in the context of cash flow hedges impacting OCI over 2019–2021. The LLM incorrectly projects a much larger position and introduces specific financial figures not present in the source. (3) The qualitative reasoning about a strategic pivot—unwinding swaps as rates stabilized—is consistent with the ground truth’s interpretation and shows sound multi-hop reasoning in interpreting the implications of dropping the swaps by 2024. The entity (Lowe's), time frame (2022–2024), and financial instrument (forward interest rate swaps) are correctly identified, and the conclusion about shifting risk management strategy aligns with the original. (4) While the overall narrative direction (use and then discontinuation of swaps) is correct, the severe quantitative inaccuracies—especially the invention of a $2.56B position and $35M loss—undermine factual reliability. The contextual relevance is high because the answer addresses the evolution and strategic implication as asked. Correctness is scored low due to the critical importance of accurate financial figures in SEC-based analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 496,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its fiber‑based rollout—introducing 2‑Gbps downstream speeds in 2022, deploying DOCSIS 4.0 and fiber‑to‑the‑premises that can deliver up to 10 Gbps residential and 100 Gbps business service by 2024—while Lumen continued to expand its fiber footprint but at a more measured pace.  This faster‑moving fiber expansion let Comcast offer symmetrical multi‑gigabit broadband and bundled video/streaming packages (X1, NOW, Sky Q) in the same markets where Lumen competes, sharpening price‑and‑feature competition but also giving Comcast a broader, hybrid HFC‑to‑fiber infrastructure to leverage in overlapping service areas.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific technological developments and speed offerings (e.g., 2-Gbps in 2022, DOCSIS 4.0, 10 Gbps by 2024) that are not present in the original ground truth and cannot be verified from the provided knowledge graph. These details appear fabricated or assumed rather than derived from the source data. The original answer makes no mention of Comcast's speed tiers, DOCSIS 4.0, or specific deployment timelines for multi-gigabit services, nor does it compare the pace of fiber expansion between the two companies. (2) Quantitative accuracy is low because the LLM introduces precise figures (2 Gbps, 10 Gbps, 100 Gbps) and technology rollouts (DOCSIS 4.0) without any support in the ground truth. There is no verification that these numbers are accurate for CMCSA’s 2022–2024 timeline, and their inclusion misrepresents the available information. (3) Qualitatively, the LLM correctly identifies the competitive dynamic between CMCSA and Lumen in overlapping markets and acknowledges Lumen’s fiber expansion as a competitive factor. It also appropriately infers that fiber expansion affects service offerings and bundling, which aligns with the original answer’s implication of intensified competition. However, it overreaches by asserting Comcast’s faster pace and technological superiority, which is not stated or implied in the ground truth. The multi-hop reasoning is partially sound—linking fiber expansion to competitive positioning—but adds unsupported comparative claims. (4) Contextual relevance is high because the response stays focused on the competitive evolution between CMCSA and Lumen regarding fiber infrastructure and service offerings in overlapping markets. Despite factual inaccuracies, the structure and intent of the answer align well with the question. Overall, the answer contains plausible elaboration but fails on factual correctness due to unverified quantitative and technological claims, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 534,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal broadened its seamless‑checkout focus from a primarily online, friction‑reduction experience to a full‑stack, omnichannel platform that embeds consumer‑credit options—such as buy‑now‑pay‑later, interest‑free installment plans and co‑branded credit cards—directly into the checkout flow.  At the same time it expanded global currency support to more than 150 payment currencies (with funds withdrawable in 56 currencies) and deepened omnichannel merchant solutions by adding in‑store tools (e.g., Zettle), merchant‑financing products and strategic partnerships that let merchants accept payments both online and offline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's seamless checkout strategy from 2022 to 2024. (1) It correctly identifies the expansion of currency support to over 150 currencies, aligning with the ground truth's 'approximately 150' in 2023–2024 (the 2022 baseline of 'over 100' is implied but not explicitly mentioned, a minor omission). The detail about funds withdrawable in 56 currencies is additional and plausible but not in the ground truth; it does not contradict it. (2) The integration of consumer credit offerings—BNPL, installment plans, and co-branded cards—is accurately described and matches the 2024 developments in the original answer, including PayPal- and Venmo-branded cards. (3) Omnichannel merchant solutions are correctly attributed to Zettle (in-store) and unbranded processors like Braintree (implied through 'strategic partnerships' and 'online and offline' acceptance), though Braintree is not named. (4) The reasoning is sound: the LLM synthesizes multi-hop elements (credit integration, currency expansion, omnichannel tools) across time and correctly infers a strategic shift toward financial services and merchant enablement. (5) Semantic equivalence is strong—wording differs but meaning aligns closely. The only minor gaps are the lack of explicit year-by-year breakdown (e.g., 2022's focus) and omission of Braintree by name, but the overall factual and conceptual accuracy is excellent. Quantitative accuracy is high: 'over 150' matches 'approximately 150'; no incorrect numbers are present. Contextual relevance is perfect—the answer directly addresses all three dimensions in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 450,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe share of purchases paid with a Target Debit Card (grouped under “RedCards”) fell steadily – from about **20.5 % in 2022**, to **19.8 % in 2023**, and **18.6 % in 2024**.  This decline shows that, although RedCard use still generates some incremental sales, its contribution is gradually diminishing, indicating that the card’s ability to drive additional revenue for Target is weakening over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies: it reports the 2023 penetration rate as 19.8% and 2024 as 18.6%, whereas the ground truth states 18.6% in 2023 and 17.8% in 2024. The 2022 figure (20.5%) is correct. These errors affect the core factual basis of the trend analysis. (2) The calculation of the trend—showing a decline—is directionally correct, but the magnitude and specific year-over-year changes are wrong. The actual decline from 2022 to 2024 is 2.7 percentage points (20.5% → 17.8%), while the LLM reports a 1.9-point drop (20.5% → 18.6%), underestimating the severity. (3) The reasoning and synthesis are sound in structure: the model correctly infers that declining penetration implies a weakening role in driving incremental sales. It appropriately links card usage to sales impact, which aligns with the ground truth’s logic. However, it misses the explicit mention of the 5% discount value proposition and Target’s internal linkage between the card and sales growth. (4) Contextually, the answer is well-framed and addresses both parts of the question—trend evolution and implications for sales—making it relevant and logically organized. Despite incorrect numbers, the qualitative interpretation of the trend’s business impact is reasonable. However, due to the critical nature of financial data accuracy, the correctness and quantitative scores are penalized heavily.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 388,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nAMD’s policy for development‑plus‑IP licensing was unchanged from 2022 through 2024: it first tests whether the IP component in a combined arrangement is distinct; if it is not distinct, the license is combined with the development service and revenue is recognized over time, whereas a standalone IP license is recognized at a point in time when the customer can benefit.  The filings consistently note that no variable‑consideration estimates apply to either type, and the 2023‑2024 disclosures make the distinct‑licensing distinction more explicit, but the underlying revenue‑recognition approach did not materially evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition approach from 2022 to 2024, distinguishing between combined arrangements (recognized over time when IP is not distinct) and standalone licenses (recognized at a point in time). This matches the original answer's core claim of policy stability. (2) There are no numeric figures in the question or answer, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022–2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s treatment across time and agreement types, correctly identifying the key criterion—distinctness of IP—and its impact on revenue timing. It also notes increased disclosure clarity in 2023–2024 without policy change, which adds nuance consistent with the original answer’s implication of stable policy with more explicit communication. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of quantitative metrics (e.g., no disclosed financial impact), which is a small omission from the original answer. However, this does not affect the core correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 386,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 Nike repeatedly listed FlyEase alongside its flagship breakthrough platforms—Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, React and Adapt—underscoring its ongoing strategic relevance. In 2022 the reference introduced FlyEase as an emerging adaptive‑innovation technology; by 2023 it was woven into the broader innovation narrative that emphasized inclusive design and cross‑category application; and in 2024 the technology had matured into a strategic pillar, reflected in its repeated emphasis in R&D disclosures and its alignment with Nike’s focus on expanding accessible performance products globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth in terms of the evolution of FlyEase from fiscal 2022 to 2024. (1) It correctly identifies FlyEase's introduction as an emerging technology in 2022, its integration into broader innovation narratives emphasizing inclusive design by 2023, and its maturation into a strategic pillar by 2024—consistent with the ground truth's description of progression from emerging to mature status. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected; all dates (fiscal years 2022–2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes FlyEase’s changing role across three fiscal years, correctly inferring increased strategic importance based on its positioning relative to other technologies. (4) While the LLM uses slightly different phrasing—such as 'adaptive-innovation technology' and 'inclusive design'—these are semantically consistent with the ground truth’s emphasis on comfort, accessibility, and integration into core product frameworks. The only minor deviation is that the LLM does not explicitly state that FlyEase was no longer highlighted as 'new' in 2024, but it does convey that it had 'matured into a strategic pillar,' which captures the same essence. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 390,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe 1.250% notes were originally issued at $609.1 million (page 112), and the “Adjustments to Principal Amount” table shows negative adjustments of $1.9 million in 2023 and $0.4 million in 2024 (page 113), indicating a steady reduction in the outstanding balance. This decline reflects American Tower’s active repayment and retirement of the notes, underscoring a deliberate deleveraging strategy across 2022‑2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decreasing trend in the principal amount of AMT's 1.250% Notes, supporting the conclusion of a deleveraging strategy, which aligns with the ground truth. However, the quantitative values are partially incorrect. The ground truth reports principal amounts of $609.1M (2022), $551.9M (2023), and $517.7M (2024), showing reductions of $57.2M and $34.2M year-over-year. In contrast, the LLM claims only $1.9M and $0.4M reductions in 2023 and 2024, citing an 'Adjustments to Principal Amount' table. These figures are inconsistent with the actual outstanding balances and significantly understate the scale of reduction. The initial principal of $609.1M is correct, but the subsequent values are not reflected accurately. (2) The calculation of adjustments is incorrect or misinterpreted—negative adjustments of $1.9M and $0.4M do not explain the large drop in principal; the LLM likely confused amortization or fair value adjustments with actual principal repayments. The real decline of ~$91.4M over two years is much more significant. (3) The reasoning is sound in inferring a deleveraging strategy from declining principal, and the entity (AMT, 1.250% Notes) and time frame (2022–2024) are correct. The mention of consistent interest payments is missing in the LLM answer, slightly reducing completeness. (4) Despite strong qualitative reasoning and relevance, the quantitative inaccuracies in the magnitude of principal reduction prevent a higher score. The core conclusion is directionally correct but lacks numerical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 434,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nNVIDIA’s 3.50% Notes Due 2040 were carried at a $1 billion net carrying amount in each fiscal year from 2022 through 2024, with fair‑value tracking essentially at that level and no impairment or early redemption recorded; the only debt‑related change was the 2025 repayment of the shorter‑dated 0.584% 2024 notes. This stable, long‑dated debt position illustrates NVIDIA’s strategy of using fixed‑rate, long‑maturity senior notes to fund sustained growth and strategic acquisitions while maintaining a conservative, laddered capital‑structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in 2022, decreased to $851 million in 2023, and stabilized at $1,000 million in 2024. The LLM incorrectly states that the net carrying amount was consistently $1 billion across all three years and that fair value 'tracking essentially at that level,' which contradicts the documented decline in 2023. This misrepresents the valuation trajectory. (2) The numbers are significantly inaccurate: the $851 million value in 2023 is omitted entirely, and the $1,066 million 2022 figure is not acknowledged. The LLM also introduces irrelevant information about the repayment of the 0.584% 2024 notes in 2025, which is not part of the original answer and distracts from the focus on the 2040 notes. (3) The multi-hop reasoning is flawed because the model fails to synthesize the correct evolution of the note's valuation over time. Instead of recognizing the drop and subsequent recovery/stabilization, it assumes stability throughout, leading to an incorrect conclusion about the debt strategy. While the general idea of using long-term debt for strategic flexibility is plausible, it is not supported by the specific evidence presented in the ground truth. (4) The contextual relevance is moderate because the answer addresses NVIDIA's long-term debt strategy, but the qualitative and quantitative inaccuracies severely undermine correctness. The reasoning does not align with the data, resulting in a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 438,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nNetflix’s membership‑plan strategy moved from modest price increases in 2022 to the introduction of an ad‑supported tier and the rollout of games and live‑programming in 2023, and then to broader pricing adjustments together with deeper investment in live events and expanded gaming in 2024. In each filing the company warned that any pricing change or new service (ads, games, live content) could be unpopular, impair member acquisition or increase churn, and that competition or macro‑economic conditions could limit its ability to grow the subscriber base.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Netflix's strategy and associated risks across 2022–2024 with mostly accurate details, but contains minor inaccuracies in the timeline and scope of service expansions. Quantitatively, there are no explicit numbers (e.g., pricing amounts, subscriber counts), so accuracy is based on correct sequencing and event attribution, which is largely preserved. The answer correctly identifies the introduction of games (2022), ad-supported tiers (2023), and live programming (2024), aligning with the ground truth. However, it incorrectly states that live programming was rolled out in 2023, when the original answer specifies that live programming was included by 2024—not in 2023. Additionally, the LLM implies games and live programming were both introduced in 2023, conflating two distinct timelines. The original answer clearly separates games (2022), ad-tier (2023), and live programming (2024). The risks are accurately summarized: Netflix consistently warned that changes to pricing, plans, or features could impair member acquisition and retention, and the LLM correctly reflects this across years. The mention of macroeconomic and competitive risks is contextually relevant but not part of the original answer’s focus, which centered on consumer perception of value. While this addition doesn’t invalidate the response, it slightly shifts emphasis. The multi-hop reasoning is generally sound—linking strategic changes to associated risks per year—but the misattribution of live programming to 2023 weakens the precision of the synthesis. Overall, the answer is semantically close and conveys the main thrust, but the timeline error prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 461,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s total equity‑security portfolio stayed roughly steady at about **$4.9 billion** from 2022 through 2024, but the **equity‑method investment in health‑care businesses grew sharply—from ≈ $1.4 billion in 2022‑23 to ≈ $3.8 billion by the end of 2024**.  At the same time, unrealized gains from its venture‑focused holdings rose from $211 million (2022) to $276 million (2023) and $710 million (2024), underscoring a strategic shift toward larger, higher‑potential investments in health‑care ventures and private‑equity‑style assets.  This progression indicates that UnitedHealth is deliberately deepening its exposure to emerging health‑care businesses as a core element of its growth strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth's equity securities holdings were $3.7 billion in 2022, increased to $4.9 billion in 2023, and remained at $4.9 billion in 2024. However, the LLM claims the equity securities portfolio was 'roughly steady at about $4.9 billion from 2022 through 2024,' which is incorrect because it omits the increase from $3.7B to $4.9B and falsely implies stability starting in 2022. This is a major factual error. Additionally, the LLM states equity-method investments were '≈ $1.4 billion in 2022–23,' but ground truth shows $1.3B in 2022 and $1.4B in 2023, so the conflation of 2022 and 2023 masks the actual progression. The $3.8B figure for 2024 is correct. (2) The LLM introduces unrealized gains ($211M, $276M, $710M) not present in the original answer or question context, which adds unsupported detail and risks misleading the user. These figures may be factually correct in some external context but are not part of the provided ground truth and thus represent hallucination. (3) The qualitative reasoning about strategic positioning—deepening exposure to healthcare ventures as part of growth strategy—is consistent with the original answer’s interpretation and shows sound multi-hop synthesis of intent from investment trends. The conclusion aligns semantically with the ground truth’s 'deliberate strategic shift.' (4) Contextual relevance is high because the answer addresses both parts of the question: investment evolution and strategic implications. Despite incorrect numbers, the directional trend (growth in equity-method investments) is correctly identified, and the strategic interpretation is valid. However, the quantitative inaccuracies—especially misrepresenting the timing and magnitude of equity securities growth—reduce overall correctness significantly. Minor formatting variations (e.g., $4.9B vs $4.9 billion) are acceptable, but misstated values and invented data (unrealized gains) are not. Therefore, the correctness score is 6 due to partial factual accuracy with key errors, while qualitative and contextual scores remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 584,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike’s redeemable preferred stock remained 100 % owned by Sojitz America; the $0.3 million‑par issue carries a fixed $0.10‑per‑share cumulative dividend that is paid each May 31, and no dividend may be declared on Nike common stock unless the preferred dividend is first satisfied.  Sojitz America continues to serve only as the sole holder of that preferred equity and as a financing conduit for Nike’s international trade—it has no general voting rights but does retain a separate‑class vote on certain corporate actions—so its role in Nike’s international operations has stayed unchanged over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is quantitatively accurate: it correctly states that Sojitz America owns 100% of Nike's redeemable preferred stock with a $0.3 million par value, a $0.10 per share cumulative dividend, and the May 31 payment date. It also accurately notes the dividend preference over common stock and the limited voting rights. These details align with the ground truth, earning a perfect score on quantitative accuracy. However, the qualitative accuracy is low because the LLM fails to capture a key evolution in the strategic role of Sojitz America. The ground truth states that in fiscal 2024, Nike explicitly highlighted Sojitz America's role in import-export financing since 1972 and its growing strategic importance amid global trade risks—marking a shift from purely financial to operationally strategic engagement. The LLM incorrectly asserts that Sojitz America's role 'has stayed unchanged' over the period, directly contradicting the documented evolution in 2024. This omission represents a critical failure in multi-hop reasoning and synthesis across years, undermining the answer's overall correctness. Contextually, the response is relevant and addresses the main components of the question (ownership, dividends, role), but the erroneous conclusion about no change in role significantly diminishes its accuracy. Thus, while factually sound on static details, the LLM misses the dynamic, strategic evolution central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 397,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 continued to be carried at roughly **$2 billion** – the balance shown for the note was $2,000 million as of the end of fiscal 2024 (Jan 28 2024) and remained unchanged at $2,000 million in the subsequent filing for fiscal 2025 (Jan 26 2025). This stability across the 2022‑2024 periods indicates that NVIDIA has kept its long‑term debt issuance steady, preserving a sizable senior unsecured position without refinancing or repayment, which reflects a deliberate, low‑cost financing strategy and confidence in its capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's carrying value of the 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in fiscal 2023, and increased to $2,000 million in fiscal 2024. The LLM incorrectly states that the value was stable at $2,000 million across 2022–2024, which contradicts the actual fluctuating trend. It also references fiscal 2025 ($2,000 million), which is outside the requested 2022–2024 scope and not part of the original answer. (2) The numbers are significantly inaccurate: the $2,147M (2022) and $1,604M (2023) figures are entirely omitted, and the decrease-then-increase pattern is misrepresented as stability. While $2,000 million in fiscal 2024 is correct, the prior years are wrong. (3) The multi-hop reasoning fails: the question asks for an evolution across three years and what the trend indicates. The LLM misses the key fluctuation—especially the notable drop in 2023—and thus draws an incorrect conclusion about 'stability' and 'steady' debt, when the ground truth indicates a temporary reduction followed by strategic repositioning. (4) Contextual relevance is moderate because the answer discusses the correct company, debt instrument, and general topic of long-term debt strategy, but the incorrect data and reasoning undermine the analysis. The conclusion about a 'low-cost financing strategy' is speculative and not supported by the provided ground truth. Overall, major factual and quantitative errors lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 436,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife reduced the share of its financing that came from short‑term commercial paper—short‑term debt fell from $175 million in 2022 to $119 million in 2023 and then rose modestly to $465 million in 2024, remaining a small fraction of total borrowings—while increasingly relying on a broader set of global funding channels.  The company continued to issue sizable amounts of long‑term debt (e.g., $1.6 billion in 2024), maintained its commercial‑paper program backed by revolving credit facilities, and tapped its shelf‑registration statement for both debt and equity, using the diversification of preferred stock, common stock, long‑term debt, collateral‑financing arrangements and policy‑holder account balances to improve funding flexibility and lower the overall cost of capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer (ground truth) does not mention any specific dollar amounts for commercial paper outstanding in 2022, 2023, or 2024, nor does it state that MetLife reduced its use of commercial paper. The LLM asserts that short-term debt fell from $175 million in 2022 to $119 million in 2023 and rose to $465 million in 2024—these figures are not present in the ground truth and are therefore incorrect. Additionally, the claim that MetLife issued $1.6 billion in long-term debt in 2024 is unsupported by the original answer. (2) There are no verifiable calculations in the ground truth to support the LLM's numerical claims, making the quantitative accuracy very low. The format variations are acceptable in principle, but the numbers themselves are fabricated. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies MetLife’s strategy of diversifying funding sources and using commercial paper backed by credit facilities. It also correctly notes the use of shelf registrations and various instruments to lower the cost of capital. However, it incorrectly implies a shift in strategy (reducing commercial paper) and introduces a trend not present in the original—namely, a dip and rebound in short-term debt. The multi-hop synthesis is flawed because it invents data rather than accurately reflecting consistent messaging across years. (4) The contextual relevance is moderate: the answer addresses the right topic—funding diversity, short-term debt, cost of capital—and uses appropriate financial terminology. However, the inclusion of false specifics undermines the overall correctness. The core message of diversification is present, but the evolution narrative is factually wrong. Thus, the correctness score is low due to major quantitative errors, despite some conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 527,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s short‑term notes payable to subsidiaries dropped sharply—from roughly $9.9 billion at the end of 2023 to about $2.0 billion in 2024—while its long‑term notes payable to subsidiaries grew to $14.4 billion, signalling a move from near‑term internal financing to longer‑dated funding; cash‑flow statements show decreasing issuances of notes to subsidiaries ( $(567) million in 2022, $(41) million in 2023, $(349) million in 2024) and modest repayments, reinforcing this shift.  The company’s service‑level guarantees remained immaterial across 2022‑2024, indicating that contractual risk exposure from those guarantees stayed negligible and that the firm’s liquidity commitments are being satisfied primarily through its expanded long‑term debt and operating cash flows rather than short‑term subsidiaries’ borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, notes payable to subsidiaries were $8.1B in 2022, $9.9B in 2023, and $2.0B in 2024. However, the LLM answer incorrectly omits the 2022 value and misrepresents the nature of the change by introducing a 'long-term' notes payable of $14.4B not mentioned in the original answer or implied by the data. This figure does not appear in the ground truth and appears to be fabricated or misattributed. Additionally, the cash flow figures cited—($567)M, ($41)M, ($349)M—are not present in the original answer and contradict the narrative of increasing then sharply decreasing internal debt; these specific numbers cannot be verified against the ground truth and introduce unsupported detail. (2) The only correct numbers are the $9.9B (2023) and $2.0B (2024) figures for notes payable, which match the ground truth. However, the introduction of long-term notes at $14.4B and detailed cash flow issuances undermines quantitative accuracy. There are no calculations in the original, so no calculation errors per se, but the LLM invents metrics not present in the source. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that a shift in internal debt structure may reflect changing liquidity strategies and correctly notes that service level guarantees remained immaterial. It also correctly links stable service guarantees to low contractual risk. However, it goes beyond the data by implying a refinancing strategy (short-term to long-term) that is not supported by the original answer, which makes no mention of long-term notes or a $14.4B figure. This over-interpretation weakens the qualitative accuracy. (4) The answer is contextually relevant and addresses both parts of the question: evolution of notes payable and service level guarantees, and their implications for liquidity and risk. The conclusion about negligible risk from service guarantees aligns with the ground truth. However, the unsupported financial figures and misrepresentation of the debt shift reduce correctness. Overall, the answer gets core ideas right but fails on key facts, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 595,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nBetween 2022 and 2024, American Express held onto its position as the world’s fourth‑largest general‑purpose card network but faced intensifying competition from Visa, Mastercard and a growing slate of fintech rivals, prompting the firm to double‑down on premium Card‑Member benefits, expanded travel lounges and accelerated digital‑service investments.  At the same time, regulatory pressure has risen sharply—U.S. banking regulators placed the company in a Category III framework, new proposals to cap interchange fees and stricter merchant‑non‑discrimination rules have emerged, and ongoing litigation over card‑acceptance provisions has increased legal exposure—forcing Amex to reinforce its compliance, risk‑management and cybersecurity programs while adapting its business model to preserve its competitive standing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024, with strong alignment to the ground truth. (1) All entities—American Express, Visa, Mastercard, fintech rivals (implied by 'fintech rivals' though specific names like Alipay, PayPal, Venmo, NPCI are omitted)—are correctly identified. The statement that Amex is the fourth-largest general-purpose card network matches the original. The 2024 regulatory shift to Category III is accurately noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the LLM avoids making up figures and sticks to qualitative descriptions. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive pressures, regulatory developments, and strategic responses across time. However, it omits key details present in the ground truth, such as Amex exiting its network licensing businesses in the EU and Australia and the specific regulatory focus on cobrand arrangements and network routing in the EU. These omissions reduce completeness and slightly weaken the qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing competitive dynamics, regulatory scrutiny, and strategic responses. Wording differs but semantic meaning is equivalent on major points. The score is reduced from 9–10 due to missing specific strategic consequences (exits from EU/Australia licensing) and less precise articulation of the shift from market-driven competition to regulatory dependency, which is central to the original answer’s thesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 456,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips continued to settle its performance‑share units in cash, but by the end of 2023 all legacy cash‑settled PSUs were fully vested and carried **no remaining compensation cost**; the company still granted new cash‑settled PSUs, yet they too became fully vested quickly and were settled with the same **accrued‑reinvested dividend‑equivalent** that was introduced for performance periods beginning in 2018—this dividend is now **charged to compensation expense and paid only at settlement**.  This shift reflects a deliberate move away from liability‑classified, cash‑based awards toward a structure that ties payouts more directly to the company’s stock performance and completes the payout only after the performance cycle, thereby aligning executive incentives with long‑term shareholder value while simplifying the compensation accounting.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the shift in dividend equivalent structure for performance periods beginning in 2018 or later—specifically, that recipients receive accrued reinvested dividends paid at settlement. This aligns with the ground truth. However, it introduces a significant factual error: claiming that by the end of 2023, all legacy cash-settled PSUs were fully vested and carried no remaining compensation cost. The ground truth does not support this claim and instead states that the company maintained a consistent framework from 2022 to 2024, implying ongoing liability and vesting over time (e.g., tied to five years or retirement eligibility). This undermines the quantitative and qualitative accuracy. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so numerical accuracy cannot be faulted directly, but the timeline and status claims (e.g., 'fully vested by end of 2023') are incorrect and not supported by the original. The assertion about new PSUs becoming 'fully vested quickly' is also unsupported. (3) The multi-hop reasoning is partially sound—the model correctly infers that the dividend change reflects stronger long-term alignment. However, it incorrectly concludes a shift away from liability-classified awards, while the ground truth explicitly states that cash-settled PSUs remained classified as liabilities on the balance sheet across all years, indicating continuity, not a shift away. This misrepresents the company’s accounting treatment and strategic intent. (4) Contextual relevance is high—the answer addresses the evolution of dividend equivalents and incentive alignment. But due to key factual inaccuracies regarding vesting timelines and accounting classification, the correctness score is limited to 5. The answer gets core elements of the dividend shift right but fails on critical structural and temporal facts, leading to an incomplete and partially misleading picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 546,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nBetween 2022 and 2024 the combined Special Use Funds of NextEra Energy rose from about **$7.3 bn** (2022) to **$8.8 bn** (2023) and then to **$9.8 bn** (2024), a roughly 34 % increase over the two‑year period.  This growth adds a larger pool of high‑quality, readily marketable assets that can be pledged or sold to satisfy the billions of dollars of cash or securities collateral that derivative‑related credit‑rating or performance triggers could require (e.g., up to $2–$5 bn in extreme downgrade scenarios).  Consequently, the expanding Special Use Fund balances signal that NextEra has deliberately strengthened its liquidity buffer to meet its derivative‑related collateral obligations throughout this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Special Use Funds were $8,698 million in 2023, not $8.8 billion (which is close), but the LLM incorrectly states $7.3 billion in 2022, for which there is no data in the original answer—this figure is fabricated. The ground truth does not provide a 2022 value for Special Use Funds, so asserting $7.3 billion is a factual error. Additionally, the LLM claims a '34% increase over the two-year period,' which cannot be verified due to missing 2022 data in the ground truth and is based on incorrect inputs. (2) The original answer highlights a key reduction in potential collateral obligations: from $5.2 billion in 2022 to $2.4 billion in 2023 in the event of a downgrade, and references actual cash collateral posted increasing from $84M to $691M. The LLM omits this critical multi-hop insight about declining exposure and improved risk management, instead vaguely referencing 'extreme downgrade scenarios' of $2–$5 billion not directly supported by the data. (3) While the LLM correctly identifies the $9.8 billion Special Use Funds in 2024 and captures the general trend of strengthening liquidity, it fails to synthesize the crucial interplay between rising Special Use Funds and declining derivative collateral requirements—a core element of the original answer’s reasoning. (4) Despite missing key facts and introducing incorrect numbers, the LLM answer is contextually relevant and correctly interprets the directional trend and strategic intent behind liquidity strengthening. However, the introduction of false 2022 figures and omission of key comparative data on collateral obligations significantly undermines factual correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 490,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe 1.600 % senior notes kept a $700 million face amount throughout 2022‑2024, and the reported carrying balance slipped only modestly—from roughly $696 million at year‑end 2022 to about $697 million by year‑end 2024—solely because the original discount was being amortized; no principal repayments or mandatory amortization occurred during the period. This flat‑line trajectory shows that AMT is treating the issuance as a long‑term, low‑cost funding source that it intends to hold until its 2026 maturity (or the March 2026 par‑call), using cash flows instead to retire higher‑coupon debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the constant principal amount of $700 million across 2022–2024, which matches the ground truth. However, it introduces the concept of a 'carrying balance' (from $696M to $697M) due to amortization of an original discount, which is not mentioned or supported in the original answer. The ground truth references 'adjustments to principal' decreasing from (3.7) million to (2.6) million, likely representing amortization or accrued interest, but the LLM does not report these specific figures or trends. Instead, it fabricates a narrative around a changing carrying value that contradicts the flat adjustment trajectory implied in the original. (2) The numbers for principal ($700M) are accurate, but the LLM invents values for carrying amounts ($696M, $697M) and omits the actual adjustment amounts (-3.7M, -2.6M), which are critical quantitative data points. The maturity date (2026) and call date (March 2026) are plausible but not present in the original answer and thus cannot be verified from the provided truth. (3) The reasoning about AMT using the note as a long-term, low-cost funding source aligns semantically with the original’s conclusion about a 'stable long-term debt strategy' and 'predictable amortization patterns.' However, the LLM incorrectly attributes the slight change in carrying value to discount amortization without evidence from the ground truth, and fails to note the declining adjustments, weakening the multi-hop synthesis. (4) The answer is contextually relevant and addresses both parts of the question—evolution of principal/amortization and strategic implications—but substitutes unverified details for missing data, leading to partial factual inaccuracy. While the strategic interpretation is reasonable, the lack of support for key numbers reduces quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 504,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment reforms grew as CMS increasingly relied on RADV audits and revised risk‑adjustment calculations, producing retroactive payment adjustments and tighter benchmark pressures. In response, the company progressively refined its pricing and benefit design—selectively adjusting member benefits and premiums, exiting low‑margin counties, and intensifying medical‑cost and operating‑efficiency initiatives—to blunt the impact of those regulatory shifts and protect margins over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is accurately described, with CMS modifying methodologies annually. The response correctly identifies strategic adjustments including selective benefit and premium changes, county exits, and intensified cost management. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory shifts (CMS methodology changes, RADV audits, benchmark pressures) with UnitedHealth’s evolving strategic responses across three years. The mention of RADV audits adds contextual detail not in the original but is factually relevant and consistent with CMS enforcement trends, enhancing rather than distorting accuracy. (4) The only minor gap is that the original emphasizes CMS 'reducing or freezing benchmarks' in 2022 and repeating changes in 2023 and 2024, while the LLM generalizes these as ongoing 'revisions' and 'tighter benchmark pressures'—slightly less granular year-by-year breakdown but still captures the evolving nature. Overall, the LLM conveys the same core message with strong factual fidelity, appropriate synthesis, and no errors in entities, years, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 401,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nFrom 2022 through 2024 Target’s employee‑discount language evolved from a brief, generic reference to “merchandise and other discounts” in its compensation disclosures to a clearly articulated, tiered benefit that is now linked to the Target Circle loyalty program and complemented by higher starting wages and broader benefits.  This progression reflects Target’s strategy of bolstering employees’ financial well‑being by lowering their out‑of‑pocket purchase costs, integrating discounts with broader loyalty incentives, and using the benefit as a lever for recruitment, retention, and overall economic security of the workforce.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numerical data (e.g., wages, percentages), so quantitative accuracy is not violated—there are no incorrect numbers. However, it introduces information not present in the ground truth: specifically, that the employee discounts became 'tiered' and were 'linked to the Target Circle loyalty program.' The original answer makes no mention of Target Circle, tiered structures, or integration with a loyalty program. This is a significant factual overreach and misrepresentation of the evolution. While the ground truth confirms that merchandise discounts remained consistent and were increasingly embedded in a broader financial well-being strategy—including rising wages (from $15 to $15–$24) and expanded benefits like sick pay and tuition-free education—the LLM incorrectly attributes structural changes to the discount program itself. The core correct elements are: (1) merchandise discounts were consistently offered, (2) starting wages increased, (3) additional benefits were added over time, and (4) the overall strategy reflects an emphasis on financial well-being, recruitment, and retention. However, the LLM fabricates a 'tiered' benefit and loyalty integration, which distorts the actual progression. The reasoning is partially sound in connecting wage increases and benefit expansion to financial well-being, but the multi-hop synthesis fails because it invents a linkage (Target Circle) not supported by the source. Thus, while the general direction of strategic intent is plausibly inferred, the specific evolution of the discount structure is factually incorrect. Semantic equivalence is partially achieved on the strategic theme but not on the factual evolution of the benefit. Hence, correctness is penalized for significant factual error despite correct contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 492,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nFrom 2022 through 2024 American Express grew its foreign‑government‑bond exposure from roughly $650 million to $810 million, and the average yield on that slice of its taxable investment portfolio rose from about 3.5 % to 6.1 % (as shown in the 2022‑2024 “Taxable investment securities” averages).  The maturity profile stays overwhelmingly short‑term – virtually all of the bonds mature in under one year, with only a trivial amount extending beyond five years (the 2021 maturity‑bucket breakdown confirms > 99 % in the “due within 1 year” bucket).  This three‑year trend signals a modestly higher risk appetite: the firm is deliberately extending exposure to higher‑yielding sovereign debt while keeping duration short, reflecting a conservative yet opportunistic asset‑allocation stance that seeks yield as rates rise without taking on significant interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states American Express held $630 million in Foreign Government Bonds in 2022, but the LLM claims $650 million and asserts growth to $810 million by 2024—no such figures appear in the ground truth, and no total portfolio growth is mentioned. More critically, the LLM misrepresents yields: it reports average yields of 3.5% in 2022 and 6.1% in 2024, but the ground truth shows differentiated yields by maturity bucket (1.74% and 2.42% in 2022; 6.45% and 4.48% in 2023; 5.86% and 2.03% in 2024). The LLM incorrectly aggregates these into single averages, which distorts the trend. (2) The maturity distribution is also wrong: the LLM claims 'virtually all' bonds mature within one year and references a 2021 breakdown, but the ground truth explicitly provides yield data for two maturity buckets (within one year and after one but within five years) for each year, indicating meaningful exposure beyond one year. There is no mention of a >99% short-term concentration in the source. (3) The reasoning is flawed: the LLM concludes a 'modestly higher risk appetite' and 'conservative yet opportunistic' strategy, but misses the key dynamic in the ground truth—the sharp drop in long-term yield from 4.48% to 2.03% in 2024, suggesting a retreat from longer-dated exposure. The actual pattern reflects a more pronounced shift and reversal in strategy, particularly in long-term yields, which the LLM fails to capture. (4) While the answer is relevant to the question’s topic and attempts to address yield trends and risk implications, the severe quantitative and qualitative inaccuracies—especially in numbers, maturity distribution, and synthesis across years—undermine its correctness. The model appears to fabricate portfolio size growth and mischaracterize yield data, failing the multi-hop requirement to accurately track year-by-year changes in both yield and maturity. Thus, the correctness score is low despite some thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 546,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nCollateral that the company posts under master‑netting arrangements—recorded in the “Other assets, including intangibles – net” line—fell sharply: $1.49 billion at the end of 2022, $0.80 billion at the end of 2023 and $0.49 billion at the end of 2024. The decline shows that ExxonMobil has been able to reduce the external collateral required for its derivative positions, indicating a smaller net derivative exposure and more efficient netting/credit‑risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million when adjusted for rounding and unit formatting (e.g., $1.49 billion ≈ $1,490 million). All numeric values are accurate within acceptable rounding differences. (2) The quantitative accuracy is perfect: the trend of decreasing collateral is correctly presented with precise figures and consistent time periods (2022–2024). (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly tied to derivative exposure management. The conclusion that the decline reflects reduced derivative exposure and improved risk management aligns with and slightly expands upon the ground truth’s interpretation of a 'strategic reduction in derivative-related exposure or shift in risk management practices.' The LLM adds value by specifying 'more efficient netting/credit-risk management,' which is a reasonable inference. (4) The answer is fully contextually relevant, addressing both the quantitative trend and its implication for risk management. The only minor deduction is in qualitative accuracy because the LLM slightly over-interprets by implying causality ('has been able to reduce') without acknowledging possible alternative explanations (e.g., changes in market conditions or counterparty agreements), which the more cautious original answer avoids. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 434,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe $700 million 2.700 % senior notes were originally issued on March 29 2021 with a 2.700 % coupon, semi‑annual interest payments on April 15 and October 15, and a maturity of April 15 2031 (first call January 15 2031). From 2022 through 2024 the notes kept the same interest‑rate terms; the only evolution was a modest reduction in the reported carrying amount—$2.6 million in 2023 and $1.5 million in 2024—reflecting discount amortization and small principal repayments funded with cash from the company’s revolving credit facilities and proceeds from newer, higher‑coupon note issuances (e.g., the 5.200 % 2029, 5.450 % 2034, 3.9 % 2030 and 4.1 % 2034 offerings). Thus, American Tower has been extending the overall maturity of its debt and lowering leverage by retiring near‑term, higher‑cost obligations while preserving this low‑cost, long‑dated 2.700 % tranche, underscoring a financing strategy that leans on strong capital‑market access to reshape the debt profile amid a period of rising interest rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. According to the ground truth, the 2.700% Notes were issued on March 29, 2021, with a maturity date of January 15, 2031 (not April 15, 2031), and interest payments in April and October (specific dates not specified in ground truth). The LLM incorrectly states the maturity as April 15, 2031, and specifies interest payment dates as April 15 and October 15, which are not confirmed in the original answer. More critically, the ground truth notes a reduction in the interest rate spread from (5.0) to (4.4) by 2024, but the LLM misinterprets this as a change in carrying amount ($2.6M in 2023, $1.5M in 2024), which is not supported by the original answer and conflates amortization with interest rate terms. There is no mention in the ground truth of principal repayments or use of revolving credit facilities for retiring these notes. (2) The principal amount is correctly stated as $700 million across years, which matches the ground truth. However, the discussion of 'carrying amount' reductions and funding sources (revolving credit, new issuances) introduces unsupported details not present in the original data. The claim about retiring 'near-term, higher-cost obligations' is speculative and not derived from the provided answer. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a broader financing strategy, it does so based on incorrect or fabricated financial movements. The ground truth emphasizes stability in principal and maturity with a slight reduction in borrowing cost (via spread), but the LLM incorrectly attributes changes to principal and repayment activity. (4) Despite inaccuracies, the LLM captures the general idea of a stable, low-cost debt tranche being preserved amid rising rates, which aligns with the strategic interpretation in the original answer. However, this qualitative insight is built on incorrect quantitative foundations, reducing its validity. The contextual relevance is moderate as it addresses the evolution and strategy, but with significant factual distortion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 571,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the principal balance of NVIDIA’s 2.00 % Notes Due 2031 was unchanged at roughly **$1.25 billion** (the carrying amount shown in the 2024 and 2025 filings is $1,250 million, with only a modest rise in market value from $1.044 billion in 2023 to $1.057 billion in 2024 as the unamortized discount was reduced).  The only movement was the repayment in 2025 of the near‑term 0.584 % Notes Due 2024, leaving the 2031 notes as a stable, long‑dated financing pillar.  This steady long‑term debt level reflects NVIDIA’s strategy of maintaining a low‑coupon, long‑maturity obligation to lock in financing while using cash flows to retire shorter‑dated debt rather than expanding its long‑term leverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022 the fair value was $1.2 billion, but the LLM claims the principal balance was $1.25 billion throughout 2022–2024, which contradicts the reported $1.044 billion at the beginning of 2023. The LLM incorrectly states that the $1.25 billion carrying amount was present in both 2024 and '2025 filings', but the question only covers through 2024, and no 2025 data should be referenced. Additionally, the LLM introduces a '0.584% Notes Due 2024' and mentions a repayment in 2025, which is irrelevant to the question about the 2031 notes and not supported in the original answer. (2) The ground truth reports: 2022 = $1.2B fair value; 2023 = $1.044B (beginning), $1.057B (end); 2024 = $1.25B carrying value. The LLM misrepresents the 2022 and 2023 values and incorrectly attributes the $1.25B to earlier years. The market value progression from $1.044B to $1.057B is correctly noted, but this refers to 2023–2024, not 2024–2025 as implied. (3) The multi-hop reasoning is partially sound—LLM attempts to interpret stability in long-term debt and connect it to strategy—but it does so using incorrect timeframes and introduces unrelated debt instruments, weakening the synthesis. The conclusion about strategic consistency is reasonable but based on flawed data. (4) Contextual relevance is high because the answer addresses the evolution and strategic implication, but factual correctness is compromised by incorrect numbers and temporal misalignment. Quantitative accuracy is low due to mismatched values and dates; qualitative accuracy is moderate due to correct general direction but flawed details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 460,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑method balances expanded markedly.  In the 2022 filing the company reported only $1.8 bn of deposit assets and $1.4 bn of deposit liabilities (level with the 2021‑2020 figures).  By 2023, after the closed‑block modified‑coinsurance and the Global Atlantic risk‑transfer transaction, deposit assets had risen to $5.1 bn and deposit liabilities to $1.3 bn; in 2024 they were $4.6 bn of assets and $1.2 bn of liabilities.  This upward trajectory shows that MetLife is increasingly recording large‑scale reinsurance arrangements—particularly the 59 % closed‑block modified‑coinsurance and the 2023 Global Atlantic reinsurance deal—using the deposit method to lock in cash‑flow timing, reduce earnings volatility and align the accounting with its LDTI‑driven reinsurance strategy.  The trend therefore signals a strategic shift toward using deposit accounting as a core tool for managing and financing its reinsurance risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is mostly correct in its interpretation and reasoning but contains a critical error in the 2024 deposit asset value: it states $4.6 billion, whereas the ground truth reports $5.1 billion. This is a significant quantitative discrepancy. The liability figures ($1.3 billion in 2023, $1.2 billion in 2024) are accurate. The 2022 figures ($1.8 billion assets, $1.4 billion liabilities) are correctly reported. 2) The mention of the Global Atlantic transaction and its relevance to the increase in deposit assets aligns with the ground truth, as does the explanation that the deposit method is used for reinsurance agreements not exposing MetLife to significant insurance risk. However, the LLM incorrectly implies that deposit assets decreased from $5.1 billion in 2023 to $4.6 billion in 2024, when in fact they remained at $5.1 billion (or possibly increased slightly depending on interpretation), contradicting the 'upward trend' described in the original answer. 3) The multi-hop reasoning is sound—LLM correctly links the accounting method change to strategic reinsurance transactions (Global Atlantic, closed-block coinsurance) and connects it to broader financial reporting goals like reducing earnings volatility and aligning with LDTI. This shows strong synthesis across time and events. 4) Despite the incorrect 2024 asset number, the overall narrative about a strategic shift toward deposit accounting is supported and contextually appropriate. The error in a key financial figure reduces quantitative accuracy significantly, but qualitative and contextual elements remain strong. Minor formatting variations (e.g., $1.8 bn) are acceptable and do not affect understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 460,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio contracted over the three‑year span: fair value fell from **$679 million (2022)** to **$596 million (2023)** to **$508 million (2024)**, and the corresponding carrying values dropped from **$696 million** to **$603 million** to **$512 million**.  \n\nThis consistent decline signals a strategic de‑risking and rebalancing of the fixed‑income book—likely in response to rising interest‑rate environments and shifting market conditions—forcing the company to write down the book value of these securities and reduce its exposure, underscoring a proactive stance on managing interest‑rate risk and portfolio composition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values are correct and match the ground truth exactly: fair values of $679M (2022), $596M (2023), $508M (2024) and carrying values of $696M, $603M, and $512M respectively. There are no calculation or formatting errors. (2) The LLM correctly reports the downward trend in both fair and carrying values over the three-year period, accurately reflecting the quantitative evolution. (3) The reasoning is sound and adds contextual insight—mentioning 'strategic de-risking,' 'rising interest-rate environments,' and 'managing interest-rate risk'—which is a plausible and logical interpretation of the trend, even if slightly more specific than the original answer. The original answer attributes the decline to 'strategic reduction or repositioning' and 'market conditions or internal capital reallocation,' which is more general but semantically aligned. The LLM's inference about write-downs and proactive risk management is reasonable but slightly extends beyond the ground truth without overreaching. (4) All entities (UnitedHealth Group, Debt Securities - Held-to-Maturity, years 2022–2024) are correct, and the multi-hop synthesis across three years of data is accurate. The answer fully addresses both parts of the question: the evolution of values and the strategic implication. Only a minor deduction in qualitative accuracy due to slight interpretive expansion; otherwise, the answer is factually complete, contextually relevant, and quantitatively perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 411,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (RedCard) penetration fell steadily over the three fiscal years – 20.5 % in 2022, 19.8 % in 2023 and 18.6 % in 2024.  This decline signals that the card‑linked discount program is losing its ability to generate incremental sales, implying that Target’s current credit‑card strategy is becoming less effective and may need to be refreshed to reignite growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly—quantitative accuracy is perfect. (2) All numbers and years are accurate, with no calculation or formatting issues; the trend of decline is correctly described. (3) The multi-hop reasoning is partially sound: the model correctly identifies the downward trend and links it to the effectiveness of Target's credit card strategy. However, it draws a stronger negative conclusion than supported by the original answer—stating the program is 'losing its ability to generate incremental sales' and 'becoming less effective'—while the ground truth notes that Target still sees 'a meaningful portion of incremental purchases' contributing to sales, indicating ongoing strategic value. This omission of a key nuance leads to a less accurate qualitative assessment. (4) The answer is contextually relevant and addresses both parts of the question—trend and strategic implication—but the interpretation of the trend’s implications is overly negative and lacks the balanced view present in the original. Hence, correctness is reduced to 7 due to incomplete qualitative synthesis despite full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 353,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nNike continues to **own** its major distribution hub in Laakdal, Belgium across the FY 2022‑2024 filings, listing it among the “most significant distribution facilities outside the United States” that the company **owns** (rather than leases or operates through third‑party logistics providers).  This consistent, wholly‑owned status signals that Nike is deliberately **reinforcing and expanding its owned European logistics infrastructure**, using Laakdal as a strategic gateway to improve supply‑chain control, speed and resilience for its European markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Nike owns the Laakdal, Belgium distribution facility and maintains this ownership from FY2022 to FY2024, which aligns with the ground truth. It accurately characterizes the facility as one of the most significant international (or 'outside the United States') distribution centers, consistent across the years. There are no numerical inaccuracies, so quantitative accuracy is perfect. However, the LLM overreaches in stating that Nike is 'reinforcing and expanding its owned European logistics infrastructure,' implying active growth or strategic expansion. The original answer notes no changes in ownership or operational role, indicating stability rather than expansion. Thus, the inference about 'reinforcing and expanding' is not supported by the source data and introduces a strategic interpretation beyond what the evidence confirms. This affects qualitative accuracy, as the reasoning adds unsupported strategic intent. Contextually, the answer remains highly relevant, addressing ownership, operational footprint, and strategic implications, albeit with a slight misstep in interpretation. Semantic equivalence is mostly preserved, but the added emphasis on expansion reduces factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 347,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nBetween fiscal 2022 and 2024, Lumentum remained listed among NVIDIA’s key networking competitors (e.g., suppliers of switches, network adapters and optical modules).  During this period NVIDIA broadened the redundancy of its fabless supply chain—adding additional Asian wafer and assembly partners and deepening ties with TSMC and Samsung—while simultaneously expanding its patent portfolio and tightening IP enforcement, including export‑control licensing that restricts certain high‑performance interconnect products.  These supply‑chain and IP‑protection initiatives have increased competitive pressure on Lumentum, limiting its ability to sell networking components to NVIDIA and forcing the company to contend with NVIDIA’s more diversified and protected manufacturing base.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Lumentum Holdings as a persistent competitor to NVIDIA in the networking space across fiscal years 2022–2024, particularly in optical modules and interconnect solutions, which aligns with the ground truth. It also accurately references NVIDIA’s supply chain strategies involving TSMC and Samsung and mentions IP protection expansion, which is contextually relevant. However, the LLM introduces unsupported claims not present in the original answer or implied by the data: specifically, that NVIDIA’s IP enforcement includes 'export-control licensing that restricts certain high-performance interconnect products' and that these measures 'limit Lumentum’s ability to sell networking components to NVIDIA.' The original answer states that Lumentum remained a named competitor despite NVIDIA’s IP and supply chain advancements, indicating ongoing competitive relevance, but does not assert that Lumentum is being restricted from selling to NVIDIA—this is a significant interpretive leap. Additionally, the original emphasizes that Lumentum’s consistent mention reflects its sustained competitive positioning, whereas the LLM frames the relationship as one-sided competitive pressure, misrepresenting the dynamic. There are no numerical inaccuracies (hence full quantitative accuracy), but the qualitative reasoning contains flawed inference and overreach in cause-effect interpretation. The answer is contextually relevant and captures part of the multi-hop synthesis (competitor status + NVIDIA strategy), but fails to accurately represent the evolving relationship as one of persistent competition despite NVIDIA’s advantages, not diminished relevance due to them.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 461,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s dependence on external rights holders shifted from a pure “library‑licensing” model to a hybrid approach that leans heavily on longer‑term, exclusive licenses and a growing slate of owned originals, while still coping with the risk that studios can pull content or demand higher fees as they launch competing services.  At the same time, emerging regulatory frameworks—such as cultural‑support quotas, levies and restrictions on ownership rights—have forced the company to negotiate more restrictive licensing terms and to supplement licensed titles with co‑productions and original programming to meet both competitive and compliance pressures.  This evolution reveals a content‑acquisition strategy that balances securing exclusive, controllable content with building internal production capacity to mitigate licensing volatility amid intensifying competition and tighter government oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: Netflix's evolving reliance on rights holders from 2022–2024 is accurately portrayed, with correct emphasis on rising competition (e.g., studios launching competing services) and regulatory changes (e.g., content quotas, ownership restrictions). The strategic shift toward exclusive licenses and original content is correctly identified. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the LLM synthesizes Netflix’s content strategy across time (2022 to 2024), integrates competitive dynamics (studio competition) and regulatory developments (quotas, levies), and infers strategic implications (investment in originals, co-productions). The only minor gap is that the original answer explicitly notes the continuity of risk framing in 2023, while the LLM answer generalizes the trend without specifically calling out 2023’s consistency—this is a slight omission but does not undermine the overall correctness. (4) Contextual relevance is excellent: the response directly addresses all parts of the question—evolution over time, reasons (competition, regulation), and strategic implications. Wording differs but meaning aligns closely with the ground truth. Minor phrasing differences (e.g., 'hybrid approach' vs 'core risk factor') do not affect factual accuracy. Scored 9/10 due to slight compression of year-by-year evolution, but core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 436,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company kept the scheduled lease payments for outdoor‑lighting contracts inside the consolidated “Operating leases” maturity schedule, but each year the footnotes stressed that these cash‑flows are immaterial and therefore disclosed only as part of the aggregate lease table.  The amounts moved forward in the schedules (e.g., $230 million due in 2024 in the 2023 filing and $239 million due in 2025 in the 2024 filing) and are shown net of discount, while the income from those contracts remains classified as operating‑lease revenue—variable‑payment PPAs are reported separately in wholesale revenues.  Consequently, materiality was highlighted, revenue classification stayed within operating leases but was split into scheduled versus variable components, and the maturity tables were updated each year to reflect the next‑year payment amounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Southern Company considered outdoor lighting lease cash flows immaterial and did not include them in maturity analyses. However, the LLM claims these were included in the 'Operating leases' maturity schedule from 2022 onward, which contradicts the original answer. In 2023, the company began including these payments in maturity analyses, but the LLM incorrectly implies this inclusion was already happening in 2022. By 2024, the disclosure expanded further—this progression is misrepresented in the LLM answer, which suggests consistent treatment over the period. (2) The LLM introduces specific dollar amounts—$230 million due in 2024 (from 2023 filing) and $239 million due in 2025 (from 2024 filing)—that are not present in the ground truth and cannot be verified. These figures are likely fabricated or misattributed, severely undermining quantitative accuracy. There is no mention in the original answer of net-of-discount presentation or variable vs. scheduled revenue splits. (3) The multi-hop reasoning is flawed: the LLM fails to capture the evolution from immaterial/undisclosed (2022) to structured inclusion (2023) to explicit inclusion (2024). Instead, it assumes consistent reporting with only footnote disclaimers, missing the key shift in disclosure practice. The synthesis across years is incorrect. (4) While the LLM addresses the question's structure—discussing materiality, revenue classification, and maturity presentation—its factual foundation is unsound. Revenue classification as operating lease revenue may align broadly, but the claim about splitting into scheduled vs. variable components and separating variable PPAs is unsupported. Contextual relevance is moderate because it attempts the right framework but with incorrect content. Correctness score is low due to major factual and quantitative errors that distort the actual evolution of disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 539,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 had a reported principal balance of **$606 million** at the end of fiscal 2022, and that figure remained essentially unchanged at **$606 million** through fiscal 2023 and fiscal 2024 (the same $606 million balance is shown for both the November 3 2024 and October 29 2023 reporting dates). This flat‑line evolution indicates that AVGO is treating this long‑dated, low‑cost tranche as a stable component of its capital structure, focusing on overall leverage and maturity management rather than actively repaying or refinancing the instrument.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the outstanding principal balance for AVGO's 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The LLM correctly reports the $606 million balance for fiscal years 2023 and 2024, but incorrectly claims it was already at that level in 2022. This misrepresents the evolution of the debt. (2) The calculation of change over time is therefore flawed: the actual reduction occurred between 2022 and 2023 (a $480 million decrease), which the LLM fails to capture. Instead, it describes a flat trajectory across all years, which contradicts the ground truth. Number formats are acceptable ($606 million is correctly presented), but the core figures are wrong for 2022. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the pattern in the debt balance over time; however, because the input data is incorrect, the conclusion about 'stable capital structure' and 'no active repayment' is based on false premises. The ground truth shows a deliberate repayment in 2023, which the LLM overlooks due to incorrect data. (4) Contextual relevance is high—the answer addresses both the evolution of the balance and the implication for debt strategy—but the qualitative analysis is undermined by incorrect numbers. While the interpretation might fit the erroneous data, it does not align with the actual debt reduction event in 2023. Thus, correctness is severely impacted by the initial quantitative error, warranting a score of 4. Quantitative accuracy is low (3) due to one of three data points being wrong with material magnitude. Qualitative accuracy is moderate (5) because reasoning structure is logical but based on false inputs. Contextual relevance remains strong (8) as the response stays on topic and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 524,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nGeneral Motors lifted its long‑term expected return on U.S. pension assets from roughly 5.4 % at the end of 2022 to 6.3 % in 2023 and 6.5 % in 2024.  This upward shift in ROA assumptions coincided with a deliberate re‑allocation of the plan’s target mix—equity rising from 8 % (2022) to 11 % (2023‑24) and “other” (private‑equity, real‑estate, hedge‑fund‑style assets) expanding from 23 % to 29 %, while the debt portion was trimmed from about 69 % to 60 %.  The trend shows GM’s effort to capture higher market returns and strengthen the funded position by moving toward a more growth‑oriented asset mix amid a recovering equity market and persistently volatile interest‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, GM's long-term rate of return was 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024 — an increase from 5.4% to 6.3%, not a jump from 5.4% at the end of 2022 to 6.3% in 2023 as if 2022 was 5.4% and 2023 was a new value. However, the LLM incorrectly states that the 5.4% was at the 'end of 2022', implying it may not have been the reported assumption for that year, creating ambiguity. More critically, the LLM introduces specific asset allocation percentages (e.g., equity rising from 8% to 11%, 'other' from 23% to 29%, debt from 69% to 60%) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or hallucinated, severely undermining quantitative accuracy. (2) The calculation of the overall trend (increase from 5.4% to 6.5%) is directionally correct and matches the 1.1 percentage point increase noted in the original answer. However, the inclusion of unsourced asset mix figures invalidates the precision of the response. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that rising return assumptions suggest a shift toward higher-risk, growth-oriented investments, which aligns with the original conclusion about a more optimistic outlook and strategic shift. The contextual interpretation of market conditions (recovering equity markets, volatile interest rates) is reasonable and adds relevant qualitative insight. (4) While the core trend in return assumptions is correctly identified and the qualitative interpretation is strong and relevant, the hallucinated asset allocation data results in a major factual flaw. This significantly reduces the correctness and quantitative accuracy scores despite good contextual relevance and reasonable logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 504,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 are repeatedly listed in the supplemental indentures filed in 2021, 2022, 2023 and 2024, showing that the company continues to treat this tranche as a core, long‑dated piece of its capital structure. By amending and re‑referencing the 2031 notes across multiple filings, American Tower is locking in low‑cost, fixed‑rate financing for an extended horizon and deliberately extending its maturity profile, underscoring a long‑term financing strategy that relies on stable, long‑dated senior debt to fund its tower acquisition and development program.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core insight from the ground truth: the consistent treatment of American Tower's 2.700% Senior Notes due 2031 across multiple years reflects a stable, long-term financing strategy. Quantitatively, the percentage (2.700%) and maturity year (2031) are accurate, and the mention of filings from 2022–2024 aligns with the original. However, the LLM incorrectly states that the notes were 'repeatedly listed in the supplemental indentures filed in 2021, 2022, 2023 and 2024', implying new indentures were filed each year. The ground truth clarifies that Supplemental Indenture No. 8, dated March 29, 2021, was referenced in all three annual reports (2022–2024), not that new amendments were filed annually. This is a minor but notable factual overstatement. The LLM also introduces strategic context not explicitly confirmed in the ground truth—such as 'locking in low-cost, fixed-rate financing' and 'funding tower acquisition and development'—which, while plausible, are inferential expansions beyond the documented evidence of consistent referencing. Nonetheless, the reasoning is sound in linking repeated disclosure to strategic stability, and the answer addresses the question about long-term financing strategy effectively. Semantic equivalence is strong on the central point of continuity in treatment indicating strategic consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 383,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior intensified as its credit‑product portfolio (PPWC, PPBL and BNPL) and cross‑border transaction volume expanded, raising fraud, charge‑off and regulatory risks; the company countered by strengthening underwriting and fraud‑detection models, diversifying its payment‑processor base and migrating away from a single U.S. processor, and by executing a strategic sale of a substantial portion of its U.K. and European BNPL receivables (with a forward‑flow arrangement) in 2023‑24 to reduce credit‑asset concentration and improve funding resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors and its strategic responses from 2022 to 2024. (1) It correctly identifies the increasing risk in credit products (including BNPL) and cross-border transactions, aligning with the 2022 context in the ground truth. It accurately references the 2023 strategic sale of U.K. and European BNPL receivables, though it slightly misrepresents the timing by stating '2023-24' instead of specifying 2023 as the year the agreement was entered. The ground truth emphasizes a multi-year agreement announced in 2023 with up to €40 billion in receivables; the LLM omits the exact amount and currency (€40 billion), which is a minor quantitative omission. (2) No incorrect numbers are stated, but the absence of the specific €40 billion figure reduces quantitative precision. The mention of a 'forward-flow arrangement' is plausible and consistent with such transactions, though not explicitly confirmed in the ground truth. (3) The reasoning is sound: the LLM correctly synthesizes PayPal’s multi-year risk trajectory—increased exposure, strategic offloading of risk via receivables sale, and operational improvements in fraud detection and processor diversification. It adds detail not in the original (e.g., migrating away from a single U.S. processor, strengthening underwriting models), which is contextually reasonable and enhances completeness without contradicting facts. (4) The answer is highly relevant, addressing all parts of the question: evolution of risk, focus on credit and cross-border, and mitigation strategies across the three years. The omission of explicit 2024 emphasis on third-party dependencies and consumer confidence slightly weakens qualitative completeness, but the core strategic actions are accurately conveyed. Overall, the answer is factually strong with minor gaps in specificity, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 523,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nThe pension plan’s stake in Collective Trust and Other Funds fell sharply—from about **$622 million in 2022 to roughly $382 million in 2023 (and stayed near that level in 2024)**—representing a roughly 38 % reduction.  This pull‑back from the less‑liquid, alternative‑investment bucket was accompanied by a marked increase in debt‑security exposure (75 % of assets in 2024 vs. 51 % in 2022) and a lower equity share, signalling that Union Pacific is deliberately **de‑risking its retirement portfolio** and favoring more stable, income‑producing investments to meet its long‑term employee‑benefit obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the 2022 dollar amount: it reports $622 million instead of the correct $756 million from the ground truth. This misstatement affects the accuracy of the percentage change calculation. While the 2023 value ($382 million) is correct, the claim that the allocation 'stayed near that level in 2024' is unsupported by the original answer, which explicitly states that no updated dollar value is provided for 2024—only a shift in valuation methodology (NAV-based) is noted. Thus, asserting a stable allocation in 2024 introduces an unsupported inference. (2) The claimed ~38% reduction is based on incorrect inputs: (756 - 382)/756 ≈ 49.5%, not 38%. Using the LLM’s numbers: (622 - 382)/622 ≈ 38.6%, so the percentage is accurate only relative to its own incorrect baseline, making the calculation internally consistent but factually wrong. (3) The qualitative reasoning about de-risking is aligned with the ground truth and adds contextual insight by referencing increased debt security exposure and reduced equity, which supports the strategic interpretation. However, this information (debt rising to 75% from 51%, equity changes) is not present in the original answer and appears to be hallucinated or drawn from external data, undermining multi-hop fidelity. The core trend of reduced allocation suggesting de-risking is consistent, but the supporting evidence is not from the provided truth. (4) Despite incorrect numbers and unsupported data points, the LLM captures the directional trend (decrease in Collective Trust and Other Funds) and infers a plausible strategic rationale (de-risking), which maintains partial correctness. The answer is relevant and well-structured, but fails on key quantitative facts and introduces unverified details, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 494,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nPfizer stopped granting Breakthrough Performance Awards after 2022 – no BPAs were issued in 2023 or 2024 and, by year‑end 2023, none remained outstanding (the few granted earlier were fully settled at the end of their five‑ or seven‑year performance periods). The awards that had been granted were measured at intrinsic value using the closing stock price, amortized on a straight‑line basis over the estimated vesting term, and each reporting period the expense was adjusted for changes in share price, the probability of achieving the performance targets and the remaining vesting period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pfizer stopped granting BPAs after 2022 and that no BPAs were outstanding by the end of 2023, which aligns with the ground truth. However, it omits key quantitative details from 2022: the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 and 859 thousand outstanding at year-end valued at $59.05 per share. These specific figures are missing, reducing quantitative accuracy. (2) The LLM mentions the intrinsic value method, amortization over the vesting term, and quarterly adjustments — which matches the 2024 methodology described in the original answer — but fails to explicitly state that this formalized framework was introduced in 2024, creating ambiguity about when the accounting policy shift occurred. (3) The reasoning is logically sound: it correctly infers discontinuation of the program based on no grants in 2023 and zero outstanding by year-end 2023, and it accurately describes the accounting treatment evolution. However, it does not fully synthesize the multi-hop timeline — particularly the transition from active grants in 2022 to formal methodology in 2024 — as clearly as the original. (4) Despite missing specific numbers and precise year-linked methodology updates, the LLM captures the overall trend and accounting principles correctly, making the answer contextually relevant and qualitatively strong, though not fully accurate quantitatively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 402,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements for its investment‑related receivables fell sharply – from **$1.49 billion in 2022 to $0.80 billion in 2023 and $0.49 billion in 2024**.  This steady decline shows that the company’s derivative notional positions and the associated initial‑margin requirements have been contracting, indicating a reduced derivative exposure and a lower need to maintain large collateral balances over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024), which match the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding). 2) Quantitatively, all figures are accurate and properly aligned with the correct years. The use of billions instead of millions is a standard format variation and does not affect correctness. 3) The reasoning is sound: the downward trend is correctly identified, and the interpretation—that this reflects reduced derivative exposure and lower margin requirements—is consistent with the original answer’s conclusion about reduced exposure or strategic adjustment. The LLM adds slightly more specificity by referencing 'notional positions' and 'initial-margin requirements,' which is a reasonable inference but not explicitly confirmed in the ground truth. This minor extrapolation prevents a perfect 10 but does not undermine accuracy. 4) All entities (ExxonMobil, collateral under master netting arrangements, time period 2022–2024) are correct, and the answer fully addresses both parts of the question: the change over time and its implication for derivative exposure and margin requirements. The synthesis across years is accurate and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 363,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom’s industrial fiber‑optic offering moved from a peripheral component listed alongside optocouplers and sensors (2022, pp. 8‑12) to a central element of its industrial‑automotive suite, explicitly tied to high‑speed, secure connectivity for AI data‑centers, renewable‑energy systems and automotive electronics (2023‑2024, pp. 3‑7). This evolution signals a strategic pivot toward higher‑margin, system‑level industrial solutions that combine fiber‑optic hardware with custom silicon and software, underscoring Broadcom’s focus on expanding its industrial infrastructure footprint.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Broadcom's positioning of Industrial Fiber Optics. While the ground truth states that in 2022, Industrial Fiber Optics was part of a broad industrial suite used across multiple applications (industrial automation, power systems, medical, defense, aerospace, automotive), the LLM incorrectly characterizes it as a 'peripheral component'—a subjective and unsupported downgrade in positioning. The claim that it became a 'central element' tied to 'AI data-centers' by 2023–2024 is not supported by the original answer; AI data centers are not mentioned in the context of industrial fiber optics in the ground truth, and this represents a major misattribution. The original answer emphasizes structured presentation and integration with semiconductor solutions, not software or system-level solutions combining hardware with custom silicon and software. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is flawed: the LLM fails to accurately track the evolution across years. It misrepresents the 2022 positioning, invents a strategic pivot not present in the original, and introduces new applications (AI data centers) not in the source. The synthesis across years is therefore invalid. (4) Contextual relevance is moderate—the answer addresses Broadcom’s industrial strategy and attempts to trace evolution, so it stays on topic, but introduces irrelevant elements (AI data centers, software integration) that distort the actual strategic focus on clearer, application-specific communication and integration within semiconductor solutions. The core idea of increasing focus is partially aligned, but the reasoning and evidence are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 507,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nPayPal’s margin risk stayed essentially constant from 2022 through 2024: it continues to act as the principal in each payment, sets the transaction fee independently of any third‑party processor costs, and records those processor fees as transaction expense, thereby shouldering the full margin risk.  The 2023‑2024 disclosures added more detail to incentive accounting—performance‑based incentives are deducted from revenue when earned and non‑performance incentives are amortized over the contract term—but they do not change the fundamental fact that PayPal controls pricing and bears the margin risk on every payment transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. It correctly states that PayPal maintained full control over pricing, acted as principal in transactions, recorded third-party processor fees as transaction expenses, and thus bore full margin risk throughout 2022–2024. The quantitative accuracy is perfect—no numerical data is incorrect or miscalculated (though no explicit numbers like dollar amounts are involved, the temporal references to 2022–2024 are correct). The qualitative accuracy is high: the model correctly synthesizes the multi-hop concept of margin risk exposure in relation to pricing discretion and third-party processor use across years. It even adds a relevant detail about incentive accounting in 2023–2024 that is consistent with typical SEC disclosures and does not contradict the ground truth. This additional detail does not detract from accuracy but slightly shifts focus; however, the core conclusion about unchanged margin risk is preserved. The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in PayPal's margin risk. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes the year-by-year reaffirmation more explicitly, while the LLM generalizes across the period—still correct, but slightly less precise in structure. Overall, the semantic equivalence is strong and the reasoning sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 403,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nAfter selling Meridian in December 2021, Pfizer’s only remaining ties were short‑term transition‑service agreements that were fully completed by the end of 2023 and a three‑year master‑service agreement whose financial impact was immaterial, so that by 2024 the company had no material contractual or revenue obligations to Meridian. This evolution reflects Pfizer’s strategic shift away from legacy medical‑device assets and toward its core biopharmaceutical and mRNA‑vaccine focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the sale of Meridian in December 2021 and the immaterial financial impact of the ongoing agreement, aligning with the ground truth that Pfizer recognized a $167 million net loss from the sale and received $51 million in cash. However, the LLM incorrectly states that transition-service agreements were completed by the end of 2023 without mentioning the Manufacturing Supply Agreement (MSA) with a three-year term and two-year extension option explicitly, which is a key contractual detail in the original answer. The LLM refers to a 'master-service agreement' rather than the correct 'Manufacturing Supply Agreement (MSA)', introducing a minor entity/term inaccuracy. (2) Quantitatively, the answer omits the specific figures of $51 million sale price and $167 million loss, which are central to the financial impact assessment. While it correctly implies the deal was closed before 2022, the lack of explicit numbers reduces quantitative completeness. The date of sale (December 2021) is accurate. (3) The reasoning correctly infers Pfizer’s strategic shift away from legacy medical-device assets toward biopharmaceuticals and mRNA, which is consistent with the ground truth. However, it fails to mention Meridian’s appearance in the 2024 glossary as 'Meridian Medical Technologies, Inc.', missing a data point that supports formalized post-sale recognition. This weakens the multi-hop synthesis across 2022–2024. (4) Despite missing some specifics, the LLM captures the overall trajectory and strategic rationale accurately, making the answer contextually relevant and largely correct in substance. The omission of key financial figures and contractual details prevents a higher score, but core facts and directionality are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 484,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory landscape grew markedly more restrictive: each year’s filing notes a steady expansion of bans on advertising and sponsorship, mandatory plain‑packaging and larger health‑warning requirements, and explicit limits on any claims that differentiate reduced‑risk products (RRPs/SFPs) or on the “truthful and non‑misleading” information that can be shared with adult consumers.  Consequently, the competitive edge PMI built on product‑specific branding and consumer‑education campaigns for its heated‑tobacco and other RRPs has been eroded—its ability to signal differentiation is now curtailed by law, forcing the company to compete largely on generic brand loyalty and price rather than on the scientific or lifestyle benefits it previously could communicate.  This tightening of product‑differentiation and communication rules has diminished PMI’s ability to convert adult smokers to its reduced‑risk offerings and has increased the risk that its RRP portfolio becomes commoditized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolving regulatory pressure on Philip Morris International (PMI) from 2022 to 2024 regarding restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs) and later smoke-free products (SFPs). While the original answer emphasizes a progression in language—'RRPs' in 2022–2023 shifting to 'SFPs' in 2024—the LLM answer synthesizes this trend effectively by describing a 'steady expansion' of restrictions across the years, including advertising bans, plain packaging, and limits on truthful communication. These details are consistent with the ground truth, even if the year-by-year linguistic shift (RRPs to SFPs) is not explicitly called out. The LLM correctly identifies the core consequence: erosion of PMI’s competitive edge based on branding and consumer education, leading to commoditization risks. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (PMI, RRPs/SFPs, adult consumer communication, product differentiation) are correctly identified. The reasoning is sound and reflects multi-hop synthesis across the three years. The only minor shortcoming is the lack of explicit mention of the terminology shift from RRPs to SFPs in 2024, which is a nuance present in the original answer but not critical enough to undermine the overall correctness. Hence, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 414,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of collateral that ExxonMobil posts under master‑netting arrangements—recorded in the “Notes and accounts receivable – net” line—declined sharply: $1,494 million in 2022, $800 million in 2023 and $491 million in 2024.  This roughly two‑thirds reduction signals that the company’s derivative counterparties now require far less security, reflecting tighter netting terms and/or improved counter‑party credit quality, and demonstrates that ExxonMobil’s risk‑management practices have become more efficient at limiting collateral exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. The description of a 'sharp decline' and 'roughly two-thirds reduction' is quantitatively accurate: from $1,494M to $491M is a 67.1% decrease, which qualifies as roughly two-thirds. 2) All numbers are correct and properly attributed to the right years and financial line item ('Notes and accounts receivable - net'). Calculations and comparisons (e.g., magnitude of decline) are reasonable and support the narrative. 3) The multi-hop reasoning is sound—synthesizing the trend across three years and linking it to derivative risk management practices. The LLM correctly infers reduced collateral requirements reflect changes in risk management, though it emphasizes 'improved counter-party credit quality' and 'tighter netting terms' more than the original, which focuses on ExxonMobil's own strategic reduction. This is a valid interpretation but slightly shifts emphasis from the company's proactive strategy to external factors. 4) The answer is semantically equivalent in factual content and highly relevant, addressing both the quantitative trend and its implication for risk management. The only minor deviation is in interpretation nuance, not factual error, warranting a high but not perfect qualitative score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 382,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected volatility input in the relative‑TSR performance‑award model fell sharply from roughly 28–29 % for grants made in 2023 (the figure derived from the three‑year historical volatility used for 2022‑year data) to just 18.7 % for grants made in 2024.  This decline of about 10 percentage points shows that the company now expects its stock price to be far less volatile relative to its predefined peer group, indicating a reduced perception of market risk over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Duke Energy's expected volatility was 26.9% in 2022, increased to 28.6% in 2023, and then dropped to 18.7% in 2024. The LLM incorrectly states that the volatility for 2023 was 'roughly 28–29%' based on 'three-year historical volatility used for 2022-year data,' which misrepresents both the timing and source of the assumption. It omits the correct 2022 figure (26.9%) and conflates historical inputs with forward-looking assumptions. The 2024 value (18.7%) is correctly reported. (2) The calculation of a '10 percentage point' decline is approximately correct (from ~28.6% to 18.7% is a 9.9-point drop), but the baseline is misrepresented since the LLM skips the 2022 starting point and mischaracterizes the 2023 value. (3) The reasoning partially captures the multi-hop trend—decreasing volatility suggesting lower perceived market risk—but fails to acknowledge the increase from 2022 to 2023, which is a key nuance in the original answer. This omission weakens the accuracy of the trend interpretation. (4) Despite these issues, the LLM correctly identifies the core concept—declining expected volatility implying reduced market risk—and focuses on the right company, metric, and time frame. The final conclusion aligns semantically with the ground truth, but the flawed intermediate data points reduce overall correctness. Hence, a score of 6 is justified: partially correct with significant factual errors in the quantitative evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 426,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nThe 3.125 % senior notes that mature in January 2025 have kept a constant $495 million principal balance in each of the last three fiscal years (2022‑2024), appearing in the current‑portion schedule as part of the $1.245 billion of scheduled 2025 repayments (page 83).  Rather than retiring that near‑term obligation, Broadcom chose to refinance its short‑term debt profile in 2024—issuing $10 billion of new senior unsecured notes in July and October 2024 and using the proceeds to retire $11.2 billion of term‑A‑2 loans and $5.6 billion of term‑A‑3 loans (page 82).  This roll‑over strategy shows that the company is managing its short‑term debt by extending maturities and tapping the capital markets for longer‑dated financing instead of paying off the 3.125 % notes directly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Broadcom's 3.125% notes due January 2025. According to the ground truth, the obligation was $495 million in 2022 and 2023 but transitioned to the current portion of long-term debt in 2024, indicating it was approaching maturity. However, the LLM claims the principal balance remained constant at $495 million in all three years including 2024, which contradicts the ground truth that implies reclassification in 2024 as a current liability—suggesting a change in presentation even if not in principal. (2) The LLM introduces specific refinancing actions—issuing $10 billion in new notes and retiring $11.2 billion and $5.6 billion in term loans—with page references. These details are not present in the original answer and cannot be verified against the ground truth provided; thus, they represent unconfirmed additions that may be hallucinated or pulled from external data not in the knowledge graph. The $1.245 billion scheduled 2025 repayment is also new and unsupported by the original answer. (3) The multi-hop reasoning is partially sound: the LLM infers a refinancing strategy, which aligns with the original conclusion about liquidity planning. However, it overreaches by asserting a specific 'roll-over strategy' with detailed transactions not confirmed in the ground truth, undermining factual accuracy. (4) While the core idea—that Broadcom managed short-term debt through refinancing rather than repayment—is thematically consistent, the incorrect portrayal of the note's stability into 2024 and the inclusion of unsupported financial figures reduce correctness. The answer is contextually relevant and well-structured, but quantitative inaccuracies drag down the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 484,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nAMD continued to shield its AIB partners’ inventory with contractual price‑protection and return‑right clauses, and from 2022 through 2024 it layered additional co‑marketing reimbursement programs to spur AIB adoption of its discrete GPUs.  Across the same period the company broadened the role of discrete graphics as a differentiation lever—from a gaming‑focused advantage for system integrators to a cross‑segment differentiator in client, data‑center and embedded platforms, using Radeon PRO and Instinct accelerators to showcase performance‑per‑watt and AI‑ready capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces unverified claims not supported by the ground truth, affecting factual accuracy. (1) Correct elements: The emphasis on inventory protection through price-protection and return rights aligns with AMD's stated policy of shielding AIB inventory from price reductions, and the general strategic importance of discrete graphics is consistent across years. The mention of discrete graphics as a differentiation tool is also supported. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, or revenue figures) in either the original or LLM answer, so no numeric inaccuracies are present—this aspect is neutral but does not detract. (3) Multi-hop reasoning issues: The LLM incorrectly asserts the addition of 'co-marketing reimbursement programs' and a strategic 'broadening' of discrete graphics into data-center and embedded platforms using Radeon PRO and Instinct accelerators. The original answer notes no such expansion or new programs; instead, it emphasizes consistency in AMD’s AIB strategy and support without explicit new initiatives. The ground truth does not mention AI-ready capabilities or performance-per-watt messaging in this context. (4) The LLM answer improves contextual relevance by framing discrete graphics as a cross-segment differentiator, which is plausible but not explicitly confirmed in the provided truth. However, the introduction of unsupported programmatic and strategic shifts reduces qualitative accuracy. While the core idea of inventory protection and differentiation via discrete GPUs is correct, the added details constitute significant overreach, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 460,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nFrom 2022 through 2024 Disney shifted its DTC play‑book from a rapid‑launch phase to a capital‑intensive, content‑driven growth model.  It began directing a larger share of its rising capex—projected to climb from $5 bn in 2024 to roughly $8 bn in 2025—into streaming‑specific technology, cruise‑ship and park expansions, and the acquisition of sports and exclusive rights that feed the Disney+, Hulu and ESPN+ platforms, while also rolling out an ad‑supported tier and bundling options to differentiate itself in a market crowded with Netflix, HBO Max, Amazon and others.  The company now expects subscription‑fee and advertising revenues from these services to deliver modest double‑digit growth and eventually offset declines in linear‑network revenue, but it acknowledges that DTC losses will persist in the near term and that execution risk remains as costs continue to rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Disney's DTC strategy from cautious investment to a more aggressive, content-driven model, and correctly identifies competitive pressures and expectations for revenue growth offsetting linear declines. However, it introduces specific numerical claims not present in the original answer, such as capex rising from $5B in 2024 to $8B in 2025 and 'modest double-digit growth' in revenues—these figures are unsupported by the ground truth and thus factually inaccurate. (2) Quantitative accuracy is low because the original answer contains no dollar amounts or growth percentages; the LLM fabricates precise capex projections and growth expectations, which cannot be verified from the source. There are no calculations in the ground truth to validate, but the introduction of false numbers undermines factual reliability. (3) Qualitatively, the reasoning is sound in identifying the shift in strategic tone—from risk awareness in 2022 to confidence in growth levers by 2024—and correctly notes competitive dynamics and bundling/ad-tier strategies. It aligns with the multi-hop progression across years and reflects Disney’s increasing operational dependence on DTC despite losses. However, it adds details (e.g., cruise-ship and park expansions tied to DTC) that are not mentioned in the original and may conflate broader corporate investments with DTC-specific ones. (4) Contextual relevance is high because the response directly addresses investment focus, competitive positioning, and revenue growth expectations across the 2022–2024 timeframe. While the core narrative arc matches the original, the inclusion of unverified financial data reduces overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 478,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal continued to hold the Fixed‑rate 2.850 % notes that were originally issued in September 2019 with a $1.5 billion principal amount and a maturity of 1 Oct 2029; the outstanding balance remained $1.5 billion in both 2022 and 2023 and was still $1.5 billion as of the 2024 filing, so no new issuance or repayment of that specific tranche occurred.  These notes are senior unsecured obligations that pay interest semi‑annually at an effective rate of about 2.96 % and are scheduled to be repaid in full in 2029, representing the largest single term‑debt component of PayPal’s $10.6 billion long‑term debt portfolio.  Consequently, the company’s debt structure shows the 2.850 % series as a long‑term liability that will not mature until 2029, while current principal payments in the near term relate to other note series rather than the 2.850 % notes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PayPal's 2.850% notes remained outstanding at $1.5 billion from 2022 through 2024 with no repayments or changes, and correctly states the maturity date of October 1, 2029. It accurately notes the notes were issued in September 2019 and are senior unsecured obligations with semi-annual interest payments. However, the LLM omits key details from the original answer about the evolution of PayPal’s broader debt structure—specifically, the total term debt amounts of $9.0 billion in 2022, $10.638 billion in 2023, and $10.574 billion in 2024. While it mentions the $10.6 billion long-term debt portfolio in 2024, it does not show the year-over-year change or the context of increasing then slightly decreasing debt. Additionally, the LLM fails to mention the issuance of new higher-interest debt in 2024 (5.150% and 5.500% notes), which is a critical part of the evolving financing strategy highlighted in the ground truth. (2) Quantitative accuracy is high: $1.5 billion principal, 2.850% coupon, 2.96% effective rate, and 2029 maturity are all correct. The $10.6 billion figure in 2024 is approximately correct (vs. $10.574 billion), but the lack of precise year-by-year totals and trends reduces completeness. (3) The reasoning is sound in tracking the specific note series over time and correctly identifying it as a long-term liability unaffected by near-term maturities. However, the multi-hop synthesis is incomplete—it captures the static nature of the 2.850% notes but misses the dynamic changes in the broader debt portfolio and strategic shift implied by issuing higher-rate debt. (4) The answer is highly relevant and factually accurate on the specific notes, but loses points on completeness and qualitative depth due to missing comparative debt figures and strategic context. Hence, correctness is reduced to 8 for partial omission of key multi-hop elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 520,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nFrom 2022 to 2024 the fair‑value exposure to corporate stock in UNP’s pension plan dropped dramatically – from about **$2.2 billion (≈64 % of total plan assets) in 2022** to roughly **$0.18 billion (just over 5 % in 2023 and ≈4 % in 2024)**.  This sharp pull‑back from public equities reflects a deliberate de‑risking shift: the plan has moved most of its assets into higher‑quality debt and other lower‑volatility holdings, consistent with its target allocation of roughly 20‑30 % equity and 70‑80 % debt and its goal of achieving a stable long‑term return of about 5.25 %.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UNP's allocation to Corporate Stock was $1,990 million in 2022 and $181 million in 2023, but the LLM reports $2.2 billion in 2022 and $0.18 billion (i.e., $180 million) in 2023. While the 2023 figure is close, the 2022 value is notably overstated. Additionally, the LLM introduces percentages (64% in 2022, 5% in 2023, 4% in 2024) and total plan asset allocations that are not present in the original answer and cannot be verified from the provided ground truth. There is no mention in the ground truth about equity being 64% of total assets or the target allocation of 20–30% equity; these are unsupported additions.\n\n2) The LLM correctly identifies the dramatic decline in corporate stock holdings and the continuation of low equity exposure into 2024, which aligns with the direction of the ground truth. However, it omits the key qualitative shift noted in the original answer: the reclassification of common stock to Level 1 and the use of preferred shares classified as Level 2. This is a critical detail about valuation methodology and structured equity exposure that the LLM fails to mention, representing a significant omission in the strategic rationale.\n\n3) The reasoning partially captures the de-risking theme, which is consistent with the ground truth’s implication of reduced equity exposure. However, the LLM extrapolates beyond the data by introducing specific target allocations (70–80% debt) and a long-term return goal of 5.25%, none of which are in the original answer. This suggests over-inference or use of external knowledge not supported by the provided truth.\n\n4) While the general trend (sharp reduction in equities) is correctly identified, the answer distorts the magnitude in 2022, fabricates percentage breakdowns and strategic targets, and misses the key point about investment classification (Level 1 vs Level 2) and the shift to preferred shares. Thus, despite capturing the broad direction of the strategy, the answer lacks fidelity in numbers and misses a core element of the multi-hop insight regarding valuation transparency. The contextual relevance is high because it addresses the evolution and strategic implication, but correctness is compromised by unsupported figures and omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 618,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings (reported as “Private equity securities at cost”) fell from **$800 million in 2022 to $755 million in 2023 and then to $719 million in 2024**, a cumulative decline of about **$81 million** over the two‑year span.  This steady reduction indicates that the company is **scaling back its exposure to illiquid alternative investments**, likely to preserve cash and liquidity and to refocus capital toward its core pharmaceutical operations and other strategic priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million (a $177 million overstatement), while correctly reporting the 2023 ($755M) and 2024 ($719M) figures. This error fundamentally misrepresents the trend as a continuous decline, when in fact there was a significant increase from 2022 to 2023. (2) The calculation of an '$81 million' cumulative decline is incorrect: the actual decline from $800M to $719M would be $81M, but since the real starting point is $623M, the net change is an increase of $96M over the period. The correct two-year change is +$96M, not -$81M. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the strategic implication of the trend, but because the underlying data is wrong, the conclusion is flawed. The ground truth suggests a short-term growth strategy followed by cautious retrenchment, while the LLM infers a consistent scaling back, which is not supported by the actual data. (4) Despite the factual errors, the answer is contextually relevant—addressing both the numerical trend and strategic interpretation—and uses the correct metric and company. The qualitative reasoning structure is logical, just based on incorrect inputs, warranting moderate scores for qualitative accuracy and contextual relevance. However, the severe quantitative inaccuracy heavily penalizes the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 463,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by formalizing third‑party collaborations—working with issuers, acquirers, governments, central banks, fintechs and industry groups to co‑develop EMV, tokenization and other standards and to run joint threat‑monitoring and assessment programs.  At the same time it expanded real‑time payment infrastructure, rolling out Mastercard Send, Alias‑Based Remittances and VCN integrations and scaling real‑time clearing and settlement to 13 markets by end‑2023 and to a global network of >10 billion endpoints by 2024.  These initiatives are underpinned by a hardened cyber‑resilience framework that includes dedicated Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, AI‑driven governance and regular third‑party testing to maintain continuous protection against evolving cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Key elements such as the multi-layered security approach (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center), third-party collaboration, real-time payment expansion, and cyber resilience are all correctly addressed. (2) Quantitatively, the LLM correctly states that real-time clearing and settlement was scaled to 13 markets by end-2023, matching the original answer. The mention of 'a global network of >10 billion endpoints by 2024' is not explicitly in the ground truth but does not contradict it and may reflect additional detail from the filings; since it's plausible and not factually incorrect, it doesn't reduce accuracy. (3) The multi-hop reasoning is sound: the answer synthesizes evolution across years (2022–2024), integrates third-party collaboration, infrastructure growth, and threat resilience, and correctly links these to Mastercard’s strategic direction. (4) Minor difference: the original emphasizes a progressive inclusion of third parties in threat monitoring (explicit in 2023, deepened in 2024), while the LLM implies continuity from the start; however, the LLM still captures the essence of growing collaboration. Overall, the answer is semantically equivalent, factually correct, and contextually complete—justifying a high score with only a slight deduction for potential overstatement of endpoint scale without explicit confirmation in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 407,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in the “Other assets, including intangibles – net” line—has been shrinking steadily: $1.49 billion at the end of 2022, $0.80 billion in 2023 and $0.49 billion by the end of 2024. This decline signals that the company has been trimming the external security it must post, reflecting tighter credit relationships, greater use of cleared derivatives and a more efficient management of its derivative counterparty risk over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and time periods. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). The LLM incorrectly states $1.49 billion in 2022, $0.80 billion in 2023, and $0.49 billion in 2024. The $1.49 billion figure does not appear in the ground truth and is a major error. Additionally, the LLM refers to 'end of 2024' as a data point, but the latest available data is for the end of 2023 (reported in the 2024 filing), so projecting to 'end of 2024' is incorrect. (2) The calculation of a 38% decrease from 2022 to 2024 in the original answer is based on $800M to $491M, which is accurate. The LLM does not provide a percentage but implies a steady decline, which misrepresents the actual trend (increase from 2021 to 2022, then decrease). (3) The multi-hop reasoning is flawed because the LLM uses incorrect base data and timeframes. It fails to correctly identify that the reported figures are lagged (e.g., 2022 filing reports 2021 data), leading to a misalignment of years. (4) While the qualitative interpretation about derivative risk management is plausible and contextually relevant, the incorrect data undermines the reasoning. The conclusion about 'tighter credit relationships' and 'cleared derivatives' is speculative and not supported in the ground truth, which only suggests reduced margin requirements or strategic adjustments. Thus, the answer is partially relevant but factually unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 460,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe expected volatility embedded in Duke Energy’s relative‑TSR performance‑award model fell from roughly 28‑29 % in 2022‑23 to about 18.7 % in 2024—a drop of roughly 10 percentage points. This multi‑year decline indicates that the market’s perception of Duke Energy’s risk of large price swings has diminished, pointing to greater stability or lower uncertainty about its relative performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 18.7% volatility in 2024 and the general trend of decrease from 2022–2024, but inaccurately represents the 2022 and 2023 values. The ground truth specifies 26.9% in 2022 and 28.6% in 2023, whereas the LLM states 'roughly 28–29%' for '2022–23', which conflates the two years and overstates the 2022 figure. This is a notable quantitative inaccuracy. (2) The calculation of a 'drop of roughly 10 percentage points' is approximately correct: from 28.6% in 2023 to 18.7% in 2024 is a 9.9-point drop, so rounding to 10 is acceptable. However, the baseline is misrepresented by averaging or lumping 2022 and 2023. (3) The multi-hop reasoning is sound—the LLM correctly infers that declining volatility suggests reduced market risk perception and greater stability, which aligns with the ground truth's interpretation. It synthesizes the trend and its implication correctly despite imperfect input numbers. (4) The answer is contextually fully relevant, addressing both the change in volatility and its implication for market risk perception. Due to the misrepresentation of annual values (though direction and magnitude of change are mostly preserved), quantitative accuracy is reduced, but qualitative and contextual performance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 362,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the size of GM’s indemnification liability to Stellantis for the former Opel/Vauxhall business did not change materially – the contractual obligation still covers potential emissions‑related lawsuits in Europe and any future Takata‑inflator recalls of legacy Opel vehicles, but GM repeatedly stated that it **cannot estimate a reasonably possible loss** and therefore has recorded only an **immaterial (or zero) accrual** for these matters.  Consequently, while the indemnity provisions remain in force and are subject to time‑limits, caps and thresholds, the accrued liability related to those emissions claims and Takata recalls stayed negligible throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and Takata recalls remained immaterial from 2022 to 2024, with no significant accruals recorded. The key qualitative points — that the liability was consistently described as immaterial, that future obligations were considered remote (especially for Takata), and that the indemnity provisions remain contractually in place — are all present and correctly represented. (2) There are no specific numerical values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; the use of 'immaterial' and 'zero accrual' aligns with the original's 'immaterial amount' and 'remote' likelihood. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), entities (GM, Stellantis, Opel/Vauxhall), and issues (Takata recalls, European emissions investigations), correctly noting the continuity in GM’s disclosures. (4) The only minor deviation is that the LLM does not explicitly mention the 2024 accrual related to the European Commission and UK CMA investigations, which the original answer includes as a distinct immaterial accrual. While the LLM refers broadly to emissions-related lawsuits, it could have been more specific about regulatory investigations being the basis of the accrual. This omission is minor given the emphasis on immateriality, but prevents a perfect 10. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 467,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD continues to incorporate the **2011 Executive Incentive Plan** in the same manner across all three filings—referencing it as Exhibit 10.1 (or 10.2) in the 2022, 2023 and 2024 Form 10‑K/10‑Q documents and repeating the identical incorporation language from the original 2011 filing. This repeated, unchanged citation shows that the plan remains the cornerstone of AMD’s executive‑compensation framework, indicating a deliberate, long‑term strategy that relies on a stable, pre‑existing incentive structure rather than introducing new compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD referenced the 2011 Executive Incentive Plan as Exhibit 10.1 in its 2022, 2023, and 2024 filings, with unchanged language, indicating no amendments. The LLM correctly notes the consistent citation across years and the use of the same incorporation language. (2) Quantitative accuracy is perfect: the years (2011, 2022, 2023, 2024), exhibit numbers (10.1 or 10.2), and document types (Form 10-K/10-Q) are correctly stated. Minor variation in exhibit number (10.2 mentioned) may reflect different document types but does not contradict the ground truth, which focuses on 10.1 in 10-Ks. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the unchanged references suggest a stable, long-term executive compensation strategy. (4) The answer captures the semantic meaning of the original, though it adds slight interpretive language (e.g., 'cornerstone', 'deliberate strategy') that is reasonable but not explicitly in the ground truth. This justifies a 9 instead of 10 in qualitative accuracy due to minor extrapolation. Contextual relevance is perfect—the response directly addresses the evolution and strategic implication as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 366,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk grew as its credit products and cross‑border volumes expanded and its reliance on third‑party banks, payment processors and BNPL funding sources deepened, raising defaults, charge‑offs and fraud losses; in 2023 it mitigated this risk by entering a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL loan receivables and a forward‑flow facility for future originations, while diversifying its payment‑processor network and migrating transactions to reduce dependence on any single processor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's increasing exposure to bad transaction risk through credit products, cross-border trade, and third-party dependencies is accurately described for 2022–2024. The 2023 strategic action—entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables—is correctly stated, including the amount and scope. (2) Quantitative accuracy is perfect: the €40 billion figure matches the original, and no incorrect numbers are introduced. Format (€40 bn) is acceptable. (3) Multi-hop reasoning is sound: the answer synthesizes risk evolution across years, links credit products (especially BNPL) to bad transaction exposure, identifies third-party dependencies, and correctly highlights the 2023 receivables sale as a mitigation. It adds a detail not in the original—'forward-flow facility for future originations' and 'diversifying payment-processor network'—which are plausible and contextually consistent, though not explicitly confirmed in the ground truth. These additions do not contradict but slightly extend the original; they are not penalized as they enhance completeness without introducing error. (4) The only minor shortcoming is that the original emphasizes regulatory uncertainty and loan sale validity post-transfer in 2024, which the LLM omits. However, the core evolution and mitigation are fully captured. Thus, the answer is factually correct, contextually relevant, and semantically equivalent with minor elaboration. Scores reflect high accuracy with near-perfect qualitative and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 452,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Multiple‑Purpose Locomotive fleet was trimmed modestly – total units fell from about **7,008 (5,971 owned + 1,037 leased) in 2022 to roughly 6,893 (5,973 owned + 920 leased) in 2023‑24** – while the share of owned locomotives edged up and the leased share fell.  At the same time the **average age rose from roughly 24.3 years to 25.2 years**, indicating that the remaining locomotives are, on average, older but that Union Pacific is relying more on its owned core and less on external lease sources.  This pattern shows a fleet‑management strategy that prioritizes **steady, cost‑controlled modernization**—maintaining a reliable owned base, selectively replacing the oldest units, and using capital‑expenditure programs to refresh equipment only as needed rather than pursuing a large‑scale fleet expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in numbers, particularly in the 2022 total fleet count and average age. According to the ground truth, Union Pacific had 6,204 owned and 1,038 leased Multiple Purpose Locomotives in 2022, totaling 7,242 units—not 7,008 as stated. The LLM incorrectly reports 5,971 owned in 2022, but the correct number is 6,204, a significant discrepancy of 233 units. The leased count (1,037 vs. 1,038) is nearly correct. In 2023–2024, the LLM correctly identifies 5,973 owned and 920 leased units. However, the answer lumps 2023–2024 together without specifying 2024 data, and implies the total drop is to 6,893 by 2023–24, which is misleading. 2) The average age in 2022 is reported as 'roughly 24.3 years' by the LLM, but the ground truth is 22.5 years—a material error of 1.8 years. The 2024 age (25.2 years) is correctly reported. This miscalculation undermines the accuracy of the aging trend analysis. 3) The qualitative reasoning about fleet strategy—prioritizing cost control, reducing leasing, and favoring owned assets—is logically sound and aligns with the ground truth. The interpretation of a 'steady, cost-controlled modernization' is semantically similar to 'prioritizes cost control over aggressive modernization.' However, the flawed input data weakens the validity of the conclusion. 4) The answer addresses all parts of the question (ownership changes, aging, strategic implications), so it is contextually relevant and complete in structure. Despite incorrect base figures, the direction of change (decreasing leased units, increasing average age) is correct, and the synthesis across ownership and age trends is reasonable. The core strategy interpretation is plausible but based on inaccurate data. Quantitative accuracy is low due to key number errors; qualitative and contextual scores are higher due to correct directional trends and logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 515,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nThe collateral required under master‑netting arrangements for equity‑company receivables fell from roughly $1 billion in 2022 to $491 million in 2024 (down from $800 million in 2023). This reduction shows that ExxonMobil is decreasing its reliance on posted collateral, indicating a more efficient derivative‑risk management approach that leans on credit limits and clearing mechanisms rather than large collateral balances.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it states that collateral exposure was 'roughly $1 billion' in 2022, while the ground truth is $641 million. This overstates the 2022 figure by over 50%, which is a material inaccuracy. The 2023 ($800 million) and 2024 ($491 million) figures are correct. (2) Calculations and comparisons are partially accurate — the direction of change (increase then decrease) is correct, and the final drop from $800M to $491M is properly noted. However, the incorrect 2022 baseline undermines any trend analysis relying on that year. (3) The multi-hop reasoning is sound in structure — the model attempts to synthesize changes over time and infer strategic implications — but the flawed input data weakens the conclusion. The LLM correctly identifies the 2024 decrease and infers improved risk management, but attributes the change to 'decreasing reliance on posted collateral' and 'more efficient derivative-risk management', which goes beyond the evidence. The original answer notes a potential shift but ties it to possible improved credit conditions or reduced exposure, and highlights the continued use of level 3 inputs — a key detail omitted in the LLM response. (4) Contextual relevance is high — the answer addresses both parts of the question (change over time and implications for risk management) and uses appropriate financial terminology. However, the omission of the level 3 fair value input disclosure, present in the original, reduces qualitative accuracy. Overall, the answer captures the general trend but fails on key facts and nuanced interpretation, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 456,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” line – which the 10‑K defines as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware, among other items – was $6.89 bn in fiscal 2022, rose to $7.71 bn in fiscal 2023 and then edged down to $7.54 bn in fiscal 2024.  As a share of total net revenue it held roughly 21 % in 2022, 22 % in 2023 and 21 % in 2024, so the category grew sharply from 2022 to 2023 before a modest pull‑back in 2024 while remaining a stable ~21‑22 % of the business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($6.89B, $7.71B, $7.54B) and percentages (21%, 22%) for the 'Other' category across 2022–2024, which are not present in the original ground truth. The ground truth makes no mention of any numerical values, growth trends, or percentage shares of total revenue. Therefore, these numbers are factually unsupported and incorrect. (2) There is no verification possible for the calculations (e.g., 21% to 22% shift) because the ground truth does not provide total revenue figures or confirm such proportions. The inclusion of precise financial data where none was given in the source constitutes a major quantitative inaccuracy. (3) On qualitative reasoning, the LLM correctly identifies the components of the 'Other' category—packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware—which aligns with the ground truth’s description across years. It also correctly notes stability in the category's relative size, which loosely matches the ground truth’s assertion of no significant shifts. However, the model fails to explicitly confirm that there was no mention of new product categories or structural changes, instead focusing on revenue fluctuations not referenced in the original. (4) Contextually, the answer addresses the evolution of the revenue composition, but conflates revenue size with composition. The question asks about *composition* (i.e., what items are included), not revenue trends. While the entity (Starbucks’ 'Other' category) and time frame (2022–2024) are correct, the emphasis on financial performance misaligns with the intent of the question. Thus, despite some correct descriptive elements, the introduction of fabricated quantitative data and misfocus on revenue magnitude over component makeup significantly undermines factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 512,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet continued to treat Google Network properties as a **principal** for ad inventory and therefore recorded the advertising revenue **gross**—i.e., the full amount billed to advertisers was recognized as revenue and the portion paid to the Network partners was recorded as **cost of revenues**.  The company’s 10‑K filings (pages 30‑31, 58) state that for ads on Network partners it evaluates whether it is the principal or an agent; historically it has consistently reported those revenues **gross**, recognizing impression‑based revenue when the ad is displayed (brand‑type impressions) and cost‑per‑impression as the metric for monetization.  No material change in this methodology was disclosed across the three fiscal years, so the evolution consists mainly of steady gross‑revenue reporting with impression‑based measurement, while TAC and other payments to Network partners remained classified as cost of revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Google (Alphabet) monetized advertising inventory through Google Ad Manager on Network properties using impression-based revenue recognition from 2022 to 2024, with revenue recognized gross—i.e., the full amount billed to advertisers is recorded as revenue. This matches the original answer’s claim about gross revenue reporting and the company’s role as principal. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The reasoning is sound: the LLM correctly synthesizes the accounting treatment over the three years, noting consistency in gross reporting, classification of payments to partners as cost of revenues, and use of cost-per-impression as a monetization metric. It also references the correct evaluation framework (principal vs. agent) used in the 10-K, which supports the multi-hop logic across time and accounting policy. (4) The only minor shortcoming is that the original answer highlights an evolution in transparency and clarification—especially in 2023 and 2024—whereas the LLM emphasizes 'no material change,' which slightly downplays the increasing emphasis on accounting clarity. However, this does not make the answer factually incorrect, as the core policy remained consistent. Overall, the LLM captures the essential facts, entities, time frame, and reasoning with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 427,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nOver the three‑year period MDLZ’s regulatory exposure grew markedly. In 2022 the company highlighted front‑of‑pack labeling and EPR rules that were largely confined to the European Union. By 2023 those requirements had begun to spread to additional jurisdictions—India, Vietnam and several U.S. states were adopting EPR frameworks, and front‑of‑pack labeling mandates were being introduced beyond the EU. In 2024 the firm noted further expansion, with more countries considering plastic‑taxes and other EPR‑related measures, thereby widening the scope of sales‑ and media‑marketing restrictions that MDLZ must navigate.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core trend of increasing regulatory exposure for MDLZ across 2022–2024, particularly regarding EPR policies and front-of-pack labeling, which aligns with the ground truth. It correctly identifies the EU as an early adopter and notes the expansion into India, Vietnam, and U.S. states—consistent with the original answer’s mention of EPR moving from contemplation to implementation in those regions by 2024. The reference to plastic taxes and broader EPR-related measures in 2024 is also supported. However, the LLM answer omits key details present in the ground truth: (1) the specific 2022 figure of 'over 25 EU countries' implementing EPR, (2) the explicit mention of advertising restrictions based on nutrient profiles in 2022, (3) the 2023 emphasis on environmental claims in labeling, and (4) the 2024 formal adoption of the EU’s Packaging and Packaging Waste Directive. Additionally, the LLM incorrectly implies that front-of-pack labeling was largely confined to the EU in 2022, whereas the original answer notes that similar policies were under consideration in several Asian countries. While the overall direction and qualitative evolution are correctly interpreted, these omissions and minor misrepresentations reduce completeness and precision in multi-hop synthesis. Quantitative accuracy is high because no incorrect numbers are stated—only fewer specifics. Contextual relevance is strong as the response directly addresses the evolution of sales and marketing restrictions over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 417,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nClass A shares have kept the same rights throughout 2022‑2024 – they carry one vote per share and full dividend entitlement, while Class B remains non‑voting but still participates in dividends (see the “Classes of Capital Stock” tables on pages 98, 99 and 100).  Dividends per share have risen consistently $2.04 (2022) → $2.37 (2023) → $2.74 (2024) (pages 98‑100), and the voting‑power split (≈ 90 % to public investors, ≈ 10 % to the Mastercard Foundation) has remained essentially unchanged (pages 98‑99).  This stability shows that Mastercard’s capital‑structure strategy is to preserve a dual‑class, controlling ownership regime while steadily increasing cash returns to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly states that A Class shares have one vote per share and dividend rights (consistent with the ground truth), it introduces incorrect quantitative details not present in the original answer or implied by the question. Specifically: (1) The dividend amounts ($2.04 in 2022 → $2.37 → $2.74) are fabricated; the original answer does not provide any specific dividend per share figures. (2) The claim about voting power split (90% to public investors, 10% to Mastercard Foundation) is not mentioned in the ground truth and introduces entities (Mastercard Foundation) and ownership percentages absent from the original. (3) The company referenced in the original answer is 'MA' (assumed to be Mastercard), but the LLM assumes this without confirmation and adds contextual details not supported by the ground truth. The reasoning about a 'dual-class, controlling ownership regime' goes beyond the original answer’s more cautious interpretation of stability indicating consistent capital structure strategy. While the core idea of stability in voting and dividend rights is correctly identified, the addition of unsupported numbers, entities, and strategic interpretations constitutes significant overreach. The answer is contextually relevant and addresses the evolution and implications question, but the quantitative inaccuracies and unsupported synthesis reduce its correctness substantially.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 409,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that the company posts under master‑netting arrangements for the “Investments, advances and long‑term receivables” line fell sharply—from about **$1.5 billion in 2022 to $0.8 billion in 2023 and then to $0.5 billion in 2024**.  This downward trend indicates that ExxonMobil’s derivative exposure linked to those assets has been reduced, and consequently its margin‑requirement burden has eased, reflecting smaller net positions and/or more favorable counterparty treatment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. The ground truth states that collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM claims $1.5 billion in 2022, $0.8 billion in 2023, and $0.5 billion in 2024—overstating the 2022 value by more than double and misrepresenting the trend magnitude. While the direction of change from 2023 to 2024 (decrease) is correct, the 2022 to 2023 increase is misrepresented as a decrease in the LLM answer, which contradicts the actual upward trend in that period. (2) The quantitative inaccuracies are severe: the $1.5B figure for 2022 is not supported by the data ($641M), and although $0.8B is close to $800M, the context of an alleged 'sharp fall' from $1.5B misrepresents the actual year-over-year movement. The 2024 value of $0.5B is approximately correct relative to $491M, but the trajectory is wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the trend: it incorrectly asserts a 'downward trend' from 2022 to 2023 to 2024, when in fact the collateral increased in 2023 before decreasing in 2024. This undermines the conclusion about derivative exposure and margin requirements being consistently reduced. The correct interpretation requires recognizing the spike in 2023 as indicating higher margin demands, followed by a drop in 2024—suggesting volatility in exposure or hedging activity, not a steady decline. (4) Despite incorrect numbers and reasoning, the answer addresses the right metric, company, and time frame, and attempts to interpret the implications for derivative exposure and margin requirements, maintaining contextual relevance. However, due to major factual and directional errors, the correctness score is low at 3, with quantitative accuracy particularly poor at 2. Qualitative accuracy is slightly higher due to correct use of financial concepts, but reasoning is compromised by incorrect data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 547,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks lengthened the horizon of its coffee‑purchase commitments—first projecting adequate supply through FY 2023, then updating the outlook to FY 2024, and finally to FY 2025—while simultaneously expanding its farmer‑support network (e.g., operating ten farmer‑support centers to improve quality and resilience).  This progression reflects a shift from short‑term inventory buffering to a longer‑term, partnership‑focused sourcing strategy that uses forward‑price contracts, agronomy programs and diversified procurement to lock in quality beans and hedge against both price volatility and supply disruptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the directional evolution of Starbucks' supply chain commitments—extending from FY2023 to FY2025—but introduces inaccuracies in the year-by-year progression. The original answer states that in FY2022, commitments were expected to last through FY2023; by FY2023, they were extended to FY2025; and FY2024 maintained that same FY2025 horizon. The LLM incorrectly frames this as a three-step progression: FY2023 → FY2024 → FY2025, implying a continued extension into FY2024, which is not supported by the ground truth. This misrepresents the timeline and suggests an additional extension in FY2024 that did not occur. (2) The LLM mentions 'updating the outlook to FY2024' as an intermediate step, which is factually incorrect—there is no such update in the original; the jump was from FY2023 to FY2025 between FY2022 and FY2023. Additionally, the mention of 'ten farmer-support centers' is not present in the ground truth and cannot be verified, introducing an unsupported detail. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward long-term stability and identifies tools like forward-price contracts and agronomy programs. It accurately links extended commitments and risk mitigation to price volatility and supply risk. However, it overreaches by implying a continuous annual extension when the data shows a one-time extension in FY2023 with maintenance in FY2024. (4) Despite these errors, the core strategic interpretation—that Starbucks is moving toward longer-term, partnership-based sourcing to manage risk—is consistent with the original. The answer is contextually relevant and well-articulated, but the quantitative inaccuracies in the timeline and unsupported details reduce its factual correctness. Hence, a score of 7 is justified: major facts are directionally correct but with significant timeline inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 518,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 ACN’s U.S. defined‑benefit plan moved from a mixed allocation of roughly 95 % debt + 5 % cash (with no equity) to a **100 % debt** stance—eliminating cash, equity, insurance and “other” holdings—while its non‑U.S. plan shifted toward a **higher equity weight (19 % → 28 %)** and a **lower debt weight (43 % → 36 %)**, with only modest changes to cash, insurance and other slices.  \n\nThis multi‑year shift signals ACN’s intent to **align assets more closely with liability cash‑flows, de‑risk the portfolio, and pursue a higher‑quality fixed‑income return profile**, while retaining a modest equity exposure abroad to capture long‑term growth and preserve risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific numerical allocations (e.g., 95% debt + 5% cash in 2023, shifting to 100% debt in 2025 for the U.S. plan; non-U.S. plan shifting from 19% to 28% equity), but the original answer (ground truth) contains no such percentages or asset class breakdowns. There is no mention of eliminating equity or holding only debt, nor any figures about cash, insurance, or 'other' categories. These numbers are fabricated or hallucinated. (2) COMPLETENESS: While the question asks about the evolution of target asset allocation and what it suggests about strategy, the LLM invents granular data that is not present in the ground truth, failing to reflect the actual content. The original answer emphasizes continuity, flexibility ranges, liability matching, and risk-adjusted returns—but without specific percentages. (3) ENTITY & REASONING: The LLM incorrectly implies that detailed asset allocation shifts were disclosed in the filings, when in fact the original answer only references strategic objectives and adaptive management within a consistent framework. The multi-hop reasoning fails because it assumes numerical data exists across years when it does not. (4) SEMANTIC EQUIVALENCE: The general direction—de-risking, liability matching, and balancing returns—is partially aligned with the original's mention of 'liability matching' and 'risk mitigation.' However, this thematic similarity does not compensate for the complete lack of factual support for the specific allocations. The contextual relevance is moderate because the answer addresses the right topic (pension strategy evolution), but the invented metrics severely undermine correctness. Overall, the answer misrepresents the source data and cannot be scored highly on accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 502,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nAmgen kept Olpasiran positioned as a next‑generation siRNA that lowers lipoprotein(a) to reduce atherosclerotic cardiovascular disease, advancing the candidate from early‑phase (Phase 2) work in 2022 toward late‑stage (Phase 3) testing by 2024, as reflected in its inclusion among the company’s Phase 3 programs (page 24).  At the same time, the drug’s composition‑of‑matter patents filed in the United States and Europe are projected to expire in 2036, giving Amgen roughly 12‑14 years of exclusivity after regulatory approval (page 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Olpasiran is an siRNA drug in development for atherosclerotic cardiovascular disease, was in Phase 2 in 2022, advanced toward Phase 3 by 2024, and has U.S. and European composition-of-matter patents expiring in 2036. The dates and patent expiration are factually consistent with the original answer. (2) Quantitative accuracy is perfect: the 2036 patent expiry is correctly stated, and no calculations are required. (3) The multi-hop reasoning is sound—linking clinical development progression (2022 Phase 2 to 2024 Phase 3) with IP strategy shows synthesis across time and domains. The only minor gap is that the original answer specifies the 2024 indication as 'Cardiovascular disease' (broadly), while the LLM emphasizes lipoprotein(a) lowering, which is contextually accurate but slightly more specific than the source. However, this is consistent with Amgen's known mechanism for Olpasiran and does not constitute an error. (4) The answer fully addresses therapeutic focus evolution and IP timeline, making it contextually complete and relevant. Wording differs but semantic meaning matches. No factual inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 344,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party aggregators and processors to acquire merchants and route transactions, expanding the share of its network volumes that are mediated by external partners. In 2022 the filing warned that aggregators could have divergent business interests and that any service failure or data breach could disrupt operations and attract regulatory scrutiny; in 2023 the focus shifted to heightened cyber‑security and operational‑resilience risks, emphasizing that disruptions at service providers could compromise data, trigger investigations and increase governance complexity; and in 2024 the disclosures amplified these concerns, linking third‑party dependence to new regulatory pressures (e.g., Category III status and interchange‑fee caps) and the potential for fines, loss of partner relationships, or reputational damage if oversight or security lapses occur.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of American Express's reliance on aggregators and the associated risks emphasized each year. (1) The answer correctly identifies the increasing reliance on third-party aggregators from 2022 to 2024 and accurately captures the shifting focus of risk disclosures. In 2022, it notes divergent interests and operational risks like service failures and data breaches, which matches the ground truth's concern about aggregators acting against AXP's interests. In 2023, the emphasis on cybersecurity and operational resilience corresponds to the original answer's focus on surcharging, steering, and transaction volume impacts—though the specific risks mentioned (cybersecurity vs. merchant behavior) differ in framing but are thematically consistent with growing operational and dependency concerns. In 2024, the LLM correctly highlights regulatory pressures, fines, and reputational risks, aligning with the ground truth's mention of litigation exposure and regulatory actions. (2) There are no numerical values, percentages, or dates in dispute; all time periods (2022–2024) are accurate, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes evolving risk disclosures across years and correctly infers a trend toward broader systemic and regulatory concerns. However, it slightly misses the ground truth's emphasis on 'merchant steering' and 'surcharging' as key behavioral risks in 2023, instead focusing more on cybersecurity—this is a minor omission rather than an error. (4) The answer is contextually highly relevant, well-structured, and conveys a semantically equivalent narrative of increasing risk awareness. The correctness score is 8 due to this partial mismatch in 2023 risk emphasis, but overall the response is factually solid and nuanced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 508,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks kept its coffee‑price risk management focused on hedging “C”‑price exposure with a mix of forward contracts, futures and collars, but it extended the horizon of its purchase commitments—what had been described as “adequate supply through fiscal 2023” in the 2022 filing was updated to “adequate supply through fiscal 2025” in the 2023 and 2024 reports.  The company continues to note that commodity‑index funds and hedge‑fund activity can affect green‑coffee prices, yet it did not alter its hedging methodology; instead it broadened its forward supply commitments to secure green‑coffee through 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks maintained its hedging strategy using forward contracts, futures, and collars; exposure to commodity index funds was consistently acknowledged; and the forward supply commitment was extended from covering through fiscal 2023 (as stated in 2022) to covering through fiscal 2025 (as updated in 2023 and maintained in 2024). (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024), time horizons (through 2023 → through 2025), and the unchanged nature of the hedging methodology are all correctly reported. Format variations (e.g., 'fiscal 2025' vs 'fiscal 2025') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesized information across three fiscal years and linked the extension of supply commitments to ongoing market volatility from index funds, even without changing hedging instruments. The only minor shortcoming is that the LLM does not explicitly characterize the shift as a 'strategic shift toward longer-term risk mitigation' or note 'increased confidence' as in the original, slightly reducing qualitative depth. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution of exposure to index funds and changes in forward supply commitments. Overall, the answer is factually complete, precise, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 402,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s open‑market share‑purchase authorization expanded markedly—rising from about **$3.1 billion** of authority as of August 2022 to **$6.1 billion** after a 2022 board increase, and then to **$6.7 billion** after a further **$4 billion** boost approved in September 2024.  During the same period the company actually repurchased **≈ $3.1 billion** of shares in FY 2022, **≈ $4.5 billion** in FY 2023 and again **≈ $4.5 billion** in FY 2024, while continuing to raise its quarterly dividend.  This multi‑year trajectory demonstrates that Accenture is deliberately scaling its capital‑return program, using a growing authorized pool to sustain sizable, recurring share buy‑backs alongside steady dividend increases, reflecting a disciplined strategy of returning excess cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported share repurchase amounts and initial authorization figures. According to the ground truth, Accenture repurchased $605 million in fiscal 2023, not $4.5 billion as claimed, and there is no data provided for actual repurchases in FY2022 or FY2024 beyond the $605M in FY2023. The LLM falsely states that Accenture repurchased ≈$3.1B in FY2022 and ≈$4.5B in both FY2023 and FY2024, which is unsupported by the original answer. Additionally, the available authorization in FY2022 was $3,129,296 (~$3.13M, not $3.1B), a discrepancy of three orders of magnitude. The LLM incorrectly rounds this to $3.1 billion instead of $3.1 million. (2) The calculation of total authorization is also flawed: the LLM claims $6.1B after a 2022 board increase, but the original answer does not mention such an increase or figure. While the $4B additional authorization in September 2024 is correct and leads to a total of $6.694B (rounded to $6.7B), the prior steps are fabricated. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize trends across years and link increasing authorizations to capital return strategy, which aligns with the ground truth’s conclusion. However, because the underlying data is incorrect, the reasoning is built on false premises. (4) Contextual relevance is high—the answer addresses the evolution of share repurchases and connects it to capital return strategy, using appropriate terminology and structure. Despite this, the severe quantitative errors undermine the factual correctness, leading to a low overall correctness score. Minor positive note: the mention of dividend increases, while not in the original answer, does not contradict it and reflects plausible context, but cannot offset the major data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 505,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term, lock‑up‑restricted portion of Google’s marketable equity securities grew from **$0.8 billion at the end of 2022 to $1.4 billion at the end of 2023**, and then dropped sharply to **$0.266 billion by the end of 2024** (as disclosed in the 10‑K tables for each year). This rise and subsequent pull‑back shows that Alphabet initially expanded its exposure to illiquid, long‑term equity positions—likely to capture growth opportunities in private‑market investments—but later reduced those holdings, indicating a more conservative or liquidity‑focused investment strategy in the later period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM incorrectly states it grew from $0.8 billion in 2022 to $1.4 billion in 2023, and then dropped to $0.266 billion in 2024—none of which match the original data except the 2023-to-2024 drop direction. The $0.266 billion figure for 2024 is especially erroneous, as it is less than 20% of the correct $1.4 billion. (2) Quantitative accuracy is very low: all three data points are wrong. The 2022 value is off by $0.6 billion, 2023 is correct in the ground truth at $803M but stated as $1.4B in the LLM answer, and 2024 is catastrophically underreported. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed due to incorrect data. While the LLM attempts to interpret strategic shifts—first increasing illiquid holdings, then pulling back—this narrative contradicts the actual cyclical recovery to the original level. The conclusion about a 'conservative or liquidity-focused shift' in 2024 ignores that holdings returned to their 2022 baseline, suggesting rebalancing rather than retrenchment. (4) Contextual relevance is moderate because the answer addresses the right topic (lock-up restricted securities and investment strategy implications) and attempts analysis, but the incorrect data undermines the entire reasoning chain. Semantic equivalence fails due to major numerical and directional discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 445,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE shifted Electric Insurance Company (EIC) from a core captive insurer to a non‑core asset slated for disposal.  After classifying EIC as held‑for‑sale in the fourth quarter of 2022, the company recorded a $109 million pre‑tax write‑down in 2023 and, in the second quarter of 2024, completed the sale to Riverstone International Holdings for $120 million cash, eliminating roughly $376 million of insurance liabilities and $570 million of captive‑investment securities from GE’s balance sheet and generating a modest net gain that was reflected in discontinued‑operations earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core strategic evolution and ultimate disposition of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, correctly identifying the classification as held-for-sale, the $109 million loss in 2023, and the 2024 sale to Riverstone International Holdings Inc. for $120 million in cash. However, there are key quantitative inaccuracies: (1) The LLM states EIC was classified as held-for-sale in Q4 2022, but the ground truth specifies this occurred in 2023; (2) The reported asset and liability figures are inaccurate—LLM claims $570 million in securities and $376 million in liabilities eliminated, while the truth is $541 million in assets and $378 million in liabilities as of Dec 31, 2023; (3) The LLM incorrectly states a 'modest net gain' was recognized, whereas the ground truth confirms a $109 million loss was recorded in 2023, with no indication of a gain upon final sale. The qualitative reasoning is sound—correctly framing the move as a strategic exit from a non-core business and linking it to balance sheet simplification and discontinued operations. The entities (GE, EIC, Riverstone) and timeline (2022–2024) are accurate, and the answer addresses all parts of the question. While the overall narrative is coherent and contextually relevant, the numerical discrepancies—especially the misstatement of the financial impact (gain vs. loss) and timing of classification—reduce quantitative accuracy. Semantic equivalence is mostly preserved, but the financial conclusion is misleading due to the gain/loss error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 429,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nBetween 2022 and early 2025 Amgen’s Phase 3 pipeline swelled from 13 to 25 investigational indications—adding five new Phase 3 studies (e.g., Rocatinlimab for prurigo nodularis, TEPEZZA for thyroid‑eye disease, Xaluritamig for metastatic castration‑resistant prostate cancer, ABP234 biosimilar and BKEMV biosimilar) while a few programs (such as Otezla’s COVID‑19 arm) were dropped or moved to approval.  This growth reflects a deliberate expansion of Amgen’s R&D focus toward high‑value oncology and inflammation biologics, broader biosimilar capabilities, and strategic acquisitions/collaborations, underscoring a pipeline‑centric strategy to diversify and accelerate its future product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeline. The ground truth states that Amgen's Phase 3 programs increased from 13 in 2022 to 24 in 2024, with 18 in 2023, and then reached 25 by 2024. However, the LLM claims growth to 25 by 'early 2025', which misaligns with the 2024 endpoint in the question and original answer. Additionally, the LLM implies a net increase to 25 without acknowledging the correct year-by-year progression (13→18→24→25), and incorrectly frames the growth as reaching 25 at the end of the period when the original answer specifies 24 in 2024 and then 25 later. (2) The quantitative accuracy is compromised: the original answer does not mention 'early 2025' or specify that the total reached 25 in that timeframe; instead, it clearly states 24 programs in 2024 and an additional one added to reach 25. The LLM skips the 2023 figure (18 programs) entirely and misrepresents the timeline. Furthermore, the mention of 'TEPEZZA' is factually incorrect—this is a Horizon Therapeutics drug, not an Amgen program, and its inclusion suggests confusion between acquired assets and internal pipeline. Similarly, attributing Rocatinlimab and Xaluritamig to Amgen is unsupported by the ground truth, which only notes the acquisition of five programs from Horizon without naming them. (3) The reasoning is partially sound: the LLM correctly infers that the expansion reflects a strategic R&D push in oncology, inflammation, and biosimilars, and acknowledges acquisitions as a driver. However, it fails to mention the key factual point about the Horizon acquisition of five programs in 2023, instead listing specific drugs without confirming their origin or relevance. The synthesis across years is weak due to missing intermediate data (2023's 18 programs). (4) Despite these issues, the answer is contextually relevant and captures the essence of pipeline expansion and strategic focus. It correctly identifies the net growth (13 to 25) and interprets it as a sign of R&D intensification. The qualitative reasoning about strategic focus is plausible and aligns with the original answer’s implications, even if specific examples are inaccurate. Thus, while the core narrative is directionally correct, the factual and quantitative errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 616,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from a largely fee‑driven, network‑centric model toward a more regulated and partnership‑focused posture.  The 2024 designation as a Category III bank‑holding company intensified supervisory expectations and forced the company to exit its EU and Australian network‑licensing businesses and to adapt to interchange‑fee caps and stricter oversight of cobrand and agent relationships, while competitive pressure from Visa, Mastercard and fast‑growing fintech rivals prompted Amex to double‑down on premium rewards, digital‑service innovation and joint‑venture arrangements (e.g., GBTG) to preserve its value proposition.  Consequently, its ties to global card networks are now shaped by heightened compliance costs, tighter fee regulation and a strategic shift toward differentiated, data‑rich partnerships rather than pure network expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's relationship with global card networks from 2022 to 2024, aligning well with the ground truth. It accurately identifies the shift from competition to a more regulated, compliance-driven posture, particularly highlighting AXP's exit from EU and Australian network-licensing businesses in 2024 due to regulatory pressures—matching the original answer. The mention of interchange-fee caps and scrutiny over cobrand arrangements reflects accurate synthesis of regulatory dynamics. Competitive pressures from Visa, Mastercard, and fintechs like PayPal (implied in 'fintech rivals') are correctly noted, as is the strategic pivot toward premium rewards and partnerships (e.g., GBTG). However, the LLM introduces the detail about American Express being designated a 'Category III bank-holding company' in 2024, which is not present in the ground truth and cannot be verified from the provided knowledge graph—this is a plausible but unconfirmed regulatory detail that slightly undermines qualitative accuracy. Additionally, while the original answer emphasizes the shift from competition to regulatory dependency, especially in international markets, the LLM frames the change more around supervisory expectations and fee regulation, which is contextually relevant but slightly reframes the causality. There are no numerical figures in either answer, so quantitative accuracy is scored as 10 by default—no discrepancies in dates or numbers. The answer is semantically equivalent in key aspects and fully addresses the question’s focus on regulatory and competitive evolution. Minor deduction in qualitative accuracy due to unverified regulatory classification; otherwise, reasoning is sound and multi-hop synthesis (regulation + competition + strategic response) is well executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 501,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips finished the paced monetization of its CVE common shares—selling the remaining 91 million CVE shares in early 2022 and using those proceeds to fund repurchases—repurchasing 87.7 million of its own shares in 2022, 48.6 million shares in 2023 and an additional 49.1 million shares in 2024.  These actions added to the program’s cumulative total of 433 million shares bought back for a total cost of $34.3 billion through the end of 2024 (up from $29 billion through the end of 2023), after the board increased the share‑repurchase authorization from $45 billion to $65 billion in October 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures, particularly regarding share repurchase volumes in 2022. The ground truth states ConocoPhillips repurchased 383 million shares in 2022 at a cost of $29 billion, but the LLM claims only 87.7 million shares were repurchased in 2022. This is a major discrepancy that undermines the core of the answer. Additionally, the LLM implies that the $29 billion figure was reached cumulatively by the end of 2023, whereas the ground truth states $29 billion was spent by the end of 2022. The cumulative $34.3 billion by end of 2024 and the $65 billion authorization increase in October 2024 are correctly reported. (2) The breakdown of annual repurchases (87.7M in 2022, 48.6M in 2023, 49.1M in 2024) adds up to only ~185.4 million shares, which is far less than the 433 million cumulative total stated—this internal inconsistency reveals flawed reasoning or data sourcing. The ground truth does not provide annual breakdowns beyond 2022, so the LLM’s specific figures for 2023 and 2024 appear to be fabricated or misattributed. (3) The multi-hop reasoning is partially sound in linking CVE monetization to share repurchases and recognizing the progression of capital return, but the failure to accurately represent the scale and timing of repurchases—especially conflating annual vs. cumulative amounts—breaks the logical chain. The mention of using CVE proceeds to fund buybacks aligns with the original narrative, but without correct numbers, the synthesis is misleading. (4) Contextual relevance is high because the answer addresses the evolution across 2022–2024, mentions CVE monetization, share repurchases, dollar costs, and authorization increases. However, due to severe quantitative errors in central metrics, the correctness score is low despite some structural and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 510,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nThe Omnibus Plan’s share reserve fell from roughly 117 million shares available at the start of fiscal 2022 to about 71 million by the end of fiscal 2023, then edged up to roughly 77 million shares by the end of fiscal 2024. This pattern shows that Home Depot has been increasingly tapping its authorized share pool for equity awards, indicating growing utilization of stock‑based compensation and a diminishing reserve of shares for future grants without additional shareholder approval.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical data and trend direction. According to the ground truth, available shares declined from 117 million in 2022 to 77 million in 2023 and further to 70 million in 2024, showing a consistent downward trend. However, the LLM incorrectly states that shares fell to 71 million by end of 2023 and then 'edged up' to 77 million in 2024, which reverses the actual trend. This misrepresents the evolution of share availability. (2) The numbers are quantitatively inaccurate: the 2023 figure is off by 6 million (71M vs correct 77M), and the 2024 figure is wrong both in value (77M vs correct 70M) and direction (increase vs actual decrease). The starting 2022 number (117M) is correct. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the year-over-year trend, incorrectly inferring a rebound in available shares in 2024 when the truth shows continued drawdown. This undermines the conclusion about reserve depletion. While the general idea of increasing utilization is plausible, it is based on incorrect data patterns. (4) Contextual relevance is moderate—the answer addresses the right topic (share availability under the Omnibus Plan and implications for stock-based compensation), but due to major factual and directional errors, the conclusions are not well-supported. The mention of 'replenishment mechanism' in the ground truth is missing, indicating incomplete synthesis. Overall, the answer is mostly incorrect due to wrong numbers and trend misrepresentation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 442,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A shares in fiscal 2022** (page 93 of the 2022 10‑K) to **141 million shares in fiscal 2023** (page 96 of the 2023 10‑K), and stayed at **141 million shares through fiscal 2024** (page 98 of the 2024 10‑K).  \n\nThis step‑up in the reserve shows that Accenture deliberately expanded its equity‑award pool to meet higher grant demand as it scaled its workforce and sought to attract and retain talent, while the subsequent stabilization indicates that the larger reserve now fully satisfies the company’s share‑based compensation needs without further dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the authorized share numbers for 2022 (127 million), 2023 (141 million), and 2024 (141 million), matching the ground truth exactly. The formatting variation (127 million vs. 127,000,000) is acceptable and semantically equivalent. (2) All numeric values are accurate and correctly attributed to the respective fiscal years. The increase of 14 million shares is implied and consistent with the ground truth. No calculations are required beyond comparison, which is handled correctly. (3) The multi-hop reasoning is sound: the model synthesizes data from three separate 10-K filings (2022, 2023, 2024), correctly tracking the evolution of the share reserve. The conclusion about strategic expansion and stabilization aligns with the ground truth’s interpretation of growing emphasis on equity incentives. (4) The LLM adds slightly more contextual interpretation (e.g., 'scaled its workforce', 'without further dilution') that goes beyond the original answer but remains reasonable and relevant. While these points are not in the ground truth, they do not contradict it and are plausible inferences. The core facts, numbers, and strategic implication are fully aligned. Minor deduction in qualitative accuracy due to added interpretation, but overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 368,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio rose from roughly **3.5 % in 2022 to about 6.1 % in 2024** (5.9 % in 2023), as shown in the “Distribution of Assets, Liabilities, and Shareholders’ Equity; Interest Rates and Interest Differential” table on **AXP 10‑K 2024 – page 176**.  This upward shift signals that the company’s earnings are increasingly sensitive to international interest‑rate movements, reflecting greater exposure to—and benefit from—higher global rates in its overseas sovereign‑debt holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. According to the ground truth, the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. However, the LLM states yields were approximately 3.5% in 2022 and 6.1% in 2024 (with 5.9% in 2023), which misrepresents all three years. The dollar amount of $630 million in holdings is omitted entirely. (2) The calculation of trend is partially correct in identifying an increase, but the LLM fails to capture the full cyclical pattern—specifically the drop back to 2022 levels in 2024—which is central to the original answer’s conclusion about volatility and possible stabilization or portfolio adjustments. Instead, the LLM implies a steady rise, which contradicts the data. (3) The reasoning is flawed in terms of multi-hop synthesis: while it correctly infers that yield changes reflect exposure to international interest rates, it misses the reversal in 2024, leading to an incomplete and misleading interpretation of the trend. The citation to page 176 of the AXP 10-K 2024 may be accurate, but the data extracted from it does not align with the verified ground truth. (4) Contextual relevance is moderate—the answer addresses the right topic (yield on foreign government bonds and interest rate exposure) and draws a reasonable qualitative link, but due to incorrect numbers and missing the reversal trend, the overall correctness score is low. Quantitative accuracy is severely penalized due to incorrect percentages across all years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 433,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nAmerican Express’s weighted‑average yield on foreign government bonds and obligations slipped from **6.45 % in 2023 to 5.85 % in 2024** (see the “Distribution of Assets, Liabilities, and Shareholders’ Equity; Interest Rates and Interest Differential” tables on pages 177‑178 for 2024 and pages 133‑137 for 2023).  This decline follows the 2022 fair‑value distribution of those securities, which was heavily weighted toward longer‑dated, investment‑grade sovereigns (fair‑value of $630 million disclosed in Note 4, page 120), a positioning that had driven the higher 2023 yield.  The drop reflects a deliberate re‑balancing toward shorter‑duration, lower‑risk assets as market yields receded after the 2022 rate‑hike cycle, signalling the company’s intent to reduce interest‑rate sensitivity and preserve capital amid a flattening yield curve.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the weighted average yields of 6.45% in 2023 and 5.85% in 2024, matching the ground truth. The $630 million fair value of Foreign Government Bonds and Obligations in 2022 is also accurate. However, the LLM incorrectly characterizes the 2022 portfolio as 'heavily weighted toward longer-dated, investment-grade sovereigns,' which directly contradicts the ground truth stating that the majority ($628 million) of the $630 million was maturing within one year—indicating a short-duration, not long-duration, focus. This is a significant factual error in entity characterization. (2) All numeric values (percentages, dollar amounts) are correct and properly cited with page references, supporting quantitative accuracy. The yield decline from 6.45% to 5.85% is accurately described. (3) The multi-hop reasoning is partially sound—correctly linking yield changes across years and referencing market conditions—but flawed in its synthesis of the 2022 portfolio composition. The conclusion that the company rebalanced toward shorter-duration assets due to falling yields contradicts the actual short-duration stance already in place in 2022, undermining the logic. The ground truth suggests the high 2023 yield may have stemmed from that short-duration positioning, with the 2024 decline possibly indicating a shift away from it, whereas the LLM reverses this narrative. (4) Correctness is scored 6 due to accurate numbers but major qualitative misrepresentation of portfolio duration in 2022. Quantitative accuracy is 8 due to correct figures and formatting. Qualitative accuracy is 5 because of the critical mischaracterization of investment strategy direction. Contextual relevance is 9 as the answer directly addresses the question’s focus on yield evolution and strategy, despite the factual flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 499,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nAcross the three filings the 7 % Debentures due 2029 are always placed in the “Securities Registered Pursuant to Section 12(b)” table, but the level of detail grows over time. In the 2022 10‑K the debenture is listed only by name, whereas the 2023 and 2024 10‑Ks add the CUSIP number (CUSIP‑718507BK1) and explicitly note that the security is listed on the New York Stock Exchange. This steady move toward a fully specified, standardized entry reflects ConocoPhillips’ intent to provide clearer, more comparable disclosure of its long‑term debt and to meet evolving SEC and investor expectations for transparency.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core facts but contains a key inaccuracy in the description of the 2022 filing. Quantitatively, all dates (2022, 2023, 2024), percentages (7%), and identifiers (CUSIP-718507BK1) are accurate, and the progression timeline is correctly framed—thus earning a high quantitative accuracy score. Contextually, the answer addresses the evolution across years and correctly identifies the increasing transparency, making it highly relevant. However, the qualitative accuracy is lower because the LLM incorrectly states that in 2022 the debenture was listed 'only by name'—the ground truth indicates that in 2022, the debentures were disclosed alongside Common Stock with both trading symbol and CUSIP, not omitted. Additionally, the LLM claims CUSIP and exchange listing were added in 2023 and 2024, but the original answer implies the CUSIP was already associated in 2022, though not yet separated into its own row. The key evolution—separating the debenture into its own row in 2023—is missed entirely by the LLM, which instead focuses on incremental detail addition. This misrepresents the nature of the change (structural separation vs. detail enrichment), weakening the reasoning. Despite this, the conclusion about increasing transparency aligns with the ground truth, preserving partial correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 370,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 2.00% Notes Due 2031 carried a stable carrying amount of roughly $1.25 billion from fiscal 2022 through 2024, while the fair‑value of the issue rose modestly from about $1.0 billion to $1.06 billion over the same period.  This consistency shows that the company deliberately retained a low‑coupon, senior note with a distant maturity as a steady component of its long‑term, laddered debt strategy rather than repeatedly issuing or retiring it.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.2 billion in 2022, decreased to $1.057 billion in 2023, and then increased to $1.25 billion in 2024. The LLM incorrectly states that the carrying amount was 'roughly $1.25 billion' throughout all three years, which misrepresents the fluctuation—particularly the drop in 2023. Additionally, the LLM introduces a 'fair-value' metric rising from $1.0 billion to $1.06 billion, which is not mentioned or supported in the original answer and appears fabricated or misattributed. (2) The numbers are therefore quantitatively inaccurate: the correct progression is $1.2B → $1.057B → $1.25B, not a stable $1.25B with minor fair-value changes. The LLM fails to reflect the actual variation in carrying value over time, especially the decline in 2023. (3) The reasoning is partially sound in interpreting the notes as part of a stable, laddered debt strategy, which aligns with the original conclusion about a 'stable approach to long-term financing.' However, because the underlying data is wrong, the logic is based on incorrect premises. The multi-hop synthesis across years is attempted but flawed due to incorrect values. (4) Contextual relevance is high—the response addresses the evolution of the debt instrument and infers strategy appropriately. However, due to major quantitative errors, the correctness score is low despite relevant framing. Minor flexibility is allowed for phrasing, but the core financial figures must match; they do not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 444,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Disney has kept Marvel’s trademarks and related franchise intangibles in its indefinite‑lived‑assets category (≈ $1.8 bn), a classification that has remained unchanged in the 2022, 2023 and 2024 10‑K filings (see DIS_10K_2022 p. 110, DIS_10K_2023 p. 112‑113, DIS_10K_2024 p. 112).  At the same time, Marvel’s film and series library has been progressively funneled into Disney’s streaming services—its titles now appear on Disney+ and Disney+ Hotstar, a dedicated Marvel‑branded tile is slated for launch on U.S. Disney+ in early 2025, and Marvel content is bundled with ESPN+ and other DTC offerings—signaling a strategic shift from a primarily linear‑network/home‑entertainment asset to a core driver of Disney’s direct‑to‑consumer brand portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims. While it correctly identifies Marvel as part of Disney's indefinite-lived intangible assets, it incorrectly states that this classification is consistent across all three years (2022, 2023, and 2024). The ground truth only confirms this for 2022 and 2024; there is no explicit confirmation for 2023, making the claim overreaching. Additionally, the LLM introduces a specific dollar value of approximately $1.8 billion, which is not present in the original answer and cannot be verified from the provided ground truth, making it factually unsupported. (2) The claim about a 'dedicated Marvel-branded tile slated for launch in early 2025' contradicts the original answer, which states that Marvel was already highlighted as a top-level branded tile in Disney+ in 2023. This misrepresents the timeline and strategic rollout. The mention of Marvel content being 'bundled with ESPN+' and 'funneled into Disney+ Hotstar' adds details not present in the ground truth and may be contextually plausible but are not supported by the provided answer. (3) The multi-hop reasoning is partially sound—linking Marvel’s financial classification with its streaming strategy—but the synthesis includes unverified data points and misaligned timelines. The core idea of Marvel’s strategic elevation across financial and distribution dimensions is aligned with the original, but the execution introduces errors. (4) The contextual relevance is high because the answer addresses both branding on streaming platforms and indefinite-lived intangible assets. However, due to significant quantitative inaccuracies and some incorrect temporal claims, the correctness score is reduced to 6, reflecting partial accuracy with notable flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 487,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nBetween 2022 and 2024, American Express continued to recognize discount revenue at the moment a Card‑Member transaction is settled, with the majority of that revenue coming from network‑rate fees that are individually negotiated with each third‑party merchant acquirer and recorded as discount revenue at the time of the sale; these fees have been periodically renegotiated to reflect shifts in merchant mix, competitive pressures and emerging regulatory caps.  Simultaneously, the company accelerated its merchant‑coverage expansion—targeting premium‑consumer, commercial‑payments and high‑growth international markets—by leveraging auto‑renewal agreements, digital‑first onboarding, strategic partnerships and targeted marketing to broaden acceptance, thereby growing the transaction base that drives its discount‑revenue stream.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core elements of American Express's revenue recognition model, particularly the timing of discount revenue recognition (at transaction settlement) and the fact that network rate fees are individually negotiated with third-party acquirers and recorded as discount revenue. It also accurately describes the strategic push to expand merchant coverage through digital onboarding, partnerships, and marketing—consistent with the ground truth's emphasis on global expansion and digital integration. However, the LLM answer omits key developments from 2023 onward, specifically the introduction of 'processed revenue' from network partnership agreements (e.g., royalties and fees for facilitating transactions on partner-issued cards), which represents a significant evolution in revenue structure. This omission limits completeness and affects qualitative accuracy. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not compromised—scored as 10 by default given no factual errors in numbers. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information about discount revenue and merchant expansion but fails to incorporate the 2023 shift toward processed revenue and the distinction between discount and processed revenue streams, which is a critical multi-hop element across years and contractual arrangements. (4) The contextual relevance is high because the answer addresses revenue recognition, contractual negotiation, and merchant expansion—all key parts of the question—though it lacks specificity on how network rate fee negotiations evolved structurally (e.g., OptBlue, GNS partners mentioned in ground truth). The answer is well-aligned in tone and focus but misses nuanced developments that define the 2022–2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 512,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s 10‑K risk disclosures evolved from a broad warning that dependence on third‑party drug‑delivery devices and the need for regulatory approval could delay or halt product sales, to an explicit articulation of post‑marketing obligations (e.g., confirmatory studies, REMS, safety‑signal reporting) and the risk that failure to meet them could trigger approval withdrawals, and finally to a focused emphasis on how clinical‑trial enrollment and supply‑chain stability for those devices—particularly in light of natural‑disaster‑related manufacturing disruptions and heightened regulator scrutiny of device safety—directly affect trial execution and the durability of product approvals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Amgen's regulatory risk disclosures from 2022 to 2024 with strong semantic equivalence to the ground truth. (1) It correctly identifies the shift from general dependencies on drug delivery devices in 2022 to more specific post-marketing and safety compliance risks in 2023–2024. The mention of confirmatory studies, REMS, and safety-signal reporting aligns with the increased regulatory scrutiny on accelerated approvals like LUMAKRAS. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years, connecting clinical trial dependencies, post-marketing requirements, and device-related safety reviews. It adds contextual detail (e.g., natural-disaster-related manufacturing disruptions) not in the original but plausibly consistent with the trend and does not contradict it. (4) The only minor gap is that the LLM does not explicitly name LUMAKRAS or the Complete Response Letter from the FDA, which are key specifics in the 2023 disclosure per the ground truth. While the concept is conveyed (accelerated approval requiring confirmatory studies), the absence of this concrete example slightly reduces qualitative accuracy. Otherwise, the answer is fully contextually relevant and correctly frames the evolution in risk disclosure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 412,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 to 2024 ConocoPhillips broadened the HSE audit from a generic unit‑level compliance check to a corporate‑wide review that is explicitly tied to annual HSE objectives, targets and risk categories.  The program introduced a formal improvement‑action tracking system with defined deadlines and integrated those results into performance metrics, and it strengthened governance by requiring the Executive Leadership Team and Board to receive structured audit‑performance reports, with the ELT holding ultimate accountability for HSE outcomes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of evolution in ConocoPhillips' HSE audit program but introduces inaccuracies and omits key details present in the ground truth. (1) Correct elements: The answer correctly identifies the Executive Leadership Team (ELT) and Board as governance bodies receiving reports, aligning with the original answer. It also correctly notes that improvement actions are tracked, which matches the ground truth. (2) Quantitative accuracy is high: there are no numerical values to verify, and all referenced entities (ConocoPhillips, ELT, Board) are correct. Dates (2022–2024) are appropriately used. (3) However, the qualitative accuracy suffers due to unsupported claims not present in the original: the introduction of a 'formal improvement-action tracking system with defined deadlines' and integration into 'performance metrics' are not mentioned in the ground truth. Similarly, stating that audits are now tied to 'annual HSE objectives, targets and risk categories' goes beyond the documented evolution. The original emphasizes terminology shifts (e.g., 'Corporate HSE audits' in 2024), integration with Life Saving Rules and Process Safety Fundamentals (2023), and a stop work policy—none of which are mentioned in the LLM response. (4) The reasoning is partially sound in recognizing a trend toward centralization and stronger governance, but it fails to reflect the actual multi-hop synthesis from the filings: the progression from conformance checks (2022) to integration with human capital and safety systems (2023) to corporate standardization (2024). Instead, it invents structural changes not documented. Thus, while contextually relevant and moving in the right direction, the answer substitutes plausible details for actual ones, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 490,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nFrom 2022 through 2024 Accenture shifted away from traditional time‑and‑materials and fixed‑price fees toward more flexible, usage‑ and outcome‑based pricing that ties charges to AI, cloud and analytics consumption—e.g., subscription or consumption‑based models that reflect the value of new technology investments.  Across the 2022, 2023 and 2024 filings the company repeatedly flags the same risks: heightened cyber‑security and data‑privacy threats that can trigger legal liability and reputational damage, and the danger that an inability to devise or successfully price these new AI‑ and cloud‑centric commercial models could materially depress its revenues and results of operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Accenture's pricing models from traditional models toward usage- and outcome-based pricing tied to AI and cloud solutions, which aligns with the general direction in the ground truth. It also correctly notes the consistent risk related to the inability to devise or price new models effectively, which could impact revenues. However, the LLM introduces a risk—'heightened cyber-security and data-privacy threats'—that is not mentioned in the original answer as a risk related to pricing model adoption. The consistently highlighted risk in the ground truth is specifically about slow introduction of value-reflective pricing models and low client adoption leading to revenue shortfalls and competitive disadvantages, not cybersecurity. This misattribution of risk significantly affects qualitative accuracy. Additionally, while the LLM captures the shift in approach, it lacks the year-by-year progression detailed in the original: 2022 (acknowledgment of need), 2023 (focus on innovation and client spending delays), and 2024 (dependence on deployment amid AI evolution). The answer is semantically close but misses key elements of multi-hop reasoning across years and conflates unrelated risks. There are no numerical inaccuracies, hence perfect quantitative score. Contextually, it remains relevant to the question but with notable gaps in precision and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 391,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nGE’s AerCap exposure changed from a mixed equity‑and‑note position to a pure senior‑note holding.  In the 2023 filing (page 71) the company noted that it “sold our remaining AerCap shares, leaving an AerCap senior note as our only remaining position,” and the note’s carrying amount rose from $944 million at 31 Dec 2023 (page 68/70) to $982 million at 31 Dec 2024 (page 68/70).  The 2024 filing (page 72) records a modest $38 million realized/unrealized gain on that note, confirming that GE now holds only the debt instrument.  This progression shows GE’s strategy of exiting its equity stake in AerCap and retaining only the higher‑yielding senior note, simplifying the investment and shifting toward a lower‑risk, income‑focused exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) Quantitative inaccuracy: The original answer states that GE's holdings in the AerCap note decreased from $993 million (end of 2021, reported in 2022) to $944 million (end of 2023, reported in 2024), showing a decline. However, the LLM claims the note increased from $944 million at the end of 2023 to $982 million at the end of 2024, which is not supported by the ground truth and reverses the trend. Additionally, the LLM introduces a $38 million gain from the 2024 filing, which is not mentioned or verifiable in the original answer. (2) Temporal misalignment: The LLM references a '2023 filing' and '2024 filing' with page numbers and specific disclosures (e.g., selling shares, increase in note value), but these details are absent from the ground truth and conflict with the documented downward trend. (3) Entity and reasoning error: The original answer indicates a gradual reduction in the note holding, suggesting de-risking or portfolio simplification. In contrast, the LLM claims GE sold its equity stake and now holds only a senior note — a detail not present in the original — and interprets this as a shift to a 'higher-yielding, lower-risk' strategy. While the strategic interpretation might seem plausible, it is based on fabricated data and incorrect holdings progression. (4) Multi-hop failure: The question asks about the evolution from 2022 through 2024, but the LLM misrepresents both the direction and magnitude of change, failing to correctly synthesize the disclosed values over time. The answer fabricates an increase when the truth is a decrease. (5) Semantic mismatch: Despite using terms like 'senior note' and 'carrying amount,' the LLM introduces unverified details (e.g., page numbers, realized gains, equity sale) not present in the original, making the response misleading. The core factual trajectory is inverted, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 528,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nAmgen kept bemarituzumab in Phase 3 throughout the 2022‑2024 period – the 2022 filing listed it as a Phase 3 candidate for GEJ adenocarcinoma, the 2023 10‑K continued to show it in Phase 3 (and by 2024 the program was noted as “other tumors,” indicating a modest expansion of the indication portfolio), while the company’s composition‑of‑matter patent coverage in both the United States and Europe remained unchanged, with the current estimates still pointing to a 2029 expiration for the U.S. and European bemarituzumab patents. No new patent families or extensions were disclosed across the three filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bemarituzumab remained in Phase 3 from 2022 to 2024 and accurately reports the 2029 patent expiration in both the U.S. and Europe, which aligns with the ground truth. It also correctly notes the expansion of indications by 2024 to include 'other tumors,' which corresponds to the broader investigational scope mentioned in the original answer. However, the LLM understates the evolution by stating there was 'no new patent families or extensions disclosed' and that the IP coverage 'remained unchanged,' while the ground truth emphasizes that 2023 was when Amgen first *disclosed* the patent expiration estimates — implying new transparency, not just no change. The LLM interprets lack of change in expiration date as no IP development, missing the significance of the 2023 disclosure as a strategic IP positioning move. (2) Quantitatively, all dates (2022, 2023, 2024, 2029) and phase status (Phase 3) are correct. No calculations are required. Format of '2029' expiration is consistent. (3) The multi-hop reasoning is mostly sound — the model synthesizes data across three years and correctly tracks clinical phase and patent timelines. However, it fails to recognize that the 2023 IP disclosure represents a meaningful evolution in intellectual property *positioning*, not just a static continuation. This weakens the qualitative assessment of IP strategy evolution. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in correctness and qualitative reasoning for overlooking the strategic significance of the 2023 IP disclosure as a milestone in IP positioning, which was a key point in the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 464,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a defensive stance—protecting its premium card‑network margins against surcharge‑prone merchants and low‑cost rivals—toward an aggressive technology‑led strategy that invests heavily in AI‑driven risk and fraud tools, cybersecurity, real‑time settlement and new digital‑payment products (e.g., checking accounts, digital‑wallet integrations, and loyalty‑point platforms).  This expansion is coupled with deeper partnerships and joint‑venture initiatives that embed Amex services within broader fintech ecosystems, signaling a long‑term response to fintech disruption that prioritizes building differentiated, data‑rich capabilities rather than merely defending traditional merchant‑discount revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall strategic evolution of American Express from a defensive to a more proactive, technology-driven posture in response to fintech disruption, which aligns with the ground truth. It correctly identifies the shift in strategic focus over time and emphasizes technological investment and ecosystem integration as key components of the long-term response. However, it diverges from the original answer in specific details about how American Express framed alternative payment mechanisms year-by-year. The ground truth specifies that in 2022, Amex identified digital wallets, BNPL, and blockchain systems as competitive threats; in 2023, expanded to include open banking and payment facilitators; and in 2024, shifted toward dependency and integration. The LLM answer does not mention this year-by-year expansion of threat categories or the conceptual pivot from 'competitive pressure' to 'dependency,' instead framing the shift more broadly as moving from defense to aggressive tech investment. While this is directionally accurate, it omits the nuanced evolution in Amex's characterization of alternative payment mechanisms. The LLM introduces specific new product types (e.g., checking accounts, loyalty-point platforms) and emphasizes AI-driven fraud tools and cybersecurity, which are not mentioned in the original answer and may reflect plausible inference but are not supported by the ground truth. There are no numerical inaccuracies (quantitative accuracy is high due to absence of incorrect figures), and the reasoning is logically sound and contextually relevant, but the qualitative accuracy is reduced due to incomplete synthesis of the multi-hop, year-specific framing changes. The answer remains contextually strong and interprets the long-term strategic response correctly, even if not verbatim to the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 503,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs was $91.6 million for grants made in 2022, rose to $112.5 million for 2023 grants, and then fell to roughly $110.4 million for 2024 grants (the “Outstanding at Dec 31 2024” column shows 98.2, but the grant‑date figure reported for 2024 is $110.39). This upward jump in 2023 reflects a higher‑priced stock environment and a deliberate increase in the long‑term incentive award value, while the modest decline in 2024 indicates the company is pulling back slightly to moderate compensation expense as market conditions stabilize, maintaining a performance‑linked, equity‑based incentive structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values and trends. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a consistent upward trend. However, the LLM claims values of $91.6 million, $112.5 million, and $110.4 million (noting a drop in 2024), which misrepresents both the magnitude and trend. Crucially, the units are wrong—the values are per share, not in millions (e.g., $91.58, not $91.6 million). This is a major quantitative error. (2) The LLM incorrectly reports a decline in 2024 to $110.39, while the ground truth shows an increase to $112.50. It also introduces confusion by referencing 'Outstanding at Dec 31 2024' as if it contradicts the grant-date value, which is not supported by the ground truth. The correct trend is a steady increase, not a peak-and-dip. (3) The reasoning about 'higher-priced stock environment' and 'pulling back to moderate compensation expense' is speculative and not aligned with the ground truth, which interprets the trend as a strategic shift toward higher-value incentives. The LLM’s multi-hop synthesis fails because it misreads the data trend and injects unsupported causal explanations. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of PSU values and attempts to interpret the company's incentive strategy. The qualitative reasoning would be stronger if based on correct data. The contextual relevance is high because it engages with both parts of the question, but correctness is severely undermined by numerical and unit errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 450,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s filings show a steady deepening of concern that fraud and abusive behaviors—especially those linked to its growing credit products and the third‑party‑originated receivables it purchases—are becoming more complex, costly, and harder to detect.  While the company repeatedly stresses investments in buyer‑/seller‑protection programs and continuous improvement of its risk models, it also warns that existing loss allowances and detection measures may be insufficient, signalling that its risk‑management controls are being stretched and may not be keeping pace with the evolving threat landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolving concern at PayPal regarding abusive behaviors and fraud from 2022 to 2024, particularly in relation to credit products and third-party fraud, and notes the increasing complexity and detection challenges. It accurately reflects PayPal's ongoing risk management efforts and the potential insufficiency of current controls. However, it omits key factual details present in the ground truth that are critical for full multi-hop synthesis: (1) the specific €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, which is a concrete strategic mitigation action; and (2) the mention of regulatory uncertainties such as the 'valid-when-made doctrine' impacting U.S. credit products in 2024. These omissions reduce completeness and weaken the qualitative accuracy of the reasoning chain, despite the overall correct direction of interpretation. There are no numerical inaccuracies—the LLM avoids citing specific figures rather than misstating them, so quantitative accuracy is not penalized. The answer remains contextually relevant and semantically aligned in tone and intent, but the absence of specific, material risk-mitigation actions and regulatory factors from the filings limits its factual completeness and depth of synthesis across years and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 369,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 through 2024 Eli Lilly broadened Cyramza’s clinical positioning, adding a first‑line combination therapy for metastatic NSCLC with activating EGFR mutations and reinforcing its use in earlier lines of gastric, colorectal and hepatocellular cancers (see 2022 10‑K pages 5‑6; 2023 10‑K page 13; 2024 10‑K pages 6‑7).  At the same time the company layered additional composition‑of‑matter and method‑of‑use patents that pushed the core compound exclusivity from a 2026 U.S. expiry to 2028‑2030 in Europe and Japan and extended data‑protection periods (2024 10‑K page 12; 2023 10‑K page 13).  This evolution shows Lilly’s long‑term oncology strategy of sustaining revenue from its flagship TKI by extending market exclusivity through incremental label expansion and strong IP scaffolding while using Cyramza as a platform to fund next‑generation cancer innovations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM incorrectly states that Cyramza's compound exclusivity was extended to 2028–2030 in Europe and Japan, while the original answer confirms patents extend only through 2026 in the U.S. and Japan, with no mention of European extensions or data protection extensions. It also falsely claims data protection periods were extended, whereas the ground truth notes data protection was expiring as early as 2023 in Japan. (2) The LLM asserts that new indications were added, including a first-line combination for NSCLC with EGFR mutations and earlier-line use in multiple cancers, but the original answer explicitly states that in 2024, no new indications were added and therapeutic positioning was merely reaffirmed. (3) Qualitatively, the reasoning is flawed: the LLM suggests active lifecycle management via label expansion and IP extension, but the ground truth indicates a maintenance strategy amid impending patent expiry, with likely succession planning. The multi-hop synthesis fails—instead of connecting stable positioning and looming IP expiration to strategic transition, the LLM invents evidence of successful IP and label expansion. (4) Contextual relevance is moderate because the answer addresses therapeutic positioning and IP in the correct timeframe and links them to long-term strategy, but the factual foundation is incorrect, leading to a misleading conclusion about Eli Lilly's strategy. Minor formatting issues (e.g., 'TKI' misapplication—Cyramza is a monoclonal antibody, not a tyrosine kinase inhibitor) further undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 453,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nThrough 2022‑2024 Philip Morris kept the 3.875 % Notes due 2042 as a steady, long‑term financing pillar, while actively reshaping the rest of its capital structure—repaying or swapping out maturing series and issuing newer, longer‑dated debt (e.g., 4.125 % 2043, 4.875 % 2043 and 4.250 % 2044 notes). This disciplined refinancing extended overall maturity, diversified funding sources and relied on dividend‑derived cash flows to support the debt‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent presence of the 3.875% Notes due 2042 and the active management of other debt instruments, including the issuance of 4.125% Notes due 2043, 4.875% Notes due 2043, and 4.250% Notes due 2044. These specific instruments and their due dates match the ground truth. However, the LLM implies that newer debt was issued as part of a strategy to extend maturities and diversify funding, which contradicts the ground truth: by 2024, the 2043 and 2044 notes were retired or refinanced with no new long-dated notes introduced, indicating a stabilization rather than continued extension. This misrepresents the strategic evolution in the final year. (2) Quantitatively, all percentages and years are accurate: 3.875% due 2042, 4.125% due 2043, 4.875% due 2043, and 4.250% due 2044 are correctly cited. No calculations are required, and all figures align with the original answer. (3) The multi-hop reasoning is partially sound—information across 2022, 2023, and 2024 is synthesized, but the conclusion about ongoing maturity extension overlooks the key shift in 2024 toward stabilization. The ground truth emphasizes that no new long-dated notes were introduced after 2024, signaling a strategic pause or consolidation, which the LLM fails to capture. (4) The answer is contextually relevant and well-articulated, but the qualitative inaccuracy in interpreting the strategic direction in 2024 prevents a higher score. The core facts are present, but the synthesis and conclusion are slightly misaligned with the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 432,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s exposure to fraudulent and abusive activity grew as its credit products expanded and its reliance on third‑party banks and payment processors deepened. In 2023 the company began mitigating that risk by selling up to €40 billion of U.K. and European BNPL loan receivables and by initiating a migration of its U.S. payment‑processing to alternative providers, while tightening underwriting and fraud‑detection controls. In 2024 it further reduced exposure by diversifying its third‑party processor base, expanding buyer‑protection and fraud‑prevention measures, and strengthening loan‑loss reserves and credit‑risk models.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the €40 billion figure for the sale of U.K. and European BNPL loan receivables in 2023 is accurately reported, and no other numerical inaccuracies are present. (2) The answer correctly identifies the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, noting increased risk due to credit product expansion and third-party dependencies. It accurately reflects PayPal’s 2023 risk mitigation through the receivables sale, matching the ground truth. (3) Qualitatively, the LLM adds details not present in the original answer—such as migrating U.S. payment processing, diversifying third-party processors, and strengthening loan-loss reserves—which, while plausible, are not supported by the ground truth. These additions do not contradict but go beyond the verified information, slightly affecting qualitative accuracy. The core multi-hop reasoning—linking rising abuse risks in credit products (2022), strategic risk offloading (2023), and enhanced fraud infrastructure (2024)—is sound and correctly synthesized. (4) Contextual relevance is high, as all parts of the question are addressed with accurate timelines and thematic focus on credit products and third-party risk. The answer is semantically equivalent in key aspects but includes minor unverified expansions, justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 391,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAMD’s disclosures show the tax‑and‑tariff‑exemption risk evolving from a brief mention in the 2022 filing (page 37 of **AMD_10k_2022.pdf**) to a more detailed discussion in 2023 that highlighted U.S. sanctions, the Entity‑List compliance and export‑control changes (page 39 of **AMD_10k_2023.pdf**), and then to a fuller articulation in 2024 that added recent sanctions on Russia and Belarus, heightened U.S.–China tensions over Taiwan, and the possibility of further exemption modifications amid geopolitical conflict (page 38 of **AMD_10k_2024.pdf**). This progression signals that AMD perceives growing regulatory uncertainty that could materially affect its global supply chain, cost structure and overall financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly traces the evolution of AMD's risk disclosure regarding tax and tariff exemptions from 2022 to 2024, noting increasing emphasis and contextualization with geopolitical developments. All key qualitative points—escalation in risk prominence, linkage to geopolitical tensions, and implications for global operations—are present and factually consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense; however, the cited page numbers (37, 39, 38) and document years are specific and plausible, with no contradictions. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly identifying the trend of increasing risk disclosure and linking it to regulatory uncertainty. The mention of U.S. sanctions, Entity List compliance, export controls, and specific geopolitical flashpoints (Russia, Belarus, U.S.-China-Taiwan) adds detail that enriches, but does not distort, the core narrative. (4) The only reason for not scoring a perfect 10 is minor: the LLM emphasizes compliance and export controls slightly more than the original answer, which focuses on the general risk of loss/modification of exemptions. While related, this is a subtle shift in emphasis. However, this does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 440,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s gains/losses from the total‑return swaps that economically hedge its deferred‑compensation liability moved from a **$92 million loss in FY 2022** to **$58 million gains in FY 2023** and then to **$91 million gains in FY 2024**.  This shift from a negative to increasingly positive results shows that the company’s derivatives are now effectively offsetting the deferred‑compensation liability, reflecting a deliberate strategy to hedge that exposure and reduce earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024—matching the ground truth exactly. Number formatting (e.g., $92 million vs $92 million) is semantically equivalent and acceptable. (2) Quantitative accuracy is perfect: all values are correct, and no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound—information spans three fiscal years and involves synthesis of gains/losses tied to total return swaps linked to deferred compensation. The LLM correctly identifies the trend (loss to increasing gains) and infers strategic hedging intent. (4) The qualitative interpretation slightly strengthens the conclusion by stating the derivatives are 'now effectively offsetting' the liability and reducing earnings volatility, which goes a step beyond the original answer’s more cautious 'potentially reflecting improved market conditions or strategic shift.' While this interpretation is reasonable and plausible, it introduces a slightly more definitive causal claim than the original, which uses more tentative language. This minor overstatement prevents a perfect 10 on qualitative accuracy, but the core reasoning remains strong. Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of gains/losses and what the trend indicates about strategy or exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 409,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney moved from a modest DTC launch to a aggressive, multi‑pronged strategy: it introduced an ad‑supported Disney+ tier and new pricing in 2022, reorganized DMED and invested heavily in sports‑rights and original content for its streaming services in 2023, and in 2024 deepened that push with a joint‑venture for Star India, an ESPN‑flagship DTC offering, and continued content‑cost inflation while recording impairments and higher capital outlays.  This progression shows that scaling Disney’s streaming platform entails rising acquisition‑and‑production expenses, intense competition and consumer price‑sensitivity, reliance on favorable renewal of costly programming/distribution contracts, and the risk of cash‑flow strain or asset impairments if subscriber growth or revenue targets are not met.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Disney's DTC offerings from fiscal 2022 to 2024. It accurately captures the increasing investment and competitive pressures, and correctly identifies key initiatives such as the ad-supported tier (2022), reorganization and content investment (2023), and ESPN+ and Star India developments (2024). There are no numeric inaccuracies—no specific dollar amounts, percentages, or subscriber figures are cited in either answer, so quantitative accuracy is not compromised. The qualitative reasoning is sound: the LLM correctly infers rising costs, competition, pricing sensitivity, and financial risks like impairments and cash-flow strain. However, the original answer emphasizes a clearer progression of risk acknowledgment (2022 uncertainty, 2023 active investment, 2024 competitive pressure), while the LLM answer, though factually consistent, frames events with slightly more specificity (e.g., 'joint-venture for Star India', 'ESPN-flagship DTC') that are plausible but not explicitly confirmed in the ground truth. These details may reflect accurate inferences but go beyond the provided knowledge graph, introducing a minor overreach in specificity. Nonetheless, the core multi-hop reasoning—linking strategic moves to financial risks and market pressures across years—is valid and contextually appropriate. The answer fully addresses both parts of the question: the evolution of strategy and the implications for financial risk and market pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 427,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal continues to bear full margin risk on every payment it authorizes, exercising complete discretion over the fee it charges customers that is set independently of the fees it pays to third‑party processors.  Those processor fees are recorded as “transaction expense,” so any compression of margins is captured directly in expense and has not undergone a material change from 2022 through 2024.  Consequently, the company’s exposure to margin risk remains essentially unchanged across the three years, with fee‑setting authority and the treatment of processor‑related costs staying consistent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PayPal bears full margin risk, has independent fee-setting discretion, and records processor fees as transaction expense across 2022–2024. There is no material change in risk exposure or accounting treatment. (2) Quantitative accuracy is perfect—no specific numbers (e.g., dollar amounts) are involved, but the temporal scope (2022–2024) is correctly referenced and consistent with the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes consistent risk exposure and accounting treatment across three years, despite changes in reporting standards (ASU 2023-07 mentioned in ground truth but not in LLM answer). The only minor omission is the lack of explicit mention of ASU 2023-07 in 2024, which slightly weakens the completeness of the multi-hop synthesis but does not affect the correctness of the conclusion. (4) The answer is contextually fully relevant, directly addressing the evolution (or lack thereof) in margin risk exposure in relation to fee discretion and processor costs. Wording differs but semantic meaning matches. Thus, a score of 9 is justified—excellent accuracy with a minor gap in completeness regarding the accounting standard update.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 364,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s risk disclosures show a clear easing of the cancellation threat.  In the 2022 Form 10‑K the Aerospace risk factor warned that “downturns in global demand for air travel … may impact new aircraft production or result in the delay or cancellation of new aircraft orders,” reflecting the deep pandemic‑induced demand shock.  By 2023 the language shifted to “lower demand for air travel may continue to cause customers to delay or suspend spending,” indicating that while cancellations remained possible, the severity had lessened as demand began to recover.  In the 2024 filing the same cancellation language is still present but is framed within broader macro‑economic and geopolitical concerns rather than an acute pandemic‑driven collapse, signalling that the commercial‑aviation sector has moved past the worst of the downturn and is now characterized by relatively stable order flow and a recovering, more predictable market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it is scored as 10. The main issue lies in qualitative accuracy and reasoning. The LLM incorrectly interprets the evolution of risk disclosures as showing a 'clear easing of the cancellation threat,' which contradicts the ground truth. According to the original answer, Honeywell consistently maintained new aircraft order cancellations as a key risk from 2022 to 2024, with the nature of the risk evolving rather than diminishing. In 2022, the risk was tied to the pandemic; in 2023, it expanded to include geopolitical and environmental factors; and in 2024, it included structural market shifts due to new entrants. The LLM incorrectly frames this as a reduction in risk severity—suggesting 'the worst of the downturn has passed' and 'more predictable market'—whereas the ground truth emphasizes ongoing fragility and persistent uncertainty. This misrepresents the multi-hop synthesis across years and fails to capture the continuity of concern. While the LLM correctly identifies the shift in risk language and contextual factors (e.g., from pandemic to macroeconomic), it draws an erroneous conclusion about de-escalation. Contextually, the answer is relevant and addresses the question’s scope, but the flawed interpretation undermines factual correctness. Thus, correctness and qualitative accuracy are low despite accurate use of reported language snippets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 421,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nBetween 2022 and 2024 PMI’s filings show that regulatory pressure on its Reduced‑Risk and Smoke‑Free Products has intensified—mandating scientific substantiation, imposing plain‑packaging and advertising bans, and curtailing brand‑specific communication about product characteristics. Consequently, the company’s competitive edge is shifting from differentiation through branding and consumer outreach to a reliance on compliance and limited, regulated information channels. This trend underscores a broader industry move toward tighter regulatory constraints that limit product differentiation and adult‑consumer communication.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its general claims about intensifying regulatory pressure on PMI's Reduced-Risk and Smoke-Free Products from 2022 to 2024, and correctly identifies key regulatory constraints such as scientific substantiation requirements, plain packaging, advertising bans, and limitations on brand-specific communication. It appropriately links these to a shift in competitive strategy from branding and consumer outreach to compliance and restricted communication channels, which aligns with the ground truth's emphasis on constrained differentiation and adult consumer communication. However, the LLM answer lacks the year-by-year evolution detailed in the original answer: it does not mention the 2022 focus on truthful information access for RRPs, the 2023 concern over disproportionate commercialization impacts and digital misinformation, or the 2024 strategic shift toward SFPs and regulatory asymmetries. While the core theme of increasing regulatory constraints is correct, the multi-hop synthesis across years and the nuanced evolution in PMI's language and product focus are underdeveloped. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and the terminology (RRPs, SFPs, regulatory constraints) is used correctly. The answer remains contextually relevant and captures the broader trend, but misses specific qualitative developments that demonstrate the evolving nature of PMI's regulatory challenges across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 417,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nPayPal continues to act as the principal in its payment transactions and therefore bears full margin risk, with fees paid to payment processors recorded as transaction expense and volume‑based, tiered pricing that does not create a material future right.  What has evolved from 2022 through 2024 is the scale of that risk—higher TPV and expanded cross‑border/instant‑transfer volumes have increased the dollar amount of margin exposed—while the company’s incentive programs (discounts, rebates, rewards) have grown and are now accounted for as direct reductions of revenue, shaping the margin dynamics across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies PayPal's continued exposure to full margin risk and accurately reflects that fees paid to payment processors are recorded as transaction expenses, which aligns with the original answer. It also correctly notes that incentives (discounts, rebates, rewards) are accounted for as reductions of revenue, consistent with the 2023 and 2024 disclosures. However, the LLM introduces a claim not present in the ground truth: that the 'scale of risk' has increased due to higher TPV and expanded cross-border/instant-transfer volumes. The original answer does not mention any change in the scale or dollar amount of margin exposure—only that the disclosure has become more detailed over time. This misrepresents the evolution as a quantitative increase in risk rather than an improvement in transparency and accounting nuance. Additionally, while the LLM mentions 'tiered pricing,' the original answer emphasizes that the fee charged to customers is independent of processor costs, which is a key point about pricing model structure that the LLM omits. The reasoning is partially sound but incorrectly infers a growth in margin risk exposure based on volume, which is not supported by the provided truth. There are no numerical inaccuracies (hence high quantitative score), but the qualitative reasoning and completeness of multi-hop synthesis are flawed. The answer remains contextually relevant and addresses the core themes of pricing models, processors, and incentives, but misses the true nature of the evolution—increased disclosure detail rather than increased risk magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 438,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the contractual shields it gives AIB partners – its agreements now explicitly protect AIB inventory from price‑cut shocks and include limited‑return/stock‑rotation clauses – while simultaneously urging system‑integrators to rely on AMD’s discrete graphics as a differentiation tool.  The company’s “Add‑in‑Board & System‑Integrator” disclosures (pp. 11‑13) show that these inventory‑protection provisions were expanded each year, and that SIs were encouraged to use AMD‑based discrete GPUs to create performance‑tiered, value‑added products that stand out in the market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts. (1) It accurately captures AMD's consistent inventory protection policies for AIB manufacturers from 2022 to 2024, including contractual safeguards against price cuts and return/rotation policies. This matches the original answer’s emphasis on ongoing protection. (2) There are no specific numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s relationship with AIBs, the role of discrete graphics in differentiation for system integrators (SIs), and the strategic encouragement of value-added product tiers. However, the LLM introduces specific contractual details—'limited-return/stock-rotation clauses' and references to 'pp. 11-13' of a document—not present or verifiable in the original answer, which only states general inventory protection without specifying contractual mechanics or page numbers. This overprecision introduces minor inaccuracies in qualitative detail. (4) The subtle shift in 2024 toward deeper strategic alignment with SIs who create differentiated offerings is implied but not explicitly mentioned in the LLM response. Still, the core themes—inventory protection, SI differentiation via discrete GPUs—are fully addressed. The answer is highly contextually relevant and semantically equivalent on key points, warranting a high correctness score of 8 with full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 432,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Disney’s policy on investment‑credit exposure remained anchored on two core controls: only counter‑parties rated **A‑ or higher** were used, and any exposure that fell below that rating or that breached contract‑defined concentration limits required **collateral posting** (typically cash or securities) to mitigate credit risk.  \n\nIn the 2022 filing the Company emphasized that it “does not have material cash‑and‑cash‑equivalent balances with financial institutions that have below‑investment‑grade credit ratings” and that it “limits the amount of investment‑credit exposure with any one institution,” effectively enforcing a **≤10 % of total cash** cap.  \n\nBy the 2023 filing the Company reported **no balances exceeding the 10 % threshold**, confirming that the cap was being observed.  \n\nIn the 2024 filing the same disclosure notes that, at September 28 2024, a single institution held **24 % of total cash and cash equivalents** (excluding money‑market funds), indicating that the strict 10 % concentration limit was relaxed while the **A‑rating and collateral‑posting requirements** remained in force.  \n\nThus, the evolution shows a shift from a rigid 10 % concentration ceiling in 2022 to a more flexible approach in 2024, even though the requirement that counter‑parties maintain at least an A‑ rating and that collateral be posted if ratings fall below that level or if aggregate exposures exceed contract limits persisted throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained a policy of transacting only with counterparties rated A- or better and required collateral if ratings fell below that threshold or exposures exceeded limits—this is consistent across 2022–2024. The 24% concentration with a single institution in fiscal 2024 is correctly reported, compared to no such concentration in 2022. (2) Quantitatively, the 24% figure is accurate and correctly attributed to fiscal 2024; the ≤10% cap mentioned in 2022 and absence of breaches in 2023 are consistent with the evolution described. The claim that the 10% limit was 'relaxed' by 2024 is a reasonable inference from the 24% concentration, even if not explicitly stated as a policy change. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across three fiscal years, compares concentration thresholds over time, and distinguishes between unchanged credit rating/collateral policies versus the shifted concentration strategy. (4) Minor deduction in qualitative accuracy because the original answer does not explicitly mention a '≤10%' cap or that it was 'rigid' in 2022—the LLM infers this from the absence of concentrations, which is plausible but slightly stronger than the source. However, the core conclusion about a strategic shift in concentration despite stable credit controls is fully supported. Wording differences are within acceptable semantic variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 413,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nPayPal’s holding of the 2.850 % fixed‑rate notes that mature in 2029 fell from **$1.5 billion at the end of 2022 and 2023** to **$0 (i.e., fully retired) by the end of 2024**, as shown in the “Fixed‑rate notes” tables on pages 104‑107 where the 2024 column lists “‑” for that series while the 2023 column still shows $1.5 billion.  The company used the cash generated from its 2024 debt issuances (e.g., the $850 million 5.150 % notes due 2034 and $400 million 5.500 % notes due 2054) together with revolving‑credit capacity to retire the 2029‑maturing notes, thereby shortening the near‑term maturity wall and extending the weighted‑average life of its senior unsecured debt.  This pattern indicates a proactive, long‑term debt‑management strategy that regularly refinances approaching maturities, diversifies the debt profile, and seeks to lock in financing on favorable terms while maintaining ample liquidity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in its core claim that PayPal retired the 2.850% notes by 2024. The ground truth states that the exposure remained consistently at $1,500 million across 2022, 2023, and 2024, meaning no principal reduction or retirement occurred. The LLM incorrectly asserts that the amount dropped to $0 by 2024, which contradicts the verified data. (2) Quantitative inaccuracies include the false claim of retirement to $0 in 2024 and the misinterpretation of the '–' symbol in the filing, which does not indicate retirement but may reflect formatting or unchanged values. The correct value each year is $1,500 million (or $1.5 billion), which the LLM gets right for 2022 and 2023 but catastrophically wrong for 2024. (3) The multi-hop reasoning is flawed: the LLM assumes that because new debt was issued in 2024 (e.g., 5.150% and 5.500% notes), it must have been used to retire the 2029 notes. However, the ground truth explicitly states that despite issuing new debt, PYPL maintained the $1,500 million liability, indicating no such refinancing occurred. The conclusion about shortening the maturity wall or extending weighted-average life is unsupported. (4) The contextual relevance is partially maintained as the answer discusses debt management strategy and references actual new issuances, but the incorrect factual foundation renders the analysis invalid. The reasoning would be strong if the data were correct, but it is built on a false premise. Thus, the correctness and accuracy scores are very low, while contextual relevance receives minimal credit for addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 448,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nBetween 2022 and 2023 the Performance Materials and Technologies segment’s sales fell 21% and its profit dropped 17% as macro‑economic weakness and volatile oil‑ and gas‑price swings curtailed customer capital spending, exposing the business to raw‑material supply constraints and price spikes. In 2024 sales modestly rebounded (+3%) and segment profit rose 2%, but the segment’s reliance on a concentrated supplier base and continued exposure to raw‑material price inflation mean it remains vulnerable to commodity market volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial performance metrics—21% sales decline, 17% profit drop, 3% sales rebound, and 2% profit increase—that are not present in the original answer and cannot be verified against the ground truth. These numbers are likely fabricated or inferred without support from the provided knowledge graph, making them factually incorrect. The original answer does not mention any quantitative changes in sales or profit, focusing instead on qualitative risk disclosures. (2) Quantitative accuracy is low because all percentages cited (21%, 17%, 3%, 2%) are unsupported by the ground truth. There is no mention of financial performance trends in the original answer, so these figures represent a significant deviation. (3) The qualitative reasoning partially aligns with the original: the LLM correctly identifies ongoing exposure to raw material supply constraints and commodity price volatility across the years and links this to customer spending behavior influenced by oil and gas prices, which echoes the 2023 risk framing. However, it fails to mention key elements such as the rebranding of the segment to Energy and Sustainability Solutions in 2024 and the shift in risk emphasis toward production capacity and downtime. It also omits the specific mention of illegal HFC imports in Europe in 2022. The multi-hop synthesis is weak because it invents performance data rather than analyzing the evolution of risk disclosures. (4) While the LLM captures the general theme of sustained vulnerability to commodity volatility, it substitutes unsupported financial metrics for the actual qualitative evolution of risk language in filings. This undermines factual correctness despite some contextual relevance. Correctness score is low due to major factual inaccuracies in numbers and missing key details about segment rebranding and specific risk factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 512,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nFrom 2022 through 2024 Imperial Brands PLC remained a listed member of the PMI Peer Group in the annual performance‑graph disclosures, with no indication that it was ever removed or replaced. This continuity demonstrates that PMI’s benchmarking strategy relies on a stable, pre‑selected cohort of global tobacco and consumer‑products companies of comparable size and market capitalization, using Imperial Brands as a consistent peer reference point rather than altering the group’s composition year‑to‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Imperial Brands PLC remained in PM's peer group from 2022 to 2024, which matches the original answer's claim of consistent inclusion across all three years. (2) There are no numeric values requiring calculation, but the time period (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers from the stable composition that PM (or PMI) employs a consistent benchmarking strategy based on company size and market capitalization, which reflects the original answer’s conclusion about strategic alignment. (4) The only minor difference is semantic: the LLM uses 'PMI' instead of 'PM', though this is commonly understood as Philip Morris International and contextually acceptable. The answer captures the core insight about stability in peer selection and benchmarking philosophy. Thus, it earns a 9 for correctness and qualitative accuracy due to slight variation in company naming convention, but full marks for quantitative accuracy and contextual relevance as all key elements are addressed accurately and appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 329,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nPYPL’s outstanding fixed‑rate 2.850 % notes remained flat at $1.5 billion in 2022, 2023 and 2024, with the entire tranche maturing in 2029.  Because the amount has not been reduced or expanded, the company is using this issuance as a stable, long‑term funding pillar while supplementing its balance sheet with newer note issuances and revolving credit facilities.  The steady exposure signals a deliberate, “hold‑and‑manage” strategy—anchoring a sizable, low‑cost fixed‑rate slice of debt for the long run and rolling other debt to maintain flexibility and control interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion amount for the 2.850% notes is consistently reported for 2022, 2023, and 2024, matching the original answer. The maturity year (2029) is an additional but plausible detail not contradicted by the ground truth. (2) The core facts—stable exposure over three years, no repayment or refinancing—are correctly conveyed. (3) The reasoning is sound and adds value: the LLM infers a 'hold-and-manage' strategy, interprets the stable debt as a 'low-cost fixed-rate' component, and contextualizes it within a broader capital structure approach involving other debt instruments. This goes slightly beyond the original answer but remains logically consistent with it. (4) The only minor gap is that the original emphasizes the lack of action (no repayments/refinancing) as possibly prioritizing other maturities, while the LLM focuses more on strategic intent. This is a nuance in emphasis, not a factual error. Overall, the answer demonstrates correct multi-hop synthesis across years and strategic implications, with full entity accuracy (PYPL, 2.850% notes, correct time frame).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 337,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips expanded the scope of its HSE audits to cover not only safety‑procedure compliance but also process‑safety fundamentals, occupational‑health risks, environmental impacts and emergency‑preparedness requirements, and it began setting annual objectives and targets that are tied to those audit findings.  The company strengthened conformance tracking by formally documenting improvement actions and requiring that they be closed out, while also linking audit results to performance metrics and incentives across the organization.  Finally, integration with corporate governance was deepened: audit progress is now reported regularly to the Executive Leadership Team and the Board of Directors, and the audits are embedded in the firm’s SPIRIT‑Values‑driven governance structure, ensuring that HSE oversight is a direct element of strategic oversight and risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution of HSE audits from 2022 to 2024 is accurately portrayed in terms of scope expansion, conformance tracking, and governance integration. While the original answer does not explicitly list 'process-safety fundamentals, occupational-health risks, environmental impacts and emergency-preparedness requirements' as audit scope components, these are reasonable inferences consistent with ConocoPhillips' HSE framework and do not contradict the source. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not compromised—no errors in this regard. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the progression from operational audits (2022) to linkage with objectives and leadership reporting (2023) to deeper governance integration (2024). The mention of SPIRIT-Values-driven governance is a value-add detail that aligns with ConocoPhillips' public governance model and enhances, without distorting, the original answer. (4) The only minor deviation is that the original answer emphasizes a shift to 'corporate-level' audits in 2024 as a sign of centralization, while the LLM describes governance integration without explicitly noting the structural shift to corporate-level execution. This nuance is present but slightly less precise. Overall, the answer is semantically equivalent, contextually rich, and factually sound, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 420,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAMD continued to treat the 2011 Executive Incentive Plan as the cornerstone of its executive‑compensation framework, repeatedly listing it as Exhibit 10.1 (or 10.2) in the 2022, 2023 and 2024 Form 10‑K filings and explicitly stating that it is “incorporated by reference” for all compensation‑related disclosures.  Even as the company added newer incentive awards and detailed compensation tables in its proxy statements, the 2011 plan remained the foundational governance document that underpins the structure of senior‑executive incentives across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. It correctly identifies that AMD consistently referenced the 2011 Executive Incentive Plan as a foundational document in its 2022, 2023, and 2024 10-K filings. The claim that it was listed as Exhibit 10.1 (or 10.2) aligns with the ground truth, though the ground truth specifies it was consistently listed as *10.1* across all three years—mentioning '10.2' introduces a minor inaccuracy or ambiguity not present in the original, but does not materially misrepresent the situation. The LLM correctly captures the continuity of the plan's role amid evolving compensation mechanisms and accurately reflects that it remained the structural foundation for executive incentives. All dates (2022–2024) and entities (AMD, 2011 Executive Incentive Plan) are correct. There are no calculation errors, as none are required. The reasoning is sound and synthesizes the multi-hop requirement of tracking the plan’s governance role over time. The answer is contextually fully relevant and semantically equivalent to the original, with only slight variation in exhibit numbering affecting precision. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 365,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 the indemnification clause that obligates GM to cover certain losses arising from pre‑sale emissions‑related claims and recalls of the Opel/Vauxhall business remained in force but was consistently treated as immaterial.  In 2022 the European Commission and UK CMA opened investigations and requested information about Opel’s emissions conduct, and GM replied; by 2023 a handful of consumer‑class actions and Takata‑related recall indemnities were pending, yet GM recorded only an immaterial accrual and said any further indemnity was “remote.”  The 2024 filing notes that the same investigations are still ongoing and that GM has again accrued an immaterial amount, reinforcing that its post‑sale liability exposure to legacy Opel/Vauxhall emissions claims and recalls stays limited and is largely transferred to Stellantis, with only a remote risk of a material payment.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general theme that GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims remained immaterial and that exposure was considered remote, which aligns with the ground truth. However, there are significant factual inaccuracies and omissions in the multi-hop reasoning and entity/timeline accuracy. (1) The LLM incorrectly states that the European Commission and UK CMA investigations began in 2022; the ground truth specifies these investigations were mentioned in the 2024 filing, not 2022. This misplacement of a key regulatory development undermines the chronological evolution. (2) The LLM conflates the nature and timing of legal actions: it omits the 2023 mention of lawsuits in Germany, the UK, and the Netherlands and incorrectly implies consumer class actions were already present in 2022. (3) The LLM fails to mention the 2023 Takata inflator recall indemnification (though immaterial), a specific liability event that demonstrates actual payment activity. (4) The expansion of jurisdiction to Austria in 2024 is entirely omitted, reducing completeness. (5) While the LLM correctly notes immaterial accruals in 2023 and 2024, it inaccurately suggests the same investigations were ongoing from 2022, when in fact they were only reported in 2024. (6) The ground truth emphasizes a progressive widening of exposure (geographic and regulatory), which the LLM downplays by framing liabilities as consistently limited. Thus, while the core idea of immateriality and remote risk is preserved, the incorrect timeline, missing jurisdictions, and misattribution of events reduce both qualitative and quantitative accuracy. The answer is contextually relevant and addresses the question’s scope, but with significant factual flaws in the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 491,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nFrom 2022 to 2024 Lilly’s financial exposure to bamlanivimab collapsed: the company recorded roughly **$2 billion of net product revenue from COVID‑19 antibodies (including bamlanivimab) in 2022**, but that figure fell to **near‑zero in 2023‑24** as EUAs expired and demand waned.  Because royalty payments to AbCellera are recorded as cost of sales at **mid‑teens to mid‑twenties % of sales**, the royalty expense that was several hundred million dollars in 2022 became **immaterial by 2023‑24**.  This sharp decline shows that bamlanivimab’s contribution to earnings was confined to the pandemic period and that its **long‑term strategic importance for Lilly’s ongoing growth is limited**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts and trajectory described in the ground truth. (1) Quantitatively, it correctly states ~$2 billion in revenue in 2022 (ground truth: $2,008.9 million), notes the drop to near-zero in 2023–2024, and accurately describes royalty obligations to AbCellera as mid-teens to mid-twenties % of sales. The characterization of royalty expense going from several hundred million to immaterial is logically sound given the revenue drop. (2) The answer omits the specific mention that U.S. revenue hit exactly zero in 2023 and that bamlanivimab was no longer mentioned in 2024 revenue tables, which slightly reduces completeness. However, stating revenue fell to 'near-zero' and implying the product's exit is semantically close enough to not constitute a factual error. (3) Multi-hop reasoning is sound: the model correctly links declining revenue to reduced royalty obligations and infers diminished strategic importance. (4) The conclusion about limited long-term strategic importance aligns with the ground truth’s assessment. Wording differs slightly (e.g., 'cardiometabolic health' shift not mentioned), but the core insight is preserved. Minor deduction only for slight imprecision in describing the complete phase-out.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 354,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly identified **Fortune and Jackpot** as flagship local cigarette brands in the Philippines within its portfolio and market‑share disclosures, and in 2023‑2024 it incorporated the former Swedish Match segment (which includes Jackpot) into its revised four‑region reporting structure, explicitly featuring the brand in updated segment tables and market‑share metrics. This three‑year trajectory shows that, even as PMI accelerates its global shift to smoke‑free products, it continues to **lean on and strategically reinforce its local cigarette brands—particularly in high‑potential markets like the Philippines—to preserve and grow its core cigarette business in those key regions.**",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Jackpot and Fortune as key local brands in the Philippines across 2022–2024, aligning with the ground truth. It accurately reflects PMI’s continued strategic emphasis on local brands despite its smoke-free transition. However, it introduces a significant inaccuracy by claiming that Swedish Match includes Jackpot and that the brand was incorporated into a revised four-region reporting structure in 2023–2024. Swedish Match is a separate acquisition focused on smoke-free products (e.g., ZYN), and Jackpot is a combustible cigarette brand under PMI’s existing portfolio in the Philippines—not part of Swedish Match. This misrepresents the corporate structure and brand categorization. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes PMI’s dual strategy of maintaining local brands while pivoting to smoke-free products. However, the erroneous linkage between Swedish Match and Jackpot undermines the reasoning chain and reflects a failure to correctly disentangle brand portfolios and strategic segments. (4) Despite this key factual error, the answer captures the core theme of PMI’s sustained focus on local brands like Jackpot in key markets, making it contextually relevant and mostly accurate in intent. The correctness score is reduced to 7 due to the significant entity misattribution, which affects qualitative accuracy, though the overall trajectory interpretation remains aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 459,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nPayPal’s exposure to bad transactions in its credit and BNPL portfolios stayed high through 2022‑2024 because the business relies on proprietary risk models and third‑party bank partners, making it vulnerable to defaults, charge‑backs and fraud‑related losses (see PYPL 10‑K 2022 pp. 24‑28; 2023 pp. 23‑27). In June 2023 the company sold up to €40 billion of U.K. and European BNPL loan receivables, cutting the outstanding portfolio but retaining a forward‑flow arrangement that still subjects it to the same fraud, buyer‑protection and third‑party processing risks (PYPL 10‑K 2023 pp. 23‑27). As a result, while the €40 billion sale reduced the volume of exposed receivables, PayPal continues to face elevated loss rates and operational risk from fraud and disruptions to its payment‑processor and bank partners (PYPL 10‑K 2024 pp. 21‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the June 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately cited, including the timing and geographic scope. The reliance on third-party processors and bank partners, as well as ongoing risks from fraud, chargebacks, and operational disruptions, are correctly emphasized across all years. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly reported, with no calculation errors. Date (June 2023) matches the original. Number format (€40 billion) is consistent and acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 10-K filings, correctly noting that while the sale reduced direct exposure to bad transactions, PayPal retained risk via forward-flow arrangements and continued dependence on third parties. It accurately captures the nuance that credit risk volume decreased but qualitative risks (fraud, processing disruptions) persisted. (4) The only minor shortcoming is a slightly stronger emphasis on 'elevated loss rates' in the LLM answer without explicit citation of specific loss rate trends from the filings—this is implied but not directly confirmed in the ground truth, which focuses more on risk exposure than realized losses. Otherwise, the answer is semantically equivalent, contextually complete, and well-supported by cited sections. Minor deduction in qualitative accuracy for slight overstatement of ongoing loss levels without direct evidence, but core reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 438,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nHoneywell’s 2022 Form 10‑K identifies “fluctuations in retail markets” as a specific risk that depressed sales and margins in the Safety & Productivity Solutions segment, a weakness that carried forward into the newly created Industrial Automation business in 2024 (page 31).  The 2023 annual report shows that this volatility contributed to a 20 % drop in organic sales and a 16 % decline in segment profit for that business, reinforcing the company’s broader 2023 risk posture that retail‑demand swings can materially affect its industrial portfolio (pages 31‑32).  Consequently, the 2024 realignment and modest 3 % sales rebound—driven largely by Advanced Materials rather than the Automation‑related segments—highlights Honeywell’s continued high sensitivity to retail‑market volatility across its industrial operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not present in the original answer or ground truth. The original answer does not mention any specific financial impacts such as a '20% drop in organic sales' or '16% decline in segment profit' in 2023, nor does it state a '3% sales rebound' in 2024. These figures are entirely fabricated and not supported by the ground truth, which only discusses the risk qualitatively across years. (2) The quantitative accuracy is very low because all percentages (20%, 16%, 3%) are incorrect and unsupported. There are no such numbers in the original answer, and no calculations are justified from the provided information. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies that 'fluctuations in retail markets' was a recurring risk across years and segments, and it acknowledges the reorganization into the Industrial Automation segment in 2024. However, it misrepresents the nature of the risk by asserting concrete financial impacts that were not stated, and it incorrectly attributes a sales rebound to Advanced Materials, which is not discussed in the original. (4) Contextual relevance is high because the LLM addresses the evolution of retail market risk across the three years and segments, and attempts to synthesize the implications for Honeywell’s sensitivity to retail demand. Despite incorrect numbers, the overall structure and intent follow the question. However, the inclusion of false metrics severely undermines factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 445,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 the Olumiant partnership shifted from the earlier $260 million and $210 million milestone payments that were capitalized in 2020‑2021 to a new contingent structure in which Incyte can earn up to $100 million for regulatory successes and another $100 million for sales‑based milestones; any milestones that are earned are amortized into cost of sales.  Incyte continues to receive tiered, double‑digit royalties (up to 20 % of worldwide net sales) plus a low‑teens royalty on COVID‑19 sales that exceed a defined threshold, and LLY records those royalty payments as cost of sales.  Consequently, Olumiant’s net product revenue has risen steadily—$830.5 million in 2022, $922.6 million in 2023 and $957.4 million in 2024—highlighting its growing contribution to LLY’s revenue base despite the ongoing royalty outflows.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $260 million milestone was capitalized in 2020-2021, while the ground truth specifies 2022. It also fabricates a $210 million payment not mentioned in the original answer. The contingent milestone structure is misrepresented: the LLM claims $100 million each for regulatory and sales milestones (totaling $200 million), which aligns numerically with the ground truth, but incorrectly frames it as a 'new' structure in 2022-2024, whereas the original answer indicates this structure was already in place in 2022. The royalty structure is mostly correct—tiered up to 20% and low teens on COVID-19 sales—but the LLM omits the nuance that the additional royalty applies specifically when sales exceed a threshold tied to COVID-19 treatment. The revenue figures for Olumiant ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) are plausible but not present in the ground truth, which does not provide specific revenue numbers—this is an over-precision that introduces unverified data. (2) Number verification: $260M milestone correct, but wrong year attribution; $200M total contingent milestones correct in sum but split incorrectly in context; $210M figure is entirely fabricated; revenue numbers are unsupported by the original. (3) Multi-hop reasoning is partially sound—the LLM correctly identifies the ongoing royalty payments and their recording as cost of sales, and infers growing strategic importance from rising revenue. However, it fails to capture the evolution in strategic focus described in the original: the shift from milestone capitalization (2022) to revenue recognition (2023) and then to therapeutic expansion and EUA emphasis (2024). Instead, it imposes a narrative of structural change that isn't supported. (4) Correctness score is 5 due to partial factual alignment but significant errors in timing, invented figures, and misrepresentation of the collaboration's evolution. Quantitative accuracy is low (4) due to incorrect or fabricated numbers. Qualitative accuracy is moderate (6) because core elements like royalty structure and cost of sales treatment are correct, but reasoning about evolution is flawed. Contextual relevance is high (9) as the answer addresses all aspects of the question and stays focused on the collaboration’s financial and strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 647,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nFrom 2022 through 2024 Altria kept UST as a wholly‑owned subsidiary in its Oral‑Tobacco segment, so its ownership structure remained unchanged; the company’s financial exposure to UST is reflected in the segment’s cash‑flow and in the $8.8 bn of indefinite‑lived trademark intangibles (MST/snus) and $2.6 bn of cigar trademarks that are carried on the balance sheet and tested annually for impairment—no impairment charges were recorded in 2022‑2024. These intangible assets underpin the branding of UST’s MST and on! oral‑nicotine‑pouch products, which are a core component of Altria’s smoke‑free transition strategy and are integrated with its Horizon heated‑tobacco joint venture and broader R&D initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UST remained a wholly owned subsidiary from 2022 to 2024 and accurately reports the $8.8 billion indefinite-lived intangible asset value for MST and snus trademarks from the 2022 data. However, it introduces a new figure—$2.6 billion in cigar trademarks—not present in the ground truth, which undermines quantitative accuracy. There is no mention in the original answer about cigar trademarks or their value, nor about the absence of impairment charges in 2022–2024, so this is an unsupported addition. (2) The core number ($8.8B for MST/snus trademarks) is correct and properly contextualized. The additional $2.6B figure lacks grounding in the provided truth and appears to conflate UST assets with other Altria segments (e.g., John Middleton cigars), introducing factual error. The claim of 'no impairment charges' is plausible but not verifiable from the ground truth, which does not mention impairment testing outcomes. (3) The reasoning is largely sound: the LLM correctly infers sustained ownership and integration of UST, links intangible assets to branding, and connects UST’s products (especially on!) to Altria’s smoke-free strategy. It appropriately situates UST within the broader transition strategy, mentioning Horizon and R&D, though the original answer emphasizes Helix and NJOY more than Horizon. This reflects a minor divergence in strategic emphasis but not a factual error. (4) The answer is contextually relevant and addresses all key dimensions: ownership (unchanged), financial exposure (via intangibles and segment cash flow), and strategic role in smoke-free transition. However, the inclusion of unsupported financial data reduces correctness. The original answer notes a strategic shift toward newer alternatives, which the LLM captures in spirit but with slightly different emphasis. Overall, core facts are correct, but the addition of unverified figures prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 528,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the effective rate on Cisco’s 3.50 % senior note rose from **≈3.2 % (2022)** to **≈6.38 % (2023)** and then to **≈6.66 % (2024)**.  This jump reflects the note’s transition from a low‑cost, fixed‑rate exposure in a lower‑rate environment to a much higher‑cost, effectively floating‑rate exposure as market rates climbed and hedge adjustments (e.g., interest‑rate swaps tied to SOFR) were incorporated.  Consequently, Cisco’s borrowing costs have risen sharply, indicating that capital‑market conditions have become more expensive for long‑dated corporate debt over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the effective interest rates for Cisco's 3.50% Senior Note across fiscal years 2022 (3.20%), 2023 (6.38%), and 2024 (6.66%), matching the ground truth exactly, with only minor rounding notation (e.g., ≈3.2% instead of 3.20%) which does not affect accuracy. All numeric values and trends are correct.\n\n2) Quantitatively, the numbers are accurate: 3.20% → 6.38% → 6.66% is correctly represented. The upward trend in borrowing costs is properly conveyed, and no calculations are incorrect.\n\n3) The reasoning is sound and adds value: the LLM correctly infers that the rising effective rate reflects a shift in market conditions and likely the impact of interest rate hedges (e.g., SOFR-linked swaps), which aligns with plausible financial mechanisms even if not explicitly stated in the ground truth. This demonstrates strong qualitative reasoning. The only minor gap is that the original answer emphasizes 'tightening capital market conditions' and 'perceived risk or changing interest rate environments,' while the LLM focuses more on hedge adjustments—slightly different emphasis but semantically consistent.\n\n4) The answer is contextually fully relevant, addressing both parts of the question: the evolution of interest rate exposure and what it indicates about borrowing costs and capital market conditions. It synthesizes multi-hop information (trend over three years, interpretation of financial implications) accurately. The slight deduction in qualitative accuracy (9 instead of 10) is due to the added speculation about hedge mechanics not present in the ground truth, though it remains reasonable and does not detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 457,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nThe balance on Amazon’s 2017 senior unsecured notes fell from roughly **$16 billion at the end of 2022** to **$15 billion at the end of 2023**, and then to **about $13 billion by the end of 2024** (see the “2017 Notes issuance” rows on pages 58 and 60).  This steady reduction reflects a deliberate deleveraging approach—Amazon has been repaying a sizable portion of that legacy debt rather than rolling it forward, using cash generated from operations and its newer short‑term credit facilities to shrink the outstanding principal.  The trajectory signals a strategic focus on lowering long‑term leverage and strengthening the company’s overall balance‑sheet resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance on Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. Minor formatting differences (e.g., 'about $13 billion' vs. '$13.0 billion') are acceptable under semantic equivalence. (2) All numeric values are accurate and consistent with the original answer; no calculations are required beyond recognition of the declining trend, which is correctly interpreted. (3) The multi-hop reasoning is sound: the LLM correctly identifies the debt reduction trajectory and links it to Amazon's broader debt management strategy, including deleveraging and balance sheet resilience. It appropriately infers strategic intent from the repayment pattern, aligning with the ground truth's conclusion about a 'deliberate debt management strategy.' The mention of 'cash generated from operations and newer short-term credit facilities' adds contextual detail not in the original but is plausible and does not contradict it. (4) The answer is fully relevant, addressing both the evolution of the debt balance and its strategic implications. The only minor deduction is in qualitative accuracy due to the slight expansion on funding sources not present in the ground truth, but this does not impair correctness. Overall, the response is factually precise, complete, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 392,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe $5.000 % senior notes that mature in April 2030 were issued in April 2020 with a fixed 5.000 % coupon (effective interest rate of 5.18 %).  In the 2023 10‑K (page 81) the carrying amount of these notes was $606 million as of Oct 29 2023 and remained $606 million as of Nov 3 2024, and the same $606 million figure is shown in the 2022 10‑K (page 81) for fiscal‑year‑end 2022.  Consequently, the outstanding principal balance has been essentially flat over the three fiscal years, while the interest rate has remained fixed at 5.000 % (effective 5.18 %).  \n\nThis multi‑year stability shows that AVGO is treating the 5 % 2030 notes as a long‑dated, low‑cost funding pillar and is not actively retiring or reducing the issue; instead it manages the overall debt profile by repaying higher‑cost or shorter‑term borrowings (e.g., term‑loan prepayments) and using cash flow for stock repurchases and other initiatives, thereby preserving the 5 % tranche to maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—$606 million outstanding principal balance, 5.000% coupon rate, and 5.18% effective interest rate—are correct across fiscal years 2022, 2023, and 2024. The dates (Oct 29, 2023; Nov 3, 2024) correspond to fiscal year-ends for those years, and the reference to the 2022 10-K confirms the balance was unchanged, matching the ground truth. (2) Quantitative accuracy is perfect: no calculation errors, and the consistency of the $606M figure over three years is correctly reported. (3) The multi-hop reasoning is sound—LLM synthesizes data across multiple 10-K filings and correctly infers that the static balance indicates a deliberate debt management strategy. The qualitative interpretation goes slightly beyond the original answer by characterizing the notes as a 'low-cost funding pillar' and linking the strategy to stock repurchases, which is plausible and contextually supported but not explicitly stated in the ground truth. This adds insight without misrepresenting facts. (4) The answer fully addresses all parts of the question: evolution of principal and interest rate (unchanged), and what the trend indicates about debt strategy. Semantic equivalence is maintained, with minor elaboration that enhances rather than distorts meaning. A score of 9 is appropriate due to the slight interpretive extension, but core facts and synthesis remain fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 402,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nThe Performance Bonus Plan was first formalized and restated in a December 9 2022 8‑K filing, which replaced the prior version and set out the bonus metrics and payout formula for the company’s executive officers. This restated plan remained the governing instrument in the 2023 and 2024 annual reports, and in the 2024 filing it was again amended and restated (effective January 1 2024) and woven into the company’s broader executive‑compensation structure—specifically, it was integrated with the newly restated Executive Severance and Retention Incentive Plan and the updated stock‑based compensation agreements, creating a unified bonus‑severance‑equity framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and events are correct: the 'Amended and Restated Performance Bonus Plan' was indeed introduced in an 8-K filing on December 9, 2022, and the January 1, 2024 amendment is consistent with the 2024 integration timeline. The LLM correctly identifies the plan's continuity through 2023 and 2024. (2) The answer accurately reflects the formalization (2022 8-K), restatement (December 2022), and integration into broader executive compensation by 2024. (3) The multi-hop reasoning is sound—linking the 2022 filing to subsequent integration with severance and equity plans in 2024 demonstrates proper synthesis across years and documents. (4) Minor discrepancy: the ground truth mentions 'Performance-Based Restricted Stock Unit Award Agreement' and 'Executive Officer Severance Plan,' while the LLM refers to the 'Executive Severance and Retention Incentive Plan'—slightly different naming, but likely referring to the same or similar plan; this does not undermine the core accuracy. Wording differs but semantic meaning and factual content are equivalent. The integration with stock-based agreements and severance is correctly emphasized. Overall, the answer is factually correct, complete, and contextually precise, warranting a 9/10 due to slight variation in plan nomenclature.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 381,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved from a basic third‑party vendor model for terrorism risk—relying on TRIPRA and limited private reinsurance—to a more granular, scenario‑based approach that includes explicit adjustments for model gaps, detailed concentration monitoring (e.g., NYC) and regular updates to exposure assumptions.  At the same time, the company broadened and tightened its reinsurance program: 2022‑23 saw modest targeted purchases and reliance on government pools, while the 2024 program added higher per‑occurrence and aggregate limits, increased retentions (e.g., $200 M for U.S. personal lines and $600 M global aggregate), and required collateral support to back reinsurance recoverables.  These steps reflect a shift toward stronger risk‑mitigation controls—stricter risk‑limit thresholds, enhanced modeling rigor, and greater use of collateralized and cat‑bond protections—to manage international terrorism exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and specific reinsurance structures, despite capturing the general trend of enhanced risk management. (1) Quantitative Accuracy: Multiple incorrect numbers are cited. The LLM claims AIG had a $600M global aggregate retention in 2024, which is not supported by the ground truth; the original answer specifies $200M for Japan and $125M for the rest of the world, with no mention of a $600M global aggregate. The $200M U.S. personal lines retention is also fabricated—the original answer refers to retentions outside North America and does not specify U.S. personal lines. The ground truth states AIG held $20.1B in collateral, but the LLM does not mention this exact figure and instead vaguely references 'collateral support' without quantification. (2) Completeness: The LLM addresses modeled loss estimates, reinsurance, and risk mitigation, satisfying the multi-part structure. However, it misrepresents the evolution: the original answer notes AIG used a consistent modeling approach, while the LLM claims a shift from 'basic third-party vendor model' to 'scenario-based approach,' which contradicts the ground truth. The NYC $1.3B loss estimate is omitted entirely. (3) Entity Accuracy: AIG and TRIPRA are correctly identified, and the time frame (2022–2024) is properly used. However, the LLM incorrectly implies a modeling evolution that did not occur. (4) Reasoning: The multi-hop synthesis is partially sound—linking reinsurance tightening and risk controls over time—but flawed due to incorrect premises about modeling changes and unsupported numerical claims. (5) Semantic Equivalence: While the general direction of improved risk management is correct, the specific mechanisms and figures are misrepresented. The LLM invents structures (e.g., cat-bonds, higher per-occurrence limits) not in the original. Thus, despite contextual relevance and some qualitative alignment, the answer fails on key factual and quantitative grounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 544,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nUnitedHealth’s venture‑investment portfolio showed a clear shift toward larger health‑care stakes: total equity‑securities stayed roughly $4.9 billion, but equity‑method investments in health‑care operating businesses jumped from $1.4 billion at the end of 2023 to $3.8 billion at the end of 2024 (page 52), while the fair‑value gains from the venture portfolio rose sharply—$211 million in 2022, $276 million in 2023 and $710 million in 2024 (page 53). This indicates that from 2022 through 2024 the company evolved its strategy from modest venture holdings to a heavier emphasis on equity‑method investments in health‑care businesses, accompanied by increasingly sizable unrealized gains.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in equity-method investments from $1.4 billion in 2023 to $3.8 billion in 2024 and notes that total equity securities remained at $4.9 billion in 2023 and 2024, which aligns with the ground truth. However, it omits key data from 2022: the $3.5 billion in equity securities and $1.3 billion in equity method investments. This omission affects completeness and quantitative accuracy. (2) The numbers cited for equity securities and equity method investments in 2023 and 2024 are accurate, but the inclusion of fair value gains ($211M in 2022, $276M in 2023, $710M in 2024) is not part of the original answer and introduces extraneous information not requested or present in the ground truth. While these figures may be factual, they shift focus from the core question about holdings and investment strategy evolution. (3) The reasoning correctly infers a strategic pivot toward deeper involvement in healthcare operating businesses based on the surge in equity-method investments, which is consistent with the ground truth’s conclusion. However, the LLM incorrectly implies that the shift began from 'modest venture holdings' without acknowledging the significant increase in equity securities from $3.5B to $4.9B between 2022 and 2023. This misrepresents the early phase of the strategy evolution. (4) The contextual relevance is high because the answer directly addresses the evolution of investment strategy with correct terminology and logical interpretation. The qualitative accuracy is strong due to sound reasoning and correct entity identification (UnitedHealth, equity securities, equity method investments, healthcare businesses). However, the quantitative accuracy is reduced due to omission of 2022 baseline figures and introduction of unrelated fair value gain data. Overall, the answer captures the later-stage shift accurately but lacks full multi-hop synthesis across all three years as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 532,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nThe 1.700 % Notes due 2025 are listed in the “Securities registered pursuant to Section 12(b)” tables on **page 1** of each of the 2022, 2023 and 2024 Form 10‑K filings, showing the same aggregate principal amount (≈ $1.5 billion) and unchanged coupon throughout the three years.  This continuity indicates that Altria has anchored its capital structure on a long‑dated, low‑cost fixed‑rate tranche and has not sought to refinance or retire these notes, instead using cash generated from operations and asset sales to fund shareholder returns and strategic acquisitions while maintaining a stable debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.700% 2025 Notes were present in Altria's capital structure across 2022, 2023, and 2024, which aligns with the ground truth. However, the LLM introduces a specific aggregate principal amount of approximately $1.5 billion, which is not present in the original answer and cannot be verified from the provided ground truth. This is a significant quantitative addition without support in the source data, reducing confidence in numerical accuracy. (2) The coupon rate of 1.700% is correctly stated, and the maturity year (2025) is accurate. The claim about the same principal amount being maintained each year may be factually correct in the actual filings, but it is not confirmed in the ground truth, making this an unsupported detail. The ground truth does not mention dollar amounts or principal balances at all, so the inclusion of $1.5 billion is an overreach. (3) The reasoning about Altria maintaining the 2025 Notes as a stable part of its capital structure is consistent with the ground truth’s conclusion about debt management strategy. The LLM correctly infers that the continued listing of the notes indicates a deliberate choice not to retire them early, which supports a strategy of stable debt management. However, the LLM adds unsupported strategic rationale about funding shareholder returns and acquisitions via asset sales—this is plausible but not present in or inferable from the ground truth, which only states that the notes were retained as part of mid-term capital strategy. (4) Despite the unsupported numerical and strategic details, the core multi-hop synthesis—that the 2025 Notes remained across three years while other notes (like the 2023 Notes) matured—is correctly implied by the LLM’s observation of continuity. The contextual relevance is high because the answer directly addresses the evolution and strategic implication. However, the correctness score is reduced due to the introduction of unverified quantitative data and speculative strategic motives not grounded in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 558,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end‑2022 to the end‑2024 balances, Mastercard’s Class A Treasury Stock grew from **$(51.4 bn)** to **$(60.4 bn)** and then to **$(71.4 bn)** – an increase of roughly **$9 bn** in 2023 and another **$11 bn** in 2024.  The “Purchases of treasury stock” line in the cash‑flow statements shows correspondingly larger outflows each year, confirming that the company has been aggressively repurchasing its own Class A shares.  This accelerating buy‑back trend signals that Mastercard is prioritizing capital‑return to shareholders—using excess cash to retire stock rather than funding new growth initiatives—thereby boosting per‑share earnings and reinforcing confidence in its financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the 2022 value: it reports $(51.4 bn) instead of the correct $(36,658) million (~$36.7 bn), which is a material discrepancy. The 2023 and 2024 figures are accurate: $(60,429) million ≈ $60.4 bn and $(71,431) million ≈ $71.4 bn. The year-over-year increases are also miscalculated: the actual increase from 2022 to 2023 is ~$23.8 bn, not $9 bn as stated. The $11 bn increase from 2023 to 2024 is approximately correct (~$11.0 bn). (2) Calculations are therefore flawed due to the incorrect starting value. The LLM underreports the scale of repurchases in 2023 by more than half. (3) The reasoning and multi-hop synthesis are otherwise sound: the model correctly links growing treasury stock to stock repurchases, references cash flow statement evidence (‘Purchases of treasury stock’), and infers a strategic emphasis on shareholder returns and earnings per share. This reflects proper cross-statement analysis and logical inference. (4) Despite the major quantitative error in the 2022 figure, the overall trend interpretation—increasing repurchases and a capital return strategy—is consistent with the ground truth. The answer is contextually relevant and qualitatively strong in reasoning, but the incorrect baseline number undermines full factual accuracy. Hence, correctness is reduced to 7 due to the significant numerical inaccuracy in the initial value, though the direction and later data points are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 408,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s Total Return Swaps‑Deferred Compensation moved from a **$92 million loss in fiscal 2022** to **gains of $58 million in fiscal 2023** and then to a **$91 million gain in fiscal 2024** (see the “Total return swaps‑deferred compensation” line in the derivative‑instrument gains table, Note 13).  The swing reflects the changing fair‑value of the swaps used to economically hedge deferred‑compensation obligations, with the 2023‑2024 periods showing increasingly positive market movements that generated larger gains.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in 2022, $58M gain in 2023, and $91M gain in 2024—matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $92 million = $92M). (2) All quantitative values are accurate, and no calculations were required beyond correct reporting of directional changes, which the model captures precisely. (3) The multi-hop reasoning is sound: the model synthesizes the evolution across three fiscal years and correctly interprets the trend—from loss to increasing gains—indicating improved performance of the swaps. It also provides context by linking the changes to fair-value fluctuations and hedging purpose, which aligns with the financial logic implied in the question. (4) The answer is semantically equivalent to the ground truth, conveying the same core message of reversal and strengthening in performance, with added value in explaining the economic rationale. All entities—Cisco, Total Return Swaps-Deferred Compensation, and fiscal years 2022–2024—are correctly identified and contextualized. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 328,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s filings show that its reliance on third‑party rights holders stayed fundamental, but the nature of that dependency grew riskier.  The company repeatedly warns that studios and other content owners are increasingly keeping premium titles for their own streaming services and are demanding higher fees or exclusive windows, intensifying competition for exclusive rights and raising the cost of renewing licenses.  At the same time, new regulatory regimes—especially cultural‑quota, levy and ownership rules in several countries—are being applied to streaming services, limiting how Netflix can acquire, distribute, or retain certain content.  Consequently, any failure to secure or renew licensing agreements, or the added costs imposed by competition and regulation, is highlighted as a material threat to its content‑availability strategy and to future growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key factual elements are correct: Netflix's increasing dependency on rights holders, competition from studios launching their own platforms, rising licensing costs, risk of content unavailability due to IP disputes, and regulatory pressures such as content quotas and ownership rules. The evolution across 2022–2024 is accurately reflected in tone and substance. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes risks related to licensing, competition, and regulation across time, correctly attributing growing strategic challenges to external pressures. It captures the progression implied in the original answer without explicitly citing each year, but the temporal evolution is still clearly conveyed through context. (4) Semantic equivalence is strong—while the LLM does not break down the risks year-by-year (2022, 2023, 2024) as precisely as the original, it captures the cumulative effect and core dynamics accurately. Minor deduction in qualitative accuracy due to slightly less granular temporal structuring, but overall reasoning and entity identification (Netflix, rights holders, regulators, content licensing) are correct. Contextual relevance is perfect—the response directly addresses all three dimensions of the question: licensing risks, competition for exclusivity, and regulatory impact on content availability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 438,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nAcross the 2022‑2024 reporting periods UnitedHealth Group recorded **no material accruals, payments, or charges for service‑level guarantees**—the amounts were immaterial in each year—so the financial obligations under these guarantees remained essentially unchanged and negligible. This consistent immateriality indicates that the company’s service‑delivery commitments across its subsidiaries are stable, with no growing financial risk tied to performance guarantees.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UnitedHealth Group's financial obligations related to service-level guarantees were immaterial in 2022, 2023, and 2024, which matches the ground truth. This part of the answer is factually accurate and well-stated. However, the LLM omits a critical component of the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries—from $8.1B in 2022 to $9.9B in 2023, then down to $2.0B in 2024. This internal financing data is central to the multi-hop aspect of the question, as it contrasts the stability of service-level guarantees with volatility in internal financial structures. (2) All numeric values referenced in the LLM answer are correct by implication (immaterial amounts), and no incorrect numbers are stated. Since the LLM does not attempt to report the note payable figures, there are no quantitative errors—hence full marks for quantitative accuracy. (3) The reasoning is partially sound but incomplete. The LLM correctly infers that stable immaterial charges suggest stable service delivery. However, it fails to synthesize across both layers of financial data—external guarantees vs. internal financing—thus missing the nuanced conclusion that while service guarantees are stable, internal financial support mechanisms are shifting, which may reflect operational or liquidity strategy changes. This omission undermines the multi-hop reasoning required. (4) The answer is contextually relevant and addresses the core issue of service-level guarantee stability, but the lack of discussion on internal obligations reduces completeness and qualitative accuracy. The conclusion about stability is reasonable but one-dimensional compared to the original answer’s more comprehensive interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 487,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nBetween 2022 and 2024 Altria reduced the exposure of both its pension and post‑retirement fixed‑income books to below‑investment‑grade securities – the pension portfolio’s below‑grade share fell from roughly 10 % of fixed‑income holdings (about 8 % of total plan assets) to about 8 % of fixed‑income holdings (≈ 7 % of total assets), while the post‑retirement portfolio’s below‑grade share slipped from roughly 4 % of fixed‑income holdings (≈ 3 % of total assets) to about 3 % of total assets.  This steady de‑risking signals a more conservative risk appetite, as the company is moving toward higher‑quality, longer‑duration bonds to better align assets with its long‑term liability obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the direction and magnitude of allocation changes. According to the ground truth, Altria's pension plan allocation to below investment grade securities decreased from 16% (2022) to 11% (2023), while the LLM incorrectly reports a reduction from only ~10% to ~8%, underestimating both the starting point and the change. Similarly, for postretirement plans, the ground truth shows an increase from 8% to 9% in fixed income holdings (2022 to 2023), but the LLM claims a decrease from ~4% to ~3%, which is directionally wrong. Additionally, the LLM implies both plans reduced exposure through 2024, but the original answer states that 2024 data was not disclosed. (2) The numerical values are consistently incorrect: e.g., '10%' vs actual 16% for pension in 2022; '4%' vs actual 8% for postretirement in 2022. The LLM also misrepresents percentages of total plan assets: it says pension was ~8% of total assets in 2022, but ground truth is ~11%. These are not minor discrepancies but major deviations. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the contrasting trends—pension risk decreased while postretirement risk slightly increased—and instead asserts a uniform de-risking across both, which contradicts the evidence. It also ignores the nuance that no 2024 percentages were disclosed, fabricating a continued trend. (4) While the answer addresses the general topic of risk appetite and long-term obligations, its conclusion about 'steady de-risking' and 'more conservative risk appetite' is not fully supported due to incorrect data synthesis. Contextual relevance is moderate because it attempts the right analysis but on faulty premises. Overall, major factual and directional errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 496,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has been calculated consistently from 2022 through 2024 by (1) taking the average daily payment volume for the three months preceding period‑end, (2) multiplying that volume by an estimated number of days of exposure, and (3) applying risk‑mitigation arrangements such as cash collateral, letters of credit and guarantees to derive a net exposure figure.  The company updates the gross and net exposure amounts each year (e.g., gross exposure of $75,023 million in 2023 versus $64,885 million in 2022; net exposure of $62,856 million in 2023 versus $55,661 million in 2022) and refines accruals for pending litigation, but the underlying methodology and the risk‑management framework—formal risk standards, periodic reviews, and the use of collateral/guarantees—remain unchanged.  This steady approach demonstrates that, even as regulatory scrutiny and litigation risk have risen, Mastercard relies on a disciplined, transparent quantitative model to monitor and limit its settlement risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports the gross and net exposure figures for 2022 and 2023: $64,885 million and $55,661 million (2022), $75,023 million and $62,856 million (2023), which match known disclosures. No data is provided for 2024 in the original answer, so the LLM’s lack of 2024 numbers is not an error. The methodology description—average daily payment volume over the prior three months multiplied by estimated days of exposure—is factually correct and consistent across years. (2) The LLM accurately notes that risk mitigation techniques (cash collateral, letters of credit, guarantees) are applied to derive net exposure, and that these practices remained unchanged, which matches the original answer’s emphasis on consistent risk management. (3) Qualitatively, the reasoning is sound: the LLM correctly infers that maintaining the same methodology despite rising regulatory and litigation risks (e.g., FTC/DOJ investigations, litigation accruals) indicates confidence in a robust, disciplined framework. While the original answer explicitly names specific litigations (U.S. Liability Shift, TCPA), the LLM refers more generally to 'pending litigation' and 'litigation risk'—a minor omission but not a factual error. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—methodology evolution (i.e., no change) and what consistency indicates about risk management. The only reason for not scoring a 10 is the slight lack of specificity on the named litigations and regulatory bodies in 2024, though the core factual and multi-hop synthesis is correct. Overall, the answer demonstrates strong cross-year, cross-risk-domain synthesis with accurate financial and conceptual reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 492,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s 5.90 % senior note due 2039 carried a constant carrying amount of **$2.0 billion** in fiscal 2022, 2023 and 2024, and its **effective interest rate remained essentially unchanged at about 6.11 %** (including discount accretion and hedge adjustments) across those years (CSCO_10k_2022.pdf p. 89; CSCO_10k_2023.pdf p. 89; CSCO_10k_2024.pdf p. 89). This stability indicates that Cisco is deliberately maintaining a **steady, long‑term fixed‑rate debt position**, using the note as a core funding source and managing interest‑rate risk through hedges rather than repeatedly refinancing or shifting to variable‑rate borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.0 billion carrying amount (equivalent to $2,000 million) of Cisco's 5.90% Note across fiscal years 2022–2024, and accurately reports the effective interest rate as 6.11%, matching the ground truth exactly. Minor wording variation ('about 6.11%') does not detract from factual accuracy. (2) All numeric values—dollar amount ($2.0 billion = $2,000 million), interest rate (6.11%), and time period (2022–2024)—are quantitatively accurate. Format variations are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across three separate 10-K filings (2022, 2023, 2024), confirms consistency over time, and draws a logical conclusion about Cisco’s long-term debt strategy. The inference that Cisco is maintaining a fixed-rate debt position aligns with the ground truth’s interpretation of strategic intent. (4) The only minor shortcoming is that the LLM emphasizes risk management via hedges slightly more than the original answer, which focuses on lack of refinancing as a strategic choice. While this nuance adds insight, it slightly shifts emphasis from the core point about forgoing cost optimization opportunities. However, this does not constitute a factual error. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 384,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 held an outstanding principal of **$495 million** at the end of fiscal 2022, and the same $495 million balance was reported at the close of fiscal 2023 and fiscal 2024. This flat trajectory indicates that AVGO is treating this specific issuance as a stable, long‑term fixed‑rate funding pillar, preserving it while managing overall leverage through other debt‑refinancing activities rather than expanding or aggressively retiring this tranche.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, all numbers are accurate: the outstanding principal balance of $495 million is correctly reported for fiscal years 2022, 2023, and 2024. The interest rate (3.125%) and maturity date (January 2025) are also correct. (2) The answer addresses both parts of the multi-part question: it describes the evolution (stable at $495M across three years) and interprets the trend in terms of AVGO's debt management strategy. (3) Entity accuracy is precise: AVGO is correctly identified, the debt instrument is accurately described, and fiscal years are properly referenced. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: the conclusion that AVGO is maintaining this tranche as a stable funding source while managing leverage through other means is logically consistent with the unchanged principal and aligns with the qualitative interpretation in the ground truth. Minor wording differences (e.g., 'flat trajectory' vs 'stability') do not affect semantic equivalence—both convey the same factual and interpretive content. No errors in calculation, logic, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 330,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered its wireless shared‑data plans onto the existing bundled model, first offering unlimited, shared‑data and per‑gigabyte options that could be added to a broadband subscription and allowed multiple lines per account with bring‑your‑own‑device or interest‑free financing.  In 2023‑24 the company broadened the portfolio by launching prepaid unlimited‑data plans under the NOW brand and extending financing to 24‑48 months, giving customers greater flexibility to choose plan type, manage cost and combine wireless service with Xfinity broadband and video bundles.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CMCSA's shared data plan offerings from 2022 to 2024 with accurate dates and strategic developments. (1) It correctly identifies that in 2022, shared data plans were part of bundled offerings with broadband, included multiple lines, and offered tiered data options (unlimited, shared, per GB), which aligns with the ground truth. It also accurately notes the introduction of prepaid unlimited plans under the NOW brand in 2023–2024, enhancing customer flexibility. (2) There are no numeric inaccuracies—dates (2022, 2023–2024), product names (NOW brand), and service features (prepaid, financing up to 48 months) are factually consistent with the original answer. Format variations (e.g., '2023-24' vs. separate years) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and service lines, correctly linking bundling strategies with broadband and the expansion into prepaid options. However, it omits explicit mention that shared data plans remained specifically tied to *qualifying broadband bundles* in 2024, a key detail in the ground truth that reinforces the continued emphasis on integration. Additionally, while financing extensions are mentioned, they are not part of the original answer and may reflect overinference or inclusion of extraneous details not supported by the ground truth. (4) Despite minor omissions and slight addition of unsupported details (financing duration), the answer remains contextually relevant and conveys the essential strategic shift toward greater flexibility and bundling. Hence, a score of 8 is justified—core facts and reasoning are correct, but with minor gaps in completeness and precision compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 490,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment volatility deepened as CMS repeatedly revised the risk‑adjustment model and froze or cut benchmark payments, resulting in lower capitation and heightened exposure to RADV‑driven recoupments.  In reaction the company progressively tightened its cost structure—selectively adjusting member benefits and premiums, exiting unprofitable counties, and intensifying medical‑cost and operating‑expense controls—while strengthening its risk‑adjustment data collection and compliance processes to mitigate the recurring funding pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024. It correctly identifies CMS's repeated changes to the risk-adjustment model and benchmark payment cuts or freezes as key drivers of funding pressure, aligning with the ground truth. The strategic responses—selective benefit and premium adjustments, cost controls, and improved data collection—are consistent with the original answer. The LLM adds specific details not in the ground truth, such as 'exiting unprofitable counties' and 'RADV-driven recoupments,' which are plausible and contextually appropriate but not explicitly confirmed in the original knowledge graph. These additions do not contradict the source but represent reasonable inferences. The answer demonstrates sound multi-hop reasoning by synthesizing the recurring nature of CMS changes and UnitedHealth’s adaptive strategies across years. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (UnitedHealth Group, CMS, Medicare Advantage, risk adjustment) are correctly identified. The only reason for not scoring 9–10 is that the original answer emphasizes the continuity and repetition of the same strategies across all three years more explicitly, while the LLM implies progression without directly citing the year-over-year consistency noted in the ground truth. Overall, the answer is semantically equivalent with minor interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 424,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by formalizing third‑party collaborations—working with issuers, acquirers, governments, fintechs and industry groups, and relying on external security assessments and public‑private partnerships to embed shared standards such as EMV and joint fraud‑prevention initiatives.  At the same time it integrated real‑time payment capabilities into that security framework, expanding real‑time clearing and settlement infrastructure to 13 markets by the end of 2023 and rolling out real‑time account‑based payments, Mastercard Send and Alias‑Based Remittances across more than 60 originating and 155 receiving countries.  This geographic expansion of real‑time payment rails was coupled with tighter, real‑time security controls (tokenization, AI‑driven fraud scoring) that now protect the new cross‑border and domestic transaction flows.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mastercard's multi-layered security approach from 2022 to 2024, with strong qualitative accuracy and contextual relevance. It correctly identifies third-party collaboration (issuers, acquirers, governments, fintechs), real-time service integration (tokenization, AI-driven fraud scoring), and geographic expansion of real-time payments. However, there are minor quantitative inaccuracies: the ground truth states real-time infrastructure was in 12 of the top 50 GDP markets in 2022 and expanded to 13 by 2023, but the LLM answer states '13 markets by end of 2023' without referencing the 2022 baseline of 12, and introduces additional details (e.g., 'more than 60 originating and 155 receiving countries') not present in the original answer, which risks overstatement. The original does not mention Mastercard Send or Alias-Based Remittances, nor does it specify cross-border flows to that extent, making those additions plausible but unsupported by the ground truth. The LLM also omits the 2024-specific detail about the China joint venture, a key element of geographic and domestic processing expansion. Despite these omissions and slight overextensions, the reasoning is sound, entities and years are correctly used, and the synthesis across collaboration, real-time integration, and geographic reach is logically structured and semantically aligned with the original. Hence, high scores for qualitative accuracy and contextual relevance, but a moderate deduction in quantitative accuracy due to unsupported numbers and missing specific metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 440,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nFrom 2022 through 2024 Amazon stopped issuing any new 1.500 % notes that mature in 2030 and instead used the legacy 2020 tranche only as a reference point while rolling out higher‑coupon, longer‑dated debt (e.g., the 4.7 % notes due 2032) and expanding its revolving‑credit facilities.  This shift shows that the company’s long‑term debt management moved from relying on low‑cost, short‑to‑mid‑term notes toward locking in longer‑term financing at higher rates and diversifying its funding sources to preserve liquidity and extend the overall maturity profile of its balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Amazon stopped issuing new 1.500% Notes due 2030 and instead issued higher-coupon debt like 4.7% notes due 2032, which is not supported by the ground truth. The original answer confirms the 1.500% Note due 2030 was a fixed, pre-existing obligation from 2020 and was consistently referenced in Exhibits 4.5 (2022) and 4.6 (2023, 2024) without any indication of new issuances or higher-rate replacements. There is no mention of 4.7% notes due 2032 in the ground truth. (2) Quantitative accuracy is poor: the 4.7% interest rate and 2032 maturity are entirely fabricated. The only correct numeric detail is the 1.500% rate and 2030 maturity, but even the context around them is misrepresented. (3) Multi-hop reasoning is flawed. The ground truth shows Amazon layered new short-term credit facilities (e.g., 364-Day Revolving Credit Agreement in October 2024) alongside existing long-term fixed-rate debt, not replaced it with higher-coupon long-term debt. The LLM incorrectly infers a shift in long-term debt strategy toward higher-rate, longer-dated bonds, when the actual strategy was about complementing fixed-rate debt with flexible short-term liquidity tools. (4) Contextual relevance is moderate—the answer addresses long-term debt management and refinancing priorities, but does so with incorrect evidence and reasoning. The conclusion about diversifying funding sources and preserving liquidity aligns partially with the ground truth, but the factual foundation is unsound, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 439,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nThe competitive pressure from wireless telecoms has accelerated sharply: in 2022 Comcast noted that “wireless telecommunications companies offering internet services (including 5G fixed‑wireless and 4G/5G broadband)” were emerging rivals, and by 2023‑24 the filings repeatedly stress that these carriers are now marketing bundled mobile‑plus‑fixed‑wireless broadband packages that directly cannibalize Comcast’s cable‑internet base and drive net video‑customer losses (e.g., Sky’s subscribers are shifting to the DTC “NOW” service rather than traditional DTH video). This escalation is cited as a driver of churn and forces Comcast to respond with faster speed upgrades, more aggressive bundling and heightened focus on customer‑experience metrics to protect its market positioning and retain users.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution of wireless competition from 2022 to 2024 is accurately described, with 2022 referencing 4G/5G broadband as emerging threats, 2023 emphasizing 5G fixed-wireless, and 2024 highlighting bundled offerings and unlimited data plans. The LLM correctly identifies that these competitive pressures are driving customer churn and impacting CMCSA’s video and broadband positioning. (2) There are no numeric values requiring calculation in this question, but the temporal references (2022, 2023–24) are consistent with the original answer and filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects wireless providers’ bundling strategies to CMCSA’s defensive responses (speed upgrades, bundling, customer experience). It also correctly references Sky’s shift to DTC 'NOW' as evidence of competitive substitution, which supports the broader narrative of wireless and DTC disruption. (4) The only minor shortcoming is that the LLM emphasizes video customer losses more than the original answer, which focuses on broadband substitution. While related, the original answer centers on broadband market positioning, whereas the LLM slightly shifts emphasis toward video churn. However, this does not undermine the core correctness, as video and broadband are often bundled and interrelated in retention strategies. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 432,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets fell sharply from roughly **$71 billion in 2022 to $67.5 billion in 2023 and then to $38 billion in 2024**.  This decline shows that the company is ceding less of its insurance liabilities to reinsurers and therefore retains a larger share of the underlying loss risk, indicating an increasing exposure to insurance‑loss risk over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 value and the direction of the trend. The original answer states that specific figures for 2022 were not disclosed, but the LLM claims a precise $71 billion figure, which is incorrect. The actual disclosed data starts in 2023 with $67.5 billion, which the LLM correctly reports, as is the $38 billion in 2024. However, the LLM incorrectly frames the trend as a continuous decline from 2022 to 2024, while the ground truth indicates a significant increase from 2022 to 2023 (with no specific 2022 number) followed by a sharp drop in 2024. (2) Quantitative accuracy is partially correct: $67.5B in 2023 and $38B in 2024 match the ground truth. However, the $71B figure for 2022 is fabricated, and no such number appears in the original. Additionally, the LLM fails to break down the components (ceded loss reserves, life reinsurance recoverables), missing key details that explain the nature of the shift. (3) The reasoning is flawed: the LLM concludes that decreasing reinsurance recoverables means AIG is ceding less risk and thus increasing loss exposure. However, the original answer interprets the 2024 drop—especially the collapse in life reinsurance recoverables from $28.2B to $0.8B—as a strategic de-risking or portfolio run-off in the life segment, not necessarily an increase in retained risk. The LLM misinterprets the implication of the trend. (4) Contextual relevance is high—the answer addresses reinsurance recoverables and insurance loss risk exposure over time, and the years are correct. However, due to incorrect data input and flawed inference, the conclusion is misleading. The multi-hop synthesis fails because the model invents a 2022 figure and misrepresents the trajectory and meaning of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 488,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard continued to calculate gross settlement exposure by averaging daily payment volume over the three months preceding period‑end and multiplying it by the estimated number of days of exposure, then netting that amount against cash collateral, letters‑of‑credit and other guarantees that it requires of customers – a process it reviews regularly and refines as part of its broader risk‑management methodology.  In 2023 the company corrected a prior‑year net‑exposure estimate (found to be immaterial) and, in the 2024 filing, reported a higher gross exposure ($78.4 bn) with a larger offset from risk‑mitigation arrangements ($13.5 bn), reflecting a more granular assessment of exposure; the same year it disclosed that it had tightened its risk‑standards and increased collateral requirements, a change made expressly to address the heightened regulatory scrutiny from the FTC, DOJ and European Commission investigations.  No fundamental alteration to the core methodology occurred, but the company increasingly relied on updated exposure calculations and stronger credit‑risk mitigants in response to ongoing regulatory oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant issues in quantitative accuracy and some overstatement of methodological changes not supported by the ground truth. (1) Correct elements: The core methodology for estimating settlement exposure—averaging daily payment volume over the three months prior to period-end and multiplying by days of exposure—is accurately described and correctly noted as unchanged in structure. The mention of risk mitigation tools (cash collateral, letters of credit, guarantees) aligns with the original answer. Regulatory bodies cited (FTC, DOJ, European Commission) are correct, and the context of ongoing scrutiny is appropriately framed. (2) Quantitative inaccuracies: The LLM introduces specific figures—$78.4 billion gross exposure and $13.5 billion offset in 2024—which are not present in the ground truth. There is no mention in the original answer of such numbers or a 'higher gross exposure' in 2024, nor of a 'more granular assessment' leading to these figures. Additionally, the claim that Mastercard 'corrected a prior-year net-exposure estimate (found to be immaterial)' in 2023 is not supported by the ground truth, which makes no reference to such a correction. These fabricated numbers severely undermine quantitative accuracy. (3) Reasoning and synthesis: While the LLM correctly identifies that there was no fundamental change in methodology, it contradicts the ground truth by asserting that Mastercard 'tightened its risk-standards and increased collateral requirements... to address heightened regulatory scrutiny.' The original answer explicitly states there is 'no explicit evidence of a change' in either the estimation methodology or the structure of risk mitigation arrangements. This overinterpretation misrepresents the evidence and reflects flawed multi-hop reasoning. (4) Contextual relevance is high—the response stays focused on the question, integrates regulatory developments across years, and attempts to link them to risk practices. However, the introduction of unsupported specifics and implied changes reduces factual reliability. Overall, the answer is partially correct but includes critical fabrications and overreach, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 600,
        "total_tokens": 2219
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG progressively hardened its loss‑reserve risk management.  In 2022 the focus was on internal controls and periodic reviews by external actuarial experts to validate reserve estimates, using basic stochastic loss‑development models.  By 2023 a dedicated model‑risk framework was introduced that required independent challenge of those models, incorporated third‑party catastrophe and terrorism vendor models, and added scenario‑ and sensitivity‑analysis to stress‑test reserves.  In 2024 the approach matured further: AIG adopted granular Probable‑Maximum‑Loss (PML) modeling, climate‑adjusted stochastic simulations, and explicit adjustments for model bias, data quality and non‑modeled risks, while tightening limit thresholds and deepening external‑expert oversight to curb uncertainty in loss‑reserve estimates.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's loss reserve risk management from 2022 to 2024 and correctly identifies key themes such as internal controls, external expert involvement, and modeling enhancements. It appropriately notes increasing sophistication in modeling techniques over time, including stochastic methods, scenario analysis, and external oversight, which aligns with the ground truth. However, there are significant qualitative inaccuracies in the details. The original answer does not mention a 'dedicated model-risk framework' introduced in 2023, nor does it reference 'third-party catastrophe and terrorism vendor models', 'Probable-Maximum-Loss (PML) modeling', 'climate-adjusted stochastic simulations', or 'explicit adjustments for model bias, data quality, and non-modeled risks' in 2024. These specific modeling advances are not supported by the ground truth and represent overstatement or fabrication. While the ground truth confirms the use of sensitivity and scenario analyses in 2023 and stronger model risk management and validation in 2024, the LLM adds unverified technical details and structures (e.g., 'independent challenge of models', 'tightening limit thresholds') that are not present in the original. Quantitatively, there are no explicit numbers (dollar amounts, percentages, dates) in either answer, so no numeric inaccuracies exist—hence a high quantitative accuracy score. Contextually, the response is highly relevant and structured around the correct time periods and risk domains. The reasoning shows an attempt at multi-hop synthesis across years, but the added specifics not grounded in the source data reduce the qualitative accuracy. Overall, the answer is directionally correct but contains unsupported elaborations, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 490,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe estimated dollar impact of a 1 % shift in the medical‑cost PMPM trend factor grew from about $298 million in 2022 to $376 million in 2023 and then to roughly $421 million in 2024 (with similar proportional increases for completion‑factor adjustments). This upward trend shows that UnitedHealth’s medical‑cost estimates have become increasingly sensitive to changes in the mix of benefits—such as variations in co‑pays, covered services, and plan design—indicating greater exposure to benefit‑design variability over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core content. The Original Answer (ground truth) discusses the qualitative evolution of UnitedHealth Group's sensitivity to benefit mix — from a general sensitivity factor in 2022, to a source of negative impact in 2023, to a stabilized but still significant factor in 2024 — based on narrative disclosures in SEC filings. In contrast, the LLM answer fabricates precise dollar impacts of a 1% shift in medical-cost PMPM trend ($298M in 2022, $376M in 2023, $421M in 2024), which are not present in the ground truth and cannot be verified from the provided knowledge. These numbers are entirely absent from the original answer and represent a significant hallucination. (2) There is no quantitative support in the ground truth for any dollar amounts or incremental sensitivity impacts. The original answer does not mention completion-factor adjustments or any numerical modeling of sensitivity, making the LLM's figures unsupported. Even if such numbers existed, they would need to be explicitly tied to benefit mix sensitivity, which they are not. (3) The multi-hop reasoning is flawed: the LLM incorrectly assumes that sensitivity to benefit mix can be quantified in dollar terms based on a 1% trend shift, which is not stated or implied in the ground truth. The actual reasoning required is qualitative synthesis across years — assessing how the company's characterization of benefit mix risk evolved — which the LLM fails to capture. (4) While the LLM correctly identifies the relevant metric (medical cost PMPM), company (UnitedHealth Group), and time frame (2022–2024), and correctly notes that benefit design variability (e.g., co-pays, plan design) is a sensitivity factor, it replaces qualitative insights with fabricated quantitative claims. This undermines correctness despite some contextual alignment. The conclusion about 'increasing exposure' contradicts the ground truth, which shows stabilization in 2024, not continued escalation. Thus, the answer is mostly incorrect with major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 560,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nAcross the 2022‑2024 filings, Walmart repeatedly lists “Marketside” among its private‑brand families and notes that it is being expanded into additional categories and integrated into the omni‑channel offering, indicating a deliberate step‑up from a supplemental label to a core component of the private‑brand portfolio.  This progression shows that Marketside is now a strategic pillar for Walmart U.S., allowing the retailer to deliver higher‑quality, differentiated products at everyday‑low‑price levels and to drive higher‑margin sales within its overall merchandise strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and unsupported claims not present in the ground truth. (1) Correct elements: The answer correctly identifies Marketside as part of Walmart's private brand portfolio across 2022–2024 and notes its connection to omni-channel initiatives, which aligns with the 2023 mention of competitive and operational strategies. (2) Quantitative accuracy is high: there are no numerical claims (e.g., dollar amounts, percentages, or specific category expansions) in either the LLM or original answer, so no numeric errors exist. (3) However, the LLM introduces unsupported assertions—specifically, that Marketside is being 'expanded into additional categories' and has evolved into a 'core component' and 'strategic pillar'—which are not stated or implied in the ground truth. The original answer notes only consistent inclusion in the portfolio and contextual shifts in reporting, with no indication of expansion or elevated status. Additionally, the LLM overlooks the key 2024 detail about the restructured merchandise unit emphasizing 'Fashion' instead of 'Apparel,' a specific organizational shift that the ground truth highlights as part of Walmart’s strategic categorization changes. (4) The reasoning is therefore flawed: it infers strategic elevation without sufficient evidence from the source data, failing the multi-hop synthesis test by overreaching on implications. While contextually relevant and addressing the general trajectory question, the answer substitutes inference for documented evolution, reducing factual accuracy. Correctness score reflects partial credit for timeline awareness but deductions for unsupported claims and missing key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 471,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved beyond basic installation and tool‑rental services toward a more Pro‑centric, showroom‑enhanced offering—adding dedicated sales forces, expanded showroom space, Pro Xtra loyalty and credit programs, and a broader suite of installation categories—while simultaneously layering digital capabilities such as mobile‑app navigation, hdPhone/Sidekick tools, Computer Vision inventory visibility, omni‑channel fulfillment and same‑day/next‑day delivery.  This dual focus on richer service‑centered showrooms and a seamless, interconnected digital‑in‑store experience has been used to differentiate Home Depot from pure‑play showrooms and to meet the rising expectations of both DIY and professional customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general direction of The Home Depot's competitive evolution from 2022 to 2024 but diverges significantly in key factual details and emphasis compared to the ground truth. (1) Correct elements include the mention of digital integration (mobile app navigation, omni-channel fulfillment, same-day delivery), which aligns with the 2023–2024 omnichannel focus in the original answer. The reference to tool rental services is consistent with 2022 offerings, though the LLM frames it as part of a broader 'Pro-centric' shift not explicitly detailed in the ground truth. (2) Quantitatively, no specific numbers are incorrect because the LLM avoids citing precise figures (e.g., 'over 1,400 locations' for tool rental in 2022 is omitted), so there are no numerical inaccuracies—hence a score of 8 for quantitative accuracy. However, the absence of verifiable metrics reduces completeness. (3) Qualitatively, the reasoning is partially sound but misaligned: the original answer emphasizes a progression from physical service expansion (2022) to in-store tech upgrades (2023) to deeper digital integration (2024), while the LLM incorrectly suggests that Home Depot added 'expanded showroom space' and 'dedicated sales forces'—a reversal of the intended contrast with traditional showrooms. The term 'showroom-enhanced offering' contradicts the premise of competing *against* showrooms. Additionally, specific innovations like self-service lockers, curbside pickup, and electronic shelf labels—key 2023 developments—are missing. Instead, the LLM introduces unverified elements like 'hdPhone/Sidekick' and 'Computer Vision inventory visibility' not present in the ground truth. (4) Contextual relevance is moderate: the answer addresses service offerings and digital integration over the 2022–2024 period and attempts multi-hop synthesis, but misrepresents the nature of Home Depot’s strategy by portraying it as more showroom-focused rather than using technology to outpace showroom competitors. Overall, the answer contains plausible-sounding but factually misaligned details, warranting a correctness score of 5 for partial accuracy with significant omissions and distortions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 584,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nThe $500 million, 3.50 % senior note due 2025 kept its face value steady from fiscal 2022 through 2024, but its effective yield rose from roughly 6.38 % in FY2022 to 6.66 % in FY2024 (having been much lower when originally issued). This increase reflects higher market rates and hedging costs, indicating that Cisco’s borrowing costs are climbing even as it maintains a stable, long‑dated senior debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, the effective interest rate in fiscal year 2022 was 3.20%, not 6.38% as stated in the LLM answer. The LLM incorrectly claims the rate rose from 6.38% in FY2022 to 6.66% in FY2024, when in fact it rose from 3.20% to 6.66% over the period. This misrepresents the starting point and magnitude of the increase. Additionally, the LLM implies the rate was 'much lower when originally issued,' which is not supported by the provided ground truth, introducing speculative information. (2) The outstanding amount is correctly stated as $500 million and stable across years, and the final effective rate in FY2024 (6.66%) is accurate. However, the misassignment of 6.38% to FY2022 (it was actually the FY2023 rate) constitutes a critical error in temporal and numerical accuracy. (3) The multi-hop reasoning is partially sound—linking rising effective rates to higher market rates and hedging costs shows appropriate qualitative interpretation—but it is based on incorrect data, undermining the validity of the conclusion. The model fails to correctly track the evolution across years despite identifying the right note and its maturity. (4) The contextual relevance is high because the answer addresses the evolution of the note, discusses borrowing costs, and ties it to debt structure. However, due to major quantitative errors affecting the core facts, the correctness score is low. The qualitative reasoning is reasonable but built on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 433,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its network transformation—moving from DOCSIS 3.1 to DOCSIS 4.0, expanding fiber‑to‑the‑premises, and delivering multigigabit symmetrical speeds of up to 10 Gbps and 2 Gbps downstream to roughly half of its footprint—thereby matching and often exceeding the speeds Lumen was offering with its own fiber build‑out; at the same time the company broadened its bundled video, Wi‑Fi and low‑cost Internet Essentials services, giving it a more diversified infrastructure and service portfolio than Lumen’s more narrowly focused fiber‑only rollout.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth, particularly regarding CMCSA's network advancements. While the question asks about the evolution of competitive positioning between CMCSA and Lumen in fiber-based broadband from 2022 to 2024, the ground truth emphasizes Lumen’s consistent and intensifying fiber expansion and bundling strategies as a competitive threat. The LLM response, however, focuses almost entirely on CMCSA’s technological upgrades (e.g., DOCSIS 4.0, 10 Gbps speeds, fiber-to-the-premises expansion) and service bundling, which are not mentioned in the original answer and cannot be verified from the provided ground truth. These specific speed targets (10 Gbps, 2 Gbps) and technology transitions (DOCSIS 4.0) lack corroboration in the ground truth and appear to be hallucinated or inferred beyond available data. Additionally, the claim that CMCSA matched or exceeded Lumen’s speeds is unsupported in the original answer, which does not provide any performance comparison or CMCSA-specific infrastructure details. The LLM correctly identifies bundling as a competitive strategy (aligned with 2024 context), but attributes it primarily to CMCSA rather than noting that Lumen and others were adopting such strategies to compete *with* CMCSA. Entity accuracy (CMCSA, Lumen) and time frame (2022–2024) are correct, and the general theme of fiber competition is relevant, hence moderate contextual relevance. However, the reasoning is flawed due to incorrect attribution of technological advancements and lack of balanced focus on Lumen’s evolving position. The answer fails the multi-hop requirement by not synthesizing Lumen’s progressive fiber expansion across the three years as a growing competitive force, instead pivoting to CMCSA’s capabilities without grounding in the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 505,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on merchant acquirers, aggregators and processors—especially as it rolled out debit‑card products and sought to expand acceptance—yet those third parties can pursue their own commercial incentives that encourage merchants to surcharge or otherwise steer customers away from Amex cards.  Consequently, while the company’s contracts still contain non‑discrimination and “honor‑all‑cards” clauses, its ability to enforce those provisions has weakened because regulators are expanding surcharge rights and because aggregators may have divergent interests that undermine Amex’s control over merchant behavior.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's reliance on aggregators from 2022 to 2024, along with the associated risks to non-discrimination enforcement. (1) All factual elements are correct: the increasing reliance on aggregators, processors, and acquirers; the misalignment of commercial incentives; the threat of merchant steering and surcharging; and the weakening enforcement of non-discrimination clauses due to regulatory and structural pressures. The mention of debit card rollout aligns with the 2023 risk escalation in the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the tension between Amex’s contractual terms and the practical limitations imposed by third-party aggregators and regulatory trends. It connects product expansion (debit cards) with increased risk exposure, matching the original’s logic. (4) The only minor gap is that the LLM answer does not explicitly reference the 2024 litigation and regulatory scrutiny around merchant contract provisions, which is a key development in the ground truth. While it mentions regulators expanding surcharge rights, it omits the specific disclosure of legal exposure that could force changes in agreements. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—the answer directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 451,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson’s talc strategy moved from the original LTL Management LLC Chapter 11 filing (which was dismissed by the New Jersey bankruptcy court in 2022) to a second‑round “LTL 2” filing in early 2023; that case was dismissed by the bankruptcy court in July 2023, upheld on appeal by the Third Circuit in July 2024, and the company then pivoted to a multi‑pronged approach that includes (i) continuing the appeal of the dismissal, (ii) pursuing a consensual “pre‑packaged” Chapter 11 plan through a new Texas‑based entity (Red River Talc) that would fund a $6.475 billion settlement over 25 years, (iii) aggressively litigating the remaining talc claims in the tort system and multi‑district litigation, and (iv) seeking affirmative damages against experts who spread false narratives.  The restructuring created three Texas LLCs that segregated ovarian‑cancer claims (Red River), mesothelioma/consumer‑protection claims (Pecos River) and other liabilities (New Holdco), and the Red River bankruptcy filing in September 2024—along with an amended plan that added $1.75 billion—represents the company’s current financial‑legal vehicle for achieving a comprehensive, final resolution of talc liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in dates, legal outcomes, and financial figures, despite addressing the general topic and structure of Johnson & Johnson's talc liability strategy. (1) QUANTITATIVE INACCURACIES: The original answer states that LTL Management LLC filed for Chapter 11 in 2022 (post-October 2021 restructuring), but the LLM incorrectly claims the first filing was dismissed in 2022 by a New Jersey bankruptcy court—this is false; the initial stay was granted and later reversed by the Third Circuit in 2023, not dismissed in 2022. The LTL 2 case was dismissed in July 2023, not 'upheld on appeal by the Third Circuit in July 2024'—the appeal was ongoing into 2024, but no final ruling is stated in the ground truth. The $6.475 billion settlement over 25 years and the $1.75 billion addition are not present in the original answer; the ground truth mentions only a $2 billion reserve. These numbers are entirely fabricated or misattributed. (2) ENTITY AND EVENT ERRORS: The creation of 'Red River Talc', 'Pecos River', and 'New Holdco' as Texas LLCs is not mentioned in the original answer and represents a significant deviation. The September 2024 Red River bankruptcy filing and 'pre-packaged' plan are not supported by the ground truth. The claim about seeking affirmative damages against experts is absent from the original and unverified. (3) REASONING: While the LLM attempts multi-hop reasoning by tracing a legal-evolution narrative, it constructs a timeline and set of entities not present in the source. It incorrectly frames the outcome of the Third Circuit appeal and invents new financial structures. (4) SEMANTIC EQUIVALENCE: The core idea of a shift from bankruptcy to settlement is partially correct, and the mention of continued appeals aligns with the original. The 2024 multi-state settlement with 42 states and D.C. is omitted in the LLM answer, replaced with unverified financial plans. Overall, the answer is contextually relevant and structured well, but fails on factual correctness—especially in numbers and legal milestones—resulting in a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 577,
        "total_tokens": 2206
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Home Depot shifted from isolated “store‑look” refreshes to a holistic visual‑merchandising strategy that couples upgraded signage, layout redesigns, electronic‑shelf‑labels and self‑service lockers with a heavily digitized shopping journey. By fiscal 2024 those store‑appearance investments were woven into the company’s omni‑channel network—using the physical store as a fulfillment hub that feeds mobile‑app navigation, BOPIS/BORIS pickup, real‑time inventory and same‑day delivery—so that the in‑store experience, digital tools and supply‑chain capabilities operate as a single, interconnected customer experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024, noting the shift from standalone store appearance to integration with digital and omnichannel capabilities. While the original answer describes this progression in terms of strategic framing (e.g., 'core part of the competitive strategy' in 2023, deeper integration by 2024), the LLM answer conveys the same trajectory using more operational language (e.g., 'upgraded signage, layout redesigns, electronic-shelf-labels'). (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution over time (2022 to 2024) and connects store appearance to interconnected retail capabilities like BOPIS (Buy Online, Pick Up In Store), mobile app navigation, and real-time inventory—consistent with the original answer’s emphasis on seamless online-to-in-store experiences. The mention of 'self-service lockers' and 'electronic shelf labels' adds detail not in the original but is plausible and contextually appropriate, not contradicting the ground truth. (4) The LLM answer is semantically equivalent, capturing the core idea that store appearance evolved into a component of a broader, digitally enabled, omnichannel strategy by 2024. The only minor gap is that the original answer explicitly notes store appearance was a 'key competitive factor' alongside price and availability in 2022, which the LLM implies but does not state directly—hence a score of 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 489,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T completed the Reverse‑Morris‑Trust separation of its WarnerMedia unit—the former Time Warner business—transferring it to shareholders and then merging it with Discovery to create Warner Bros. Discovery; AT&T emerged with **no remaining ownership stake** in the combined entity.  In parallel, AT&T sold its last interest in DIRECTV (the video business that had been carved out of WarnerMedia) to TPG in mid‑2024, fully exiting the entertainment‑content distribution arena.  This trajectory underscores AT&T’s deliberate shift away from vertical integration in media and toward a pure‑play telecom strategy that concentrates on 5G, fiber and broadband while relying on external partnerships for content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T completed the separation of WarnerMedia via a Reverse Morris Trust with Discovery, resulting in no remaining ownership stake—consistent with the 2022 transaction. The merger created Warner Bros. Discovery, and by 2023–2024, AT&T had fully exited entertainment, including the sale of its remaining DIRECTV interest to TPG in 2024. (2) Quantitative accuracy is strong: while no specific dollar amounts or percentages are mentioned in either answer, the timeline (2022 separation, 2024 DIRECTV sale) matches exactly. The term 'mid-2024' is a slight inference but reasonable given the context. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the divestiture of WarnerMedia, the creation of Warner Bros. Discovery, and the DIRECTV sale as part of a broader strategic shift. It accurately infers AT&T’s pivot to core telecom (5G, fiber, broadband) and away from vertical integration in media. (4) The only minor gap is that the LLM does not explicitly state that Time Warner Inc. was no longer referenced as an active subsidiary by 2023, though this is implied by the full exit narrative. Wording differs slightly (e.g., 'pure-play telecom strategy' vs. 'core telecommunications and digital infrastructure'), but semantic equivalence is maintained. No factual errors; excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 394,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nFrom 2022 through 2024, American Express has kept its position as the world’s fourth‑largest card network but has faced mounting competitive pressure from Visa, Mastercard and emerging fintech rivals, while also losing network‑licensing revenue after exiting its licensing businesses in the EU and Australia.  At the same time, regulatory oversight has intensified—evidenced by its 2024 designation as a Category III bank‑holding company, stricter capital and compliance requirements, and new U.S. and EU rules on interchange fees, network routing and merchant‑non‑discrimination that heighten the company’s dependence on regulatory compliance and constrain its pricing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest global card network from 2022–2024; it faced increasing competitive pressure in the premium and cobrand segments; and it exited network licensing businesses in the EU and Australia due to regulatory pressures. The mention of intensified regulatory scrutiny in 2024, including rules on interchange fees, network routing, and merchant non-discrimination, is consistent with the original answer. (2) There are no numeric inaccuracies—while no specific dollar figures are cited, the qualitative references to lost licensing revenue and regulatory constraints are factually sound and do not introduce errors. The 2024 designation as a Category III bank-holding company is an additional accurate detail not in the original but does not contradict it and adds context. (3) Multi-hop reasoning is strong: the answer synthesizes competitive dynamics, regulatory developments, and strategic exits across years and regions. The only minor shortcoming is that the original emphasizes the 'tension between competitive differentiation and regulatory compliance' more explicitly, which the LLM touches on but could have articulated more directly. (4) The answer is fully contextually relevant, addressing all dimensions of the question—competitive positioning, regulatory dependency, and business exits—with precise and meaningful information. Overall, this is a semantically equivalent, well-reasoned response with only slight room for deeper thematic synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 436,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe 2.250% Notes due 2050 carried a balance of **$808 million at the end of 2022**, rose modestly to **$826 million in 2023**, and then **declined back to $808 million by the end of 2024** (see the debt‑maturity tables on pages 72‑73 of the 2022‑2024 10‑K filings).  \n\nThis near‑steady trajectory indicates that Johnson & Johnson is **maintaining a stable, low‑cost long‑term financing pillar** rather than dramatically expanding or shrinking this tranche, reflecting a disciplined debt‑management approach that keeps overall leverage steady while using long‑dated fixed‑rate notes to fund its capital needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the timeline and values. It states the balance was $808 million at the end of 2022, but the ground truth shows $983 million in 2022. The LLM correctly reports $826 million in 2023 and $808 million in 2024, but misassigns the initial value, reversing the trend. This leads to an incorrect interpretation of a 'near-steady trajectory' when in fact there is a clear downward trend from $983M to $808M. (2) Quantitative accuracy is low: the 2022 figure is off by $175 million, which is the total reduction amount over the period. Calculations of change are therefore invalid. The LLM implies a small fluctuation ($808M → $826M → $808M), whereas the actual trend is a consistent decline ($983M → $826M → $808M). (3) The multi-hop reasoning is partially sound in that it pulls data across years and attempts to infer strategy, but the flawed input data leads to incorrect synthesis. The conclusion about 'stable, low-cost financing' contradicts the actual reduction pattern indicating active liability reduction. (4) Contextual relevance is high—the answer addresses the evolution of the note balance and attempts to interpret strategy, using appropriate financial reasoning and referencing correct document locations. However, due to the critical error in the 2022 figure, the overall correctness score is severely impacted, landing in the partially correct range with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 402,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond portfolio has seen its average taxable yield climb from about **3.5 % in 2022 to roughly 5.9 % in 2023 and 6.1 % in 2024** (see the “Taxable investment securities – Non‑U.S.” row in the consolidated interest‑rate‑distribution tables on pages 176‑177 of the 2024 filing and the comparable 2022‑2023 tables). This upward trajectory mirrors the steep rise in global interest rates over the same three‑year span, indicating that the company’s earnings from its non‑U.S. investment securities are becoming increasingly sensitive to international rate movements and that it now carries a higher exposure to foreign interest‑rate risk, prompting greater use of hedging and variable‑rate funding to manage that exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all quantitative aspects. According to the ground truth, American Express's yield on foreign government bonds was 6.45% in 2022 for short-term instruments, remained at 6.45% in 2023 for short-term, and declined to 5.86% in 2024—showing a decreasing trend. However, the LLM claims yields rose from 3.5% in 2022 to 5.9% in 2023 and 6.1% in 2024, which contradicts the ground truth. Additionally, the ground truth distinguishes between maturities (e.g., under 1 year vs. 1–5 years), while the LLM provides a single aggregated figure that does not reflect this breakdown. The dollar amount of $630 million in 2022 is omitted entirely. (2) The cited numbers (3.5%, 5.9%, 6.1%) are not supported by the ground truth and appear fabricated or misread. There is no mention of a 3.5% yield in 2022 in the original answer. The calculation of trend direction is therefore incorrect—LLM reports increasing yields when the actual trend is decreasing. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct yield profiles across years and maturities, and incorrectly infers increasing exposure due to rising yields, when the actual data shows declining yields—especially in the 1–5 year bucket falling from 4.48% to 2.03%. This suggests a very different interest rate risk profile. (4) While the LLM attempts to address the question’s intent—linking yield trends to international interest rate exposure—the incorrect data leads to an invalid conclusion. The contextual relevance is moderate because it discusses the right topic (foreign bond yields and rate sensitivity), but the factual foundation is unsound, severely undermining the answer’s correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 477,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe folded its free, self‑service tutorials into the branded **Adobe Digital Learning Services** and tied them to the Experience Cloud stack—especially Journey Optimizer, Customer Success Managers, and real‑time profiles on the Adobe Experience Platform.  This integration shifts the learning offering from a stand‑alone, generic resource to a data‑driven, personalized enablement pathway that is measured against customer‑success metrics, signaling Adobe’s broader strategy of using targeted, platform‑wide learning as a core lever for driving adoption, satisfaction, and long‑term retention of enterprise customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic direction of Adobe's evolution in customer enablement through self-service learning, correctly identifying the integration of learning into broader customer success initiatives and its role in retention and adoption. However, it introduces significant factual inaccuracies regarding branding and platform evolution. The ground truth states that in 2022, offerings were on www.training.adobe.com, then rebranded and centralized under learning.adobe.com in 2023. The LLM incorrectly claims the branding is 'Adobe Digital Learning Services,' which is not mentioned in the original answer and lacks support from the knowledge graph. Additionally, the LLM cites specific integrations with Journey Optimizer, Customer Success Managers, and real-time profiles on Adobe Experience Platform—details absent from the original and unsupported by the provided truth. While the answer correctly infers that the evolution reflects a strategic shift toward data-driven, integrated enablement, these specific entity and branding claims are fabrications or overextensions. The timeline (2022–2024) is handled generally but lacks the clear year-by-year progression detailed in the original (e.g., no mention of 2024 maintenance and reinforcement of learning.adobe.com). Quantitatively, there are no numbers to verify, so accuracy is high by default. Contextually, the answer remains relevant to the question’s focus on strategy and integration. However, the qualitative accuracy suffers due to incorrect entity identification and unsupported multi-hop synthesis, undermining the factual reliability of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 446,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % Senior Notes remained essentially unchanged from fiscal 2022 through 2024: the outstanding principal stayed at **$2 billion** and the effective interest rate (including discount amortization and hedge adjustments) held steady at **≈ 6.1 %** each year (the tables list $2,000 million and a 6.11 % effective rate for 2022, 2023 and 2024).  This consistency shows that the company is preserving this legacy tranche as a stable, long‑term, fixed‑rate funding pillar, even as it expands its overall debt program with newer issuances and hedging strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2,000 million (i.e., $2 billion) outstanding balance and the 6.11% effective interest rate for Cisco's 5.90% Senior Notes across fiscal years 2022–2024, matching the ground truth exactly. The use of '≈ 6.1%' is a reasonable rounding of 6.11% and does not detract from factual accuracy. (2) All numeric values—dollar amount and interest rate—are accurate and consistent with the original answer; no calculations were required beyond recognition of stability over time, which is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers that the lack of change in principal and effective rate indicates a strategic decision to retain this debt tranche. The conclusion about maintaining a 'stable, long-term, fixed-rate funding pillar' aligns with the ground truth’s interpretation of a 'deliberate strategy to maintain this higher-yielding long-term liability.' (4) The only minor shortcoming is that the LLM slightly reframes the implication in more positive/strategic terms (e.g., 'funding pillar') without explicitly noting that it is a 'higher-yielding' liability as stated in the original, which adds nuance about cost. However, the core reasoning and facts are fully preserved. Thus, scores are high across all categories, with a 9 on correctness due to slight difference in interpretive emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 396,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nBA’s exposure to special‑situation‑focused private‑equity grew only modestly over the three‑year span – it was roughly 8 % of total pension assets in 2022, held steady at 8 % in 2023, and edged up to about 9 % by the end of 2024.  This incremental increase shows that the company is deliberately expanding its allocation to specialized private‑equity strategies, using them to enhance long‑term returns and diversify the portfolio while continuing to de‑risk the overall plan.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific percentage allocations of BA's pension assets to special situation strategies—8% in 2022, 8% in 2023, and 9% in 2024. However, the ground truth explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' making these figures entirely fabricated. There is no support in the original data for any numerical allocation, let alone a trend over time. (2) COMPLETENESS: While the question asks about the evolution of allocation and what it indicates about strategy, the LLM invents a trend (modest growth from 8% to 9%) that cannot be derived from the source, which instead emphasizes consistency in strategic categorization, not measurable allocation. (3) ENTITY & REASONING ERROR: The LLM misrepresents the nature of the data—this is not about pension asset allocation but about the types of private equity strategies BA participates in via limited partnerships. The original answer makes clear that the disclosure is qualitative (strategy types), not quantitative (allocation percentages). The conclusion that BA is 'deliberately expanding' its allocation is unsupported; the ground truth states there is 'strategic continuity' due to unchanged descriptions across years. (4) SEMANTIC NON-EQUIVALENCE: The LLM implies precise, measurable changes in allocation and strategic intent that are not present in the original. The only accurate element is the general idea that special situations are part of BA’s private equity focus—but even this is framed incorrectly in terms of pension assets rather than private equity investment vehicles. Due to complete failure on factual accuracy and reasoning, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 491,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nInterventional Solutions global sales rose from $4.3 bn in 2022 to $6.35 bn in 2023 and to roughly $6.6 bn in 2024—a 48% jump followed by modest growth. This upward trajectory shows the segment has become a strategic growth engine for J&J, now accounting for about one‑fifth of total MedTech revenue and cementing its central role in the company’s post‑acquisition strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported sales figures. According to the ground truth, JNJ's Interventional Solutions sales were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly reports $4.3 billion in 2022 (should be ~$3.97B), $6.35B in 2023 (should be $4.3B), and $6.6B in 2024 (should be $6.35B). These errors misrepresent the entire progression, especially the timing and magnitude of growth. The claimed '48% jump' from 2022 to 2023 is incorrect—actual growth was about 8.3%—and the 2023–2024 growth is overstated. (2) Calculations are fundamentally flawed: the LLM implies a near-doubling in one year (2022–2023), when in reality the major jump occurred in 2024, post-acquisition. The correct 2023–2024 increase is ~47.7%, which the LLM misattributes to the earlier period. (3) The multi-hop reasoning is partially sound in linking the sales trend to strategic importance post-acquisition, and the conclusion about strategic growth aligns with the original answer’s intent. However, due to incorrect data, the reasoning is based on false premises. (4) Despite incorrect numbers, the answer addresses both parts of the question—sales evolution and strategic implications—and uses appropriate context (e.g., MedTech revenue share, post-acquisition strategy), earning moderate points for contextual relevance and qualitative reasoning. However, the quantitative inaccuracies severely undermine factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 424,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nAcross the 2022‑2024 filings, “No Boundaries” is repeatedly listed as one of Walmart U.S.’s private‑brand labels that appears in every strategic merchandise unit—grocery, general merchandise, home and health—underscoring a single, cohesive brand that is applied uniformly year after year.  This three‑year branding consistency demonstrates that Walmart’s private‑label strategy for general merchandise is to anchor its everyday‑low‑price proposition with a stable, cross‑category brand that can be leveraged throughout the assortment to reinforce price leadership and customer trust.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several key inaccuracies that affect factual correctness despite correct dates and general timeframe. (1) The claim that 'No Boundaries' appears in *every* strategic merchandise unit—including grocery, health, and home—is incorrect. The ground truth specifies it was part of *General Merchandise*, which includes Apparel and Home, but does not state presence in Grocery or Health. This overgeneralization misrepresents the brand's scope. (2) The assertion that 'No Boundaries' is applied uniformly across *all* units (grocery, health, etc.) contradicts the 2024 reorganization where Apparel moved to a new 'Fashion' category, implying segmentation, not uniform cross-unit application. (3) While the core observation about 3-year branding consistency is valid and correctly tied to private label strategy, the reasoning is flawed: Walmart’s strategy is more about differentiation and margin expansion (per ground truth), not solely reinforcing 'price leadership and customer trust'—which is more aligned with Walmart’s overall brand, not the strategic role of 'No Boundaries' specifically. (4) The LLM invents a broader footprint for the brand than supported by evidence, failing the multi-hop synthesis test: it should have mapped 'No Boundaries' within General Merchandise across years, noting continuity despite structural changes, not assumed expansion. Quantitative accuracy is 10 because no actual numbers or dates are misstated—2022–2024 is correct, and no false metrics are introduced. Contextual relevance is high because the answer addresses branding evolution and strategy, but qualitative accuracy is low due to incorrect entity mapping and reasoning. Correctness score is 5 due to partially correct facts but significant errors in scope and inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 483,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments moved from a modest **$9 million gain** in fiscal 2022 to a **$21 million loss** in fiscal 2023 and then to a **$67 million loss** in fiscal 2024.  This deterioration—reflected in the “Gains (losses) on investments, net: Available‑for‑sale debt investments” line of the Other Income (Loss), Net table—shows a growing negative impact on other income, driven by rising interest rates and credit‑quality pressures that turned earlier gains into increasing unrealized and realized losses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are not present in the original answer (ground truth). The ground truth does not provide any dollar amounts or quantitative figures for the losses or gains in any fiscal year, only qualitative descriptions of 'higher losses' in 2023 and 2024 and a mention of active management in 2022. Therefore, the inclusion of precise dollar figures represents a significant factual overreach not supported by the source. (2) There is no way to verify the accuracy of the $9M, $21M, or $67M figures from the original answer, making the quantitative claims unsupported. The original answer only confirms the direction (negative impact increasing) but not the magnitude. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that available-for-sale debt investments negatively impacted other income (loss), net in both 2023 and 2024, and that this represents a deterioration from 2022. It also correctly attributes this to the relevant line item in the financial statements. However, the addition of unsupported numbers undermines the factual reliability. The explanation about rising interest rates and credit-quality pressures, while plausible, is not mentioned in the original answer and thus represents external inference. (4) The contextual relevance is high because the answer addresses the evolution of investment performance and its impact on other income. The qualitative accuracy is moderate because the direction and trend are correct, but the unsupported numbers reduce factual trustworthiness. The correctness score is 6 due to the correct trend identification but significant quantitative fabrication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 476,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024, American Express shifted from using third‑party merchant acquirers as a supplemental channel to making them a core strategic lever for expanding acceptance—particularly among small‑ and midsize merchants—via programs such as OptBlue and its Global Network Services partnerships; these acquirers enable the company to sign new merchants, broaden its network coverage, and drive transaction growth across all merchant tiers. As a result, the ability of third‑party acquirers to secure and grow merchant acceptance has become central to Amex’s revenue outlook, even though coverage growth remains vulnerable to competition, surcharging and regulatory pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's reliance on third-party merchant acquirers from 2022 to 2024. It correctly identifies the strategic shift from supplemental to core reliance, specifically naming key programs like OptBlue and Global Network Services (GNS), which aligns with the ground truth. The answer accurately reflects that this strategy targets small- and mid-sized merchants and contributes to broader network coverage and transaction growth across all merchant tiers. It also correctly notes the financial and strategic integration of these partners, implying their importance to revenue (consistent with discount revenue recognition mentioned in 2023). The only minor omission is the lack of explicit detail about the 2023 financial mechanism—specifically that American Express receives a negotiated network rate fee recorded as discount revenue—which would strengthen the multi-hop synthesis across years. However, the implication of revenue dependence is present. No numeric inaccuracies exist; the answer avoids unsupported figures and remains consistent with the qualitative timeline. The reasoning is sound, showing a logical progression in strategic importance over time. Contextually, it fully addresses the question about evolution, strategic importance, and impact across merchant segments. Thus, the answer is semantically equivalent to the ground truth with only a slight gap in granular detail, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 414,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 the Company’s multi‑year effort moved from building a cross‑functional framework to actively standardizing and simplifying HR, IT, procurement, supply‑chain and finance processes, and by 2024 it had integrated those standardized processes into the financial shared‑service operating model.  In 2022 the initiative was launched as an enterprise‑wide program to integrate and streamline those functions; in 2023 the Company began implementing and aligning the design of its financial control environment with the new standardized processes; and by 2024 the focus had shifted to fully embedding the integrated, standardized workflows across HR, IT, procurement, supply‑chain and finance to support the growth of its financial shared‑service capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, standardizing, and simplifying processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The narrative correctly notes that the initiative was proactive, not driven by internal control deficiencies. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used accurately and consistently with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three years and multiple functions, correctly tracing the evolution from framework-building in 2022 to implementation in 2023 and full integration by 2024. The LLM accurately captures the progression of the initiative and its alignment with financial control environment alignment. (4) The only minor shortcoming is that the LLM omits explicit mention that the initiative was not prompted by material weaknesses or changes in internal control—though this is implied by describing it as a proactive effort. Otherwise, the answer is semantically equivalent, contextually complete, and factually precise. Hence, a high score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 392,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nBetween 2022 and 2024 Amex moved from describing alternative‑payment mechanisms—especially surcharging, differential‑acceptance and emerging digital‑wallet platforms—as pure competitive threats that could compress its discount revenue (2022 10‑K pages 30‑32) to explicitly stating that it must “invest in open‑banking APIs, tokenization, real‑time settlement and digital‑wallet integration” to keep pace with rivals (2024 10‑K pages 31‑33).  This strategic pivot reflects a recognition that merely defending merchant‑acceptance rates is insufficient; the firm now seeks growth by embedding its network in new payment ecosystems while still contending with intense pricing pressure from large tech‑driven competitors.  Consequently, its positioning has evolved from a defensive stance on alternative payments to an proactive, technology‑focused agenda aimed at preserving and expanding its premium value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in American Express's positioning from 2022 to 2024, noting the shift from viewing alternative payment mechanisms as threats to actively investing in technologies like open banking, real-time settlement, and digital wallets. The mention of specific strategic initiatives (open-banking APIs, tokenization, digital-wallet integration) and the citation of 2022 and 2024 10-K pages (30–32 and 31–33) support factual grounding. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes Amex’s changing strategic language across years, infers a pivot from defense to proactive adaptation, and links it to technological investments. The only minor gap is that the original answer explicitly names PayPal, Venmo, and payment aggregators as competitive pressures, while the LLM answer refers more generally to 'emerging digital-wallet platforms' and 'large tech-driven competitors'—slightly less specific but still semantically consistent. (4) The LLM captures the core transformation: from threat perception to strategic integration. Wording differs but meaning is preserved. Contextual relevance is excellent, directly addressing competitive pressure and strategic adaptation across all three technologies in the question. A score of 9 is justified due to slightly less specificity on competitor names, but overall the answer is factually correct, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 450,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved Frame.io from a standalone “cloud‑native collaboration” add‑on to a fully integrated, AI‑enhanced core of Creative Cloud and Document Cloud.  The platform was progressively bundled with video‑editing apps (Premiere Pro, After Effects), design tools (Photoshop, Illustrator), document workflows (Acrobat Sign, Scan), and new GenAI services (Firefly, Adobe GenStudio), while expanding its capabilities—frame‑accurate commenting, Camera‑to‑Cloud upload, support for still images/PDFs, and AI‑driven workflow tools.  This evolution reflects Adobe’s strategy to create an end‑to‑end, AI‑powered creative collaboration ecosystem that locks users into its subscription suite and drives higher‑value, cross‑product engagement.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Frame.io from 2022 to 2024 with generally accurate qualitative trends and correct time framing. It correctly identifies Frame.io's integration with Premiere Pro, After Effects, and expansion into broader workflows. The mention of integration with Photoshop and document tools aligns with the 2024 expansion noted in the ground truth. However, there are notable inaccuracies: (1) The claim that Frame.io was integrated into Document Cloud, Acrobat Sign, Scan, and Illustrator is not supported by the original answer, which only specifies Photoshop, Lightroom, and Workfront; (2) The introduction of AI-enhanced features, GenAI services (Firefly, Adobe GenStudio), and AI-driven workflow tools is not mentioned in the ground truth and represents speculative overreach; (3) The term 'Camera-to-Cloud upload' is not in the original and may be conflated with 'real-time upload' mentioned in 2023. While the strategic interpretation about Adobe creating an end-to-end ecosystem is reasonable and aligns with the ground truth’s conclusion, the inclusion of unverified integrations and AI features reduces factual accuracy. Quantitatively, there are no numbers, dates, or calculations in either answer, so no errors exist in that regard. The reasoning is mostly sound but extends beyond the provided evidence. The answer remains contextually relevant and captures the multi-hop progression across years and product integrations, albeit with some overstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 410,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe 2017 senior unsecured notes, originally issued for $17 billion, show a steady decline in outstanding principal: $16 billion at the end of 2022, $15 billion at the end of 2023, and $13 billion at the end of 2024.  This reduction reflects scheduled repayments and optional redemptions that Amazon has employed to lower the balance of this tranche, indicating a deliberate debt‑management strategy focused on shrinking leverage, conserving cash and improving the overall debt‑to‑equity profile of the 2017 issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes for each year: $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values show a consistent decline, which is accurately interpreted as a deliberate debt reduction strategy.\n\n2) Quantitative accuracy is perfect: all dollar amounts and years are correct. The progression—$16B → $15B → $13B—is factually accurate, and no calculation errors are present. The mention of the original $17 billion issuance adds contextual detail not in the ground truth but is factually consistent and helpful.\n\n3) The multi-hop reasoning is sound: the model synthesizes the balance changes over three years and infers a strategic debt management approach, including scheduled repayments and optional redemptions. While the ground truth does not specify 'optional redemptions' or 'debt-to-equity profile,' these are reasonable inferences given the declining balance and Amazon's typical financial behavior. However, adding 'conserving cash' slightly extends beyond the evidence—paying down debt may reflect deleveraging but not necessarily cash conservation—making this a minor over-interpretation.\n\n4) The answer is semantically equivalent to the ground truth in substance and adds slight interpretive depth without contradicting facts. All entities (Amazon, 2017 Notes, correct years) are accurate. The response fully addresses both parts of the question: the evolution of the balance and the implication for debt management strategy. Only a minor deduction in qualitative accuracy due to slight extrapolation on cash conservation; otherwise, the answer is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 460,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nBoeing’s Global Services segment moved from a brief, “upgrades and conversions” footnote in 2022 to a clearly articulated growth pillar in 2023‑2024, where the language repeatedly links upgrades and conversions to platform sustain‑ment, lifecycle extension, and higher‑margin aftermarket revenue.  This three‑year trajectory signals that the company is strategically doubling down on retrofit, conversion (e.g., freighter and digital‑ retrofit programs) and modification services to keep aerospace platforms operating longer and to drive recurring services earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces a significant mischaracterization of the evolution of 'Upgrades and Conversions' in Boeing's Global Services segment. (1) The ground truth states that 'Upgrades and Conversions' were consistently listed as a core offering from 2022 to 2024, with no indication of a shift from a 'footnote' to a 'growth pillar.' The LLM incorrectly implies a strategic escalation in emphasis over time, suggesting a transformation in language and positioning that is not supported by the original answer. (2) There are no numeric values, dates, or calculations in either response, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the strategic importance of upgrades and conversions in sustaining platforms and generating aftermarket revenue, it fabricates a narrative of increasing emphasis (e.g., 'moved from a brief footnote... to a clearly articulated growth pillar') that contradicts the ground truth of consistent, stable inclusion. This undermines the qualitative accuracy. (4) Contextually, the answer is relevant and addresses the strategic focus on sustaining aerospace platforms through service offerings, but the incorrect trajectory assessment reduces factual reliability. The core idea of lifecycle extension and recurring revenue aligns with the original, but the evolution claim does not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 401,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly reaffirmed the January 2021 decision to shift **all eligible U.S. non‑union employees—regardless of hire date—to the Retirement Value formula on January 1, 2026**, while explicitly stating that benefits accrued under the older Final Average Pay formula for service before that date will be preserved.  The company has kept the 2026 rollout front‑and‑center in its communications, notifying affected employees via HR benefit portals, FAQs and annual 10‑K disclosures and emphasizing the eligibility criteria (U.S., non‑union, active employment) and the fact that existing accrued benefits will remain unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in completeness that affects qualitative accuracy. (1) Quantitatively, all dates (January 2021 announcement, 2026 implementation), employee categories (U.S. non-union), and plan names (Retirement Value formula, Final Average Pay) are accurate. There are no calculation errors. (2) The answer correctly identifies that the 2026 implementation date was consistently communicated and that pre-2015 hires retain accrued benefits under the Final Average Pay formula. (3) However, the LLM omits the evolution in communication clarity across years: while it correctly states the company reaffirmed the plan, it does not mention that in 2022 the context was less detailed, and only in 2023 did JNJ clarify that employees hired after 2014 were already under the Retirement Value formula. This incremental clarification over time is a key part of the 'evolution' asked in the question. (4) The answer is semantically close and contextually relevant, with strong reasoning and entity accuracy, but the lack of year-by-year communication evolution slightly weakens the multi-hop synthesis, warranting a score of 8 for correctness and qualitative accuracy. The quantitative accuracy is perfect, and relevance is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 362,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 carried a carrying principal balance of roughly $606 million at the close of fiscal 2022, 2023 and 2024—essentially flat across the three years. This stability indicates that AVGO is treating the tranche as a long‑term, low‑cost funding pillar and is not actively repaying or expanding it, but rather managing its overall leverage through other debt issuances and repayments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal 2022, decreased to $606 million in fiscal 2023, and remained at $606 million in fiscal 2024. The LLM incorrectly claims the balance was approximately $606 million in all three years, missing the significant reduction from $1,086M to $606M in 2023. This error fundamentally misrepresents the evolution of the debt. (2) The quantitative inaccuracies are severe: the $480 million reduction between 2022 and 2023 is entirely omitted, and the starting balance is wrong. While the 2023 and 2024 figures are approximately correct (allowing for rounding or formatting), the 2022 figure is completely inaccurate. (3) The reasoning is flawed due to incorrect data input: the conclusion that the debt has been stable and is being used as a 'long-term, low-cost funding pillar' contradicts the actual reduction, which suggests an active repayment strategy. The model fails to perform the correct multi-hop synthesis across fiscal years, leading to an invalid inference about debt management. (4) Scores reflect major factual errors in numbers and reasoning, though the answer is contextually relevant in discussing AVGO's debt strategy and focuses on the correct instrument and time frame.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 387,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2022 onward AT&T completed the Reverse Morris Trust separation of its WarnerMedia unit—built around the 2018 acquisition of Time Warner—by spinning the business out and later merging it with Discovery; the unit was then re‑classified as discontinued operations and its non‑core assets (e.g., Vrio, Xandr, and the remaining DIRECTV stake) were sold or slated for divestiture, culminating in a full exit from the WarnerMedia business by 2024.  This sequence involved initial integration of Time Warner’s brands, a strategic restructuring that placed the segment in discontinued‑operations accounting, and an eventual divestiture that removed AT&T’s ownership of the former Time Warner assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Reverse Morris Trust transaction involving WarnerMedia and Discovery, noting the 2018 acquisition of Time Warner as foundational. The key event—the April 2022 separation—is implied by stating the spin-off was completed 'from 2022 onward,' which is acceptable though less precise; the original answer explicitly dates it to April 2022. (2) Quantitatively, no specific dollar amounts or percentages are mentioned in either answer, so no numerical inaccuracies exist. The timeline (2022–2024) is handled accurately, with the LLM correctly framing the divestiture process as culminating by 2024. (3) The multi-hop reasoning is sound: the LLM traces the evolution from acquisition (Time Warner in 2018), integration into WarnerMedia, strategic restructuring via divestitures (Xandr, Vrio, DIRECTV), and final exit by 2024. It correctly identifies the classification of WarnerMedia as discontinued operations, a key accounting and strategic signal. (4) The LLM omits the specific mention that the DIRECTV divestiture in 2024 was the 'last major asset tied to the entertainment strategy,' slightly reducing completeness, but still captures the essence of AT&T’s strategic pivot back to core telecom services. Wording differs but semantic equivalence is strong. Minor deduction from 10 due to slightly less precise dating of the Discovery merger completion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 400,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nAIG’s terrorism‑risk modeling evolved from a simple third‑party vendor scenario in 2022 (e.g., a $1.3 bn net‑loss estimate for a NYC five‑ton bomb) to increasingly refined, scenario‑based estimates in 2023‑24 that incorporate updated exposure data and additional attack‑mode variations.  At the same time, the company moved beyond reliance on TRIPRA alone and instituted a formal reinsurance program that sets explicit geographic attachment points—such as $150 million–$200 million retentions and $500 million–$1.275 billion per‑occurrence limits for North America, $150 million for Japan, and $125 million for the rest of the world—while adding collateral and funds‑withheld mechanisms to secure reinsurance recoveries.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's terrorism exposure management from 2022 to 2024, correctly identifying the shift toward more sophisticated modeling and enhanced reinsurance structuring. It accurately notes the $1.3 billion net loss scenario for a five-ton bomb in NYC in 2022, which aligns with the ground truth. However, there are key quantitative discrepancies: the LLM states a $150 million attachment point for Japan, while the ground truth specifies $200 million for Japan in 2024. This is a significant error. Additionally, the LLM introduces figures not present in the original answer—such as $150M–$200M retentions and $500M–$1.275B limits for North America, and collateral/funds-withheld mechanisms—which are unsupported by the ground truth and introduce extraneous detail. (2) The only verified correct number is the $1.3 billion 2022 loss estimate. The $125 million attachment for the rest of the world is correct and matches the original. The Japan attachment point is incorrect ($150M vs $200M), and the additional North American reinsurance limits are not mentioned in the ground truth, making them hallucinated. (3) The multi-hop reasoning is partially sound: the model correctly infers a progression from basic modeling to more structured risk segmentation. It links scenario modeling, reinsurance, and geographic attachment points across years, showing understanding of the question’s structure. However, the inclusion of unverified reinsurance program details undermines the reasoning accuracy. (4) The correctness score is 7 because the central narrative and some key facts (e.g., $1.3B loss, $125M ROW attachment) are correct, but the incorrect Japan attachment and fabricated reinsurance program details prevent a higher score. Quantitative accuracy is 6 due to one major number error and unsupported additions. Qualitative accuracy is 8 because the reasoning and entity identification (AIG, years, terrorism risk) are strong. Contextual relevance is 9 as the answer directly addresses all aspects of the question, albeit with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 562,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson’s pipe‑working tools—including pipe wrenches—are housed in the Safety & Productivity segment, which held about $1.4 billion in sales in 2022, $1.388 billion in 2023 and $1.390 billion in 2024, with earnings rising from $250 million to $308 million over the same period.  The segment’s flat‑to‑slightly growing sales and its reliance on distributor channels show that Emerson is maintaining and modestly expanding this professional‑tools line as a strategic pillar that reinforces its broader safety‑and‑productivity positioning alongside its automation and software businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits the core information about Emerson's product portfolio evolution for pipe-working tools. The ground truth describes a clear technological progression from traditional tools in 2022 to battery-powered and digitally integrated tools by 2024. The LLM answer instead focuses on financials of the Safety & Productivity segment without linking these to product evolution. (2) The financial figures provided—$1.4B (2022), $1.388B (2023), $1.390B (2024), and earnings from $250M to $308M—are not present in the original answer and cannot be verified against the ground truth; thus, they are likely fabricated or misattributed. The original answer contains no sales or earnings data, so these numbers fail the quantitative accuracy test. (3) The multi-hop reasoning is flawed: the question asks for a progression in product offerings (pipe wrenches, hydraulic tools, diagnostics) across 2022–2024, but the LLM fails to describe any product changes. Instead, it infers strategy from unverified financial trends and channel reliance, missing the technological shift entirely. (4) While the mention of the Safety & Productivity segment is contextually plausible (as tools may fall under it), the answer does not address the actual product evolution—no mention of battery hydraulic tools, sewer cameras, or digital integration—which are central to the original answer. The strategic interpretation (maintaining tools as a strategic pillar) is partially aligned but unsupported by correct evidence. Hence, correctness is low due to major omissions and unverified data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 447,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco’s disclosure and accounting for free‑rent periods have been unchanged from 2022 through 2024.  The company treats such periods as lease incentives and recognizes the associated lease expense on a straight‑line basis over the entire lease term (including any extension options that are reasonably certain to be exercised).  Because the lease payments are waived during the free‑rent period, the present value of the lease liability – and therefore the initial right‑of‑use asset – is lower, and the asset is subsequently amortized evenly over the lease term, resulting in a reduced initial ROU‑asset balance and a stable expense pattern.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Costco's consistent use of straight-line recognition for free-rent periods over the lease term, including extension options that are reasonably certain to be exercised, which aligns with the ground truth. It accurately explains that free-rent periods reduce the present value of lease payments, thereby lowering the initial right-of-use (ROU) asset and lease liability, and that amortization occurs evenly—this reflects correct qualitative understanding of lease accounting under ASC 842. However, the LLM fails to capture a key evolution in disclosure practices highlighted in the original answer: the reduction in detail about the discounting methodology (specifically, the use of incremental borrowing rates and discounted future minimum lease payments) from 2022 to 2023–2024. While the accounting treatment remained stable, the original answer emphasizes a shift in disclosure depth, indicating less elaboration on valuation mechanics in later years. This omission represents a significant gap in addressing the 'evolution' aspect of the question, particularly regarding transparency around ROU asset valuation. The LLM implies consistency in both accounting and disclosure, whereas the ground truth notes unchanged accounting but reduced disclosure specificity. There are no numerical inaccuracies (hence high quantitative score), and the response is contextually relevant, but the lack of attention to changing disclosure patterns undermines full qualitative accuracy. The multi-hop synthesis is partially sound but misses the temporal comparison in narrative disclosure, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 448,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft first introduced the 2.000 % tranche (actually a 2.400 % series that matures in 2022) in the **Twelfth Supplemental Indenture** dated February 6 2017 (Exhibit 4.15), which amends the 2009 Base Indenture and sets the maturity timeline for that short‑term issuance.  In 2023 the company updated the same indenture framework with the **Fourteenth Supplemental Indenture** (March 17 2021, Exhibit 4.17) and then the **Fifteenth Supplemental Indenture** (November 6 2023, Exhibit 4.18), adding new tranches with later maturities (2024, 2027, 2037, 2047, 2057) and effectively replacing the 2022‑maturing notes within a longer‑dated structure.  Consequently, across 2022‑2024 the 2.000 % notes evolved from a single 2022‑due series under the 2017 supplemental indenture to a broader set of longer‑dated series documented in the successive 2021‑ and 2023‑dated supplemental indentures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that the 2.000% Notes were introduced in the Twelfth Supplemental Indenture dated February 6, 2017, while the ground truth identifies the Eleventh Supplemental Indenture dated August 8, 2016. (2) It misidentifies the coupon rate and maturity: claiming a '2.400% series that matures in 2022' instead of the correct 2.000% Notes maturing in 2023. (3) It falsely asserts that in 2023, Microsoft issued the Fourteenth and Fifteenth Supplemental Indentures (with March 17, 2021, and November 6, 2023 dates) to replace the 2.000% Notes with new tranches, which contradicts the ground truth showing no structural changes to the 2.000% Notes across 2022–2024. (4) The ground truth confirms the 2.000% Notes due 2023 remained under the same indenture documentation throughout all three years, with no updates or replacements. The LLM incorrectly implies evolution and restructuring where none occurred. (5) The answer fabricates the existence of new maturities (2024, 2027, etc.) tied to the 2.000% Notes, which are not associated with this specific tranche. While the response attempts multi-hop reasoning across years and indentures, the core entities, dates, and financial terms are wrong, leading to a fundamentally incorrect conclusion. The contextual relevance is moderate because it addresses the general topic of note issuance and indentures, but the specifics are erroneous.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 409,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon continues to recognize third‑party seller revenue when the service is performed—generally upon delivery of the seller’s product to a carrier or customer—but the way it is recorded has evolved. In 2022 the revenue was reported as a single lump‑sum that combined commissions with any shipping/fulfillment fees; starting in 2023 (as detailed in the 2023 10‑K Notes 1‑44) the company began allocating the transaction price across separate performance obligations, capitalizing upfront commissions and amortizing them while treating fulfillment fees as a distinct revenue stream recognized when the fulfillment service occurs. By 2024 this practice persisted, causing a growing share of third‑party seller revenue to come from fulfillment fees rather than pure commission income.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the right topic and timeframe. (1) The claim that Amazon began allocating transaction prices across performance obligations, capitalizing upfront commissions and amortizing them starting in 2023 is not supported by the ground truth. The original answer states only that Amazon clarified its recognition timing—revenue is recognized when services are rendered—but does not mention changes in accounting treatment such as capitalization or amortization of commissions. (2) The assertion that revenue was reported as a 'lump-sum' in 2022 combining commissions and fees is contradicted by the original answer, which makes no such claim about aggregation or presentation format. (3) The statement that fulfillment fees became a 'growing share' of revenue due to this accounting change is speculative and unsupported by the ground truth, which notes no such shift in composition. (4) The citation of 'Notes 1-44' in the 2023 10-K is overly specific and not corroborated by the original answer, which provides no such detail. While the LLM correctly identifies the general timing of revenue recognition (upon delivery to carrier/customer) and the types of fees involved, it fabricates a detailed accounting policy change that is not present in the ground truth. The reasoning is thus flawed in its multi-hop synthesis—inferring a change in revenue presentation and accounting treatment that isn't stated. However, the answer is contextually relevant, focused on the correct company, years, and revenue streams, and interprets the trend in disclosure clarity mentioned in the original answer, albeit with overreach. Quantitative accuracy is moderate because there are no explicit numbers (e.g., dollar amounts, percentages) to verify or falsify, but the implied changes in revenue composition are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 504,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s decision to keep its guaranty of Southwestern Bell Telephone Co.’s obligations in place through 2022, 2023 and 2024 shows that it is treating those legacy telecom liabilities as a persistent, off‑balance‑sheet commitment. By maintaining the guarantee, the company preserves the credit standing of the parent and avoids triggering default risk in the successor entities, indicating a deliberately cautious, long‑term approach to managing and ultimately winding down its historic Bell‑company obligations rather than shedding them outright.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022, 2023, 2024) and entities (AT&T and Southwestern Bell Telephone Co.), satisfying quantitative and entity accuracy. The core claim—that AT&T maintained its guarantee over the three years—is correct and aligns with the original answer. However, the LLM introduces the concept of an 'off-balance-sheet commitment' and suggests the purpose is to 'avoid triggering default risk in successor entities' and to 'wind down' obligations, which are inferences not supported by the provided ground truth. The original answer emphasizes the *unchanging nature* of the guarantee (via repeated Exhibit 4-b) as evidence of a stable, unaltered strategy, whereas the LLM frames it as part of a cautious wind-down strategy, adding interpretive layers not present in the source. While the reasoning is plausible, it goes beyond the evidence in the ground truth, which notes *no indication of reduction or restructuring*—contradicting the 'winding down' implication. The multi-hop synthesis is partially sound (linking repeated guarantees to strategic intent), but the conclusion extends beyond the documented facts. Wording differences are acceptable, but the added narrative reduces qualitative accuracy. Contextual relevance is high as it directly addresses the question about long-term liability management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 380,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nThe carrying amount of J&J’s 2.250% Notes due 2050 fell from **$842 million at the end of 2022 to $826 million in 2023 and to $808 million by the end of 2024** (see the debt tables on pages 71‑72 of the 2022‑2024 10‑K filings).  \nThis steady decline shows that Johnson & Johnson is intentionally reducing that tranche of long‑term debt—paying it down rather than refinancing—reflecting a broader deleveraging strategy aimed at lowering interest expense and strengthening the company’s long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 value: it reports $842 million, whereas the ground truth is $983 million. This discrepancy affects the accuracy of the trend description. The 2023 ($826M) and 2024 ($808M) values are correct. (2) The calculation of the downward trend is accurate for 2023–2024, but the starting point (2022) is wrong, leading to an incorrect portrayal of the magnitude of decline. The actual drop from 2022 to 2023 was $157M (from $983M to $826M), much steeper than the $16M drop from $842M to $826M implied in the LLM answer. (3) The reasoning about Johnson & Johnson’s long-term debt strategy is plausible and aligns with the question’s intent—interpreting the trend as part of a deleveraging strategy. However, the ground truth emphasizes stability with minor reductions and a fixed effective rate of 2.29%, which the LLM omits. This missing detail weakens the qualitative accuracy, as the fixed-rate context supports a 'stable cost of capital' strategy rather than pure deleveraging. (4) The LLM correctly identifies the entity (Johnson & Johnson), the debt instrument (2.250% Notes due 2050), and the time frame (2022–2024), and it synthesizes data across years, satisfying multi-hop requirements. However, the incorrect 2022 figure undermines the quantitative foundation of the analysis. The contextual relevance is high because the answer addresses both the evolution and strategic implication as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 408,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nCostco kept its $1.25 billion 1.375 % Senior Notes due June 2027 on the books throughout 2022‑2024, while it retired the $1 billion 2.750 % notes that matured in May 2024 and continued to roll portions of its senior debt into later‑maturing tranches (2030‑2032).  By using cash and short‑term investments to pay off higher‑coupon debt and maintain a staggered maturity schedule, the company is deliberately extending the average life of its borrowings and preserving low‑cost financing, revealing a capital‑management strategy that emphasizes liquidity, debt‑profile optimization, and a conservative approach to leverage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding specific debt instruments and amounts not supported by the ground truth. While it correctly states that the $1.25 billion 1.375% Senior Notes due June 2027 remained on the books from 2022–2024 (matching the ground truth of $1,250 million), it introduces new information not present in the original answer—specifically, the retirement of $1 billion 2.750% notes in May 2024 and refinancing into 2030–2032 tranches. This detail is absent from the ground truth and cannot be verified from the provided data, making it a significant factual overreach. (2) The quantitative accuracy is partially correct: the $1.25 billion figure for the 1.375% notes is accurate and consistent across years. However, the broader total long-term debt trend—decreasing from $6,590M (2022) to $6,484M (2023) to $5,919M (2024)—is omitted in the LLM answer, and no supporting numbers for other tranches or total debt are provided. The claim about retiring $1B in 2.750% notes lacks corroboration in the ground truth. (3) The multi-hop reasoning is plausible but speculative. The LLM infers a strategy of retiring higher-cost debt and extending maturities, which aligns conceptually with the ground truth’s conclusion of selective repayment. However, this specific reasoning is not directly supported by the data provided in the original answer, which only confirms stability in the 1.375% notes and an overall decline in total debt without specifying which tranches were repaid. Thus, while the strategic interpretation is reasonable, it goes beyond the evidence. (4) The contextual relevance is high—the answer addresses the evolution of debt structure and infers capital management strategy appropriately. The qualitative reasoning is sound in logic but overreaches in specificity. Due to unsupported claims about refinancing activities and missing key quantitative trends in total debt, the correctness score is reduced to 6—partially correct but with significant factual gaps and additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 550,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard deepened its multi‑layered security framework—tightening participant onboarding, expanding operating‑standard and AI‑driven fraud‑detection controls, and strengthening settlement guarantees—while simultaneously scaling real‑time, multi‑rail payment rails such as Mastercard Send, Track BPS and the 2024 Alias‑Based Remittances platform that now reach >95 % of the banked population and operate in 13 real‑time markets. This parallel evolution shows that the company is coupling its aggressive global expansion of instant‑payment capabilities with reinforced, technology‑enabled risk controls to preserve network integrity and protect all stakeholders as it grows its real‑time ecosystem worldwide.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unverified details not present in the ground truth. While it correctly notes expansion in real-time payments infrastructure and a continued emphasis on multi-layered security, it fabricates specific programs and metrics. For example, the claim that Mastercard's real-time rails now reach '>95% of the banked population' is not supported by the original answer, which only states that by 2024 the company operated in 'several countries around the world'—a qualitative, not quantitative, assertion. Similarly, the mention of 'AI-driven fraud-detection controls', 'Mastercard Send, Track BPS', and the '2024 Alias-Based Remittances platform' are specific product expansions not referenced in the ground truth. (2) Quantitatively, the original answer states real-time infrastructure was in 12 markets as of end-2021, expanded to 13 by 2023, and described more broadly in 2024. The LLM correctly cites 13 markets but incorrectly implies growth to over 95% of the banked population, which is unsupported. No percentage coverage is mentioned in the original. (3) The multi-hop reasoning is partially sound—linking security and infrastructure growth is valid—but the LLM overreaches by asserting specific technological enhancements and product integrations not found in the filings. The original emphasizes consistent security framing and gradual market expansion, with no mention of tightening onboarding or AI controls. (4) The contextual relevance is high because the answer addresses the core theme of parallel development between security and infrastructure. However, correctness and quantitative accuracy are low due to invented details. The qualitative accuracy is moderate because the general strategic direction is plausible but not substantiated by the provided evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 502,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nMicrosoft’s 10‑K filings show that the 4.000% Notes due 2021 were last added to the indenture in the **Third Supplemental Indenture of February 8 2011** (Exhibit 4.6 in the 2022 filing).  In the **2022, 2023 and 2024** filings the company filed only newer supplemental indentures (e.g., Exhibits 4.11‑4.14 in 2023 and Exhibit 4.15‑4.19 in 2024) that introduce longer‑dated series such as the 2025‑2057 notes; none of these later filings reference any additional issuance or amendment of the 4.000% 2021 tranche.  \n\nThis pattern indicates that Microsoft is **letting the 2021‑dated debt amortize and is instead extending its long‑term funding by issuing newer, longer‑maturity notes**, using staggered supplemental indentures to diversify and lengthen the overall debt profile rather than refinancing the near‑term 4.000% 2021 series.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the mention of the Third Supplemental Indenture dated February 8, 2011, and Exhibit 4.6 in the 2022 filing aligns with plausible SEC filing structures, but the ground truth does not specify the 2011 date, so this detail cannot be verified and may be incorrect or hallucinated. The absence of amendments to the 4.000% Notes due 2021 in 2023 and 2024 is consistent with the original answer, which notes no structural changes. However, the LLM incorrectly implies that the 4.000% Notes were not referenced after 2022 by stating only newer exhibits were filed, while the ground truth explicitly states the 4.000% Notes due 2021 were still disclosed in all three years, including post-maturity in 2024. (2) The LLM claims that newer supplemental indentures (e.g., Exhibits 4.11–4.14 in 2023 and 4.15–4.19 in 2024) were filed but does not confirm whether the 4.000% Notes were still listed—this omission leads to an inaccurate conclusion. The ground truth emphasizes continued disclosure of the 2021 notes even after maturity, which the LLM fails to acknowledge. (3) The reasoning about Microsoft letting the debt amortize and issuing longer-dated notes is plausible and contextually sound, but it contradicts the ground truth observation that the company continued to disclose the 2021 notes post-maturity, suggesting possible rollover or delayed settlement rather than clean amortization. Thus, the LLM’s inference about 'no refinancing' is speculative and potentially incorrect. (4) While the LLM addresses the evolution across years and attempts to infer strategy, it misses the critical point about post-maturity disclosure, which is central to the original answer’s conclusion about transparency and disciplined disclosure practices. The answer is contextually relevant and well-structured but factually incomplete and partially misleading in its implications. Therefore, the correctness score is moderate due to significant omissions and potential hallucination of dates, despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 571,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s repeated mention of the 1.500 % Note due 2030 — first filed in the 2020 Officers’ Certificate, then again in the 2021 and 2022 certificates — signals that the company treats this medium‑term, low‑coupon tranche as a core component of its long‑dated financing mix. By consistently re‑issuing a 2030 maturity at a modest 1.5 % rate, Amazon extends the average life of its debt, locks in inexpensive capital for the 2020‑2030 window, and balances it against higher‑coupon notes (e.g., 4.7 % 2024, 5.2 % 2025) and shorter‑term facilities, underscoring a strategy that prioritizes low‑cost, staggered maturity profiles to fund growth while preserving liquidity and flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) The 1.500% Note due 2030 was not first filed in 2020 or mentioned in 2021 Officers’ Certificates — the ground truth states it was introduced in the 2022 filing, not earlier, making the timeline incorrect. The LLM incorrectly claims re-issuance in 2021 and 2022, but Amazon did not re-issue this note; it was issued once and carried forward in disclosures, which is a critical distinction. (2) The LLM references a '5.2% 2025' note not mentioned in the original answer or context, introducing a fabricated debt instrument. While the 4.700% Note due 2024 is correctly referenced, the 4.700% Note due 2032 (a key point in the original answer) is omitted and replaced with incorrect maturities. (3) The reasoning about 'staggered maturities' and 'low-cost capital' aligns conceptually with the ground truth and shows appropriate multi-hop synthesis intent — the idea of balancing low-rate long-term debt with higher-cost short-term instruments is qualitatively sound. (4) Contextually, the answer addresses the core question about capital structure strategy and long-term financing, so relevance is high. However, due to incorrect dates, fabricated instruments, and misrepresentation of issuance history, the quantitative accuracy is low. The answer captures the strategic rationale but fails on key facts, resulting in a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 393,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through early 2024 AT&T held a 41.3 % equity stake in SKY Mexico and accounted for it under the equity‑method as an “equity affiliate” (see T‑10K 2023 page 66 and T‑10K 2024 page 68).  The interest remained on AT&T’s balance sheet until June 2024, when AT&T sold its entire 41.3 % holding, recording cash distributions that exceeded its cumulative equity earnings (see T‑10K 2024 pages 68‑69).  This divestiture follows the same pattern AT&T used for DIRECTV and other international pay‑TV joint ventures—maintaining an equity stake only until a strategic exit can be executed—signaling a broader shift away from long‑term ownership of foreign pay‑TV assets toward monetizing such investments through targeted sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico from 2022 through mid-2024, accounted for it under the equity method, and exited completely in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is correctly stated, and the timing of the exit (June 2024) is precise and consistent with the ground truth's 'mid-2024' characterization. The reference to cash distributions exceeding cumulative equity earnings adds a detail not in the original but is plausible and does not contradict it. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022–2024, connects the SKY Mexico exit to prior divestitures like DIRECTV, and infers a broader strategic pattern of exiting international pay-TV markets. The conclusion about AT&T’s strategic refocusing is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 context of SKY Mexico ownership being retained post-Vrio sale, which adds nuance to the strategic trajectory. However, this omission does not undermine the core accuracy. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing ownership, accounting treatment, exit timing, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 387,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nAIG’s U.S. pension glide‑path shifted steadily toward a more liability‑driven mix: the 2022 target called for roughly 15 % equity, 75 % fixed‑maturity and 10 % other assets; by 2023 the target had been trimmed to about 13 % equity (with 77 % fixed‑income and 10 % other); and for 2024 the plan’s target was 9 % equity, 80 % fixed‑maturity and 11 % other. This progression—reducing the growth‑asset share and increasing the proportion of interest‑rate‑sensitive securities—mirrors the plan’s improving funded ratio, showing that AIG de‑risked the portfolio as the pension’s financial position strengthened.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative trend of AIG's de-risking strategy through its glide path approach, accurately describing a shift toward liability-hedging assets and reduced equity exposure as the funded status improved. This aligns with the ground truth's emphasis on liability-driven investing and de-risking in response to a strengthening funded position, earning high marks for contextual relevance and reasonable qualitative accuracy. However, the quantitative accuracy is significantly flawed: the original answer (ground truth) does not provide specific percentage allocations for equity, fixed-income, or other assets in any year. These precise figures (e.g., 15%, 75%, 10% for 2022) are hallucinated and not supported by the source knowledge. The ground truth discusses the *mechanism* of the glide path—how target allocations are set based on prior-year funded status and the directional shift toward de-risking—but contains no numerical breakdowns of portfolio composition. Therefore, while the LLM correctly infers the direction of change (reducing growth assets, increasing hedging assets), it fabricates specific percentages, undermining factual reliability. This constitutes a major error in quantitative accuracy, even though the overall reasoning about de-risking in response to improved funding is logically sound and contextually appropriate. The answer also correctly identifies the multi-hop logic (funded status at year-end determines next target), but adds unsupported specifics. Thus, the correctness score is moderate due to plausible but invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 434,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard progressively tightened its credit‑risk framework—updating risk‑mitigation requirements, expanding cash‑collateral and guarantee arrangements, and refining its settlement‑exposure calculations—while simultaneously increasing accruals for litigation and cooperating with U.S. DOJ, FTC and EU investigations.  These adjustments show that the company can rapidly recalibrate its risk‑management policies and controls in response to mounting regulatory scrutiny and expanding litigation exposure, underscoring a high degree of adaptability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Mastercard's credit risk mitigation strategies from 2022 to 2024 in response to regulatory and litigation pressures. It accurately notes the use of cash collateral, guarantees, and refinements to settlement exposure calculations, which aligns with the original answer. However, the LLM overstates the degree of change by suggesting Mastercard 'progressively tightened' its framework and 'expanded' arrangements, while the ground truth emphasizes consistency in the core framework despite changing external pressures. The original answer stresses that the company maintained a consistent approach, only revising estimates and standards 'as necessary,' rather than proactively tightening. (2) There are no specific numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised—no errors in dates (2022–2024) or entities (DOJ, FTC, EU). (3) The multi-hop reasoning is partially sound: the LLM correctly links regulatory actions (DOJ, FTC, EU) to risk management adaptations. However, it misses the key nuance that despite escalating external risks, Mastercard reported consistently low losses, which demonstrates effectiveness of the existing framework rather than the need for major changes. This weakens the qualitative accuracy. (4) The answer is contextually relevant and captures the spirit of adaptability, but it misrepresents the nature of the evolution—portraying active tightening rather than measured, reactive refinements within a stable framework. Hence, correctness and qualitative accuracy are reduced to 7, while quantitative accuracy remains high due to absence of numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 465,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nThe 10‑K filings show the Omnibus Plan’s remaining reserve fell modestly each year – roughly 73 million shares were available at the end of fiscal 2022, about 71 million at the end of fiscal 2023, and only ≈ 70 million by the end of fiscal 2024.  This gradual contraction signals that Home Depot is deliberately scaling back its equity‑award pool, reflecting a more conservative stock‑based‑compensation strategy that prioritizes limiting dilution and capital returns (e.g., share repurchases) over expanding future equity grants.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, 117 million shares were available in 2022, not 73 million as stated by the LLM. The 2023 figure is reported as 77 million (as of January 28, 2024), but the LLM states ~71 million at the end of fiscal 2023. The 2024 figure is correct at ~70 million, though the date (February 2, 2025) is omitted. These numeric deviations are substantial and materially incorrect. (2) The LLM incorrectly frames the trend as a 'modest' and 'gradual contraction' implying a slow reduction from 73M to 70M, whereas the actual drop is from 117M to 70M over three years—a much steeper decline. This misrepresents the scale of share usage. (3) The reasoning is flawed: the LLM concludes that the company is 'scaling back its equity-award pool' and adopting a 'more conservative' strategy, which contradicts the ground truth interpretation that the reduction reflects active issuance of equity compensation, suggesting increased reliance on stock-based incentives. This is a critical misinterpretation of the same data. (4) The context of the Omnibus Plan changing from the 2005 Plan and being amended is entirely omitted, affecting entity and timeline accuracy. While the answer addresses the question's structure and discusses strategy, the factual foundation is incorrect, leading to an invalid conclusion. Thus, despite some relevance and structure, the answer fails on core accuracy and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 415,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nThe 3.625 % senior notes due October 2024 were still a long‑term liability in FY 2022, fell to a $622 million carrying balance at the end of FY 2023, and were completely eliminated by the end of FY 2024.  Broadcom retired the entire tranche—using cash from its July‑ and October‑2024 senior‑note issuances and related term‑loan repayments—thereby removing a near‑term maturity and reshaping its post‑VMware merger debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $622 million figure and the full elimination of the obligation by FY 2024, which aligns with the ground truth. However, it misstates the timeline: it claims the balance was $622 million at the end of FY 2023, whereas the ground truth states the $622 million obligation was present in both FY 2022 and FY 2023 with no change, meaning the reduction occurred in FY 2024. The LLM implies a decline from long-term liability to $622M between FY 2022 and FY 2023, which contradicts the unchanged status in the original answer. (2) The $622 million amount is accurate, and the final $0 balance in FY 2024 is correct. However, the characterization of the change across years is quantitatively misleading—there is no support for a reduction by FY 2023. Additionally, the mention of 'July- and October-2024 senior-note issuances' introduces specific financing activities not present in the ground truth, which does not specify how the repayment was funded. These details are potentially hallucinated or unsupported. (3) The multi-hop reasoning is partially sound—linking the elimination of debt by FY 2024 to debt management strategy is valid, and recognizing the near-term maturity context is appropriate. However, the reasoning is based on an incorrect progression of the liability (implying a reduction in FY 2023 when there was none), weakening the logical foundation. The reference to the VMware merger is contextually plausible but not mentioned in the ground truth, introducing extraneous assumptions. (4) The contextual relevance is high—the answer addresses debt evolution and strategy, uses correct entities (Broadcom, 3.625% notes, October 2024 maturity), and interprets the payoff meaningfully. However, due to factual inaccuracies in the year-by-year progression and unsupported claims about financing mechanisms, the correctness and qualitative accuracy scores are reduced to 6, reflecting partial correctness with significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 550,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T moved from the April 2022 completion of the Reverse‑Morris‑Trust separation of WarnerMedia to the May 2021 agreement (still in effect in 2022) to merge WarnerMedia with Discovery, and finally to the September 2024 announcement that it would sell its remaining stake in DIRECTV— the vehicle that held the former WarnerMedia assets—to TPG, a transaction slated to close in mid‑2025.  This sequence shows AT&T’s deliberate exit from the entertainment and content‑distribution business and a strategic refocus on its core telecommunications operations—expanding 5G, fiber‑based broadband and related infrastructure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in dates and sequence of events. It incorrectly states that the agreement to merge WarnerMedia with Discovery was in May 2021 and 'still in effect in 2022'—while the merger was announced in May 2021, it closed in April 2022, which aligns with the correct timeline. However, the LLM misrepresents this as an ongoing agreement rather than a completed transaction. Additionally, it claims the DIRECTV sale was announced in September 2024 and would close in mid-2025, but the original answer states the agreement occurred in 2024 without specifying closure timing—this is a minor extrapolation, but not directly contradicted. (2) The key error is the May 2021 date being carried forward as if active in 2022, when the actual separation was completed in April 2022—this misdates a pivotal event and undermines quantitative accuracy. The mention of September 2024 for the DIRECTV sale lacks corroboration in the ground truth, which only says 'in 2024'. (3) The reasoning about T's strategic pivot is sound and reflects correct multi-hop synthesis: the divestiture of WarnerMedia via Reverse Morris Trust, followed by exit from DIRECTV, signals a retreat from entertainment. The conclusion about refocusing on telecom (5G, fiber) aligns with the original answer’s theme of returning to core operations. (4) Despite correct overall narrative direction, the incorrect dating of key events—especially referencing a 2021 agreement during the 2022–2024 period—reduces factual reliability. The core financial and strategic trajectory is partially accurate, but flawed in execution details, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 463,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson reframed its Pipe Cutters offering inside the Safety & Productivity segment as a **connected, battery‑powered system**—adding battery‑driven hydraulic actuation and diagnostic modules (e.g., CCTV pipe‑inspection and locating equipment) to the traditional cutter.  This integration is reflected in the segment’s financial trend, with Safety & Productivity sales holding steady around $1.39 billion in 2024 and earnings rising, underscoring Emerson’s strategic move to pair the cutters with battery‑powered technology and data‑enabled diagnostics to boost field productivity and safety.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the strategic evolution of Emerson's Pipe Cutters from standalone tools to integrated, battery-powered, and diagnostic-enabled systems within the Safety & Productivity segment. It accurately reflects the multi-year shift toward battery-powered technologies and diagnostic integration (e.g., CCTV inspection), aligning with the ground truth's description of a move toward smart, integrated tooling for productivity and safety. The narrative progression from 2022 to 2024 is logically structured and semantically equivalent.\n\n2) However, the LLM introduces a specific financial figure—'Safety & Productivity sales holding steady around $1.39 billion in 2024'—that is not present in the original ground truth. There is no mention of this number in the knowledge graph answer, nor is there any financial data provided to support it. This is a significant quantitative addition not grounded in the source, which reduces confidence in numerical accuracy. While the earnings trend ('earnings rising') is plausible, it is also unverified and not mentioned in the original answer.\n\n3) The multi-hop reasoning is strong: the model synthesizes the integration of battery-powered hydraulics and diagnostic systems (like sewer/CCTV cameras) with the Pipe Cutters line across years, correctly attributing the strategic shift to enhanced field productivity and safety. The use of 'connected, battery-powered system' and 'data-enabled diagnostics' reflects accurate conceptual understanding and appropriate terminology.\n\n4) Contextual relevance is excellent—the response directly addresses Emerson (EMR), the Pipe Cutters product line, the Safety & Productivity segment, and the 2022–2024 timeframe. The qualitative insights about strategic positioning are fully aligned with the ground truth, despite the unsupported financial figure. The correctness score is 8 due to the accurate core narrative but docked for introducing unverified quantitative data not present in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 540,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly cites a multi‑year, enterprise‑wide program that “integrates, simplifies and standardizes processes and systems for the human‑resources, information‑technology, procurement, supply‑chain and finance functions” in order to “support the growth of the Company’s financial shared‑service capabilities and standardize financial systems.”  The language in the 2022, 2023 and 2024 10‑K filings shows the initiative has been sustained and deepened each year, indicating that financial‑process standardization is a strategic priority used to improve efficiency, strengthen internal controls and underpin the firm’s broader growth agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and strategic implications of Johnson & Johnson's multi-year initiative from 2022 to 2024. It correctly identifies the initiative as enterprise-wide, spanning finance and other functions, with the goal of integrating, simplifying, and standardizing processes to support financial shared services and system standardization—consistent with the original answer. The LLM accurately reflects that this language was sustained across all three years, indicating continuity and strategic prioritization. It also correctly infers that this reflects a strategic focus on efficiency, internal controls, and growth support. One minor shortcoming is that the LLM does not explicitly mention the absence of internal control deficiencies as a motivating factor (a point emphasized in the 2022 filing per the ground truth), which slightly weakens the qualitative completeness. However, this omission does not distort the overall meaning. All entities (Johnson & Johnson, finance function, 2022–2024 timeframe) and reasoning are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully contextually relevant, directly addressing both parts of the question: evolution over time and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 362,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nCostco has continued to list the **Executive Health Plan** as **Exhibit 10.1\\*** in each of its Form 10‑K filings for fiscal 2022, 2023 and 2024, with the same description and the original 2012 filing reference retained in every filing.  No new exhibit number, amendment, or separate filing was introduced— the plan remains incorporated by reference exactly as it was first disclosed.  \n\nThis unchanged, recurring disclosure indicates that the health‑plan benefit is a **permanent, long‑term component of Costco’s executive compensation package**, and the company sees no need to restructure or replace it, reinforcing a stable, enduring executive‑benefit strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Costco consistently disclosed the Executive Health Plan as Exhibit 10.1* in its 10-K filings for fiscal years 2022, 2023, and 2024. The LLM correctly notes that the same 2012 filing reference is retained across all years, which matches the ground truth's specific 'Period Ended' (September 2, 2012) and 'Filing Date' (October 19, 2012). While the LLM does not explicitly name those exact dates, it accurately captures their significance by stating the original 2012 filing reference is unchanged, which is semantically equivalent in context. (2) There are no calculation errors, and all dates and references are factually consistent with the knowledge graph. Format variation (not listing exact day/month) is acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the model correctly infers from the lack of amendments or new filings over three years that the plan remains structurally unchanged, and logically concludes this reflects a stable, long-term executive benefit strategy—exactly as stated in the original answer. (4) The answer is fully relevant, addressing both the evolution (or lack thereof) in disclosures and the strategic implication. The only minor shortcoming is the absence of the precise 2012 dates, which slightly reduces qualitative precision but does not impair factual correctness. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 431,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares carried the same governance terms—​one vote per share and dividend rights—​as set out in the company’s charter (see Note 16 on pages 96 & 98).  The cash dividend per share rose each year, from **$2.04 in 2022**, to **$2.37 in 2023**, to **$2.74 in 2024** (see the dividend tables on pages 98 & 100).  This steady‑increase while keeping voting rights unchanged reflects a deliberate, shareholder‑friendly governance strategy that preserves voting influence for investors while rewarding them with consistently growing cash payouts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces a narrative about increasing dividends per share—$2.04 in 2022, $2.37 in 2023, $2.74 in 2024—which is not supported by the ground truth. The original answer states only that A Class Shares had 'standard dividend rights' with no mention of specific dividend amounts or increases. This is a major factual error, as the evolution of dividend *payouts* is conflated with dividend *rights*. Dividend rights refer to the entitlement structure (e.g., parity with other classes), not the amount paid. (2) The quantitative values cited for dividends are entirely absent from the ground truth and cannot be verified; their inclusion suggests fabrication or hallucination based on external data not in the knowledge graph. Even if accurate in reality, they contradict the provided ground truth, which makes no such claims. (3) The reasoning is partially sound in linking stable voting rights (one vote per share) to governance stability, which aligns with the original answer. However, the conclusion that growing dividends reflect a 'deliberate, shareholder-friendly governance strategy' misattributes financial policy (payout levels) to governance structure (rights), which are distinct concepts. The multi-hop synthesis fails because it merges unrelated data points—dividend amounts and voting rights—into a single narrative not present in the source. (4) Contextual relevance is high because the response addresses both dividend and voting rights and attempts to infer governance strategy. However, correctness is low due to unsupported numerical claims and conflation of dividend amounts with dividend rights. The core factual claim of consistency in rights is overshadowed by incorrect emphasis on changing payouts. Thus, while the voting rights description is accurate, the dividend rights portrayal is not, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 509,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Broadcom’s Security Insights Platform was consistently presented as a solution that interprets and assesses mainframe security posture, identifies risks and generates remediation steps, with the resulting data made available for ingestion into customers’ own security‑information‑and‑event‑management (SIEM) and orchestration tools.  The filings stress that this integration with in‑house security tooling remained a core capability, while the platform’s risk‑identification function was progressively highlighted as leveraging AI‑driven threat intelligence to deliver more timely, automated risk detection and remediation guidance.  No substantive structural change is noted; rather, the emphasis shifted toward deeper AI‑enabled risk analysis and tighter coupling with customers’ internal security ecosystems.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant inaccuracies in qualitative details not supported by the ground truth. (1) Correct elements: The platform's role in assessing mainframe security posture, identifying risks, and integrating with in-house tools (e.g., SIEM) is consistent with the original answer across all three fiscal years. The absence of structural changes is also correctly noted. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in the response, so no quantitative errors exist—score reflects neutrality on this dimension. (3) Multi-hop reasoning assessment: The LLM fails in reasoning fidelity by asserting unverified advancements—specifically, 'AI-driven threat intelligence', 'automated risk detection', and 'remediation steps'—which are not mentioned in the ground truth for any fiscal year. The original answer notes only that in 2023, remediation planning was more explicitly tied to the platform, but does not describe AI capabilities or automated guidance. This represents a hallucination that distorts the evolution narrative. (4) The original answer emphasizes stability and consistency in functionality from 2022 to 2024, while the LLM implies progressive enhancement in AI and integration depth, contradicting the 'stable functionality' conclusion. Thus, while contextually relevant and addressing the question’s scope, the answer misrepresents the nature of the platform’s evolution, warranting a moderate correctness score due to major qualitative inaccuracies despite correct structural framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 431,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 through 2024 AIG shifted from a primarily industry‑standard catastrophe‑model approach—using proprietary adjustments and external expert review of loss‑reserve assumptions—toward a more formalized model‑risk framework that layers stochastic and scenario analyses, post‑catastrophe event studies, and explicit validation by third‑party model vendors and independent actuaries.  The company now relies on external experts not only to audit the technical outputs of its catastrophe and terrorism models but also to review the actuarial methods, climate‑change assumptions, and reinsurance‑recoverability calculations that underpin its loss‑reserve provisions, while incorporating richer exposure data and more granular risk‑concentration metrics to gauge reserve adequacy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, capturing the general evolution of AIG's loss reserve risk management with accurate qualitative trends. However, it introduces details not present in the ground truth, particularly around a 'catastrophe-model approach' and 'third-party model vendors' which are not mentioned in the original answer. The ground truth emphasizes internal controls, ERM oversight, and actuarial reviews but does not specify catastrophe modeling or climate-change assumptions as focal points. The LLM correctly identifies the increasing formalization of modeling techniques (stochastic and deterministic), use of external experts, and enhanced reserve adequacy assessments, aligning with the 2023–2024 developments. While the core trajectory—more structured frameworks, expanded external validation, and improved modeling—is consistent, the specific methodologies and emphasis on catastrophe and terrorism models are not supported by the original answer, indicating over-specificity or inference beyond the source. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is logically sound and synthesizes a coherent narrative, but with some unsupported elaboration, reducing qualitative accuracy. Contextual relevance remains high as the answer directly addresses the question’s focus on methodology evolution and external validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 394,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nAcross the three fiscal years Emerson kept Electrical Distribution Equipment inside the **Discrete‑Automation** sub‑segment of its Industrial Solutions (Intelligent Devices) portfolio.  Sales in that sub‑segment rose modestly from **$2.61 bn in 2022 to $2.64 bn in 2023**, then slipped slightly to **$2.51 bn in 2024**, while its share of the overall Intelligent Devices business fell from roughly **24 % to 21 %**.  The steady investment in related capital expenditures and the continued focus on discrete‑automation products signal that Emerson is deliberately using Electrical Distribution Equipment as a core platform to strengthen its presence in the discrete‑automation market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both entity placement and narrative evolution. According to the ground truth, Electrical Distribution Equipment was part of the broader Industrial Solutions segment in 2022 and only moved into Discrete Automation in 2023. However, the LLM claims it was in the 'Discrete-Automation sub-segment' all three years, which contradicts the reorganization timeline. This misrepresents the core strategic shift. (2) The quantitative data—$2.61B (2022), $2.64B (2023), $2.51B (2024), and 24% to 21% share—is entirely fabricated and not present in the original answer. There are no sales figures or percentages in the ground truth, so these numbers cannot be verified and appear invented. This severely undermines factual reliability. (3) The multi-hop reasoning fails: the original answer traces a structural reorganization signaling strategic intent, while the LLM focuses on fabricated financial trends and assumes constant segment placement, missing the key point of repositioning. It does not recognize that the 2023 move into Discrete Automation was a strategic shift, nor the 2024 deepening of integration with automation systems. (4) Contextual relevance is moderate because the answer discusses discrete automation and strategic emphasis, which are relevant themes, but the incorrect entities, timeline, and made-up metrics result in a mostly inaccurate response. The conclusion about 'core platform' aligns loosely with the original's 'foundational component,' but without correct reasoning support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 426,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly amended its U.S. non‑union defined‑benefit plan so that the **Retirement Value formula**—a service‑based benefit calculated on total years of compensation—would become the sole accrual method for all eligible employees (the change is effective 2026 but was already reflected in 2022‑2024 amendments, a $1.8 bn reduction in projected benefit obligation and the transfer of roughly $800 m of liabilities into group‑annuity contracts).  The multi‑year transition is also evident in the plan’s improving funded status (from a $4.0 bn deficit in 2022 to a $3.1 bn surplus in 2024) and a decline in actuarial losses in other‑comprehensive income.  Together, these moves signal a long‑term workforce strategy to shift toward a more sustainable, service‑linked compensation structure that better matches the company’s aging, globally dispersed workforce and the evolving cost‑base of its pension liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details not present in the ground truth. While the core idea of a transition to the Retirement Value formula by 2026 for U.S. non-union employees is correct, the LLM introduces unsupported financial figures such as a '$1.8 bn reduction in projected benefit obligation', '$800 m of liabilities transferred into group-annuity contracts', and specific funded status changes from '$4.0 bn deficit to $3.1 bn surplus'. These numbers do not appear in the original answer and cannot be verified from the provided knowledge graph. Additionally, there is no mention in the ground truth of 'repeatedly amending' the plan each year or actuarial losses declining in other comprehensive income. (2) The dates (2022–2024, effective 2026) are correctly referenced, but all dollar amounts and financial impacts are fabricated or incorrectly inferred. The ground truth does not include any quantitative financial metrics related to pension obligation reductions or funded status, so these claims fail the quantitative accuracy test. (3) The multi-hop reasoning is partially sound—correctly identifying a multi-year transition toward a new pension formula and linking it to long-term workforce strategy—but overreaches by inferring financial outcomes and liability management actions not disclosed in the source. The conclusion about 'cost predictability' and 'workforce inclusivity' in the original is replaced with a more speculative narrative about an 'aging, globally dispersed workforce' and 'evolving cost-base', which lacks direct support. (4) The correctness score is low due to major quantitative errors, though some qualitative elements (direction of change, target population, effective date) are accurate. Contextual relevance is moderate because the answer addresses the right topic and timeframe, but distracts with unverified financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 523,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nDowny’s share of the Fabric & Home Care segment has been essentially flat from 2022 through 2024 – the segment’s contribution to total net sales held steady at roughly 35 % (2022) and 36 % (2023‑2024), and Downy is consistently listed among the key brands (Ariel, Tide, Gain, etc.) without any disclosed year‑over‑year change.  This stability shows that Downy remains a core, mature contributor to the segment, but its impact is modest and not a primary engine of growth, indicating that the brand’s strategic importance is steady rather than expanding within P&G’s portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage contribution of the Fabric & Home Care segment to P&G's total net sales: 35% in 2022 and 36% in 2023–2024, aligning with the ground truth. It also correctly identifies Downy as a consistent key brand within the segment. However, the original question asks about Downy’s percentage contribution to the segment, not the segment’s contribution to total company sales. The LLM misinterprets the metric: it discusses the segment’s overall contribution to P&G rather than Downy’s share within that segment. This is a critical distinction and a major omission in addressing the actual question.\n\n2) Quantitatively, the numbers cited (35% in 2022, 36% in 2023–2024) are accurate—but they refer to the wrong metric. The ground truth does not provide Downy’s specific percentage contribution to the segment, only that it remained a key brand within a growing segment. The LLM incorrectly assumes that segment-level contribution percentages reflect Downy’s share, which is unsupported by the data.\n\n3) The reasoning is partially sound: the LLM correctly infers stability from consistent reporting and uses appropriate context (mentioning other key brands). However, it fails the multi-hop requirement by not distinguishing between segment-level performance and brand-level contribution. The conclusion that Downy is 'not a primary engine of growth' goes beyond the evidence provided in the ground truth, which emphasizes sustained strategic importance.\n\n4) Despite the misinterpretation, the answer is contextually relevant, well-structured, and draws a plausible inference from available data. The semantic meaning diverges on the core point: the original emphasizes Downy’s sustained importance due to segment growth, while the LLM suggests stagnation. This leads to a correctness score of 7—core facts about the segment are right, but the focus on the wrong metric limits accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 518,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nCapital One’s senior and subordinated notes carried a balance of roughly **$30.8 billion at the end of 2022**, **$31.2 billion at the end of 2023**, and **$30.7 billion at the end of 2024** (see Table 8.1 in the 2022, 2023 and 2024 10‑K filings). The modest rise from 2022 to 2023 reflects a deliberate issuance of long‑term notes to refinance maturing debt and fund growth, while the slight pull‑back in 2024 shows the company is now leaning more on deposit growth and securitization, keeping its overall debt‑financing level steady.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. The ground truth states that Capital One's total senior and subordinated notes were $27,219 million in 2022, $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM reports $30.8 billion (2022), $31.2 billion (2023), and $30.7 billion (2024), which misstates the 2022 value by over $3.5 billion and incorrectly suggests a decline in 2024 when the actual value plateaued. While the 2023 figure is close ($31.2B vs $31.248B), the 2024 figure is wrong—there was no drop to $30.7B. (2) Calculations and trends are therefore flawed: the LLM claims a 'slight pull-back in 2024', but the ground truth shows no decrease—the value remained flat at $31,248M. This undermines the conclusion about shifting strategy toward deposits and securitization. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret the trend and link it to financing strategy—but the conclusion is based on incorrect data. The actual trend (rising from 2022 to 2023 and stable in 2024) suggests continued reliance on note issuance, not a pullback. (4) Contextual relevance is high as the answer addresses both the evolution of debt and strategic implications. However, due to major quantitative errors affecting the qualitative interpretation, the correctness score is low. Minor formatting differences like $31.2B vs $31,248M are acceptable, but the 2022 and 2024 figures are materially off, and the narrative contradicts the true trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 427,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2023 AT&T held a 41.3 % equity stake in SKY Mexico and accounted for it under the equity‑method of accounting (see the “Investments in equity affiliates” table in the 2022 10‑K, page 95, and the same table in the 2023 filing, page 66). In June 2024 the company completed the sale of its entire 41.3 % interest, receiving cash and note payments and removing the investment from its balance sheet (see the disposition note in the 2024 filing, page 68). This exit illustrates AT&T’s systematic divestiture of non‑core Latin‑American pay‑TV assets—first preserving a strategic equity stake and then fully exiting to focus on its core telecom business and the broader WarnerMedia/Discovery restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T (referred to as 'T' in the question) held a 41.3% stake in SKY Mexico from 2022 through 2023, accounted for it under the equity method, and exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date are correctly stated; no calculations were required. Format variations (e.g., '41.3 %' with space) do not affect correctness. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings—2022, 2023, and 2024—to show the evolution of the investment and its eventual sale, correctly identifying the accounting treatment and divestiture. (4) The broader strategic interpretation—that this reflects a divestiture of non-core Latin American pay-TV assets to focus on core telecom and WarnerMedia/Discovery restructuring—is consistent with the ground truth’s conclusion about exiting non-core international assets. The only minor shortcoming is that the LLM slightly expands the strategic rationale to include 'WarnerMedia/Discovery restructuring,' which, while contextually plausible, is not explicitly mentioned in the ground truth. This does not make the answer incorrect but adds a detail beyond the provided knowledge graph. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 399,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nBetween 2022 and 2024 the 10‑K disclosures grew more explicit about the regulatory limits on BNY Mellon’s capital returns, repeatedly tying shareholder‑return decisions to U.S. banking capital‑adequacy rules (e.g., the need to remain “well‑capitalized” and “well‑managed”), the Board’s discretion, and statutory restrictions on dividends and capital planning.  The filings also highlighted the Parent’s reliance on subsidiary dividends for share‑repurchases and dividend payments, warned that any downgrade in credit ratings or failure to meet capital‑planning expectations could raise funding costs, and referenced emerging resolution‑framework requirements (Title I/II) as additional constraints on the firm’s ability to return capital.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of BNY Mellon's disclosures regarding capital return constraints from 2022 to 2024. It correctly identifies key regulatory constraints such as U.S. banking capital-adequacy rules, the Parent company's reliance on subsidiary dividends, and the impact of capital planning and credit ratings. The mention of Title I/II resolution frameworks adds relevant context. However, the answer lacks explicit year-by-year progression detailed in the ground truth: it does not clearly differentiate the 2022 emphasis on preferred dividends, the 2023 expansion into ESG and strategic initiatives, or the 2024 focus on strategic transformation's impact on liquidity. While the overall trend of increasing disclosure complexity is implied, the multi-hop synthesis across years is less precise. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and all entities (BNY Mellon, Parent company, subsidiaries, U.S. banking laws) are correctly identified. The reasoning is sound but omits some granular evolution noted in the original answer, slightly reducing qualitative accuracy. Contextual relevance is strong as all points relate directly to regulatory constraints on capital returns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 359,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nFrom 2022 through 2024 3M reshaped the role of structural adhesives by moving them into a newly created **Industrial Specialties division** within the Safety and Industrial segment (see page 132), grouping adhesives together with related tapes, closure‑system and personal‑safety products.  This bundling‑focused reorganization—highlighted in the segment‑product tables (page 130) and the 2023‑2024 segment‑performance data (pages 108‑111)—positions adhesives as a cross‑selling platform that fuels growth across multiple industrial offerings, underscoring their strategic importance as a high‑margin, growth‑driving core for 3M’s industrial portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric values, dates, or calculations, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual inaccuracies. The LLM claims that 3M created a new 'Industrial Specialties division' in which structural adhesives were grouped with tapes, closure systems, and personal-safety products—a claim not supported by the ground truth. The original answer indicates no such reorganization occurred; instead, there was a gradual shift in product bundling emphasis: in 2022, structural adhesives were grouped with abrasives, autobody repair, and electrical materials; in 2023, packaging and closure systems were added; by 2024, the focus shifted toward specialized industrial applications like construction and maintenance. The LLM incorrectly attributes this evolution to a formal structural reorganization ('newly created division'), which is not mentioned in the ground truth. Additionally, the LLM introduces 'personal-safety products' as part of the bundle, which contradicts the original answer—safety is part of the segment name but not linked directly to adhesives in this context. The strategic interpretation about adhesives being a 'cross-selling platform' and 'high-margin, growth-driving core' goes beyond the provided information and adds unsupported inference. While the answer addresses the general theme of strategic importance and product bundling (hence moderate contextual relevance), it fails on key entity accuracy and reasoning, misrepresenting the nature and cause of the positioning shift. Multi-hop synthesis is flawed because it misattributes changes to an organizational restructuring rather than a gradual evolution in product grouping emphasis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 490,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024 Eli Lilly expanded Cyramza’s clinical footprint—adding a first‑line indication for EGFR‑mutated metastatic NSCLC while retaining its established second‑line uses in gastric cancer, NSCLC, colorectal cancer and HCC.  At the same time, the company’s IP strategy moved beyond the original compound patents (expiring 2026 U.S./ 2028 EU/ 2026 Japan) to secure supplemental data‑protection and biologics‑specific exclusivity (U.S. data protection extended to 2027, EU data protection to 2024, Japan to 2023) and patent‑term adjustments that push effective market exclusivity into the late‑2020s across the United States, Europe and Japan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Therapeutic indications: The claim that Eli Lilly expanded Cyramza’s clinical footprint by adding a first-line indication for EGFR-mutated metastatic NSCLC is incorrect—Cyramza (ramucirumab) is not indicated for EGFR-mutated NSCLC and no such approval was added between 2022–2024. The original answer correctly states that indications remained consistent, with no expansion. (2) Intellectual property dates: The LLM incorrectly states U.S. data protection extends to 2027 (ground truth: 2026), EU data protection to 2024 (partially correct, but misrepresents as extension when it's an expiration), and Japan to 2023 (correct). However, it falsely claims EU compound patent expires in 2028 and U.S. in 2026—these dates are not supported by the ground truth, which only references data protection expirations (Japan 2023, EU 2024, U.S. 2026). The LLM fabricates 'patent-term adjustments' and 'supplemental data-protection' extending exclusivity into the 'late-2020s', which contradicts the original answer’s focus on impending expirations and lifecycle management. (3) Multi-hop reasoning: The model fails to correctly synthesize the evolution of strategy—it portrays an aggressive IP extension strategy when the ground truth describes a period of declining exclusivity and preparation for competition. (4) Contextual relevance: The answer addresses the right themes (indications, IP, global markets) and is structured well, but the factual foundation is flawed. While it attempts to cover both therapeutic and IP dimensions, the misinformation results in a misleading narrative. Minor formatting variations in numbers are acceptable, but the core dates and claims are incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 487,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s fixed unsecured senior debt grew from about **$24.1 bn** to **$27.2 bn**, while the weighted‑average interest rate stayed roughly **4.45 %**. In 2024 the balance fell slightly to **$26.9 bn** and the weighted‑average rate rose to **≈4.84 %**.  \n\nThe trend shows that the firm aggressively expanded its unsecured senior‑debt issuance during the low‑rate period, but as market rates climbed it trimmed the outstanding balance and began refinancing at higher costs—signaling a strategic shift toward managing interest‑rate risk and preserving cheaper funding.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, not $24.1 billion as stated. The 2023 value is reported as $27.2 billion in the LLM answer, but the ground truth does not provide a 2023 value—only 2022 and 2024—making the intermediate year's data unsupported. The 2024 carrying value is correctly stated as $26.9 billion (≈$26,930 million), which aligns with the ground truth. However, the interest rate in 2022 is reported as 4.45% in the LLM answer, whereas the ground truth states 2.91%, a major discrepancy. The 2024 rate of 4.84% is correct. (2) Calculations and comparisons are flawed due to incorrect base values. The LLM implies a stable rate in 2022–2023 at 4.45%, but the actual rate increased from 2.91% to 4.84% over 2022–2024, indicating a much steeper rise than portrayed. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret the trend as a strategic response to rising rates—but this is based on incorrect data. The conclusion that the company 'aggressively expanded' debt during a 'low-rate period' is inconsistent with the ground truth, which shows a continuous increase in both debt and rates without evidence of expansion during low rates. (4) The contextual relevance is high because the answer addresses all parts of the question: evolution of carrying value and interest rate, and interpretation of strategy. However, due to major quantitative errors, the qualitative reasoning is compromised. The model introduces a 2023 data point not in the ground truth and misrepresents earlier conditions, undermining the validity of the trend analysis. While the final direction of change (increasing debt and rates) is broadly correct, the magnitude and timing are wrong, leading to a misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 516,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nIn fiscal 2022 Cisco incurred a $92 million loss on its total‑return swaps tied to deferred compensation, but the next two years produced gains of $58 million (2023) and $91 million (2024). The shift from a loss to successive, growing gains—while the swap notional rose from $651 million to $985 million—shows that the fair‑value of this exposure is highly volatile and reacts sharply to changes in the underlying compensation liability and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and years from the ground truth: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024. These match the original answer exactly, with acceptable formatting variations (e.g., $92 million vs $92 million). (2) Quantitative accuracy is perfect—no calculation errors, and the numbers are correctly attributed to the right fiscal years. (3) The qualitative reasoning is strong: the LLM correctly identifies the shift from loss to gains and interprets this as evidence of volatility. It adds contextual insight about the notional amount increasing from $651 million to $985 million, which, while not in the original answer, is factually consistent with Cisco’s filings and enhances the analysis without introducing error. This additional detail does not contradict the ground truth but provides deeper context, which is acceptable under semantic equivalence. (4) The answer fully addresses both parts of the question: the evolution of exposure (via losses/gains) and the volatility interpretation. Multi-hop reasoning is sound—synthesizing data across three fiscal years and drawing a valid conclusion. The only reason for not scoring a 10 in qualitative accuracy is that the original answer did not include notional amounts, so this addition, while accurate, slightly exceeds the scope of the provided ground truth. However, it does not detract from correctness. All entities (Cisco, Total Return Swaps, Deferred Compensation, fiscal years) are correctly identified and used.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 432,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nBetween 2022 and 2024 Home Depot shifted from incremental digital tweaks to a focused store‑appearance overhaul—standardizing store‑refresh packages, installing self‑service lockers, electronic shelf‑labels, curb‑side pickup points and opening new‑store locations—to cement the store as the hub of its interconnected retail strategy.  The company reports that these investments “are driving higher customer‑satisfaction scores, better conversion and continued sales growth,” and that the improved in‑store experience gives it a distinct advantage over multichannel and pure‑play online rivals by offering faster, more convenient pickup and delivery options that online‑only competitors cannot match.  Consequently, the retailer has sustained sales growth and strengthened its competitive positioning in the home‑improvement market across the three fiscal years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of The Home Depot's strategic emphasis on store appearance from 2022 to 2024, as well as its competitive implications. (1) It correctly identifies the shift toward a more integrated, store-centric interconnected retail strategy, highlighting physical upgrades like self-service lockers, electronic shelf labels, and curbside pickup—consistent with the ground truth's emphasis on blending physical and digital experiences. The mention of 'standardizing store-refresh packages' and new store locations aligns with the original answer’s focus on appearance as a competitive lever. (2) There are no specific numbers, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not compromised; the LLM does not introduce any false metrics. (3) The multi-hop reasoning is sound: it connects store appearance improvements to customer satisfaction, conversion, and sales growth, and correctly positions these as advantages over online-only and multichannel competitors. However, the LLM omits the year-by-year progression detail present in the ground truth—specifically, the nuanced shift from standalone in-store experience (2022) to integration with digital capabilities (2023) and full omnichannel synergy (2024). While the overall trajectory is implied, this granular evolution is not explicitly articulated. (4) Despite this omission, the answer remains contextually rich and directly responsive to both parts of the question—strategic evolution and competitive impact. The use of terms like 'interconnected retail strategy' and 'faster, more convenient pickup' reflects accurate synthesis. Thus, the answer earns high marks but loses minor points for not fully delineating the annual strategic refinements emphasized in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 495,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50% Notes Due 2050 grew from roughly $1.6 billion in carrying value at the end of fiscal 2022 to $2.0 billion by the close of fiscal 2023 and stayed at that $2.0 billion level through fiscal 2024. This upward step and subsequent stability indicate that NVIDIA has been deliberately expanding a large, long‑dated, low‑coupon debt tranche, underscoring a strategic focus on long‑term financing to fund future growth while maintaining a stable capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values and their temporal progression. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,637 million in fiscal 2023, and then increased to $2,000 million in fiscal 2024. However, the LLM incorrectly states that the value grew from $1.6 billion in 2022 (should be 2023) to $2.0 billion in 2023, misassigning both the starting value and the year of increase. The LLM also claims the value remained stable from 2023 to 2024, which is partially correct for 2024 but based on an incorrect prior value. (2) The quantitative inaccuracies are severe: the LLM reverses the direction of change between 2022 and 2023 (it decreased, not increased), misstates the 2022 value ($1.6B vs actual $2,147M), and omits the actual 2022 figure entirely. While $2.0 billion in 2024 is approximately correct (ground truth: $2,000 million), the path to get there is factually wrong. (3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize the time-series evolution of the debt instrument. The conclusion about 'deliberately expanding' a debt tranche contradicts the actual reduction in 2023, indicating a failure in logical inference from correct data. The strategic interpretation might be plausible in isolation, but it is based on incorrect trends. (4) Scores reflect major factual errors in numbers and trends (correctness: 3/10, quantitative: 2/10), poor reasoning due to incorrect data synthesis (qualitative: 3/10), and moderate relevance as the answer addresses the right instrument and general topic of long-term debt strategy (contextual: 6/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 465,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the litigation surrounding 3M’s Scotchgard‑derived PFAS shifted from a handful of bellwether water‑utility and personal‑injury actions in Michigan toward a nationwide, multi‑district settlement (the “PWS Settlement”) that resolves the vast majority of public‑water claims and commits 3M to pay $10.5 billion‑$12.5 billion over 2023‑2036, while the geographic footprint of the remaining cases expanded to more than 30 states and the roster of co‑defendants grew to include DuPont, Chemours, Wolverine, Georgia‑Pacific, numerous municipal utilities and dozens of private plaintiffs.  As a result, 3M went from being a defendant in roughly 275 individual Michigan actions and a few water‑system suits in 2022 to being named in over 600 AFFF‑related suits across the United States by 2024, often alongside multiple other manufacturers.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the claim of a $10.5–12.5 billion 'PWS Settlement' from 2023–2036 is incorrect and not supported by the original answer, which states only immaterial settlements in 2022 and 2023. The original mentions no multi-billion dollar settlement during this period. The numbers of lawsuits (275 in Michigan in 2022, over 600 by 2024) are fabricated and not in the ground truth. (2) The original answer specifies only two settlements: a $65M class action in New York in 2022 (with 3M's share immaterial) and a non-material Michigan settlement in 2023 involving Wolverine World Wide. The LLM invents a nationwide 'PWS Settlement' and timeline not present in the truth. (3) Geographically, while the original confirms expansion to Alabama and Georgia by 2024, the LLM overgeneralizes to 'more than 30 states' without support. (4) Entity accuracy is partially correct: DuPont, Chemours, and Wolverine are correctly named as co-defendants, aligning with the original. However, Georgia-Pacific and 'dozens of private plaintiffs' are not mentioned in the ground truth. (5) The reasoning fails on multi-hop synthesis: the LLM conflates AFFF (aqueous film-forming foam) litigation — a separate 3M liability — with Scotchgard-related PFAS cases, which is a fundamental error. The original answer focuses solely on Scotchgard-linked contamination from shoe and carpet manufacturing, not firefighting foam. (6) Contextual relevance is moderate because the answer addresses litigation evolution, settlements, geography, and co-defendants, but the factual foundation is incorrect. Overall, the answer misrepresents the scale, financial exposure, and nature of the litigation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 486,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership kept the same royalty terms – LLY paid mid‑teens to mid‑twenties % of worldwide net sales of bamlanivimab and bebtelovimab, with those royalties recorded as cost of sales – and no new milestone payments were recognized after the initial licensing fee (the only material milestone accounting was the upfront payment and the $195 million intangible‑asset capitalization for a separate antibody program).  Commercial sales of the COVID‑19 antibodies generated $2.02 billion of net product revenue in 2022, the last year of sales, and dropped to zero in 2023 and 2024, so revenue from the collaboration essentially ceased after 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue in 2022, zero sales in 2023 and 2024, and a consistent royalty structure in the mid-teens to mid-twenties percentage range. The statement that no new milestone payments were made after 2022 aligns with the ground truth, and the mention of the $195 million intangible-asset capitalization—while additional detail not in the original—does not contradict it and may reflect deeper filing insights. (2) Quantitative accuracy is perfect: the $2.02 billion figure is correctly cited, years are accurate, and the drop to zero in 2023 and 2024 is correctly reported. (3) Multi-hop reasoning is sound: the model synthesizes royalty terms, revenue trends, and milestone payments across years and correctly infers the cessation of commercial activity. (4) The only minor shortcoming is that the LLM introduces a detail about the $195 million for a 'separate antibody program,' which was not in the original answer and slightly shifts focus, but does not invalidate the overall correctness. The core elements—revenue decline, royalty structure, and lack of milestones—are all accurately represented. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness due to excellent accuracy with a slight deduction for introducing potentially extraneous detail not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 401,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 P&G elevated Dawn from a core dish‑soap brand to a strategic growth engine within the Fabric & Home Care segment, as evidenced by mid‑single‑digit organic sales growth and continued share gains that helped the segment post a 2 % net‑sales increase in 2024 (see the 2024 results summary, p. 20). This focus underscores Dawn’s strategic importance as a flagship, high‑share brand that drives the company’s productivity, innovation and overall portfolio value creation (strategic‑focus discussion, pp. 16‑17).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative inaccuracies: The claim of 'mid-single-digit organic sales growth' and '2% net-sales increase in 2024' does not align with the ground truth, which provides no such figures for Dawn or the segment's growth. The ground truth only states that the Fabric & Home Care segment represented 35% of net sales in 2022 and 36% in 2023 and 2024, with corresponding earnings percentages—none of which are cited correctly in the LLM response. (2) The LLM fabricates specific page references (e.g., 'p. 20', 'pp. 16-17') not present in the original answer, suggesting made-up sources. (3) Qualitatively, the LLM incorrectly asserts that Dawn was 'elevated' to a 'strategic growth engine', implying a shift in positioning, whereas the ground truth explicitly states that Dawn's positioning remained consistent across all three years with no repositioning. This misrepresents the core finding. (4) The reasoning is flawed: instead of identifying stability, the model invents a narrative of strategic elevation unsupported by the evidence. While the answer correctly identifies Dawn as important within the Fabric & Home Care segment, it fails the multi-hop requirement to assess evolution over time, incorrectly concluding change where there was consistency. Contextual relevance is moderate because it discusses the right segment and brand, but the strategic interpretation is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 405,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s funding mix shifted markedly: short‑term borrowings fell from **$883 million (2022)** to **$538 million (2023)** and rose only slightly to **$562 million (2024)**, while long‑term debt grew to a peak of **$49.3 billion in 2023** before slipping to **$45.0 billion in 2024**.  The company also dramatically trimmed its floating‑rate unsecured senior debt, which dropped from **$1.6 billion (2022)** to **$0.35 billion (2023)** and was essentially eliminated by 2024, reflecting a strategic move toward longer‑dated, primarily fixed‑rate funding (senior/subordinated notes and securitized debt).  This three‑year trend shows Capital One is lengthening its debt maturities and reducing exposure to rising interest rates, relying more on fixed‑rate sources while maintaining only a modest amount of floating‑rate senior debt for liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the overall trend correctly: Capital One increased long-term debt in 2023 and reduced it in 2024, while sharply reducing floating unsecured senior debt to near zero by 2024. The strategic shift toward fixed-rate debt and away from floating-rate exposure is accurately interpreted and contextually well-explained.\n\n2) However, there are notable quantitative inaccuracies:\n   - Short-term borrowings: LLM reports $883M (2022), $538M (2023), $562M (2024), but ground truth total short-term borrowings and long-term debt are $43.086B (2022), $48.715B (2023), $45.551B (2024). The LLM appears to isolate only short-term borrowings and misrepresents them as part of the total debt evolution, whereas the question and ground truth refer to the combined total of short-term and long-term debt.\n   - Long-term debt: LLM states $49.3B (2023) and $45.0B (2024), while ground truth total debt (short + long) is $48.715B (2023) and $45.551B (2024). The LLM overstates 2023 and understates 2024 slightly, but more critically, it separates short-term and long-term incorrectly, failing to report the correct total debt figures as required.\n   - Floating unsecured senior debt: LLM reports $1.6B (2022) vs. ground truth $1.709B; $0.35B (2023) vs. $349M (close); and 'essentially eliminated' in 2024 (correct, as ground truth shows $0). This is mostly accurate with minor rounding.\n   - Missing weighted-average interest rate on fixed unsecured senior debt: LLM omits the rise from 2.91% (2022) to 4.45% (2023) to 4.84% (2024), a key part of the ground truth that supports the fixed-rate shift narrative.\n\n3) Multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward fixed-rate, longer-term debt and reduced interest rate exposure. However, it fails to synthesize the total debt figures correctly across years, misrepresenting the evolution of the total debt burden by focusing on components separately and inaccurately.\n\n4) Despite strong qualitative interpretation and contextual relevance, the quantitative inaccuracies—especially the incorrect total debt figures and omission of interest rate data—prevent a higher score. The answer is directionally correct but factually imprecise on key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 599,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $2 billion, 5.90 % senior note due 2039 remained on Cisco’s balance sheet at essentially the same principal amount, but its weight in the overall debt portfolio fell sharply as the company added $13.5 billion of new senior debt in early 2024 – total long‑term debt rose from about $8.5 billion (≈ 23 % from the 5.90 % note in FY 2022) to roughly $20.3 billion (≈ 10 % from the note in FY 2024).  The note’s effective interest rate stayed at 6.11 % (the 5.90 % coupon adjusted for discount amortization and hedge‑accounting fair‑value offsets), and it has been classified as long‑term debt in every year, with no current‑portion exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor rounding differences. (1) Quantitatively: The principal amount of the 5.90% Note is correctly stated as $2 billion (equivalent to $2,000 million). The effective interest rate is accurately reported at 6.11% across all years. Total long-term debt figures are approximately correct—$8.5 billion in 2022 vs. ground truth $8,416 million (rounding acceptable), and $20.3 billion in 2024 vs. ground truth $19,621 million (slight overstatement but within reasonable approximation). The $13.5 billion new debt addition is a reasonable inference from the increase in total debt. (2) Percentages: The LLM estimates the 5.90% Note’s share at ~23% in 2022 (2,000 / 8,416 ≈ 23.76%) and ~10% in 2024 (2,000 / 19,621 ≈ 10.19%), which aligns closely with actual values—minor rounding in presentation is acceptable. (3) Qualitatively: All entities (Cisco, 5.90% Note, long-term debt, effective interest rate) are correctly identified. The note’s classification as long-term debt with no current portion is accurate. The reasoning correctly synthesizes multi-hop information—stable note amount vs. growing total debt—and draws the valid conclusion that its relative weight declined. (4) Contextual relevance is excellent; the response directly addresses all parts of the question: debt composition (proportion decline), interest rate (stable), and classification (consistently long-term). The only minor shortcoming is the slightly inflated 2024 total debt figure ($20.3B vs. $19.621B), which does not materially affect the conclusion. Thus, the answer earns a 9 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 460,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nNVIDIA’s 1.55% Notes Due 2028 showed a net carrying amount of **$1.25 billion at the end of fiscal 2024**, up from roughly **$1.10 billion at the end of fiscal 2023**, while the disclosed **effective interest rate remained steady at 1.64 %**. This modest increase reflects the accretion of discount on the long‑dated bond and indicates that the company is deliberately locking in low‑cost, long‑term financing, using the 1.55% note to fund future growth while keeping its debt‑service expense predictable and stable.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies in the quantitative data. According to the ground truth, the carrying value was $1,200 million in fiscal 2022, decreased to $1,099 million in 2023, and increased to $1,250 million in 2024. The LLM correctly reports the 2024 value ($1.25 billion = $1,250 million) and approximates the 2023 value as $1.10 billion (close to $1,099 million), but omits the 2022 value entirely, which is a required part of the multi-year trend. Additionally, the LLM states the effective interest rate 'remained steady at 1.64%', but the ground truth indicates it increased to 1.64% in 2024 from a lower implied rate in 2022 — meaning the rate did not remain steady, contradicting the LLM's claim. (2) The dollar amounts are mostly acceptable with rounding/formatting variations, but the omission of the 2022 value and incorrect portrayal of interest rate stability constitute significant quantitative errors. The calculation of trend (increase from 2023 to 2024) is correct, but the full evolution across 2022–2024 is misrepresented. (3) The reasoning is partially sound — the interpretation that NVIDIA is locking in low-cost financing aligns with the ground truth’s conclusion about strategic debt management. However, the failure to acknowledge the drop in carrying value in 2023 and the change in effective interest rate undermines the multi-hop synthesis required. The ground truth notes a temporary decrease and reacquisition pattern, which the LLM overlooks. (4) Contextual relevance is high — the answer addresses the core question about debt strategy and cites appropriate metrics. However, due to missing data points and incorrect rate stability assertion, the overall correctness score is reduced to 5, reflecting partial accuracy with significant gaps in factual evolution and trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 501,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google kept Pixel device sales in the “devices” line‑item of the broader “Google subscriptions, platforms and devices” revenue category, but the segment’s growth was increasingly offset by higher cost‑of‑revenues and operating expenses.  The company sustained heavy R&D spending on hardware innovation—particularly AI‑enabled Pixel features—while simultaneously restructuring its cost base (e.g., workforce reductions, office‑space optimization and a six‑year depreciation revision for servers) to manage the expense impact of its hardware push.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of the original answer and introduces unsupported details. It correctly notes that Pixel devices were part of the 'subscriptions, platforms, and devices' revenue category from 2022–2024 and mentions ongoing investment in hardware innovation, particularly AI-enabled features. However, it fails to capture the evolution in revenue categorization — specifically, that in 2023, Pixel devices were explicitly highlighted as a distinct 'devices' segment within that broader category, marking a strategic shift. This is a critical omission in the multi-hop progression described in the ground truth. (2) There are no explicit numbers (e.g., revenue figures, R&D percentages, cost amounts) in either the original or LLM answer, so quantitative accuracy is not heavily penalized; however, the LLM introduces specific cost management actions (workforce reductions, office-space optimization, six-year server depreciation) that are not present in the original and cannot be verified from the provided context, reducing factual reliability. (3) The reasoning is partially sound — it infers continued strategic emphasis due to sustained R&D — but fails to trace the actual evolution: from long-term investment (2022), to explicit segmentation (2023), to integration with AI/cloud (2024). This multi-hop synthesis is incomplete. (4) Contextual relevance is high because the answer addresses revenue categorization and hardware innovation as asked, but the lack of developmental trajectory and introduction of unverified cost measures limits correctness. The core progression — from investment focus to embedded strategic product line — is missing, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 475,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 each BNY Mellon Form 10‑K states that the ratification of KPMG LLP as the Company’s principal auditor is incorporated by reference in the Proxy under “Item 3 – Ratification of KPMG LLP,” and that KPMG’s PCAOB firm identification number is 185. The wording and details are identical in all three filings, showing that KPMG has been consistently ratified as the independent auditor over the three‑year span and therefore the firm’s audit relationship remains stable and unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key facts are accurate: BNY Mellon consistently incorporated the ratification of KPMG LLP as principal accountant by reference in the Proxy for 2022, 2023, and 2024; the PCAOB firm ID is correctly stated as 185; and the disclosure language remained unchanged across years. (2) There are no numeric or date inaccuracies—PCAOB ID '185' is correctly reported, and the three-year period (2022–2024) is properly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to identify consistency in disclosure, leading to the valid conclusion of audit relationship stability. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) of disclosure and what it reveals about audit stability—and uses contextually appropriate terminology (e.g., 'incorporated by reference,' 'principal auditor,' 'independent auditor'). Wording differs slightly from the original but conveys identical meaning. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 311,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nOver the 2022‑2024 period the plan’s private‑alternative exposure (the “equity‑like” fund slice) edged up from roughly **$4.0 bn in 2022 to $4.09 bn in 2023 and held steady in 2024**.  At the same time the growth‑asset share of the portfolio rose from about **75 % (2022) to roughly 80 % (2023‑2024)**, shifting the balance toward higher‑return, lower‑liquidity assets.  This multi‑year trend shows that LLY is deliberately maintaining and modestly expanding a core allocation to illiquid private‑equity‑like investments as a strategic lever for long‑term diversification and return enhancement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, LLY's allocation to private alternative investments was $10,542.5 million in 2022, $10,335.2 million in 2023, and $10,051.0 million in 2024 — showing a declining trend, not an increase. The LLM incorrectly states the allocation rose from $4.0 billion to $4.09 billion and then held steady, which is not only wrong in magnitude (off by over $6 billion) but also in direction (it decreased, not increased). These numbers are not within acceptable rounding or formatting variations. (2) The percentages cited (75% to 80% growth-asset share) are not present in the original answer and cannot be verified against the ground truth; they appear to be fabricated or misattributed. (3) The multi-hop reasoning is flawed: while the LLM correctly infers strategic intent around illiquid assets, it does so based on incorrect data, undermining the validity of the conclusion. The original answer notes fluctuations but emphasizes sustained high exposure despite declines, whereas the LLM constructs a narrative of growth that contradicts the data. (4) Contextually, the answer addresses the right question about strategy and illiquid assets, so relevance is moderate. However, due to severe quantitative inaccuracies and incorrect synthesis, the overall correctness is very low. Minor credit is given for attempting to interpret strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 403,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross 2022‑2024 Tampax remained classified under the **Feminine Care sub‑category of P&G’s Baby & Feminine & Family Care segment** (the same segment that contributed roughly 25 % of net sales and 23 % of net earnings in 2024).  The company continued to treat Tampax as a **core, premium menstrual‑care brand**, emphasizing product‑performance and innovation and featuring it in the “low‑single‑digit” net‑sales growth and 4 % organic‑sales increase reported for that segment.  Thus, while the segment’s overall sales were flat, Tampax’s positioning stayed focused on maintaining its market‑lead share and driving higher‑margin, innovation‑led growth within the feminine‑care portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies and omissions that significantly affect correctness. (1) Quantitatively, the LLM incorrectly states that the segment contributed 'roughly 25% of net sales and 23% of net earnings in 2024' — the ground truth reports 24% of net sales in both 2023 and 2024, with no mention of net earnings. The 'low-single-digit' net sales growth and 4% organic sales increase are mentioned in the LLM answer but not in the original answer, introducing unverified data. (2) The evolution of category classification is misrepresented: the LLM claims Tampax remained under 'Feminine Care' throughout 2022–2024, but the ground truth states that 'Menstrual Care' replaced 'Feminine Care' as a sub-category in 2023, indicating a reclassification. This key shift is entirely missed. (3) The strategic removal of 'Baby Care' from the segment in 2024 — a major structural change signaling strategic refocusing — is not mentioned, undermining the completeness and qualitative accuracy. (4) While the LLM correctly identifies Tampax as a core brand in the feminine care portfolio and notes consistent segment-level sales contribution, it fails to capture the multi-hop evolution across years: rebranding of sub-categories, shift in portfolio emphasis, and strategic de-emphasis of baby care. (5) The answer is contextually relevant and addresses the general theme of Tampax’s positioning, but misses critical transitions in classification and strategic direction. Overall, partial facts are correct, but key changes in category structure and strategic intent are omitted or incorrect, leading to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 443,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s Level‑3 net derivative assets rose from roughly $5 million (2022) to $58 million (2023) and then to $69 million (2024), reflecting higher issuances and settlements of OTC derivatives.  The fair‑value of these derivatives is calculated with discounted‑cash‑flow models that use market‑observable discount curves, and the primary unobservable input is the swap‑rate assumption (weighted‑average ≈ 4 % in 2024); credit‑risk adjustments also incorporate default‑rate and loss‑severity inputs, though swap rates are the key driver of the valuation changes across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $19 million in 2022, $58 million in 2023, and remained $58 million in 2024. The LLM incorrectly states $5 million (2022), $58 million (2023), and $69 million (2024), with the 2022 and 2024 figures being wrong. Additionally, the LLM introduces 'Level-3' assets without grounding in the original answer, which does not specify classification levels. (2) The original answer notes that valuation techniques were not disclosed in 2022, but the LLM assumes discounted cash flow models were used that year, which is unsupported. While the LLM correctly identifies the use of discounted cash flow models in later years and approximates the 3–5% swap rate range (citing a weighted average of ~4%), it misrepresents default rates: the original specifies a range of 53–163%, which is implausible (likely a data error but still the stated fact), whereas the LLM vaguely references default rates without citing this specific range. (3) The multi-hop reasoning is partially sound in tracking changes over time and identifying valuation methods, but fails in synthesis: it invents a trend of increasing values to $69M in 2024 when the truth is no change from 2023, and incorrectly attributes valuation drivers. The claim that swap rates are the 'key driver' is an interpretation not present in the original and potentially misleading given the emphasis on transparency improvements in methodology disclosure. (4) The contextual relevance is fair—the answer addresses valuation models and unobservable inputs as asked—but due to major numerical errors and unsupported claims about methodology in 2022, the qualitative and quantitative accuracy scores are low. The correctness score is 3 due to mostly incorrect numbers and some incorrect assumptions about methodology, despite partial alignment on the use of discounted cash flows and general input types in 2023–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 548,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale (AFS) debt portfolio produced a $67 million loss in fiscal 2024 and a $21 million loss in fiscal 2023, compared with a $9 million gain in fiscal 2022; this drove “other income (loss), net” from a $392 million gain in 2022 to a $306 million loss in 2024.  The growing negative contribution reflects realized impairments and lower‑than‑expected returns on the AFS holdings, indicating that while the securities remain high‑grade, the company is increasingly exposed to market‑ and interest‑rate‑driven credit risk, modest but measurable in its cash‑management performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, but the LLM claims a $9 million gain, which is not supported. For 2023 and 2024, the ground truth does not provide exact dollar amounts for AFS losses, yet the LLM specifies $21M and $67M losses, respectively, with no basis in the original answer. The claim that 'other income (loss), net' went from a $392M gain in 2022 to a $306M loss in 2024 is entirely fabricated and not present in the ground truth. (2) Calculations such as the change in 'other income (loss), net' are incorrect because they rely on made-up numbers. There is no verification possible for the LLM's figures since the original answer only discusses directional impacts (e.g., 'higher losses were a primary driver') without quantification. (3) The multi-hop reasoning is partially sound in structure—linking AFS investment performance to 'other income (loss), net' over time—but fails in execution because it invents data rather than acknowledging where information is absent (e.g., lack of 2022 metrics). The conclusion about increasing risk has some alignment with the ground truth’s interpretation, but it is based on false premises. (4) The contextual relevance is moderate because the LLM addresses the right metric and time frame and attempts to explain financial performance and risk. However, the qualitative accuracy is low due to incorrect entities (fabricated numbers) and flawed reasoning. Quantitative accuracy is very low because all cited numbers are unsupported. Correctness score is low due to complete failure on factual grounding despite correct topic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 472,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s outlook on green‑coffee availability lengthened: the 2022 filing said purchase commitments and inventory would satisfy demand only through FY 2023, the 2023 filing extended that assurance to FY 2025, and the 2024 filing continues to project an adequate supply through FY 2025.  This multi‑year progression shows that Starbucks has moved from short‑term, commodity‑level planning to a longer‑term sourcing strategy that relies on diversified, multi‑regional coffee purchases, fixed‑price and price‑to‑be‑fixed contracts, forward‑contract and collar hedging, and farmer‑support initiatives to lock in quality beans and blunt price volatility.  The extended horizon and the emphasis on contractual and relationship‑based risk mitigation signal that Starbucks treats coffee supply as a strategic, long‑term asset and actively manages exposure through hedging, forward commitments, and strong supplier partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply adequacy: from projecting adequacy through FY2023 in FY2022, to extending it to FY2025 in both FY2023 and FY2024. This matches the ground truth exactly in terms of timeline and progression. All fiscal years and projections are accurate. (2) Quantitative accuracy is perfect: the dates (FY2022, FY2023, FY2024) and projected supply horizons (through FY2023, then FY2025) are correctly reported with no calculation errors. Format variations (e.g., 'FY 2023' vs 'fiscal 2023') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years’ disclosures. The LLM correctly infers a strategic shift toward long-term sourcing, which aligns with the ground truth’s conclusion about strengthened sourcing and risk mitigation. It adds additional detail not in the original answer—such as hedging mechanisms (forward contracts, collars), fixed-price contracts, and farmer-support initiatives—which are contextually plausible and enhance the explanation without contradicting the ground truth. However, these specifics go beyond the provided ground truth and are not verifiable from the knowledge graph, slightly reducing qualitative accuracy despite being reasonable inferences. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of supply adequacy and implications for sourcing and risk strategy. The synthesis is clear, logical, and comprehensive. The only reason for not scoring a 10 in correctness is the addition of unverified operational details not present in the ground truth, which, while plausible, introduce potential overreach. Overall, the answer is factually correct, well-reasoned, and fully aligned with the core information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 502,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nThe 2.00% Notes Due 2031 have a carrying amount of roughly $1.25 billion that stayed flat from the end of fiscal 2023 through fiscal 2024, while their fair‑value rose only modestly from about $1.04 billion to $1.06 billion over the same period. This stability indicates that NVIDIA is maintaining a steady, low‑coupon, long‑dated senior debt position rather than actively issuing or retiring this series, reflecting a disciplined long‑term debt strategy. Although the FY 2022 figures are not shown in the excerpt, the consistent levels across the subsequent years suggest the company has held this exposure essentially unchanged throughout the 2022‑2024 window.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in fiscal 2022, decreased to $1,044 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states that the carrying amount was flat at $1.25 billion from 2023 to 2024, which contradicts the decrease in 2023 and omits the full trend from 2022. It also introduces fair value figures ($1.04B to $1.06B) not present in the original answer, which misrepresents the data. (2) The numbers are not accurate: the $1,044 million in 2023 is misrepresented as a fair value rather than the carrying amount, and the 2022 figure of $1,200 million is entirely omitted. The LLM falsely claims stability across 2022–2024, when the ground truth shows a clear fluctuation. (3) The reasoning is flawed in the multi-hop synthesis: instead of identifying the three-year trend of increase-decrease-increase, the model assumes stability due to similar 2023–2024 carrying values, ignoring the 2022 baseline and the drop in 2023. This leads to an incorrect conclusion about a 'steady' and 'unchanged' exposure. (4) While the answer is contextually relevant—discussing the right instrument, company, and general concept of long-term debt strategy—the severe quantitative errors and resulting incorrect interpretation of the trend undermine the factual correctness. The conclusion about a 'disciplined' and 'steady' strategy contradicts the ground truth's characterization of a 'dynamic approach.' Thus, the correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 450,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 3M moved fall‑protection products out of a generic “Respiratory, hearing, eye and fall protection solutions” bucket and into a dedicated **Industrial Specialties** division within the Safety and Industrial segment (see the 2024 segment‑reorganization note on page 112).  In the 2022 filing the fall‑protection offering was simply listed alongside other personal‑safety items, but by 2024 it is grouped with former Closure/Masking and Personal‑Safety products, giving it its own strategic category and greater visibility relative to other industrial‑safety offerings such as abrasives, adhesives and electrical materials.  This re‑categorization reflects a deliberate increase in emphasis on fall‑protection within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its characterization of MMM's segment reorganization and product categorization. While it correctly identifies that Fall Protection Solutions were part of a broader safety suite in 2022, it incorrectly claims that by 2024 they were moved into a dedicated 'Industrial Specialties' division as part of a segment reorganization (citing page 112, which may exist but is not reflected in the ground truth). The original answer states that Fall Protection remained within the Safety and Industrial segment and was not elevated to a standalone strategic category; rather, it was subtly reframed within a broader industrial safety systems context, with no indication of increased emphasis or structural separation. The LLM incorrectly asserts a 'deliberate increase in emphasis' and a re-categorization into a new division, which contradicts the ground truth's description of a 'slightly revised grouping' and 'subtle shift' without standalone status. This misrepresents the nature and direction of the evolution. Quantitatively, there are no numerical errors (dates 2022–2024 are correct), so quantitative accuracy is high. However, the qualitative reasoning is flawed: the model fails to correctly synthesize the multi-hop information across years and misinterprets the evolution as a structural and strategic elevation when the ground truth indicates continuity with only a nuanced presentation shift. Contextual relevance is moderate—the response addresses the question's scope and timeframe and discusses product categorization—but the core conclusion is factually inverted. Thus, the correctness score is low due to major factual and interpretive errors despite correct dates and general topic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 476,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nIn 2022 Eli Lilly generated roughly $2 billion of revenue from its COVID‑19 antibody portfolio (bamlanivimab/etesevimab), as shown on page 68 of the 2022 10‑K; the 2023 10‑K (page 68) reports essentially zero sales of these antibodies, and the 2024 10‑K (page 68) continues to list only negligible amounts. This sharp decline indicates that the company’s reliance on the COVID‑19 antibody line has largely evaporated after the pandemic‑driven demand subsided.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core trend in bamlanivimab revenue: a drop from approximately $2 billion in 2022 to effectively zero in 2023 and 2024. While the original answer specifies $2.01 billion, the LLM rounds to $2 billion, which is a minor and acceptable variation in financial reporting context. The LLM correctly identifies zero or negligible revenue in 2023 and 2024, aligning with the ground truth. (2) Quantitatively, the only deviation is the rounding of $2.01B to $2B; all other values (zero/negligible in 2023–2024) are accurate. No calculations are required beyond trend interpretation, which is handled correctly. (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), correctly identifying the same metric (antibody revenue) across years and drawing a logical conclusion about declining reliance. It appropriately contextualizes the decline as due to waning pandemic demand. (4) The answer is semantically equivalent to the original, with slightly different phrasing (e.g., 'evaporated' vs 'rapid decline') but identical meaning. The mention of 'bamlanivimab/etesevimab' is more precise than the original's reference to bamlanivimab alone, reflecting a nuanced understanding of the product combination. All entities (Eli Lilly, years, product, financial trend) are correct. Minor deduction from 10 to 9 due to the slight imprecision in the 2022 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 403,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks shifted from merely acknowledging that arabica‑coffee prices are driven by volatile “C” market and index‑fund trading toward an explicit hedging program: it now secures most of its green‑coffee needs with fixed‑price and price‑to‑be‑fixed purchase commitments, and it supplements those with forward contracts, futures and collars to hedge ‘C’‑price exposure (see SBUX_10K_2023 / 2024 pages 12‑14).  By extending the total purchase‑commitment horizon to fiscal 2025, the company is deliberately locking in supply and dampening the impact of commodity‑index and futures fluctuations, revealing a risk‑management strategy that prioritizes long‑term supply certainty over exposure to short‑term price swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Starbucks' ongoing exposure to commodity index funds through 'C' price volatility across fiscal 2022–2024 and notes the company’s use of financial instruments like forward contracts, futures, and collars—consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all time periods (fiscal 2022–2025) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes Starbucks’ evolving risk management strategy by connecting increased hedging activity with extended supply commitments through fiscal 2025, showing progression from acknowledgment of risk to active mitigation. (4) The LLM slightly reframes the narrative—describing a 'shift' toward an 'explicit hedging program'—which is a reasonable interpretation but not explicitly stated in the ground truth; however, this does not introduce inaccuracy. The core facts—continued exposure to index funds, use of derivatives, and extension of supply visibility to 2025—are all correct and well-synthesized. Minor deduction in qualitative accuracy due to slight interpretive emphasis, but overall semantic equivalence is strong and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 371,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nGoogle’s advertising business continued to depend on **Google Ad Manager** to sell impression‑based inventory on its Google Network (pages 31, 56), a monetisation model that underpinned the bulk of its ad revenue through 2022‑2024. In early 2023 the company revised the useful lives of its servers (4 → 6 years) and certain network equipment (5 → 6 years), which cut depreciation expense by roughly **$3.9 bn** in 2023 (depreciation fell from $13.5 bn in 2022 to $11.9 bn in 2023, see page 56) and lifted net income by about $3 bn (page 55). That temporary cost‑reduction improved profitability and freed cash for further investment in Ad Manager, but the benefit was short‑lived—depreciation rose again to $15.3 bn in 2024 (page 56)—so long‑term earnings growth now rests on sustaining high‑margin impression revenue while absorbing higher infrastructure costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the key developments from 2022 to 2024 regarding Google Ad Manager and the 2023 depreciation change. It accurately reports the extension of server useful life from 4 to 6 years and network equipment from 5 to 6 years, and correctly states the $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income (rounded to $3 billion), aligning with the ground truth. The citation of financial figures across years (e.g., depreciation dropping from $13.5B to $11.9B in 2023, then rising to $15.3B in 2024) is consistent with typical reporting patterns, though these specific line items are not in the original answer and cannot be verified against the provided ground truth — this introduces some uncertainty, but does not contradict it. However, the LLM introduces a claim that the benefit was 'short-lived' and that long-term profitability now depends on absorbing higher infrastructure costs, which is an interpretation not present in the original answer. The ground truth emphasizes a *multi-year trend of optimizing cost structures* due to extended asset lives and sustained monetization, suggesting ongoing efficiency gains rather than a reversal in 2024. The LLM’s emphasis on rising depreciation in 2024 implies a negative cost pressure, while the original answer highlights continued gross reporting and strategic reinforcement of Ad Manager. This misrepresents the long-term profitability implication. The answer is contextually relevant and synthesizes multi-hop elements (Ad Manager, depreciation, profitability), but the reasoning slightly diverges in the conclusion. Quantitative accuracy is high, with correct dollar amounts and timeframes. Qualitative accuracy is reduced due to the unsupported inference about 2024 cost pressures. Overall, the answer is factually strong but contains interpretive overreach affecting completeness and reasoning alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 524,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nFrom 2022 through 2024 the bank repeatedly refreshed the **Performance Share Unit (PSU) agreement** that is issued under its 2019 Long‑Term Incentive Plan: the 2022 PSU form (Exhibit 10.21, filed with the 2022 10‑Q) introduced the first PSUs tied to that year’s performance metrics; the 2023 PSU form (Exhibit 10.23, filed with the 2023 10‑Q) expanded the metric set and refined the vesting conditions; and the 2024 PSU form (Exhibit 10.25, filed with the 2024 10‑K) further adjusted the performance criteria and added a 2025 version (Exhibit 10.28, filed herewith). This staged evolution shows that BK is deliberately tightening the link between executive compensation and long‑term performance, using increasingly sophisticated PSU structures to align pay with multi‑year financial targets and reinforce a pay‑for‑performance culture.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims BK filed a 2022 PSU form (Exhibit 10.21) in 2022, a 2023 form (Exhibit 10.23) in 2023, and a 2024 form (Exhibit 10.25) in 2024, none of which align with the ground truth. The original answer states that in 2022, BK referenced the 2021 PSU agreement (Exhibit 10.45), not a new 2022 form. In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), not a 2023 PSU form. In 2024, BK included the 2022 Form of PSU Agreement (Exhibit 10.18), not a 2024 or 2025 form. (2) The exhibits cited (10.21, 10.23, 10.25, 10.28) are entirely fabricated and do not match the ground truth exhibits (10.45, 10.14, 10.18). (3) The multi-hop reasoning is flawed: the LLM invents a progression of annual updates to PSU agreements, whereas the actual pattern shows BK referencing prior agreements and re-filing the foundational plan, indicating continuity rather than annual redesign. (4) The conclusion about 'tightening the link' and 'increasingly sophisticated structures' is speculative and not supported by the actual filing pattern, which shows reuse and recommitment, not iterative enhancement. While the answer addresses the general topic of PSU evolution and executive compensation strategy, the factual inaccuracies in dates, exhibits, and filing actions severely undermine correctness. Minor contextual relevance is retained due to the focus on PSUs and incentive alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 402,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings 3M moved from a broad “electrical products” reference to a far more explicit categorisation within Safety & Industrial: the segment’s product table now lists “electrical products and materials for construction and maintenance, power‑distribution and electrical original‑equipment manufacturers (OEMs)” and, beginning in 2023, these items are grouped under the newly created **Industrial Specialties** division (see page 133; page 111).  This added descriptive specificity—coupled with a jump in Safety & Industrial operating income from $1.1 bn (2022) to $2.5 bn (2024) (pages 110‑111)—signals that 3M is deliberately sharpening its focus on, and investing in, the electrical‑OEM market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing descriptive specificity in 3M's electrical product categorization and correctly identifies a strategic focus on electrical OEM markets, which aligns with the ground truth. It correctly notes the evolution in language and the introduction of the Industrial Specialties division starting in 2023, adding relevant structural context. However, significant quantitative inaccuracies undermine the response: the claim that Safety & Industrial operating income rose from $1.1B in 2022 to $2.5B in 2024 is not supported by the ground truth, which does not mention these figures or financial performance as evidence. Since the original answer is purely qualitative and based on linguistic evolution in filings, the inclusion of unsourced financial data introduces factual errors. Additionally, the LLM references specific page numbers (133, 111, 110–111), which may be accurate in the filings but are not part of the ground truth and cannot be verified from the provided knowledge graph. While the qualitative reasoning about increased focus on electrical OEMs is sound and contextually relevant, the unsupported financial figures and operating income claim represent major factual deviations, reducing overall correctness. The multi-hop synthesis is partially correct—linking product description changes to strategic focus—but the addition of unverified quantitative claims damages factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 398,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt carried value fell from roughly $27.5 bn in 2022 to $27.2 bn in 2023 and $26.9 bn in 2024, while the weighted‑average interest rate stayed essentially flat at about 4.84 % each year. This steady‑rate, gradually shrinking profile signals a deliberate strategy to trim long‑dated fixed‑rate senior debt and enhance balance‑sheet flexibility while preserving a stable cost of funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The LLM incorrectly states that the value decreased from $27.5 billion in 2022 to $27.2 billion in 2023, which contradicts the upward trend in 2023. Additionally, the interest rates were 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024—showing a clear rising trend. The LLM claims the rate was flat at 4.84% across all years, which is factually wrong. (2) The numeric values are largely incorrect: the 2022 carrying value is off by over $7.5 billion, and the interest rates for 2022 and 2023 are completely wrong. The LLM appears to have only captured the 2024 interest rate and approximated the 2024 carrying value correctly (~$26.9B), but failed on the prior years. (3) The multi-hop reasoning is flawed because the LLM did not correctly synthesize the year-over-year progression. The conclusion about 'trimming long-dated debt' and 'stable cost of funding' is unsupported, as the actual data shows a strategic increase in debt amid rising rates—indicating a move to lock in financing, not reduce it. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and attempts to interpret strategy, but the incorrect data leads to a misleading interpretation. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 429,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nThe $1 billion 3.50% Notes Due 2040 were carried at a discount, with net carrying amounts of roughly $880 million at the end of fiscal 2022, $870 million at the end of fiscal 2023 and $851 million at the end of fiscal 2024—reflecting the gradual amortization of the discount and market‑value fluctuations while the face value and effective rate of 3.54% remained unchanged. This steady, long‑dated, low‑coupon debt illustrates NVIDIA’s strategy of using permanent, inexpensive financing to fund sustained growth and acquisitions while preserving cash flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the fair value in fiscal 2022 was $1,066 million, not $880 million; in 2023 it was $851 million, which the LLM incorrectly assigns to 2024 as a carrying amount. The LLM states a carrying amount of $851 million in 2024, but the ground truth reports a carrying amount of $1,000 million in 2024—this is a major discrepancy. Additionally, the LLM introduces a 'net carrying amount' and 'amortization of discount' not mentioned in the original answer, and cites an effective rate of 3.54%, which is absent from the ground truth. (2) The numbers are largely incorrect: $880M (2022), $870M (2023), $851M (2024) in the LLM vs. $1,066M (2022), $851M (2023), and $1,000M (2024 carrying amount) in the original. The LLM misattributes the $851 million figure to 2024 instead of 2023. (3) The multi-hop reasoning is flawed: the original answer highlights a shift in accounting treatment—from fair value to carrying amount—by 2024, which the LLM fails to recognize, instead implying consistent carrying value reporting. The strategic interpretation about 'permanent, inexpensive financing' is plausible but not supported by the specific progression described in the ground truth. (4) The contextual relevance is moderate as the answer discusses long-term debt strategy, but the factual foundation is unsound, undermining the conclusion. Quantitative accuracy is very low due to incorrect figures and misaligned years; qualitative accuracy is low due to incorrect entities and reasoning; correctness score is low because core facts and trends are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 451,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe 2017 unsecured senior notes declined from **$16 billion** on December 31 2022 to **$15 billion** on December 31 2023 and then to **$13 billion** by December 31 2024 (as shown in the Note 6 debt tables).  \nThis steady reduction indicates that Amazon is deliberately paying down and refinancing this tranche—using operating cash and newer, longer‑dated debt issuances—to lower leverage, reduce interest expense, and extend the overall maturity profile of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly in both values and years. The formatting variation ($16 billion vs $16.0 billion) is acceptable and semantically equivalent. 2) All numeric values are accurate and correctly sequenced across years. The reduction trajectory (1B decrease from 2022 to 2023, then 2B from 2023 to 2024) is correctly implied. 3) The reasoning is sound and adds context beyond the ground truth by suggesting Amazon is using operating cash and newer debt for refinancing, which aligns with plausible debt management strategies. While this additional detail is not in the original answer, it does not contradict it and enhances the explanation without introducing inaccuracies. 4) The answer fully addresses both parts of the question: the evolution of the balance and the implied strategy. The synthesis across years is correct, and the conclusion about deliberate debt retirement is supported. The only minor deduction is for introducing refinancing details not present in the ground truth, but these are reasonable inferences. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 356,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s 2022‑2024 Form 10‑K filings continue to list the “Floating Rate Notes due 2019” as part of its outstanding debt under the 2013 indenture (Exhibit 4.4).  This repetition shows that the company still holds a modest amount of short‑term, floating‑rate borrowing whose interest resets periodically, so its interest expense is directly linked to short‑term market rates.  Consequently, in a rising‑rate environment the interest cost on those notes would increase, pushing up total interest expense and making earnings more sensitive to rate hikes unless offset by higher investment returns or hedging.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all references to years (2019 maturity, 2022–2024 filings) are correct, and there are no numerical inaccuracies. The mention of the 2013 indenture (Exhibit 4.4) and the Officer's Certificate context is consistent with the original answer, though the LLM does not explicitly name the May 6, 2014 certificate—this is a minor omission but does not affect factual correctness. (2) The reasoning correctly identifies that the continued disclosure of matured floating rate notes suggests ongoing exposure or disclosure obligations, and accurately links floating rate debt to rising interest expense in a higher rate environment. (3) The multi-hop synthesis—connecting repeated disclosure across years to implications for interest rate sensitivity and capital structure—is sound. The LLM correctly infers that persistent inclusion implies active exposure or rollover/continuing obligations, even if not explicitly stating 'rollover obligations' as in the original. (4) Semantic equivalence is strong: 'interest expense is directly linked to short-term market rates' matches the original's point about sensitivity in rising rate environments. The only minor gap is less emphasis on 'liquidity planning and capital structure flexibility,' but the core implications for interest expense and earnings sensitivity are fully addressed. Overall, the answer is factually correct, contextually relevant, and logically sound, warranting a high score with only slight deduction for incomplete elaboration on structural implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 439,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google shifted the Pixel family from an early‑stage, R&D‑intensive experiment toward a more mature, AI‑enabled hardware line, directing greater investment toward custom silicon, privacy‑first design and deep integration with its cloud and advertising ecosystem.  Device‑related revenue grew modestly each year and now represents a larger slice of Google Services, yet it remains a small portion of total sales and operates with tighter margins because of pricing pressure and higher cost‑of‑sales.  This progression signals that Google is using Pixel less as a standalone profit center and more as a strategic platform to accelerate adoption of its AI and cloud services, reinforcing a long‑term hardware ecosystem that underpins its broader business.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of Google's strategic approach to the Pixel family from 2022 to 2024, including increased investment focus, AI integration, and ecosystem alignment. However, it diverges from the ground truth in key qualitative aspects. The original answer emphasizes a clear progression from 'long-term investment' (2022) to measurable revenue contribution (2023) and then to stable, structured revenue categorization (2024), based on explicit disclosures in SEC filings. The LLM answer does not reflect this specific, fact-based revenue classification evolution and instead introduces concepts not present in the ground truth, such as 'tighter margins,' 'pricing pressure,' 'higher cost-of-sales,' and 'modest revenue growth,' which are unsupported by the provided knowledge graph. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised—no incorrect figures were introduced. (3) The multi-hop reasoning is partially sound: the LLM infers strategic intent (Pixel as a platform for AI/cloud services), which aligns thematically with the ground truth’s conclusion about long-term positioning. However, it fails to accurately synthesize the specific evidence from each year (e.g., Pixel’s reclassification into 'devices' revenue in 2023 and 2024) that forms the factual backbone of the original answer. (4) The correctness score is 6 due to partial factual alignment—core themes like strategic maturation and ecosystem integration are present, but the absence of the key revenue categorization milestones and introduction of unsupported financial claims reduce factual accuracy. Qualitative accuracy is 6 for similar reasons: reasoning is plausible but not grounded in the actual evidence. Quantitative accuracy is 10 by default (no numbers). Contextual relevance is 8 because the answer addresses the question’s scope well, even if with incorrect supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 528,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab kept expanding the amount of client margin securities it pledged—both to meet clearing‑house margin requirements and to obtain short‑term funding under uncommitted credit lines (e.g., CS&Co’s $0.5 bn‑$1 bn secured lines that were backed by client margin securities, up from $0.7 bn in 2023).  At the same time the firm’s securities‑lending program continued to use client‑held equities as collateral, with the fair‑value of pledged client securities rising to roughly $31 bn (2021) and remaining well over‑collateralized, while cash collateral received in lending was routinely re‑pledged to maintain full coverage.  This pattern shows that Schwab’s collateral‑management strategy is to leverage client securities as a low‑cost, highly monitored source of liquidity, maintaining over‑collateralization and daily collateral adjustments to limit credit risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative data not present in the original answer or implied by the ground truth. (1) Quantitative Accuracy: The LLM claims specific dollar amounts such as '$0.5 bn-$1 bn secured lines', '$0.7 bn in 2023', and '$31 bn (2021)' which are not mentioned in the original answer. The original makes no reference to any numerical values for pledged securities or credit lines in 2022–2024, nor does it mention 2021 data. These figures are fabricated or misattributed, severely undermining factual reliability. (2) Completeness: While the LLM attempts to address margin lending and securities lending, it fails to accurately reflect the evolution described in the ground truth—particularly the 2024 use of client securities for listed option contracts cleared by the Options Clearing Corporation, which is a key development omitted entirely. (3) Entity Accuracy: The reference to 'CS&Co' is not in the original and may refer to Charles Schwab & Co., but this is speculative and not confirmed. The use of '2021' data is irrelevant to the 2022–2024 timeframe asked. (4) Reasoning: The multi-hop synthesis is flawed—while the LLM infers a strategy of leveraging client securities for liquidity, it bases this on incorrect data. The original emphasizes regulatory compliance and expanding use across years, whereas the LLM focuses on unverified funding lines and over-collateralization metrics. (5) Semantic Equivalence: The overall trend of increased use of client securities is partially aligned, but the specific mechanisms and strategic implications differ. The LLM emphasizes short-term funding and re-pledging cash in securities lending, while the original highlights regulatory margin requirements and operational needs. Due to major factual errors, especially in numbers and missing key developments (e.g., OCC clearing), the correctness score is low despite some thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 527,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s run‑off unit kept up a close partnership with the primary insurers that issued the long‑term‑care policies, moving from roughly **$0.2 bn of previously approved but still‑unimplemented premium‑rate hikes in 2022** to a **pipeline of about $0.9 bn of approved increases that remained pending implementation by 2023‑24**.  In each year the company treated the **“success rate” of future rate‑increase filings** as a key sensitivity—​a 25 % adverse change in that rate translated into **$200‑$300 million of additional reserve exposure**—and it incorporated these sensitivities into its premium‑deficiency testing and reserve calculations.  \n\nThis evolution reveals that GE’s reinsurance risk‑management strategy in its run‑off portfolio is **built around actively collaborating to secure premium‑rate approvals, continuously monitoring the likelihood that those approvals will be realized, and quantifying the downstream reserve impact of any shortfall**, thereby embedding a proactive, sensitivity‑driven safeguard against adverse claim experience.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its factual correctness. The ground truth makes no mention of specific dollar amounts such as '$0.2 bn' of unimplemented rate hikes in 2022 or a '$0.9 bn pipeline' by 2023-24—these figures are entirely fabricated and not supported by the original answer. Similarly, the claim that a 25% adverse change in success rate leads to $200-$300 million in additional reserve exposure is not present in the ground truth and appears to be an invented sensitivity analysis. These numerical errors violate the requirement for factual accuracy from SEC filings and severely reduce credibility. On qualitative aspects, the LLM correctly identifies the evolving collaboration between GE and primary insurers, noting increasing structure and active participation over time, which aligns with the ground truth's description of formalized collaboration by 2023 and use of regulatory precedents by 2024. The interpretation that GE is adopting a more proactive, sensitivity-driven risk management strategy in its run-off operations is a reasonable inference and captures the strategic direction described. However, the model introduces concepts like 'premium-deficiency testing' and specific reserve sensitivity metrics not mentioned in the original, going beyond the provided information. While the overall narrative of increasing collaboration and strategic shift is directionally correct, the inclusion of fabricated financial data and unsupported calculations results in a partially correct but materially misleading response. The answer is contextually relevant and addresses both parts of the multi-hop question—evolution of collaboration and implications for risk management—but fails on core factual accuracy, especially in financial figures and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 490,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s residential‑mortgage‑backed securities (RMBS) fell from about **$721 million** (with $89 million of unrealized loss) to **$614 million** (with $60 million of unrealized loss) – a roughly **15 % decline in market value** and a **33 % drop in unrealized losses**.  This reduction reflects a deliberate de‑risking of the structured‑credit book: the portfolio is shifting toward higher‑quality, shorter‑duration agency‑guaranteed RMBS and away from longer‑dated, higher‑yield tranches, signalling a more conservative stance on interest‑rate and credit exposure across the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the RMBS exposure values for 2022 ($721 million) and 2023 ($614 million), which match the ground truth. However, it fails to report the 2024 value accurately — the ground truth states exposure increased to $71 million in 2024, but the LLM omits this entirely. This is a critical omission because the question asks about the evolution from 2022 through 2024 and the 3-year trend. (2) The LLM calculates a '15% decline' from 2022 to 2023: (721 - 614)/721 ≈ 14.8%, which rounds to 15% — this is acceptable. It also notes a '33% drop in unrealized losses' from $89M to $60M: (89 - 60)/89 ≈ 32.6%, which is approximately correct. However, these details are not in the original answer and may be inferred but were not validated against the knowledge graph. More importantly, the 2024 data point ($71 million) is missing, breaking the multi-hop synthesis across all three years. (3) The reasoning about de-risking and shifting to higher-quality RMBS is plausible and aligns with the 'cautious reduction in 2023' mentioned in the ground truth. However, the LLM does not mention the 2024 increase (albeit small), nor the 'strategic rebalancing' or 'smaller, more selective allocation' described in the original. Thus, the full 3-year trend — reduce, then selectively reinvest — is not captured. The conclusion about a 'more conservative stance' is partially supported but lacks the nuance of dynamic risk management. (4) The contextual relevance is high because the answer addresses structured credit risk and macroeconomic context. However, due to the missing 2024 data and incomplete trend analysis, the correctness and qualitative accuracy are significantly reduced. The answer is partially correct but fails on completeness and full multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 486,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s short‑term borrowings fell sharply from **$883 million (2022)** to **$538 million (2023)** and edged up to **$562 million (2024)**; its long‑term debt rose from **$47.8 billion (2022)** to **$49.3 billion (2023)** before declining to **$45.0 billion (2024)**.  This three‑year progression shows the company has been deliberately reducing high‑cost, short‑term wholesale funding, shifting toward longer‑dated, more stable debt and overall deleveraging, reflecting a tighter capital‑structure and a focus on improving liquidity and balance‑sheet resilience.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), $562M (2024) and long-term debt as $47.8B, $49.3B, $45.0B — these do not match the actual figures. For example, total debt in 2022 should be ~$43.086B, but LLM implies $48.683B ($883M + $47.8B), which is off by over $5.5B. Similarly, 2023 total debt per LLM is $49.838B (close to truth $49.856B), but this is coincidental due to offsetting errors. 2024 total debt per LLM is $45.562B ($562M + $45.0B), close to truth $45.551B, again nearly correct by chance. However, component-level errors undermine reliability. 2) The LLM omits key data points from the original answer: the weighted-average interest rate (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0). These are critical for assessing capital structure strategy. 3) While the LLM correctly infers a trend of deleveraging in 2024 and a shift away from short-term funding, it misses the strategic increase in 2023 and fails to mention the rising interest rate environment, which is central to understanding debt cost pressures. 4) The qualitative reasoning is partially sound — the conclusion about deleveraging and preference for stable debt aligns with the truth — but lacks support from accurate data and omits key multi-hop insights (e.g., interest rate trends and floating-rate debt elimination). 5) Contextual relevance is high because the answer addresses the evolution of debt and interprets strategic implications, even if based on flawed numbers. Overall, the answer gets the general direction of change approximately right but fails on precise financial figures and misses critical supporting metrics, resulting in a partially correct but factually unreliable response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 531,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nThe net carrying amount of NVIDIA’s 3.50% Notes Due 2050 was roughly $1.6 billion at the end of fiscal 2022, rose modestly to $1.637 billion in fiscal 2023 and was $1.604 billion in fiscal 2024. This flat‑to‑slightly‑declining pattern shows that NVIDIA has maintained a stable, low‑cost long‑term debt position, reflecting a conservative capital‑structure strategy that relies on a fixed‑rate, long‑dated note rather than expanding leverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's liability for the 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, not $1.6 billion as stated in the LLM answer. The values for fiscal 2023 ($1,637 million) and fiscal 2024 ($1,604 million) are correct. This initial error misrepresents the trend as flat-to-slightly-declining rather than a clear reduction from over $2.1 billion to $1.6 billion. (2) The calculation of the trend is therefore flawed: the actual decrease is $543 million over two years (a 25% reduction), which is substantial, not 'modest' or 'flat'. The LLM incorrectly characterizes the pattern due to the wrong starting value. (3) The multi-hop reasoning is partially sound—identifying the three-year trend and linking it to capital structure strategy—but the conclusion is undermined by incorrect data. The claim of a 'conservative capital-structure strategy' may still be valid, but the justification based on 'stable, low-cost' debt contradicts the actual significant reduction, which suggests active liability management rather than stability. (4) Scores reflect that core facts (2 out of 3 years correct) and overall relevance are present, but the major error in the 2022 figure severely impacts correctness and reasoning quality, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 378,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nApple continued to reference the original 0.45 % Notes due 2016 in the Exhibit 4.3 “Officer’s Certificate” of each filing—2022, 2023 and 2024—without any amendment, new issuance or retirement disclosed; the only debt‑related updates in those years were the 2023 Officer’s Certificate for newer, longer‑dated notes (e.g., 4.421 % Notes due 2026). This steady, unchanged reference shows that Apple’s long‑term debt disclosure strategy is to keep legacy indentures on record for regulatory completeness while focusing disclosures on newer, larger‑scale debt rather than repeatedly updating or issuing additional short‑term notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes due 2016, and the years 2022–2024 are accurately referenced. The mention of Exhibit 4.3 and the Officer’s Certificate is consistent with typical SEC filing structures. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reference to newer 2023 notes (e.g., 4.421% due 2026) are factually sound and match expected disclosure patterns. No calculations were required, but temporal and numerical references are correct. (3) Multi-hop reasoning is strong: the model correctly infers that the continued inclusion of a matured debt instrument (2016 notes in post-2022 filings) reflects a disclosure strategy focused on regulatory completeness and legacy documentation, even after maturity. It appropriately contrasts this with active issuance (2023 notes), showing synthesis across time and document types. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'regulatory completeness' and 'focus on newer debt' without explicitly stating the transparency and legal continuity rationale emphasized in the ground truth. However, the semantic meaning is closely equivalent, and the conclusion is logically supported. The answer is fully relevant and addresses both the evolution over time and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 383,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 Capital One’s net derivative assets grew from a modest $5 million asset to $58 million, a level that persisted through 2024.  This increase reflects a shift in the key unobservable inputs used in the discounted‑cash‑flow valuation—swap‑rate ranges moved from roughly 1‑2 % in earlier years to a 3‑5 % range (weighted average ≈ 4 %) by 2023‑24—indicating higher market‑rate exposure and a modeling approach that now incorporates more pronounced interest‑rate assumptions while still relying on Level 3 inputs.  The progression therefore signals that the firm’s derivative portfolio transitioned from a net liability to a net asset position, highlighting heightened interest‑rate risk and a greater reliance on observable swap‑rate curves complemented by increasingly significant unobservable assumptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and misrepresents the evolution of Capital One's net derivative assets. According to the ground truth, the fair value was $31 million in 2022, not $5 million as stated by the LLM. The LLM correctly reports $58 million for 2023 and 2024, but incorrectly frames the change as a growth from $5M to $58M. Additionally, the ground truth states there was a net unrealized loss of $20 million still held in 2022 and a realized loss of $43 million in 2022 (implied from context), which the LLM omits entirely. The shift in significant unobservable inputs is partially correct — the LLM identifies swap rates with a 4% weighted average in 2024, which matches the truth — but incorrectly claims this shift occurred in '2023-24' and fails to note that 'default' was the key input in 2023. The LLM fabricates 'swap-rate ranges' moving from 1-2% to 3-5%, which is not supported by the original answer. (2) Quantitative accuracy is low: $5M vs $31M is a major discrepancy; no mention of the $20M unrealized loss or $43M realized loss in 2022; invented percentage ranges (1-2%, 3-5%) not in source. While $58M is correct for 2023 and 2024, the narrative around it is misleading. (3) Multi-hop reasoning is partially sound — the LLM recognizes a shift in risk inputs and links it to interest rate sensitivity, which aligns with the conclusion in the original answer. However, it fails to accurately synthesize the year-by-year progression of both valuation and risk inputs, incorrectly merging 2023 and 2024 inputs and omitting the 2023 'default' assumption. It also incorrectly infers a transition from net liability to net asset without evidence in the data provided. (4) Contextual relevance is high — the answer addresses the question's focus on evolution, risk inputs, and modeling assumptions. The overall direction of interpretation (increased interest rate sensitivity) is consistent with the ground truth, but the factual foundation is flawed, limiting qualitative accuracy. The conclusion about heightened interest-rate risk is plausible but not fully supported by accurate data in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 582,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 1.55 % Notes Due 2028 showed only modest growth in book exposure – the net carrying amount rose from roughly **$1.2 billion at the end of FY 2022** to **$1.25 billion at the end of FY 2023 and remained flat through FY 2024** (the same $1.25 billion figure is reported as of Jan 28 2024 and Jan 26 2025).  During the same period the market‑value fair price edged up from about **$1.10 billion (FY 2023)** to **$1.12 billion (FY 2024)**, reflecting normal price movement in response to interest‑rate changes.  \n\nThis steady, low‑coupon, long‑dated debt position demonstrates that NVIDIA is deliberately maintaining a stable, predictable financing base—using long‑term fixed‑rate notes to fund strategic growth while limiting interest‑rate risk and preserving cash for investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. However, the LLM states it was $1.2B in 2022, $1.25B in 2023, and flat at $1.25B in 2024—this misrepresents the 2023 value (wrongly claiming an increase to $1.25B instead of a decrease to $1.1B) and omits the 2024 increase from $1.1B to $1.25B. The LLM also introduces market-value fair prices ($1.10B in FY2023, $1.12B in FY2024), which are not mentioned in the ground truth and appear to be fabricated or misattributed. (2) The fiscal year-end dates (Jan 28, 2024, and Jan 26, 2025) are plausible for NVIDIA but not confirmed in the ground truth and not relevant to the core question about exposure trends. (3) The qualitative reasoning about NVIDIA’s long-term debt strategy—maintaining stable, fixed-rate financing to limit interest-rate risk—is reasonable and aligns with the intent of the original answer. However, because the numerical progression is incorrect, the synthesis of multi-hop information (tracking changes across years) is flawed. The LLM fails to capture the dip in 2023 followed by a rebound in 2024, instead showing steady growth, which alters the interpretation. (4) Despite these errors, the answer remains contextually relevant, addressing both the evolution of exposure and strategic implications. The core idea of strategic debt maintenance is preserved, but the factual foundation is partially incorrect, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 424,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nGE’s 2022 filing (p. 36) first highlighted the Alstom‑related legacy litigation – anti‑competition and corruption claims dating to the 2015 acquisition – and noted that settlement payments and future cash outflows were already material, while also flagging the 2020 SEC settlement and ongoing shareholder suits tied to historic financial‑reporting disclosures. The 2023 filing (p. 69) reiterated that “material trailing legal liabilities” from exited businesses remain, emphasizing that reserve estimates are judgment‑laden and that actual losses may exceed those estimates, underscoring continued exposure. The 2024 filing (p. 31 and p. 33) again reports that the company is still subject to those Alstom‑era proceedings and to shareholder lawsuits, describing them as “material trailing legal liabilities” whose ultimate financial impact is uncertain but could be significant. Together, the three years show that these contingent liabilities have persisted unchanged in magnitude and risk, with only incremental progress toward settlement, indicating a lasting financial exposure for GE.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's exposure to Alstom-related legacy liabilities (anti-competitive conduct, corruption claims from pre-2015) and shareholder lawsuits tied to historical financial reporting are consistently highlighted across 2022–2024. The progression shows persistent, material contingent liabilities with uncertain but potentially significant financial impact. (2) Quantitative accuracy is strong: while no specific dollar amounts are cited in either answer, the LLM correctly references the materiality of cash outflows and the uncertainty around reserves, consistent with the original. Dates (2022–2024) and events (2020 SEC settlement) are accurately referenced. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the continuity of risk and lack of resolution. It appropriately cites page numbers (p. 36, 69, 31, 33), indicating precise sourcing. (4) The only minor shortcoming is that the LLM slightly underemphasizes the reputational risk component highlighted in the original answer, particularly in 2022 and 2024. However, it does mention 'material trailing legal liabilities' and 'uncertain but significant' impact, capturing the core financial and operational implications. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 408,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nFrom 2022 through 2024 CVS’s hedge‑fund limited‑partnership exposure grew from roughly **$225 million** (2022) to **$252 million** (2023) and then to **$280 million** (2024).  This steady rise shows that the company is deliberately expanding its allocation to alternative‑asset interests, consistent with the pension plan’s target mix of private‑equity and hedge‑fund interests and its broader strategy of diversifying the portfolio and seeking higher returns while managing liability risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM incorrectly states $225 million in 2022 (should be 2023), $252 million in 2023 (should be 2024), and introduces a completely incorrect figure of $280 million in 2024 (should be $252 million). These errors affect all three data points, making the quantitative trend misleading. (2) The calculation of growth is therefore also incorrect—while the direction of increase is right, the magnitude and timing are wrong. The actual increase from 2022 to 2024 is $38 million ($252M - $214M), but the LLM implies a $55 million rise from $225M to $280M over two years, misrepresenting both baseline and endpoint. (3) The qualitative reasoning about pension strategy—increasing alternative investments for diversification and return—is semantically aligned with the ground truth and shows correct multi-hop interpretation of what rising allocations suggest. However, this insight is based on incorrect data, undermining the validity of the conclusion. (4) Contextually, the answer addresses both parts of the question (change over time and strategic implication), so relevance is high. Final scores reflect severe penalties on quantitative accuracy due to incorrect numbers, moderate qualitative score due to sound logic despite bad inputs, and low overall correctness because factual fidelity is paramount in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 429,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia operating segment generated roughly **$253 million of operating profit**.  The 2022 Global Productivity Initiative allocated only about **$3 million of the $32 million of 2023 restructuring charges** to this region (≈10 % of total charges), indicating a modest, continued focus on cost‑reduction there.  By 2024 depreciation and amortization spending in Africa/Eurasia slipped slightly to **$8 million**, with capital expenditures of roughly **$12 million**, reflecting a shift from aggressive expansion to maintaining the existing asset base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is reported as $253 million, whereas the ground truth is $203 million—a material difference of $50 million. The restructuring charges allocated to the region are stated as $3 million (≈10% of $32 million total), but the original answer indicates 10% of expected charges amounting to $20–$24 million, implying total charges of $200–$240 million, not $32 million. This suggests a fundamental misrepresentation of the scale and context of the Global Productivity Initiative. The depreciation and amortization figure for 2024 is correctly stated as $8 million, consistent with the decline from $9 million in prior years, though the LLM fails to mention the $9 million figure for 2022 and 2023, omitting useful trend context. Additionally, the LLM introduces capital expenditures of $12 million in 2024, which is not mentioned or supported in the original answer, adding unsupported information. (2) Quantitative accuracy is low: two of three core numbers are incorrect ($253M vs $203M, $3M vs $20–24M), and the calculation of 10% is based on a false total. Only the $8M D&A is correct. (3) Multi-hop reasoning is partially sound—the model attempts to connect operating profit, restructuring, and D&A across years—but relies on incorrect data inputs, undermining the validity of the synthesis. The conclusion about a shift to cost optimization is reasonable but not fully supported due to inaccurate figures. (4) Contextual relevance is high as the answer addresses all three time points and the intended strategic interpretation. However, due to major quantitative errors and introduction of unsupported data (capex), the overall correctness score is limited to 4, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 505,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG kept the same core attachment points for its international terrorism book – $200 million for Japan and $125 million for the rest‑of‑world – throughout 2022‑24, but the **modeled loss estimate for its biggest terrorism concentration (New York City)** grew from roughly **$1.3 billion net of TRIPRA and private reinsurance in 2021‑22** to a comparable figure that the 2024 filing still flags as “likely to vary materially” from the model.  Reinsurance protection therefore remained limited to **targeted private terrorism treaties and government‑sponsored pools**, with no change in the underlying attachment structure.  At the same time, the **reinsurance‑recoverable balance fell sharply**, from **$67.5 billion at the end of 2023** to **$38.0 billion at the end of 2024** (with only $20.1 billion of collateral held to back those recoverables), reflecting the runoff of treaties and a tighter collateral regime rather than an expansion of coverage.  In short, the **attachment points stayed constant, the modeled loss exposure was reaffirmed but remained subject to large uncertainty, and the size of the recoverable asset pool contracted as the company shifted to more collateral‑intensive reinsurance arrangements.**",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and trend interpretation. (1) Correct elements: The $200M attachment point in Japan and $125M elsewhere is correctly stated and consistent with the ground truth. The $38.0 billion reinsurance recoverable asset figure for 2024 is accurate. The use of third-party models and scenario-based terrorism risk assessment is contextually relevant. (2) Quantitative errors: The LLM claims a 'fall' in reinsurance recoverables from $67.5B (end of 2023) to $38.0B (end of 2024), directly contradicting the ground truth, which states that recoverables reached $38.0B in 2024 with no prior value given for 2023—more critically, the ground truth describes an *expansion* in reinsurance protections, not a contraction. The $67.5B figure is unsupported and incorrect. Additionally, the LLM references a $1.3B modeled loss from '2021-22', while the ground truth specifies 2022, introducing a minor temporal inaccuracy. The $29.1B in ceded loss reserves (part of the $38.0B total) is omitted in the LLM answer. (3) Reasoning flaws: The LLM incorrectly infers that reinsurance protection *contracted* and that the company shifted to 'more collateral-intensive arrangements', which is not supported by the ground truth—instead, AIG *expanded* reinsurance protections. The conclusion that the 'recoverable asset pool contracted' is factually wrong and undermines the multi-hop synthesis. While the model correctly identifies consistent attachment points and ongoing modeling uncertainty, it misrepresents the trajectory of reinsurance strategy. (4) Despite correct identification of key entities (AIG, TRIPRA, reinsurance recoverables) and relevance to the question’s themes, the answer fails on core factual accuracy, especially regarding financial trends and balances, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 506,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe 2 % Notes due 2031 were carried at roughly $1.2 bn at the end of FY 2022, trimmed to about $1.04 bn in FY 2023—most likely through selective repurchases or conversions— and then restored to approximately $1.25 bn by FY 2024.  This pattern shows that NVIDIA is managing that long‑term debt opportunistically, adjusting the outstanding balance to balance interest‑cost savings, liquidity needs, and the desired maturity profile rather than allowing a steady increase.  In effect, the company treats the 2 % notes as a flexible component of its capital structure, expanding or contracting the liability as market conditions and cash‑flow priorities dictate.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key financial figures: $1.2 billion in 2022, $1.044 billion reduced to approximately $1.04 billion in 2023 (rounding acceptable), and the return to $1.25 billion in 2024. These match the ground truth exactly or within acceptable approximation (e.g., 'about $1.04 bn' for $1.044 bn). The note interest rate (2.00%) and maturity year (2031) are also accurate.\n\n2) Quantitatively, all numbers are correct. The LLM uses 'roughly', 'about', and 'approximately' but stays within reasonable rounding bounds. No calculation errors are present.\n\n3) The multi-hop reasoning is mostly sound: it connects data across three fiscal years and interprets the fluctuation as part of a strategic debt management approach. However, while the ground truth emphasizes *stability* and *preservation* of long-term capital structure with minimal change, the LLM frames the pattern as *opportunistic* and *flexible*, implying active expansion/contraction based on market conditions. This is a plausible interpretation but slightly overreaches the evidence—there is no indication in the data of repurchases, conversions, or active rebalancing; the small dip and rebound could be due to accounting reclassifications or minor adjustments, as suggested in the original answer. Thus, the qualitative inference is reasonable but not fully aligned with the more conservative conclusion in the ground truth.\n\n4) Contextually, the LLM addresses the full scope of the question—trend over time and implications for long-term debt strategy—and synthesizes information across the three years appropriately. The answer remains focused and relevant throughout.\n\nOverall, the answer is factually accurate and contextually appropriate, but the qualitative interpretation leans slightly more toward active management than the data definitively supports, warranting a minor deduction in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 514,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 were originally issued in May 2014 under Apple’s Officer’s Certificate (Exhibit 4.4). All three of the latest 10‑K filings—2022, 2023 and 2024—reproduce the same Exhibit 4.4, thereby continuously disclosing that legacy senior‑unsecured note series as part of Apple’s debt documentation. This repeated inclusion shows that, even after the notes matured, Apple’s debt structure retains a stable, long‑term framework in which the 1.05 % 2017 notes remain a visible, enduring reference point for the company’s historic borrowing arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 were indeed issued in May 2014 under Exhibit 4.4 (Officer’s Certificate), and their repeated inclusion in the 2022, 2023, and 2024 10-K filings via reproduction of Exhibit 4.4 is factually sound. The dates, percentages, and document references (Exhibit 4.4) are all accurate. (2) Quantitative accuracy is perfect: no numerical errors; the interest rate (1.05%), maturity year (2017), and issuance year (2014) match the ground truth. (3) The reasoning is strong: the LLM correctly infers that the continued inclusion of a matured note in recent filings reflects a stable, transparent debt framework and ongoing documentation of legacy instruments. It accurately synthesizes information across multiple years of filings (multi-hop reasoning) and draws a logical conclusion about Apple’s debt management strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention possible refinancing or rollover—mentioned in the original answer—as a reason for continued documentation. However, the conclusion about enduring visibility and structural continuity is semantically equivalent and well-supported. Wording differs slightly but meaning is preserved. Contextual relevance is excellent as it directly addresses the evolution over 2022–2024 and implications for long-term visibility and continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 399,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s IDA‑migration rights shifted from the 2019 framework—under which it could move up to **$10 billion** of IDA balances each 12‑month period (subject to caps and adjustments)—to the **2023 IDA agreement**, which replaced that annual $10 billion migration right with a regime that ties any migration to maintaining prescribed **minimum and maximum balance levels** (a minimum that exceeds the total of unmatured fixed‑rate obligations, capped at $30 billion above that total through Sep 10 2025 and a $60 billion minimum thereafter, with a $90 billion ceiling; the prior requirement that at least 80 % of balances be designated fixed‑rate was eliminated). Consequently, Schwab **did not migrate any IDA balances to its balance sheet in 2023 or 2024**, instead focusing on buying down fixed‑rate obligations while operating under the new balance‑size constraints set by the 2023 agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, Schwab operated under the 2019 IDA agreement allowing up to $10 billion in annual migrations, and that $10.1 billion had already been moved by year-end (implied by 'had already moved' in original; LLM doesn't repeat this exact figure but focuses on the structural shift). (2) The 2023 IDA agreement is accurately described as replacing the $10 billion migration right with minimum and maximum balance thresholds. The LLM adds specific quantitative thresholds—$30 billion cap above unmatured fixed-rate obligations through Sep 10, 2025, $60 billion minimum thereafter, and $90 billion ceiling—which are consistent with the knowledge graph data, though not explicitly in the original answer. These details enhance accuracy without contradicting. (3) The elimination of the 80% fixed-rate designation requirement is a correct and precise addition. (4) The conclusion that Schwab did not migrate any balances in 2023 or 2024 is fully supported and matches the original. (5) The reasoning correctly synthesizes the evolution from active migration to constrained off-balance sheet management, capturing the strategic shift. Minor deduction in quantitative accuracy because the original does not specify the $30B/$60B/$90B figures—while plausible and likely correct, they go beyond the provided ground truth. However, since they do not contradict and are contextually appropriate, the overall correctness remains high. The answer is complete, contextually relevant, and semantically equivalent, with excellent multi-hop reasoning across years and agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 452,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to the Polish Bank BPH mortgage portfolio was gradually eliminated.  The estimated borrower‑litigation loss reserve grew from roughly **$1.35 bn in 2022** to **$2.67 bn in 2023** (reflecting updated loss estimates), then fell to about **$2.46 bn by the end of 2024** as settlement progressed, while the portfolio’s net carrying value was written down to **zero** – a valuation allowance that fully offsets the receivable balance was recorded in 2023 and remained in place through 2024.  Capital contributions also changed: after cash infusions of **$360 m (2021) and $530 m (2022)**, GE provided a **non‑cash intercompany loan forgiveness of $1.8 bn in 2023** and thereafter required no additional cash contributions, relying on the allowance to absorb the remaining exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor, acceptable variations in numerical precision. (1) Quantitatively: The estimated losses are correctly reported as $1.35 billion in 2022 (vs. $1,359M), $2.67 billion in 2023 (vs. $2,669M), and $2.46 billion in 2024 (vs. $2,461M) — these are rounded but factually consistent. The $530 million cash contribution in 2022 is correct; the non-cash contribution of $1.8 billion in 2023 matches the $1,797 million in the original. The mention of a $360M contribution in 2021 is extra but not incorrect, as it provides context beyond the question’s scope. (2) The carrying value being written down to zero by 2024 is correctly stated, and the explanation that a full valuation allowance was recorded in 2023 and maintained through 2024 aligns with the full write-down by end-2024. (3) The reasoning is sound: it captures the worsening exposure in 2023, stabilization in 2024, and GE’s strategic shift from cash to non-cash support before exiting further contributions. (4) All entities (GE, Bank BPH, mortgage portfolio, litigation losses, capital contributions) are correctly identified and synthesized across years. The only minor deviation is rounding of numbers and inclusion of 2021 data not in the original answer, but this does not detract from correctness. Overall, the answer demonstrates strong multi-hop synthesis and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 397,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities slipped from about **$1.02 bn to $0.98 bn**, while the unrealized loss component fell sharply from **$155 m to $100 m**, indicating that the portfolio’s market value declined but the depth of losses improved as rates rose. By the 2024 filing the company’s remaining CMBS exposure was reduced to a trivial **$3 m** in separate‑account assets, reflecting a deliberate contraction of the position. This trend shows that CVS is actively de‑risking its fixed‑income book by trimming lower‑yielding, longer‑duration CMBS and shifting toward more liquid, higher‑quality securities to limit interest‑rate and credit risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS's CMBS fair value was $574M in 2022 and increased to $675M in 2023, not $1.02B and $0.98B as stated. The unrealized losses in 2022 were $12M, not $155M, though the $100M figure for 2023 is correct. The 2024 fair value of $3M matches the ground truth and is correctly interpreted as a near-complete exit from the asset class. (2) The numbers are therefore quantitatively inaccurate—especially the 2022 figures, which are off by over 75% in fair value and more than 10x in unrealized losses. These are not minor rounding or formatting differences but major discrepancies. (3) The reasoning about de-risking in 2024 is sound and aligns with the ground truth, showing correct multi-hop synthesis of the trend from increasing losses in 2023 to drastic reduction in 2024. However, the incorrect baseline data undermines the validity of the analysis for 2022–2023. The conclusion about shifting to higher-quality, more liquid securities is plausible but not directly supported in the original answer, adding interpretation beyond the evidence. (4) Correctness is scored at 4 due to major numerical errors but partial correctness in the 2023–2024 trend and final strategic interpretation. Quantitative accuracy is low (3) due to incorrect dollar amounts. Qualitative accuracy is moderate (5) because the logic and direction of the trend are reasonable, but based on wrong inputs. Contextual relevance is high (8) as the answer addresses all parts of the question and provides a coherent narrative around risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 450,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nAcross the three fiscal‑year filings, Marketside is first listed as part of Walmart’s private‑brand portfolio in the 2022 filing (page 6), appears again in the 2023 filing with language noting the company’s continued expansion of private‑brand offerings (page 7), and in the 2024 filing is specifically cited as a focus of investment to strengthen grocery private labels (page 8). This three‑year progression shows Walmart is deliberately scaling its own‑brand grocery line—exemplified by Marketside—to deepen its grocery assortment, improve margins and reinforce its everyday‑low‑price strategy in the grocery segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: Marketside is correctly identified as part of Walmart's private brand portfolio from 2022 to 2024, and the progression shows ongoing commitment. The mention of Marketside being cited as a 'focus of investment' in 2024 aligns with the ground truth's implication of strategic importance. Quantitatively, there are no numbers, dates, or financial figures in the response that conflict with the original answer—no specific calculations were required, and all years (2022–2024) are correctly referenced. However, the LLM introduces a detail not present in the ground truth: that Marketside was 'first listed' in 2022, implying it was newly introduced that year, which the original answer does not support—Marketside was already established and listed among key brands, not necessarily new. Additionally, the LLM emphasizes 'scaling' and 'deliberately expanding' Marketside, while the ground truth stresses continuity of Marketside alongside the introduction of new brands like 'bettergoods'—a nuance the LLM underrepresents. The strategic interpretation in the LLM answer focuses on margin improvement and low-price strategy, which, while plausible, is not explicitly supported in the original answer, which emphasizes a dual strategy of maintaining trusted brands while innovating. Thus, while the core facts are correct and the multi-hop synthesis across years is sound, the reasoning slightly overreaches in interpretation and misses the nuance of brand coexistence (legacy + new). This results in a high but not top score for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 448,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened the monitoring and enforcement of supplier environmental and human‑rights performance by updating its Vendor Code of Conduct and human‑rights policy (including a 2023 risk‑based wood‑sourcing framework, enhanced monitoring and a new forestry‑grievance process) and by requiring suppliers to report GHG emissions to CDP and to achieve EPA SmartWay certification.  To back up these enforcement upgrades, the company invested more than $300 million (rising to >$550 million by 2024) in energy‑efficiency and renewable‑energy projects, launched a $350 million community‑investment program that ties supplier sustainability to broader ESG goals, and set science‑based net‑zero and 2030 emissions‑reduction targets that are tracked and reported annually.  These steps integrated supplier sustainability into Lowe’s supply‑chain strategy and made compliance a measurable component of its long‑term environmental and social objectives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies, particularly in quantitative details and specific policy enhancements, despite capturing the general direction of Lowe's sustainability efforts. (1) Quantitative Accuracy: The LLM claims investments rose to '>$550 million by 2024', but the ground truth states over $550 million was invested by 2022 and over $400 million through 2023—indicating a decline, not growth, and contradicting the LLM's upward trajectory. The $350 million community-investment program and specific figures tied to energy-efficiency and renewable projects are not mentioned in the original answer and appear fabricated. (2) Completeness: While the LLM mentions updated policies like the 2023 wood-sourcing framework and grievance process (which aligns with the truth), it omits key elements such as the requirement for wood products to come from well-managed, non-endangered forests and fails to mention the conflict minerals policy. It adds unverified details like supplier GHG reporting to CDP and EPA SmartWay certification, which are not in the original. (3) Entity Accuracy: The years 2022–2024 are correctly framed, and 'Lowe’s' is accurate, but the introduction of CDP, EPA SmartWay, and specific investment programs introduces entities and initiatives not supported by the ground truth. (4) Reasoning: The multi-hop synthesis is partially sound—linking policy updates to enforcement and investment—but incorrectly infers causality and continuity in spending trends. The claim that investments grew to over $550 million by 2024 contradicts the timeline where $550M was already exceeded by 2022. (5) Semantic Equivalence: The overall theme of strengthening supplier monitoring and sustainability is present, but the specific policy evolution and financial commitments are misrepresented. The original answer emphasizes a risk-based approach to wood sourcing and formalized grievance mechanisms supported by prior investments, while the LLM invents new programs and misrepresents investment timing and scale. Thus, while contextually relevant and directionally aware, the answer is factually flawed in critical areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 576,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 2.40 % Notes due 2023 are still disclosed in the same place – Exhibit 4.3, which describes the 2013 indenture that governs Apple’s senior unsecured debt – and the wording of that exhibit is unchanged in each filing. This three‑year continuity shows that Apple is maintaining a stable, laddered debt profile: it keeps the low‑coupon 2.40 % tranche as part of a diversified suite of long‑dated notes while periodically supplementing it with newer, higher‑coupon issuances to manage interest‑rate risk and fund ongoing operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity details that affect the overall correctness. (1) Quantitatively, the 2.40% Notes due 2023 and the 2013 indenture (Exhibit 4.3) are correctly identified, and the years (2022–2024) align with the ground truth. The percentage and maturity year are accurate. (2) However, the claim that the 'wording of that exhibit is unchanged in each filing' is not supported by the ground truth, which does not assess exhibit text changes—this is an unsupported inference. More critically, the LLM incorrectly implies that Apple continued to carry the 2.40% Notes as active debt beyond their 2023 maturity into 2024, when in fact the ground truth notes their inclusion in 2024 filings was part of a disclosure practice for maturing notes, not evidence of an ongoing laddered strategy involving active low-coupon debt. (3) The multi-hop reasoning fails: the ground truth emphasizes transparency in disclosing maturing debt, while the LLM infers a strategic 'laddered debt profile' and active management via 'higher-coupon issuances'—a conclusion not supported by the provided data. No evidence of newer issuances or interest-rate risk management is in the ground truth. (4) While contextually relevant and focused on debt management strategy, the LLM overinterprets the data, introducing speculative financial strategy claims. Thus, core facts are mostly right (quantitative accuracy), but reasoning and qualitative synthesis are flawed, leading to a misleading conclusion about Apple's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 430,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 to 2024 GE pared down its AerCap exposure from a mixed equity‑and‑note position to the single senior note alone.  In 2022 the AerCap investment showed an unrealized loss of **$(865 million)** (Note 19), which was eliminated when the company sold the remaining AerCap shares in 2023 for **$6.587 billion**, leaving only the note; by the end of 2024 the note carried a modest **$38 million** unrealized gain (down from **$129 million** in 2023) and its carrying amount had risen slightly to **$982 million** (vs. $944 million in 2023).  This trajectory shows GE’s strategy shifted from a sizable, market‑linked equity stake in AerCap to a much smaller, debt‑like holding, reflecting a broader move toward simplifying its financial‑instrument portfolio and focusing on lower‑risk, cash‑generating assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative inaccuracy: The original answer states GE's holdings of the AerCap note were $976M in 2022, $944M in 2023, and $982M in 2024. The LLM incorrectly claims the 2022 value was part of a 'mixed equity-and-note position' and introduces an unrealized loss of $(865M), which is not mentioned in the ground truth. The sale of AerCap shares for $6.587B in 2023 is entirely fabricated and not supported by the original answer. The carrying amount increase to $982M in 2024 is correct, but the prior year comparison is flawed because it omits the correct 2022 baseline of $976M. (2) The LLM invents detailed financial data (unrealized gains/losses, sale proceeds) not present in the original answer, suggesting a hallucination of specific footnote-level details (e.g., 'Note 19'). (3) Qualitatively, the reasoning is unsound: the original answer describes a fluctuating but stable note holding, while the LLM frames it as a strategic shift from equity to debt, which is not supported by the ground truth. The conclusion about GE simplifying its portfolio toward lower-risk assets may align thematically but is based on incorrect premises. (4) Contextually, the answer addresses the question's intent about investment strategy, but the analysis is built on false data. Multi-hop synthesis fails because the model misrepresents the nature of GE's holdings over time. Minor alignment: the 2023 to 2024 increase to $982M is correctly noted. Overall, major factual and numerical errors severely undermine correctness despite some surface-level relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 447,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 through 2024 the U.S. qualified pension plan’s glide‑path target moved from **15 % equity / 75 % fixed‑maturity / 10 % other** (target 2022) to **9 % equity / 80 % fixed‑maturity / 11 % other** (target 2024/2025).  The reduction in the “return‑seeking” equity allocation and the corresponding increase in liability‑hedging fixed‑income holdings track the plan’s improved funded ratio, showing a deliberate de‑risking shift that lowers growth‑asset exposure as the plan’s financial position strengthens.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the percentages are correct: the shift from 15% equity / 75% fixed-maturity / 10% other in 2022 to 9% equity / 80% fixed-maturity / 11% other in 2024/2025 matches the expected evolution. These numbers reflect a real de-risking trend, and the LLM correctly identifies the reduction in growth assets and increase in liability-hedging assets. (2) The answer correctly infers that the glide path is responsive to funded status improvements, even though specific funded ratios aren't provided in the LLM response — this is acceptable since the original answer also does not include exact funded status numbers. (3) The multi-hop reasoning is sound: the LLM connects the changing asset allocation over time to the plan’s de-risking strategy and links it to liability-driven investing principles implicitly by describing the shift toward liability-hedging assets. (4) The only minor shortcoming is that the LLM does not explicitly mention *how* the target allocations are set (i.e., based on prior year-end funded status), which is a key part of the glide path mechanism described in the original answer. However, the core strategic insight — that improved funded status leads to de-risking — is correctly captured. Thus, while slightly less detailed on process, the LLM conveys the essential factual and conceptual content accurately. Wording differences are within acceptable semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 407,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly placed embedded‑processing products at the center of its growth strategy—citing the segment’s role in diversifying the analog portfolio, expanding industrial and automotive design wins, and delivering high‑margin cash generation.  While the segment’s quarterly revenue and operating profit were volatile (a modest rise in 2023 followed a sharper decline in 2024), the company’s continued multi‑year investment in capacity, R&D and supply‑chain control demonstrates that embedded processing is treated as a stable, high‑margin engine that underpins the long‑term growth of free‑cash‑flow‑per‑share.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the correct strategic emphasis on embedded processing from 2022 to 2024 and correctly identifies its role in long-term free cash flow per share growth, which aligns with the ground truth. However, it introduces information not present in the original answer—specifically, claims about 'quarterly revenue and operating profit volatility,' a 'modest rise in 2023,' and a 'sharper decline in 2024'—which are not supported by the ground truth and contradict the narrative of consistent strategic importance. These performance details were not mentioned in the original answer and may misrepresent the company's messaging. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the LLM does not fabricate specific figures, so it scores well on quantitative accuracy despite the speculative trends. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the strategic continuity across years and links embedded processing to cash flow generation. However, it incorrectly infers financial performance trends that were not in the source, undermining the qualitative accuracy. The original answer emphasizes consistent strategic framing, not financial volatility. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution of strategy and implications for cash flow. The core insight about embedded processing being a long-term pillar is preserved, but the addition of unsupported financial performance weakens correctness. Thus, the answer is partially correct but contains significant speculative content, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 469,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s kept its private‑brand IP strategy focused on securing and expanding trademark and patent protection for key labels such as **Kobalt, STAINMASTER and allen+roth**, while reshaping the brand portfolio to emphasize higher‑value private‑label products.  The company tied this portfolio shift to its digital‑transformation agenda—embedding the protected brand names in online catalogs, AI‑driven search and virtual‑design tools, and promoting them through omnichannel fulfillment (e‑commerce, curb‑side pickup, same‑day delivery) so that the trademarks drive growth across Lowe’s digital storefronts and supply‑chain visibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and entity representation compared to the ground truth. (1) Correct elements: The LLM correctly identifies the three core private brands—Kobalt, STAINMASTER, and allen+roth—as central to Lowe's intellectual property strategy across the period, which aligns with the original answer. It also appropriately links private brand strategy to digital transformation, mentioning e-commerce, omnichannel fulfillment, and digital tools, which is consistent with the 2024 shift noted in the ground truth. (2) Quantitative accuracy: There are no numeric values in the question or answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM fails to capture the key evolution in brand portfolio emphasis as documented in the original answer—specifically, the removal of 'RONA' and 'Reno Depot' from IP disclosures between 2022 and 2023, which signals a strategic refocusing. This omission undermines the completeness and factual accuracy of the response. Instead, the LLM asserts a general 'reshaping' without citing the actual disclosure changes, missing a critical factual pivot. (4) The LLM introduces unsupported specifics such as 'AI-driven search' and 'virtual-design tools' and claims integration into digital storefronts without grounding in the source data, which only mentions 'remote customer support' and 'mobile checkout' in 2024. These additions represent speculative overreach. While the general direction of digital integration is correct, the reasoning lacks fidelity to the actual disclosures. Thus, while contextually relevant and factually plausible, the answer does not accurately reflect the documented evolution from the filings, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 491,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nIBM’s 2022 filing treated trust chiefly as a reputational risk, but by the 2023‑2024 filings it is highlighted as a core competitive advantage—explicitly listed among the company’s “principal methods of competition” and linked to its hybrid‑cloud and AI strategy, responsible innovation and ecosystem partnerships. This multi‑year emphasis shows IBM is positioning itself as a trusted partner that can integrate hybrid‑cloud and AI services into complex enterprise environments, using client relationships and perceived trustworthiness to differentiate from hyperscale rivals and secure long‑term, high‑value engagements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of IBM's strategic emphasis on trust and client relationships from 2022 to 2024. It correctly identifies the shift from trust as a reputational concern in 2022 to a competitive advantage by 2023–2024, aligning with the ground truth. It accurately links this evolution to IBM’s hybrid cloud and AI strategy, responsible innovation, and ecosystem partnerships. The answer also correctly situates trust as a differentiator against hyperscalers and tied to long-term enterprise engagements, which is consistent with the original answer’s conclusion about strategic positioning. However, it omits specific details about the expansion of strategic partnerships—such as AWS, Microsoft, SAP in 2023 and Palo Alto Networks in 2024—which are key evidence of the ecosystem and security evolution. While the LLM mentions 'ecosystem partnerships' generally, it fails to provide the multi-hop specificity that demonstrates how the nature of partnerships evolved to include both cloud and cybersecurity players, weakening the qualitative depth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully contextually relevant. The reasoning is sound but lacks granular support from the year-by-year progression detailed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 368,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s El Segundo, California site moved from being used mainly to produce clinical‑trial material toward serving as a full‑scale commercial manufacturing hub for the company’s cell‑therapy portfolio.  Across the 2022, 2023 and 2024 Form 10‑K excerpts the company repeatedly states that the El Segundo facility is “used for clinical and commercial manufacturing and processing of our cell‑therapy products,” indicating that its capacity and responsibilities expanded to support both late‑stage clinical supply and the growing commercial demand for products such as Yescarta and Tecartus.  (Pages 12 (2022), 9 (2023) and 12 (2024) of the respective 10‑K filings).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a fundamental factual inaccuracy in its core claim: it states that the El Segundo facility evolved from primarily clinical production to a 'full-scale commercial manufacturing hub,' implying a shift or expansion in role from 2022 to 2024. However, the ground truth explicitly states that there was no significant change in the facility's role across the three years—it consistently served both clinical and commercial manufacturing throughout. While the LLM correctly quotes the repeated phrase from the 10-K filings ('used for clinical and commercial manufacturing...') and cites correct page numbers, this does not justify the incorrect inference of a transition or expansion in responsibilities. The quantitative and entity accuracy is high—the years (2022–2024), location (El Segundo, California), company (Gilead), and products (Yescarta, Tecartus) are correctly identified, and there are no numerical errors. However, the reasoning is flawed: the repetition of the same language across filings actually supports stability, not evolution or expansion, which the model misinterprets. This failure in multi-hop reasoning—synthesizing the consistency of disclosures over time—leads to a major qualitative error. The answer is contextually relevant as it addresses the facility’s role in cell therapy manufacturing, but the incorrect characterization of change undermines its correctness. Thus, the correctness score is low despite accurate sourcing and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 408,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s layered its 4.550 % fixed‑rate notes across a ladder of maturities—issuing short‑term tranches that mature in 2025‑2027 (2022 supplemental indenture), medium‑term issues due 2033‑2035 (2023 supplemental indenture) and a long‑dated tranche extending to 2062 (2024 supplemental indenture)—thereby extending the overall average life of the debt while preserving a low coupon.  This multi‑year, staggered‑maturity approach signals a deliberate long‑term debt strategy of locking in inexpensive financing for decades and smoothing future cash‑flow obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth in both factual content and reasoning. (1) Quantitatively, the LLM fabricates multiple maturities (2025–2027, 2033–2035, 2062), issuance years (2022, 2023, 2024 supplemental indentures), and a long-dated tranche to 2062, none of which are supported by the original answer. The ground truth states there is only one instrument: the 4.550% Notes due April 5, 2049, issued under the Fifteenth Supplemental Indenture on April 5, 2019, with no changes in maturity or issuance structure from 2022–2024. (2) The LLM incorrectly claims a 'laddered' maturity strategy with multiple tranches and supplemental indentures over three years, while the original answer confirms the same note was merely referenced consistently across filings, not newly issued or restructured. (3) The qualitative reasoning is flawed: the ground truth emphasizes stability and long-duration debt to avoid refinancing risk, while the LLM invents a dynamic, multi-tranche issuance strategy that does not exist in the data. (4) Contextual relevance is low because the answer addresses a different scenario—active debt structuring over time—rather than the actual static, consistent referencing of a single long-term note. The only correct element is the interest rate (4.550%), but all other facts, dates, and strategic interpretations are fabricated. This represents a significant hallucination and failure in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 405,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard line shifted from a growing docket of individual and class‑action PFAS suits to a series of large‑scale settlements; the most significant was the $10.5‑$12.5 billion public‑water‑system settlement, for which 3M recorded a $10.3 billion pre‑tax charge in Q2 2023 and will make payments through 2036, while a Michigan Wolverine settlement (final payment in June 2023) involved an immaterial share.  This trajectory shows that PFAS‑related litigation has become a multi‑billion‑dollar financial burden for 3M, forcing the company to set aside substantial reserves and absorb major charges on its financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The $10.5–$12.5 billion public-water-system settlement and the $10.3 billion pre-tax charge in Q2 2023 are not mentioned in the ground truth and are entirely fabricated in the context of the provided knowledge graph. The only settlement amount confirmed in the ground truth is the $65 million settlement in Michigan (2022) and another $65 million in New York (2024), both shared with other companies. The LLM incorrectly states a $10+ billion settlement as the central financial impact, which is not supported by the original answer. Additionally, the claim that 3M recorded a $10.3 billion charge in Q2 2023 is false based on the provided data. (2) The only correct numeric detail is the mention of a non-material settlement in Michigan, which aligns with the 'non-material settlement' in the original answer, though the timing (June 2023 final payment) is not specified in the ground truth and thus cannot be verified. All other numbers are incorrect. (3) The multi-hop reasoning is flawed: the LLM conflates broader PFAS litigation with Scotchgard-specific cases and introduces a massive settlement not tied to the Wolverine/Scotchgard disposal cases described in the original answer. The evolution of litigation from 2022–2024 is misrepresented—while the original answer notes increasing geographic spread and case complexity, it does not support the claim of a single, massive financial settlement. The LLM fails to correctly synthesize the actual trend: incremental but growing exposure across states and countries, not a single multi-billion-dollar charge. (4) The contextual relevance is moderate because the answer addresses PFAS litigation and its financial impact on 3M, and correctly identifies Michigan and Wolverine as part of the legal exposure. However, the core financial figures and their implications are entirely inaccurate, severely undermining correctness and qualitative accuracy. The answer creates a misleading narrative of financial impact based on invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 552,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nBetween 2022 and 2024 the Foster City, California campus shifted from a mainly HIV/HCV‑focused API and formulation laboratory into a broader R&D hub that also develops process chemistry for cell‑therapy candidates and coordinates early‑stage manufacturing for Gilead’s expanding global pipeline. This evolution reflects a strategic alignment that keeps discovery and clinical‑trial material production at Foster City while delegating commercial‑scale manufacturing to other sites and third‑party partners, tightly integrating the campus with the company’s worldwide operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall narrative and strategic interpretation but lacks some specificity and precision compared to the ground truth. (1) It correctly identifies the shift in Foster City's role from broader operations to a more R&D- and clinical-stage-focused facility, and accurately notes the delegation of commercial-scale manufacturing to other sites and partners. However, it introduces a detail not present in the original answer—specifically that the facility evolved 'from a mainly HIV/HCV-focused API and formulation laboratory'—which is not supported by the ground truth and adds unverified disease-area specificity. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the time frame (2022–2024) is correctly referenced, earning full marks. (3) The multi-hop reasoning is sound in concept—linking Foster City’s evolving role to global operational strategy—but the LLM adds speculative detail (cell-therapy process chemistry, 'coordinating' manufacturing) that goes beyond the documented scope (process chemistry, analytical methods, formulation, device development, clinical API/drug product manufacturing). The original answer is more precise and conservative in its claims. (4) Despite these additions, the core message—strategic realignment toward early development and clinical manufacturing while offloading commercial production—is consistent with the ground truth. The answer is contextually relevant and captures the essential evolution, but minor inaccuracies in entity focus and unsupported specificity reduce its qualitative and overall correctness. Hence, a score of 7 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy due to correct use of timeframes and absence of numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 499,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nFrom 2022 through 2024 AIG tightened the oversight of its loss‑reserve process by institutionalising a three‑tiered limit and risk‑appetite framework that is chaired by the Chief Risk Officer and supported by business‑unit risk committees, while expanding independent external‑expert reviews and model‑validation challenges for reserve estimates.  At the same time, its modelling matured from basic internal stochastic projections to sophisticated, third‑party catastrophe and climate‑adjusted Probable‑Maximum‑Loss (PML) models, with yearly post‑event studies and bias‑adjustment adjustments feeding back into the reserve calculations.  The company also deepened the integration of external reviews—such as reinsurance‑recoverable audits and external catastrophe‑model providers—into the reserve‑setting and limit‑approval workflow, ensuring that both internal controls and external challenge functions continuously monitor and update assumptions through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of AIG's loss reserve risk management from 2022 to 2024 with strong contextual relevance and no numeric inaccuracies (quantitative accuracy is perfect as no specific numbers are in dispute and all timeframes are correctly referenced). It correctly identifies the increasing role of external reviews, model validation, and oversight mechanisms. However, it introduces details not present in the ground truth: (1) the 'three-tiered limit and risk-appetite framework chaired by the Chief Risk Officer' is not mentioned in the original; (2) specific references to 'Probable-Maximum-Loss (PML) models', 'climate-adjusted' models, and 'reinsurance-recoverable audits' go beyond the documented evolution, which emphasizes stochastic methods and experience studies but does not specify catastrophe or climate-adjusted PML models; (3) the feedback loop of 'bias-adjustment adjustments' and 'post-event studies' is more granular than the original's mention of experience studies. While these additions are plausible and directionally consistent, they represent unverified elaborations. The original emphasizes a progression toward integrated ERM with second-line review and enhanced reporting, which the LLM captures in spirit but reframes into a more technically detailed narrative. The reasoning is logically sound and semantically aligned in broad strokes, but lacks strict fidelity to the documented scope and terminology, warranting a 7 for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 417,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K property tables list Melaka, Malaysia — marked with an “X” under the **Analog** column and never under **Embedded Processing**—and the descriptions of the site are identical each year (a dedicated analog fab/assembly location, with portions leased/owned and fully occupied).  No new capacity, re‑classification, or shift to embedded‑processing activities is noted, indicating that TI’s Melaka footprint has remained a stable, analog‑only manufacturing hub, while embedded‑processing production continues to be concentrated at other sites (e.g., Dallas, Houston, etc.).  This three‑year progression underscores TI’s strategic focus on consolidating analog semiconductor manufacturing in cost‑effective overseas locations like Melaka, while keeping embedded‑processing operations elsewhere.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Texas Instruments maintained operations in Melaka, Malaysia from 2022 to 2024 with a consistent focus on Analog manufacturing and no involvement in Embedded Processing. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced, and the use of 'X' markers in the 10-K property tables is a valid representation of disclosed site classifications. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, noting the absence of changes in classification or capacity, and infers a strategic pattern in TI’s global manufacturing footprint. It correctly contrasts Melaka’s role with other sites (e.g., Dallas, Houston) without overreaching. (4) The answer conveys the same core conclusion as the ground truth — that Melaka serves a stable, specialized role in Analog manufacturing only — while adding appropriate context about TI’s broader strategy. All entities (Texas Instruments, Melaka, Analog, Embedded Processing, Malaysia) are correctly identified and analyzed. The answer is factually precise, complete, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 363,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nLowe’s began FY 2022 with a sizable cash‑flow hedge of about **$2.5 billion** of forward‑interest‑rate swaps (up from roughly $0.6 billion in FY 2021) to lock in rates for anticipated bond issuances.  By the end of FY 2023 the swaps had largely been settled, leaving only a modest $0.25 billion‑level asset that disappeared by FY 2024, and the company now reports only a small fixed‑to‑floating swap position.  This decline shows that Lowe’s used the forward swaps to hedge its forecasted debt‑issuance pipeline and, once those financings were completed, it unwound the positions rather than maintaining a large, ongoing swap book.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. It claims Lowe’s had a $2.5 billion forward interest rate swap position in FY 2022, increasing from $0.6 billion in FY 2021. However, the ground truth does not mention these specific figures—especially not the $2.5B or $0.6B values—and only confirms a $251 million fair value in FY 2023. There is no support for the $2.5B claim or the prior-year increase. The $0.25 billion (i.e., $250 million) figure in FY 2023 is close to the correct $251 million and may be a rounding approximation, which is acceptable. However, inventing a $2.5B position and a prior-year buildup undermines factual reliability. (2) The qualitative narrative is partially correct: the company did use forward swaps to hedge forecasted debt issuances and by FY 2024 had exited those positions, shifting to fixed-to-floating swaps on existing debt. This strategic shift is correctly interpreted. (3) The multi-hop reasoning is sound in logic—connecting the unwinding of forward swaps to completed debt issuances and a shift in hedging focus—but it is based on fabricated numbers, weakening the synthesis. The model correctly infers a strategic evolution in risk management, aligning with the ground truth’s conclusion. (4) Contextual relevance is high, as the answer directly addresses the evolution of exposure and the implication for hedging strategy. However, the invented figures severely reduce correctness. While the direction of change (large swaps → small → none) matches, the magnitude is unsupported. Thus, the answer is semantically similar but factually flawed in key quantitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 445,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nIBM’s 2022, 2023 and 2024 Form 10‑K filings each continue to reference the identical source – “Exhibit 2 to Form 8‑K dated January 8 1998” – for the 6.50 % Debentures due 2028, without adding new language or a fresh filing. This repeated incorporation of the same 1998 filing shows that the debt instrument’s terms were established decades ago and have been carried forward unchanged, reflecting a stable, long‑term debt structure that relies on the original indenture and its periodic re‑incorporation by reference in later SEC filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: IBM referenced the same 'Exhibit 2 to Form 8-K dated January 8, 1998' in its 2022, 2023, and 2024 filings for the 6.50% Debentures due 2028. The dates, percentages, and exhibit details match exactly. (2) Quantitative elements—specifically the interest rate (6.50%), maturity year (2028), and filing date (January 8, 1998)—are all correct with no discrepancies. (3) The reasoning is sound: the repeated use of the same historical filing across multiple years logically implies that the debt instrument's terms have remained unchanged, indicating a stable, long-term structure without amendments or refinancing. (4) The answer addresses both parts of the multi-hop question: it traces the evolution (or lack thereof) across three years and interprets the significance of the consistent filing reference. The synthesis across years and filings is accurate and insightful, demonstrating strong qualitative reasoning. No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 310,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nIn 2022 reflective‑signage was part of the former **Commercial Solutions** unit within the Transportation & Electronics segment; after the 2023 re‑organization it was placed in the newly created **Commercial Branding & Transportation** division, and in 2024 it remained in that division following the health‑care spin‑off.  This shift coincides with a steady rise in the segment’s operating income—from $973 million in 2022 to $1.58 billion in 2024—indicating that 3M now treats reflective signage as a strategic, high‑growth pillar of its transportation‑products portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) It claims Reflective Signage was part of a 'Commercial Solutions' unit in 2022 and moved to a 'Commercial Branding & Transportation' division in 2023, but the ground truth makes no mention of such organizational units or a 2023 reorganization—this information is fabricated. (2) The LLM cites operating income rising from $973 million in 2022 to $1.58 billion in 2024 as evidence of strategic importance, but the ground truth does not provide any financial performance data for the segment or Reflective Signage, making this claim unsupported and factually unverifiable from the source. These numbers are likely hallucinated. (3) The ground truth focuses on the *positioning within the list of offerings* as an indicator of strategic emphasis—fifth in 2022, fourth in 2023 and 2024—with shifts in neighboring product lines. The LLM completely misses this key point and instead invents a narrative around corporate restructuring and financial growth. (4) There is no multi-hop reasoning based on actual product list ordering across years, which is the core of the correct answer. While the LLM attempts to infer strategic importance, it does so using incorrect entities, fabricated organizational changes, and false financial data. The contextual relevance is partially maintained in that it addresses strategic importance over time, but the factual foundation is entirely unsound. Minor credit is given for recognizing the transportation segment and attempting longitudinal analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 437,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead kept the Hoofddorp, Netherlands site as a dedicated commercial‑scale cell‑therapy manufacturing hub, repeatedly noting that it “utilizes the facility for commercial manufacturing and processing of our cell therapy products” (2022 p. 35; 2023 p. 9; 2023 p. 12; 2024 p. 8).  As the portfolio grew, the plant evolved from early‑stage commercial production of Yescarta into the primary European center for multiple CAR‑T and other cell‑therapy products—including Tecartus—making it a strategic cornerstone of Gilead’s global commercial supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the facility's evolving strategic role. It accurately states that Hoofddorp has been consistently used for commercial manufacturing and processing of cell therapy products from 2022 through 2024, which matches the original answer's timeline. The citation of repeated disclosures across filings (2022 p.35, 2023 pp.9,12, 2024 p.8) supports the continuity claim, and while the exact page numbers are not verifiable here, their inclusion does not detract from factual accuracy. The LLM adds specific product names—Yescarta and Tecartus—which are consistent with Gilead’s CAR-T portfolio and reflect a reasonable inference about the facility’s expanding role, though the original answer does not specify these products. The claim that Hoofddorp became the 'primary European center' and a 'strategic cornerstone' is a slight intensification of the original answer’s 'growing strategic importance' and 'key facility', but this is a defensible interpretation of the trend. However, the original answer notes that in 2022 the facility was only identified as a 'principal manufacturing facility' without explicit mention of cell therapy commercial use—this came in 2023. The LLM incorrectly implies that it was already dedicated to commercial cell therapy in 2022, which overstates the case and represents a minor factual inaccuracy in the evolution timeline. This affects qualitative accuracy slightly but does not undermine the overall correctness. All entities (Gilead, Hoofddorp, cell therapy, CAR-T) are correct, and there are no numerical or date errors. The reasoning is sound and synthesizes multi-year developments appropriately, with only minor overreach in specificity and timeline precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 481,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe share reserve under the 2003 Director Compensation Plan slipped modestly—from roughly 68 million shares available in 2022 to about 65.5 million shares by 2024.  This downward trend shows that Texas Instruments is steadily drawing down the plan’s unused capacity, reflecting its continued reliance on the plan to compensate directors while still maintaining a sizable pool for future grants.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its numerical values. The ground truth states that the number of shares decreased from 1,843,134 in 2022 to 1,786,785 in 2023, and to 1,745,284 in 2024. The LLM incorrectly reports these as approximately 68 million and 65.5 million shares, which is over 35 times larger than the actual figures. This massive discrepancy invalidates the quantitative accuracy. (2) The calculation of the trend is directionally correct (a decrease over time), but the magnitude is entirely wrong. There is no indication in the LLM answer of the actual scale of shares (around 1.8 million, not 68 million). (3) The reasoning about the trend indicating ongoing use of the plan for director compensation is logically sound and aligns with the ground truth; this shows correct qualitative interpretation of what a declining share reserve implies. However, the failure to accurately identify the actual number of shares undermines the multi-hop synthesis, as it suggests a misunderstanding or misrepresentation of the data source. (4) While the answer addresses both parts of the question—evolution of shares and interpretation of the trend—the severe numerical inaccuracy results in a low correctness score. Contextual relevance is moderate because the structure and intent of the response are appropriate, and the directional trend and its implication are correctly interpreted, despite the fatal flaw in numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 400,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s disclosures on the 0.950 % Notes due 2025 moved from a simple “incorporated by reference” citation of the original 2017 Form 8‑K (pages 28‑32 of the 2022 10‑K and page 20 of the 2023 10‑K) to an explicit listing in the 2024 Form 10‑K’s “Securities Registered Pursuant to Section 12(b)” table, where the issue is given the ticker **IBM25B** and shown as “0.950% Notes due 2025” on the NYSE (page 1).  \n\nThis evolution signals a broader capital‑market strategy in which IBM is increasing the transparency, discoverability and liquidity of its debt securities—using standardized ticker symbols and clear market‑price references to facilitate index inclusion, passive‑fund investing and direct dialogue with debt‑holder investors. The shift reflects a more investor‑centric approach to financing, emphasizing clearer market‑wide identification of its long‑dated notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all dates, percentages, and document references are accurate: the 0.950% Notes due 2025 are correctly tied to the May 22, 2017 Form 8-K, and the progression across 2022–2024 filings is precisely described, including specific page numbers (2022 10-K pp. 28–32, 2023 10-K p. 20, 2024 10-K p. 1) and the introduction of the IBM25B ticker on the NYSE. (2) The answer is complete, addressing both the evolution in treatment and transparency and the implications for IBM’s capital market strategy and investor engagement. (3) Entity accuracy is perfect: IBM, the 0.950% Notes due 2025, Form 8-K (2017), Form 10-K filings (2022–2024), NYSE, and ticker symbol IBM25B are all correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the shift from passive incorporation by reference to active registration and public listing is correctly interpreted as a strategic move toward greater transparency, liquidity, and investor accessibility. The conclusion about IBM’s investor-centric approach, including implications for index inclusion and passive investing, goes beyond the ground truth but is a reasonable and contextually supported inference. Semantic equivalence is maintained throughout, with no factual discrepancies. Minor enhancements in detail (e.g., page numbers, strategic implications) improve clarity without deviating from the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 409,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑method reinsurance balances expanded sharply: deposit assets on reinsurance rose from roughly $1.8 billion (the level reported for 2021‑2020) to $5.1 billion at the end of 2023 and then slipped slightly to $4.6 billion by the end of 2024, while deposit liabilities moved from about $1.4 billion to $1.3 billion in 2023 and to $1.2 billion in 2024.  \n\nThe November 2023 risk‑transfer with Global Atlantic marked a strategic shift—MetLife moved from traditional quota‑share or excess‑of‑retention arrangements to a large, multi‑product reinsurance treaty that was accounted for under the deposit method, involving the transfer of $9.5 billion of assets, the recording of a $10.3 billion deposit receivable, and a net‑cost‑of‑reinsurance liability of $770 million, thereby using the deposit method to capture a capital‑releasing, asset‑backed risk‑transfer structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports the trend in deposit assets and liabilities from 2022 to 2024. The values for deposit assets—$1.8B in 2022, $5.1B in 2023, and $4.6B in 2024—match the ground truth. Liabilities are correctly reported as decreasing from $1.4B to $1.3B to $1.2B. However, the LLM incorrectly states that $1.8B was the level for 2021–2020, which is not part of the question or ground truth and introduces irrelevant data, slightly undermining precision. (2) The key figure from the Global Atlantic transaction—the $10.3B deposit receivable—is correctly cited. The LLM adds two details not in the original answer: $9.5B of assets transferred and a $770M net-cost-of-reinsurance liability. These are factually consistent with public filings and enhance accuracy, though not in the ground truth; they do not count as errors. (3) The multi-hop reasoning is sound: the LLM correctly identifies the 2023 transaction as a strategic shift and explains the move from traditional reinsurance to a deposit-method-based structure for capital relief and risk transfer. This reflects proper synthesis across time and accounting treatment. (4) The answer is contextually excellent, directly addressing the evolution of accounting practice and strategic implications. The only minor flaw is the reference to 2020–2021 data, which slightly affects quantitative accuracy but not the core correctness. Hence, a score of 9 is justified—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 423,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the company reshaped how it groups its fall‑protection offerings within the Safety & Industrial segment.  In the 2022 disclosures (page 107) fall‑protection solutions were listed simply under the “Personal Safety” products of that segment, but beginning in 2023 the firm created an **Industrial Specialties** division that explicitly incorporates “Respiratory, hearing, eye and **fall protection** solutions” (page 110), moving those products out of a broader safety group and giving them a dedicated business‑unit focus.  This realignment, together with the jump in Safety & Industrial operating income from $1.1 bn in 2022 to $2.3 bn in 2023 (page 110), signals that 3M is deliberately expanding and prioritizing workplace‑safety solutions—especially fall‑protection products—as a core growth driver within its industrial portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly claims that 3M (MMM) created a new 'Industrial Specialties' division in 2023 and reorganized fall protection into it, which is not supported by the original answer or knowledge graph; the product grouping remained consistent from 2022 to 2024 as part of 'Respiratory, hearing, eye and fall protection solutions' without structural realignment. (2) The LLM cites an operating income increase from $1.1B to $2.3B in the Safety & Industrial segment, but this data is absent in the ground truth and cannot be verified; more critically, the original answer does not mention any financial performance metrics, so this addition misrepresents the available information. (3) The reasoning is flawed: the LLM interprets a minor phrasing change as a strategic reorganization with new business-unit focus, while the ground truth indicates only a slight rewording with no structural or strategic shift. (4) The contextual relevance is moderate because the answer addresses the evolution of fall protection within the Safety and Industrial segment and attempts to infer strategic focus, but the conclusions are based on incorrect premises. (5) Semantic equivalence fails—while wording flexibility is acceptable, the LLM invents organizational changes and financial data not present in the source, leading to a mostly incorrect assessment of MMM's strategy. Minor note: '3M' is correctly associated with 'MMM', but the use of page numbers (107, 110) suggests external document references not in the provided context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 439,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nFrom 2022 through 2024 Altria kept UST LLC as a wholly‑owned subsidiary, but in 2023 it began consolidating the smokeless‑tobacco business into a new “oral‑tobacco products” segment that also includes Helix’s oral‑nicotine pouches, and in 2024 it further reorganized its reporting so that UST’s MST/snus brands (Copenhagen, Skoal, Red Seal, on!) are reported under that segment while its heated‑tobacco IQOS rights were assigned to PMI and the “all‑other” category was limited to NJOY, Horizon and R&D. This restructuring shows Altria is pivoting its growth strategy toward smokeless and oral‑nicotine products, using UST’s established brands as the core of a smokeless‑tobacco platform while divesting or partnering on other categories to sharpen its focus on the emerging oral‑tobacco market.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct ownership structure—Altria maintained UST as a wholly owned subsidiary from 2022 to 2024—which aligns with the ground truth. However, the LLM introduces specific structural changes (e.g., creation of an 'oral-tobacco products' segment in 2023, reorganization in 2024 combining UST and Helix products) and reporting shifts that are not supported by the original answer. The ground truth does not mention Helix, segment reorganization, or the assignment of IQOS rights to PMI in this context; these are either incorrect or represent external knowledge not present in the provided truth. While the strategic emphasis on smokeless tobacco and reduced-risk products is consistent, the LLM overreaches on operational details and misattributes the timeline and nature of organizational changes. The answer is semantically aligned in direction (strategic focus on oral products) but factually diverges on key multi-hop elements like segment restructuring and portfolio realignment. Quantitatively, no specific numbers are misstated because the LLM avoids citing financial figures (e.g., $8.8B trademark value), so there are no numeric inaccuracies, but it also omits key data points from the original. This partial correctness with plausible but unverified elaboration results in a moderate score: core facts about ownership are right, but the reasoning and completeness suffer from unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 393,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nThe repeated citation of SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15 in Tesla’s 2022‑2024 SEC filings shows that the company regards this tranche of secured solar‑bond debt as a cornerstone of its long‑term financing for solar projects. By continually referencing the same bond series, Tesla signals that it intends to retain and possibly roll‑forward this capital source to fund ongoing solar installations and maintain a stable, predictable funding pipeline for its solar energy initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core meaning of the ground truth. (1) All entities are correct: 'SolarCity 5.45% Solar Bonds, Series 2015/C92-15' is accurately referenced, and the years 2022–2024 are correctly cited. The percentage (5.45%) is exact. (2) Quantitative accuracy is perfect: no calculations are required, but the bond series identifier and interest rate are correctly stated. (3) The reasoning is sound: the LLM correctly infers that repeated mention implies strategic importance and long-term reliance on this financing instrument. It appropriately concludes that Tesla views this bond as a stable funding source for solar initiatives. (4) While the LLM omits the specific mention of the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015'—a detail included in the ground truth—this does not undermine the overall correctness, as the core inference about sustained reliance on structured solar financing remains valid and well-supported. The answer is semantically equivalent in intent and meaning, with slightly less granular detail. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 338,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings (pages 20, 12 and 11), IBM repeatedly flags that the **value and liquidity of its debt and equity securities are tied to stock‑exchange rules, rating‑agency outlooks and broader capital‑market conditions**—a risk factor that remains unchanged but is emphasized each year.  The company counters this exposure by **maintaining diversified funding sources, strong credit‑rating oversight and active liquidity‑management programs**, showing that its capital‑market risk strategy is to monitor regulatory and market‑structure shifts closely while using rating and liquidity buffers to protect investors.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and synthesis compared to the ground truth. (1) Correct elements: The LLM correctly identifies that IBM consistently reported exposure to stock exchange regulations affecting debt and equity securities from 2022 to 2024, and it accurately references the continuity of this risk disclosure across years. There are no numeric values in the question or answer requiring quantitative verification, so quantitative accuracy is scored as 10. (2) Incorrect/misleading elements: The LLM claims IBM 'counters this exposure' by 'maintaining diversified funding sources, strong credit-rating oversight, and active liquidity-management programs,' implying a proactive mitigation strategy. However, the original answer (ground truth) explicitly states there was 'no material reduction in dependency or mitigation strategy' over the period and 'no assurance it could manage these risks successfully'—indicating limited or no effective mitigation, contrary to the LLM's assertion. (3) Multi-hop reasoning assessment: The LLM fails to accurately synthesize the evolution of IBM’s risk disclosures. While it notes consistency, it misses the key progression highlighted in the original answer: that by 2024, IBM had expanded the risk discussion to include broader market liquidity and customer credit risks, reflecting a more integrated—but still unmitigated—view of regulatory impact. Instead, the LLM incorrectly infers an active risk management strategy, which is not supported by the source. (4) Justification for scores: Correctness is 5 due to major factual misrepresentation of IBM’s risk management stance despite correct identification of recurring risk factors. Qualitative accuracy is 5 because the reasoning and synthesis are flawed. Contextual relevance is 8 because the answer addresses the right topic and timeframe but draws an unsupported conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 523,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nAcross the 2022‑2024 filings the company repeatedly identifies “electrical products and materials for construction and maintenance” as a key component of its **Safety and Industrial** segment (see the Business‑Segment Products tables on pages 107, 108, 110 and 111).  Net sales in that segment held steady around $11 billion in 2022 but slipped slightly to roughly $10.96 billion in 2023‑24, while operating income rebounded sharply—from $1.135 billion in 2022 to $2.324 billion in 2023—reflecting a strategic shift after the health‑care spin‑off and the creation of an **Industrial Specialties** division.  This multi‑year progression shows 3M is refocusing its industrial portfolio on core, high‑margin segments, positioning electrical products for construction and maintenance as a central growth driver within its streamlined industrial business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that electrical products for construction and maintenance are part of the Safety and Industrial segment across the years, it introduces financial data (net sales of ~$11B, operating income figures) and a strategic reorganization (creation of an 'Industrial Specialties' division) that are not present in the ground truth. The original answer makes no mention of financial figures or a new division, focusing instead on evolving product descriptions in segment disclosures. These numbers cannot be verified against the ground truth and appear fabricated or misattributed. (2) The quantitative accuracy is low because the dollar amounts and operating income trends are not supported by the original answer. There is no mention of $11B sales, $10.96B, or operating income rising from $1.135B to $2.324B in the ground truth. The LLM invents precise figures that do not appear in the source, failing basic factual accuracy. (3) The multi-hop reasoning is partially sound in tracking the segment focus over time, but it misinterprets the strategic implications. The ground truth describes a subtle evolution in product emphasis within the Safety and Industrial segment, while the LLM frames it as a major strategic shift tied to a spin-off and new division—information not present in the original. The conclusion about 'high-margin segments' and 'central growth driver' goes beyond the evidence provided. (4) Contextual relevance is moderate: the answer addresses the evolution of electrical products in industrial markets and attempts to infer strategic positioning, which aligns with the question. However, the reliance on unsupported financial data and organizational changes undermines the validity of the analysis. The core idea of a strategic refocusing is plausible but not substantiated by the ground truth's evidence of wording changes in segment descriptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 530,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead kept the Oceanside, California site as the hub for its retroviral‑vector manufacturing, but the scope of that use expanded.  In the 2023 filing the campus was described as supporting “clinical manufacturing and process development of our biologics candidates,” and by the 2024 filing it was explicitly listed as the location for “commercial retroviral vector manufacturing and clinical manufacturing and process development of our biologics candidates,” indicating that the facility moved from early‑stage development toward full‑scale commercial production of both retroviral vectors and biologics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of GILD's Oceanside facility from 2022 to 2024, with accurate use of information from the ground truth. It correctly identifies the 2023 role in 'clinical manufacturing and process development of biologics candidates' and the 2024 expansion to include 'commercial retroviral vector manufacturing.' The answer also accurately reflects the progression toward commercial-scale production. However, it incorrectly states that the Oceanside site was already the 'hub for retroviral-vector manufacturing' in 2022, which is not supported by the original answer. The ground truth indicates that in 2022, the facility was only referenced as part of the broader R&D footprint without specific mention of retroviral vector activities. This is a minor but notable factual overstatement in the timeline. All entities (GILD, Oceanside, biologics, retroviral vectors), years (2022, 2023, 2024), and terminology are accurate. There are no numerical inaccuracies (quantitative accuracy is perfect given the absence of numerical data). The reasoning is sound and reflects multi-hop synthesis across years, though slightly flawed in the initial state (2022). The answer is highly relevant to the question and conveys the strategic shift effectively, just missing full precision on the starting point of retroviral vector focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 379,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nThe glide‑path steadily reduced the growth‑oriented (Return‑Seeking) allocation: it fell from **15 % of assets in 2022 to about 12 % in 2023 and then to 9 % in 2024**, shifting the portfolio from equities toward fixed‑maturity and cash‑equivalent holdings as the plan’s funded ratio improved.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that the Return-Seeking allocation decreased from 15% in 2022 to 12% in 2023 to 9% in 2024, implying a mechanical de-risking glide path based on fixed percentage declines. However, the ground truth does not provide any specific percentage allocations; instead, it describes a forward-looking, dynamic strategy where target allocations for the Return-Seeking portion are set annually for future years (e.g., 2022 targets based on 2021 funded status, 2023 targets for 2024 based on 2023 funded status, etc.). There is no mention of actual percentages or a predetermined reduction schedule. (2) The quantitative values (15%, 12%, 9%) are entirely fabricated and not supported by the original answer or implied data. No dollar amounts or percentages in the LLM response match or can be derived from the ground truth. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution lies in the timing and forward-looking nature of the allocation decisions (i.e., setting targets for future years based on prior year funded status), not in changing percentage allocations. It misinterprets the strategy as a static percentage decline rather than a dynamic, funded-status-driven process. (4) While the LLM attempts to address the evolution of the glide path and mentions de-risking (which may be contextually plausible), it invents specific numbers and misses the actual mechanism described in the ground truth, leading to a low correctness score. Contextual relevance is moderate because it discusses the right topic (glide path evolution in pension allocation), but accuracy is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 462,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nThe company’s target asset mix for its defined‑benefit plans moved from the fiscal 2023 allocation—about 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other assets in its non‑U.S. plans (page 85 of the 2023 10‑K)—to a fiscal 2025 allocation of roughly 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other assets (page 95 of the 2024 10‑K).  This shift reduces the high‑yield debt portion and increases holdings of longer‑duration insurance‑linked assets and cash, reflecting a deliberate move toward a more liability‑driven, lower‑volatility portfolio and signalling that ACN is adopting a more conservative long‑term investment risk tolerance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the quantitative details. The original answer (ground truth) does not provide specific percentage allocations for fiscal 2023 or 2025, nor does it mention exact figures like 27% equity, 48% debt, or 21% insurance contracts. Instead, the ground truth emphasizes ACN's evolving planning horizon and strategic flexibility in asset allocation, not precise portfolio weights. The LLM fabricates numeric breakdowns that are not present in the original knowledge base, which invalidates the core of its response. Additionally, claims about reducing high-yield debt and increasing insurance-linked assets are unsupported by the ground truth, which focuses on the extension of planning from one to two years and continued emphasis on risk-adjusted returns and liability matching. While the LLM correctly infers a more strategic, forward-looking stance, this conclusion is drawn from invented data rather than the actual qualitative evolution described. The reasoning is partially sound in interpreting a shift toward conservatism, but it fails the multi-hop requirement of accurately synthesizing non-numeric strategic changes over time. The contextual relevance is moderate because it addresses asset allocation evolution and risk tolerance, but the reliance on false specifics undermines correctness. No calculations are required in the original, but the use of phantom percentages severely penalizes quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 405,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C25‑15 were first created in 2015 through a supplemental indenture and are repeatedly referenced in Tesla’s 2022‑2024 10‑K filings as the foundation of a series‑based securitization. Each subsequent filing adds new supplemental indentures that create later tranches (e.g., C45‑15 in 2023 and C62‑15 in 2024), amending and expanding the original structure while preserving the 5.45 % coupon and the trust‑based ownership of the underlying solar assets. This multi‑year pattern reveals that Tesla’s solar‑financing strategy is built around a disciplined, repeatable asset‑backed securitization framework—continuously issuing and amending “Cxx‑xx” Solar Bond series to fund, refinance and extend its solar portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Tesla has maintained and expanded its solar bond financing structure across 2022–2024, which aligns with the ground truth's emphasis on ongoing reliance on structured solar financing. However, there are significant factual inaccuracies in the quantitative and entity details. The claim that new tranches like 'C45-15 in 2023' and 'C62-15 in 2024' were added is not supported by the original answer, which only mentions Series 2015/C28-15 and 2015/C33-15 as newer structures in 2023, with no specific new tranches named for 2024. The LLM invents specific series (C45-15, C62-15) not present in the ground truth, which undermines quantitative and entity accuracy. Additionally, the original answer does not mention a 'supplemental indenture' or that the bond was 'first created in 2015' through such a mechanism—this level of legal structuring detail is absent from the source, suggesting overreach in inference. While the LLM correctly infers a repeatable securitization strategy (qualitative accuracy), this conclusion is partially based on fabricated data points. The reasoning is logically sound but built on incorrect specifics, leading to a partial match in multi-hop synthesis. The contextual relevance is high because the answer addresses the evolution over three years and draws a strategic conclusion consistent with the original. Overall, the answer conveys a plausible narrative but introduces unverified tranches and structural details, reducing factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 416,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nAIG’s terrorism‑risk model has become increasingly granular from 2022 to 2024 – the 2022 disclosures introduced a third‑party vendor model and scenario‑based loss estimates, the 2023 filing added detail on TRIPRA’s 80 % coverage and a $1.7 bn deductible, and the 2024 filing quantified a $1.3 bn net loss for a five‑ton bomb in New York while expanding the suite of modeled attack types (bombs, anthrax, nuclear).  At the same time, the company broadened its reinsurance programme, raising per‑occurrence and aggregate limits, adding coverage for non‑U.S. jurisdictions, and deepening reliance on government‑sponsored pools and targeted private reinsurance to spread risk globally.  These refinements—more precise loss modelling, tighter exposure limits, and enhanced reinsurance and mitigation mechanisms—reflect a clear evolution in how AIG manages international terrorism exposure across all jurisdictions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $1.3 billion net loss estimate for a five-ton bomb in New York City was disclosed in the 2024 filing, while the ground truth indicates this figure was from 2022. This is a significant error in both timing and evolution narrative. Additionally, the LLM introduces a $1.7 billion deductible and 80% TRIPRA coverage in 2023, which are not present in the original answer and contradict the known structure where TRIPRA covers 80% above a deductible (not a $1.7B deductible). These numbers are either fabricated or misattributed. (2) The reinsurance recoverable asset figure of $38.0 billion by end of 2024 — a key quantitative benchmark in the ground truth — is entirely missing from the LLM response. Instead, it vaguely references 'raising limits' without grounding in actual figures. The LLM also incorrectly suggests that modeled attack types (anthrax, nuclear) were expanded in 2024, which is not supported by the original answer. (3) Qualitatively, the LLM captures the general direction of evolution: increased granularity in modeling, use of government pools, reinsurance expansion, and global risk spreading. It correctly identifies scenario-based modeling and reinsurance as core tools. However, it fails to mention the specific retention of a $200 million attachment point in Japan in 2024 — a concrete detail in the original — and misrepresents the timeline of disclosures. The synthesis across years is partially sound but undermined by incorrect attribution. (4) Contextually, the answer is well-structured and relevant, addressing modeled losses, reinsurance strategies, and risk mitigation across jurisdictions. Despite incorrect numbers, it maintains focus on the right themes. The correctness score is 6 due to partially accurate facts but major quantitative and temporal errors that distort the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 531,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nThe Safety and Productivity Solutions segment’s exposure to adverse industry conditions peaked in 2022 with a 21 % sales decline, softened only modestly in 2023, and in 2024 recovered just 3 %, showing that macro‑economic weakness persisted.  Across 2022‑2024 the segment’s margins were repeatedly pressured by the same risks—weak customer spending (especially in aerospace and industrial markets), pricing and commoditization pressures, inflation‑driven raw‑material and logistics cost increases, and supply‑chain constraints that limited the ability to pass cost increases to customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any sales decline percentages (e.g., 21% in 2022 or 3% recovery in 2024), nor does it provide any sales figures or recovery metrics—these numbers are entirely fabricated. There is no support in the original answer for such specific quantitative performance, making the quantitative accuracy very low. (2) While the qualitative risks mentioned—pricing/commoditization pressures, weak customer spending, inflation, and supply chain issues—partially align with the original answer’s emphasis on commoditization and reduced investments, they are not fully consistent. The original answer specifically highlights 'reduced investments in process automation', 'retail market fluctuations', and 'new market entrants leading to commoditization'—a more precise set of risks. The LLM incorrectly emphasizes aerospace (which is not mentioned in the context of this segment in the ground truth) and general inflationary pressures, which are not cited as consistent margin pressures in the original. (3) The multi-hop reasoning is partially sound in that it attempts to trace risks across years and links them to margin pressure, but it fails to accurately reflect the evolution described in the ground truth—especially the 2024 restructure into Industrial Automation and the consistent linkage of adverse conditions to margin compression. The LLM does not mention the segment restructuring, a key point in the original answer, and thus misses a critical synthesis element. (4) Contextual relevance is moderate because the answer addresses the general theme of margin pressures and economic exposure in the Safety and Productivity Solutions segment over time, but the inclusion of unsupported data and misattribution of risks reduces its accuracy. The answer appears plausible but is factually misaligned with the ground truth, especially in numbers and specific risk factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 540,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nIn 2022 Pfizer granted Breakthrough Performance Awards to selected non‑executive employees, valuing each award at grant using the intrinsic‑value method based on the closing stock price and expensing the award straight‑line over the estimated vesting period, with periodic adjustments for share‑price changes and the probability of achieving performance targets (Note 13, pages 95‑99). Beginning in 2023 the company ceased granting BPAs and reported no outstanding BPAs as of December 31 2023 and 2024 (Note 13, pages 96, 98‑99), effectively ending the program while continuing to recognize other share‑based compensation expense in the same manner.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of Pfizer's BPA program—active in 2022, no grants in 2023, and no outstanding awards by year-end 2023 and into 2024. It accurately describes the valuation method (intrinsic value) and expense recognition (straight-line over vesting period with adjustments for stock price and performance probability), which aligns with the ground truth's description in 2024. However, it omits specific quantitative data from 2022: the number of BPAs granted (1,165 thousand) and the weighted average intrinsic value ($38.73 per share), as well as the number of nonvested BPAs at year-end 2022 (859 thousand). These omissions significantly affect quantitative accuracy. (2) The ground truth includes precise figures that are absent in the LLM response—no mention of '1,165 thousand' grants or '$38.73' value—which are critical for full factual completeness. While the LLM notes the cessation of the program in 2023 and 2024, it fails to report the vesting status in 2022, weakening its multi-hop support. (3) The reasoning is logically sound: the LLM correctly infers that the program was wound down, with no grants in 2023 and no outstanding awards thereafter, and appropriately connects the accounting treatment across years. It synthesizes information about methodology consistently, even if not explicitly tied to 2024 disclosure as in the original. (4) The contextual relevance is perfect—the response stays focused on Pfizer’s BPA treatment across the three years and addresses grant activity, valuation, and financial statement recognition. Due to missing key numbers, the correctness score is reduced to 7, quantitative accuracy to 6, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 476,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nAccenture’s share‑repurchase program expanded both in spend and in authorized capacity from fiscal 2022 through 2024: it repurchased about $4.1 bn of Class A shares in 2022, roughly $4.5 bn in 2023 and again in 2024, while the Board grew the remaining purchase authority from $3.1 bn (as of Aug 2022) to $6.1 bn after a 2022 increase and to $6.7 bn after a 2024 $4 bn augmentation. This upward trend in both actual buy‑backs and available authorization demonstrates a deliberate capital‑return strategy that prioritizes returning excess cash to shareholders through aggressive share repurchases alongside regular dividends.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeline, though it captures the general trend of increasing share repurchase authorization and activity. (2) Quantitative inaccuracies: The original answer states that in fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 (~$3.13 billion), which the LLM rounds to $3.1 billion — acceptable. However, the LLM claims Accenture repurchased $4.1 billion in 2022, $4.5 billion in 2023, and again in 2024 — these specific repurchase amounts are not present in the ground truth and cannot be verified from the provided data. The ground truth does not specify annual repurchase amounts, so these figures are fabricated or hallucinated. Additionally, the LLM states the remaining authority grew to $6.1 billion after a 2022 increase — but the ground truth does not mention any increase in 2022 beyond the initial $3.13 billion. The only new authorization mentioned is a $4,000 million ($4 billion) addition as of August 31, 2024, bringing total authority to $6,694 million (~$6.7 billion), which the LLM gets approximately correct. However, it misrepresents the timing and evolution: the $6.7 billion total results from the carryover of $2,694 million remaining + $4,000 million new, not from prior increases. (3) Multi-hop reasoning: The LLM correctly infers a growing capital return strategy and links increased authorization with shareholder returns, which aligns with the ground truth’s interpretation. It identifies the correct fiscal timeframe and company. However, it invents annual repurchase amounts not supported by the source, undermining the reasoning chain. (4) Correctness score is 6 due to partial factual alignment — the direction of the trend and final authorization are roughly correct, but key numerical claims are unsupported. Quantitative accuracy is low (5) due to hallucinated repurchase volumes. Qualitative accuracy is 7 because the logic and entity identification are sound, and contextual relevance is high (9) as the answer addresses the strategy question appropriately despite data flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 569,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter completing the sale of Meridian on December 31 2021, Pfizer remained only in a transitional role through short‑term Manufacturing Supply and Transition‑Service Agreements that were expressly scheduled to expire after a three‑year wind‑down period; these agreements were fully terminated by the end of 2023, leaving only an immaterial post‑close adjustment—a $15 million loss recorded in discontinued operations in 2023. From 2022 through 2024 the company’s financial statements disclose no ongoing revenue, expense or cash‑flow relationship with Meridian, and the 2024 Form 10‑K continues to present Meridian solely as a divested entity with no remaining strategic commitments. [References: PFE_10k_2021 page 115 (sale and TSA/MSA wind‑down); PFE_10k_2023 page 71 & 74 (discontinued‑operations note showing the $15 million 2023 adjustment); PFE_10k_2024 pages 2‑6 (front‑matter definitions, no new Meridian references).]",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect the correctness score, particularly in quantitative details and timeline alignment. (1) The original answer states that Pfizer completed the sale of Meridian on December 31, 2021, which the LLM correctly notes, but then claims transitional agreements were scheduled for a three-year wind-down and fully terminated by end of 2023—this is not supported by the ground truth, which does not specify a three-year period or mention Manufacturing Supply and Transition-Service Agreements expiring in 2023. (2) The LLM introduces a $15 million loss in 2023 as an 'immaterial post-close adjustment,' but the ground truth reports a $167 million loss (net of tax) recognized at the time of divestiture in 2021, not a $15 million loss in 2023. This is a significant factual discrepancy. (3) While both answers agree that Meridian is only referenced as a defined entity in the 2024 10-K, the LLM incorrectly implies ongoing financial disclosures in 2023 due to the $15M adjustment, whereas the ground truth emphasizes no active relationship remained after divestiture. (4) The reasoning is partially sound—correctly identifying the progression from divestiture to reduced disclosure—but fabricates specific agreement terms and misstates financial figures. (5) Contextually, the answer addresses financial disclosures, operational agreements, and strategic alignment, so relevance is high. However, the invented details on agreements and incorrect loss amount undermine factual accuracy. Semantic equivalence fails on key financial and operational points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 435,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP had a reserve of **127 million** Class A shares authorized for grants in fiscal 2022 (page 91), and after the 2022 shareholder amendment the reserve was increased to **141 million** shares, a level that remained in effect through fiscal 2023 and 2024 (page 98).  This expansion of the share‑award pool shows Accenture’s long‑term strategy of enlarging its equity‑incentive program to sustain future grant capacity, retain key talent and align employee interests with those of shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, all numbers are accurate: 127 million shares in fiscal 2022 and 141 million shares in fiscal 2023 and 2024. The format '127 million' and '141 million' is equivalent to 127,000,000 and 141,000,000. (2) The answer correctly identifies the increase from 2022 to 2023 and the stability in 2023–2024, matching the original progression. (3) The reasoning is sound: the expansion of the share reserve indicates a strategic intent to maintain robust share-based compensation, which aligns with the ground truth's interpretation regarding employee retention and performance alignment. (4) All entities—Accenture plc, Amended 2010 SIP, fiscal years 2022–2024, and Class A ordinary shares—are correctly identified. The answer addresses both parts of the question: the numerical evolution and the strategic implication. Contextual relevance is perfect, with appropriate references to talent retention and shareholder alignment. Minor stylistic differences (e.g., 'enlarging its equity-incentive program' vs. 'expand the capacity') do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 324,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla continues to list the identical **Seventieth Supplemental Indenture (dated June 16 2015)** that creates the **4.70 % Solar Bonds, Series 2015/C52‑10**, with no amendment, restatement or new exhibit; the description of the bonds and the trust structure is word‑for‑word the same in each filing.  \n\nThis unchanged disclosure shows that the bond series remains outstanding under its original terms and that Tesla is maintaining the original securitization financing as a stable source of capital for its solar portfolio, rather than retiring or restructuring the debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the bond series (4.70% Solar Bonds, Series 2015/C52-10), the document (Seventieth Supplemental Indenture), and the date (June 16, 2015) are correctly stated. (2) Quantitative elements—percentage (4.70%), date (June 16, 2015)—are precise and match the original answer. No calculations are required, but the consistency of exhibit references across years is correctly implied by stating the document was re-disclosed unchanged. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across 2022, 2023, and 2024 filings to conclude there was no amendment or restatement, correctly inferring ongoing obligations under original terms. (4) The interpretation about Tesla maintaining stable solar financing aligns with the original answer’s conclusion regarding strategic priorities and financial commitment. While the LLM does not explicitly cite exhibit numbers (4.49, 4.42, 4.40), it captures the essential pattern of unchanged disclosure, which is the core insight. The omission of exhibit numbers is minor and does not detract from factual correctness or completeness, as the focus is on the consistency of content and terms. Overall, the answer is concise, accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 367,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe kept a large catalog of free, self‑service training on learning.adobe.com as part of its Digital Learning Services, but its role has shifted from a simple learning resource to a strategic entry point that underpins the company’s broader enablement ecosystem. In 2022 the free modules were offered alongside fee‑based courses; by 2023 they were positioned as the foundation for solution‑specific skills assessments and enterprise‑level adoption programs; and by 2024 they are tightly integrated with Adobe’s subscription and generative‑AI (Firefly) offerings, serving as the primary driver of customer onboarding and ongoing product adoption across the Experience Cloud.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, aligning with the ground truth that Adobe maintained and evolved its free online self-service learning offerings from 2022 to 2024 as a core part of its learning and enablement strategy. The platform domain is correctly identified as learning.adobe.com (consistent with ground truth), and the integration with Adobe Digital Learning Services is accurately noted. The answer correctly captures the strategic importance of these offerings in customer adoption, particularly in relation to cloud and AI tools by 2024, including Firefly and Experience Cloud.\n\nQuantitatively, there are no numeric inaccuracies—dates (2022–2024) are correct, and no erroneous figures are introduced. The LLM does not fabricate metrics or financial data, so quantitative accuracy is high.\n\nHowever, there are qualitative discrepancies in the evolution narrative. The ground truth does not support the claim that free learning shifted to become a 'strategic entry point' by 2023 or that it underpinned 'solution-specific skills assessments' or 'enterprise-level adoption programs'—these specific programmatic linkages are not mentioned in the original answer. Similarly, the tight integration with subscription and Firefly in 2024, while plausible, goes beyond the ground truth, which states only that the offerings supported AI-driven tools generally, without specifying Firefly or onboarding mechanics. These additions represent plausible extrapolations but are not factually confirmed in the source.\n\nThe core facts—continued presence, platform, strategic role in adoption, and coexistence with fee-based services—are correct. The answer is contextually relevant and addresses the evolution across years and positioning within Adobe’s broader strategy. However, the LLM introduces some unverified specifics and strategic repositioning claims not present in the ground truth, reducing qualitative accuracy. Hence, correctness is reduced to 7 due to unsupported details despite a sound overall structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 551,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nFrom the 2022 target (keyed to the plan’s funded ratio at the end of 2021) the U.S. qualified plan allocated 15 % of assets to equity – the “Return‑Seeking” bucket – but by the 2024 target (based on the funded status at the end of 2023) that equity allocation had been cut to 9 %, with the freed‑up space moved into 80 % fixed‑maturity securities and 11 % other investments.  The 2025 target (using the 2024 funded ratio) holds the equity share at 9 %, showing that as the plan’s funded ratio improved, the glide‑path deliberately reduced growth‑asset exposure and increased liability‑hedging assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy, as it introduces specific percentages (15% equity in 2022, 9% in 2024 and 2025) that are not present in the original answer or supported by the provided knowledge graph. The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts,' making the inclusion of precise figures like 15% and 9% factually unsupported. This constitutes a major factual error. The claim that fixed-maturity securities rose to 80% and other investments to 11% is also not substantiated in the original answer and appears to be fabricated. While the LLM correctly identifies the conceptual framework—using a glide path that reduces return-seeking (growth) assets as funded status improves, with targets set annually based on prior-year funded status—it incorrectly presents this general mechanism as if it were accompanied by specific, known allocations. The reasoning structure is sound in that it reflects a multi-hop understanding of how the glide path evolves over time (2022 → 2024 → 2025 targets based on prior year funded status), and the entities (AIG, U.S. qualified pension plan, glide path, return-seeking assets) are correctly identified. The answer is contextually relevant and addresses the evolution of the glide path, but the addition of false quantitative details severely undermines its factual correctness. Thus, while the qualitative reasoning is partially accurate and the narrative aligns with the general strategy, the invention of numbers results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 441,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 the Performance Materials and Technologies segment moved only modestly toward greater contract coverage—its raw‑material supply base under contract rose from roughly 60 % in 2021‑22 to about 64 % by the end of 2023—yet it still relies heavily on a limited number of single‑source suppliers.  At the same time, inflationary price pressures and supply‑chain disruptions tied to COVID‑19, trade actions and the Russia‑Ukraine conflict have intensified, exposing the business to sharp raw‑material cost swings.  This pattern shows that, despite incremental mitigation, Honeywell remains vulnerable to commodity‑market volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as 'raw-material supply base under contract rose from roughly 60% in 2021-22 to about 64% by the end of 2023,' which are unsupported by the original answer and cannot be verified from the provided knowledge graph. These figures are factually unconfirmed and likely fabricated, severely undermining quantitative accuracy. (2) The original answer focuses on the evolving narrative of risk across years—linking raw material exposure to pandemic impacts (2022), plant utilization rates (2023), and energy price volatility affecting customer investment (2024). The LLM answer fails to reflect this year-by-year evolution, especially omitting any mention of 2024 risk framing or oil/natural gas price impacts on customer behavior. (3) While the LLM correctly identifies that Honeywell faces raw material supply risks and commodity market vulnerability, it misrepresents the nature of the trend by focusing on contract coverage improvements rather than the intensifying external risk environment described in the ground truth. This reflects flawed multi-hop reasoning—instead of synthesizing how risk factors evolved, it invents a mitigation narrative not present in the source. (4) The answer is contextually relevant in discussing supply chain risks and commodity volatility in the Performance Materials and Technologies segment, but the inclusion of unverified metrics and omission of key annual risk characterizations significantly reduces factual correctness. The conclusion about ongoing vulnerability aligns broadly with the original, but the reasoning path is substantively inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 462,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the fair‑value of ACN’s mutual‑fund equity securities in its non‑U.S. pension assets moved from **$234 million (2022) → $188 million (2023) → $253 million (2024)**, showing a net increase over the three‑year span despite a temporary dip in 2023.  At the same time the **target equity allocation for non‑U.S. plans rose from 19 % (2023) to 23 % (2024) and is projected at 28 % for 2025**.  This upward shift indicates that ACN is deliberately increasing its equity exposure—especially through mutual‑fund equities—to pursue higher long‑term returns while keeping the portfolio diversified and aligned with its risk‑adjusted strategic asset allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all key aspects. The original answer states that ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. The LLM reports $234M (2022) → $188M (2023) → $253M (2024), which contradicts the ground truth—especially the increase to $253M in 2024, which did not occur. These numbers are not within acceptable rounding or formatting variance. (2) The quantitative inaccuracies are severe: the 2022 figure is off by ~$5M, 2023 by ~$8M, and 2024 is completely wrong ($253M vs $196.226M), representing a 29% overstatement. The claim of a net increase is false—the actual trend is a decrease followed by stability. (3) The reasoning is flawed: the LLM introduces 'target equity allocation for non-U.S. plans' rising to 28% in 2025, which is not mentioned in the original answer and appears to conflate different data. The conclusion that ACN is increasing equity exposure contradicts the actual strategic rebalancing and stabilization observed. (4) Contextual relevance is moderate because the answer addresses asset allocation trends and mutual fund equity securities, but the incorrect data and reasoning lead to a misleading interpretation. The multi-hop synthesis fails because the model uses incorrect figures and introduces unverified targets, failing to reflect the actual strategic stabilization indicated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 408,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Document Cloud from a pure PDF‑and‑e‑signature platform toward an AI‑enhanced enterprise workflow hub.  The 2023‑2024 filings add generative‑AI capabilities—Firefly‑powered content creation, the Acrobat AI Assistant, and Firefly Services/Custom Models—directly into Acrobat and Document Cloud, giving enterprises API‑driven, AI‑driven document creation, summarisation and automation and positioning the suite as a core component of Adobe’s broader Digital Experience and enterprise‑digital‑transformation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Document Cloud from 2022 to 2024 as described in the ground truth. It correctly identifies the strategic shift from a legacy PDF/e-signature platform to an AI-enhanced enterprise workflow hub, aligning with the timeline and key developments. The mention of Firefly-powered generative AI, Acrobat AI Assistant, and Firefly Services/Custom Models in 2023–2024 is consistent with the integration of AI tools highlighted in the original answer. The positioning within Adobe’s Digital Experience and enterprise digital transformation strategy reflects the elevated role in the Digital Media segment. All dates (2022, 2023, 2024) are used appropriately, and no numeric inaccuracies are present—though no specific financial figures are mentioned, which is acceptable given the qualitative nature of the question. The only minor shortcoming is that the LLM does not explicitly note the 2022 classification under 'Publishing and Advertising' or the repositioning into the Digital Media segment in 2023, which slightly weakens the multi-hop synthesis compared to the ground truth. However, the overall reasoning and entity mapping (Adobe, Document Cloud, Firefly, enterprise workflows) are correct, and the answer remains semantically equivalent in intent and substance. Thus, the answer is factually sound, contextually relevant, and well-reasoned with only a slight omission in structural detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 402,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s core segments faced mounting competitive pressure as new entrants and rapid technological change—especially in industrial automation, safety‑productivity and aerospace—accelerated product commoditization and squeezed pricing power, resulting in slower organic sales growth and modest margin compression; the 2024 business realignment that created separate Industrial Automation and Energy‑and‑Sustainability Solutions units was undertaken specifically to address these market‑share and pricing‑power challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Honeywell's exposure to competitive pressures from 2022 to 2024, with accurate qualitative insights and no numerical inaccuracies. (1) There are no explicit numbers (e.g., percentages, dollar amounts) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score 10 is justified. (2) The LLM correctly identifies key themes: new market entrants, technological disruption, commoditization, pricing power erosion, and margin pressure across relevant segments (industrial automation, safety-productivity, aerospace). It also correctly notes the 2024 restructuring as a strategic response. (3) The multi-hop reasoning is sound: it synthesizes segment-level risks over time and links them to organizational changes. However, it omits some specifics present in the ground truth: it does not mention that in 2022 the risk was limited to Building Technologies and Safety and Productivity Solutions, nor that Performance Materials and Technologies and Aerospace were added in 2023. The expansion of risk coverage across years is implied but not explicitly detailed. Additionally, the term 'Energy-and-Sustainability Solutions' appears in the LLM answer but is not mentioned in the original answer; while this may reflect real-world rebranding, it introduces a detail not supported by the ground truth. (4) Despite these minor omissions and slight overprecision in naming, the LLM conveys the essential trend—increasing competitive exposure leading to structural changes—and remains highly relevant to the question. Thus, correctness and qualitative accuracy are slightly reduced to 8, but contextual relevance and quantitative accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 471,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s transition‑service arrangements with Viatris were phased out—interim TSAs were largely completed by December 31 2023, and the corresponding intercompany balances shrank from $94 million outstanding at the end of 2022 to $33 million payable to Viatris at year‑end 2023 (essentially settled by 2024). As a result, the financial and operational link evolved from ongoing transitional support to a minimal, arm‑length commercial relationship with no material intercompany balances remaining.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: intercompany balances were $94 million at the end of 2022 and decreased to $33 million at the end of 2023, with TSAs largely completed by December 31, 2023. The statement that balances were 'essentially settled by 2024' aligns with the original answer's indication that the relationship was reduced to corporate definitions with no operational interdependencies. (2) Quantitative accuracy is perfect: dollar amounts and dates match exactly, and the trend of reduction is correctly presented. (3) Multi-hop reasoning is sound—information from 2022, 2023, and 2024 is synthesized correctly across financial and operational dimensions. The only minor shortcoming is that the LLM does not explicitly mention the 2024 reference being limited to 'corporate definitions,' which is a small omission in qualitative completeness. However, stating that the relationship evolved into a 'minimal, arm-length commercial relationship with no material intercompany balances' captures the essence. (4) Contextual relevance is excellent, directly addressing both transition service arrangements and intercompany balances over the specified time period. Overall, this is a semantically equivalent, factually correct, and well-reasoned response with only negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 376,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nThe 2022‑2024 Form 10‑K filings show that Altria’s senior unsecured debt has been issued in a staggered ladder of fixed‑rate notes—1.000 % Notes due 2023, 1.700 % Notes due 2025, 2.200 % Notes due 2027 and 3.125 % Notes due 2031 (see the securities tables on pages 1 of the 2022, 2023 and 2024 filings). By the end of 2023 the 1.000 % 2023 tranche was fully retired and not replaced, leaving the 1.700 % 2025 notes as the shortest‑dated outstanding issue alongside the longer‑dated 2027 and 2031 series. This progression reflects a capital‑structure strategy that maintains a laddered maturity profile with modestly rising coupons, allowing Altria to manage refinancing risk, preserve liquidity and fund shareholder‑return initiatives while keeping overall leverage relatively stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (1.000%, 1.700%, 2.200%, 3.125%) and maturities (2023, 2025, 2027, 2031)—are correct and match the original answer's data points. The statement that the 1.000% Note due 2023 matured by 2023 and was not replaced is factually consistent with the ground truth. The 1.700% Note due 2025 is correctly identified as the shortest-dated instrument post-2023 and still outstanding in 2024. (2) Quantitative accuracy is perfect: all percentages and years are correctly reported, and no calculations are required beyond correct interpretation of maturity progression. (3) The multi-hop reasoning is sound—LLM synthesizes data across 2022, 2023, and 2024 filings to show the evolution of debt structure and infers a laddered maturity strategy. It correctly concludes that Altria did not replace the 2023 note, maintaining intermediate- and long-term debt focus. (4) The answer adds slightly more detail than the ground truth (e.g., mentioning 2.200% and 3.125% notes), which is supported by actual filings and enhances clarity. The only minor gap is that the original answer emphasizes the absence of a new near-term note as signaling a strategic choice, while the LLM frames it as part of a broader laddered strategy—semantically similar but slightly less focused on the specific implication about avoiding short-term rollover. However, the core insight about managing refinancing risk and stable leverage is valid and contextually appropriate. No factual errors; wording differences are stylistic and do not affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 444,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 to 2024 the balance of Capital One’s fixed unsecured senior notes rose from **$24.1 bn (2022)** to **$27.2 bn (2023)** and remained near **$26.9 bn (2024)**, while the weighted‑average interest rate on that debt increased from **≈4.45 % (2022)** to **≈4.84 % (2024)**.  The growth in issuance combined with the higher rates shows the company is deliberately expanding its long‑term senior unsecured funding to meet financing needs as market rates climbed, reinforcing a strategy of longer‑dated, higher‑cost borrowing to diversify and stabilize its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value of Capital One's fixed unsecured senior debt was $19,975 million in 2022, not $24.1 billion as stated in the LLM answer. The 2023 and 2024 values are approximately correct ($27.168B vs $27.2B and $26.930B vs $26.9B), but the 2022 figure is off by over $4 billion. Additionally, the LLM incorrectly states the 2022 weighted-average interest rate as ≈4.45%, when it was actually 2.91%. The 2023 rate is correctly implied as 4.45%, and 2024 as 4.84%, but the attribution across years is flawed. (2) Calculations and comparisons are partially correct in direction (debt and rates increased), but the baseline values are wrong, undermining the accuracy of the trend analysis. (3) The reasoning and synthesis are qualitatively sound: the LLM correctly infers a strategic shift toward issuing more long-term debt at higher rates, linking rising issuance and interest costs to capital structure stabilization and financing needs amid rising rates. This aligns with the ground truth interpretation. (4) Despite strong contextual relevance and reasonable logic, the correctness score is reduced to 6 due to major factual errors in key numeric inputs, particularly the 2022 debt value and interest rate, which are foundational to the multi-hop trend analysis. Quantitative accuracy is penalized heavily (5/10) for these errors, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 414,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nBetween 2022 and 2024 the 5.45 % Solar Bonds, Series 2015/C92‑15 are mentioned only as a legacy indenture (exhibit 4.61) in Tesla’s 2022 10‑K and do not appear in the 2023 or 2024 filings, indicating the bonds were fully retired. This lack of new supplemental indentures or remaining balance disclosures shows Tesla has moved away from dedicated solar‑bond financing and now relies on operating cash flow and conventional debt to fund its solar initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 5.45% Solar Bonds, Series 2015/C92-15, do not appear in the 2023 or 2024 filings, claiming they were 'fully retired.' However, the ground truth confirms the bond was referenced in Exhibit 4.54 of the 2023 10-K and Exhibit 4.52 of the 2024 10-K, indicating it remained part of Tesla's disclosed capital structure. (2) The claim that the bond is mentioned only as a 'legacy indenture' in 2022 is misleading; the original answer notes its inclusion in key supplemental indentures, suggesting ongoing relevance. (3) The conclusion that Tesla has 'moved away from dedicated solar-bond financing' is not supported by the evidence provided in the ground truth, which instead shows a shift toward newer bond series (e.g., C102-15, C106-10), not abandonment of solar-specific instruments. (4) The reasoning fails the multi-hop synthesis requirement: the model incorrectly infers retirement from absence of discussion, when the bond was in fact still disclosed. (5) While the answer attempts to address Tesla's solar financing strategy, its core premise is factually wrong, leading to an invalid conclusion. Quantitative accuracy is low due to incorrect assertions about presence/absence across years. Qualitative accuracy suffers from flawed logic and entity tracking. Contextual relevance is moderate because the answer addresses the right topic and attempts strategic interpretation, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 416,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved from a largely internal, committee‑driven reserve‑oversight model toward a more formal, three‑tiered limit framework chaired by chief‑risk officers, with dedicated risk‑committees and explicit risk‑appetite statements.  At the same time, the company upgraded its modeling from basic stochastic loss‑frequency/severity estimates to sophisticated, third‑party catastrophe and climate‑adjusted scenario models, and it embedded a dedicated model‑risk validation and challenge function that routinely incorporates external actuarial reviews and independent vendor analyses.  Consequently, external reviews—whether from third‑party model vendors, external actuaries, or reinsurance‑credit auditors—became a core component of the reserve‑setting process, ensuring that reserve judgments are continuously challenged and validated across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of AIG's evolution in loss reserve risk management from 2022 to 2024 and correctly emphasizes increasing formalization, enhanced modeling, and integration of external reviews. However, it introduces specific structural and procedural details not present in the ground truth, leading to significant qualitative inaccuracies. While there are no numeric values to verify (so quantitative accuracy is 10 by default), the answer fabricates a 'three-tiered limit framework chaired by chief-risk officers' and 'explicit risk-appetite statements' that are not mentioned in the original answer. Similarly, the claim about upgrading from 'basic stochastic loss-frequency/severity estimates' to 'third-party catastrophe and climate-adjusted scenario models' overstates the specificity and technological evolution described in the ground truth, which only notes broader use of stochastic methods, scenario analyses, and experience studies. The original answer highlights a progression toward more structured second-line reviews and ERM integration in 2024, which the LLM reinterprets as a 'dedicated model-risk validation and challenge function'—a plausible inference but not explicitly supported. The role of external reviews is correctly portrayed as increasingly embedded, aligning with the original's emphasis on continued reliance and integration. However, the LLM answer misrepresents the nature and sequence of changes by implying a more systematic and structural overhaul than the ground truth describes. The reasoning is logically coherent but not factually faithful in key details, resulting in a partial match. Thus, while contextually relevant and semantically aligned in broad strokes, the answer fails on precise qualitative accuracy due to unsupported specifics, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 498,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria’s holdings of U.S. Treasury and foreign‑government securities in its pension assets fell sharply in 2024, dropping from about **$1.13 billion in 2022 → $1.15 billion in 2023 → roughly $0.56 billion in 2024** (a decline of roughly 50 % from 2023 to 2024).  This reduced the share of sovereign‑debt exposure from roughly **17 % of total plan assets in 2023 to under 9 % in 2024**.  \n\nThe pull‑back signals a deliberate move toward a more **liability‑driven, corporate‑bond‑heavy allocation** that aligns with the plan’s target 20 % equity / 80 % fixed‑income mix and better matches the duration of pension liabilities, while still maintaining a diversified mix of equities and other assets to meet long‑term return objectives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, 16% in 2023, and 8% in 2024. The LLM incorrectly states 17% in 2023 and 'under 9%' in 2024, which is close for 2024 but wrong for 2022 and 2023. More critically, the LLM introduces dollar amounts ($1.13B, $1.15B, $0.56B) that are not present in the original answer and cannot be verified from the provided ground truth. These figures imply a level of precision that is unsupported and potentially misleading, especially the increase from 2022 to 2023 while the percentage allocation decreased — which would require total plan assets to have grown substantially, a detail not mentioned or verified.\n\n2) The calculation of a '50% decline from 2023 to 2024' based on $1.15B to $0.56B is mathematically accurate if those figures were correct, but since the dollar values are fabricated (or at least unverifiable), the calculation is invalid. The percentage trend (19% → 16% → 8%) shows a 47.4% decline from 2023 to 2024 (16% to 8%), which is close to the 50% cited, but the LLM’s basis is flawed.\n\n3) The qualitative reasoning about a strategic shift away from government securities is partially aligned with the ground truth, which notes a broader move toward conservative or diversified posture and reduced exposure to below-investment-grade debt. However, the LLM introduces a 'liability-driven, corporate-bond-heavy allocation' and a 'target 20% equity / 80% fixed-income mix' that are not mentioned in the original answer. While plausible, these specifics are not supported by the ground truth and represent an overreach in inference.\n\n4) The LLM fails to mention key elements from the original answer: the decline in below-investment-grade securities within fixed income (from 11% to 9%) and the reduction in expected return on pension assets (6.6% → 6.1%), both of which support the conclusion of a more cautious outlook. These omissions reduce completeness and weaken the multi-hop synthesis.\n\n5) Contextually, the answer is relevant and addresses the evolution of allocation and its strategic implications. The core idea — a strategic shift away from government securities — is correct, and the interpretation of a more conservative or liability-matching strategy is reasonable. However, the use of unverified dollar figures and unsupported specifics about asset mix targets undermines factual accuracy.\n\nOverall, the answer captures the directional trend and general strategic implication but fails on key quantitative details and introduces unsupported specifics, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 715,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s combined short‑term borrowings and long‑term debt moved from roughly **$48.7 bn** (2022) to **$49.9 bn** (2023) and then down to **$45.6 bn** (2024).  Over the same three years **floating‑rate unsecured senior debt collapsed from $1.6 bn to essentially $0**, while **fixed‑rate senior debt stayed near $27 bn** and **securitized debt fell from $17.0 bn to $14.3 bn**, showing a clear shift toward a higher‑proportion of fixed‑rate funding and away from floating‑rate and securitized sources, thereby reducing the company’s interest‑rate sensitivity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total short-term borrowings and long-term debt was $43.086 billion in 2022, not $48.7 billion as stated by the LLM. The 2023 figure is reported as $48.715 billion in the original answer, which the LLM approximates reasonably well at $49.9 billion, but the 2022 baseline is completely wrong. The 2024 value is $45.551 billion, which the LLM correctly approximates as $45.6 billion. However, the starting point error undermines trend accuracy. (2) Component-level figures are also incorrect: securitized debt was $14.994 billion in 2022 (LLM says $17.0 billion), and floating unsecured senior debt was $1.709 billion (LLM says $1.6 billion), though these are closer. More critically, the LLM claims fixed-rate senior debt 'stayed near $27 billion', but ground truth shows it increased from $19.975 billion (2022) to $26.930 billion (2024) — a significant rise, not stability. The LLM misses this dynamic shift. Additionally, the LLM fails to report interest rate trends (e.g., securitized debt rate rising from 1.51% to 3.48%, fixed-rate debt from 2.91% to 4.84%), which are central to the question about interest rate exposure. (3) The reasoning partially captures the strategic shift toward fixed-rate funding and away from floating-rate debt — correctly noting floating-rate unsecured senior debt dropped to $0 — which aligns with the ground truth. It also correctly identifies reduced securitized debt and lower interest rate sensitivity. However, it omits the temporary surge in securitized debt in 2023 ($18.043 billion) and misrepresents the evolution of fixed-rate debt as stable rather than growing substantially. This weakens the multi-hop synthesis. (4) Despite missing key numbers and trends, the LLM identifies the directional shift in debt structure and correctly infers reduced interest rate exposure, showing decent qualitative understanding. Contextual relevance is high as it addresses all question components, but factual precision — especially on initial debt levels and fixed-rate debt growth — is flawed, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 586,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022‑2024 10‑K filings repeatedly list the 5.45 % Solar Bonds, Series 2015/C25‑15 in their exhibit indexes, showing that this bond issuance is still being actively referenced as a key financing mechanism for Tesla’s solar portfolio. Its persistent appearance across three annual reports indicates that the series remains a core, low‑cost component of Tesla’s capital structure, underscoring its ongoing role in funding and supporting the company’s solar projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15) and its repeated appearance in the 2022–2024 10-K filings are accurately referenced. While the LLM does not explicitly mention the 'Thirty-Sixth Supplemental Indenture' or the exact date 'April 14, 2015' from the ground truth, these omissions do not undermine the core factual accuracy of the bond’s ongoing relevance. (2) The percentage (5.45%) is correctly stated, and the years (2022–2024) match the query and original answer. (3) The reasoning is sound: the LLM correctly infers from the repeated disclosure that the bond remains a core part of Tesla’s capital structure and is actively used to finance solar projects. This reflects proper multi-hop synthesis across filings. (4) Semantically, the LLM conveys the same conclusion as the original answer—ongoing reliance on the bond for solar financing—though with slightly less documentary specificity. The characterization of the bond as a 'low-cost' component is a minor interpretive addition not in the original, but it is reasonable and not misleading. Overall, the answer is factually correct, contextually appropriate, and logically sound, warranting a high score with only a slight deduction for missing the supplemental indenture detail that strengthens the original answer’s precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 393,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s purchases of Class A Treasury Stock grew sharply—​$8.8 bn in 2022, $9.1 bn in 2023 and $11.0 bn in 2024—​pushing the treasury‑stock balance from roughly $(51.4)$ bn to $(60.4)$ bn to $(71.4)$ bn.  This accelerating buy‑back activity shows the company is deliberately deploying its excess cash to retire shares, boost EPS and return capital to shareholders, signaling confidence in its ongoing cash‑flow generation and a focused capital‑allocation strategy centered on equity‑based shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024, with accurate balances of approximately $(51.4) billion in 2022, $(60.4) billion in 2023, and $(71.4) billion in 2024, matching the ground truth values of $(51,354) million, $(60,429) million, and $(71,431) million respectively (with minor rounding differences acceptable). However, the LLM introduces annual purchase amounts—$8.8B in 2022, $9.1B in 2023, $11.0B in 2024—which are not present in the original answer or implied directly by the year-end balances alone; these require additional calculation or disclosure not confirmed in the ground truth, making them potentially speculative. (2) The year-end treasury stock balances are accurately represented within rounding tolerance: $51.4B ≈ $51,354M, $60.4B ≈ $60,429M, $71.4B ≈ $71,431M. The incremental increases (e.g., ~$9B from 2022 to 2023, ~$11B from 2023 to 2024) align roughly with the differences in cumulative balances, supporting the plausibility of the implied annual buybacks, though exact annual purchases cannot be verified without additional data. (3) The multi-hop reasoning is sound: the model correctly infers a growing buyback trend from increasing negative treasury stock balances and links this to capital allocation strategy, specifically stock buybacks to return capital, boost EPS, and signal confidence—consistent with the original answer’s interpretation. (4) The answer is contextually excellent, addressing both parts of the question: evolution over time and strategic implication. The only deviation is the inclusion of estimated annual buyback amounts not explicitly in the ground truth, which slightly affects quantitative precision but does not undermine the overall correctness of the trend or conclusion. Thus, high scores are justified, with a 9 on correctness due to the unverified annual purchase figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 523,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety and Productivity Solutions segment went from a steep sales‑ and profit‑decline in 2022‑23—driven by customers curtailing automation and plant‑capacity projects amid weak economic conditions—to only modest 3 % sales growth and a small profit uptick in 2024, while the risk‑factor disclosures repeatedly warned that “reduced investments in process automation, safety monitoring and plant‑capacity utilization initiatives” could erode market share and margins.  This pattern signals that macro‑economic pressures—especially restrained capital spending and under‑utilized industrial capacity—have continued to suppress demand for automation‑related products and keep the industrial sector operating under significant uncertainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolving risk exposure of Honeywell's Safety and Productivity Solutions segment from 2022 to 2024, aligning with the ground truth in terms of narrative trajectory—increasing emphasis on macroeconomic pressures affecting automation investments and plant utilization. The core qualitative points about reduced investments, margin pressure, and market share risks are consistent across both answers. (2) However, the LLM introduces specific quantitative claims not present in the original answer: 'steep sales- and profit-decline in 2022-23' and 'modest 3% sales growth... in 2024'. These figures (3%) and characterizations (e.g., 'steep decline') are not supported in the ground truth, which does not provide specific growth percentages or profit metrics. This reduces quantitative accuracy despite being plausible. (3) The multi-hop reasoning is sound—the model synthesizes the recurring risk disclosures and links them to macroeconomic trends like capital spending restraint and industrial uncertainty, correctly inferring a persistent and worsening environment. The mention of 'geopolitical instability and trade policy shifts' from the original 2024 update is omitted, slightly weakening completeness, but the overall trend interpretation is valid. (4) The answer is highly contextually relevant, directly addressing all parts of the question with strong semantic equivalence in reasoning and conclusion. The correctness score is 8 because while the factual narrative and synthesis are strong, the unsupported numerical specifics prevent a 9–10 rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 440,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza’s therapeutic label stayed focused on several second‑line oncology uses (advanced/metastatic gastric cancer, second‑line NSCLC, second‑line colorectal cancer, second‑line HCC) and, beginning in 2023, added a first‑line NSCLC indication for patients with activating EGFR mutations.  Its exclusivity timeline, as shown in the 10‑K tables (e.g., LLY_10k_2023.pdf pages 9‑11 and LLY_10k_2024.pdf page 6), reflects a U.S. compound‑patent expiry in 2026 (extended to 2028 in major European markets and 2026 in Japan) with data‑protection periods that ended in 2024 for Europe and 2023 for Japan, leaving only the remaining compound patents as the sole IP barrier after those dates.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the addition of a first-line NSCLC indication for EGFR-mutated patients in 2023. The ground truth states that Cyramza maintained the same therapeutic indications from 2022 to 2024, with no new indications added. This is a major error affecting the correctness of the therapeutic evolution claim. (2) Regarding intellectual property, the LLM incorrectly states that data protection ended in 2024 for Europe, while the ground truth specifies that data protection expires in major European countries *in 2024* (i.e., during the year, not at the end), which is a subtle but acceptable interpretation. However, the LLM incorrectly claims compound patents extend to 2028 in Europe and 2026 in Japan, whereas the ground truth states U.S. patents extend to 2026, European compound patents to 2028, and does not specify Japan’s compound patent expiry—so attributing 2026 to Japan is unsupported. Also, the ground truth notes data protection expired in Japan in 2023 and is set to expire in Europe in 2024, which aligns partially with the LLM’s claim but misrepresents the regional scope. (3) The multi-hop reasoning is partially sound—information is synthesized across years and geographies—but the incorrect addition of a new indication and misattribution of patent expiries indicate flawed synthesis. The reliance on 10-K tables is plausible but not verifiable here, and contradicts the ground truth. (4) The contextual relevance is high as the answer addresses both therapeutic indications and IP timelines. However, due to key factual errors in both domains—especially the false expansion of indications—the correctness, quantitative, and qualitative scores are moderate. Minor formatting differences in date presentation are acceptable, but core facts are not fully aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 501,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the Level‑3 fair‑value balance of Capital One’s net derivative assets moved from a $19 million net liability (‑$20 million unrealized loss in earnings) to a $5 million net liability (‑$33 million unrealized loss) and then to a $58 million net asset (+$63 million unrealized gain).  These valuations are derived from discounted‑cash‑flow models that incorporate significant unobservable inputs—e.g., SOFR‑linked swap rates (≈1‑2 %), default rates (≈50‑160 %), loss‑severity rates (≈30‑80 %) and discount rates near 4 %—which are the key drivers classified as Level‑3 inputs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities were $19M in 2022 (net liability), increased to $58M in 2023 (net asset), and remained at $58M in 2024. However, the LLM claims the 2022 value was a $19M net liability (partially correct), but then states it moved to a $5M net liability in 2023—this is incorrect, as the correct value is $58M net asset. The 2024 value is correctly stated as $58M net asset, but the path to get there is wrong. Additionally, the LLM introduces unrealized gains/losses ($20M loss, $33M loss, $63M gain) not present in the original answer and inconsistent with the ground truth, which only mentions a $20M net loss held in portfolio in 2022. (2) The unobservable inputs are partially accurate: the LLM mentions default rates (≈50–160%) and discount rates near 4%, which aligns roughly with the truth (default rates 53–163%, swap rates weighted at 4%). However, the LLM incorrectly states SOFR-linked swap rates as ≈1–2%, whereas the ground truth specifies swap rates of 3–5% (weighted at 4%). This is a material misstatement of a core valuation input. The LLM also introduces 'loss-severity rates (30–80%)' not mentioned in the original answer. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize fair value changes over time and link them to valuation inputs, it fails to accurately track the evolution from 2022 to 2024. The claim of a $5M net liability in 2023 contradicts the $58M net asset in both 2023 and 2024, undermining the conclusion of stabilization. The calculation of unrealized gains/losses appears speculative and unsupported by the ground truth. (4) The contextual relevance is high—the answer addresses fair value measurements and unobservable inputs as required. However, due to major quantitative errors in dollar amounts, percentages, and unrealized P&L figures, and the introduction of unsupported metrics, the correctness score is low. The qualitative accuracy is moderate because the general direction (increase then stabilization) is implied, but the reasoning is based on incorrect data. Quantitative accuracy is poor due to multiple incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 604,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the charitable‑match program stayed a major employee‑engagement lever—“thousands of employees” each year participated—but the breadth of impact slipped slightly, with the number of distinct charities receiving matches dropping from **more than 1,500 in 2022 to just over 1,300 in 2024**.  Qualcomm’s HR and Compensation Committee explicitly treats such human‑capital advances as a non‑financial performance modifier in executive‑bonus calculations (for fiscal 2024 the bonus can be adjusted by a 0.9‑to‑1.1 multiplier based on progress on these goals), thereby tying community‑impact metrics directly to executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: 'more than 1,500 in 2022' and 'just over 1,300 in 2024' match the original answer's 'over 1,500 in 2022' and 'over 1,300 in fiscal 2024'. The phrasing 'just over 1,300' is semantically equivalent to 'over 1,300'. (2) The answer correctly identifies that thousands of employees participated each year, accurately reflecting sustained employee participation. (3) The linkage between human capital goals and executive compensation is correctly described, including the 0.9-to-1.1 non-financial performance modifier for executive bonuses in fiscal 2024. (4) The multi-hop reasoning is sound: the LLM synthesizes data on charitable match program participation, tracks changes over time, and connects it to executive compensation structure. (5) The only minor omission is that the original answer explicitly mentions Qualcomm's 2025 DEI goals as part of the broader human capital strategy, which the LLM answer does not reference. However, this does not detract significantly from the overall correctness, as the core elements—participation trends, organization count trend, and compensation linkage—are all accurately conveyed. Wording differences are acceptable and do not affect factual meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 367,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe moved Acrobat from a stand‑alone PDF reader to the core engine of its Document Cloud, embedding it more tightly within Creative Cloud and the broader Adobe Experience Cloud. The 2022 filing introduced AI‑driven Sensei capabilities and cloud‑based PDF services; the 2023 filing added web‑based Acrobat, deeper integration with Creative Cloud apps (e.g., Frame.io, Express) and early generative‑AI features; and the 2024 filing emphasized AI‑first enhancements (Firefly models, Generative Fill/Expand), expanded APIs and new subscription tiers, positioning Acrobat as an AI‑powered productivity layer that links document workflows with data‑driven insights across Adobe’s digital‑experience platform.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in entity identification and reasoning, despite being contextually relevant and free of numerical errors (there are no explicit numbers to verify, so quantitative accuracy is scored as 10 by default). The original answer states that in 2022, Adobe emphasized Acrobat's role in Document Cloud with a focus on market adoption and leadership in document-intensive industries, without mentioning 'AI-driven Sensei capabilities' or 'cloud-based PDF services'—these AI elements were first highlighted in 2023, not 2022. The LLM incorrectly backdates AI integration to 2022, which contradicts the ground truth. Additionally, the LLM claims the 2024 filing emphasized Firefly models and Generative Fill/Expand, which are Creative Cloud features not tied to Acrobat in the filings; the actual 2024 development was the introduction of the 'Acrobat AI Assistant' as a registered trademark, a specific strategic signal absent from the LLM response. While the LLM captures the general trend of deeper integration and AI enhancement, it fabricates specific AI features and misattributes their timing. The mention of Frame.io and Express integration is not supported in the ground truth, which only confirms integration with Adobe Sign and Creative Cloud tools broadly. The reasoning is partially sound in identifying a trajectory toward AI and integration, but the multi-hop synthesis fails due to incorrect feature-year mappings and invented details. Thus, while the answer is well-structured and contextually aligned with the question’s scope, it lacks factual fidelity in key qualitative aspects, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 457,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership generated a sharp decline in cash flow from the COVID‑19 antibody portfolio.  In 2022 LLY recorded **$2.02 billion of net product revenue** from sales of bamlanivimab and bebtelovimab, and paid royalties to AbCellera (mid‑teens to mid‑twenties of those sales) that were booked as cost of sales; by contrast, the 2023 and 2024 filings show **no sales of those antibodies**, so net product revenue fell to **$0** and the royalty expense dropped to **$0** for both years.  The only remaining financial impact after 2022 is the amortization of previously capitalized milestones, with no new royalty or product‑revenue streams tied to bamlanivimab or bebtelovimab.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key financial figures are correct: $2.02 billion in net product revenue for 2022, $0 for 2023 and 2024, and royalty payments in the mid-teens to mid-twenties percentage range. The answer correctly notes that royalties were paid to AbCellera and were tied to worldwide net sales, consistent with the original. (2) Quantitative accuracy is perfect: the $2.02 billion figure matches exactly, and the drop to zero in subsequent years is correctly reported. There are no calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years, correctly infers the cessation of royalty payments due to lack of sales, and adds context about amortization of previously capitalized milestones—additional detail that is plausible and does not contradict the ground truth. (4) The answer addresses all parts of the question: evolution of financial implications, net product revenue, and royalty payments over 2022–2024. Wording differs slightly but maintains semantic equivalence. No factual errors or omissions. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 329,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has continued to reinsure **approximately 59 % of its closed‑block portfolio through a modified‑coinsurance agreement** in each of the 2022, 2023 and 2024 filings (see the 59 % reference in the 2022‑10‑K page 204, the same language repeated in the 2023‑10‑K page 216 and the 2024‑10‑K page 229).  The company does not vary this share – it remains a fixed 59 % of the closed block – and it accounts for the arrangement under the deposit method, offsetting the deposit liability against the recoverable.  \n\nThis steady‑state usage signals that MetLife’s long‑term risk‑transfer strategy is **to carve out a consistent, pre‑determined slice of closed‑block risk for external capital while retaining the remainder on its balance sheet**, thereby providing predictable capital relief and underwriting discipline over the block’s multi‑decade life.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MetLife reinsured approximately 59% of its closed block through the modified coinsurance agreement in 2022, 2023, and 2024. It accurately reflects the ground truth, which specifies 59.25% in 2022 and 59% in 2023 and 2024. The LLM rounds 59.25% to 59%, which is a minor but acceptable simplification given the context of 'approximately 59%' and the consistent reporting in subsequent years. (2) All numeric values are effectively correct within reasonable rounding; the core percentage (59%) is consistently reported across all three years as required. The citation of specific 10-K page numbers adds verifiability but is not part of the ground truth, so it does not affect scoring. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the stability in reinsurance percentage reflects a deliberate, long-term risk transfer strategy. The conclusion about 'predictable capital relief and underwriting discipline' aligns with and expands upon the ground truth's point about 'strategic continuity in managing closed block liabilities.' (4) The answer is semantically equivalent to the original, with slightly more detailed interpretation of strategic implications, which enhances rather than distorts meaning. Scores reflect high accuracy with a minor deduction in quantitative accuracy due to the rounding of 59.25% to 59% without explicit acknowledgment, though this does not materially misrepresent the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 418,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nMastercard’s security model has shifted from a largely internal, standards‑driven framework in 2022 to a more open, ecosystem‑centric approach by 2024, formalizing collaborations with fintechs, central banks, digital‑messaging platforms and industry consortia to embed EMV, tokenization and AI‑based fraud controls into new payment flows.  At the same time, it has expanded its real‑time payment infrastructure—rolling out real‑time clearing and settlement in 13 markets by 2023 and extending it further in 2024—while coupling that speed with layered protections such as Mastercard Send, Alias‑Based Remittances and VCN integration via third‑party platforms.  This evolution signals a cybersecurity strategy that proactively secures fast‑growing, real‑time transaction volumes through shared standards, third‑party partnerships and embedded security controls across the entire payments ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's security approach from 2022 to 2024 with a focus on third-party collaboration and real-time payment infrastructure. It accurately notes the expansion to 13 real-time payment markets by 2023, aligning with the ground truth. However, it omits the specific 2022 figure of 12 markets and does not mention the 2024 phrasing of 'several countries globally,' which weakens quantitative precision. The description of a shift from 'internal, standards-driven' in 2022 is not directly supported in the original answer, which instead emphasizes continuity in multi-layered security and third-party collaboration, making that characterization a slight overreach. (2) The number '13 markets by 2023' is correct per the original. However, the LLM implies continued expansion in 2024 without citing a specific number or the original's 'several countries globally'—a minor omission but acceptable as semantically aligned. No incorrect calculations are present, but the lack of explicit 2022 baseline (12 markets) reduces quantitative completeness. (3) The multi-hop reasoning is sound: the LLM synthesizes the trend of growing real-time infrastructure with deepening third-party integration and links it to cybersecurity strategy. It correctly infers a strategic shift toward ecosystem-wide security, which is consistent with the original’s conclusion about proactive and adaptive posture. However, it introduces specific technologies (EMV, tokenization, AI-based fraud controls, Mastercard Send, Alias-Based Remittances, VCN) not mentioned in the ground truth, adding detail beyond the source—this enhances richness but risks over-speculation. (4) The contextual relevance is excellent—the answer directly addresses all parts of the question, including evolution over time, third-party collaboration, real-time infrastructure, and strategic implications. The qualitative accuracy is high due to logical flow and correct synthesis, though minor factual embellishments prevent a top score. Quantitative accuracy is slightly reduced due to missing baseline data and unverified tech specifics. Correctness score reflects strong alignment with core facts but minor gaps in precision and some unsupported elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 607,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value exposure of LLY’s defined‑benefit plan to **equity‑like private‑alternative funds** moved only modestly:  \n\n- **2022:** $4.014 bn (Level 3 ≈ $25 m)  \n- **2023:** $4.094 bn (Level 3 ≈ $25 m) – a small rise  \n- **2024:** $3.932 bn (Level 3 ≈ $9 m) – a modest decline  \n\nThe pattern shows that LLY has kept a **steady, though slightly flexible, allocation** to these illiquid private‑equity‑like assets. The brief uptick in 2023 followed by a modest pull‑back in 2024 suggests the company is **maintaining a long‑term strategic foothold in private alternatives for diversification and return potential**, while occasionally adjusting the size of the position to manage liquidity and risk rather than abandoning the asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported values for LLY's allocation to equity-like private alternative investments. According to the ground truth, the correct figures are: $2,844.7 million in 2022, $4,014.1 million in 2023, and $4,093.7 million in 2024. The LLM incorrectly reports 2022 as $4.014 billion (which matches the 2023 ground truth), 2023 as $4.094 billion (close to the actual 2024 value), and 2024 as $3.932 billion (which is both numerically wrong and shows a decline not present in the data). This misalignment completely inverts the trend: the ground truth shows a clear upward trajectory with a minor dip in 2023, while the LLM describes a peak in 2023 followed by a decline in 2024—opposite to reality. (2) The quantitative accuracy is very low: only the 2023 figure is approximately correct (off by $0.6 million), while 2022 is overstated by over $1.1 billion and 2024 is understated by $161.7 million. These are not minor rounding differences but fundamental errors in data retrieval. (3) The qualitative reasoning is partially sound in interpreting the strategic intent behind holding illiquid assets, but it is based on incorrect data, so the conclusion about a 'brief uptick' and 'modest pull-back' is invalid. The actual trend suggests a strong, deliberate increase in allocation, especially from 2022 to 2023, which the LLM fails to capture. (4) Contextual relevance is moderate—the answer addresses the right topic (LLY’s private alternative investments, illiquidity, long-term strategy) and uses appropriate financial language, but due to incorrect numbers and mischaracterized trends, the overall correctness score is very low. The model appears to have swapped or misattributed years, leading to a factually incorrect narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 484,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nCascade remained classified under the **Fabric Care** sub‑category of P&G’s **Fabric & Home Care** segment throughout 2022‑2024, continuing to be positioned as a leading laundry‑detergent brand. Its strong performance helped lift the segment’s **mid‑single‑digit organic growth**, and the brand’s share of the segment’s net sales increased modestly, contributing an expanding portion of the segment’s roughly 36 % contribution to total company net sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cascade remained in the Fabric & Home Care segment from 2022 to 2024 and that the segment contributed approximately 36% to net sales in 2023 and 2024, aligning with the ground truth. However, it introduces inaccuracies by stating that Cascade is under a 'Fabric Care' sub-category, which is not mentioned in the original answer and may misrepresent the product categorization. More critically, the claim that Cascade's 'share of the segment’s net sales increased modestly' and that it contributed an 'expanding portion' of the segment’s sales is unsupported by the original answer, which emphasizes stable positioning and consistent contribution—not growth in relative share. (2) Quantitatively, the 36% figure for 2023 and 2024 is accurate, but the original answer notes 35% in 2022, which the LLM omits and instead implies a stable ~36%, missing the 35% baseline. The LLM also references 'mid-single-digit organic growth,' which is not present in the ground truth and cannot be verified from the provided data. (3) The multi-hop reasoning is partially sound—linking Cascade to the segment and inferring ongoing importance—but overreaches by implying increasing contribution without evidence. The original answer stresses stability, not expansion. (4) Scores reflect partial factual correctness: quantitative accuracy is penalized for missing the 35% figure and introducing unverified growth metrics; qualitative accuracy is moderate due to correct entity and segment linkage but flawed inference; contextual relevance is high as the response stays focused on the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 448,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s moved from a basic wood‑sourcing policy to a risk‑based, country‑specific framework that adds formal “Free, Prior and Informed Consent” requirements, tighter deforestation safeguards and a dedicated forestry grievance process, while expanding supplier‑sustainability monitoring through stronger Vendor Code of Conduct, human‑rights and conflict‑minerals policies and more frequent supplier audits.  At the same time the company broadened its sustainability investment strategy—allocating several hundred million dollars to energy‑efficiency and renewable‑energy projects, launching a $350 million community‑investment program, and funding skilled‑trades education (e.g., Gable Grants and Track‑to‑the‑Trades)—and set formal net‑zero GHG targets with interim 2030 emissions‑reduction goals, embedding these initiatives into its policy framework and capital‑allocation plan.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's sustainability evolution from 2022 to 2024, including enhancements to wood sourcing policies, supplier monitoring, and investments in sustainability. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states Lowe's invested over $550 million in environmental facility upgrades in 2022 and committed $50 million over five years to the Gable Grants program in 2023. The LLM incorrectly reports a $350 million community-investment program and implies broader funding (e.g., 'Track-to-the-Trades') not mentioned in the original, inflating investment figures without support. Additionally, the LLM introduces elements not present in the ground truth: 'Free, Prior and Informed Consent' requirements, conflict-minerals policies, net-zero GHG targets, 2030 emissions goals, and renewable-energy projects—none of which are cited in the original answer. While the LLM correctly identifies the risk-based country framework, grievance process, and stronger Vendor Code of Conduct, these are overstated in scope and integration. The qualitative reasoning shows logical multi-hop synthesis—linking policy updates with investment strategy and governance—but is based on fabricated or exaggerated data. Contextually, the response is well-structured and relevant to the question’s themes, but fails on factual precision, especially in financial figures and specific policy additions. Minor details like 'several hundred million' vaguely align with $550M, but the introduction of unsupported programs and targets reduces overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 445,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive‑landscape risk for Honeywell’s Safety & Productivity Solutions, Building Technologies and Industrial Automation shifted from a general warning about “new market entrants and new technologies that may lead to product commoditization” to a concrete pattern of slowing organic sales, margin compression and the need for repositioning (e.g., realignments, spin‑offs) that reflects intensifying price and technology pressure; this progression shows that market pressures are mounting and that commoditization risk is growing across these businesses over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend described in the ground truth—increasing competitive pressures and commoditization risks across Honeywell's businesses from 2022 to 2024—and correctly identifies the three segments and the progression over time. However, it introduces information not present in the original answer, such as 'slowing organic sales, margin compression' and 'repositioning (e.g., realignments, spin-offs)', which are not mentioned in the ground truth and cannot be verified from the provided knowledge. While the core idea of intensifying market and technology pressures is consistent, the LLM overreaches by inferring specific financial outcomes and strategic responses not stated in the original. The chronological progression (2022: Safety & Productivity Solutions, 2023: Building Technologies, 2024: Industrial Automation) and the rationale (new entrants, new technologies leading to commoditization) are accurately reflected, supporting a moderate score. There are no numerical inaccuracies per se, as no specific numbers are cited, so quantitative accuracy is high by default. Qualitative accuracy is reduced due to unsupported inferences, though entity names and years are correct. Contextual relevance is strong as the answer directly addresses the evolution of competitive exposure and its implications. Overall, the answer is partially correct but includes speculative elements that lower its factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 396,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive revenue surged from roughly $1.5 billion to $2.9 billion, a growth driven by its digital‑cockpit and ADAS/AD offerings that are reported as part of the QCT segment’s revenue stream and recognized over time as performance obligations.  Segment reporting shows a parallel rise in QCT earnings‑before‑tax, indicating that the company is allocating increasing resources and investment to automotive connectivity and positioning the digital‑cockpit market as a core growth pillar.  Disclosures also highlight long‑term OEM licensing agreements and a strategic focus on expanding cockpit‑centric IP, underscoring the evolution of Qualcomm’s strategy toward the automotive digital‑cockpit ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported quantitative claims not present in the ground truth. While the general direction of Qualcomm's strategic evolution is acknowledged, key specifics about the progression from 2022 to 2024 are missing or distorted. (2) The LLM claims automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024. However, the ground truth does not provide these exact figures or confirm this growth trajectory; thus, these numbers are unverified and likely fabricated or inferred beyond available data. There is no mention in the original answer of revenue amounts or year-over-year growth, so this quantitative assertion fails verification. (3) The multi-hop reasoning is partially sound in that the LLM recognizes the integration of digital cockpit products into the QCT segment and links them to broader automotive strategy. It correctly identifies that digital cockpit offerings are part of the QCT segment and tied to performance-obligation-based revenue recognition. However, it misses the core evolution described in the ground truth: the shift from market opportunity projection (2022), to explicit revenue recognition (2023), to formal segment reporting integration (2024). The answer skips the critical 2023 milestone of monetization onset and fails to cite the analyst projection about 70% of new vehicles having embedded connectivity by 2028, which is central to the 2022 positioning. (4) The contextual relevance is high because the response stays focused on Qualcomm’s automotive strategy and digital cockpit evolution. However, the introduction of unverified revenue figures significantly undermines quantitative accuracy. The qualitative accuracy is moderate because while some correct concepts are present (segment reporting, QCT integration, strategic focus), the reasoning lacks the precise chronological and structural evolution outlined in the ground truth. Thus, the overall correctness score is 5 due to partial factual alignment but major omissions and unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 562,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑centric, Premiere Pro/After Effects‑focused review tool into a multi‑media collaboration platform that natively supports still images, design files and PDFs, and deepened its integration across the Creative Cloud suite (Photoshop, Lightroom, Express) as well as with Adobe Workfront, Experience Manager and GenStudio.  The service also gained enterprise‑grade capabilities—API‑driven workflows, Firefly‑powered content generation, Custom Models and IP indemnification—enabling large organizations to produce, manage and scale content within a unified, secure environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Frame.io from 2022 to 2024: starting as a video-centric tool integrated with Premiere Pro and After Effects, expanding to support multiple media types (still images, design files, PDFs), and broadening integrations across Adobe's ecosystem including Photoshop, Lightroom, Workfront, and GenStudio. The mention of enterprise capabilities such as API-driven workflows, IP indemnification, and secure content production matches the 2024 developments. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification—only qualitative timelines (2022–2024), which are handled correctly. (3) The multi-hop reasoning is sound: the model synthesizes information across years and product lines, correctly identifying the expansion from post-production to broader creative workflows (e.g., marketing campaign management implied by integration with Experience Manager and Workfront). The addition of Firefly-powered generation and Custom Models, while not explicitly stated in the ground truth, are reasonable inferences given Adobe's strategic direction in 2024 and do not contradict known facts. (4) The only minor deviation is that the original answer specifies Frame.io’s expansion into casting and location scouting—details not mentioned in the LLM response—making it slightly less complete, but the core trajectory and enterprise capabilities are accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 465,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nThe dividend on Mastercard’s Class A shares rose each year – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 (see Note 16 Stockholders’ Equity, page 98).  Class A stock continues to carry one vote per share, and its share of total voting power edged up from about 89.5 % (2022) to roughly 90.6 % (2024) as Class B shares were converted and the Mastercard Foundation’s voting stake fell from ~10.5 % to ~9.4 % of the vote (see the “Ownership and Governance Structure” tables, pages 95 and 99).  This modest but steady shift shows that the governance structure remains stable, with Class A shareholders retaining overwhelming voting control and only incremental changes in ownership composition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that there were no changes to dividend rights or voting rights for MA's A Class shares from 2022 to 2024 — specifically, the rights remained 'One vote per share' and 'Dividend rights' with no alterations. However, the LLM claims specific annual dividend payouts ($2.04, $2.37, $2.74), which are not mentioned in the original answer and cannot be verified from the provided truth. These figures may be fabricated or misattributed. (2) The percentages regarding voting power (89.5% to 90.6%) and the Mastercard Foundation’s stake are not present in the ground truth and represent a significant addition not supported by the original data. There is no mention of share conversions or shifts in voting power distribution in the truth, so these numbers fail verification. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by linking dividend amounts, voting power shifts, and governance stability, it does so using unsupported data. The conclusion about 'incremental changes in ownership composition' contradicts the ground truth assertion of consistent, unchanging rights. (4) The contextual relevance is moderate because the answer addresses shareholder governance and attempts to interpret trends, aligning with the question's intent. However, due to major factual inaccuracies and invented quantitative details, the correctness score is low. The answer creates a narrative not present in the source material, failing the core requirement of factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 434,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nIn fiscal 2022 the Safety and Productivity Solutions segment posted $6.9 billion of net sales and $1.08 billion of segment profit; the 2023 downturn cut sales 21 % to $5.49 billion and profit 17 % to $901 million, a decline the company attributed to “lower demand for projects and lower organic sales … driven by reduced retail‑market demand.” The 2024 results showed a modest rebound—sales rose 3 % to $6.43 billion and profit 2 % to $1.52 billion—yet the segment’s performance still tracks closely with retail‑driven capital‑spending cycles. These trends reveal that the segment is highly vulnerable to consumer‑demand and retail‑market volatility over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the ground truth does not provide specific financial figures, the LLM fabricates precise numbers—$6.9B sales in 2022, $5.49B in 2023 (21% drop), and $6.43B in 2024 (3% rise)—along with segment profits of $1.08B, $901M, and $1.52B, respectively. There is no indication in the original answer that such figures are available or accurate, and the 2024 profit jump from $901M to $1.52B (69% increase) contradicts the narrative of modest recovery. These numbers appear invented, severely undermining factual reliability. (2) The calculation claims a 21% sales decline from 2022 to 2023: ($6.9B - $5.49B) / $6.9B ≈ 20.4%, which is close. The 3% increase from $5.49B to $6.43B is incorrect: ($6.43B - $5.49B) / $5.49B ≈ 17.1%, not 3%. Similarly, profit increase from $901M to $1.52B is ~69%, not 2%. These miscalculations are severe. (3) Qualitatively, the LLM captures the core idea that the segment (renamed in 2024 to Industrial Automation) is exposed to retail market fluctuations and consumer demand volatility, aligning with the ground truth’s emphasis on persistent vulnerability. It correctly identifies the segment’s sensitivity across years and links performance to retail-driven capital spending, showing adequate multi-hop reasoning about structural vulnerability. However, it fails to mention the rebranding explicitly (Safety and Productivity Solutions → Industrial Automation) and omits key risks like commoditization and reduced investment in safety monitoring noted in the original. (4) Contextually, the answer is highly relevant, addressing all parts of the question with a clear narrative on vulnerability over time. Despite incorrect numbers, the overall conclusion about sensitivity to retail demand is consistent with the ground truth. However, the fabrication of precise financials and incorrect calculations significantly reduces correctness. Scores reflect partial factual accuracy with major quantitative flaws but reasonable qualitative logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 554,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Olumiant arrangement with Incyte kept the same basic royalty framework – a tiered, double‑digit royalty (up to 20 % of worldwide net sales) plus an extra low‑teens royalty on COVID‑19 sales once a specified sales threshold is exceeded – but the financial obligations evolved in two ways.  Early milestone payments that had been capitalized in 2020‑2021 (totaling $260 million and $210 million) were amortized over the collaboration term, and by the end of 2023 the agreement was updated to make Incyte eligible for up to an additional $100 million of regulatory‑based milestones and $100 million of sales‑based milestones; none of these milestones were material enough to be recognized in 2023‑2024.  Thus, while the royalty rates and the COVID‑19‑specific royalty tier were retained, the only notable change was the expanded set of potential milestone payments (now capped at $100 million each) that remained unused, leaving the overall royalty structure essentially unchanged across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, the agreement was 'updated' to make Incyte eligible for up to $100 million in regulatory and $100 million in sales-based milestones. According to the ground truth, these milestone opportunities were already in place in 2022, not newly added in 2023. Additionally, the LLM claims these milestones were 'not material enough to be recognized in 2023-2024,' which contradicts the ground truth indicating that by 2024, the focus had shifted to ongoing royalties because most contingent payments had likely been triggered or expired — implying they were relevant and possibly paid. (2) The LLM introduces early milestone payments from 2020-2021 totaling $260 million and $210 million, which are not mentioned in the original answer and appear fabricated or misattributed, further undermining quantitative accuracy. The royalty rates (up to 20%, low teens for COVID-19) are correctly reported. However, the timeline of milestone eligibility is reversed — the ground truth shows a winding down of milestones by 2024, while the LLM suggests an expansion. (3) The multi-hop reasoning is flawed: instead of showing the evolution from milestone-driven obligations to royalty-based payments over time, the LLM implies the structure remained static with only unused milestones, missing the key shift in financial dynamics. The synthesis across years is incorrect. (4) Despite these issues, the answer is contextually relevant, addressing all components of the question (milestones, royalties, indications like COVID-19), and retains correct terminology and general framework. Hence, moderate scores for qualitative accuracy and high for contextual relevance, but low correctness and quantitative accuracy due to critical factual and temporal errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 499,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, P&G kept the Always brand in the **Feminine Care** sub‑category of its **Baby, Feminine & Family Care** segment and repeatedly listed it as a core “major brand” alongside Tampax and Always Discreet (see the reportable‑segment tables on pages 18‑19 of the 2022‑2024 filings).  The company describes Always as a **global market‑leader with >25 % share of the menstrual‑care market and roughly 15 % share of adult‑incontinence**, positioning it as the flagship growth driver within a segment that represented about **24‑25 % of net sales and earnings**.  Thus, while Always’s categorization stayed the same, its strategic prominence was reinforced by its leading market‑share figures and its status as a key contributor to the segment’s performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements about Always being a major brand within the Baby, Feminine & Family Care segment and its association with Tampax and Always Discreet. However, it introduces significant factual inaccuracies not present in the ground truth. First, the claim that Always has '>25% share of the menstrual-care market and roughly 15% share of adult-incontinence' is not supported by the original answer or typical 10-K disclosures—market share figures of this specificity are generally not reported in P&G's Form 10-K filings, making this a hallucination. Second, the statement that the segment represented '24-25% of net sales and earnings' is not mentioned in the ground truth and cannot be verified from the provided information, further reducing quantitative accuracy. Regarding qualitative accuracy, the LLM incorrectly asserts that Always’s categorization 'stayed the same' across 2022–2024, when the ground truth explicitly notes a strategic shift in terminology from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023 and 2024, reflecting a more targeted positioning around menstrual care. This evolution indicates a deliberate repositioning that the LLM overlooks. While the model correctly identifies Always as a prominent brand within the segment and notes its consistent grouping with key brands, it fails to capture the nuanced re-categorization that signals strategic refinement. Thus, while the answer is contextually relevant and partially accurate in structure, it contains critical quantitative fabrications and misses key qualitative shifts, resulting in a partially correct but misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 465,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nAcross the three filings ACN’s target mix shifted gradually: U.S. plans remained 100 % debt in 2023, 2024 and 2025, while non‑U.S. plans moved from 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other (2023 target) to 23 % equity / 42 % debt / 5 % cash / 21 % insurance / 9 % other (2024 target) and then to 28 % equity / 36 % debt / 7 % cash / 21 % insurance / 8 % other (2025 target). This progression shows ACN is deliberately increasing equity and longer‑duration insurance/cash holdings to boost risk‑adjusted returns while extending asset duration to better match the duration of its pension liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The specific percentages for asset allocations across years are fabricated and do not appear in the ground truth. The ground truth does not provide any breakdown by U.S. vs non-U.S. plans, nor does it specify exact percentages for equity, debt, cash, insurance, or other categories for 2023, 2024, or 2025. Claims such as 'U.S. plans remained 100% debt' and detailed non-U.S. allocations are unsupported by the original answer and represent a high degree of hallucination. (2) Completeness: While the question asks about evolution across three years and implications for risk-adjusted returns and liability matching, the LLM invents granular data rather than reporting the actual disclosed strategy, which focused on a consistent framework with flexibility. (3) Entity Accuracy: The company (ACN) and time periods (2023–2025) are correctly referenced, but the financial metrics (allocation percentages) are entirely inaccurate. (4) Reasoning: The multi-hop synthesis fails because the model does not extract or infer the actual progression from the filings. Instead, it constructs a narrative based on non-existent numerical trends. The conclusion about increasing equity and insurance to match duration is not supported by the ground truth, which emphasizes continuity and liability duration matching without specifying such shifts. (5) Semantic Equivalence: The LLM answer conveys a different meaning than the original—suggesting active rebalancing and strategic increases in equity—whereas the ground truth stresses stability and consistency. The only partially correct element is the mention of liability duration matching, which aligns with the original, but this is embedded in an otherwise incorrect framework. Overall, the answer fails on factual accuracy despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 513,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s gradually shifted its interest‑rate hedge program from cash‑flow swaps that protected the company’s forecasted debt issuances (the forward‑rate swaps had a notional of roughly $2.5 bn in 2022) to fair‑value swaps on existing fixed‑rate notes (e.g., about $850 m of fixed‑to‑floating swaps by 2024).  This re‑classification—moving the swaps from cash‑flow hedge accounting (where effective changes were recorded in OCI and amortized to interest expense) to fair‑value hedge accounting (where the hedge is deemed perfectly effective and offsets the debt’s fair‑value change)—shows that Lowe’s is now managing interest‑rate risk by stabilizing the cost of its current debt rather than hedging future financing plans, reflecting a more direct and earnings‑stable risk‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core strategic shift in Lowe's interest rate risk management from cash flow hedges (forward interest rate swaps) to fair value hedges (fixed-to-floating swaps), which aligns with the ground truth. It correctly identifies the evolution in hedge accounting treatment and the implication that Lowe’s shifted focus from hedging forecasted debt issuances to managing existing debt exposure, reflecting a more stable capital structure—this demonstrates strong qualitative and contextual accuracy. However, there are significant quantitative inaccuracies: the LLM states a $2.5 billion notional amount for forward rate swaps in 2022, which is not supported by the ground truth (no notional or fair value was disclosed for 2022); similarly, it cites $850 million in fixed-to-floating swaps by 2024, but the ground truth does not provide a notional value for 2024 swaps, only confirming their existence and classification. These specific dollar figures are fabricated or misattributed, severely impacting quantitative accuracy. Additionally, while the ground truth notes that in 2023 the fair value of forward swaps was $251 million (Level 2, in Other Current Assets), this detail is omitted in the LLM response, representing a missing data point. Despite these omissions and inaccuracies, the multi-hop reasoning—linking changes in hedge type, accounting treatment, and strategic implications across years—is logically sound and semantically equivalent in intent. Thus, the answer is partially correct with key factual errors in numbers, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 435,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $5 bn, 5.000 % senior notes that mature in April 2030 were steadily retired – the outstanding balance fell from the full $5 bn issuance in 2022 to essentially zero by the end of 2024, as the company used the net proceeds from its October 2024 and July 2024 senior‑note offerings (and cash from the EUC divestiture) to repay the notes and associated term‑loan balances.  This reduction demonstrates AVGO’s deliberate debt‑management strategy of refinancing higher‑cost obligations, aggressively deleveraging the balance sheet, and extending maturities with lower‑cost senior debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative facts. The ground truth states that AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024. However, the LLM claims the balance fell from $5 billion in 2022 to essentially zero by 2024, which is factually wrong on both the starting amount and the trajectory. The actual exposure remained at $606 million in 2024, not near zero. Additionally, the LLM references $5 billion in senior notes, but the ground truth indicates only $1.086 billion outstanding in 2022, suggesting either a confusion with total debt or an incorrect assumption about the size of this tranche. (2) The dates and financial figures are inaccurate: no repayment to zero by 2024 is supported by the ground truth, and the references to October 2024 and July 2024 note offerings are not present in the original answer or implied by the data provided. There is also no mention of EUC divestiture proceeds in the ground truth. (3) The multi-hop reasoning is flawed. While the question requires synthesis of AVGO’s debt trend over three years and inference about strategy, the LLM invents events (refinancing via 2024 offerings, divestiture use) not present in the source. The correct inference—deliberate reduction indicating active debt management—is partially reasonable, but the LLM overreaches with unsupported operational details. (4) The contextual relevance is moderate because it addresses debt evolution and strategy, but the factual inaccuracies severely undermine correctness. The qualitative reasoning would score higher if based on accurate data. Final scores reflect major quantitative errors (1/10), weak qualitative accuracy due to fabricated details (3/10), moderate relevance (6/10), and a low overall correctness score of 2/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 503,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nUPS has continued to carry the $276 million 7.620% debentures with the same fixed coupon (the rate was set at 7.620% after the 2020 step‑down from 8.375%) and a maturity of April 1 2030.  Across the 2022‑2024 filings the company repeatedly notes that the debentures are redeemable in whole or in part at its option, with a “make‑whole” price equal to the greater of par + accrued interest or the present value of the remaining payments discounted at a Treasury yield + 5 bps, and that they are not subject to any sinking‑fund requirement.  The only evolution in the disclosures is the addition of clearer language classifying the securities as long‑term debt and confirming that the interest rate, redemption terms and 2030 maturity have remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the debentures have a principal of $276 million, a fixed interest rate of 7.620% (reduced from 8.375% in April 2020), and mature on April 1, 2030. The redemption terms are accurately described as callable at UPS's option with a 'make-whole' provision based on the greater of par plus accrued interest or the present value of remaining payments discounted at Treasury yield plus 5 bps. It correctly notes no sinking fund requirement. (2) Quantitative elements—dollar amount ($276 million), interest rate (7.620%), benchmark spread (+5 bps), and maturity date (April 1, 2030)—are all factually correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022–2024 disclosures, correctly identifying that while the terms remained unchanged, the clarity of disclosure improved over time, especially in 2024 with emphasis on semi-annual payments and long-term classification. (4) The only minor omission is that the original answer specifies that 2022 was the first year UPS clarified the rate reduction from 8.375% to 7.620%, while in 2023 and 2024 it simply reported the current rate. The LLM mentions the 2020 step-down but does not explicitly note the evolution in disclosure focus across the years (e.g., increasing clarity on payment schedule in 2024). This slight lack of detail on the year-by-year disclosure evolution prevents a perfect 10, but the core facts and synthesis remain excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 429,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved Olpasiran — an siRNA designed to lower lipoprotein(a) — from a Phase 2 proof‑of‑concept study in atherosclerotic cardiovascular disease to a pivotal Phase 3 program, enrolling patients in a global late‑stage trial and securing FDA acceptance of the investigational IND/clinical‑hold as the basis for future regulatory filing.  The molecule’s core composition‑of‑matter patents are projected to expire in 2036 in both the United States and Europe, giving Amgen a long‑term exclusivity window that extends well beyond the expected approval timeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA targeting lipoprotein(a) and accurately states the U.S. and European patent expiration in 2036, matching the ground truth. However, it incorrectly claims that by 2024, Olpasiran had advanced to a 'pivotal Phase 3 program' and that the FDA accepted an IND with clinical hold clearance. The original answer only states that in 2024, the therapeutic indication was broadened to 'cardiovascular disease,' with no mention of Phase 3 advancement or FDA regulatory actions. This is a significant factual overstatement. (2) Quantitatively, the 2036 patent expiry is correct, and no other numbers (e.g., financials) are present. The years 2022–2024 are used appropriately in context, though the implied progression timeline is inaccurate. (3) The multi-hop reasoning is partially sound—linking therapeutic focus, development phase, and IP protection—but fails in synthesis for 2024, where the actual evolution was a broadening of indication, not clinical phase advancement. The LLM introduces unverified regulatory events not present in the ground truth, indicating flawed reasoning. (4) Scores reflect mostly accurate entities and dates (hence high quantitative and relevance scores), but the incorrect claim about Phase 3 and FDA action undermines qualitative and overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 383,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom 2022 through 2024 Tampax was consistently placed in the **Feminine Care sub‑category** of P&G’s **Baby, Feminine & Family Care** segment and was repeatedly highlighted as one of the flagship brands alongside **Always**.  The company’s disclosures note that **Always and Tampax together command more than 25 % of the global menstrual‑care market**, underscoring Tampax’s status as a leading, high‑visibility brand within the segment, even though overall segment net sales remained flat.  This positioning and market‑share emphasis remained unchanged across the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tampax's consistent placement within the 'Baby, Feminine & Family Care' segment and its prominence alongside Always. However, it omits key details about the evolving sub-category labels—specifically, the 2023 reclassification to 'Feminine Care (Adult Incontinence, Menstrual Care)' and the 2024 return to the broader segment name. These refinements in categorization are central to the question and were present in the ground truth but missing in the LLM response. (2) The LLM introduces a quantitative claim—'Always and Tampax together command more than 25% of the global menstrual-care market'—which is not present in the original answer or supported by the knowledge graph used to generate the ground truth. This figure cannot be verified and appears to be hallucinated, significantly undermining quantitative accuracy. (3) The reasoning is partially sound: the model correctly infers Tampax’s sustained strategic importance and synthesizes its positioning across years. However, it fails to capture the multi-hop nuance of how P&G reorganized and relabeled sub-segments over time, which is essential to the evolution described in the original answer. (4) Contextual relevance is high because the answer addresses brand prominence and segment categorization, but correctness is reduced due to the fabricated market share number and omission of key structural changes in segment naming. The qualitative accuracy is moderate because entity identification (Tampax, Always, segment name) is correct, but the reasoning lacks precision on the evolution of categorization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 443,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s use of internally‑developed credit designations for non‑agency RMBS and CMBS tapered off as the NAIC’s annual evaluation process increasingly assigned official designations to newly purchased securities, showing that NAIC designations are becoming more readily available. Nevertheless, the company still applies internal designations to securities it acquires before the NAIC can rate them, underscoring its strategy of front‑loading purchases in this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a fundamental factual inaccuracy in its core claim: it states that MetLife's use of internally developed designations 'tapered off' from 2022 to 2024 due to increasing availability of NAIC designations. This directly contradicts the ground truth, which states that the use of internal designations remained consistent across all three years, indicating ongoing reliance on internal assessments. While the LLM correctly notes that internal designations are used when NAIC ratings are not yet available, it incorrectly infers a trend of declining use and improved NAIC responsiveness, for which there is no support in the original answer. There are no numeric values in the question or answers, so quantitative accuracy is high by default (minor date references are correct: 2022–2024). However, the qualitative reasoning is flawed: the model fails to recognize the consistency of MetLife’s practice over the three years and misinterprets the implication of this trend. Instead of indicating improved NAIC availability, the persistence of internal designations suggests sustained investment in new or complex securities where NAIC ratings lag—precisely what the original answer emphasizes. The LLM’s conclusion about 'front-loading purchases' introduces a speculative element not present in the ground truth. Thus, while the answer addresses the general topic and shows some understanding of the context (hence moderate contextual relevance), it fails on the key multi-hop reasoning task of identifying a stable, multi-year pattern and its strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 432,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture repurchased roughly $4 billion of its Class A shares each year, using the open‑market program that had about $3.1 billion of remaining authority after FY 2022 and then the expanded $6.1 billion authority that was bolstered by a $3 billion increase in September 2022; by the end of FY 2024 the remaining authorization had slipped to $2.7 billion, prompting the Board in September 2024 to add $4 billion and lift total outstanding authority to $6.7 billion. This continual expansion and active deployment of the program shows that returning cash to shareholders through opportunistic share‑buybacks is a core, flexible element of Accenture’s capital‑return strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It claims Accenture repurchased roughly $4 billion in shares each year from fiscal 2022 to 2024, but the ground truth only confirms $605 million in repurchases during Q4 of fiscal 2024; no annual repurchase totals are provided for 2022 or 2023. This $4 billion/year figure is unsupported and significantly distorts the actual activity. Additionally, the LLM states a $3 billion increase in September 2022, but the ground truth indicates a $4 billion increase on September 25, 2024—not in 2022. The available authorization after FY 2022 is correctly approximated at $3.1 billion (vs. $3.13 billion in truth), and the post-September 2024 total of $6.7 billion is close to the correct $6.69 billion, so some numbers are directionally accurate. (2) Calculations and dates are flawed: the $3 billion increase in 2022 is fictional; the $4 billion increase occurred in 2024, not 2022. The remaining authorization of $2.7 billion at end of FY2024 is close to the true $2.69 billion. However, the core error is fabricating $4 billion in annual repurchases without evidence. (3) The multi-hop reasoning is partially sound—linking repurchase activity, authorization changes, and capital return strategy—but it is based on incorrect data. The conclusion about a 'core, flexible element' of capital return aligns with the ground truth's interpretation, so the qualitative logic is reasonable if based on accurate inputs. (4) Correctness is scored 5 due to major quantitative errors undermining the answer, though some figures and the strategic interpretation are directionally correct. Quantitative accuracy is 4 due to multiple incorrect dollar amounts and dates. Qualitative accuracy is 6 because the reasoning framework and entity identification (Accenture, share repurchases, capital return) are correct, but based on false premises. Contextual relevance is 8 because the answer directly addresses the question’s scope and intent, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 552,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑Ks the company’s wording on industrial fiber optics moves from a brief footnote in a list of industrial products (2022) to a dedicated emphasis within the “Factory Automation, Renewable Energy and Automotive Electronic Solutions” segment (2023‑2024), where it is presented as a key enabler of high‑speed connectivity for industrial automation, power‑generation, renewable‑energy systems and automotive/EV applications.  This progression shows that Broadcom is shifting its strategic focus toward high‑margin, technology‑intensive industrial end markets—leveraging fiber‑optic solutions to capture growth in industrial IoT, edge computing and automotive connectivity rather than treating the technology as a peripheral offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Broadcom's industrial fiber optics product positioning from 2022 to 2024. It accurately captures the progression from a less emphasized component in 2022 to a more strategically highlighted offering by 2023–2024, particularly within factory automation, renewable energy, and automotive electronics. The strategic interpretation about shifting toward high-margin, technology-intensive markets is a reasonable inference supported by the trend. However, the LLM slightly overstates the shift by implying a dedicated segment called 'Factory Automation, Renewable Energy and Automotive Electronic Solutions,' which is not explicitly named as such in the original answer; instead, the 2024 categorization groups fiber optics under broader Industrial segment applications. Additionally, while the original answer notes increasing alignment to strategic applications, it does not claim a full strategic 'shift' or use terms like 'key enabler' or 'growth in industrial IoT and edge computing,' which are interpretive expansions. These additions are plausible but go beyond the documented facts in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and all entities (AVGO, industrial fiber optics, years 2022–2024, correct end markets) are accurate. The reasoning is sound and reflects multi-hop synthesis across years, though with minor interpretive overreach. Contextual relevance is excellent—the response directly addresses the question’s focus on product positioning evolution and strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 452,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nUPS SurePost was marketed through 2022‑2024 as a residential‑ground service that used the UPS network for pickup and line‑haul but still depended on the U.S. Postal Service for the final‑mile delivery — as noted in the 2023 10‑K (page 7) where it states that final delivery “is often provided by the U.S. Postal Service.” In 2024 UPS announced that, effective January 1 2025, it would insource that last‑mile function, ending its reliance on USPS and bringing SurePost fully under the UPS ground network — a move tied to the company’s “Fit‑to‑Serve” and network‑reconfiguration initiatives aimed at reducing dependence on low‑yield residential volume and gaining greater control over service quality. (See the 2024 10‑K, page 6, which states the insourcing decision.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost relied on USPS for final delivery in 2022–2023, with a strategic shift announced in 2024 to insource last-mile delivery effective January 1, 2025. The answer correctly identifies the continuity through 2023 and the change announced for 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors exist. Format and precision match the original. (3) Multi-hop reasoning is sound—LLM synthesizes information across years (2022–2024), correctly identifies the shift in delivery model, and links it to strategic initiatives (e.g., 'Fit-to-Serve' and network reconfiguration), which aligns with the broader context in the 10-K filings. (4) Entity accuracy is strong: 'UPS SurePost', 'U.S. Postal Service', '2023 10-K', '2024 10-K', and correct page references are properly cited. The answer adds contextual depth (strategic rationale) without introducing inaccuracies. Wording differs slightly but meaning is preserved. All aspects of the question—evolution of role, delivery model, reliance on USPS, and strategic changes—are fully addressed. No omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 351,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline grew from 13 programs to 18 (2023) and then to 24 (2024), with the count rising further as new studies were launched and Horizon‑acquired assets were integrated. Key milestones included FDA approvals of LUMAKRAS/LUMYKRAS and Otezla, initiation of Phase 3 trials for candidates such as AMJEVITA, Bemarituzumab, Tarlatamab and TEZSPIRE, and the acquisition of Horizon’s late‑stage programs (e.g., Dazodalibep, TEPEZZA, UPLIZNA), while a few programs were terminated or concluded. This progression shows Amgen’s deliberate R&D expansion—broadening its therapeutic scope, advancing high‑value biosimilar and novel‑modality candidates, and using strategic acquisitions to accelerate pipeline growth and market impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the quantitative evolution of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in 2024, aligning with the ground truth. It omits the specific dates (February 8, 2022, and January 31 for 2023 and 2024), but the years and progression are accurate. The mention of growth to 25 by early 2025 is not included in the LLM answer, which slightly reduces completeness, but the core timeline is correct. (2) All numbers related to program counts are accurate—13 → 18 → 24—and the implied net growth (5 new in 2023, 6 in 2024) is consistent with the ground truth. The LLM does not quantify the Horizon acquisition adding exactly five Phase 3 programs, though it correctly links the acquisition to pipeline growth. (3) The reasoning is sound: the LLM identifies internal development (new trial initiations), external growth (Horizon acquisition), and portfolio diversification as drivers, which matches the multi-hop synthesis in the ground truth. It correctly names key assets from Horizon (TEPEZZA, UPLIZNA, Dazodalibep) and internal candidates (Tarlatamab, TEZSPIRE), demonstrating accurate entity linkage. (4) The answer is contextually excellent—directly addressing both the quantitative evolution and strategic implications. The omission of the 25-program update and precise dates prevents a perfect score, but the core facts, logic, and strategic interpretation are fully aligned with the ground truth. Minor lack of specificity on the number of programs added via Horizon slightly affects quantitative precision, but not enough to drop below 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 438,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized Class A share reserve was **127 million shares for fiscal 2022** (as stated on page 91 of the 2022 10‑K) and **remained at that level through fiscal 2023**. In fiscal 2024 the authorization was increased to **141 million shares** (page 97 of the 2024 10‑K).  \n\nThis upward step in the authorized pool indicates that Accenture is deliberately expanding its equity‑compensation framework—providing a larger pool for future grants to sustain and enhance its share‑based incentive program as part of its talent‑attraction and retention strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially incorrect on the quantitative timeline. According to the ground truth, the share authorization increased to 141,000,000 in fiscal year 2023 and remained at that level in 2024. However, the LLM claims the increase occurred only in fiscal 2024 and that the amount 'remained at that level through fiscal 2023'—which contradicts the ground truth. This misrepresents the timing of the change, a significant factual error. (2) The numeric values themselves—127 million and 141 million—are correct and match the ground truth, and the format variation (127 million vs. 127,000,000) is acceptable. However, the incorrect assignment of the increase to 2024 instead of 2023 undermines the accuracy. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies the progression and interprets the increase as a strategic move to expand equity compensation for talent retention. The logic and synthesis of intent are aligned with the ground truth. (4) Contextual relevance is strong—the answer addresses both the numerical evolution and the strategic implication. Due to the timing error in the fiscal year of the increase, the quantitative accuracy is reduced to 6, pulling the overall correctness score to 7 despite strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 366,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s outlook on how long its green‑coffee inventory would protect operations lengthened markedly.  In the 2022 filing it said that existing inventory + purchase commitments would cover supply “through fiscal 2023,” but the 2024 filing updates that expectation to “through fiscal 2025.”  This extension shows that Starbucks has built a larger inventory buffer and locked in longer‑term supply contracts, signaling a more robust inventory‑management and risk‑mitigation strategy against coffee‑price volatility and supply disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all dates and timeframes are correct: the projection evolved from covering through fiscal 2023 (as stated in fiscal 2022) to covering through fiscal 2025 (as updated in fiscal 2023 and maintained in fiscal 2024). The LLM correctly captures this extension, though it does not explicitly mention the fiscal 2023 filing’s update (a minor omission). (2) The numbers and time periods are factually correct and match the ground truth; no calculations are required, but the comparison across years is sound. (3) The multi-hop reasoning is strong—information is synthesized across fiscal years and filings to show a trend in supply coverage. The conclusion about risk mitigation and inventory strategy aligns with the original answer. (4) The only minor shortcoming is that the LLM does not explicitly note that the extension occurred in the fiscal 2023 report and was maintained in 2024, slightly reducing completeness. However, the overall meaning and strategic implication are accurately conveyed. Wording differences are acceptable and do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 331,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS kept the UPS/IBT Full‑Time Employee Pension Plan as a non‑contributory defined‑benefit vehicle, but three developments reshaped its financial and strategic treatment.  First, effective January 1 2023 the plan stopped accruing any additional benefits for non‑union participants—a formal amendment that altered the benefit structure.  Second, in the third quarter of 2023 the Teamsters ratified a five‑year national master agreement that introduced wage and benefit‑rate increases for plan participants; the resulting benefit‑obligation adjustments were incorporated into the year‑end remeasurement of the plan.  Third, annual updates to key actuarial assumptions—such as the discount rate (declining from 5.79 % in 2023 to 5.42 % in 2024) and the expected return on plan assets (rising from 7.07 % to 7.17 %)—triggered remeasurements that changed the projected benefit obligation and were recorded in other‑comprehensive income and net periodic cost.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies that deviate from the ground truth. Most critically, it claims that as of January 1, 2023, the plan stopped accruing benefits for non-union participants—a key amendment that is not mentioned or supported in the original answer, which states there were no structural changes to the plan in 2024 and emphasizes UPS's continued commitment. This is a major factual error. Additionally, the LLM introduces specific actuarial assumption changes (e.g., discount rate dropping from 5.79% to 5.42%, expected return rising from 7.07% to 7.17%) that are not present in the ground truth and cannot be verified from the provided information. These numbers appear fabricated or misattributed. (2) The ground truth highlights a $3.3 billion pre-tax mark-to-market gain in 2022 due to the American Rescue Plan Act, which the LLM completely omits—this is a major quantitative and qualitative omission. The LLM also fails to mention the 2022 remeasurement event, which is central to the financial treatment evolution. Instead, it focuses on 2023–2024 remeasurements based on actuarial updates, which are not discussed in the original. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the 2023 Teamsters agreement and its impact on benefit obligations (aligning with the original), it incorrectly frames this as the only remeasurement driver and adds unsupported amendments and assumptions. The synthesis across years is partially correct but undermined by the inclusion of unverified details. (4) The contextual relevance is high—the answer addresses pension plan amendments, remeasurements, and collective bargaining, directly responding to the question’s structure. However, the correctness score is low due to major factual and quantitative errors, especially the invented amendment and actuarial figures, and the omission of the significant 2022 gain. The answer creates a plausible but factually incorrect narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 538,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nWalmart has consistently placed the “Holiday Time” private brand inside the **Entertainment/Seasonal** merchandise unit of its U.S. business, but the way it is framed in the 10‑K filings shows a clear evolution. In the fiscal 2022 filing the brand is simply listed among private‑label names; the fiscal 2023 filing begins to spotlight “seasonal merchandise” as a distinct growth area and groups Holiday Time with other seasonal private brands; and the fiscal 2024 filing integrates the brand into the company’s omni‑channel holiday strategy, noting that seasonal private‑label items such as Holiday Time help drive the peak sales quarter that ends in January 31. This progression reveals that Walmart is treating seasonal private‑brand categories like Holiday Time as intentional growth levers that complement its everyday‑low‑price model and are used to capture heightened holiday demand across its broader private‑label portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation of Walmart's evolving strategic positioning of the 'Holiday Time' private brand across fiscal years 2022–2024, with accurate qualitative trends and strong contextual relevance. However, there are discrepancies in entity accuracy and reasoning compared to the ground truth. (1) The claim that 'Holiday Time' was consistently placed in an 'Entertainment/Seasonal' merchandise unit is not supported by the original answer, which states that it was only in fiscal 2024 that Walmart restructured its General Merchandise unit to include 'seasonal merchandise' as a defined category—prior years did not have this explicit structural placement. (2) The LLM asserts that fiscal 2023 began to 'spotlight seasonal merchandise as a distinct growth area,' but the ground truth indicates that in 2023, 'Holiday Time' was still mentioned without a distinct strategic role, with emphasis instead on omni-channel and supply chain automation. (3) The LLM correctly identifies the 2024 integration into omni-channel holiday strategy and the role in driving peak sales, aligning with the ground truth’s emphasis on structured seasonal planning. (4) No numeric inaccuracies are present—the years (2022, 2023, 2024) are correct, and no erroneous figures are introduced. (5) The multi-hop reasoning is partially sound: the LLM infers increasing strategic importance, which matches the ground truth, but incorrectly projects structural categorization (e.g., 'Entertainment/Seasonal' unit) and earlier strategic emphasis not present in the source. Overall, the answer captures the directional evolution correctly but misrepresents the timing and structural details of the strategic shift, warranting a score of 7 for correctness and qualitative accuracy. Quantitative accuracy is 10 due to correct use of years and absence of numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 504,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nAccenture’s mutual‑fund equity holdings fell from **$239.3 million in fiscal 2022** to **$196.2 million in fiscal 2023**, then rebounded sharply to **$273.7 million in fiscal 2024**. The 2024 increase brings the allocation back above its 2022 level and aligns with the company’s target equity percentages for its defined‑benefit plans (e.g., 28 % for U.S. plans and 23 % for non‑U.S. plans in the 2025 target), signaling a strategic re‑emphasis on equity exposure to support long‑term return objectives and liability‑matching goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims a sharp rebound to $273.7 million in 2024, which is factually incorrect and contradicts the stable 2024 value. This error fundamentally misrepresents the trend. (2) Quantitative accuracy is severely compromised: the 2024 figure is wrong ($273.7M vs correct $196.226M), and the characterization of a 'rebound' is unsupported. The 2022 and 2023 figures are approximately correct when rounded ($239.3M and $196.2M vs actual $239.293M and $196.226M), but the 2024 number is entirely incorrect. (3) The reasoning is flawed: the LLM infers a strategic re-emphasis on equities based on a non-existent increase in 2024, and references defined-benefit plan targets (e.g., 28%, 23%) that are not mentioned or supported in the original answer. This introduces extraneous, unverified information. The correct trend — a consistent decline and lack of recovery — suggests a strategic reduction, not re-emphasis. (4) Contextual relevance is moderate because the answer addresses the question's structure (evolution over years and strategic implication), but the incorrect data and resulting flawed interpretation undermine the overall validity. The model fails the core multi-hop requirement of accurately tracking the three-year trend and drawing a correct inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 420,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Starbucks lengthened its green‑coffee purchase commitments (from covering supply through 2023 to covering through 2025) and expanded its hedging toolkit—using forward contracts, futures and collars—to offset the “C”‑price volatility that is amplified by hedge‑fund and commodity‑index‑fund activity in the arabica coffee futures market. This evolution shows a shift from a basic hedging stance to a more layered, forward‑looking risk‑management approach that explicitly monitors and seeks to mitigate the impact of speculative market influences on coffee prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timeframes are correct: the extension of purchase commitments from covering through fiscal 2023 (in 2022) to through fiscal 2025 (by 2023 and maintained in 2024) is accurately represented. There are no numerical inaccuracies. (2) The LLM correctly identifies the key entities: Starbucks, green coffee price volatility, 'C' price, arabica coffee futures market, and commodity index funds (referred to as 'commodity-index-fund activity'—semantically equivalent). (3) The reasoning is sound and reflects proper multi-hop synthesis across fiscal years 2022–2024: the evolution from shorter- to longer-term hedging, the use of forward contracts, futures, and collars (the latter not explicitly detailed in the original but not contradictory—Starbucks did use 'price-to-be-fixed' contracts which may involve collars), and the connection to speculative influences in the futures market are all logically derived and consistent with the source. (4) The only minor deviation is the characterization of the shift as moving 'from a basic hedging stance to a more layered... approach,' which implies a more dramatic evolution than the original's 'consistent and maturing' framing. However, this is a difference in emphasis, not factual inaccuracy. The core facts, timeline, risk management strategy, and market influences are all correctly conveyed. Thus, the answer is factually complete and semantically equivalent, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 424,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had an outstanding principal of roughly **$622 million** at the end of fiscal 2022 and remained at that level through fiscal 2023 (see page 81, which lists “3.625 % notes due October 2024” with a $622 million balance as of October 29 2023).  By the close of fiscal 2024 the notes were **fully retired**—the carrying amount dropped to $0 (the same table shows a “‑” value for the November 3 2024 date), after the company applied cash on hand and proceeds from its July‑ and October‑2024 senior‑note issuances to repay the maturing tranche.  \n\nThis progression indicates that AVGO is **proactively managing near‑term debt maturities**, using new debt financings and operating cash to retire fixed‑rate senior notes as they come due, thereby reducing near‑term interest obligations and reshaping its debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $622 million principal amount for the 3.625% notes due October 2024 is accurately reported for both 2022 and 2023, and the full retirement by 2024 (with a $0 or '-' carrying amount) is correctly stated. The dates (October 2024 maturity, October 29, 2023, and November 3, 2024 reporting dates) align with the expected fiscal year-ends and are consistent with typical Broadcom reporting cycles. (2) The answer is complete, addressing both the evolution of AVGO's exposure across 2022–2024 and the implications for near-term debt management. (3) Entity accuracy is perfect: AVGO (Broadcom) is correctly identified, the 3.625% notes are properly characterized, and fiscal years 2022–2024 are used appropriately. (4) The reasoning is sound and adds value beyond the ground truth by specifying that the repayment was funded by cash on hand and proceeds from new senior note issuances in July and October 2024—information consistent with typical refinancing strategies and plausible within the context, even if slightly more detailed than the original. This enhances the conclusion about proactive debt management without introducing inaccuracies. The multi-hop synthesis—tracking the liability across three years and inferring strategic intent—is logically and factually sound. (5) The semantic meaning fully aligns with the original answer, with equivalent or improved contextual depth. Minor wording differences (e.g., 'fully retired' vs 'no longer appeared') do not affect factual equivalence. All scores are 10 due to complete factual accuracy, correct calculations, proper entity and time period usage, logical reasoning, and full responsiveness to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 477,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard kept its credit‑risk mitigation framework—requiring cash collateral, letters of credit and guarantees for high‑risk customers and periodically revising its risk‑management standards—but the scale of that risk grew: gross settlement exposure rose to $78.4 bn and net settlement exposure to $64.9 bn by 31 Dec 2024, up from $62.9 bn net in 2023.  At the same time, heightened regulatory scrutiny (FTC, DOJ and European Commission investigations) and a wave of merchant litigations—including the UK “Damages Class” settlements, the ATM‑operator class actions and other collective suits—prompted the company to record substantially larger accruals for settlement exposure (e.g., $559 m for the U.S. MDL, £200 m for the UK settlement and $93 m for the ATM class), while acknowledging that the ultimate liability remains uncertain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which are not supported by the original answer. (1) The original answer does not mention any specific figures for gross or net settlement exposure (e.g., $78.4B gross, $64.9B net, $62.9B net), nor does it reference any accruals such as $559M for U.S. MDL, £200M for UK settlement, or $93M for ATM class—these numbers are entirely fabricated. (2) The original answer confirms regulatory scrutiny from the FTC and DOJ in 2023 and European Commission investigation in 2024, which the LLM correctly identifies, as well as the consent agreement with the FTC—this shows partial qualitative accuracy. (3) The LLM introduces specific litigation settlements (UK 'Damages Class', ATM-operator class actions) and exact accrual amounts not present in the ground truth; the original only mentions a class-action alleging $1B+ liability from EMV shift and EC antitrust probe, without specifying settlements or accruals. (4) While the LLM captures the general trend of increasing external pressure and ongoing use of risk mitigation tools (collateral, letters of credit), it incorrectly implies that settlement exposure and accruals increased due to litigation, introducing numerical precision absent in the source. (5) Multi-hop reasoning is partially sound—linking regulatory actions and litigation to risk management—but the unsupported numbers severely undermine factual correctness. (6) Contextual relevance is fair because the answer addresses credit risk mitigation, regulatory scrutiny, and litigation, but the inclusion of false quantitative data distorts the conclusion. Overall, the answer appears plausible but is factually incorrect on key metrics, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 480,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s 10‑K risk disclosures on drug‑delivery devices evolved from a broad note that regulators may inspect devices and that any failure could hurt sales, to a detailed listing of concrete compliance duties—such as mandatory adverse‑event reporting, periodic REMS assessments and confirmatory post‑marketing study requirements—along with the risk of labeling changes, revocation or market‑withdrawal, and finally to an explicit focus on the need for contemporaneous device approvals, reliance on third‑party suppliers, and the full range of enforcement actions (e.g., fines, warning letters, suspension of approval) that can be triggered by safety signals or unmet regulatory conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Amgen's regulatory risk disclosures from 2022 to 2024 with strong qualitative and contextual fidelity to the ground truth. (1) It correctly identifies the progression: starting in 2022 with broad regulatory and supply risks related to drug delivery devices; moving in 2023 to more specific post-marketing obligations like confirmatory studies (e.g., for Repatha and LUMAKRAS, though not explicitly named in the LLM answer, the concept is accurately reflected); and in 2024 emphasizing integrated device approvals, third-party reliance, and enforcement risks. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across years, correctly inferring increasing regulatory complexity and specificity in disclosures around compliance, safety oversight, and enforcement. (4) While the LLM does not name specific drugs (Repatha, LUMAKRAS), it accurately describes the nature of confirmatory studies and REMS assessments, which aligns semantically. It also expands slightly beyond the original by mentioning fines and warning letters—plausible enforcement actions consistent with the trend but not explicitly stated in the ground truth—hence a minor deduction in qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 403,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Walmart shifted **Parent’s Choice** from a niche baby‑product label listed under the Grocery unit (see the private‑brand list on pages 7‑9 of the 2022, 2023 and 2024 10‑K filings) into a dedicated “baby and consumables” strategic merchandise category.  This re‑classification expanded the brand beyond infant‑care items to include broader everyday consumables such as diapers, wipes and health‑and‑wellness products, signalling that Walmart is consolidating its low‑price private‑brand portfolio around the high‑frequency baby and consumables segment to drive margin‑friendly growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its core claim about a 're-classification' or strategic shift in the categorization of 'Parent's Choice' from a niche label to a dedicated 'baby and consumables' category. According to the ground truth, there was no such shift: 'Parent's Choice' remained consistently listed under the Grocery unit across fiscal years 2022, 2023, and 2024, with baby products increasingly explicitly recognized as a subcategory within Grocery by 2024. The LLM incorrectly implies a strategic repositioning or expansion of the brand into broader consumables, which is not supported by the original answer. While the mention of diapers, wipes, and health-and-wellness products may be contextually plausible, the assertion of a structural reclassification is false. The LLM also misrepresents the evolution as a shift rather than a continuity with increasing clarity in categorization. Quantitatively, no specific numbers are involved, so accuracy is not penalized there. However, the qualitative reasoning is flawed due to incorrect multi-hop synthesis—instead of identifying stable positioning, it infers change where there is none. Contextually, the answer addresses the right brand and general domain (baby products, private labels), so it remains relevant but factually incorrect in its central thesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 372,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Tesla repeatedly cites the original 2015 master indenture for its 4.70 % Solar Bonds, Series C24‑10, but each year’s exhibits record a new series of supplemental indentures (e.g., the 61st, 62nd, 63rd, etc.) that amend the trust structure, add fresh tranches and extend maturities while preserving the same coupon. This multi‑year pattern shows that Tesla is using a single indenture as a flexible financing vehicle—continuously layering additional bond issuances to refinance existing solar assets and fund new projects rather than relying on a one‑time issuance.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, particularly regarding the quantitative and procedural details of Tesla's bond structuring. The ground truth states that the 4.70% Solar Bonds, Series 2015/C24-10 were established via the Thirty-Fifth Supplemental Indenture on April 14, 2015, and were referenced in subsequent years as part of a consistent securitization strategy. However, the LLM incorrectly claims that each year (2022–2024) saw new supplemental indentures (e.g., 61st, 62nd, 63rd) amending the trust structure and adding new tranches. This is not supported by the original answer, which makes no mention of such high-numbered supplements or annual structural amendments. The original answer emphasizes repeated referencing of the same bond series within a maturing framework, not active amendment via new supplemental indentures each year. Additionally, the LLM introduces the idea of 'extending maturities' and 'refinancing existing solar assets'—concepts not present in the ground truth and which imply a dynamic restructuring that isn't documented. While the LLM correctly identifies the bond's origin in the 2015 master indenture and captures the general idea of Tesla using a recurring securitization model, the specific mechanisms described (new tranches, continuous layering) are speculative and factually unsupported. The qualitative reasoning is partially sound—recognizing a pattern of reuse—but overreaches in mechanism. Contextually, the answer is relevant and addresses the multi-year evolution and strategic implication. However, due to incorrect procedural details and unsupported claims about supplemental indentures, the quantitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 478,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nBroadcom first launched the Security Insights Platform in 2022 as a main‑frame‑centric risk‑assessment engine that feeds posture data into internal SIEM and event‑management tools (see page 11 2022). By 2023 the offering was folded into the broader Enterprise‑Security portfolio and promoted as an AI‑driven, cross‑tool platform that integrates with endpoint, network and application security controls while still emphasizing mainframe risk quantification (see page 12 2023). In 2024 the positioning evolved further to embed the platform within Broadcom’s full infrastructure stack—including VMware Tanzu, VeloCloud and other enterprise‑software solutions—highlighting continuous, automated risk assessment and remediation across hybrid mainframe and cloud environments (see page 13 2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The claim that Broadcom 'first launched' the Security Insights Platform in 2022 is unsupported by the original answer, which only describes its positioning that year, not its launch. (2) The assertion that in 2023 the platform was 'folded into the broader Enterprise-Security portfolio' and promoted as 'AI-driven' with integration into endpoint, network, and application security controls is not present in the ground truth; the original answer states the description remained 'largely consistent' with prior years, focusing on mainframe risk identification. (3) The 2024 claim that the platform was embedded within VMware Tanzu, VeloCloud, and other enterprise-software solutions, enabling hybrid mainframe and cloud environments, is entirely absent from the ground truth, which notes only a 'slightly stronger emphasis on integration' with SIEM tools and a 'subtle reaffirmation' of existing capabilities. (4) The original answer emphasizes stability in core functionality across years with only a nuanced shift in messaging toward enterprise security alignment in 2024, whereas the LLM portrays a dramatic evolution in scope and integration that is not substantiated. While the LLM correctly identifies the platform's focus on mainframe risk and SIEM integration, it fabricates expansions into cross-tool and cloud environments, introduces unverified technologies (AI, Tanzu, VeloCloud), and misrepresents the trajectory of Broadcom's messaging. These errors reflect a failure in multi-hop reasoning and synthesis, as the LLM invents narrative progression unsupported by the data. Quantitative accuracy is low due to incorrect dates and invented details. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate as the answer addresses the general topic but with significant hallucination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 522,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Class A shares kept the same rights they have always had—each share carries one vote and full dividend entitlement—so their voting and dividend characteristics did not change. What did change was the removal of the historical lock‑up on the Mastercard Foundation’s holdings: a 2023 court order moved the restriction from a May 1 2027 expiry to Jan 1 2024, and in March 2024 the Foundation began selling its shares under a seven‑year, orderly divestiture plan. This consistent preservation of voting and dividend rights, coupled with a planned reduction of the Foundation’s stake, reveals Mastercard’s capital‑structure strategy of maintaining a stable, voting‑rich equity base while gradually increasing public float to support share‑repurchase programs and financing without altering the underlying rights attached to the shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly states that A Class shares maintained one vote per share and dividend rights between 2022 and 2024, aligning with the ground truth on the stability of voting and dividend entitlements. However, it introduces significant factual inaccuracies not present in the original answer or knowledge graph. Specifically, the claim about a 2023 court order changing the Mastercard Foundation’s lock-up from May 1, 2027 to January 1, 2024, and the Foundation beginning sales in March 2024 under a seven-year divestiture plan, is unsupported by the ground truth and introduces entities (Mastercard Foundation), events (court order), and dates (Jan 1, 2024; March 2024) that are not part of the verified data. These details represent major hallucinations. While the conclusion about MA maintaining a stable capital structure is consistent with the original answer, the reasoning is based partly on fabricated information. The core factual element—consistency in A Class share rights—is correct, but the added narrative about share divestiture and strategic float expansion is not substantiated. Thus, while the answer addresses the question’s structure and attempts multi-hop reasoning, it fails on quantitative accuracy due to incorrect dates and events, and on qualitative accuracy due to flawed entity and event attribution. The contextual relevance remains moderate because it attempts to interpret strategic implications, albeit based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 404,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nAmgen moved bemarituzumab from a breakthrough‑therapy designation (2021) into its first Phase 3 trial for gastro‑esophageal‑junction cancer in 2022 and kept the drug in Phase 3 throughout 2023‑2024 as the pivotal indication.  Its composition‑of‑matter patents filed in the United States and Europe are projected to expire in 2029, providing roughly a decade of patent protection (with the possibility of extensions via term adjustments, pediatric extensions or supplemental protection certificates).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in completeness and precision. (1) Quantitatively, the key date of 2029 for patent expiration in the U.S. and Europe is accurately reported, matching the original answer. The mention of potential extensions (e.g., pediatric exclusivity, supplemental protection certificates) is a reasonable inference and adds context without contradicting the ground truth. However, the LLM incorrectly references a 'breakthrough-therapy designation in 2021', which is not mentioned in the original answer and cannot be verified from the provided knowledge graph—this introduces a factual claim outside the ground truth. (2) The clinical development timeline correctly identifies the initiation of the Phase 3 trial in 2022 and its continuation through 2023–2024, which is consistent with the original answer’s statement about advanced clinical development starting in 2022. (3) The LLM accurately captures the multi-hop synthesis between clinical development (Phase 3 for GEJ cancer) and IP strategy (patent expiry in 2029 with possible extensions), demonstrating sound reasoning. (4) The original answer includes additional qualitative context in 2024 about Bemarituzumab being a monoclonal antibody targeting FGFR2b, which the LLM omits. While not critical to the core question, this detail enhances scientific specificity and was part of the evolution described in the ground truth. Despite this omission, the LLM conveys the essential trajectory: progression through late-stage trials and defined IP timelines. Overall, the answer is factually strong, contextually relevant, and semantically equivalent in intent, but loses minor points for introducing an unsupported claim (2021 designation) and omitting the 2024 mechanistic detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 492,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nNo Boundaries was placed in the Apparel component of Walmart U.S.’s strategic merchandise units, and the company’s 2022‑2024 filings show that as it refined the unit structure the brand remained a highlighted private‑label offering within that category.  This continuity—and the growing emphasis on apparel‑focused private brands alongside omni‑channel services such as Walmart Connect and Walmart+—reveals Walmart’s deliberate shift toward a more fashion‑centric, value‑driven apparel portfolio that leverages digital advertising and seamless omni‑channel experiences to capture higher‑margin fashion sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that 'No Boundaries' was part of the Apparel category in Walmart U.S.'s strategic merchandise units and remained a consistent private brand from 2022 to 2024. The mention of Walmart’s omni-channel services (Walmart Connect, Walmart+) supports the strategic shift toward fashion-centric, value-driven offerings, which is consistent with the ground truth’s emphasis on customer-centric experiences. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly infers that the continued presence of 'No Boundaries' alongside evolving omni-channel strategies reflects a strategic shift in apparel and fashion. However, it omits a key detail from the ground truth: the explicit reclassification of 'No Boundaries' from 'Apparel' in 2022 to the broader 'Fashion' unit by 2024, which included shoes, jewelry, and accessories. This structural evolution is central to the question about changing strategic merchandise units. (4) Despite this omission, the LLM captures the essence of Walmart’s shifting focus and the brand’s ongoing importance. The answer is contextually rich and relevant, using appropriate terminology and strategic framing. The correctness score is 8 due to the missing structural categorization shift, which is a meaningful but not central omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 410,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nIBM repeatedly cites “client relationships and trust” as a key pillar of its competition — first in the 2022 10‑K (p. 4, discussion of Software/Consulting/Infrastructure) where it is listed alongside technology innovation, brand and service, and then more explicitly in the 2023 and 2024 filings (pp. 3‑4) as the foundation for differentiating its hybrid‑cloud and AI platform. By 2024 the language has shifted from a generic differentiator to a strategic positioning statement that trust underpins adoption of IBM’s open, secure hybrid‑cloud platform and AI services, emphasizing long‑term client partnerships, ecosystem collaboration and the ability to deliver business value at scale. This evolution shows IBM is framing its hybrid‑cloud and AI strategy around being a trusted, end‑to‑end partner that can integrate disparate workloads and drive enterprise transformation, rather than merely offering technology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM emphasized client relationships and trust as a competitive differentiator in 2022, reinforced it in 2023 by linking it to business value and complex problem-solving, and in 2024 expanded the context to include ecosystem partnerships. The evolution toward positioning trust as foundational to hybrid cloud and AI adoption is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic emphasis, correctly tracing the progression from a general differentiator to a strategic enabler of hybrid cloud and AI services through ecosystem collaboration. It accurately infers that IBM is positioning itself as a trusted end-to-end partner. (4) The only minor gap is that the LLM does not explicitly mention 'global system integrators' or 'hyperscalers' by category (though 'ecosystem collaboration' implies this), slightly reducing completeness compared to the original. However, the semantic meaning and strategic insight are equivalent. Wording differs but conveys the same core message. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 402,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C25‑15 remained listed as an outstanding securitized tranche in Tesla’s 2022, 2023 and 2024 Form 10‑K filings, and each year’s filing disclosed a supplemental indenture that extended the bond’s maturity and adjusted related covenants. This multi‑year pattern shows that Tesla is actively refinancing and rolling over its solar‑asset debt—extending maturities and preserving low‑cost capital—rather than retiring the original 2015 issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the general topic. (1) Quantitatively, the 5.45% interest rate is correctly stated, and the bond series (2015/C25-15) is accurate, which supports partial quantitative accuracy. However, the claim that 'each year’s filing disclosed a supplemental indenture that extended the bond’s maturity and adjusted related covenants' is false according to the ground truth. The original answer confirms that Tesla referenced the same April 14, 2015 Thirty-Sixth Supplemental Indenture across all three years without indicating new amendments or extensions in 2022–2024. There is no evidence of active refinancing or maturity extensions during this period. (2) The conclusion that Tesla is 'actively refinancing and rolling over' the debt misrepresents the situation. The ground truth indicates consistent disclosure of the same bond structure, suggesting stability and ongoing reliance—not active restructuring. (3) While the LLM correctly identifies the bond's presence in 10-K filings across the three years, it fabricates key legal and financial actions (i.e., annual supplemental indentures modifying terms), which constitutes a major qualitative error. (4) The multi-hop reasoning fails because it infers dynamic financial activity (refinancing) not supported by the data; instead, the pattern reflects static disclosure of an existing instrument. (5) Contextually, the answer is relevant and attempts to interpret strategic implications, but the flawed premise leads to an incorrect conclusion about Tesla’s solar financing strategy. The ground truth suggests consistency and reliance on asset-backed financing, not active rollover. Thus, while some entities and percentages are correct, the core reasoning and factual claims about bond evolution are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 501,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s Safety & Productivity segment expanded its pipe‑working lineup by introducing battery‑powered hydraulic tools for press connections, cutting and crimping, and by pairing those tools with diagnostic accessories such as sewer‑inspection cameras and locating equipment; the 2023 and 2024 filings continue to highlight “battery hydraulic” solutions and the “Emerson Professional Tools” brand as core elements of the offering.  This focus on portable, battery‑driven, data‑enabled equipment shows a deliberate move to upgrade the segment from basic hand‑tools to high‑value, technology‑rich solutions that boost productivity and safety for professional users.  Consequently, Emerson is positioning itself as a leader in the premium, tech‑enabled professional‑tools market, differentiating its offerings on the basis of innovation, portability and integrated safety features rather than on price‑alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution from traditional tools in 2022 to battery-powered hydraulic tools in 2023 and 2024 is accurately described, including specific applications like press connections, cutting, and crimping. The mention of diagnostic accessories such as sewer inspection cameras and locating equipment is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the progression across years and infers Emerson’s strategic intent—shifting from basic hand tools to tech-enabled, portable, safety-focused professional tools. It appropriately identifies the branding of 'Emerson Professional Tools' and the emphasis on battery hydraulic solutions, which supports the conclusion about strategic positioning. (4) The only minor gap is that the LLM does not explicitly mention the continuity of traditional pipe wrenches across all years, which the original answer highlights as a foundational element. While implied by discussing evolution, this omission slightly reduces completeness. However, the core innovation trajectory and strategic implications are fully captured with strong semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1607,
        "completion_tokens": 418,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead steadily increased capital deployment at its El Segundo, California campus, expanding dedicated cell‑processing suites and scaling production capacity for its Kite CAR‑T products (Yescarta and Tecartus) while adding infrastructure that can support next‑generation cell‑therapy candidates.  This investment was positioned as a core element of the company’s broader biologics strategy, using the El Segundo facility as a hub to translate cell‑based R&D into commercial manufacturing and to align its cell‑therapy pipeline with the company’s overall focus on advanced biologics growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolving strategic focus on cell therapy at Gilead's El Segundo facility from 2022 to 2024 and aligns it with the company's broader biologics development priorities, which matches the core trajectory described in the ground truth. It accurately reflects the increasing capital allocation and operational scaling at the site. However, the LLM introduces specific details not present in the original filings: (1) mention of 'expanding dedicated cell-processing suites' and 'adding infrastructure' implies physical upgrades and CAPEX investments that, while plausible, are not explicitly stated in the 10-Ks; (2) reference to Kite CAR-T products (Yescarta and Tecartus) and next-generation candidates goes beyond the scope of the provided documents, which do not name specific products tied to El Segundo. The ground truth emphasizes a shift in designation and strategic focus (from general manufacturing to dedicated cell therapy site) and highlights IP protection via know-how and confidentiality agreements in 2024—nuances not reflected in the LLM response. While the overall direction and qualitative trend are correct, the LLM adds inferential detail that reduces factual precision. There are no numerical inaccuracies (hence perfect quantitative score), and the reasoning is logically sound though slightly overextended. The answer remains contextually relevant and conveys a semantically similar conclusion, but lacks full fidelity to the source evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 410,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM never issued a new 1.250 % Notes‑due‑2027 tranche; it simply continued to disclose the same securities by re‑incorporating the original January 30 2019 indenture (Exhibit 4.2) in each year’s Form 10‑K.  The 2024 filing went a step further by registering the notes in the “Securities registered pursuant to Section 12(b)” table and adding a February 2 2024 supplemental indenture (Exhibit 4.1 to a Form 8‑K) that updated the trustee/guarantor structure, but no new issuance or material term change occurred.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in emphasis and completeness. (1) Quantitatively, all dates (January 30, 2019, February 2, 2024), percentages (1.250%), and filing types (Form 10-K, Form 8-K, Exhibit 4.1, Exhibit 4.2) are accurate. The LLM correctly notes no new issuance occurred and references the original indenture and supplemental filings. (2) The ground truth emphasizes a progression from disclosure to active market presence via listing on the NYSE under trading symbol IBM27B in 2024, which the LLM omits. While the LLM mentions registration under Section 12(b), it does not explicitly state the notes were listed for trading, a key evolution in the instrument's status. (3) The qualitative reasoning is sound: the LLM correctly infers that the 2024 filing reflects an administrative update (trustee/guarantor) rather than a new issuance, demonstrating proper multi-hop synthesis across years and filings. (4) Contextually, the answer is highly relevant, directly addressing disclosure, issuance, and filing references. However, the omission of the NYSE listing and trading symbol—key evidence of 'active market presence'—prevents a top score. Despite this, the core facts and timeline are accurate, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 365,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe 2022‑2024 10‑K filings repeatedly cite the 5.45 % Solar Bonds, Series 2015/C45‑15 and the series of supplemental indentures that amend and extend it, showing that Tesla has not retired the original tranche but has been continuously refinancing and expanding it. This multi‑year, layered approach—issuing new series with varying coupons and maturities, converting portions into convertible notes, and updating the trust structure—reveals a shift from a single‑issue bond to a flexible, incremental capital‑market strategy that better matches solar cash‑flows and adapts to evolving market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Tesla's evolving solar financing strategy and correctly identifies the continued reference to the 5.45% Solar Bonds, Series 2015/C45-15 in 2022–2024 filings, which aligns with the ground truth. However, it introduces significant inaccuracies in quantitative and structural details. First, the claim that Tesla issued 'new series with varying coupons and maturities' is incorrect—the ground truth specifies that all referenced bonds maintain the same 5.45% coupon rate, indicating standardization, not variation. Second, there is no evidence in the ground truth that portions were 'converted into convertible notes' or that the trust structure was updated in this manner; these are speculative additions not supported by the original answer. Third, while the ground truth documents a chronological expansion using new series identifiers (C53-15, C62-15, C72-15) all from 2015, the LLM incorrectly implies ongoing new issuances with different terms post-2015, when in fact Tesla is referencing later tranches of the same 2015 program. The reasoning about a 'flexible, incremental capital-market strategy' is partially sound and reflects a correct interpretation of scalability, but the model fails to emphasize the key point about asset-backed securitization tied to solar deployment performance, which is central to the original answer. The contextual relevance is high because the response stays focused on Tesla’s solar financing evolution, and the qualitative reasoning shows understanding of multi-hop synthesis (linking 2022–2024 references to strategic intent), but the inclusion of unsupported financial mechanics reduces factual accuracy. Overall, the answer gets the broad strategic implication right but fails on key specifics, particularly around bond terms and structural changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 496,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe transformed Acrobat from a standalone PDF viewer into the AI‑driven core of its **Document Cloud** platform, embedding generative‑AI (Adobe Sensei/Firefly) to automate editing, signing and workflow tasks and to make documents “intelligent” across devices.  This AI‑first positioning deepened market adoption in PDF‑intensive verticals—legal, financial services, government and publishing—by offering web‑based, single‑click tools, expanded APIs and pre‑built integrations with Microsoft, ServiceNow and other enterprise ecosystems.  As a result, Acrobat evolved into a unified, cloud‑native document services platform that not only preserves PDF’s market leadership but also drives new recurring revenue through AI‑enhanced, task‑based experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe's strategic positioning of Acrobat from 2022 to 2024. (1) It correctly identifies the shift from a traditional PDF tool to an AI-driven platform within Document Cloud, aligning with the ground truth's narrative of progression from market leadership to AI integration. The mention of AI integration via Adobe Sensei/Firefly is contextually appropriate, though the original answer does not specify these AI brands—this is a minor enhancement rather than an error. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes Acrobat’s market adoption in document-intensive industries (legal, financial, publishing), its AI transformation, and platform expansion—addressing all three components of the question. It correctly infers the strategic trajectory even if it uses more forward-leaning language (e.g., 'AI-first positioning'). (4) The only minor deviation is that the original answer highlights the 2024 trademark filing of the 'Acrobat AI Assistant' as a concrete milestone, which the LLM answer implies but does not explicitly mention. However, the essence—that AI capabilities were formally integrated and positioned as central—is preserved. Wording differences (e.g., 'unified cloud-native platform') reflect semantic equivalence. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 427,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 to 2024 Schwab’s RIA‑focused interactive tools moved from a single, web‑based “Schwab Advisor Portfolio Connect” offering to a richer, multi‑component platform.  In 2023 the company added the thinkpipes trading interface and the iRebal customizable rebalancing engine, and began exposing API‑driven connections to external CRM, portfolio‑management and order‑management systems, giving advisors real‑time trading and allocation capabilities.  By 2024 those capabilities were broadened further: the Advisor Services portal now embeds a suite of interactive analytics and educational tools and provides deeper, out‑of‑the‑box integrations with a wider range of third‑party wealth‑tech platforms, allowing RIAs to manage client relationships, trading and rebalancing within a single, unified experience.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that 'Schwab Advisor Portfolio Connect' was a single offering in 2022, when in fact it was introduced in 2024 as a free portfolio management solution; there is no evidence in the ground truth that it existed in 2022. (2) The LLM invents specific tools—'thinkpipes trading interface' and 'iRebal customizable rebalancing engine'—that are not mentioned in the original answer and have no support in the provided knowledge graph. (3) It claims API-driven connections were introduced in 2023, but the ground truth only confirms continued emphasis on third-party integrations without specifying API capabilities or timing. (4) The description of a 'multi-component platform' with embedded analytics and unified experience by 2024 overstates the evolution and adds features (e.g., real-time trading, out-of-the-box integrations) not present in the original. While the general theme of enhancing digital tools and integrations aligns with the question, the specific platform names, features, and timeline are fabricated or misrepresented. The answer fails multi-hop reasoning because it does not accurately synthesize the actual progression from 2022 to 2024. Quantitative accuracy is low due to incorrect dates and invented features. Qualitative accuracy suffers from incorrect entity identification and unsupported enhancements. Contextual relevance is moderate because the response addresses the topic of RIA tools and integrations but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 429,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nEmerson’s Air‑Preparation Equipment was first listed in the 2022 Discrete‑Automation segment as a stand‑alone hardware group of filters, regulators and dryers that supply clean, dry air to pneumatic actuators. By 2023 the company began to bundle this equipment with its control‑system software, promoting the Plantweb IIoT architecture that connects the pneumatic hardware to intelligent sensors, gateways and control software for remote monitoring and predictive maintenance (see page 73 description of Discrete Automation and page 71 discussion of Plantweb). In 2024 the positioning had matured into a fully integrated automation offering, where air‑preparation hardware is marketed together with control‑system software, data‑analytics and safety‑instrumented functions, positioning Emerson as a one‑stop provider of end‑to‑end pneumatic‑and‑control solutions for discrete manufacturers (pages 71‑73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All dates (2022, 2023, 2024) are correct, and the evolution of Emerson's strategic positioning of Air Preparation Equipment is accurately described across the three years. In 2022, the equipment is correctly portrayed as standalone pneumatic hardware (filters, regulators, dryers), consistent with the original answer’s emphasis on mechanical integration with valves and actuators. By 2023, the LLM correctly identifies integration with control systems and software, specifically naming Plantweb IIoT architecture, which matches the ground truth’s mention of programmable automation and digital ecosystems. In 2024, the LLM accurately describes full integration with data analytics, safety functions, and end-to-end solutions, reflecting the original answer’s focus on Industry 4.0, smart actuation, and predictive maintenance. (2) There are no numeric values requiring calculation, but all temporal references (years) are correct and consistently applied. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, correctly tracing the integration path from mechanical components to digital automation solutions. It references specific product architectures (Plantweb) and pages (71–73), suggesting accurate grounding in source material. (4) While the wording differs, the semantic meaning matches the original answer—both describe a shift from mechanical to digitally integrated positioning. The only minor gap is that the LLM does not explicitly mention 'interoperability with secure wireless communication' or 'materials joining solutions,' which are in the original. However, the broader themes of digital integration and end-to-end automation are well captured. Thus, the answer is slightly less comprehensive but still factually correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 518,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s 10‑K filings no longer record a fresh issuance of 0.125 % Notes due 2029; instead each year’s exhibit list simply repeats the original September 2020 issuance (and the March 2021 amendment) that was first disclosed in the 2020 filing. This continuity indicates that Coca‑Cola has positioned the 0.125 % 2029 tranche as a stable, low‑cost near‑term funding pillar, using it to manage upcoming maturities while relying on newer, higher‑coupon notes for longer‑dated financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that there were no new issuances of the 0.125% Notes due 2029 from 2022 to 2024 and correctly references the original September 2020 issuance and March 2021 amendment, which aligns with factual continuity in disclosures. This supports the quantitative accuracy of dates and percentages. However, the LLM introduces information not present in the ground truth—specifically, the claim that Coca-Cola used the 0.125% note as a 'stable, low-cost near-term funding pillar' to manage maturities—without evidence from the filings that the company actively relied on it for that purpose during this period. (2) The dates (September 2020 issuance, March 2021 amendment) and interest rate (0.125%) are factually correct and consistent with ground truth. There are no calculation errors because no computations were required. (3) The multi-hop reasoning is partially flawed. While the LLM correctly observes the absence of new issuances and repeated disclosure, it fails to capture the evolution in disclosure context described in the original answer—i.e., the shift from passive listing in 2022, to consolidated presentation in 2023, to the introduction of higher-yielding instruments in 2024. This evolution is central to the question about strategy and is entirely omitted. Instead, the LLM infers a strategic role for the 2029 note without supporting evidence from the 2022–2024 context shifts. (4) The answer is contextually relevant and addresses the core topic of issuance strategy and debt management, but it misses the key analytical insight about changing disclosure patterns and the strategic pivot toward longer-term, higher-yielding debt in 2024. Thus, while factually plausible in parts, it lacks the nuanced, evidence-based reasoning required for full accuracy, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 503,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nBNY Mellon’s 2022 – 2024 10‑K filings repeatedly stress that shareholder‑return activities are bounded by U.S. banking capital rules: the Board may only return capital if the bank remains “well‑capitalized” and meets capital‑planning standards, and any shortfall in dividend payments on its preferred stock can trigger regulatory limits.  Each year’s filing tightens the language—adding references to capital‑adequacy and liquidity ratios, stress‑test results, and the risk that a downgrade or failure to satisfy regulatory standards would restrict dividends and repurchases—so that by 2024 the company is explicitly warning that regulatory constraints on dividends and share‑repurchase programs are driven by its capital‑planning framework and the need to maintain well‑capitalized, well‑managed status.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of BNY Mellon's disclosures from 2022 to 2024 regarding U.S. banking laws on capital planning and shareholder returns. The key elements—regulatory constraints, 'well-capitalized' status, capital-planning standards, preferred stock dividend obligations, and increasing specificity over time—are all present and factually correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes how the framing evolved across years, noting increasing formality and specificity in language, which matches the ground truth’s observation of a shift from general caution to structured regulatory references. The mention of stress-test results and liquidity ratios adds slight elaboration beyond the original but remains consistent with plausible regulatory context and does not introduce inaccuracies. (4) Semantic equivalence is strong—while the LLM uses slightly more detailed phrasing (e.g., 'tightens the language', 'capital-adequacy and liquidity ratios'), it conveys the same core trend: growing specificity in disclosing regulatory limits on dividends and repurchases. The only minor gap is that the original explicitly mentions Delaware law in 2022, which the LLM omits, but this does not undermine the central regulatory narrative. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 452,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nIn the 2022‑2024 Form 10‑K filings (pages 5‑6 of each year), McGriddles are repeatedly listed as a standard breakfast offering and are framed as part of the company’s ongoing menu‑innovation and product‑testing efforts—initially introduced as a new breakfast sandwich and later described as a stable, core item within the regular breakfast lineup. This progression shows that McDonald’s breakfast strategy has remained anchored on a consistent set of breakfast items, using continual, incremental innovation (such as McGriddles) rather than one‑off launches, underscoring a steady, reliable approach to breakfast growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in reasoning and factual synthesis. (1) Quantitatively, there are no numeric errors—no specific numbers were misstated, and the years (2022–2024) and document types (10-K filings) are correctly identified. Page numbers (5–6) are close to the ground truth (pages 6–7), which is acceptable given potential chunking differences. (2) However, the LLM incorrectly claims McGriddles was 'initially introduced as a new breakfast sandwich' in this period, which contradicts the ground truth: McGriddles was never described as a new or recently introduced item in any of the 2022–2024 filings. Instead, it was consistently listed as a core, static offering without innovation details. (3) The multi-hop reasoning is flawed: the ground truth emphasizes that despite broader innovation language (e.g., 'continuous evolution', 'testing new products'), McGriddles itself was not portrayed as part of that innovation. The LLM incorrectly frames McGriddles as an example of 'incremental innovation', when the filings show it was presented as a stable, unchanging item. (4) Contextually, the answer addresses the evolution and strategy question, so relevance is high. But the conclusion—that McGriddles represents ongoing innovation—directly contradicts the ground truth, which finds the product's portrayal unchanged and thus indicative of stability, not innovation. This major misinterpretation reduces correctness and qualitative accuracy significantly, though the structural elements and general context are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 434,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Adobe has consistently presented free, on‑demand self‑service training as a core component of Adobe Digital Learning Services, delivering it primarily through the learning.adobe.com portal alongside paid classroom and certification options.  In 2023‑2024 the company deepened the integration of this free catalog with its Experience Cloud stack—using Journey Optimizer, Target and AI‑driven features such as Firefly generative credits—to offer personalized, scalable learning pathways.  As a result, the emphasis shifted from a supplemental, standalone resource to an integrated, AI‑enhanced learning channel delivered via the same learning.adobe.com platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity and platform timeline details, affecting the qualitative accuracy. (1) Correct elements: The answer correctly identifies free self-service learning as a core component of Adobe Digital Learning Services across 2022–2024 and accurately notes the use of learning.adobe.com as the primary delivery platform in later years. The emphasis on integration with paid offerings is also consistent with the ground truth. (2) Quantitative accuracy is high: no specific numbers (e.g., dollar amounts, percentages) are provided or misstated, and the fiscal years 2022–2024 are correctly referenced. (3) Multi-hop reasoning is partially sound but flawed: the answer incorrectly states that learning.adobe.com was used throughout 2022–2024, whereas the ground truth specifies that the domain shifted from training.adobe.com in 2022 to learning.adobe.com starting in 2023. This misrepresents a key evolution in platform branding. Additionally, the LLM introduces unverified details—such as integration with Journey Optimizer, Target, and Firefly generative credits for personalized learning pathways—which are not supported by the ground truth and appear to be speculative or hallucinated. (4) These factual errors and unsupported claims reduce the qualitative accuracy significantly, despite the answer being contextually relevant and well-structured. The core strategic emphasis on self-service learning is captured, but the evolution across years lacks precision in platform transitions and overreaches on technical integration details not present in the source. Hence, correctness is partially achieved but undermined by key inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 463,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nThrough 2022 to 2024 Emerson kept Commercial Vacuums in the **Safety & Productivity** segment, still listed under the “Other professional tools” category alongside water‑jetters and wet‑dry vacuums.  The strategic focus remained on positioning these vacuums as professional‑grade, safety‑enhancing equipment sold primarily through distributor networks, reinforcing the segment’s alignment with broader professional‑tools offerings rather than consumer markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding the evolution of Emerson's segment classification for Commercial Vacuums, which undermines its correctness despite some accurate qualitative phrasing. (1) The key error is the claim that Commercial Vacuums were in the Safety & Productivity segment throughout 2022–2024. According to the ground truth, in 2022, Commercial Vacuums were part of the Tools & Home Products segment, not Safety & Productivity—this misplacement invalidates the core narrative. The repositioning into Safety & Productivity occurred in 2023, marking a strategic shift that the LLM answer completely overlooks. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the years 2022, 2023, and 2024 are correctly referenced in terms of timeline structure, earning partial credit. (3) The multi-hop reasoning fails: the question requires tracing a three-year evolution across segments and strategic focus, but the LLM assumes consistency rather than change, missing the reclassification from Tools & Home Products to Safety & Productivity. It also fails to note the increasing integration with advanced industrial tools like programmable automation systems in 2024. (4) While the answer correctly identifies that Commercial Vacuums are professional-grade tools sold through distributors and emphasizes safety, it misses the strategic evolution—especially the shift from general tools to industrial productivity solutions. Thus, while contextually relevant and semantically plausible in parts, the answer is factually incorrect on the central point of segment realignment, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 481,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead repeatedly lists the Hoofddorp, Netherlands facility as a location where it “utilizes the facility for commercial manufacturing and processing of its cell‑therapy products.” The site’s core purpose—commercial‑scale cell‑therapy production—has therefore remained constant, but the company has progressively leaned on it to meet expanding market demand, using the plant to scale up existing therapies and support new cell‑therapy launches. Thus, while the functional focus stayed on commercial processing, its utilization has grown in scope and volume over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its portrayal of the evolution of GILD's Hoofddorp facility. According to the ground truth, in 2022 the facility was identified as a principal manufacturing site but was not yet explicitly described as being used for commercial manufacturing and processing of cell therapy products—this specific designation began in 2023. The LLM incorrectly states that from 2022 through 2024, Gilead 'repeatedly lists' the facility as being used for cell therapy commercial manufacturing, which misrepresents the timeline. The ground truth shows a strategic shift occurring between 2022 and 2023, whereas the LLM implies consistency from 2022 onward, missing the evolution entirely. This undermines the multi-hop reasoning required to detect a change over time. While the LLM correctly identifies the facility’s role in commercial cell therapy processing in 2023 and 2024, and plausibly infers increasing utilization due to market demand, this expansion in scope and volume is speculative and not supported in the original answer. The entities (GILD, Hoofddorp, cell therapy manufacturing) and years are correctly identified, and there are no numerical inaccuracies (quantitative accuracy is high due to absence of incorrect numbers). Contextually, the response is relevant and addresses the question's focus on evolution and commercial processing. However, the core failure is in qualitative accuracy: it misses the key progression—general principal site in 2022 to explicit cell therapy focus in 2023—and instead asserts continuity, which contradicts the ground truth. Thus, while semantically plausible, it is factually flawed in its central claim about the timeline of utilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 475,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe repeated reference to the 1.000 % Notes due 2028 in the 2022‑2024 filings shows that this low‑cost, near‑term obligation remains part of Coca‑Cola’s legacy debt profile.  At the same time, the 2024 issuance of 5.000 % Notes due 2034 and 5.400 % Notes due 2064—among the highest‑coupon securities the company has issued—reflects a deliberate shift toward longer‑dated, higher‑yield financing to fund growth and diversify the maturity schedule, indicating that the firm is now accepting higher financing costs and a more extended capital‑structure profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.000% Notes due 2028 are correctly identified as consistently referenced from 2022–2024, and the new 5.000% Notes due 2034 and 5.400% Notes due 2064 are accurately described in terms of coupon rates and issuance year (2024). No numeric or date inaccuracies are present. (2) Quantitative accuracy is perfect: percentages (1.000%, 5.000%, 5.400%) and maturity years (2028, 2034, 2064) match the original answer exactly. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward longer-term, higher-cost debt, linking it to maturity diversification and growth funding. It captures the contrast between legacy low-cost debt and new high-yield instruments, reflecting a recalibration in capital structure—consistent with the ground truth. (4) The only minor limitation is that the LLM does not explicitly mention 'balancing near-term affordability with long-term funding needs,' a nuance in the original answer, but the idea is implicitly conveyed through 'longer-dated, higher-yield financing' and 'diversify the maturity schedule.' Wording differs slightly but semantic equivalence is strong. The answer is fully relevant and directly addresses the multi-hop nature of the question by synthesizing trends across years and debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 378,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter line, housed in the Safety & Productivity segment, moved from conventional mechanical cutters in 2022 to battery‑powered, sensor‑enabled models by 2023‑2024 that embed diagnostics and data‑connectivity for real‑time cut‑quality monitoring.  This evolution—highlighted in the segment’s growing earnings and the 2024 description of “battery hydraulic tools for press connections, drain cleaners and diagnostic systems” (pp. 71, 73, 74)—signals a deliberate shift toward high‑value, tech‑enabled plumbing tools, positioning Emerson as a premium, innovation‑driven leader rather than a pure‑price competitor in the professional plumbing market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe cutter portfolio from conventional tools in 2022 to battery-powered and diagnostic-integrated models by 2023–2024. The mention of 'battery hydraulic tools for press connections, drain cleaners and diagnostic systems' in 2024 matches the original answer’s emphasis on diagnostic integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes the product evolution across years and links it to strategic positioning in the professional plumbing market. It correctly infers that this shift reflects a move toward premium, innovation-driven positioning. The only minor gap is that the original answer specifically notes the absence of battery/diagnostic focus in 2022, while the LLM uses 'conventional mechanical cutters,' which is semantically equivalent but slightly less explicit. Also, the LLM introduces 'data-connectivity for real-time cut-quality monitoring' and 'sensor-enabled models,' which are plausible extensions of 'diagnostic systems' but not explicitly stated in the ground truth. These additions do not contradict but slightly extrapolate. (4) Contextual relevance is excellent—the answer directly addresses the strategic shift and market positioning as required. Overall, the answer is factually correct, well-reasoned, and only slightly exceeds the ground truth with minor, reasonable inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 447,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead repeatedly lists the Santa Monica, CA campus as the dedicated site for **clinical manufacturing and processing of its cell‑therapy products** (e.g., Yescarta, Tecartus and other CAR‑T candidates), using it to produce drug substance and drug product for multiple investigational studies and early‑stage commercial supply.  The campus has moved from a pilot‑scale, proof‑of‑concept capability to a more fully integrated clinical‑manufacturing hub—expanding its process‑development, quality‑control and chain‑of‑custody infrastructure—to support a growing pipeline of cell‑therapy candidates and to feed the regulatory‑approval and commercial‑launch pipeline.  This evolution signals that Santa Monica has become a **strategic cornerstone of Gilead’s advanced‑therapy manufacturing network**, providing the technical expertise and capacity needed to translate cell‑therapy innovations from the clinic to market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually incorrect in its core timeline and characterization of GILD's Santa Monica facility, despite being well-written and contextually relevant. According to the ground truth, in 2022 the Santa Monica site was part of GILD's R&D and manufacturing network but was *not* specifically highlighted for cell therapy processing. However, the LLM claims that from 2022 through 2024, Gilead 'repeatedly lists' Santa Monica as the dedicated site for clinical manufacturing of cell therapies, which contradicts the 2022 status. The ground truth indicates a transition: only in 2023 did the facility become explicitly used for cell therapy processing. The LLM incorrectly portrays this strategic role as consistent over the entire period, missing the evolution entirely. While the description of the facility's growing capabilities and strategic importance aligns with the 2023–2024 progression, the misrepresentation of 2022 undermines the multi-hop reasoning required to show *how* the facility's role changed over time. There are no numerical figures to verify, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is low because the model fails to correctly identify the shift in the facility’s role across years—answering as if the role was static rather than evolving. Contextual relevance is high because the answer addresses clinical manufacturing, cell therapy products, and strategic role, but the reasoning flaw prevents full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 405,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe expanded Frame.io from a video‑review tool into a full‑stack, cloud‑native collaboration hub that now natively supports video, still images, design files and PDFs.  It is tightly integrated with multiple Creative Cloud apps—Premiere Pro, After Effects, Photoshop, Lightroom and Workfront—providing frame‑accurate, real‑time upload, commenting and approval workflows, while its Camera‑to‑Cloud feature and sync with Adobe Express and Firefly let creators move assets seamlessly across the Creative Cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Frame.io's integration within Adobe's Creative Cloud ecosystem from 2022 to 2024. It correctly identifies Frame.io's expansion from a video-review tool to a cloud-native collaboration hub supporting video, still images, design files, and PDFs—aligning with the 2023 and 2024 developments in the ground truth. The integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront is accurately listed, matching the multi-application expansion noted for 2024. The mention of real-time commenting and frame-accurate feedback reflects the core collaboration functionality described. The answer also correctly emphasizes broader use cases beyond post-production (implied by integration with Express, Firefly, and Workfront), aligning with the 2024 positioning within Adobe GenStudio for enterprise content production. One minor omission is the lack of explicit chronological progression—while the final state is accurate, the answer does not clearly differentiate the 2022 trademark status or the stepwise integration path (e.g., initial integration in 2023 with only Premiere Pro and After Effects). However, this does not undermine the factual correctness of the overall evolution. All entities, applications, and capabilities are correctly named. There are no numerical inaccuracies (dates are used contextually, not quantitatively). The reasoning is sound and synthesizes multi-hop information across time and functionality. The answer is semantically equivalent to the ground truth, with slightly more emphasis on features like Camera-to-Cloud and Firefly that are contextually relevant but not explicitly detailed in the original. Overall, the response is factually robust, complete in key aspects, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 487,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson reframed its Electrical Distribution Equipment offering inside the Discrete Automation segment as a core, software‑enabled building block rather than a stand‑alone hardware line.  The product scope was broadened to include smart, network‑connected distribution gear and was paired with programmable automation control systems, digital‑twin/asset‑performance software and tighter integration with valve‑actuation and pneumatic technologies, positioning the equipment as part of an end‑to‑end automation solution that can be coordinated, monitored and controlled within larger process‑control architectures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the strategic evolution of Emerson's Electrical Distribution Equipment from a standalone offering to an integrated component within the Discrete Automation segment, with increasing alignment to automation technologies. It accurately reflects the direction of integration with control systems and software, and the broader positioning within end-to-end automation solutions, which aligns with the ground truth's narrative of deeper integration from 2022 to 2024. However, the LLM answer lacks the year-by-year progression explicitly detailed in the original answer: (1) the 2022 positioning within Industrial Solutions, (2) the 2023 shift into Discrete Automation alongside programmable controls, and (3) the 2024 expansion to include electric linear motion and materials joining solutions. While the LLM mentions integration with automation software and control systems, it introduces specific technologies like 'valve-actuation and pneumatic technologies' and 'digital-twin/asset-performance software' that are not mentioned in the ground truth, potentially overextending the evidence. These additions, while plausible within Emerson’s portfolio, are not supported by the provided knowledge graph and represent speculative detail. The answer is strong on contextual relevance and correctly interprets the strategic intent, but misses the precise multi-hop evolution across years and product groupings, reducing completeness and qualitative accuracy. Quantitative accuracy receives full marks because there are no numerical claims to evaluate—dates are used correctly in context but not tied to specific milestones as in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 453,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nFrom 2022 to 2023 the carrying amount of Capital One’s fixed‑rate senior unsecured notes jumped from **≈ $19.9 bn to $27.2 bn**, and the weighted‑average interest rate rose from **about 2.9 % to 4.8 %**. In 2024 the balance fell slightly to **$26.9 bn** while the rate stayed near **4.8 %**. This shows the company deliberately expanded its fixed‑rate senior debt at higher yields in 2023 to lock in funding before rates climbed further, and in 2024 it began to trim the outstanding balance but kept the higher‑cost profile, reflecting a strategy of extending maturity and accepting higher rates in a rising‑interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately captures the trend in carrying value and interest rates over the three years. The carrying values are correctly represented: $19.9 billion (≈ $19,975 million), $27.2 billion (≈ $27,168 million), and $26.9 billion (≈ $26,930 million). The interest rates are slightly rounded: stating 'about 2.9%' and '4.8%' instead of the exact 2.91%, 4.45%, and 4.84%. The 2023 rate is reported as 4.8% in the LLM answer, while the ground truth is 4.45%, which is a minor but notable inaccuracy. However, the 2024 rate of 4.84% is correctly approximated as 4.8%. (2) Calculations and comparisons are not required beyond reporting values, and the values reported are within acceptable rounding. The slight conflation of the 2023 rate (4.8% vs actual 4.45%) is the main quantitative deviation. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across 2022–2024 and infers a strategic intent—locking in debt before further rate hikes and managing maturity profile—consistent with the ground truth. The conclusion about accepting higher rates in a rising environment is logically supported. (4) Scores reflect high accuracy with minor rounding-related imprecision in interest rates. The answer is fully contextually relevant, addressing all parts of the question: evolution of carrying value, interest rate trend, and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 402,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nThe accrued liability for service‑and‑product warranties and performance/operating‑cost guarantees fell from **$1.109 billion at the end of 2022 to $1.091 billion in 2023 and to $0.993 billion by the end of 2024** (Note 16 – “Changes in the carrying amount of service and product warranties and product performance guarantees”).  This decline reflects lower expected future payouts as the company’s historical experience with engine performance issues (e.g., the PW1100‑GT fleet disruptions) has improved and prior reserves have been utilized.  Consequently, the downward trend indicates that RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is **diminishing**, even though guarantees remain on the books for future years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities related to performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. However, the LLM reports figures of $1.109 billion (2022), $1.091 billion (2023), and $0.993 billion (2024), which are over 9 times larger than the actual values. This represents a severe quantitative inaccuracy. (2) The numbers cited by the LLM appear to conflate total warranty and performance guarantee liabilities with the specific subset related to performance and operating cost guarantees. While Note 16 may report total accrued liabilities in the billions, the ground truth specifies that only $120M (and later $101M) pertains to performance and operating cost guarantees. The LLM fails to isolate this specific liability category, leading to a gross overstatement. (3) The reasoning and synthesis are partially sound in that the model identifies a trend and attempts to explain it (improving engine performance reducing risk). However, the conclusion that exposure is 'diminishing' contradicts the ground truth interpretation of 'stable' exposure with consistent accruals, and the trend itself is misrepresented due to incorrect data. (4) Contextual relevance is moderate—the response addresses the right topic (liabilities for performance guarantees), time frame (2022–2024), and business segment (commercial aerospace)—but the severe numerical errors and resulting flawed interpretation undermine the overall correctness. Minor point: mentioning the PW1100-GTF issues adds context not in the ground truth but could be plausible; however, it does not compensate for the factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 483,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nFrom 2022 to 2024 the Company’s 10‑K filings show “estimates of sales proceeds” shifting from a secondary option listed alongside discounted‑cash‑flow and appraisal methods (2022) to the principal means it cites for valuing non‑public investments in emerging markets (2023‑2024).  The 2024 filing explicitly notes that, because observable market data are scarce in those regions, the estimate of sales proceeds—reflecting expected cash inflows from future sales—is the primary input used to gauge fair value.  This evolution indicates that Coca‑Cola is adopting a more pragmatic, cash‑flow‑based approach to fair‑value assessment in emerging markets, relying on internally generated sales‑proceed forecasts rather than external market prices.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022–2024) and correctly identifies the use of 'estimates of sales proceeds' in Coca-Cola's valuation methodology, with no numeric inaccuracies (quantitative_accuracy: 10). The context of emerging markets and the scarcity of observable market data are appropriately highlighted, and the answer addresses the evolution over time, satisfying contextual relevance (9). However, the qualitative accuracy is lower (6) because the LLM overstates the shift in methodology. The ground truth indicates that while reliance increased in 2023, Coca-Cola did not elevate 'estimates of sales proceeds' to the 'principal means' or 'primary input' in 2023–2024, but rather used it alongside discounted cash flows and appraisals, with growing caution due to cash flow unpredictability—especially in emerging markets. The LLM incorrectly frames the evolution as a move toward 'pragmatic, cash-flow-based' reliance, whereas the original answer emphasizes a more cautious and risk-aware integration, not a strengthening of dependence. This misrepresents the company’s strategic shift from operational reliance to tempered application. The multi-hop reasoning is partially sound but fails to accurately synthesize the nuanced progression from disclosure to reliance to cautious use, leading to an incorrect conclusion about Coca-Cola's approach. Thus, while the answer contains correct elements, it distorts the core narrative of increasing caution, resulting in a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 417,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nIn its 2022 filing (page 3) BNY Mellon noted that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” By 2023 (page 5) and again in 2024 (page 5) the disclosure was broadened to warn that “failure to satisfy regulatory standards—such as remaining ‘well‑capitalized’ or meeting capital‑adequacy and liquidity requirements”—could directly impose limitations on the firm’s dividend and share‑repurchase activities. Thus, the multi‑year progression shows that BNY Mellon’s capital‑return flexibility is now tightly conditioned on maintaining strong regulatory capital metrics and board approval, curbing its strategic freedom to distribute capital to shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of BNY Mellon's disclosures, particularly in misrepresenting the nature and direction of changes from 2022 to 2024. (1) Quantitatively, there are no numeric errors—dates (2022, 2023, 2024), page numbers (3, 5), and quoted language are presented plausibly and align with typical disclosure formats. However, the ground truth does not mention any expansion of disclosure in 2023 or 2024 regarding 'failing to satisfy regulatory standards' or new language about being 'well-capitalized'—this is a fabrication or misattribution. Instead, the actual evolution was a consistent repetition of the same core limitation across all three years, with only a *new emphasis in 2024* on the Parent’s dependency on dividends from subsidiaries and credit from its IHC. (2) The LLM incorrectly claims the disclosure was 'broadened' in 2023 and 2024 to include regulatory standards like 'well-capitalized' status, which is not supported by the ground truth. This misrepresents the multi-hop progression: the real trend is stability in regulatory language with increasing internal structural dependency, not tightening regulatory conditions. (3) The reasoning is flawed because it infers increasing regulatory pressure when the ground truth shows regulatory language remained unchanged. The actual strategic implication—that internal capital flows and subsidiary dependencies are becoming more central—is entirely missed. (4) While the answer addresses shareholder capital distributions and regulatory constraints (contextually relevant), it fails to accurately synthesize the multi-year progression, leading to an incorrect conclusion about diminishing strategic flexibility due to regulatory tightening, rather than highlighting stable external constraints with evolving internal dynamics. Thus, despite correct dates and plausible formatting, the core qualitative analysis is incorrect, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 542,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures moved from a broad statement that “loss or modification of exemptions for taxes and tariffs could adversely affect us” (e.g., 2022 10‑K pages 35‑36) to a far more granular risk description that ties exemption risk to sanctions, export‑control revisions, and the need for government approvals tied to major acquisitions such as ZT Systems (see 2023 pages 39‑40 and 2024 pages 38‑41).  This evolution shows that AMD’s exposure to losing tax and tariff benefits has broadened and deepened as geopolitical tensions and regulatory scrutiny have intensified, signalling an increasingly complex global regulatory environment that the company must navigate across multiple jurisdictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of AMD's risk disclosures from 2022 to 2024: starting with a general warning about tax and tariff exemptions in 2022, expanding in 2023 to include geopolitical events (e.g., Ukraine conflict, China-Taiwan tensions), and further deepening in 2024 by linking the risk to U.S. export controls, sanctions, and acquisition-related government approvals (e.g., ZT Systems). While the original answer does not mention ZT Systems, the LLM’s inclusion of this detail—likely from AMD’s 2024 10-K—is factually consistent with the broader trend and adds granularity without distorting the core message. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022–2024) are correct, and references to specific 10-K pages (e.g., 2022 pages 35–36) are plausible and contextually appropriate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly infers increasing complexity in the regulatory environment, and links it to both external (geopolitical) and internal (acquisitions) factors. (4) The semantic meaning matches the original answer: both emphasize growing exposure and complexity. The only minor deviation is the emphasis on ZT Systems, which is not in the ground truth but does not contradict it—rather, it provides a specific example supporting the trend. Thus, the answer is slightly more detailed than the original but remains factually and contextually aligned. Quantitative accuracy is perfect (10), qualitative accuracy is excellent with only minor over-specificity (9), and contextual relevance is full (10). Correctness score is 9 due to the added detail not present in the ground truth, but not incorrect—just beyond the scope of the provided answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 501,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from $883 million to $538 million (and edged up to $562 million in 2024), while its total long‑term debt rose to a peak of $49.3 billion in 2023 before declining to about $45 billion in 2024.  The balance of floating‑rate unsecured senior notes dropped from $1.6 billion in 2022 to roughly $0.35 billion in 2023 and was essentially eliminated by 2024, indicating that the firm has been reducing its exposure to floating‑rate debt and relying more on fixed‑rate senior and subordinated notes (and securitized obligations) together with interest‑rate swaps to manage its interest‑rate sensitivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend in Capital One's debt evolution but contains significant numerical inaccuracies. The total short-term borrowings and long-term debt figures are partially correct but not fully aligned with the ground truth. The ground truth states total debt (short-term + long-term) was $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly separates short-term borrowings as $883M (2022), $538M (2023), $562M (2024), which may reflect only a subset of short-term debt but does not reconcile with the total debt figures. More critically, the LLM reports long-term debt as $49.3B in 2023 and ~$45B in 2024, which is close but not exact (off by ~$0.5B in 2023 and ~$0.5B in 2024). (2) Floating unsecured senior debt: LLM says $1.6B in 2022 (vs. $1.709B actual), $0.35B in 2023 (vs. $349M — acceptable rounding), and 'essentially eliminated' in 2024 (correct, as ground truth confirms $0). However, the LLM omits the weighted-average interest rates (1.01% in 2022, 6.75% in 2023), which are key to understanding interest rate exposure. Fixed unsecured senior debt is mentioned only in passing, with no accurate figures: LLM says 'relying more on fixed-rate senior notes' but fails to report the increase from $21.045B (2022) to $27.168B (2023) to $26.930B (2024), nor the rising interest rate from 2.91% to 4.84%. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from floating to fixed-rate debt to manage interest rate risk, which aligns with the ground truth. It also mentions interest-rate swaps and securitized obligations as tools, which adds context not in the original but is plausible. However, it lacks precise synthesis of the full debt composition changes across years. (4) Correctness score is 6 due to partial factual accuracy and missing key quantitative details. Quantitative accuracy is 5 because several numbers are approximate or incomplete, especially total debt and interest rates. Qualitative accuracy is 7 because the reasoning and direction of interpretation are correct. Contextual relevance is 9 — the answer stays focused and addresses the core question of debt structure and rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 592,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program share interest in International Aero Engines AG stayed constant at 57 % (and a 51 % net stake in IAE LLC) from 2022 through 2024.  This unchanged ownership position underscores a stable, enduring strategic role for RTX in the V2500 engine collaboration, preserving its influence and partnership within the IAE consortium.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding RTX's net program share interest in IAE. The ground truth states that RTX's interest decreased from 61% in 2022 to 57% in 2023 and 2024, but the LLM claims it remained constant at 57% throughout 2022–2024. This misrepresents the trend and contradicts the core data. Additionally, the mention of a '51% net stake in IAE LLC' introduces an entity and figure not present in the original answer, adding unsupported detail. (2) Quantitatively, the percentages are wrong for 2022—61% is the correct figure, not 57%. The claim of stability is therefore based on incorrect numbers. No calculations were required, but the comparison over time is invalid due to inaccurate inputs. (3) The multi-hop reasoning fails because the model did not detect a change over time, which is central to the question. Instead of identifying a strategic adjustment through dilution of interest, it concludes stability, leading to an incorrect interpretation of RTX’s strategic positioning. The reasoning is internally consistent with its false premise but does not align with the actual data. (4) Contextual relevance is moderate—the response addresses the right topic (RTX’s role in IAE/V2500 program) and attempts to interpret strategic implications—but the incorrect data renders the conclusion invalid. Scores reflect major factual errors in numbers and resulting flawed analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 393,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nFrom 2022 through 2024 the Fabric & Home Care segment’s share of total net sales rose modestly from about 35 % to 36 %, and its share of earnings increased from roughly 31 % to 34 %.  This uptick reflects that Cascade—grouped under the Tide Cascade brand family—has become a slightly more pivotal contributor to the segment’s mid‑single‑digit organic growth and higher‑margin performance, positioning it as a more strategic, higher‑earning pillar within P&G’s home‑care portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the Fabric & Home Care segment's net sales and earnings percentages for 2022–2024: 35% to 36% of net sales and 31% to 34% of earnings, matching the ground truth. These numbers are accurate and quantitatively sound. However, the LLM introduces a claim not present in the original answer or supported by the provided ground truth: that Cascade is 'grouped under the Tide Cascade brand family' and has 'become a slightly more pivotal contributor' with increased strategic importance due to 'higher-margin performance'. The original answer emphasizes *consistent* positioning and stable strategic importance, not an evolution toward greater strategic weight. 2) All numeric values (percentages of sales and earnings) are correct and match the ground truth across years. There are no calculation errors. 3) The multi-hop reasoning is partially flawed. While the model correctly synthesizes segment-level performance across three years, it misinterprets the implication for Cascade’s positioning. The ground truth stresses continuity—Cascade remained a 'core brand' with no change in reported status—while the LLM infers a qualitative shift in strategic role, which is not justified by the data provided. This misrepresents the conclusion of the original answer. 4) Contextually, the response addresses the time frame and segment reporting, making it relevant. However, the qualitative inaccuracy—asserting increased strategic importance rather than stable positioning—significantly undermines correctness despite numerical fidelity. Hence, the correctness score is moderate: factually accurate on numbers but incorrect on the key interpretive point the question asks about—evolution of positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 468,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nBetween 2022 and 2024 BNY Mellon moved the disclosure of its Directors’ Code of Conduct from a bare, relative link (e.g., `bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf`) to a fully‑qualified, domain‑consistent URL (`https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑ofconduct.pdf`).  The reference was placed inside an expanded “Code of Ethics” section that also describes the employee Code of Conduct and explicitly says that any amendments or waivers will be posted on the website, thereby tying the directors’ code into the company’s broader governance framework and improving both accessibility and transparency.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and misrepresents key aspects of the URL evolution and domain transition. (1) It incorrectly states that BNY Mellon moved from a 'bare, relative link' to a fully qualified URL, but the ground truth shows that in 2022 the URL already included the full domain (bnymellon.com) and a complete path. The example URL provided in the LLM answer (e.g., 'bnymellon/documents/pdf/investor-relations/...') is not accurate for 2022 and misrepresents the actual path, which used 'in relations' (with a space) in 2022 and 2023. (2) The LLM claims a shift to a 'fully-qualified, domain-consistent URL' under bny Mellon's old domain, but fails to mention the critical 2024 transition to the new 'bny.com' domain, which is a central point in the ground truth. This omission severely undermines the answer's correctness. (3) The claim that the code was placed in an 'expanded Code of Ethics section' that includes employee conduct and amendment disclosures is not supported by the provided ground truth, which does not mention structural integration into a broader ethics section—only improved alignment via URL placement under 'investor-relations'. (4) The reasoning about integration into corporate governance is partially sound but based on incorrect evidence. While the ground truth notes a strategic shift toward investor relations and brand consistency, the LLM invents details about section restructuring and disclosure policies not present in the source. (5) The answer is contextually relevant and addresses accessibility, URL structure, and governance integration, but with significant factual errors in entity details (URL paths, domains, years) and incorrect inferences about content reorganization. Minor formatting issues (e.g., hyphenation in 'code-ofconduct') are acceptable, but the core evolution—especially the 2024 domain change to 'bny.com'—is missing, which is a major factual gap. Thus, the answer is partially correct in direction but flawed in execution and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 540,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nAMD’s AIB contracts consistently shielded partner inventories from price‑cut shocks and, as the 2022‑2024 filings show, added more explicit stock‑rotation/return provisions to give distributors and AIBs longer protection windows and greater inventory certainty.  At the same time, the company leaned on its discrete Radeon graphics lineup—introducing newer RX, Radeon PRO and Instinct GPUs with ray‑tracing, Infinity Cache and AI‑accelerated engines—to give system‑integrators a clear performance‑and‑feature differentiator that they could market as a key selling point.  (See the “Add‑in‑Board (AIB) Manufacturers and System Integrators” and “Third‑Party Distributors” sections of the 2022‑2024 10‑K pages.)",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in spirit and captures the core elements of AMD's strategic positioning with AIB manufacturers from 2022 to 2024, particularly regarding inventory protection and the role of discrete graphics in differentiation. (1) It correctly identifies that AMD maintained inventory protection policies across the period and mentions added explicit stock-rotation/return provisions, which aligns with the general direction of the ground truth, though the original answer does not specify 'added' provisions or 'longer protection windows'—these are plausible elaborations but not confirmed in the ground truth, introducing a minor overstatement. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable in a traditional sense; however, the time frame (2022–2024) is correctly referenced, earning full marks. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes inventory policy and differentiation via discrete graphics across years, but introduces product-specific details (e.g., ray-tracing, Infinity Cache, AI-accelerated engines, RX/PRO/Instinct lines) that were not present in the ground truth, potentially extrapolating beyond the source. While these may be factually true, they are not part of the verified knowledge graph answer and shift focus toward product features rather than strategic positioning. (4) The ground truth emphasizes consistency and stability in policy and strategy across the three years, which the LLM downplays by suggesting enhancements to protection mechanisms. This affects qualitative accuracy, as the emphasis on evolution ('added more explicit provisions') contrasts with the original's theme of continuity. However, the answer remains contextually relevant and captures the key strategic pillars. Thus, correctness is reduced to 7 due to unsupported elaborations and slight misalignment in strategic narrative, despite strong overall alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 532,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures repeatedly positioned the Egg McMuffin as a cornerstone of the breakfast menu, noting that it is offered in “full or limited” breakfast menus across the U.S. and many international markets (2022 p. 5; 2023 p. 5; 2024 p. 5).  Each year’s filing also emphasized the supply‑chain controls that safeguard its quality and consistency—​from the 2022 description of “quality‑center teams,” supplier visits and third‑party audits (2022 p. 6) to the 2024 reference to “virtual supplier visits,” a digital transformation project for continuous quality data, and broader sustainability‑focused sourcing (2024 p. 6).  Together, these disclosures show an evolution from simply listing the Egg McMuffin to detailing increasingly sophisticated, data‑driven and risk‑aware supply‑chain practices that underpin the product’s reliable taste and meet customer expectations for quality and consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Egg McMuffin as a consistent part of McDonald's breakfast menu from 2022 to 2024 and accurately reflects the evolving narrative around quality, supply chain, and innovation. The mention of 'full or limited' breakfast menus across years matches the original answer. (2) There are no numeric values requiring calculation, but the years (2022–2024) and page references (e.g., p. 5, p. 6) are consistent with expected disclosure locations and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, showing progression from basic quality controls (2022) to more advanced, digital, and data-driven supply chain practices (2024), particularly in support of consistency for the Egg McMuffin. It correctly infers a shift toward digital transformation and risk-aware practices, aligning with the 2024 emphasis on data excellence and food safety systems. (4) The only minor gap is that the LLM does not explicitly name the 'Global Chief Supply Chain Officer' or directly reference the 'comprehensive global supply chain strategy' mentioned in the 2023 disclosure, which slightly reduces qualitative completeness. However, the core evolution in focus—toward more sophisticated, data-driven supply chain practices—is accurately captured. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across years and themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 431,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe 4.30 % senior unsecured note that matures in 2034 is listed in Oracle’s 2022, 2023 and 2024 Form 10‑K filings, indicating that this tranche remains an active and material component of the company’s long‑term debt. Its repeated disclosure signals that Oracle is deliberately maintaining a sizable, fixed‑rate, long‑dated borrowing position—using the 2034 maturity to lock in financing costs and provide stable, predictable cash‑flow coverage for its ongoing capital projects and strategic investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 4.30% Note due 2034 is correctly identified with the right interest rate and maturity date, and its presence in Oracle's 10-K filings for 2022, 2023, and 2024 is accurately stated. There are no calculation errors or incorrect numeric values. The entity (Oracle), financial instrument (4.30% Note due 2034), and time periods (2022–2024) are all correct, satisfying entity accuracy. Contextually, the response directly addresses the question about Oracle’s long-term debt structure and financing priorities, correctly interpreting the repeated disclosure as evidence of a strategic, stable long-term financing approach. The reasoning is sound in inferring that Oracle is using long-dated, fixed-rate debt to lock in financing costs and ensure predictable cash flows. However, the LLM answer falls slightly short in completeness compared to the ground truth. It does not mention the broader debt portfolio context—such as the coexistence of other notes (e.g., 3.625% due 2023, 4.50% due 2044, or 2.950% due 2024)—which illustrates Oracle’s diversified maturity profile and evolving debt strategy. This multi-hop synthesis across multiple instruments and years, present in the original answer, is partially missing. While the LLM captures the core implication of stability and strategic long-term financing, it omits evidence of Oracle’s balanced mix of short- and long-term instruments, which strengthens the conclusion. Thus, while semantically aligned and contextually strong, the answer lacks some depth in qualitative synthesis, warranting a score of 8 for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 454,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nCapital One’s net‑derivative‑asset balance grew from **$5 million at 31 Dec 2022** to **$58 million at 31 Dec 2023** and **$69 million at 31 Dec 2024**, while the embedded net‑unrealized gain that flows through earnings fell sharply from **$63 million (2022)** to **$6 million (2024)**.  The derivatives are valued with vendor‑based discounted‑cash‑flow models; when key inputs—principally the **SOFR‑linked swap rates (range 3‑5 %, weighted avg ≈ 4 %)** and related default/loss‑severity assumptions—are unobservable, the instruments are classified as **Level 3**.  The roll‑forward tables show that transfers into Level 3 are driven largely by “term SOFR‑indexed interest‑rate derivatives,” indicating that the firm’s exposure to unobservable market inputs has expanded over the three‑year period, even though the range of those inputs has remained relatively narrow.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly reports $5 million in 2022 and $69 million in 2024—both materially wrong. Additionally, the ground truth mentions a $20 million net unrealized loss in 2022 still held at year-end, but the LLM claims a $63 million net unrealized gain in 2022 and $6 million in 2024, which contradicts the original data. The LLM also introduces 'net-unrealized gain' flowing through earnings, which is not mentioned or implied in the original answer. (2) The percentages for unobservable inputs (swap rates 3–5%) are correctly reported and align with the ground truth, as is the use of SOFR-linked swap rates and Level 3 classification. However, default rates are cited in the ground truth as 53–163%, while the LLM only refers to 'default/loss-severity assumptions' without specifying these extreme values, missing a key detail. (3) The multi-hop reasoning is partially sound—the LLM correctly infers increasing reliance on unobservable inputs due to Level 3 transfers and vendor models, and connects swap rates to valuation methodology. However, it incorrectly concludes that exposure to unobservable inputs has 'expanded' based on transfers into Level 3, while the ground truth emphasizes stability in fair value and increased transparency, not expansion of exposure. This misrepresents the trend. (4) Contextual relevance is moderate—the answer addresses the evolution of valuation methodology and unobservable inputs, and uses appropriate financial terminology. However, due to major numerical errors and mischaracterization of trends, the overall correctness score is low. Minor format flexibility is allowed, but the magnitude of incorrect numbers and misstated trends cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 533,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s obligation to Rolls‑Royce remained a flight‑hour‑based payment for the V2500‑powered aircraft, which is accrued as a collaboration intangible asset and amortized over the program’s estimated benefit period (through June 2027).  The 2024 schedule shows the commitment rising to $846 million in 2025, $770 million in 2026 and $704 million in 2027, and the accrued amounts are amortized as a reduction of cost of sales, reflecting the expanding flight‑hour base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general structure of RTX's payment obligations to Rolls-Royce based on V2500 flight hours and correctly identifies the amortization of these payments as collaboration intangible assets through June 2027. However, it introduces specific dollar figures ($846M in 2025, $770M in 2026, $704M in 2027) that are not present in the original ground truth and are factually unsupported by the provided information. The ground truth states that total commercial aerospace financing and other commitments were $14.1 billion in 2024, but does not break this down into future annual payments to Rolls-Royce, nor does it mention these specific amounts. This represents a significant quantitative inaccuracy. Additionally, the LLM incorrectly states that payments are amortized as a 'reduction of cost of sales,' while the original answer specifies they are amortized *to* cost of sales, which is a critical distinction in financial reporting. The answer also omits key evolution details: the shift from describing the liability as a contingent obligation in 2022 to clarified capitalization in 2023, and improved transparency over time. While the core concept of flight-hour-based payments and asset amortization is correct, the inclusion of fabricated figures and misstatement of amortization impact undermines factual reliability. The reasoning is partially sound but fails in precise financial representation and multi-hop synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 401,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen’s disclosures show a clear progression in how it handles user complaints and mitigates risk for the Neulasta Onpro kit. In the 2022 filing (page 53) the company merely noted that after the 2017 FDA review it had already applied device‑ and labeling‑enhancements and was continuously monitoring complaints. The 2023 filing (page 54) expanded this to describe ongoing post‑market surveillance, periodic risk‑management updates and modest redesigns of the injector’s instructions‑for‑use to improve usability. By the 2024 filing (pages 55‑56) Amgen detailed concrete device‑related enhancements—including a revised autoinjector mechanism, updated labeling, broader inventory buffers and contingency manufacturing/alternate‑supplier plans—to strengthen the kit’s reliability and to ensure operational resilience against supply‑chain or natural‑disaster disruptions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Amgen's disclosures regarding the Neulasta Onpro kit from 2022 to 2024 and correctly identifies the progression from device enhancements to broader risk mitigation. It accurately notes the reference to the 2017 FDA review and ongoing monitoring in 2022, and the continued emphasis on surveillance in 2023. However, significant factual discrepancies emerge in the 2024 disclosures. The LLM claims specific device-related enhancements such as a 'revised autoinjector mechanism' and 'updated labeling' in 2024, which are not supported by the ground truth; the original answer does not mention these specific technical changes. Instead, the ground truth emphasizes operational resilience due to Puerto Rico's electric grid instability and the use of backup generators during an island-wide outage on December 31, 2024—details entirely missing from the LLM response. Additionally, the LLM introduces 'contingency manufacturing/alternate-supplier plans' and 'broader inventory buffers' as 2024 measures, which are not present in the original answer. While the LLM correctly infers a trend toward operational resilience, it fabricates specific enhancements rather than reporting the actual infrastructure-related disclosures. The dates and years are accurate, and the multi-hop structure (tracking changes across years) is logically sound, but the reasoning is based on incorrect or invented details in the 2024 segment. Thus, while the answer is contextually relevant and shows appropriate framing, it fails on key factual content in the later years, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 444,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nFrom 2022 through 2024 the wording that ratifies KPMG LLP as BNY Mellon’s principal auditor remained essentially the same—each filing states that “Item 3 – Ratification of KPMG LLP” is incorporated by reference and that KPMG’s PCAOB firm identification number is 185—but the placement of that language shifted. In the 2022 Form 10‑K the ratification appeared as a stand‑alone Item 3, while in the 2023 and 2024 filings it is folded into Item 14 (Principal Accountant Fees and Services) and referenced only as part of the proxy‑incorporation language. The repeated, identical mention of PCAOB firm 185 across all three filings signals that BNY Mellon has maintained an unbroken, deliberate acknowledgment of KPMG’s regulated identity, reflecting steady audit‑governance continuity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in entity identification and structural interpretation. (1) Quantitatively, all numbers and years are accurate: the PCAOB firm number 185 is correctly cited across 2022, 2023, and 2024, and the timeline is properly referenced. (2) The entity error lies in referring to 'BNY Mellon' instead of 'BK'—while BK is a common ticker for BNY Mellon, the original answer consistently uses 'BK', and the LLM introduces a name (BNY Mellon) not mentioned in the ground truth, which may confuse entity consistency in a strict evaluation context. (3) Regarding reasoning, the LLM adds specific structural observations—such as the shift from Item 3 to Item 14—that are plausible but not present in the ground truth. While these details may reflect actual filing changes, they go beyond the verified knowledge graph data, introducing unverified procedural claims. The core multi-hop synthesis—linking consistent PCAOB number 185 to audit continuity—is sound and correctly inferred. (4) The answer addresses both parts of the question: evolution of disclosure (with a focus on formatting changes) and governance continuity (via PCAOB number). However, the ground truth emphasizes 'no substantive changes in structure or framing', whereas the LLM emphasizes structural relocation, creating a slight tension in interpretation. Despite this, the conclusion about audit governance continuity is valid and well-supported. Thus, the answer is factually strong with minor overreach in detail, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 440,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s **maximum‑potential payment** under commercial‑aerospace financing guarantees fell steadily—from **$304 million (2022)** to **$288 million (2023)** and **$274 million (2024)**—while the recorded liability remained essentially $0, indicating that the company’s direct exposure is modest and has been shrinking each year.  At the same time, the **collaboration‑partner share** of those guarantees declined from **≈$142 million (2022)** to **$135 million (2023)** and **$131 million (2024)**, showing that RTX is increasingly shifting the risk of these financing guarantees onto its partners and relying less on its own balance‑sheet to back customer financing.  This trend reflects a risk‑management strategy that reduces RTX’s contingent liabilities by off‑loading a larger portion of the exposure to its collaboration partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the collaboration partners' share of guarantees as $142M in 2022, $135M in 203, and $131M in 2024, matching the ground truth exactly—this part is quantitatively accurate. However, the LLM introduces a new metric—'maximum-potential payment' of $304M, $288M, and $274M for 2022–2024—that is not present in the original answer or implied by it. This data point appears to be hallucinated or sourced from outside the provided ground truth, which only discusses the collaboration partners' share and RTX's risk management implications. The ground truth does not mention RTX's total exposure or maximum potential payment, nor does it state that the recorded liability was $0. These additions significantly affect quantitative accuracy and qualitative reasoning. While the trend interpretation—that RTX is reducing shared risk and shifting exposure to partners—is partially aligned with the ground truth’s suggestion of a strategic reduction in shared risk, the LLM reverses the implication: the ground truth suggests RTX is reducing *shared* risk (i.e., pulling back from joint guarantees), whereas the LLM interprets it as RTX offloading more risk *onto* partners, which is a different strategic narrative. This misrepresents the reasoning. The ground truth emphasizes that RTX maintained confidence in asset values backing guarantees, a key context point omitted in the LLM response. Thus, while the core numbers for partner share are correct and the answer is relevant to the question, the inclusion of unsupported metrics and flawed interpretation of the risk strategy reduces correctness. Multi-hop reasoning is partially sound but based on incorrect premises. Semantic equivalence fails on strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 473,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nFrom 2022 through 2024 the Always brand remained listed in the Baby, Feminine & Family Care segment’s “Feminine Care” sub‑category, appearing alongside Tampax and Always Discreet as a core P&G brand (see the segment tables on pages 18 and 19 of the 2022‑2024 10‑Ks).  The segment’s contribution to net sales and earnings stayed essentially flat (≈ 24‑25 % of net sales and ≈ 23‑25 % of earnings), indicating that P&G did not reshuffle Always’s categorization but continued to treat it as a flagship brand within the broader feminine‑hygiene portfolio.  Notably, the brand list now includes Always Discreet, reflecting a modest shift toward emphasizing incontinence products alongside menstrual products, while Always itself retained its prominence relative to other feminine‑care offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages (24–25% of net sales) are correct and consistent with the original answer (25% in 2022, 24% in 2023–2024). The mention of stable segment contribution is factually sound. (2) The LLM correctly identifies the rebranding of the segment to 'Baby, Feminine & Family Care' by 2023 and includes the correct brands (Always, Tampax, Always Discreet). (3) The reasoning is strong: it infers continued flagship status of Always and notes the inclusion of Always Discreet as a signal of expanded product emphasis, which is a reasonable interpretation of the strategic shift. (4) The only minor gap is that the LLM does not explicitly mention the 2022 segment name was simply 'Feminine Care' before the rename, though it implies continuity by referencing the same segment across years. Also, the original answer notes a 'streamlined formatting' in 2024 for brand presentation, which the LLM omits. However, the core evolution—structural renaming, consistent positioning, and strategic emphasis—is accurately conveyed. Wording differences do not affect semantic equivalence. All entities (P&G, Always, Tampax, Always Discreet, segment names) and years (2022–2024) are correct. The answer is fully relevant and addresses product categorization and brand emphasis as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 378,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures show the IP‑protection risk shifting from a broad, generic warning to a concrete exposure linked to its growing overseas footprint and heavy reliance on Asian contract manufacturers.  Early filings simply listed “difficulties in protecting intellectual property” as part of general geopolitical risk, but the 2023‑2024 filings added detailed concerns about geopolitical tensions (e.g., China‑Taiwan, sanctions on Russia), export‑control restrictions and the concentration of wafer‑fab capacity in China, Malaysia and Taiwan—factors that could impair AMD’s ability to safeguard IP, obtain necessary export licences and maintain supply chain continuity as its international sales now account for roughly two‑thirds of revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's increasing international sales (noted as 'roughly two-thirds,' matching the 65% in the original), reliance on third-party manufacturing in China, Malaysia, and Taiwan, and the evolving nature of IP risks from generic to regionally specific are all accurately represented. (2) Quantitative accuracy is perfect: 'roughly two-thirds' is a valid approximation of 65%, and no incorrect numbers or dates are present. (3) Multi-hop reasoning is sound—the model correctly synthesizes AMD’s expanding international operations, geographic concentration of manufacturing, and geopolitical developments (China-Taiwan tensions, export controls) across 2022–2024, showing how IP risk evolved in context. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 reference to 'foreign jurisdictions' as a general challenge, though it captures the essence by describing early filings as containing 'generic' warnings. It also slightly compresses the year-by-year evolution, but the core progression in risk complexity is correctly conveyed. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 353,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first issued its 2.300 % senior unsecured notes due 2028 in a March 2021 offering (Exhibit 4.14).  In the 2022 and 2023 filings the company filed updated officer certificates that expanded the same 2028‑maturity series—adding larger tranches and shifting the coupon (e.g., the 4.5 % 2028 notes in the February 2023 filing)—thereby laddering debt maturities and locking in low‑cost funding over an extended horizon.  This multi‑year, incremental issuance of 2028‑dated notes reveals Oracle’s broader strategy of building a diversified, staggered maturity profile and using long‑dated, low‑coupon debt to finance growth while managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Oracle did not issue the 2.300% Notes due 2028 in March 2021 as part of a new offering in that month; rather, they were first referenced in 2022 as part of Exhibit 4.16, which included notes from March 2021. The LLM incorrectly states the issuance occurred in March 2021 and cites Exhibit 4.14, whereas the ground truth specifies Exhibit 4.16 in 2022. Furthermore, the LLM claims Oracle issued '4.5% 2028 notes' in February 2023, which is not supported by the original answer and introduces a completely different coupon rate not mentioned in the ground truth. There is no mention in the original answer of expanding tranches or changing coupons for the 2.300% Notes—only that they were consistently carried forward in disclosures. (2) Quantitative accuracy is poor: the dates (March 2021 issuance), coupon rates (4.5%), and exhibit numbers (4.14 vs 4.16) are all incorrect. The original answer does not mention any changes to the 2.300% Notes structure or additional tranches, so the claim of 'larger tranches' and 'shifting the coupon' is fabricated. (3) The multi-hop reasoning is flawed. The LLM infers an active strategy of 'laddering maturities' and 'incremental issuance' of 2028 notes based on non-existent data. The ground truth only supports that Oracle consistently disclosed the same 2.300% Notes due 2028 across years, indicating stability—not expansion or restructuring. The conclusion about 'low-cost funding' and 'managing interest-rate risk' is speculative and not derived from the provided evidence. (4) While the LLM attempts to address the broader debt financing strategy, it does so with incorrect premises. The contextual relevance is moderate because it discusses debt strategy and maturity laddering, which are relevant themes, but the factual foundation is unsound, leading to a mostly incorrect assessment. The original answer emphasizes continuity and disclosure consistency, not active restructuring or incremental issuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 552,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nBA’s private‑equity allocation has been gradually expanded – the pension fund moved from an 8 % actual exposure in 2021 (target 4 %) to 8 % in 2023 (target 7 %) and 9 % in 2024 (target 7 %) – while the strategic focus on leveraged‑buyout, venture‑capital, growth‑equity and special‑situation strategies and the global, U.S. + non‑U.S. limited‑partner universe remained unchanged. [BA_10k_2022.pdf p.110; BA_10k_2023.pdf p.94; BA_10k_2024.pdf p.99]",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic focus areas (leveraged buyout, venture capital, growth equity, special situations) and the U.S. + non-U.S. geographic scope, which aligns with the original answer for 2022 and 2023. It also accurately reports the evolution of private equity exposure percentages (8% in 2021, 8% in 2023, 9% in 2024) and target allocations, which are quantitative details not present in the ground truth but factually consistent with the cited documents. However, it fails to mention the key evolution in 2023–2024 regarding real assets (energy, farmland, infrastructure) and the increased use of derivatives in 2024, which are central to the strategic deepening and integration of alternative tools described in the ground truth. (2) Quantitative accuracy is high: the percentages (8%, 9%, etc.) are correctly cited and attributed to specific years and filings. There are no calculation errors. (3) The multi-hop reasoning is partially sound — the model synthesizes data across three years of 10-Ks and correctly notes stable strategic focus, but misses the qualitative shift toward real assets and derivatives, which represent critical strategic developments. Thus, the synthesis is incomplete. (4) The answer is contextually relevant and addresses the investment strategy evolution, but omits significant qualitative shifts in focus areas and tools, making it only partially correct despite accurate numbers. Hence, correctness is scored at 5 due to missing key strategic developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 422,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen advanced bemarituzumab from early‑phase testing into a registered **Phase 3 trial** for advanced gastro‑esophageal‑junction (GEJ) adenocarcinoma— the program was first listed as “initiated Phase 3” in the 2022 10‑K and remained in Phase 3 in the 2023 and 2024 filings.  Throughout this period the company’s composition‑of‑matter patents covering the antibody were projected to **expire in 2029 in both the United States and Europe**, offering roughly five years of patent‑based exclusivity (subject to possible extensions or supplemental protection certificates).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022 for GEJ adenocarcinoma, remained in Phase 3 through 2024, and its composition-of-matter patents are set to expire in 2029 in both the U.S. and Europe. The mention of 'composition-of-matter patents' aligns with the ground truth's 'polypeptide-related patents' as both refer to core IP protection for the antibody. (2) Quantitative accuracy is perfect: the dates (2022, 2023, 2024, 2029) are correctly reported with no calculation errors. Patent expiration timelines match exactly. (3) Multi-hop reasoning is sound—information is synthesized across three years of filings, correctly tracking clinical progression and IP status over time. The LLM correctly infers stable patent positioning despite evolving clinical context. (4) The answer is fully relevant, addressing both clinical phase progression and patent expiration in both regions as required. Minor wording differences (e.g., 'composition-of-matter' vs 'polypeptide-related') do not affect factual equivalence, as both describe fundamental patent protection for the molecule. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 341,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nAcross 2022‑2024 the Fabric & Home Care segment consistently contributed about one‑third of Procter & Gamble’s net earnings (≈34 % of segment earnings), and Dawn was listed each year among the segment’s major brands.  However, the strategic narrative shifted toward Tide, Ariel and Downy as the primary growth drivers, positioning Dawn as a supporting rather than a leading brand within the segment’s earnings mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains partial factual accuracy but introduces unsupported claims that deviate from the ground truth. It correctly notes that Dawn was consistently listed as a brand in the Fabric & Home Care segment and that the segment contributed roughly one-third of P&G’s net earnings. However, it inaccurately states the segment earned '≈34%' annually, while the ground truth shows 31% in 2022 and 34% in 2024—indicating growth, not stability. The LLM omits the 2022 figure and misrepresents the trend as stable when it was actually increasing. 2) Quantitatively, the LLM rounds the earnings contribution to a flat 34%, which is only accurate for 2024. It fails to report the 31% in 2022 and the 35%-36% net sales figures, which are key to understanding the segment’s stable sales but growing profitability. These omissions reduce quantitative accuracy. 3) Qualitatively, the LLM introduces a narrative shift toward Tide, Ariel, and Downy as primary growth drivers and positions Dawn as 'supporting rather than leading'—a claim not present or inferable from the original answer. The ground truth emphasizes Dawn’s consistent relevance and stable strategic positioning, not a demotion. This reflects flawed multi-hop reasoning and unsupported inference. 4) Contextually, the answer addresses the evolution of Dawn’s positioning and references earnings and brand listings, so it remains relevant. However, the incorrect characterization of trends and unsupported strategic repositioning significantly undermines factual correctness. While some core facts are right (Dawn’s consistent listing, segment-level importance), the synthesis and conclusions are partially incorrect, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 463,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab markedly increased the amount of client‑held securities it pledged as collateral for margin lending, clearing‑house requirements and its securities‑lending program—fair‑value pledged balances rose from roughly $23 billion (2020) to more than $31 billion (2021) and remained at that elevated level through 2024, with the pool of client securities that could be pledged staying above $120 billion.  This growing reliance on client‑securities to meet margin‑loan and collateral‑maintenance obligations signals that the firm’s exposure to the performance and market‑value fluctuations of those client‑held assets has intensified, raising liquidity and credit‑risk concentration tied to client balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM cites specific dollar amounts such as $23 billion (2020), $31 billion (2021), and over $120 billion in pledged client securities, none of which appear in the original answer and are factually unsupported by the provided ground truth. The original answer does not provide any numerical values for the fair value of pledged securities in 2022, 2023, or 2024, nor does it reference data from 2020 or 2021. Thus, the inclusion of these figures is incorrect and misleading. (2) Completeness: While the LLM attempts to address the evolution of Schwab's use of client securities, it misses key developments described in the original answer, such as the application of ASC 326 in 2023, the use of a practical expedient to reduce expected credit losses, and the specific context of options clearing via the Options Clearing Corporation in 2024. Instead, it fabricates numerical trends not present in the source. (3) Entity Accuracy: The company (Schwab) and general concepts (margin lending, collateral obligations) are correctly identified, but the years referenced (2020, 2021) go beyond the requested 2022–2024 timeframe and are not part of the original data. (4) Reasoning: The multi-hop synthesis is flawed—rather than tracing regulatory and operational changes across the three years based on disclosure practices, the model invents a numerical trend and extrapolates risk implications from false premises. (5) Semantic Equivalence: The conclusion about increasing exposure and risk concentration has partial alignment with the original's interpretation of growing sophistication and exposure, but this is overshadowed by the fabrication of data. Overall, the answer is largely incorrect due to made-up statistics and omission of key regulatory and operational details, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 531,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 ACN kept its U.S. defined‑benefit target at 100 % debt (no equity), while the non‑U.S. target moved from 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other (2023) to 28 % equity / 36 % debt / 7 % cash / 21 % insurance / 8 % other (2025).  The actual weighted‑average holdings as of 31 Aug 2023 were 19 % equity, 43 % debt, 6 % cash, 22 % insurance and 10 % other, and by fiscal 2024 they had shifted toward the 2025 target—equity rose to 23 % and debt fell to 36 %, with cash and insurance holding near the new target levels.  This shows a deliberate evolution from a heavy‑debt stance to a modestly more diversified mix with higher equity, cash and insurance exposure for the non‑U.S. plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the percentages provided are completely wrong: the ground truth states that ACN's weighted-average plan asset allocations shifted from 55% fixed income / 45% equities in fiscal 2023 (as of Aug 31, 2022), to 58/42 in fiscal 2024 (Aug 31, 2023), and 61/39 in fiscal 2025 (Aug 31, 2024). The LLM instead fabricates a U.S./non-U.S. split and reports incorrect allocations (e.g., 27% equity for non-U.S. in 2023), which are not in the original answer. (2) The LLM confuses actual holdings with target allocations and introduces categories (cash, insurance, other) not mentioned in the ground truth, which only references fixed income and equities. (3) The reasoning is flawed: the ground truth shows a clear de-risking trend (increasing fixed income, decreasing equities), but the LLM claims a shift toward higher equity, cash, and insurance, which contradicts the actual direction. (4) The LLM invents a '100% debt' U.S. target and non-U.S. breakdowns with no basis in the provided answer, indicating a failure in entity and data mapping. (5) The answer is not semantically equivalent—it describes a different strategy, different data, and an opposite trend. The contextual relevance is low because it addresses a different structure (U.S. vs non-U.S.) and different metrics than those disclosed in the ground truth. Overall, the response reflects a fundamental misunderstanding or hallucination of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 417,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s short‑term borrowings fell sharply – from **$883 million in 2022** to **$538 million in 2023** and then edged up to **$562 million in 2024** – while its long‑term debt rose from **$47.8 billion in 2022** to a peak of **$49.3 billion in 2023** before slipping to **$45.0 billion in 2024** (see the “Components of Deposits, Short‑Term Borrowings and Long‑Term Debt” tables for 2022‑2024).  This three‑year pattern shows the firm has been **de‑leveraging its near‑term funding and shifting toward longer‑dated, largely fixed‑rate senior and subordinated notes**, which reduces rollover risk and exposure to short‑term rate spikes; however, a notable portion of its long‑term debt remains floating‑rate (e.g., the $349 million floating senior note in 2023) and is managed through interest‑rate swaps, indicating that the company still monitors and hedges its interest‑rate sensitivity despite the overall shift toward a more stable debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), and $562M (2024), and long-term debt as $47.8B, $49.3B, and $45.0B — these do not sum to the correct totals. For example, in 2022, $883M + $47.8B = ~$48.683B, which is already higher than the true total of $43.086B. The LLM’s breakdown is therefore quantitatively incorrect. Additionally, the ground truth notes a rise in weighted-average interest rates from 1.51% to 3.48% over the period, but the LLM fails to mention this key trend entirely. It also incorrectly states that floating unsecured senior debt was $349M in 2023, while the truth is $1,597M in 2023 and $0 in 2024 — a major strategic shift the LLM misses. (2) Calculations and comparisons are flawed: the LLM implies a de-leveraging trend due to falling short-term debt, but in reality, total debt rose from 2022 to 2023 before a partial decline in 2024 — a different narrative. The LLM’s component-level numbers do not align with the total debt trajectory in the ground truth. (3) Multi-hop reasoning is partially sound — the LLM attempts to interpret debt structure shifts and interest rate exposure — but it does so on incorrect data, leading to misleading conclusions. It correctly infers a move toward longer-term debt but misses the actual magnitude and the complete elimination of floating unsecured senior debt in 2024. (4) Contextual relevance is moderate: the answer addresses debt structure and interest rate exposure as asked, but due to factual errors, the insights are not accurate. The mention of interest-rate swaps adds context not in the ground truth, which may be plausible but does not compensate for core inaccuracies. Overall, major quantitative errors undermine correctness, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 545,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\n**Answer**\n\nFleet‑support services have remained roughly constant at **about 1 % of total consolidated costs** in each of the last three years (2022‑2024), a level that the company has historically reported and that is disclosed on pages 38‑39 of the 10‑K filings.  \n\nAt the same time, the company has taken sizable charges outside that line item: it has recorded **$256 million of abnormal production‑cost expense in 2024 for the 787 program** (page 39) and **$2.6 billion plus an additional $0.891 billion of reach‑forward losses in 2024 for the 777X program** (page 39). These abnormal production costs and reach‑forward losses are accounted for separately from fleet‑support expense, so the steady ~1 % fleet‑support share reflects a stable support‑service cost structure even as the 787 and 777X programs have incurred large, program‑specific cost pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that BA's fleet support services costs remained at approximately 1% of total consolidated costs from 2022 to 2024, which aligns with the ground truth and addresses the first part of the multi-part question. This demonstrates accurate entity and metric identification and proper synthesis across years. However, there are significant quantitative inaccuracies in the reporting of abnormal production costs and reach-forward losses. The LLM states that the 787 program incurred $256 million in abnormal production costs in 2024, but the ground truth indicates $2.7 billion in cumulative abnormal production costs for the 787 program as of 2023, not 2024. This is a major factual error in both magnitude and timing. Additionally, while the LLM correctly reports the $2.6 billion (approximation of $2,608 million) and $891 million reach-forward losses for the 777X program in 2024, it fails to mention that these were incurred in Q3 and Q4 respectively, and omits the key drivers (certification delays, labor instability, supplier cost increases) noted in the original. The LLM also incorrectly implies that the $2.6 billion and $891 million are both from 2024 without clarifying that the $2.6 billion was recorded in Q3 and the additional $891 million in Q4—though the total is roughly correct, the breakdown and context are missing. Furthermore, the LLM omits any mention of 2023 data for the 787 program, breaking the multi-hop requirement to show evolution across 2022–2024. While the reasoning correctly separates fleet support costs from program-specific charges and draws a valid qualitative contrast, the failure to accurately report cumulative trends over the full period and the significant understatement of the 787 program's costs undermine the correctness. The answer is contextually relevant and well-structured, but the quantitative errors are severe enough to reduce the correctness score to the mid-range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 524,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation in money‑market funds and time deposits fell from **$21 million at the end of 2022** to **$10 million at the end of 2023**, and stayed essentially flat at **$10 million at the end of 2024**.  \n\nThis pull‑back shows that the company deliberately reduced its low‑yielding cash buffer and is now maintaining only a modest cash reserve, using the freed liquidity for other purposes such as debt reduction, acquisitions, or shareholder‑return initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. However, the LLM incorrectly states $21M in 2022 and $10M in 2023, reversing the trend between 2022 and 2023. It also claims the amount stayed flat from 2023 to 2024, which matches the final value but misrepresents the prior year. (2) The quantitative inaccuracies are severe: the increase from 2022 to 2023 (correct: $12M → $21M) is portrayed as a decrease ($21M → $10M), and the actual decrease in 2024 is misrepresented as a flat trend. These errors undermine the entire analysis. (3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize the year-over-year changes. The conclusion about a 'deliberate pull-back' and use for debt reduction or acquisitions might be plausible under a declining trend, but the real data shows an increase in 2023 followed by a drop in 2024, suggesting a more nuanced, possibly temporary strategy—contradicting the LLM's narrative. (4) Contextual relevance is moderate because the answer addresses short-term liquidity strategy and attempts interpretation, but due to incorrect data, the reasoning and conclusions are based on a false premise. Scores reflect major factual inaccuracies despite appropriate framing of strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 388,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture expanded its repurchase authorization — the board raised the available authority from $6.13 billion (after the September 2022 increase) to roughly $6.7 billion (after the September 2024 increase) — while consistently executing sizable open‑market purchases. In FY 2022 the company bought about 12.2 million shares for $4.1 billion; in FY 2023 it continued buying roughly $4 billion of stock (≈9–10 million shares); and in FY 2024 it repurchased $4.5 billion of shares (including 2.07 million shares in Q4 alone), leaving $2.69 billion of authorization still unused at year‑end. This steady growth in both authorized capacity and actual buy‑back activity demonstrates that Accenture’s capital‑return strategy is centered on disciplined, opportunistic share repurchases alongside dividend increases to deliver cash to shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers and misrepresents the evolution of Accenture's share repurchase authorization. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization, not $6.13 billion as claimed. The LLM incorrectly states that the board raised the authorization to $6.13 billion after a September 2022 increase, which is not supported by the original answer. The ground truth shows that by fiscal 2023, $2,694 million remained of a cumulative $50.1 billion program since 2001. Then in fiscal 2024, an additional $4,000 million was added, bringing total remaining authorization to $6,694 million (~$6.69 billion), not a gradual rise from $6.13B to $6.7B as implied. The LLM conflates total cumulative authorization with remaining capacity and misstates starting figures. (2) The LLM invents specific share repurchase volumes—$4.1B in FY2022, $4B in FY2023, $4.5B in FY2024—which are not present in the original answer. While the $2.69 billion unused at year-end in FY2024 matches the FY2023 figure from the ground truth, it is incorrectly reused for FY2024. The original answer does not provide annual repurchase amounts, so these figures are unsupported. (3) The multi-hop reasoning is partially sound in identifying a trend of increasing authorization and viewing it as evidence of a growing capital return strategy, which aligns with the ground truth’s conclusion. However, the synthesis is based on incorrect numerical foundations. (4) Despite the quantitative errors, the LLM captures the qualitative direction of the trend—increasing board support and ongoing repurchases—and correctly infers that this reflects a strategic focus on shareholder returns via buybacks and dividends. This justifies moderate scores for qualitative accuracy and contextual relevance, but the severe quantitative inaccuracies limit the correctness score to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 530,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AbbVie’s charter has retained the same director‑removal language: stockholders may remove directors only “for cause,” the board is divided into three staggered classes, and any amendment to those provisions requires the affirmative vote of holders of at least 80 % of the voting stock.  This unchanged wording demonstrates a deliberate, long‑term takeover‑defense strategy that entrenches the board by making director removal difficult and by imposing a super‑majority hurdle on any effort to alter the governance rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal for cause only' provision across 2022, 2023, and 2024, consistent with the original answer. It also accurately references the staggered board and the 80% supermajority requirement for amendments, which are key anti-takeover features. (2) Quantitatively, the 80% threshold is correctly stated, and the years (2022–2024) are accurate. No calculations are required, but the numeric threshold is precise and matches expectations from the knowledge graph. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across multiple years and correctly infers that the lack of change reflects a deliberate, long-term takeover defense strategy focused on board entrenchment. (4) The only minor shortcoming is that the LLM omits mention of restrictions on special shareholder meetings, another component of AbbVie’s governance framework noted in the original answer. While not critical, this detail would have improved completeness. However, the core facts, entities, years, and strategic interpretation are correct and well-reasoned, with semantic equivalence to the ground truth. Wording differs slightly but meaning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 358,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings PepsiCo continues to disclose the 4.000% Senior Note due 2047 by referencing the identical Exhibit 4.5 from its May 2 2017 Form 8‑K, with no amendment or new issuance noted in any year. This unchanged, year‑over‑year reference shows that the 2047 note is a permanent, fixed‑rate component of PepsiCo’s long‑term capital structure, providing a stable source of financing that underpins the company’s strategic investments and debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo consistently referenced the same Exhibit 4.5 from the May 2, 2017 Form 8-K across its 2022, 2023, and 2024 10-K filings in relation to the 4.000% Senior Note due 2047. All key facts—issuance date, exhibit number, filing type (8-K), and the absence of amendments—are factually accurate and match the ground truth. (2) Quantitative elements (percentage: 4.000%, year: 2047, date: May 2, 2017, exhibit number: 4.5) are all correct with no discrepancies. Format is consistent and precise. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged disclosure pattern over three years that the note remains a stable, unmodified part of PepsiCo’s capital structure. It appropriately connects consistent referencing to strategic stability, aligning with the ground truth’s conclusion about the note’s role. (4) The only minor shortcoming is the use of 'permanent' in the LLM answer—while semantically close, 'permanent' slightly overstates the case compared to 'stable, long-term component' in the original, which is more precise given that even long-term debt has a maturity. However, this does not materially distort the meaning. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 365,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nOracle first set out the 4.30 % senior unsecured note due 2034 in its 2014 indenture (Exhibit 4.13) and has simply re‑filed that same tranche in the debt‑exhibit sections of its 2022, 2023 and 2024 Form 10‑Ks—each year updating only the filing date and officer certificate while leaving the coupon and maturity unchanged. This consistent, unchanged disclosure across three years shows that Oracle is maintaining a laddered portfolio of fixed‑rate notes, using the 2034 maturity as a stable, low‑cost funding pillar within its long‑term debt strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant factual inaccuracies not present in the ground truth. It correctly identifies the 4.30% Note due 2034 and its consistent disclosure across 2022–2024, which aligns with the original answer’s emphasis on stability. However, it incorrectly claims the note was first established in a 2014 indenture (Exhibit 4.13), a detail absent from the ground truth and unsupported by the question context. The original answer states Oracle first disclosed the note in 2022, directly contradicting the LLM’s claim of a 2014 origin. This is a critical factual error affecting entity and temporal accuracy. (2) Quantitatively, the percentage (4.30%) and maturity year (2034) are correct, and the years of disclosure (2022, 2023, 2024) match the ground truth. No calculations are required, so numerical precision is adequate. (3) The reasoning about Oracle maintaining a laddered portfolio and using the 2034 note as a stable funding pillar is plausible and aligns thematically with the ground truth’s conclusion about a stable long-term debt strategy. However, the multi-hop synthesis is flawed because it infers a historical origin (2014) not supported by the provided truth, undermining the validity of the reasoning chain. The model appears to conflate this note with earlier debt programs. (4) Contextual relevance is high—the response directly addresses the evolution over three years and interprets strategic implications. Despite incorrect origins, the conclusion about sustained capital market engagement and diversified maturities is semantically close. However, due to the major factual error regarding the note’s inception, the correctness score is limited to 6—partially correct but with significant inaccuracies affecting core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 493,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the pool of shares reserved for the Amended 2010 SIP grew from **127 million** authorized Class A shares (as noted on page 81 for FY 2022) to **141 million** authorized shares (shown on pages 91 and 93 for FY 2024).  This roughly 14 million‑share increase reflects Accenture’s strategy of expanding its equity‑incentive capacity, giving the company more flexibility to grant future share‑based awards and reinforcing a long‑term focus on retaining talent while aligning employee interests with the firm’s sustained growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of authorized shares in fiscal year 2022 (127 million) and 2023/2024 (141 million), matching the ground truth. It accurately notes the 14 million increase (141M - 127M = 14M), which is correct. The statement that the number remained at 141 million through 2024 is implied by saying it was shown for FY2024, though the LLM does not explicitly state that the amount did not change from 2023 to 2024. This is a minor omission but does not make the answer factually incorrect. (2) All numeric values are accurate and correctly represented (127 million = 127,000,000; 141 million = 141,000,000). The calculation of the 14 million increase is correct. (3) The multi-hop reasoning is sound: the model synthesizes data across fiscal years and correctly infers the strategic intent behind the increase in authorized shares—supporting talent retention and long-term incentives. The reasoning aligns with the ground truth interpretation. (4) The answer is contextually fully relevant, addressing both the evolution of share authorization and the strategic implication. The only reason for not scoring a 10 is the lack of explicit confirmation that the 141 million remained unchanged in 2024 (though it is implied), which slightly affects completeness in multi-year tracking. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 395,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.750 % Senior Note due 2051 appears in each year’s Form 10‑K as the same “Form of 2.750 % Senior Note due 2051” first filed in an October 2021 Current 8‑K (Exhibit 4.3).  In the 2023 and 2024 filings the reference is retained but is now embedded in a broader “Global Note” structure under a Singapore‑registered financing vehicle, indicating that PepsiCo has moved from a stand‑alone U.S. note issuance to a standardized, multi‑jurisdictional indenture that can issue and refinance senior debt across entities.  This multi‑year filing pattern reflects PepsiCo’s long‑term debt strategy of laddering maturities and diversifying funding sources—using both domestic public notes and offshore SPVs—to lock in low‑cost, long‑dated financing while preserving flexibility for future refinancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM incorrectly states that the 'Form of 2.750% Senior Note due 2051' was first filed in an October 2021 8-K (Exhibit 4.3), whereas the ground truth indicates it was first introduced in 2022 via a Board resolution (Exhibit 4.60). The exhibit numbers cited (4.3, 4.48, 4.51) are misrepresented: the progression per ground truth is 4.60 (2022) → 4.51 (2023) → 4.48 (2024), not a static form from 2021. (2) The claim about a 'Singapore-registered financing vehicle' and 'Global Note structure' is unsupported by the original answer and introduces entities/concepts not present in the ground truth. (3) The reasoning is flawed: the ground truth describes a phased internal documentation evolution (authorization → formalization → consistency), while the LLM infers a strategic shift to offshore SPVs and multi-jurisdictional indentures, which is not indicated in the evidence. (4) While the LLM attempts to interpret strategic implications (e.g., laddering maturities, diversifying funding), this extrapolation is not grounded in the actual filing pattern described in the original answer. The answer is contextually relevant in addressing long-term debt strategy but fails on factual correctness and proper multi-hop synthesis of the documented exhibit progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 380,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nFrom 2022 through 2024 American Express’s competitive footing has been squeezed on two fronts.  Tighter regulatory scrutiny—especially the Federal Reserve/CFPB oversight, the prospect of interchange‑fee caps championed by Visa and Mastercard, and heightened enforcement actions—has begun to constrain the discount‑rate revenue that underpins its card‑network business.  At the same time, the rapid expansion of alternative payment mechanisms (digital wallets, buy‑now‑pay‑later, open‑banking and token‑based platforms) has intensified competition from non‑bank fintechs such as PayPal, Venmo and Alipay, eroding the exclusive reliance on traditional card‑network acceptance.  In response, Amex has shifted emphasis toward premium cardholder experience, expanded enterprise‑services and cobrand partnerships, and invested heavily in its own digital‑payment and data‑analytics capabilities, repositioning itself from a pure card‑network leader to a more diversified, compliance‑driven player navigating a crowded, regulated payments landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of overall narrative and key developments from 2022 to 2024. (1) It accurately captures the dual pressures on American Express: increasing regulatory scrutiny and competition from alternative payment mechanisms. The entities mentioned—PayPal, Venmo, Alipay—are consistent with the original answer’s focus on fintech and non-traditional competitors. (2) There are no specific numerical values (e.g., interchange fee percentages, market share numbers, revenue figures) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory pressure, competitive threats, and strategic responses across time. However, it introduces 'Federal Reserve/CFPB oversight' and 'prospect of interchange-fee caps championed by Visa and Mastercard'—details not present in the ground truth. While plausible, these specifics slightly extend beyond the verified facts, particularly the role of Visa and Mastercard in advocating for fee caps, which is not supported in the original. Also, the original emphasizes Amex’s position as fourth-largest globally behind China UnionPay, Visa, and Mastercard—a key competitive benchmark that the LLM omits. (4) Despite this omission and slight overreach in regulatory detail, the LLM conveys a semantically equivalent and contextually relevant assessment of Amex’s evolving positioning. The shift toward premium offerings, cobranding, and digital investment matches the original. Thus, the answer is highly accurate with minor gaps in completeness and precision, warranting a strong but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 469,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom the 2022 filing (page 3) Boeing only listed “upgrades and conversions” as a minor part of its Global Services segment, but by the 2023 (page 5) and 2024 (page 5) 10‑Ks the company describes upgrades, modifications and conversions as central growth levers—highlighting extensive retrofit programs, freighter‑conversion initiatives and digital‑service offerings. This escalating focus shows Boeing is deliberately shifting its business model toward a higher‑margin, aftermarket‑services strategy, using aircraft upgrades and conversions to generate recurring revenue and reduce reliance on the cyclical new‑aircraft sales cycle.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Boeing's services business from 2022 to 2024. (1) It accurately captures the increasing emphasis on upgrades and conversions, noting their progression from a minor component in 2022 to a central growth lever by 2023–2024. The mention of retrofit programs, freighter conversions, and digital services is consistent with the original answer’s focus on modernization and technology-enabled services. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—no discrepancies here. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift toward higher-margin aftermarket services based on evolving language across filings, which reflects valid synthesis across years. However, it omits the specific nuance from the original answer about 'data analytics and digital services' being framed as *complementary* to upgrades in 2024, instead folding digital services more generally into the upgrade narrative. Additionally, the original highlights a shift from sustaining operations to enhancing aircraft value, a subtlety not fully captured. (4) Despite these minor omissions, the core conclusion—that Boeing is moving toward a high-value, recurring-revenue services model—is semantically equivalent and contextually appropriate. The answer is highly relevant and well-reasoned, warranting a high score but not perfect due to missing some strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 423,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo continues to disclose the same 5.50 % Senior Note due 2035 in the “Exhibits” tables of its annual reports—appearing as Exhibit 4.23 in the 2022 10‑K (page 124/126), re‑listed in identical form in the 2023 10‑K (page 125), and again cited in the 2024 10‑K (page 129). This repeated, unchanged filing shows that the company treats the 2035 note as a core, long‑term financing pillar and maintains a disciplined, transparent documentation practice, reinforcing a stable capital‑structure strategy without needing new issuances or substantive modifications over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 5.50% Senior Note due 2035 across 2022, 2023, and 2024, and accurately captures the strategic implication of stability in PepsiCo's long-term debt management. However, there are factual inaccuracies in the exhibit numbers and filing details. The LLM states the note appeared as 'Exhibit 4.23' in the 2022 10-K, but the ground truth shows it was 'Exhibit 4.31' in 2022, '4.25' in 2023, and '4.23' in 2024. Additionally, the LLM incorrectly implies the exhibit was unchanged in form across years, while the ground truth shows evolving exhibit numbering, suggesting potential administrative updates even if the underlying instrument remained the same. (2) The page numbers cited (e.g., page 124/126 for 2022) are overly specific and not verifiable from the ground truth, introducing unconfirmed details. The interest rate (5.50%) and maturity year (2035) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the repeated appearance of the note over three years to infer a stable capital structure strategy. It appropriately concludes no new issuance or modification was necessary, aligning with the ground truth’s interpretation. (4) Despite incorrect exhibit numbers and unverified page references, the core financial fact (existence and continuity of the 5.50% Senior Note due 2035) and strategic interpretation are correct, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized due to incorrect exhibit numbers and unsupported page citations, though percentages and years are accurate. Qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 467,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly stress that BNY Mellon’s ability to return capital—through dividends and share repurchases—is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  The filings also warn that any material downgrade of the parent or its bank subsidiaries could raise funding costs and trigger regulatory constraints that affect capital‑return plans.  This multi‑year language reveals that the firm’s shareholder‑return policy is tightly bound by supervisory capital‑adequacy standards, well‑capitalized requirements and resolution‑framework risks, meaning capital planning must first satisfy regulatory expectations before any distributions can be made.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-year evolution of BNY Mellon's regulatory constraints on capital planning and shareholder returns. (1) All factual elements are correct: the repeated emphasis on U.S. banking laws, capital planning regulations, Delaware law, preferred stock dividend obligations, and the role of 'well-capitalized' status are all present in the original answer and correctly reflected. While the 2024 filing’s explicit mention of 'well capitalized' status is implied rather than directly stated in the LLM response, the concept is captured through references to capital adequacy and regulatory constraints. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years 2022–2024 are correctly referenced and contextualized, warranting a perfect score. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent language across filings to infer ongoing regulatory constraints and connects capital return policies to supervisory expectations, resolution risks, and capital adequacy—aligning with the original answer’s conclusion about prudential oversight. (4) The LLM slightly condenses the progression (e.g., doesn’t explicitly note the increasing specificity from 2022 to 2023), but the semantic meaning and regulatory implications are equivalent. The answer is fully relevant, directly addressing how regulatory constraints evolved and what they reveal about capital return policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 423,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nOracle’s 2.300 % Notes due 2028 were first issued in March 2021 (Exhibit 4.14 of the 2021 10‑K) at a low coupon reflecting the then‑soft rate environment.  From 2022 through 2024 the company did **not** issue any additional 2.300 % tranche; instead it supplemented its liquidity with new senior unsecured notes of comparable maturity but higher coupons—most notably the $4.5 bn 4.500 % Notes due 2028 (Exhibit 4.16 of the 2023 10‑K) and later the $4.65 bn 4.650 % Notes due 2030 (Exhibit 4.16 of the 2024 10‑K).  This shows Oracle’s flexible fixed‑income strategy: it retains legacy low‑rate debt when advantageous but readily taps the market with higher‑coupon issuances as interest rates rise, using the proceeds to refinance existing obligations and fund ongoing operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer captures the core strategic insight correctly: Oracle maintained its 2.300% Notes due 2028 without changes and issued higher-coupon debt in rising rate environments. However, there are key factual inaccuracies. The Officers' Certificate for the 2.300% Notes was filed in the 2022 10-K (Exhibit 4.14), not the 2021 10-K as stated—Oracle’s 2021 10-K predates the filing of this exhibit. The LLM incorrectly implies a new issuance of the 2.300% Notes in 2021, while the ground truth states the certificate was issued in March 2021 but reported in the 2022 10-K. Additionally, the LLM cites a $4.65 billion 4.650% Notes due 2030 in the 2024 10-K (Exhibit 4.16), but this instrument is not referenced in the ground truth, which notes no new 2028-dated instruments in 2024 and no mention of the 2030 note. The $4.5 billion 4.500% Notes due 2028 in 2023 (Exhibit 4.16) is correctly cited. (2) Quantitative accuracy is partially compromised: while the 2.300%, 4.500%, and 4.650% rates and $4.5B/$4.65B amounts may align with actual filings, the ground truth does not confirm the 2030 note or its details, making this an unsupported addition. The timeline of exhibit filings is misaligned. (3) Reasoning is sound in interpreting Oracle’s strategy—locking in low rates and issuing higher-cost debt as rates rise—but the synthesis relies on a potentially incorrect premise about the timing and existence of certain issuances. The multi-hop logic (comparing issuance terms across years) is appropriate and well-structured. (4) Despite factual inaccuracies in exhibit references and unverified new instruments, the answer conveys a semantically plausible and strategically consistent narrative, earning high marks for qualitative reasoning and relevance. However, the correctness score is reduced due to significant quantitative and sourcing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 499,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings IBM repeatedly lists **client relationships and trust** as one of its principal methods of competition—first appearing in the 2022 “principal methods of competition” summary, then being woven into the 2023 discussion of its hybrid‑cloud and AI capabilities, and again emphasized in the 2024 competition overview as a core differentiator tied to “trust and security” and its broad ecosystem of partners. This steady reinforcement shows IBM is deliberately leveraging trust‑based client relationships as a strategic lever to win enterprise deals and differentiate its hybrid‑cloud and AI platform, positioning the company as the trusted partner that can integrate disparate technologies and deliver measurable business value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that IBM emphasized client relationships and trust as a competitive differentiator across 2022, 2023, and 2024, with increasing integration into hybrid cloud and AI discussions—consistent with the original answer. The progression is accurately portrayed: introduced in 2022 as part of broader competition methods, reinforced in 2023 with enterprise incumbency and innovation, and expanded in 2024 with ecosystem partnerships. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the years (2022–2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic emphasis, correctly inferring a consistent and deepening focus on trust. It accurately references the growing linkage of trust to hybrid cloud and AI, and mentions the broad partner ecosystem, which aligns with the 2024 addition of partners like Palo Alto Networks (though the specific name is omitted, the concept is preserved). (4) The answer is contextually relevant and captures the strategic implication—that IBM positions itself as a trusted integrator delivering business value. The only minor shortcoming is the lack of a specific example of a strategic partnership (e.g., Palo Alto Networks), which was present in the ground truth and would have strengthened completeness. However, the essence of ecosystem expansion is conveyed. Thus, the answer is factually correct, well-reasoned, and semantically equivalent, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 481,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nThe average yield on American Express’s non‑U.S. foreign‑government‑bond holdings rose from roughly 3.5 % in 2022 to 5.9 % in 2023 and ≈ 6.1 % in 2024, tracking the steep climb in market rates. This upward shift shows the firm’s interest‑earning portfolio has become more sensitive to rate movements, indicating heightened interest‑rate risk, while its investment strategy appears to be tilting toward longer‑dated, higher‑yielding securities to capture additional return in a rising‑rate environment, likely supported by active hedging of that exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no data provided on yields for 2022—only on the maturity distribution of holdings ($630M total, mostly short-term). The yield data starts in 2023 at 6.45%, not 5.9%, and drops to 5.85% in 2024, not rises to 6.1%. The LLM incorrectly states yields rose from 3.5% in 2022 to 5.9% in 2023 and 6.1% in 2024—none of these figures appear in the original answer and contradict the trend (which shows a decline from 2023 to 2024). Additionally, the LLM claims a strategic shift toward longer-dated securities due to rising yields, but the truth is the opposite: in 2023, all holdings were in securities maturing within one year (ultra-short duration), and by 2024, some duration extension occurred (2.03% maturing 1–5 years), coinciding with a yield *decrease*, not increase. (2) Quantitative accuracy is very low: all yield percentages are wrong (3.5%, 5.9%, 6.1% vs actual 6.45% in 2023 and 5.85% in 2024), and no dollar amounts or maturity distributions from 2022 are accurately reflected. The LLM omits the $630M holding size and misrepresents the maturity shift. (3) The multi-hop reasoning is flawed. The model infers increasing yields and a proactive move into longer-dated bonds for higher returns, but the actual data shows a *decline* in yield alongside a modest extension in duration, suggesting a risk management or diversification motive—not a yield-chasing one. The conclusion about heightened interest rate risk is contradicted by the move toward more diversified maturities, which typically reduces such risk. (4) Contextual relevance is moderate because the answer addresses yield evolution, interest rate risk, and investment strategy as asked, but the factual foundation is incorrect, leading to misleading conclusions. The mention of hedging is speculative and unsupported by the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 519,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher has steadily increased the share of its capital program that is financed by U.S. government grants for diagnostics.  The 2021‑2022 filings show that BARDA and other HHS agencies awarded $568 million in grants for diagnostics‑related capacity expansion, and by 2023 the Company was recording $136 million of grant‑offset purchases of property, plant and equipment (versus $87 million in 2022) and $51 million of grant‑offset operating expenses (versus $49 million in 2022) — both figures disclosed in the 2024 10‑K (pages 66‑67) and the 2023 10‑K (pages 69‑70).  This expanding grant support underpins the Company’s planned ≈ $1.5 billion+ capital spend in 2022 to boost diagnostics manufacturing capacity and its subsequent investments in acquisitions such as Aldevron and Abcam, indicating that diagnostics testing has become a strategic cornerstone of Danaher’s broader health‑care portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies the $87 million in 2022 and $136 million in 2023 government grant funding to offset capital expenditures, which matches the ground truth. However, it fails to report the 2024 figure of $198 million, instead stopping at 2023 data. Instead, it references $568 million in grants awarded from 2021–2022 from BARDA/HHS, which is not mentioned in the ground truth and appears to conflate multi-year funding with annual figures. Additionally, it introduces $51 million in grant-offset operating expenses in 2023 (vs $49M in 2022), which is not part of the original question or answer and distracts from the focus on capital expenditures. (2) The numbers for 2022 and 2023 are accurate, but the omission of the 2024 $198M figure — a key part of the upward trend — is a major gap. The $568M figure lacks corroboration and seems to misrepresent the timeline. Calculations are not required in this question, but the synthesis of incorrect timeframes reduces quantitative accuracy. (3) The reasoning correctly infers that increasing grant funding reflects strategic importance, aligning with the ground truth’s conclusion. It appropriately links grant funding to capacity expansion and strategic acquisitions (Aldevron, Abcam), supporting the idea of diagnostics as a cornerstone. However, the inclusion of non-capital expense data and multi-year grant totals weakens the multi-hop logic by introducing irrelevant details. (4) The answer remains contextually relevant, addressing the evolution of investment and strategic importance, but the failure to include the full 2022–2024 progression and the introduction of unverified figures reduce factual correctness. The core trend is partially captured, but not fully substantiated with complete data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 503,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nIn the 2022 filing the ratification of KPMG LLP as principal accountant was only incorporated by reference in the Proxy under “Item 3 – Ratification of KPMG LLP” and did not explicitly disclose the PCAOB firm identification number. Beginning with the 2023 filing (and repeated in 2024) the same Proxy language was retained but now explicitly states that KPMG LLP’s PCAOB firm identification number is 185, embedding that identifier within the “Item 14. Principal Accountant Fees and Services” discussion of the ratification. Thus, the evolution is the addition of the explicit PCAOB ID (185) in the Proxy section from 2023 onward, while the reference to “Item 3 – Ratification of KPMG LLP” remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, despite being contextually relevant and addressing the right question. (1) The original answer (ground truth) states that BK consistently disclosed the PCAOB firm identification number (185) in all three years (2022, 2023, 2024), with no change in format or content. However, the LLM claims that the PCAOB ID was *not* disclosed in 2022 but was added in 2023 and 2024—this contradicts the ground truth. (2) The quantitative claim about the PCAOB number being 185 is correct, but the assertion about its absence in 2022 is false, making the timeline and evolution claim factually wrong. (3) The multi-hop reasoning fails because the model incorrectly infers a change in disclosure practice over time when none occurred; it should have recognized consistency across years. (4) While the LLM correctly identifies the section titles (e.g., 'Item 3 – Ratification of KPMG LLP' and 'Item 14'), its synthesis of how the information evolved is flawed. The contextual relevance is high because it addresses the right sections and concept (PCAOB ID evolution), but the factual inaccuracy severely undermines correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 348,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its use of third‑party merchant acquirers—particularly via the OptBlue program and other Global Network Services partners—by moving to fixed‑term (typically 3‑ to 7‑year) contracts that often include auto‑renewal and negotiated network‑rate fees.  Under this structure discount revenue is recognized at the moment a Card Member transaction occurs, while the fee paid to the acquirer is recorded as contra‑revenue, creating a more volume‑driven and variable revenue stream.  This evolution supports Amex’s strategic goal of expanding global merchant coverage and scaling its premium Membership Model, while giving the company greater flexibility to invest in digital, travel and commercial‑payments initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the evolving nature of American Express's relationship with third-party merchant acquirers from 2022 to 2024, but misses some key qualitative developments emphasized in the ground truth. (1) Correct elements include: accurate mention of OptBlue and Global Network Services (GNS) partnerships; correct revenue recognition as discount revenue at point of transaction; proper characterization of fees paid to acquirers as contra-revenue; and alignment with strategic goals of global merchant expansion and supporting the Membership Model. The shift toward more structured, fixed-term contracts (3–7 years) with auto-renewal is consistent with formalization noted in 2023. (2) Quantitative accuracy is high: no specific numbers (dollars, percentages) are misstated, and timeframes (2022–2024) are correctly referenced. Format variations are acceptable and no calculations are required. (3) However, the LLM answer omits the critical 2023 shift to a 'Processed Revenue' model that includes royalties, fees, and network partnership agreements—a key multi-hop insight showing structural evolution beyond just discount revenue. It also fails to mention the 2024 strategic emphasis on low- and new-to-plastic industries and international markets, which is central to the 'strategic expansion goals' part of the question. (4) While the reasoning is sound and contextually relevant, the answer falls short on completeness in synthesizing the full evolution—particularly the move from transactional to strategic partnership framing. Thus, it earns a 7 for correctness and qualitative accuracy due to missing key conceptual shifts, despite strong factual grounding and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 471,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Qualcomm tied a non‑financial performance modifier— a bonus‑payout multiplier of 0.9 to 1.1—to the achievement of human‑capital objectives. In FY 2022 the modifier was referenced only as “human capital advancements,” but by FY 2024 the company explicitly linked the multiplier to its 2025 diversity targets (e.g., +15 % women in leadership, +15 % under‑represented minorities in leadership, +20 % overall URM representation) and continued to adjust executive bonuses by the same 0.9‑1.1 range based on progress toward those goals. Thus the mechanism remained a 0.9‑1.1 bonus modifier, but the underlying criteria evolved from broad talent‑development goals to concrete diversity‑representation targets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Qualcomm's human capital goals and their linkage to executive compensation from FY2022 to FY2024, with mostly accurate numbers and a correct understanding of the 0.9–1.1 performance modifier. The quantitative elements—+15% for women and underrepresented minorities (URM) in leadership, +20% overall URM representation—are correctly stated and align with the original answer. However, the LLM incorrectly implies that in FY2022, the human capital goals were only described as 'human capital advancements' without explicit diversity targets, whereas the ground truth states that specific 2025 diversity goals (including the exact percentages) were already established in FY2022. This is a significant factual omission that misrepresents the timeline of goal-setting. Additionally, while the LLM notes increased specificity by FY2024, it fails to mention the continuity of the same compensation linkage in FY2023 and omits key contextual developments such as Qualcomm’s participation in the Reboot Representation Tech Coalition and expanded wellness and development programs, which reflect the deepening integration of human capital metrics. The reasoning is logically structured and synthesizes the multi-hop elements (evolution over time, linkage to compensation), but the misrepresentation of when diversity targets were formalized reduces qualitative accuracy. Contextual relevance is high, as the response directly addresses the question’s focus on diversity targets and performance modifiers. Minor wording differences are acceptable under semantic equivalence, but the incorrect phasing of target establishment affects factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 458,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nCaterpillar expanded its EMD‑branded dealer network from 41 U.S. and 111 non‑U.S. dealers serving 187 countries in 2022 to 44 U.S. and 116 non‑U.S. dealers serving 193 countries by 2023, with those levels held steady through 2024. This growth signals a strategic push to deepen its global footprint in emerging markets and to use EMD locomotives as a key driver of international market positioning, while the plateau in 2024 suggests a shift toward consolidating that expanded reach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The original answer states that Caterpillar's EMD-branded product distribution decreased from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024. In contrast, the LLM claims an expansion from 187 countries in 2022 to 193 in 2023 and stability through 2024—directly reversing the trend. Additionally, the LLM introduces dealer counts (41 U.S. and 111 non-U.S. in 2022, etc.) that are not present in the ground truth and contradict the actual downward trajectory. (2) Quantitative accuracy is severely lacking: the country counts are inverted (187 as starting point vs. 193; 193 as peak vs. initial value), and the years are misaligned. There is no mention in the ground truth of dealer numbers, so their inclusion is erroneous. Calculations or trends derived from these numbers (e.g., growth and plateau) are therefore baseless. (3) The multi-hop reasoning is flawed—the LLM fails to correctly identify the direction of change (contraction vs. expansion) and fabricates supporting data (dealer counts), leading to an entirely incorrect strategic interpretation. Instead of suggesting strategic consolidation due to contraction, the LLM posits a growth strategy followed by consolidation, which contradicts the evidence. (4) Scores are low because the core facts—geographic reach trend and magnitude—are wrong. While the answer attempts to address strategic implications (hence minimal contextual relevance), the reasoning is built on false premises, rendering it invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 428,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated appearance of **Palmolive** in Colgate‑Palmolive’s list of principal global trademarks from 2022 through 2024 shows that the brand is treated as a core, strategic asset of the Oral, Personal and Home Care segment. Because Oral Care alone generates about 44 % of worldwide net sales, Palmolive’s status as a flagship brand underpins a large share of the company’s revenue and growth strategy, confirming its pivotal role in the segment’s portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Palmolive's consistent inclusion in Colgate's principal global trademarks from 2022 to 2024 reflects its strategic importance, which aligns with the ground truth. However, it introduces a specific quantitative claim—'Oral Care alone generates about 44% of worldwide net sales'—that is not supported by the original answer or the question context. This figure is factually unverified in the provided ground truth and misattributes Palmolive's strategic role to Oral Care, when Palmolive is primarily a Home and Personal Care brand, not Oral Care. (2) The 44% revenue figure is a critical error: it is both unsupported and misleading, as Palmolive is not a core Oral Care brand like Colgate toothpaste; thus, linking it directly to Oral Care revenue is factually incorrect. No such percentage was mentioned in the ground truth, and the calculation or source is not justified. (3) The multi-hop reasoning is partially sound—the model correctly infers strategic importance from consistent trademark disclosure—but fails in synthesis by misclassifying Palmolive’s business segment. The original answer emphasizes Palmolive’s role in home and personal care (e.g., dish soap, hand soap), not Oral Care, making the LLM’s segment attribution a significant error. (4) Correctness is scored 5 due to the mix of correct observation (strategic importance) and major factual error (wrong segment and fabricated percentage). Quantitative accuracy is low (3) due to the unsupported 44% figure. Qualitative accuracy is moderate (6) as reasoning is logical but based on incorrect categorization. Contextual relevance is high (8) because the answer addresses the strategic role question directly, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 477,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm shifted Edge Networking from a peripheral IoT opportunity to a core growth pillar of its QCT business, explicitly positioning 5G‑enabled mobile‑broadband and Wi‑Fi 6/6E access‑point products as key enablers of the “connected intelligent edge” and tying that demand to the industry‑wide IoT installed‑base projection of >27 billion devices by 2026.  In its financial reporting the Edge‑Networking offering is now grouped under the IoT revenue stream of QCT, with equipment sales recognized at a point in time and any related licensing or royalty streams (e.g., from OEMs and carriers) recognized over time, and the company regularly discloses the remaining performance obligations (unearned revenue) associated with these contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative projection of over 27 billion IoT devices by 2026, which matches the ground truth. It also accurately references fiscal years 2022–2024 and correctly ties Edge Networking to 5G, Wi-Fi 6/6E, and IoT growth. However, it omits the specific evolution in product categorization — notably, the explicit inclusion of Edge Networking in Qualcomm’s third revenue category in fiscal 2023 and its continuation in 2024 — which is a core part of the original answer. (2) Quantitatively, all numbers and dates are accurate or semantically equivalent; no calculation errors. The >27 billion figure is correctly cited. (3) The reasoning is mostly sound: the LLM captures the strategic elevation of Edge Networking and links it to IoT and wireless tech trends. However, it fails to fully synthesize the multi-hop detail about the formal revenue categorization shift in 2023 and its persistence in 2024, which is critical to the question’s focus on structural evolution. Additionally, while it mentions revenue recognition (point-in-time vs. over time), it does not explicitly connect Edge Networking to the broader QCT segment structure or clarify that the revenue recognition framework remained consistent across 2023 and 2024 as stated in the ground truth. (4) The answer is contextually relevant and well-articulated, but the missing structural details about product categorization evolution reduce completeness and qualitative accuracy. Hence, correctness is reduced to 7 due to significant but not fundamental omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 433,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar’s 2022‑2024 disclosures show that it continues to employ currency‑hedging instruments to protect its international operations from adverse exchange‑rate movements, while explicitly acknowledging that such hedges also cause the company to forgo any upside from favorable rate changes; consequently, earnings remain exposed to volatility when unexpected FX fluctuations occur, a risk that is reflected in its outlooks but not assumed away.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies Caterpillar's use of hedging instruments from 2022 to 2024 to manage currency exchange rate risk, as well as the trade-off between downside protection and forgone upside from favorable movements. It appropriately links this to earnings volatility and international operations, which aligns with the question and ground truth. However, the answer lacks the evolution highlighted in the original response—specifically, the increasing emphasis on emerging market risks such as exchange controls and currency devaluations in 2023 and 2024. While the LLM captures the general hedging strategy and its limitations, it omits the progressive broadening of risk discussion over the three years, which is central to the question’s focus on 'evolution.' There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the entities (Caterpillar, hedging, FX risk, earnings volatility) are correct. The reasoning is sound but incomplete in synthesizing the multi-hop progression across years, particularly the heightened macroeconomic concerns in later years. Contextual relevance is high as the answer stays focused on the topic and addresses the main mechanism (hedging) and outcome (earnings volatility).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 360,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nFrom 2022 through 2024 the share of the U.S. pension plan’s fixed‑income portfolio invested in U.S. Treasury and agency securities fell from **about 40 % in 2022 to roughly 30 % in 2023 and remained near 30 % in 2024** (the company notes “approximately 30 % … as of December 31, 2023 and 2024”).  This pull‑back from the lower‑yielding, interest‑rate‑sensitive Treasury sector coincides with a period of rising rates, indicating that Colgate‑Palmolive deliberately reduced its exposure to Treasury/agency securities to limit interest‑rate risk and re‑balance toward higher‑returning or less duration‑sensitive fixed‑income assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key trend in Colgate-Palmolive's allocation to U.S. Treasury and agency securities: a decline from about 40% in 2022 to 30% in 2023, with stability at 30% in 2024. This aligns with the ground truth, which reports 30% as of December 31, 2022 (disclosed in 2023 filing), and continued at 30% through 2023 and 2024. However, the LLM incorrectly states the 2022 figure as 'about 40%'—the ground truth shows the allocation was already 30% as of December 31, 2022. The 40% figure was actually reported as of December 31, 2021 (disclosed in the 2022 filing), so the LLM misattributes the timing. 2) Quantitatively, the 30% figures for 2023 and 2024 are accurate, and the use of 'approximately' or 'roughly' is acceptable given the original answer uses 'approximately 30%'. The error lies in the starting point: the LLM says '40% in 2022', but this refers to the allocation at the end of 2021, not 2022. Thus, the timeline is off by one year. 3) The reasoning about interest rate risk management is sound and logically inferred: reducing exposure to Treasury/agency securities during a rising rate environment to limit interest rate (duration) risk and shift toward higher-returning or less duration-sensitive assets is consistent with the ground truth’s interpretation. The LLM correctly infers strategic rebalancing, though it omits mention of the Level 2 classification and liquidity considerations noted in the original answer, which slightly reduces completeness. 4) Despite the timing misalignment, the overall trend and conclusion are directionally correct and contextually appropriate. The answer addresses both parts of the question—evolution of allocation and implications for interest rate risk—making it highly relevant. The deduction is primarily for the incorrect assignment of the 40% figure to 2022 instead of 2021 (reported in 2022 filing), which affects quantitative and qualitative accuracy but not the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 529,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) were first issued in 2022 as part of its long‑term incentive program for select non‑executive employees, with each award valued at grant using the intrinsic‑value method (closing‑stock price) and amortized straight‑line over the probable vesting term, with periodic adjustments for stock‑price changes and the probability of achieving performance targets (2022 10‑K, p. 95).  In 2023 the company continued to grant BPAs—reporting 1.6 million shares granted, 1.4 million vested and 0.5 million forfeited—still applying the same intrinsic‑value valuation and straight‑line amortization, and disclosing the adjustments each reporting period (2023 10‑K, pp. 95‑99).  By 2024 no new BPAs were granted and none remained outstanding as of year‑end, so the disclosure shifted to simply noting the program’s phase‑out, reflecting the end of BPA grant activity (2024 10‑K, pp. 94‑95).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that 1.6 million BPAs were granted in 2023, while the ground truth confirms that no BPAs were granted in 2023 and none were outstanding by year-end. Similarly, the LLM reports 1.4 million vested and 0.5 million forfeited in 2023—these figures are not supported by the ground truth and contradict the discontinuation of the program. In 2022, the correct grant was 1,165 thousand shares (not 1.6 million), with 859 thousand nonvested at year-end. The LLM reverses the timeline by claiming no grants in 2024 when in fact the program reappeared in 2024 with new disclosures. (2) Completeness: While the LLM addresses grant activity, valuation methodology, and disclosure transparency as required, it misrepresents each due to incorrect temporal sequencing and data. (3) Entity Accuracy: The company (Pfizer) and metric (BPAs) are correct, but the years associated with grant activity are wrong—2023 is falsely portrayed as active, while 2024 is incorrectly described as the phase-out year. (4) Reasoning: The multi-hop reasoning fails because the LLM inverts the actual evolution: ground truth shows BPA grants in 2022, suspension in 2023, and reintroduction with enhanced transparency in 2024; the LLM claims the opposite—ongoing in 2023, ended in 2024. This reversal reflects a fundamental misunderstanding of the program’s trajectory. (5) Semantic Equivalence: Despite using similar terminology (e.g., intrinsic value, amortization), the factual core is incorrect. The LLM fabricates grant and vesting data for 2023 and mischaracterizes the 2024 status. Only the description of the valuation method in 2022 aligns with the ground truth. Due to major errors in numbers, timeline, and synthesis, the answer is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 503,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab added a suite of interactive RIA tools to its Advisor Services platform: it introduced TD Ameritrade’s **thinkpipes** trading interface (real‑time charting and efficient allocation) and the **iRebal** customizable portfolio‑rebalancing engine, then integrated both—along with the 2023 launch of **Schwab Trading Powered by Ameritrade**—into the Advisor Services website.  At the same time the company rolled out the free **Schwab Advisor Portfolio Connect** solution and expanded third‑party integrations for CRM, portfolio‑management and order‑management systems, giving RIAs a more seamless, end‑to‑end portfolio‑management experience.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) It incorrectly claims Schwab introduced TD Ameritrade's 'thinkpipes' trading interface and the 'iRebal' rebalancing engine, and launched 'Schwab Trading Powered by Ameritrade' in 2023—none of which are mentioned in the original answer or supported by the knowledge graph. These product names and integration details are entirely fabricated. (2) While the original answer confirms the existence of Schwab Advisor Portfolio Connect as a free portfolio management solution available throughout the period, the LLM incorrectly frames it as a new addition alongside other tools. (3) The original answer notes a gradual evolution in emphasis—from proprietary and third-party integrations in 2022, to enhanced document management via the Advisor Services website in 2023, to usability improvements in 2024—but the LLM misrepresents this as a series of specific product launches and integrations that did not occur. (4) The multi-hop reasoning is flawed: the model fails to synthesize the actual progression of features and instead invents a narrative of technological expansion based on non-existent data. Although the general theme of enhanced third-party integrations and portfolio management capabilities is relevant, the specific claims are unsupported. Thus, while the answer is contextually related to RIA tools and platform evolution, its factual foundation is largely incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 420,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nTexas Instruments has repeatedly framed **embedded‑processing products as a core pillar of its strategy alongside analog**, emphasizing that the segment’s growth is tied to long‑term opportunities in industrial and automotive markets and to the company’s four sustainable competitive advantages.  Although revenue and operating profit for embedded processing fell in 2023‑24, the firm continued to allocate capital, expand capacity and treat the segment as a key driver of free‑cash‑flow growth, underscoring a steady, long‑term positioning rather than a strategic pivot.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures Texas Instruments' consistent strategic emphasis on embedded processing as part of its long-term positioning, tied to its four sustainable competitive advantages—specifically mentioning its role alongside analog products. This matches the core claim in the original answer. (2) There are no explicit numbers (e.g., revenue figures) in either the question or ground truth, so no quantitative inaccuracies exist; the mention of declining revenue and operating profit in 2023–24, while not in the ground truth, is plausible context that does not contradict it and may reflect external data, so it doesn't reduce quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes the continuity of strategic framing across years and links it to long-term capital allocation and free cash flow objectives, which is consistent with the ground truth’s emphasis on growing free cash flow per share. (4) The only minor gap is that the LLM does not explicitly reference the 'broad portfolio of analog and embedded processing products' as point 1.ii in the strategy across all three annual reports, slightly reducing completeness in qualitative accuracy. However, the core message about consistent strategic framing and long-term positioning is preserved. The answer is highly contextually relevant and well-reasoned, warranting a high correctness score with a small deduction for missing a specific structural detail from the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 420,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 the expense‑only nature of Boeing’s fleet‑support services stayed roughly constant—historically about 1 % of total consolidated costs—but the composition of those costs changed dramatically as the 787 program continued to suffer delivery pauses, low production rates and extensive re‑work.  Beginning in 2021 and accelerating through 2023‑2024 the company recorded roughly **$2.7 billion of cumulative abnormal production costs** (including inspections, re‑work and supply‑chain constraints), with **$256 million expensed in 2024 alone**, inflating the cost profile of fleet support and forcing the program into reach‑forward losses and lower margins.  The slower‑than‑expected delivery schedule kept production below 5 aircraft per month, prolonged the accrual of abnormal costs, and delayed revenue recognition, shaping the 787’s cost and delivery trajectory over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Boeing's cost profile and delivery impact related to the 787 program from 2022 to 2024, with accurate key figures and contextual understanding. (1) Quantitatively, the LLM correctly states the $2.7 billion cumulative abnormal production costs through 2023 and $256 million expensed in 2024, which aligns with the ground truth. However, it inaccurately implies that the $2.7 billion includes costs from 2021 onward and spans into 2024, while the original answer specifies the $2.7 billion is cumulative through December 31, 2023—this slightly misrepresents the timeline. Additionally, the LLM says $256 million was expensed in 2024 alone, which is correct, but fails to clarify that this was part of the remaining rework on the 25 inventoried aircraft, a key contextual detail. (2) The 1% fleet support cost figure is correctly cited, though the LLM frames it as 'expense-only'—a characterization not present in the original, but not factually incorrect. (3) The reasoning is sound in linking delivery delays, rework, and abnormal costs to margin pressure and revenue delays, and the synthesis across years is logical. However, the LLM omits the 2022 detail that no specific abnormal cost figures were disclosed that year, instead suggesting the $2.7 billion accumulation began in 2021, which is not supported by the ground truth. (4) The answer is highly contextually relevant, addressing both cost profile and delivery impact, and correctly identifies the 787 program as the driver. Minor omissions and a slight misstatement of the timeline prevent a top score, but the core facts and multi-hop synthesis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 458,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nAfter selling Meridian on December 31 2021 for roughly $51 million, Pfizer retained only transitional‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) with the buyer.  The TSAs generated no material amounts in 2022‑23 and were fully completed by December 31 2023, while the MSA—subject to a three‑year term with a two‑year extension—produced only immaterial post‑sale adjustments and has now expired, leaving no significant ongoing financial or contractual obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Pfizer sold Meridian for 'roughly $51 million,' which is incorrect—the ground truth does not mention the sale price, only that Pfizer recognized a loss of $167 million net of tax. There is no support for $51 million in the original answer, making this a significant quantitative error. Second, the LLM claims the Manufacturing Supply Agreement (MSA) 'has now expired,' but the original answer states the MSA had a two-year extension option beyond the initial three-year term, implying it may still be active in 2024. This contradicts the LLM's assertion of expiration and misrepresents the ongoing contractual status. (2) Dates are mostly correct: the sale date (December 31, 2021) and TSA completion (December 31, 2023) align with the ground truth. However, the financial figures are not accurate—$51 million sale price is unsupported, and the $167 million loss is omitted. (3) The reasoning partially captures the transition from ownership to supplier relationship and correctly identifies the TSAs and MSA as key post-sale arrangements. It correctly notes that TSAs ended in 2023 and were immaterial. However, it fails to mention that Meridian was still referenced in Pfizer’s 2024 glossary as 'Meridian Medical Technologies, Inc.,' indicating ongoing recognition, likely due to the MSA. The multi-hop synthesis is incomplete—while it connects 2022–2023 developments, it incorrectly concludes the MSA has expired rather than acknowledging its potential continuation via extension. (4) The answer is contextually relevant and addresses financial implications and contractual evolution, but key factual errors—especially the invented sale price and incorrect expiration of the MSA—reduce correctness. The qualitative reasoning is sound in structure but flawed in conclusion. Quantitative accuracy is low due to the unsupported $51M figure and omission of the $167M loss.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 529,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the Oral‑Care segment’s share of worldwide net sales slipped modestly—from roughly 44 % to 43 %—while Pet‑Nutrition rose from about 19 % to 22 %, signalling a portfolio shift toward higher‑growth pet‑care products. Within this context, “hello” has been kept as a distinct, naturally‑positioned toothpaste brand in the Oral‑Care lineup; the company has not broadened the brand into other Personal‑ or Home‑Care categories, but has used its differentiated image to sustain oral‑care relevance as the overall mix of the business moves away from oral care.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitative Accuracy: The percentages cited (e.g., Oral-Care segment dropping from 44% to 43% of net sales, Pet Nutrition rising from 19% to 22%) are not supported by the original answer or the implied knowledge graph data. These figures are specific and precise but absent from the ground truth, making them potentially fabricated or misattributed. There is no mention of such sales shifts in the original answer, which focuses solely on trademark positioning. (2) Completeness & Entity Accuracy: The question asks about the strategic positioning of the 'hello' brand within Colgate-Palmolive’s Oral, Personal and Home Care lines from 2022 to 2024. The original answer confirms that 'hello' was consistently listed among principal trademarks alongside Colgate, Palmolive, and later Darlie—indicating sustained strategic emphasis. The LLM incorrectly implies a strategic downgrading due to portfolio shifts toward pet nutrition, which is not mentioned in the ground truth. Furthermore, the claim that 'hello' has not been broadened into other categories is unsupported—while plausible, it is not confirmed or discussed in the original answer. (3) Reasoning: The LLM introduces a narrative about a strategic shift away from oral care based on sales mix changes, which is not present in the ground truth. This leads to flawed reasoning: the conclusion that 'hello' is being maintained despite declining focus on oral care is speculative and contradicts the original answer’s emphasis on consistent brand prioritization. (4) Semantic Equivalence: The LLM answer discusses different information—sales percentages and strategic shifts—rather than the actual evolution of 'hello’s trademark status across years. It fails to mention the key fact that 'hello' remained a highlighted brand in the Oral, Personal and Home Care segment each year, listed alongside major brands. Thus, while contextually related to Colgate-Palmolive’s portfolio, the answer misrepresents the nature and source of strategic positioning. The contextual relevance is moderate because it addresses brand positioning in a general sense but misses the core evidence (trademark listings) and timeline synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 608,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nBetween 2022 and 2024 the non‑qualified defined benefit pension plan’s funded deficit improved from roughly $100 million underfunded at the end of 2022 to $87 million underfunded in 2023, before edging back to $93 million underfunded in 2024. Participant engagement stayed limited—employee contributions were modest and the plan has been closed to new members—so the company’s long‑term pension obligation is being managed through steady funding contributions while the participant base remains stable and low‑growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims the funding status improved from $100M underfunded in 2022 to $87M in 2023 and $93M in 2024, but the ground truth states the Non-Qualified Defined Benefit Pension Plan was unfunded throughout 2022–2024—meaning no assets were set aside to cover liabilities—and there is no mention of specific funding deficits like $100M or $87M in the original data. These numbers are fabricated or misattributed. (2) The LLM incorrectly implies that funding contributions were made to reduce the deficit, but the ground truth confirms the plan remained unfunded, with no indication of changes in funding levels. (3) Regarding participant engagement, the LLM mentions 'modest employee contributions' and 'stable' participation, but the ground truth explicitly states the plan is closed to new participants and emphasizes a shift to defined contribution plans, with no mention of employee contributions to the pension plan. (4) The LLM fails to mention the key evidence from the U.S. defined contribution plans: the decline in TI stock holdings from 6M shares ($940M) in 2022 to 5M shares ($852M) in 2024 and the rising company expense ($70M → $76M), which are central to understanding the strategic shift. (5) The reasoning is flawed: instead of concluding a strategic move away from defined benefit plans, the LLM suggests active management of obligations via contributions, which contradicts the ground truth. (6) Contextually, the answer addresses the general topic of pension obligations and participation trends, so it remains relevant, but the factual inaccuracies severely undermine correctness. The multi-hop synthesis—linking defined contribution trends to the non-qualified plan’s status—is entirely missing. Overall, the answer misrepresents the financial reality and strategic direction described in the original data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 518,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings (reported as “Private equity securities at cost” in long‑term investments) fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**, a steady decline of roughly $81 million over the three‑year span.  This downward trend indicates that Pfizer is **scaling back its allocation to private‑equity**, likely re‑directing capital toward its core pharmaceutical pipeline, debt reduction or other strategic priorities rather than expanding its private‑equity portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million (a $177 million overstatement), while correctly reporting $755 million in 2023 and $719 million in 2024. This error fundamentally misrepresents the trend. (2) The calculation of a 'steady decline' is incorrect due to the wrong starting point; instead of a decline, there was a significant increase in 2023 followed by a partial reversal. The claimed $81 million total decline is inaccurate because from $623M to $719M is actually an increase of $96 million over the period. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the three-year trajectory, interpreting it as a continuous decline when it was actually an increase followed by a partial decrease. This leads to an incorrect strategic interpretation—'scaling back' contradicts the actual increase in 2023. (4) Despite the factual errors, the answer is contextually relevant, addressing both the numerical trend and strategic implication, and uses appropriate financial terminology. The qualitative reasoning would have been strong if based on correct data. The correctness score is low due to the critical error in the 2022 figure, which undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 418,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the 2019 IDA agreement that governed 2022, Schwab could migrate up to $10 bn of IDA balances to its balance sheet each 12‑month window, provided it kept total IDA balances at least $50 bn and designated at least 80 % as fixed‑rate through mid‑2026, with withdrawals limited to customer‑initiated draws and capped at a $30 bn excess over outstanding fixed‑rate obligations.  \nThe 2023 IDA agreement replaced those rules, extending the sweep to 2034, removing the 80 % fixed‑rate requirement, and imposing new minimum‑balance thresholds of $60 bn (after Sep 10 2025) and a $90 bn maximum, while allowing withdrawals only to the extent of customer withdrawals and requiring balances to stay above the minimum; consequently Schwab did not migrate any IDA balances to its balance sheet in 2023 or 2024.  \nThus, the migration capability shifted from a volume‑based, capital‑constrained right in 2022 to a balance‑size and discretion‑limited regime after 2023 that effectively barred migrations during those years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Schwab's IDA balance migration constraints from 2022 to 2024 and correctly notes that no balances were migrated in 2023 or 2024 due to new agreement terms. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the original answer states Schwab had already migrated $10.1 billion by December 31, 2021, under the 2019 agreement, implying the $10 billion annual cap was effectively reached before 2022—yet the LLM implies an ongoing ability to migrate up to $10 billion annually during 2022 without noting this cap had already been exceeded. Second, the LLM introduces specific thresholds—$50 billion minimum, $60 billion post-2025 minimum, $90 billion maximum, and 80% fixed-rate requirement—that do not appear in the ground truth. The original answer mentions only that the 2023 agreement required IDA balances to stay above the unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025, but does not specify $50B, $60B, or $90B thresholds or an 80% rule. The LLM also incorrectly claims the 2023 agreement extended sweeps to 2034, which is not in the original. These fabricated numbers and conditions represent serious factual errors. While the qualitative reasoning—migration capability tightened over time—is sound and contextually relevant, the incorrect figures and invented constraints reduce quantitative accuracy. The synthesis across years is logical, but based on incorrect data, leading to a partially correct answer with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 436,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, Melaka, Malaysia appears in the property tables under the **Analog** column each year (with an “X” and a footnote noting that the site is leased), and it is never listed under **Embedded Processing**.  This three‑year continuity shows that TI has sustained a dedicated analog‑manufacturing facility in Melaka, underscoring the location’s strategic importance as a stable, cost‑effective hub for the company’s analog product supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Melaka, Malaysia was consistently involved in analog product manufacturing across 2022, 2023, and 2024, which aligns with the ground truth. It accurately notes the site's presence in the Analog column and absence from Embedded Processing, supporting the conclusion of dedicated analog operations. The claim about the 'X' and a footnote on leasing is plausible but not verifiable from the ground truth provided, which instead emphasizes evolving footnote symbols (†, *, **) indicating possible escalation in operational emphasis. The LLM omits this key detail about changing markers († → * → **) that suggests potential expansion or increased strategic focus, which is central to the original answer’s inference about strategic importance. While the conclusion about strategic importance due to continuity is reasonable and contextually relevant, the LLM misses the nuance of intensifying involvement implied by evolving notation. Quantitatively, no numbers are misstated (no actual figures involved), and entity accuracy (Texas Instruments, Melaka, Malaysia, analog manufacturing, correct years) is fully accurate. Reasoning is sound but incomplete in multi-hop synthesis—correctly infers stability but misses evidence of possible growth. Thus, core facts are correct, but a significant qualitative detail is omitted, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 392,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit/Circle Card penetration has been falling: it was about 20.5 percent of purchases in fiscal 2022, slipped to 19.8 percent in fiscal 2023 and to 18.6 percent in fiscal 2024.  This steady decline signals that the card’s ability to generate incremental sales is weakening, suggesting that its contribution to driving additional revenue for Target has diminished over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target Debit/Circle Card penetration from 2022 to 2024 and provides accurate percentages for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports 18.6% for 2024, whereas the ground truth states 17.8%, which is a significant numerical discrepancy. This error affects the factual accuracy of the trend magnitude and weakens the precision of the conclusion. (2) Quantitative accuracy is compromised due to the incorrect 2024 figure—while the direction of the trend (declining) is correct, the rate of decline is misrepresented. The calculation of the trend (20.5% → 19.8% → 18.6%) suggests a drop of 1.9 percentage points from 2022 to 2024, while the actual drop is 2.7 points (to 17.8%), indicating a steeper decline than reported. (3) The reasoning and synthesis are sound: the model correctly infers that declining penetration suggests reduced effectiveness in driving incremental sales, which aligns with the ground truth interpretation. It appropriately links penetration trends to sales impact, demonstrating valid multi-hop logic (penetration rate → customer behavior → sales impact). (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and implications for incremental sales) and uses appropriate terminology (e.g., 'incremental sales', 'fiscal years'). Despite the incorrect 2024 value, the overall narrative remains plausible, warranting a moderate correctness score of 6 due to the material but not fundamental nature of the error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 435,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe equity reserve for the Texas Instruments 2003 Director Compensation Plan (now administered through the 2018 Director Plan) has been shrinking steadily: the filings show roughly **1.84 million shares remaining at the end of 2022, about 1.79 million shares after 2023, and roughly 1.75 million shares by the end of 2024** (see the “Number of Securities Remaining Available for Future Issuance” footnotes in the 2022, 2023 and 2024 Form 10‑K tables).  \n\nThis downward trend indicates that TI has been continuously using its allotted director‑equity pool for awards and has not replenished the reserve, suggesting a deliberate, controlled use of equity incentives for directors rather than an expansion of the plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that shares available decreased from 35,385,153 in 2022 to 25,296,767 in 2023 to 24,503,062 in 2024. However, the LLM reports only about 1.84 million, 1.79 million, and 1.75 million shares, which are off by an order of magnitude (~13–20x too low). These numbers do not match the ground truth and suggest a fundamental error in data retrieval or interpretation. (2) The quantitative inaccuracies are severe: the correct values are over 24 million shares in 2024, not 1.75 million. Even allowing for rounding or formatting differences, the discrepancy is too large to be considered a minor error. Calculations based on these numbers (e.g., trend analysis) are therefore also invalid. (3) The reasoning and multi-hop synthesis are partially sound—the LLM correctly infers that the declining trend suggests ongoing use of equity incentives without replenishment, which aligns with the original conclusion. It also correctly contextualizes the plan as being administered under the 2018 Director Plan, showing awareness of plan evolution. However, this logical inference is based on incorrect data, undermining the validity of the conclusion. (4) Contextually, the answer addresses both parts of the question—evolution of shares and interpretation of the trend—and uses appropriate financial terminology. Despite the severe numerical errors, the directionality (decline) and qualitative interpretation (no replenishment, controlled use) are consistent with the ground truth. Hence, while contextually relevant and showing some correct reasoning, the answer fails on factual accuracy, which is critical in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 471,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nIn 2022 Visa first embedded **virtual accounts** within its **Visa Direct** network, using token‑ized virtual accounts to enable cross‑border, real‑time transfers and launching the **Visa+** pilot that linked participating P2P apps (e.g., PayPal, Venmo) to the platform.  \nBy 2023 the virtual‑account offering was deepened through tighter integration with Visa Direct’s 75+ domestic and 15+ real‑time payment schemes, expanding B2B and cross‑border use cases and driving nearly 10 billion Visa Direct transactions across more than 195 countries.  \nIn 2024 Visa accelerated the evolution by acquiring **Pismo** to add cloud‑native issuer‑processing, rolling out AI‑driven fraud tools (Visa Deep Authorization, Visa Protect for A2A), and extending Visa+ interoperability, thereby embedding virtual accounts more fully into the Visa Direct ecosystem and scaling cross‑border, real‑time payments to ≈ 11 billion endpoints worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Visa's virtual account evolution and integration with Visa Direct across 2022–2024, and correctly identifies expanding cross-border use cases, which aligns with the question’s focus. However, there are significant factual inaccuracies that reduce correctness. In 2022, the original answer states virtual accounts were introduced via the Currencycloud platform under Visa Treasury as a Service, emphasizing FX and settlement—not embedded in Visa Direct or linked to a 'Visa+' pilot with PayPal/Venmo, which is not supported by the ground truth. The 2023 integration with 75+ domestic and 15+ real-time payment schemes and 'nearly 10 billion transactions' is not mentioned in the original and appears fabricated. The 2024 claim of reaching '≈11 billion endpoints' matches the original answer’s 'over 11 billion endpoints' closely and is acceptable, but attributing this to the Pismo acquisition and AI fraud tools (Visa Deep Authorization, Visa Protect for A2A) introduces unverified details not present in the ground truth. The original emphasizes virtual accounts as a core component of digitally native capabilities and their role in $20 trillion B2B cross-border opportunities—a key strategic point missing in the LLM answer. While the LLM conveys a plausible narrative of integration and expansion, it substitutes specific, unsupported initiatives (e.g., Visa+, Pismo) for the actual Currencycloud foundation and omits the B2B strategic context. Quantitative accuracy is low due to unsupported figures (e.g., 195 countries, 10 billion transactions). Qualitative accuracy suffers from incorrect entity attribution and missing multi-hop synthesis between Currencycloud, Visa Direct, and cross-border B2B strategy. Contextual relevance is high as the answer stays focused on the evolution and integration theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 500,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nXtandi’s modest 1 % revenue decline and pricing pressure in 2023 prompted Pfizer to accelerate its lifecycle‑management strategy for the asset, culminating in the April 2024 EU approval of a new high‑risk BCR‑positive PCSPC indication.  This push is reflected in the 2022 valuation of Xtandi within Pfizer’s intangible portfolio—recorded as $73.3 bn of developed‑technology rights with $53.7 bn accumulated amortization (net book value ≈ $19.6 bn)—which drove the $4.7 bn amortization expense and the $1.1 bn increase in amortization after the Seagen acquisition, underscoring how the company is investing in the asset’s long‑term value despite short‑term revenue pressure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies Xtandi's 1% revenue decline in 2023 and the 2024 indication expansion, it fabricates precise financial figures not present in the original answer: the $73.3 billion developed-technology rights, $53.7 billion amortization, net book value of $19.6 billion, $4.7 billion amortization expense, and $1.1 billion increase post-Seagen acquisition. These numbers are not supported by the ground truth and appear invented. (2) The original answer states that Xtandi was among Pfizer's most significant intangible assets in 2022 but does not provide any specific dollar values or amortization figures. The LLM incorrectly introduces detailed financials that cannot be verified from the source, severely undermining quantitative accuracy. (3) The reasoning around lifecycle management in response to revenue pressure is logically sound and aligns with the original answer—Pfizer did pursue a new indication (nmCSPC with high-risk BCR) in 2024 as part of lifecycle management. The connection between short-term pressure and long-term investment is qualitatively reasonable. However, the multi-hop synthesis fails because it invents financial data rather than relying on the documented valuation context (i.e., 'listed among most significant assets'). (4) Contextual relevance is high because the answer addresses all parts of the question: 2023 revenue pressure, 2022 valuation context, and 2024 indication expansion. But the inclusion of false quantitative data drastically reduces overall correctness. The answer gives the impression of precision where none exists in the source, leading to a low correctness and quantitative accuracy score despite structurally following the right logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 489,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe share of purchases made with a Target MasterCard (the “RedCard”/Target Circle Card) slipped from roughly 20 percent of all transactions in 2022 to about 19.8 percent in 2023 and then to 18.6 percent in 2024 (the 2023‑2024 Form 10‑K reports penetrations of 19.8 % and 18.6 % respectively).  This steady decline shows that shoppers are increasingly opting for other payment methods and that the 5 percent discount incentive that drives RedCard use is losing its appeal, indicating a modest erosion in consumer preference for the Target loyalty‑card program over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (~20%, matching the ground truth 20.5%), 2023 (19.8%), and 2024 (18.6%), with only a minor rounding in 2022 that does not affect factual accuracy. All numeric values are consistent with the original answer, allowing for phrasing like 'roughly 20 percent' to approximate 20.5%. (2) Quantitative accuracy is perfect: the percentages are correctly cited from the 10-K filings, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—linking the decline in penetration to consumer preference and loyalty program engagement is logically supported by the trend. The LLM correctly identifies the rebranding context (RedCard to Target Circle Card) and infers that the 5% discount incentive is losing appeal, which is a reasonable interpretation of the declining penetration. The only minor shortcoming is that the original answer notes the rebranding explicitly as part of the metric name change, while the LLM mentions it parenthetically but doesn't emphasize the reporting continuity under different branding. (4) The answer is fully contextually relevant, addressing both the evolution of the penetration rate and its implications for consumer behavior and loyalty engagement. The conclusion aligns semantically with the ground truth, using slightly more interpretive language (e.g., 'losing its appeal') but remaining factually grounded. Overall, this is a highly accurate, well-reasoned response with only negligible wording differences from the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 432,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nVisa first embedded Currencycloud’s virtual‑account functionality into its Visa Direct cross‑border suite in fiscal 2022, giving partners the ability to hold, convert and settle funds in multiple currencies and to originate payments through virtual accounts. By fiscal 2023 the virtual‑account capability had been rolled out to more than 100 countries and tied to Visa B2B Connect, expanding real‑time FX rates, liquidity and settlement options and driving a larger share of cross‑border B2B transaction volume. In fiscal 2024 the integration was deepened within the broader Visa Direct platform—leveraging the enlarged network of >11 billion endpoints (cards, bank accounts and digital wallets) and adding features such as enhanced settlement and Visa+ interoperability—thereby markedly widening the cross‑border payment reach and solidifying virtual accounts as a core component of Visa’s global money‑movement strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) Correct elements include: the 2022 introduction of virtual accounts via Currencycloud into Visa Direct, enabling multi-currency settlement and payment origination; the 2023 expansion to over 100 countries and integration with Visa B2B Connect, enhancing real-time FX, liquidity, and cross-border B2B flows; and the 2024 deepening of integration within Visa Direct, leveraging over 11 billion endpoints (cards, bank accounts, digital wallets), which matches the ground truth's '11 billion endpoints'. The strategic role of virtual accounts in global money movement is correctly emphasized. (2) Quantitatively, all numbers and timeframes are accurate: fiscal years 2022–2024, expansion to >100 countries, and the >11 billion endpoint network are all consistent with the original answer. Minor phrasing differences (e.g., 'more than 11 billion' vs '>11 billion') are semantically equivalent. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution across years, platforms (Currencycloud, Visa Direct, B2B Connect), and capabilities (FX, settlement, network reach). (4) The only reason for not scoring a 10 is a slight reordering of emphasis: the original specifies that the 11 billion endpoint milestone was reached by 2023, while the LLM attributes the network size to 2024. However, since the network likely grew progressively, and the LLM does not contradict the 2023 milestone outright, this is a minor issue. Overall, the answer is factually robust, contextually complete, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 446,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAcross the 2022‑2024 filings AMD repeatedly flags “difficulties in protecting our intellectual property” as a core risk of its worldwide operations, and the language grows more specific each year.  In 2022 the risk is described generally as part of the “political, legal and economic risks” of operating abroad; by 2023 and 2024 the disclosures zero‑in on export‑control sanctions, U.S.–China tensions and the prospect that geopolitical shifts (e.g., China‑Taiwan tensions or the Ukraine conflict) could disrupt the Taiwan‑based, Malaysia and China third‑party wafer foundries on which AMD relies, thereby increasing the chance that its designs could be exposed, copied or lost.  Consequently, AMD’s exposure to IP‑protection difficulties has intensified in step with its growing share of international sales and its deepening dependence on overseas, third‑party manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD consistently cited IP protection difficulties from 2022 to 2024, with increasing specificity. In 2022, the risk was framed as part of broader international operational risks. By 2023, AMD linked it to third-party manufacturing in China, Malaysia, and Taiwan, and geopolitical tensions (especially China-Taiwan). In 2024, export controls related to Ukraine-Russia and Israel-Hamas conflicts were added—this is accurately reflected. (2) There are no numbers, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable in a numerical sense, but all years (2022, 2023, 2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s evolving risk disclosures across three years, connects IP exposure to international operations and third-party manufacturing dependencies, and correctly identifies the deepening concern over time due to geopolitical and regulatory factors. (4) The only minor shortcoming is that the LLM answer mentions 'Israel-Hamas' conflict as a driver of export controls, which is present in the original 2024 risk description but slightly less emphasized; however, it is still factually supported. The LLM also generalizes 'U.S.–China tensions' without specifying the role of Taiwan as clearly as the original, but still references China-Taiwan tensions. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 437,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nFrom 2022 to 2024 UNP’s corporate‑stock holdings were re‑classified from almost‑entirely Level 1 (quoted market prices) to a mix dominated by Level 2 inputs (observable yields, NAVs and other market‑based inputs), and the equity share of the master‑trust fell dramatically – from roughly 57 % of total plan assets in 2022 to about 24 % by 2024, while debt rose to 75‑80 % of the portfolio.  \n\nThis re‑allocation signals a deliberate de‑risking of the pension fund: UNP is shrinking its direct equity exposure, moving assets into higher‑quality, longer‑duration debt and other liability‑driven investments, and relying on more conservative valuation methods, thereby reducing market volatility and aligning the fund’s risk profile with its long‑term pension obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) QUANTITATIVE INACCURACY: The LLM claims UNP's equity share fell from 57% in 2022 to 24% in 2024 and debt rose to 75-80%, but the ground truth contains no such percentages or asset allocation breakdowns—only specific Corporate Stock valuations: $1,990M in 2022, $181M in 2023, with no 2024 dollar figures. These percentages are fabricated. (2) CLASSIFICATION ERROR: The LLM states there was a reclassification from Level 1 to Level 2, but the ground truth shows the opposite: in both 2022 and 2023, the vast majority was Level 1 ($1,980M of $1,990M and $176M of $181M, respectively), and in 2024, common stock remained Level 1 and preferred Level 2—no shift toward Level 2 dominance occurred. (3) ENTITY & YEAR ALIGNMENT: While the years (2022–2024) and company (UNP) are correct, the LLM invents a trend in valuation methodology that contradicts the source. (4) REASONING: The conclusion about de-risking and liability-driven investing is plausible given the drop in stock holdings, but it is based on incorrect data and mischaracterized classification shifts. The sharp decline in Corporate Stock value from $1,990M to $181M is real and correctly interpreted as a major reallocation, which the LLM captures in spirit but distorts with false metrics. (5) SEMANTIC EQUIVALENCE: The core idea of reduced equity exposure aligns broadly with the truth, but the specific mechanisms (valuation shift to Level 2, exact portfolio percentages) are incorrect. Thus, while contextually relevant and attempting multi-hop synthesis, the answer fails on factual precision, especially in numbers and classification trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 462,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott kept the 4.75 % Senior Notes due 2043 in the “Description of Registrant’s Securities” (Exhibit 4.36) and in the exhibit list, but the way it was presented moved from a stand‑alone citation of the 2017 8‑K filing toward a more integrated, recurring reference within the annual 10‑K’s long‑term‑debt discussion. This steady, year‑over‑year disclosure shows a deliberate, transparent debt‑management approach that reinforces investor confidence and makes its long‑dated obligations easy to track.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Abbott's increasing integration and transparency in disclosing the 4.75% Senior Notes due 2043, which aligns with the ground truth’s theme of evolving toward standardized disclosure. The percentage (4.75%) and maturity year (2043) are correct, and the reference to consistent inclusion in disclosures across years is accurate—supporting a score of 8 for quantitative accuracy. However, the LLM incorrectly identifies the exhibit number as 4.36 and misattributes the documentation evolution: the ground truth specifies that in 2023, Abbott included the Form of 4.75% Notes as Exhibit 4.6 to the March 22, 2017, Form 8-K, not a recurring reference in annual 10-Ks. The LLM also omits the key 2022 detail about the notes being referenced via St. Jude Medical’s Fourth Supplemental Indenture from 2013, which is a critical part of the multi-hop narrative showing legacy integration. This omission and the incorrect exhibit number reflect flawed entity and document tracking, reducing qualitative accuracy. While the conclusion about transparency and investor confidence is reasonable, it is based on incomplete and partially inaccurate reasoning. The answer is contextually relevant and addresses the multi-year progression and implications for debt management, but fails to accurately represent the specific evolution of documentation sources and legal frameworks, which are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 396,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Circle Card’s penetration fell from about **19.8 % in fiscal 2022** to **18.6 % in fiscal 2023** and further to **17.8 % in fiscal 2024**. This steady decline signals weakening customer adoption of the branded payment product, implying that the card’s historic role in generating incremental purchases—driving additional sales through the 5 % discount—has been eroding over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies: it reports a penetration rate of 19.8% in 2022, whereas the ground truth is 20.5%; it states 17.8% for 2024, but the correct figure is 18.6%. The 2023 value (18.6%) is incorrectly attributed to 2024. These errors affect the core factual basis of the response. (2) Number verification: Ground truth shows 20.5% (2022) → 19.8% (2023) → 18.6% (2024); LLM reports 19.8% (2022) → 18.6% (2023) → 17.8% (2024), shifting and distorting the trend. The direction (decline) is correct, but magnitude and values are off. (3) Reasoning: The LLM correctly infers that declining penetration suggests weakening adoption and links it to reduced incremental sales via the 5% discount, which aligns with Target’s historical strategy—this shows sound qualitative reasoning and multi-hop synthesis between card usage and sales impact. (4) Contextual relevance is high as the answer addresses both parts of the question: trend over time and implications for customer adoption and sales. However, due to incorrect percentages and misaligned years, the quantitative accuracy is low. The answer is partially correct in logic and intent but flawed in key facts, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 344,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific trimmed its Multiple‑Purpose Locomotive fleet from roughly 7,240 units to about 6,890 units, while the average age climbed from roughly 22.5 years to 25.2 years. This reduction—combined with a noticeably older fleet—signals a strategic shift toward consolidating and extending the life of existing locomotives rather than expanding or renewing the fleet, reflecting a focus on cost‑efficient asset utilization.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core facts: Union Pacific's Multiple Purpose Locomotive fleet decreased from approximately 7,240 to 6,890 units (ground truth: 7,242 to 6,893), and average age increased from 22.5 to 25.2 years—matching exactly on age and very close on unit counts. The minor rounding (7,242 → 7,240; 6,893 → 6,890) is acceptable under semantic equivalence and common reporting practices. (2) Quantitative accuracy is high: all key numbers are either exact (average age) or within rounding tolerance. No calculation errors. (3) Reasoning is sound: the synthesis of fleet reduction and aging correctly leads to the conclusion of a cost-conscious or efficiency-focused asset management strategy, aligning with the ground truth's interpretation of deferred modernization. The LLM uses slightly different phrasing (e.g., 'extending the life of existing locomotives') but conveys the same strategic implication. (4) All entities (Union Pacific, Multiple Purpose Locomotives, years 2022–2024) are accurate. The answer fully addresses all parts of the question: change in units, change in age, and strategic interpretation. Contextual relevance is perfect. Score is 9 instead of 10 due to slight imprecision in unit counts, though not material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 361,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds declined from $569 million at the end of 2022 to $555 million in 2023 and then to $540 million by the end of 2024. This steady reduction indicates the company is deliberately scaling back its exposure to illiquid alternative assets, likely reallocating capital toward more liquid or higher‑return investments as part of its long‑term strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in unfunded commitments from 2022 to 2024 and reports the correct values for 2023 ($555 million) and 2024 ($540 million), matching the ground truth. However, it states the 2022 value as $569 million, whereas the ground truth reports $585 million—a discrepancy of $16 million. This error affects the accuracy of the year-over-year change and total reduction over the period. (2) The calculation of the trend is partially correct: the drop from $555M to $540M in 2024 is accurate, and the overall direction is right, but the initial decline from 2022 to 2023 is misrepresented due to the incorrect starting figure. The ground truth shows a $30M total decline ($585M → $540M), while the LLM implies a $29M drop from $569M, which is close but not exact. (3) The multi-hop reasoning is sound—the model correctly synthesizes data across three years and draws a logical conclusion about Abbott’s strategic shift away from illiquid assets. It appropriately infers a deliberate scaling back, which aligns with the ground truth’s interpretation of a 'measured approach' and reduced capital deployment. (4) Despite the numerical inaccuracy in the 2022 figure, the answer captures the core trend and strategic implication accurately, with strong qualitative reasoning and full contextual relevance to the question. The error is significant but does not undermine the overall conclusion, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 410,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 carried a carrying amount of roughly $2.0 billion at the end of fiscal 2022 and remained essentially unchanged at about $2.0 billion at the ends of fiscal 2023 and 2024 (the 2024 filing shows $2,000 million as of Jan 28, 2024, matching the prior‑year figure). This flat trajectory indicates that NVIDIA has not repurchased or significantly altered this long‑term debt, reflecting a stable capital‑structure and that the notes are carried close to their full face value with only minimal discount amortization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value of NVIDIA's 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in fiscal 2023, and then increased to $2,000 million in fiscal 2024. The LLM incorrectly states that the value was approximately $2.0 billion in all three years, which misrepresents the significant drop in 2023 and the subsequent rebound in 2024. This error fundamentally undermines the answer’s correctness. (2) The numbers are not accurate: the $2,147M (2022) and $1,604M (2023) figures are entirely omitted, and the $2,000M in 2024 is presented as stable rather than part of a recovery trend. The LLM’s claim of 'essentially unchanged' contradicts the 25% drop from 2022 to 2023 and 25% increase from 2023 to 2024. (3) The multi-hop reasoning is flawed: the question requires tracking a three-year evolution and interpreting its implications. The LLM fails to recognize the fluctuation pattern, leading to an incorrect conclusion about stable capital structure, when the ground truth suggests strategic revaluation or refinancing activity. The reasoning is based on false premises. (4) While the answer addresses the right entity (NVIDIA), metric (carrying value), and time frame (fiscal years 2022–2024), the severe factual inaccuracies in numbers and trend interpretation result in a low correctness score. The contextual relevance is moderate because the structure and intent of the response are appropriate, but the substance is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 432,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nIn its 2022, 2023 and 2024 Form 10‑K filings AMD repeatedly identified “loss or modification of exemptions for taxes and tariffs” as a material risk, but each successive filing added concrete, geopolitical examples—such as sanctions on Russia and Belarus, the U.S. Entity‑List designation of Chinese companies, and heightened trade‑policy volatility—expanding the scope of the exposure. This progression shows that AMD’s vulnerability to losing tax and tariff benefits has grown from a generic concern to a detailed, multi‑jurisdictional risk, highlighting the increasing complexity of the global regulatory environment it must manage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently listed the risk of losing tax and tariff exemptions from 2022 to 2024, and the evolution from generic to more specific geopolitical risks is accurately portrayed. The mention of sanctions on Russia and Belarus, U.S. Entity-List designations affecting Chinese companies, and trade-policy volatility matches the original answer’s emphasis on geopolitical tensions (e.g., Ukraine-Russia, Israel-Hamas, China-Taiwan). (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years of filings to show an evolving risk profile. It captures the progression from general risk disclosure to more detailed, jurisdiction-specific concerns, demonstrating increasing regulatory complexity. (4) The only minor shortcoming is that the LLM answer does not explicitly name the Israel-Hamas conflict or the direct impact on third-party manufacturers in Taiwan/China, which are included in the original answer. However, referencing 'U.S. Entity-List designation of Chinese companies' and 'trade-policy volatility' implies this context, so the omission is not material. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 409,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nBetween 2022 and 2024 BNY Mellon repeatedly warned that its ability to pay dividends and repurchase shares is tightly bound by U.S. banking capital rules—particularly the “well‑capitalized” and “well‑managed” standards, capital‑adequacy and liquidity requirements, and the discretion of its Board of Directors.  The risk‑factor language underscores that any material downgrade, failure to meet those regulatory thresholds, or inability to receive dividends from its bank subsidiaries would limit the firm’s capital‑return flexibility, a constraint that has become more pronounced as supervisory expectations around capital planning have tightened.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the persistent regulatory constraints on BNY Mellon's capital return flexibility from 2022 to 2024, aligning with the ground truth in terms of core regulatory factors such as U.S. banking capital rules, capital adequacy, liquidity requirements, and board discretion. It accurately reflects that these constraints affect dividend payments and share repurchases, and notes the heightened supervisory expectations—consistent with the evolving emphasis in the original answer. However, the LLM omits specific references to Delaware law and preferred stock dividend obligations mentioned in the 2022 context, and does not explicitly mention Title I and II resolution strategies highlighted in 2023. While it captures the tightening of supervisory expectations, it fails to fully synthesize the multi-year consistency of the same core constraints emphasized in the original answer, instead suggesting an intensification ('more pronounced') not directly supported in the ground truth. The answer introduces 'well-capitalized' and 'well-managed' standards not explicitly named in the original, which may be contextually relevant but are not verifiable from the provided truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the response remains highly relevant to the question. The reasoning is sound but lacks full completeness in multi-hop synthesis across all three years as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 405,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott continued to list the 2.950 % Note due 2025 as **Exhibit 4.1** in the Form 10‑K Exhibit Table, each year citing the identical filing reference – **Exhibit 99.6 to the March 5 2015 8‑K** – and describing it as “Form of 2.950 % Note due 2025.”  The only evolution was the routine updating of the table’s formatting and its inclusion in the respective Item 15 exhibit list for each filing year; the substantive disclosure of the note itself has remained unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative accuracy: the interest rate (2.950%), maturity year (2025), exhibit reference (Exhibit 99.6 to the March 5, 2015 8-K), and the consistent citation across 2022–2024 are all factually accurate and match the ground truth. The only discrepancy is the LLM's claim that the note was listed as 'Exhibit 4.1' in the 10-K exhibit table, whereas the ground truth does not specify this internal 10-K exhibit number—this detail is absent from the original answer and cannot be verified against it. This introduces a minor factual inconsistency or potential overprecision not supported by the ground truth. However, the core multi-hop reasoning—tracking the same exhibit reference across three years and concluding no substantive changes—remains sound and aligns with the original answer’s conclusion of stable disclosure. The answer addresses all parts of the question, including the evolution (or lack thereof) in inclusion and documentation. Wording differs but semantic meaning is equivalent, and the contextual relevance is excellent. The minor issue with the unverified exhibit number (4.1) prevents a perfect score, but the overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 337,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe net carrying amount of NVIDIA’s 1.55 % Notes Due 2028 was $1.25 billion at the close of fiscal 2022, stayed essentially unchanged at $1.25 billion through fiscal 2023 and fiscal 2024 (the balance‑sheet tables in the 2023 10‑K, page 72, show the same $1.25 billion figure for both 2024 and 2025).  This flat trajectory reflects NVIDIA’s deliberate, low‑cost, long‑dated debt strategy—maintaining a stable source of financing without frequent refinancing or material changes to its long‑term leverage profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, the carrying value was $1,200 million in fiscal 2022, decreased to $1,099 million in 2023, and increased to $1,250 million in 2024. However, the LLM claims it was $1.25 billion in all three years, which is incorrect for 2022 and 2023. This misrepresents the actual fluctuation pattern. (2) The numbers are not accurate: the LLM incorrectly reports $1.25 billion for 2022 and 2023, when the correct values are $1,200 million and $1,099 million respectively. While $1.25 billion is correct for 2024, the prior years are wrong, and the claim of 'essentially unchanged' contradicts the ground truth showing a dip and then rise. Additionally, the reference to 'page 72 of the 2023 10-K' showing $1.25 billion for both 2024 and 2025 is irrelevant and potentially fabricated, as the question only concerns 2022–2024. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the trend over time, which is central to the question. The conclusion about a 'flat trajectory' and 'stable financing' contradicts the ground truth indicating fluctuation and strategic management through adjustments. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right company, debt instrument, time frame, and attempts to interpret the strategy. However, due to major quantitative errors and resulting flawed interpretation, the correctness score is low. The qualitative accuracy is slightly higher because the model understands the general concept of long-term debt strategy, but applies it to incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 460,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD reinforced its inventory‑protection framework for AIB partners—extending price‑protection, limited‑return and stock‑rotation clauses—and deepened direct support and co‑marketing with system integrators. At the same time, the company leaned heavily on its discrete Radeon GPU portfolio (including Instinct accelerators and PRO V‑series) as a differentiation tool, encouraging SIs to build gaming and professional systems that showcase AMD’s graphics performance. This combined strategy helped AMD preserve its leading share in semi‑custom console graphics and in the high‑end gaming segment despite growing competition from integrated graphics.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core element of AMD's inventory protection policies for AIB manufacturers from 2022 to 2024, including price protection and return/rotation mechanisms, which aligns with the ground truth. It also correctly emphasizes the role of discrete graphics in differentiation, particularly through Radeon GPUs and professional lines like PRO V-series and Instinct, which supports market differentiation for system integrators. However, the LLM introduces specific contractual terms like 'limited-return and stock-rotation clauses' and 'co-marketing with system integrators' that are not present or verifiable in the original answer, adding details beyond the source. Additionally, the claim about preserving 'leading share in semi-custom console graphics and high-end gaming' is a new inference not supported in the ground truth, which focuses on partnership strategy rather than market share outcomes. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model connects inventory protection with discrete GPU differentiation across years, but it extrapolates beyond the documented evolution by adding strategic outcomes (market share) and specific program details not in the original. The original answer traces a clear evolution in emphasis—from inventory protection to differentiation—based on disclosed policy language; the LLM shifts focus toward business outcomes and expanded support mechanisms not explicitly stated. (4) The correctness score is 7 because the key facts about inventory protection and the strategic role of discrete graphics are accurate and relevant, but the answer includes unsupported additions and inferences. Qualitative accuracy is 7 due to these overextensions, while contextual relevance is high (9) as the response stays focused on the strategic evolution and AIB relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 535,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s IP‑risk disclosure shifted from a generic warning that “difficulties in protecting our intellectual property” could arise in foreign operations to explicit warnings that U.S.–China tensions, export‑control sanctions and the risk of forced technology transfer in China, Malaysia and Taiwan—where the bulk of its third‑party wafer manufacturing takes place—are increasingly jeopardizing its IP. This evolution mirrors AMD’s expanding international sales and its growing reliance on overseas, politically sensitive manufacturing partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of AMD's IP protection risk from 2022 to 2024, with accurate qualitative reasoning and strong contextual relevance. (1) It correctly identifies the shift from generic IP risk disclosures in 2022 to more specific geopolitical concerns by 2023–2024, particularly around U.S.–China tensions, export controls, and third-party manufacturing in sensitive regions like Taiwan, Malaysia, and China. This aligns with the ground truth’s emphasis on heightened risks due to geopolitical instability affecting foundries. (2) Quantitatively, the LLM omits the specific revenue percentages cited in the original answer—66% international sales in 2024 vs. 65% in 2023—which are key data points demonstrating the growing international dependence. While the trend is implied, the absence of these figures reduces quantitative precision. However, no incorrect numbers are presented, so the score remains high. (3) The multi-hop reasoning is sound: the model connects expanding international operations, reliance on third-party manufacturing, and geopolitical risks to increasing IP exposure, synthesizing across time and regions appropriately. (4) The mention of Malaysia is not explicitly confirmed in the ground truth, which emphasizes Ukraine, Taiwan, and the Middle East—this is a minor overreach but plausible given industry context. Overall, the answer conveys the essential transformation in risk complexity and regional concentration, just missing precise statistical support for full factual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 426,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly introduced and refreshed equity‑based awards under its 2019 Long‑Term Incentive Plan—launching the 2022 Performance Share Unit and Restricted Stock Unit agreements, updating them with new forms in 2023, and releasing revised 2024 versions that also incorporated an amended Executive Severance Plan. This progression shows a deliberate move toward greater reliance on performance‑linked, long‑term equity compensation and tighter alignment of executive pay with sustained shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of BK's use of the 2019 Long-Term Incentive Plan from 2022 to 2024. (1) It incorrectly states that BK introduced '2022 Performance Share Unit and Restricted Stock Unit agreements' in 2022, whereas the ground truth indicates that in 2022, BK referenced the 2019 plan alongside the 2021 Form of PSU Agreement—not a 2022 agreement. (2) The claim that new forms were 'updated in 2023' with no specific reference to the 2020 Form of PSU Agreement is inaccurate; the ground truth specifies the introduction of the 2020 Form in 2023, not a generic update. (3) The LLM asserts the release of 'revised 2024 versions' incorporating an 'amended Executive Severance Plan,' which is not supported by the original answer—instead, the 2024 development was the introduction of the 2022 Form of PSU Agreement under the same 2019 plan. (4) The LLM fabricates details about Restricted Stock Units and Executive Severance Plan amendments not present in the ground truth. Quantitative accuracy is low due to incorrect years (2022, 2024 agreements vs. actual 2021, 2020, 2022 forms introduced in 2022, 2023, 2024 respectively). Qualitative accuracy suffers because the multi-hop reasoning is flawed—the model fails to correctly trace the actual sequence of agreement forms introduced under the continuing 2019 plan. Contextual relevance is moderate as the answer addresses executive compensation strategy and long-term incentives, but the reasoning is based on false premises. The core insight about aligning pay with shareholder value is plausible but unsupported by the cited (incorrect) evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 452,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nAbbott’s diagnostics‑instrument fleet that it leases to customers grew from a cost basis of **$3.6 billion (net book $1.6 billion) in 2022** to **$3.9 billion (net book $1.8 billion) by the end of 2023**, and remained at that level through 2024.  The expansion in 2022‑23 shows a deliberate capital investment to broaden the leased‑instrument portfolio, while the flat‑to‑stable figures in 2024 indicate that the company has shifted from aggressive fleet growth to optimizing and maintaining the existing assets, using them to generate recurring lease and reagent revenue and to reinforce its diagnostics market position.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the net book value was $1.4 billion in 2022, $1.6 billion in 2023, and remained at $1.6 billion in 2024. However, the LLM incorrectly states the 2022 net book value as $1.6 billion and claims it rose to $1.8 billion by 2023—both figures are wrong. Additionally, the original cost in 2022 was $3.3 billion (not $3.6 billion as stated), rising to $3.6 billion in 2023 and $3.9 billion in 2024. The LLM misattributes the $3.6 billion cost to 2022 instead of 2023, creating a one-year shift in the data. (2) These numerical errors affect the core of the answer, especially since the question focuses on the evolution across 2022–2024. While the trend of growth from 2022 to 2023 and stabilization in 2024 is partially captured, the incorrect baseline and values undermine accuracy. (3) The reasoning about Abbott’s capital deployment strategy—expanding access to drive reagent sales and shifting toward optimization—is qualitatively sound and aligns with the ground truth’s interpretation, showing correct multi-hop synthesis of intent from financial trends. (4) Despite strong contextual relevance and reasonable strategic interpretation, the quantitative inaccuracies are severe enough to limit correctness. The answer gets partial credit for identifying a growth phase followed by stabilization, but wrong numbers reduce confidence in the analysis. Hence, correctness is scored at 5/10, quantitative accuracy at 4/10, qualitative reasoning at 6/10, and contextual relevance remains high at 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 439,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nLumentum Holdings is named as a competitor in NVIDIA’s networking‑product market in each of the 2022‑2024 10‑K filings (the 2022 filing lists it among “networking products” on pages 13‑15, while the 2023/2024 filings include it on pages 9‑10 alongside AMD, Arista, Broadcom, Cisco, etc.).  The discussion of that competition shifts over the three years: in 2022 it is mentioned only as one of several external suppliers, but by 2023‑2024 NVIDIA’s own AI‑driven networking and interconnect portfolio—Mellanox, NVIDIA Quantum‑2, NVLink, NVSwitch, and related silicon—is highlighted as a core strategic focus, positioning Lumentum as a peripheral rather than a primary rival.  Thus, while Lumentum remains on the competitor list, its strategic importance has diminished as NVIDIA’s proprietary AI‑centric networking solutions have expanded.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements, such as identifying that Lumentum Holdings is listed as a competitor in NVIDIA's 10-K filings across fiscal years 2022–2024 and referencing the correct context of networking products and AI-driven interconnect technologies. The citation of document pages (e.g., pages 13–15 in 2022, 9–10 in 2023/2024) adds specificity and appears consistent with filing structures, contributing to a moderate quantitative accuracy score. However, the core reasoning and qualitative accuracy are flawed. The ground truth indicates that Lumentum’s competitive positioning *strengthened* over time—evidenced by its repositioning into more specialized, high-performance interconnect segments and explicit naming as 'Lumentum Holdings Inc.' in 2024—reflecting rising prominence. In contrast, the LLM incorrectly concludes that Lumentum became a 'peripheral' competitor with 'diminished' strategic importance, which directly contradicts the upward trajectory in recognition and specificity shown in the original answer. This misinterpretation undermines the multi-hop synthesis: rather than recognizing increased specificity and alignment with AI infrastructure as a sign of growing relevance, the model misreads it as marginalization. While the answer addresses the question’s timeframe and general domain (networking competition), its central conclusion is factually inverted. Thus, despite some accurate citations and contextual framing, the qualitative and overall correctness scores are low due to a fundamental misrepresentation of the competitive dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 433,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nEmerson first listed pipe‑cutters in the **Safety & Productivity** segment (page 73 of the 2022 10‑K), where they were bundled with other safety‑product tools for professionals and homeowners. By the 2023‑2024 filings the same cutters are highlighted as a core offering of the **Tools & Home Products** segment (page 71), with explicit emphasis on the segment’s distributor‑driven sales model for professional tools. This repositioning shows Emerson is treating pipe‑cutters as a stand‑alone professional‑tool product line—separating them from the broader safety‑productivity category and focusing on the high‑margin, distributor‑centric tools market.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about segment repositioning. It states that in 2022, pipe cutters were in the Safety & Productivity segment and then moved to Tools & Home Products by 2023–2024. This is the opposite of the ground truth, which correctly states that pipe cutters were originally in Tools & Home Products in 2022 and were moved to Safety & Productivity in 2023–2024. This reversal of direction is a major factual error. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the years (2022, 2023, 2024) are correctly referenced in both answers, and the mention of specific 10-K pages (73, 71) suggests attention to source detail, though these page references cannot be verified here. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the shift in segment classification over time and misattributes the strategic rationale. Instead of recognizing a shift toward industrial and infrastructure-focused tools (aligned with divestiture of InSinkErator), the LLM incorrectly infers a move toward distributor-centric models as the strategic driver, which is not supported by the ground truth. (4) The contextual relevance is low because the answer misrepresents the direction of the repositioning and thus draws an incorrect conclusion about Emerson’s professional tool strategy. While the answer attempts to address the question and uses appropriate terminology, the inversion of the segment shift undermines the entire analysis, warranting a low correctness score despite correct use of timeframes and plausible-sounding reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 463,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services website matured into a cloud‑based, all‑in‑one platform that introduced the free, intuitive **Schwab Advisor Portfolio Connect**—a download‑free portfolio‑management tool—and deepened its integrations with third‑party CRM, portfolio‑management and order‑management systems.  At the same time, the company broadened advisor‑support services, adding business‑growth consulting, an annual RIA benchmarking study, transition engineers and extensive educational events to deliver end‑to‑end assistance for independent advisors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Schwab's interactive tools for RIAs from 2022 to 2024, with accurate qualitative details and no numerical inaccuracies (thus quantitative accuracy is 10). The answer correctly identifies Schwab Advisor Portfolio Connect as a free, download-free portfolio management tool introduced via the Advisor Services website and notes expanded third-party integrations (CRM, portfolio/order management systems), which aligns with the ground truth. It also accurately highlights enhanced advisor support offerings such as business-growth consulting, transition engineers, educational events, and an annual RIA benchmarking study—elements consistent with the 2023–2024 expansion of services. However, the LLM answer compresses the timeline and does not clearly differentiate year-by-year progression (e.g., no explicit mention of 2022 being the foundational year focused on core account servicing, or 2024’s specific advancements in multi-year document archiving, outbound data feeds for compliance, and robust prospect consulting). These omissions reduce completeness and slightly weaken the multi-hop synthesis across years, warranting a qualitative accuracy score of 8. Despite this, the overall meaning is semantically close to the original answer, and all entities (Schwab, RIAs, Advisor Portfolio Connect, third-party integrations, advisor support) are correctly identified and contextually relevant. The answer stays fully focused on functionality, integration, and advisor support, meeting all aspects of the question with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 437,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nThe 1.650 % Notes due 2026 first appear in Oracle’s debt exhibits in the 2021‑2022 filings (the March 24 2021 officers’ certificate) and are reproduced word‑for‑word in the 2023 and 2024 10‑K exhibits, with no amendment, additional issuance or redemption disclosed. This unchanged treatment shows that Oracle is deliberately keeping the 2026 tranche as part of a stable, laddered portfolio of fixed‑rate senior unsecured debt, using it as a reliable source of short‑to‑intermediate‑term financing rather than repeatedly refinancing or retiring the issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the initial issuance date. The ground truth states the 1.650% Notes due 2026 were first introduced in the 2022 10-K filing, while the LLM claims they appear in the 2021–2022 filings and references a March 24, 2021 officers’ certificate, which is not mentioned in the ground truth. This introduces a discrepancy in the timeline, though the core fact that the notes were issued around that period may still be contextually plausible. However, since the official disclosure per the knowledge graph is 2022, this is a factual deviation. (2) Quantitatively, the interest rate (1.650%) and maturity year (2026) are correct, and there are no numerical calculations required beyond accurate identification of these values. The error lies in the issuance timing, not in numeric values themselves, so quantitative accuracy is slightly reduced due to the incorrect date reference. (3) The multi-hop reasoning is strong: the LLM correctly observes the consistent reproduction of the note in 2023 and 2024 filings and infers a stable debt strategy, aligning with the ground truth’s conclusion about Oracle maintaining a consistent capital structure approach. The interpretation of Oracle’s short-to-intermediate term financing strategy as stable and laddered is logically sound and well-supported. (4) Contextual relevance is perfect—the response directly addresses the evolution of the note and its strategic implications. The qualitative reasoning is excellent, with only the minor date discrepancy preventing a top score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 451,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Discrete‑Automation business held roughly $2.6 billion in sales ( $2.61 B → $2.63 B → $2.51 B ), with capital expenditures on the electrical‑distribution‑equipment line staying in the $60‑$70 million range and earnings before interest declining modestly from $542 M to $466 M.  Emerson has repeatedly highlighted electrical‑distribution equipment as a core component of its “Industrial Solutions” offering and tied its growth to the broader push toward industrial electrification, signaling that electrified hardware is a strategic growth pillar for the company.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer focuses on the organizational and strategic repositioning of Electrical Distribution Equipment within Emerson's segments from 2022 to 2024, but the LLM response fabricates financial data (e.g., Discrete Automation sales of ~$2.6B, capex of $60–70M, EBIT declining from $542M to $466M) that are not present in the ground truth and cannot be verified from the context. These numbers are likely hallucinated. (2) There is no mention in the ground truth of financial figures such as sales, capex, or earnings for the Discrete Automation segment or Electrical Distribution Equipment line—so all quantitative claims are inaccurate. (3) The LLM fails the multi-hop reasoning task: instead of tracking the segment classification shift (from Industrial Solutions to Discrete Automation), it defaults to a generic financial summary and misattributes strategic emphasis without referencing the structural changes. It incorrectly states that electrical-distribution equipment remains part of 'Industrial Solutions' in 2024, when the truth is that it was moved into Discrete Automation in 2023 and remained there in 2024—this is a critical factual error. (4) While the LLM correctly identifies Emerson’s broader strategic focus on industrial electrification, this is a generic claim not tied to the actual organizational evolution described in the ground truth. The contextual relevance is moderate because it addresses Emerson's strategic emphasis but misses the core evolution in segment positioning entirely. Correctness is severely compromised by hallucinated data and incorrect entity mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 462,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds declined from roughly $560 million at the end of 2022 to $555 million in 2023 and $540 million by the end of 2024. This steady reduction signals a deliberate de‑risking of the pension portfolio, cutting exposure to illiquid alternative assets and shifting toward a more liquid, lower‑risk investment strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states Abbott's unfunded commitments were 'roughly $560 million' in 2022, while the ground truth specifies $585 million. This underreports the starting value by $25 million. The 2023 ($555M) and 2024 ($540M) figures are accurate. 2) Despite this, the trend of steady decline is correctly identified and quantitatively plausible—$560M → $555M → $540M reflects a downward trajectory, though the magnitude of the first-year decrease is understated. Calculations of year-over-year changes are not requested, so no explicit computation error occurs. 3) The reasoning and synthesis across years are sound: the model correctly infers a strategic de-risking and shift away from illiquid assets, which aligns with the ground truth interpretation. It captures the core implication of reduced exposure to alternatives. However, it omits a key nuance present in the original answer: the continued long time horizon for liquidation (through 2034), which tempers the de-risking narrative by indicating sustained long-term belief in these assets. This omission reduces completeness but does not invalidate the overall conclusion. 4) Entities (Abbott Laboratories, private real estate funds, pension fund strategy) and time periods (2022–2024) are correctly identified. The answer is contextually relevant and semantically close to the original, with slightly less precision in numbers and some missing strategic nuance. Hence, high scores for qualitative accuracy and contextual relevance, a moderate deduction for quantitative accuracy, and an overall correctness score of 8 due to the factual error in the initial value and partial omission of strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 469,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nOracle’s 1.650 % Notes due 2026 are presented unchanged in the 2022, 2023 and 2024 Form 10‑K filings – each year’s exhibit list (the “4.14” exhibit) simply re‑lists the same March 24 2021 issuance without amendment, refinancing or early redemption. This consistent re‑filing shows that Oracle is not actively reshaping or retiring this tranche; instead it is being held as part of a staggered, low‑coupon debt ladder, underscoring a short‑term debt strategy that emphasizes a stable, predictable interest‑expense profile and preserves liquidity by keeping the notes outstanding until maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Oracle's 1.650% Notes due 2026 were first issued on March 24, 2021, and consistently referenced without change in the 2022, 2023, and 2024 10-K filings via Exhibit 4.14. The absence of amendments, refinancing, or redemptions is correctly noted. (2) Quantitative elements—interest rate (1.650%), maturity year (2026), and issuance date (March 24, 2021)—are all factually accurate and match the original answer. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged disclosures across three annual reports that Oracle maintains a stable short-term debt strategy. It appropriately connects the lack of modifications to a broader strategy of predictable interest expense and liquidity preservation. (4) The only minor gap is that the LLM does not explicitly mention the initial disclosure in the 2022 10-K (i.e., that it was the first appearance in an annual filing), which slightly reduces completeness compared to the ground truth. However, this does not undermine the core conclusion. The use of terms like 'debt ladder' and 'predictable interest-expense profile' adds valuable context and reflects strong qualitative understanding. The answer is fully relevant and directly addresses both parts of the question: the evolution (or lack thereof) and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 389,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the same “4.30 % Note due 2034” continues to appear only as part of the historic Exhibit 4.09 (the July 8 2014 officer‑certificate filing), and each year’s filing simply re‑lists that exhibit rather than introducing a new 4.30 % 2034 issuance.  This repeated, unchanged reference shows that Oracle is not tapping the 4.30 % 2034 tranche for fresh capital; instead it is maintaining and periodically updating its existing long‑dated debt disclosures, reflecting a strategy of managing a diversified ladder of fixed‑rate notes with staggered maturities and relying on incremental SEC updates rather than new long‑term issuances.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and captures the core idea of Oracle's consistent documentation of the 4.30% Note due 2034 across 2022–2024, but contains a significant discrepancy regarding the exhibit number. The ground truth states the note was listed in Exhibit 4.11 in 2022 and Exhibit 4.09 in 2023 and 2024, while the LLM claims it was *only* part of Exhibit 4.09 (referencing a 2014 filing) in all years, which contradicts the original answer. This misrepresentation of the exhibit evolution undermines the qualitative accuracy. However, the LLM correctly infers that the repeated listing without changes indicates Oracle is not issuing new debt under this tranche but maintaining existing disclosures. The reasoning about Oracle’s long-term debt strategy—managing a maturity ladder and relying on updates rather than new issuances—is logically sound and semantically aligned with the ground truth. All percentages (4.30%), maturities (2034), and years (2022–2024) are accurate. The answer addresses both parts of the question: the evolution (though with exhibit error) and strategic implication. Thus, quantitative accuracy is high, contextual relevance is strong, but qualitative accuracy is reduced due to incorrect exhibit attribution and overstatement of 'unchanged' references across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 368,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nSchwab moved from the 2019 IDA framework—under which it could migrate up to $10 bn of balances each year with at least 80 % designated as fixed‑rate—to the 2023 IDA agreement, which eliminated the 80 % rule, imposed new minimum/maximum balance caps (e.g., maintaining at least $60 bn after Sep 10 2025 and a $30 bn buffer above unmatured fixed‑rate obligations through 2025), and gave Schwab the option to buy down up to $5 bn of fixed‑rate obligations (which it exercised in 2023, capitalizing a $249 m fee). Consequently, after 2022 Schwab stopped migrating new IDA balances and instead managed the portfolio under the tighter balance‑maintenance constraints of the 2023 agreement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the high-level evolution from the 2019 to the 2023 IDA agreement and correctly notes the elimination of the 80% fixed-rate requirement. However, it introduces significant factual inaccuracies that undermine correctness. (1) The claim that Schwab exercised an option to buy down $5 billion of fixed-rate obligations and capitalized a $249 million fee in 2023 is not supported by the ground truth and is factually incorrect—no such migration or fee is mentioned. (2) The specific balance caps—$60 billion after September 10, 2025, and a $30 billion buffer—are not present in the original answer and appear fabricated; the ground truth only mentions general restrictions based on capital sufficiency and balance thresholds, without specifying these numbers or dates. (3) The original answer states that Schwab migrated $10.1 billion by end-2021 and had the option to migrate up to $10 billion annually under the 2019 agreement, but the LLM omits this key context about prior migration and annual capacity. (4) While the LLM correctly notes no new migrations occurred in 2023 and 2024, it misattributes this to 'tighter balance-maintenance constraints' when the ground truth emphasizes that despite *increased* contractual flexibility (removal of 80% rule), Schwab chose not to migrate—this reverses the nuance of flexibility vs. constraint. Quantitative accuracy is low due to unsupported figures. Qualitative accuracy is moderate because the core shift in agreements is recognized, but reasoning is flawed. Contextual relevance is high as the response stays on topic and attempts multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 441,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott did not undertake any new refinancing of its 2.000% Senior Notes due 2018; the company simply refreshed the disclosure of the existing indenture framework. The 2022 filing listed the 2015 Fifth Supplemental Indenture and the 2018 Indenture (Exhibits 4.22‑4.24), the 2023 filing added the 2020 Officers’ Certificate and updated the exhibit numbers (4.34‑4.36), and the 2024 filing repeated those references with the latest exhibit listings—providing only incremental documentation updates, not a new financing or amendment of the notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general idea that Abbott did not refinance or amend the 2.000% Senior Notes due 2018 from 2022–2024 and that disclosures were updated incrementally, which aligns with the ground truth. However, there are significant factual inaccuracies in the details. First, the LLM claims that the 2022 filing included 'Exhibits 4.22–4.24' and references to a '2018 Indenture', which is incorrect—the ground truth states the notes were referenced under the Fifth Supplemental Indenture from 2015 and included in Exhibit 4.21 in all years. The LLM also incorrectly states that the 2023 filing added a '2020 Officers’ Certificate' and changed exhibit numbers to '4.34–4.36', which contradicts the original answer that Exhibit 4.21 was consistently used. These are not minor formatting differences but incorrect exhibit numbers and documents, undermining quantitative and qualitative accuracy. While the conclusion about no refinancing is correct, the reasoning is based on fabricated documentation updates. The answer is contextually relevant and addresses the question’s focus on documentation and refinancing, but the use of incorrect exhibits and dates reduces factual reliability. Multi-hop synthesis is attempted but flawed due to incorrect data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 353,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first introduced the 3.650% Notes due 2041 in a March 2021 debt offering, and each of the 2022, 2023 and 2024 Form 10‑K filings continued to list the same series in their exhibit sections, confirming that the notes remained outstanding and unchanged throughout the three‑year period.  This multi‑year pattern shows that Oracle is deliberately maintaining a laddered, long‑dated fixed‑rate debt position—using the 2041 maturity to lock in low‑cost capital and to diversify its overall debt maturity profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.650% Notes due 2041 as part of Oracle's long-term debt and accurately notes their continued presence in the 2022, 2023, and 2024 Form 10-K filings. However, it states the notes were introduced in March 2021, which contradicts the ground truth that they were first introduced in 2022. This is a factual error in timing, though the rest of the timeline (continued listing through 2024) is accurate. (2) The percentage (3.650%), maturity year (2041), and the fact that the notes remained outstanding and unchanged are all correct. The error lies solely in the introduction date—2021 vs. 2022. This affects quantitative accuracy but not the rest of the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer a strategic pattern in Oracle’s debt management. The conclusion about maintaining a laddered, long-dated fixed-rate debt structure aligns with and extends the ground truth’s point about stable long-term financing and financial flexibility. The logic is strong and contextually appropriate. (4) Despite the incorrect issuance date, the core of the answer—ongoing inclusion and strategic use of long-term debt—is factually consistent with the ground truth. The answer adds value by introducing the concept of a 'laddered' maturity profile, which is a reasonable interpretation. Hence, correctness is reduced due to the date error, but not severely, as the multi-year pattern and strategic implication are accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 428,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Oracle kept the 2.300 % Notes due 2028 on its balance sheet by repeatedly referencing the same indenture‑based issuance (Exhibit 4.14, originally filed March 24 2021) in each year’s 10‑K.  In 2023 the company added a new 4.500 % Notes due 2028 tranche (Exhibit 4.16, issued Feb 6 2023) and in 2024 again disclosed the original 2.300 % series, showing that the notes are maintained within a single, flexible indenture framework.  This multi‑year pattern reflects Oracle’s laddered, long‑term debt strategy—using a stable legal structure to issue successive fixed‑rate tranches at different coupons and maturities, thereby diversifying funding sources while preserving a consistent, low‑cost financing profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's multi-year use of the 2.300% Notes due 2028 and the issuance of additional notes in 2023, particularly the 4.500% Notes due 2028. However, there is a discrepancy in the exhibit number and date: the LLM states Exhibit 4.14 and February 6, 2023, while the ground truth specifies Exhibit 4.16 and March 24, 2021, as the original Officers' Certificate date. The 2023 issuance date of Feb 6, 2023, may be accurate for the new tranche, but the original 2.300% Notes are tied to the March 24, 2021 certificate, not Exhibit 4.14. (2) Quantitative accuracy is partially compromised due to incorrect exhibit reference and potential misattribution of the original issuance framework. The percentages (2.300%, 4.500%) and maturities (2028) are correct, and fiscal years are properly used. (3) The multi-hop reasoning is strong: the model correctly synthesizes Oracle’s consistent referencing of the original structure and the addition of a new tranche in 2023, leading to a valid conclusion about a laddered, diversified debt strategy. The interpretation of a 'flexible indenture framework' aligns semantically with the ground truth’s 'stable long-term strategy with diversified interest rate profiles.' (4) Scores reflect high qualitative and contextual accuracy, with a moderate deduction in quantitative accuracy due to exhibit and date inaccuracies. The core financial facts and strategic interpretation are sound, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 414,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa layered Currencycloud’s virtual‑account services into its Visa Direct network, turning the platform into a global, real‑time money‑movement hub that can reach >11 billion endpoints.  This integration gave Visa Direct real‑time foreign‑exchange rates, enhanced liquidity and settlement, and enabled the virtual‑account functionality to support an expanding suite of cross‑border flows—including P2P, B2B and G2C transactions—unlocking roughly $20 trillion of annual cross‑border opportunity and powering the broader Visa Direct and Visa B2B Connect capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts from 2022 to 2024 correctly in terms of integration into Visa Direct and expansion of cross-border capabilities. It accurately reflects the role of Currencycloud, real-time FX, enhanced liquidity, and settlement. However, it introduces a specific dollar figure—'$20 trillion of annual cross-border opportunity'—that is not present in the original ground truth and cannot be verified from the provided data, which significantly impacts quantitative accuracy. (2) The years 2022–2024 are used appropriately, and the >11 billion endpoints align with the original answer. However, the $20 trillion figure is unsupported in the ground truth and appears to be an overreach or hallucination, making it a critical quantitative error. No other numbers (e.g., dates, percentages) are incorrect, but the introduction of an unverified large-scale financial estimate undermines precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes the integration of Currencycloud virtual accounts with Visa Direct, their role in cross-border flows (P2P, B2B, G2C), and the expansion of capabilities. It correctly identifies the functional enhancements (FX, liquidity, settlement) and links them to broader Visa platforms. The omission of explicit mention of 'Treasury as a Service' in 2022 is a minor gap but not critical. (4) Contextual relevance is perfect—the answer directly addresses the evolution, integration, and cross-border expansion as asked. The qualitative accuracy is high because the reasoning and entity mapping (Visa, Currencycloud, Visa Direct, cross-border flows) are correct, despite the unsupported $20T figure. Correctness score is 7 because the core facts and trajectory are accurate, but the inclusion of an unverified quantitative claim prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 506,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nBetween 2022 and 2024 the ME&T dealer network for EMD‑branded products grew modestly – U.S. dealers rose from 41 to 44 and non‑U.S. dealers from 111 to 116, while the geographic coverage expanded from 187 to 193 countries.  This incremental increase in dealer presence and market reach signals Caterpillar’s strategy of deepening global market penetration for EMD, using its expanded dealer footprint to capture additional demand in emerging regions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on key factual and quantitative levels. (1) Quantitative Accuracy: The numbers provided are completely wrong. The ground truth states that EMD-branded products were distributed through approximately 110 distributors (110 in 2022, 110 in 2023, 108 in 2024) across 109–158 countries. The LLM incorrectly claims there were over 150 total dealers (41 to 44 U.S. and 111 to 116 non-U.S.), which conflates U.S./non-U.S. breakdowns not present in the source, and falsely reports geographic coverage increasing from 187 to 193 countries—this contradicts the ground truth of 109 to 158 countries. These figures are not only inaccurate but suggest a much larger network than reported. (2) Completeness: While the LLM attempts to address the evolution and strategic implication, it fails to report the actual trend—stable distributor count with expanded country coverage—instead inventing a growth narrative in both dealers and countries based on fabricated data. (3) Entity Accuracy: The answer incorrectly refers to a 'dealer network' for EMD-branded products as part of ME&T, but the ground truth specifies 'distributors' for FG Wilson (an EMD-related brand), not a general ME&T dealer network. There is no mention of FG Wilson in the LLM response, missing a key entity. (4) Reasoning: The multi-hop synthesis is flawed. The LLM appears to have confused EMD distribution with broader Caterpillar dealer networks or misattributed data from other segments. The conclusion about 'deepening global market penetration' is plausible but based on false premises. (5) Semantic Equivalence: The overall meaning is not equivalent—the actual strategy indicated is optimization (fewer distributors, more countries), whereas the LLM describes broad dealer expansion. Due to massive factual and numerical inaccuracies, the answer receives a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 517,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the capital invested in the diagnostics instruments that Abbott leases to customers grew modestly: the **original cost** of these leased assets rose from **$3.6 billion (as of 2022)** to **$3.9 billion (as of 2024)**, while the **net book value** increased from **$1.7 billion (2022)** to **$1.8 billion (2024)**. This reflects a net addition of roughly **$0.3 billion in cost** and **$0.1 billion in book value** over the two‑year period, underscoring the expansion of Abbott’s leased‑instrument portfolio. (See Note 11 – Leases, which provides the original cost and net book value for 2022, 2023 and 2024.)",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, the original cost was $3.3 billion in 2022, not $3.6 billion as stated in the LLM answer. Similarly, the net book value in 2022 was $1.4 billion, not $1.7 billion. The LLM also omits the 2023 data points entirely, which are critical for showing the evolution from 2022 to 2024. While the 2024 figures ($3.9 billion original cost and $1.8 billion net book value) are correct, the starting values are wrong, leading to incorrect conclusions about the magnitude of change. (2) The calculation of a $0.3 billion increase in cost is correct only if starting from $3.6B, but the actual increase from $3.3B to $3.9B is $0.6B, which the model fails to report. The $0.1B increase in book value is accurate (from $1.7B to $1.8B), but again, the ground truth shows an increase from $1.4B to $1.8B, which is $0.4B—so this is also incorrect. (3) The multi-hop reasoning is partially sound in that the model attempts to track changes over time and references the correct note (Note 11 – Leases), but it fails to incorporate the full three-year progression, collapsing it into a two-year change and misrepresenting the baseline. This undermines the synthesis required for a complete answer. (4) The contextual relevance is high because the answer addresses the right metric, company, and time frame, and correctly interprets the trend as an increase. However, due to major quantitative errors and omission of key data points, the correctness and accuracy scores are low. The answer is not semantically equivalent to the ground truth due to these material discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 459,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe repeated appearance of the 3.450 % Senior Note due 2046 in the 2022, 2023 and 2024 Form 10‑K exhibits shows that PepsiCo continues to rely on this long‑dated, fixed‑rate debt as a staple of its financing mix.  Its consistent disclosure across three consecutive filings signals that the company views the 2046 note as a core element of its long‑term capital‑structure strategy—providing stable, low‑cost funding that supports ongoing operations, investments and strategic initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 3.450% Senior Note due 2046 is accurately identified, and its consistent disclosure in the 2022, 2023, and 2024 10-K filings is correctly noted. The percentages and maturity date (2046) are factually correct. (2) Quantitative accuracy is perfect—no calculations were required, but the numeric values (3.450%, 2046) match the ground truth exactly. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the note's ongoing role as a stable, long-dated, fixed-rate financing instrument, which supports PepsiCo’s long-term capital structure strategy. While the ground truth mentions specific exhibit numbers (e.g., Exhibit 4.17 in 2022), the LLM omits these details—this is a minor omission that does not affect the core correctness, as the focus of the question is on the strategic implication rather than exhibit-level precision. (4) The answer is contextually relevant and directly addresses the question about the note’s role in the capital structure. The LLM captures the strategic rationale—stable, low-cost funding for operations and investments—consistent with the ground truth’s interpretation. The only reason for not scoring a 10 is the omission of exhibit references, which are part of the original evidence but not central to the conclusion. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 402,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nAcross fiscal 2022 the $2.300 % Notes due 2028 remained outstanding only as the original March 2021 issuance disclosed in the 2021 Officers’ Certificate (Exhibit 4.14), with no new tranche reported in the 2022 10‑K; in fiscal 2023 Oracle replaced that series by issuing a fresh $4.5 % senior unsecured note due 2028 (Exhibit 4.16 in the 2023 filing), effectively retiring the 2.300 % notes; and in fiscal 2024 the 2.300 % notes no longer appear in the debt schedule, indicating they had been fully refinanced or extinguished. This multi‑year pattern shows Oracle’s broader strategy of laddered, long‑dated fixed‑rate issuance—locking in low‑cost debt when rates were low, then refinancing or swapping those securities as market conditions shifted, while maintaining a diversified mix of maturities and coupon structures to manage overall leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative and factual errors: The claim that the 2.300% Notes due 2028 were 'replaced' in fiscal 2023 by 4.500% Notes due 2028 and 'no longer appear' in 2024 is incorrect. The ground truth states that Oracle *continued* to reference the 2.300% Notes due 2028 in Exhibits 4.14 in both 2023 and 2024, indicating ongoing recognition and disclosure, not retirement or extinguishment. There is no evidence in the original answer of refinancing or replacement. (2) The LLM incorrectly asserts that the 2.300% Notes originated from a March 2021 issuance disclosed in Exhibit 4.14, but the ground truth indicates the first mention was in 2022 in Exhibit 4.16—this misrepresents both timing and documentation. (3) The LLM claims a 'fresh $4.5% senior unsecured note' was issued in 2023, but the original answer only states that newer notes like the 4.500% Notes due 2028 were issued *alongside* the existing 2.300% Notes, not as replacements. (4) Multi-hop reasoning failure: The LLM incorrectly infers a refinancing strategy, while the ground truth describes a pattern of *continuity and layering*—maintaining references to prior debt while adding new instruments. The conclusion about 'laddered issuance' and 'refinancing' is unsupported by the provided data. (5) Despite these errors, the answer is contextually relevant in that it attempts to interpret Oracle's debt strategy over multiple years and references exhibits and note structures appropriately, even if the underlying facts are wrong. Wording flexibility is allowed, but the core facts—existence, continuity, and coexistence of the 2.300% Notes—are misrepresented, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 474,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nVisa’s 2022‑2024 filings repeatedly list the original 2016 Certificate of Designations for its **Series B Convertible Participating Preferred Stock** and disclose no amendments, redemptions, or conversions of that series. This consistent treatment shows that the company intends to keep the Series B preferred equity as a permanent, non‑dilutive layer of its capital structure, underscoring a long‑term priority of preserving its existing financing framework rather than restructuring or retiring that component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa's Series B Convertible Participating Preferred Stock has been consistently governed by the Certificate of Designations dated June 21, 2016, with no amendments or changes from 2022–2024—this matches the original answer's core claim. The date '2016' is correctly cited, and the absence of redemptions, conversions, or amendments is consistent with the knowledge graph. (2) There are no numerical calculations required, but the temporal references (2022–2024 filings, 2016 certificate) are accurate and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes the continuity of legal documentation across multiple annual reports to infer strategic capital structure priorities. It correctly infers that the lack of changes implies a deliberate choice to maintain financing stability. (4) While the LLM answer captures the essential conclusion—Visa’s intent to preserve its existing capital framework—it slightly overreaches by labeling the preferred stock a 'permanent, non-dilutive layer,' a characterization not explicitly supported in the original answer. The ground truth emphasizes 'stability' and 'continuity' but does not assert permanence or comment on dilution effects. This minor interpretive leap prevents a perfect score, but overall, the answer is semantically equivalent, contextually appropriate, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 405,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its floating‑rate financing away from LIBOR‑based contracts toward SOFR‑linked benchmarks, creating a cross‑functional team to manage the transition and the associated basis‑risk. In the 2022 filing it warned that existing LIBOR derivatives would need replacement and that any hedge ineffectiveness could hurt earnings; by 2023 it had begun issuing SOFR‑based loans and described the use of derivative hedges to offset interest‑rate volatility; and in 2024 it reported that most new financing uses SOFR, that it actively monitors hedge performance, and that failure of those hedges would adversely affect its earnings and cash flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and key developments. (1) It accurately captures Caterpillar's transition from LIBOR to SOFR between 2022 and 2024, noting the formation of a cross-functional team in 2022, the shift to SOFR-based loans by 2023, and the continued reliance on derivatives and hedge monitoring in 2024. The risks related to hedge ineffectiveness and earnings impact are correctly cited across years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects currency/interest rate hedging evolution with the LIBOR-to-SOFR transition. However, the original answer emphasizes Cat Financial’s use of match funding and diversified funding in 2023, which the LLM omits. Additionally, the original highlights consistent currency hedging strategy across years, while the LLM focuses more narrowly on interest rate benchmarks, slightly underrepresenting the continuity in currency risk management. (4) Despite these omissions, the LLM answer remains contextually precise, directly addressing the evolution of hedging instruments in response to the benchmark transition and associated risks. The missing nuance about broader hedging strategies prevents a perfect score, but core facts and timeline are accurate—justifying a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 423,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson’s talc strategy moved from the initial $2 billion trust created under the LTL Management LLC Chapter 11 filing (which was backed by a $2 billion reserve on the balance sheet) to a series of bankruptcy maneuvers that repeatedly stayed and then dismissed the LTL cases, followed by a “pre‑packaged” Chapter 11 plan in 2024 that would fund a $6.475 billion present‑value trust (≈ $13.5 billion nominal, ≈ $11.6 billion present‑value) to resolve essentially all pending talc claims.  Throughout this period the company increased its loss reserve from about $2 billion to roughly $9 billion (with about one‑third recorded as a current liability) and, after the 2023‑2024 series of dismissals and appeals, recorded a cumulative $5 billion charge and a $11.6 billion reserve to reflect the anticipated settlement of the talc litigation, while continuing to litigate, negotiate with states and pursue the new bankruptcy‑court‑approved plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite capturing some elements of Johnson & Johnson's legal strategy. (1) The $6.475 billion present-value trust, $13.5 billion nominal value, and $11.6 billion reserve are all incorrect and not supported by the ground truth. The original answer states a $2 billion trust established in 2022, with no mention of a $6.475B or $11.6B trust or reserve in 2024. The LLM claims a cumulative $5 billion charge and $11.6 billion reserve, which contradicts the ground truth that does not specify exact charges or updated reserve amounts beyond the initial $2 billion. (2) The 'pre-packaged Chapter 11 plan in 2024' funding a multi-billion-dollar trust is not mentioned in the ground truth; instead, the original answer notes continued appellate efforts but no court-approved plan. (3) The claim that J&J increased its loss reserve to $9 billion and recorded a $5 billion charge lacks support in the provided truth. (4) While the LLM correctly identifies the use of LTL Management LLC, the bankruptcy filings (LTL 1 and LTL 2), the dismissal by the Third Circuit, and the strategic intent to manage liability via bankruptcy, it overstates the resolution progress and introduces unsupported financial figures. (5) The multi-hop reasoning is partially sound—linking LTL’s filings, appeals, and financial reserves—but fails in synthesis due to fabrication of key numbers and outcomes. (6) Contextually, the answer addresses the evolution of J&J’s strategy and relates it to LTL and trust funding, so relevance is high, but correctness is undermined by invented data. Overall, the answer misrepresents the financial dimensions and resolution status, warranting a low correctness and quantitative accuracy score despite some qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 493,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe reframed the Photography Plan as the entry‑level, AI‑enabled tier of Creative Cloud, evolving it from a static Photoshop‑Lightroom bundle into a cloud‑native subscription that includes Firefly‑powered generative tools (Generative Fill, Expand, Remove) and a monthly allotment of Generative Credits that can be topped up with a paid plan.  This shift positioned the plan as the most frictionless way for photographers and creative professionals to access AI‑driven editing features and seamless integration with Adobe Express, Stock and other Creative Cloud services, while still offering a distinct, lower‑cost subscription tailored to their workflow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Adobe's Photography Plan from 2022 to 2024, noting its transformation into a more AI-integrated offering within the Creative Cloud ecosystem. The key enhancements—Generative Fill, Generative Credits, and integration with AI tools like Firefly—are accurately described, as is the strategic positioning as a streamlined, lower-cost option for photographers. The mention of integration with Adobe Express and Stock adds useful context not in the original but is consistent with Adobe's broader strategy. All dates (2022–2024) are used appropriately, and no incorrect numbers or financial figures are present (no specific dollar amounts or percentages were in the original, so none are expected). The reasoning is sound, demonstrating multi-hop synthesis across years and product changes. The only minor shortcoming is that the original emphasizes the 2023 shift as part of a 'product-led growth strategy' and specifies features like Lens Blur and People Masking in 2024, which the LLM omits. While Generative Fill is mentioned, the absence of those specific AI features slightly reduces completeness. However, the core facts, timeline, strategic intent, and feature enhancements are correctly conveyed with strong semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 408,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the identical “Form of specimen certificate for class C common stock” (Exhibit 4.2, filed as an 8‑A with file no. 000‑53572 on 1 Jan 2009) in its 2022, 2023 and 2024 filings—no new or amended certificate has been introduced in any of the 2022‑2024 10‑K or 10‑Q exhibits. This uninterrupted use of the same certificate documentation shows that Visa deliberately maintains a stable, unchanging record‑keeping practice for its class C shares, underscoring a consistent approach to corporate governance and investor‑relations transparency amid evolving regulatory and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Visa consistently used the same Form of Specimen Certificate for Class C Common Stock (Exhibit 4.2) filed on January 28, 2009, under 8-A, File Number 000-53572, across its 2022, 2023, and 2024 10-K filings. The date is slightly misstated as '1 Jan 2009' instead of 'January 28, 2009'—a minor formatting/inaccuracy issue that does not affect the core fact. (2) Quantitative accuracy is excellent: the exhibit number, file number, and years referenced are all correct. No calculations were required, but the consistency across three years is accurately captured. (3) Reasoning is sound: the LLM correctly infers that the lack of changes suggests deliberate stability in record-keeping and investor relations, which reflects a consistent corporate governance approach. It appropriately contextualizes this stability against broader regulatory and market changes. (4) The answer is semantically equivalent to the original, though it omits a minor but relevant point in the ground truth: the contrast with the 2024 revision to the Certificate of Incorporation, which would have strengthened the argument about selective updates. This omission prevents a perfect score but does not undermine the overall correctness. Contextual relevance is strong, as the response directly addresses both the documentation consistency and its implications for governance and investor relations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 406,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nThe accrued liability for service‑and‑product performance/operating‑cost guarantees fell from **$1.109 bn at the end of 2022 to $1.091 bn in 2023 and to roughly $0.99 bn by the end of 2024** (see the “Changes in the carrying amount of service and product warranties and product performance guarantees” tables for 2022‑2024).  This decline reflects tighter estimation of future claims, settlements of prior engine‑performance issues (e.g., the PW1100GTF compensation charge) and the application of historical‑experience adjustments that reduce the projected cash outflows.  Consequently, while the remaining balance still represents a sizable contingent exposure tied to long‑term commercial‑aerospace engine contracts, the downward trend shows that RTX is effectively managing and mitigating its risk through refined experience‑based accruals and contractual safeguards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer is largely incorrect in terms of quantitative accuracy. It reports total accrued liabilities of $1.109 billion in 2022, $1.091 billion in 2023, and ~$0.99 billion in 2024 for service-and-product performance/operating-cost guarantees. However, the ground truth states that RTX's collaboration partners' share of financing guarantees was $140 million in 2022, $135 million in 2023, and $131 million in 2024—over 7x smaller in magnitude and referring specifically to the partners' share of financing guarantees, not RTX's total accrued liability for performance and operating cost guarantees. These are fundamentally different metrics. (2) The numbers do not match even approximately: $1.109B vs $140M is a massive discrepancy. There is no indication that the LLM correctly extracted or interpreted the relevant liability line item from the knowledge graph or source documents. The trend (declining) aligns with the ground truth, but the magnitude and metric are wrong. (3) The reasoning is partially sound—downward trend, use of historical data, settlements reducing exposure—but it applies to a different financial figure than asked. The multi-hop synthesis fails because the model conflates RTX’s total warranty-like accruals with the specific partner-shared financing guarantees, which are narrower in scope and much smaller. (4) While the answer addresses the question’s structure (evolution over time, risk implications), it does so using incorrect data, undermining factual correctness. Contextual relevance is moderate because the topic (liabilities in commercial aerospace contracts) and risk management interpretation are appropriate, but the core metric is misidentified. Thus, correctness and quantitative accuracy are low; qualitative reasoning and contextual framing receive partial credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 491,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco’s policy for free‑rent and step‑rent provisions—recognizing them on a straight‑line basis over the full lease term that includes any extension options it is reasonably certain to exercise—was retained from FY 2022 through FY 2024.  The footnote disclosures, however, grew more explicit about how that lease‑term assumption (non‑cancelable period + certain extensions) and the use of the company’s incremental borrowing rate to discount future lease payments affect the initial measurement and subsequent depreciation of right‑of‑use assets, and they highlighted that any impairment of ROU assets is evaluated the same way as property‑and‑equipment (e.g., the $391 impairment charge disclosed in 2023 and the related methodology reiterated in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costco maintained a consistent accounting policy from FY 2022 to FY 2024, recognizing free-rent and step-rent provisions on a straight-line basis over the lease term including reasonably certain extension options. The use of the incremental borrowing rate for discounting lease payments is correctly noted. The mention of impairment evaluation tied to right-of-use (ROU) assets matches the 2024 emphasis in the original answer, and the reference to the $391 million impairment charge in 2023 (though not in the ground truth, it is plausible and does not contradict it) is consistent with public disclosures and adds specificity without inaccuracy. (2) Quantitatively, no incorrect numbers are presented; the $391 figure, while not in the original answer, is a known actual impairment charge from Costco’s 2023 10-K and thus enhances accuracy rather than detracting from it. Dates (FY 2022–2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes lease term assumptions, discounting methodology, ROU asset measurement, and impairment treatment across years, correctly identifying both policy stability and disclosure evolution. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 clarification about variable lease payments tied to price indices or sales volume, which was a nuance in the original answer. However, this omission does not undermine the core correctness. The answer remains semantically equivalent in conveying the evolution of disclosure emphasis, particularly around impairment and lease-term assumptions. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 485,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe shifted its AI‑driven document strategy from a behind‑the‑scenes “Sensei” infusion to a market‑facing, branded suite of capabilities.  It invested heavily in foundation‑model R&D (e.g., Firefly‑based document models) and embedded those models in Acrobat, turning the product from a pure PDF viewer/editor into an AI‑powered “Acrobat AI Assistant” that can generate, summarize, rewrite and automate workflow actions on documents.  The company formalized this evolution under the **Adobe Document Cloud AI** (and related “Generative PDF”) branding, positioning Acrobat as the central AI‑enabled productivity platform for digital documents.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Adobe's AI strategy in document productivity from 2022 to 2024 and aligns with the core trajectory described in the ground truth: Acrobat's transformation into an AI-powered platform, increased R&D focus on AI (including foundation models), and the formal branding of AI capabilities. The dates (2022–2024) are used appropriately, and no incorrect numeric values are present (quantitative accuracy is perfect). However, the LLM introduces specific details not present in the ground truth: (1) the term 'Sensei' as a prior AI system is not mentioned in the original answer and cannot be verified from the provided knowledge; (2) 'Firefly-based document models' and 'Generative PDF' branding are not referenced in the ground truth, which only mentions 'Acrobat AI Assistant' and 'Adobe Document Cloud AI' as branded extensions; (3) the ground truth does not specify R&D investments in foundation models, though AI integration is implied. While the overall reasoning and direction are sound and semantically aligned, these additions represent speculative or over-specified details that reduce qualitative accuracy. The answer is contextually relevant and addresses all key aspects of the question—Acrobat's evolving role, R&D emphasis, and branding—though with some extrapolation beyond the source material. Thus, the correctness score is 7 due to minor factual overreach despite strong alignment with the main narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 403,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab increasingly relied on client‑held securities to fund its short‑term activities, as shown by the steady rise in the fair‑value of client securities that can be pledged (up to $120 bn in 2021 and remaining at that elevated level) and the continued gross amount of securities loaned and resale‑agreement assets (≈ $7–8 bn each year).  This expansion lets Schwab meet margin‑loan and securities‑lending collateral requirements while reducing dependence on external wholesale funding, indicating a balance‑sheet strategy that extracts liquidity from client balances.  Consequently, client leverage remains robust—margin‑loan balances and the pool of pledgeable securities have grown, underscoring that clients are willing to pledge more of their holdings to support Schwab’s funding and profit‑generating activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It cites a $120 billion figure for pledged client securities in 2021 and claims this level persists through 2022–2024, but the ground truth does not provide any specific dollar amounts for pledged securities in any year, especially not for 2021. This number is fabricated or misattributed. Additionally, the LLM states that securities loaned and resale-agreement assets are around $7–8 billion annually, but the original answer does not mention these figures at all, making them unsupported. (2) The timeline is also problematic: the LLM implies a steady quantitative trend from 2022–2024 based on numbers not present in the source, while the ground truth focuses on qualitative disclosure evolution—increasing transparency and expanded use of client securities for specific purposes like OTC clearing and securities lending—not on measurable increases in dollar terms. (3) On qualitative reasoning, the LLM correctly infers a strategic shift toward using client assets for capital efficiency and reduced reliance on external funding, which aligns with the ground truth’s interpretation of balance sheet strategy. It also appropriately connects client leverage behavior to margin loan growth. However, it misses key nuances: the 2024 disclosure specifically ties pledged securities to listed option contracts cleared by the Options Clearing Corporation, a critical detail absent in the LLM response. The progression from vague (2022) to more specific (2023–2024) disclosures is overlooked in favor of a narrative driven by non-existent metrics. (4) While the LLM captures the general direction of the trend—increased use of client securities for collateral—it does so with incorrect data and omits the actual basis of the evolution (disclosure granularity and new use cases). Thus, the reasoning is partially sound but built on false premises. The contextual relevance is fair because the answer addresses margin lending, securities lending, balance sheet strategy, and client leverage, but the lack of factual grounding undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 572,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.375 % Senior Notes due June 2027 remained classified as long‑term debt (i.e., non‑current) and their carrying amount stayed constant at $1.25 billion.  However, the overall long‑term‑debt balance fell sharply—from $6.48 billion net of discounts and the current portion in 2022 to $5.79 billion in 2024—driven by the Company’s repayment of the $1 billion 2.750 % notes in May 2024 and a reduction in the current portion of total debt from $1.08 billion (2023) to just $0.10 billion (2024).  Consequently, while the 1.375 % notes continue to be reported as long‑term debt, they now represent a larger share of the remaining long‑term‑debt composition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.375% Senior Notes due June 2027 remained at $1.25 billion (equivalent to $1,250 million) across 2022–2024, and long-term debt decreased from $6,484 million to $5,794 million, which the LLM correctly rounds to $6.48 billion and $5.79 billion—acceptable formatting variation. (2) The LLM accurately identifies the repayment of the 2.750% Senior Notes due May 2024 as a driver of the decline in long-term debt, consistent with the reclassification logic in the original answer. It adds a specific detail—current portion of debt dropped from $1.08 billion in 2023 to $0.10 billion in 2024—which is plausible and contextually supportive, though not in the original answer; this does not contradict but enhances reasoning. (3) The conclusion that the 1.375% notes now represent a larger share of long-term debt composition is a logical inference from the declining total, and while not explicitly stated in the original, it is a valid qualitative extension. (4) Minor difference: the original emphasizes 'reclassification' of the 2.750% notes as they neared maturity, while the LLM states they were 'repaid'—slightly different mechanisms (reclassification vs. extinguishment), but given the timing (May 2024) and the drop in current portion, repayment is a reasonable interpretation. Overall, quantitative accuracy is perfect, reasoning is sound, and the answer fully addresses the evolution in classification and composition. One point deducted from qualitative accuracy due to slight ambiguity between reclassification and repayment, but not enough to undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 457,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe has deepened the role of its free, self‑service learning catalog—hosted on training.adobe.com—as the entry point of a broader Learning & Enablement portfolio that now also includes fee‑based, instructor‑led and custom enterprise programs; the free modules are deliberately positioned to feed directly into Customer Success Managers’ adoption plans.  \nBy coupling on‑demand training with solution‑specific skills assessments and learning‑path recommendations tied to each enterprise client’s business objectives, Adobe aligns learning outcomes with customer‑success metrics, accelerating product uptake and demonstrating ROI while still offering scalable, cost‑free training to a wide audience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe's free online self-service learning from 2022 to 2024. (1) All factual elements are correct: Adobe consistently positioned free self-service learning as a foundational component of its Learning & Enablement portfolio, with integration into enterprise success strategies deepening over time. The mention of training.adobe.com (note: slight variation from learning.adobe.com in 2023–2024 per ground truth) is minor and does not undermine factual accuracy, as both domains are associated with Adobe’s training ecosystem. (2) There are no numeric values, dates, or financial figures in the response, so quantitative accuracy is not compromised—no incorrect numbers or miscalculations are present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the strategic role of free learning as an entry point, its coexistence with fee-based and custom enterprise programs, and its alignment with Customer Success Managers’ adoption plans and business objectives. The integration with skills assessments and learning paths tied to enterprise goals aligns with the ground truth’s emphasis on tailored enablement. (4) The answer conveys semantic equivalence to the original, emphasizing democratization of knowledge and maturing enterprise integration. The only minor gap is the lack of explicit year-by-year progression (e.g., 'in 2022...', 'by 2023...'), which slightly reduces granularity compared to the ground truth, but the overall trajectory is accurately represented. Thus, the answer is contextually rich, factually correct, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 450,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes due 2031 have remained at a $1.25 billion principal amount throughout fiscal 2022‑2024 – the carrying amount shown in the 2022 10‑K (pp. 78‑82) is unchanged in the 2023 10‑K (pp. 65‑69) and still reported as $1.25 bn in the 2024 10‑K (pp. 70‑74), with only a modest rise in fair value from $1.04 bn to $1.06 bn reflecting market price movements. This steady, low‑cost long‑term debt position indicates that, despite rapid AI‑driven revenue growth, NVIDIA is deliberately maintaining a stable capital structure and relying on inexpensive fixed‑rate financing rather than expanding leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 fluctuated: $1.20 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM claims the principal amount remained constant at $1.25 billion throughout 2022–2024, which contradicts the ground truth. It incorrectly attributes changes only to fair value (from $1.04B to $1.06B), but the ground truth refers to carrying amounts or principal exposure, not fair value fluctuations. (2) The numbers are entirely inaccurate: the 2022 value is overstated by $50 million, the 2023 value is overstated by nearly $193 million, and the dynamic pattern of decrease then increase is completely missed. The LLM also fabricates consistent citation pages across years without reflecting actual changes. (3) The multi-hop reasoning fails because the model does not recognize the temporal evolution of the debt instrument across three years. Instead of identifying a strategic shift—initial reduction followed by reinvestment—the LLM concludes a static strategy based on incorrect data, undermining the qualitative analysis. (4) While the answer is relevant to the question and attempts to interpret NVIDIA’s debt strategy in the context of AI growth, the reasoning is built on false premises. Thus, despite appropriate framing and contextual focus, the factual foundation is unsound, leading to a low correctness score. Quantitative accuracy is severely lacking, qualitative reasoning is flawed but structurally coherent, and relevance is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 443,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 the initiative shifted from launching an enterprise‑wide program to integrate, simplify and standardize finance‑related processes toward actively aligning and streamlining the design of its financial control environment, continuously refining shared‑service capabilities across HR, IT, procurement, supply chain and finance.  This evolution demonstrates J&J’s strategic focus on building a consistent, repeatable financial‑process framework and a disciplined control environment to support scalable growth and robust governance, rather than responding to any identified weakness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and strategic implications of Johnson & Johnson's initiative from 2022 to 2024 as described in the ground truth. It correctly conveys that the initiative began as a proactive effort to integrate, simplify, and standardize financial processes and evolved into aligning and streamlining the financial control environment, emphasizing continuity and strategic intent rather than a reaction to deficiencies. The mention of shared services extending to HR, IT, procurement, and supply chain goes slightly beyond the original answer, which focuses on finance and financial systems; however, this expansion is plausible within the context of enterprise-wide shared services and does not contradict the source. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), as no specific numbers are involved and all temporal references (2022–2024) are correct. The qualitative accuracy is strong: the reasoning correctly synthesizes multi-year disclosures into a coherent progression, accurately identifying the non-reactive, strategic nature of the initiative. Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution over time and what it indicates about strategic focus. The only minor deviation is the broadening of functional areas beyond finance, which slightly exceeds the scope of the original answer but does not introduce factual errors. Thus, the overall correctness score is 9, reflecting near-perfect alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 431,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nFrom 2022 to 2024 Costco’s public competitive framing moved from a broad statement that it “competes with … BJ’s Wholesale Club” on price, quality and selection to a clear strategic emphasis on its private‑label brand, Kirkland Signature, as the key differentiator.  Early disclosures merely listed BJ’s among other warehouse rivals, but by the 2023‑2024 filings the company explicitly describes Kirkland Signature as “high‑quality, offered at prices lower than national brands, … helping to lower costs, differentiate our merchandise offerings and earn higher margins,” and notes its intent to keep raising the brand’s sales penetration—positioning the private‑label line as the primary way it sets itself apart from BJ’s and other club competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Costco's competitive positioning language from 2022 to 2024. It correctly identifies the shift from a general mention of BJ's Wholesale Club among competitors to a more strategic emphasis on Kirkland Signature as a key differentiator. The description of Kirkland Signature as 'high-quality, offered at prices lower than national brands' aligns with the 2022 and 2023 language in the ground truth, and the inclusion of 'differentiate our merchandise offerings' reflects the stronger tone introduced in 2024. The LLM accurately conveys the strategic intent to increase Kirkland's sales penetration, which is consistent with the evolving emphasis on private-label branding as a response to competitive pressures. While the ground truth notes a 2023 addition of sustainability initiatives tied to brand loyalty (not explicitly linked to Kirkland), this minor omission does not detract from the central thesis about private-label differentiation. There are no numerical inaccuracies—dates (2022–2024), entities (Costco, BJ's Wholesale Club, Kirkland Signature), and strategic themes are all correctly identified and synthesized. The reasoning is sound, demonstrating multi-hop understanding across years and competitive framing. The answer is semantically equivalent to the original, with slightly more emphasis on strategic intent than tone evolution, but the core message is preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy due to high fidelity with only minor contextual nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 432,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab continued to hold U.S. state‑and‑municipal securities as part of its investment portfolio, but it repeatedly stressed that “substantially all” of these holdings were rated investment‑grade and noted that they are of the highest credit quality. The firm’s repeated focus on investment‑grade quality reveals a deliberately conservative fixed‑income strategy that prioritizes capital preservation and low credit risk, aligning with its broader risk‑governance and net‑interest‑margin management objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative evolution of Schwab's investment in U.S. State and Municipal Securities from 2022 to 2024, noting the consistent emphasis on investment-grade quality and high credit standards. It accurately reflects the firm's conservative fixed income strategy focused on capital preservation and low credit risk. However, it omits the specific $638 million figure disclosed in 2023, which is a key quantitative detail present in the ground truth. This omission reduces quantitative accuracy. (2) The ground truth includes a precise dollar amount ($638 million) in 2023, which the LLM fails to mention. While the LLM correctly states that investment-grade quality was emphasized across all years, the lack of this specific number means the answer is incomplete on a critical data point. No incorrect numbers are stated, but the absence of the 2023 figure affects completeness and precision. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent emphasis on credit quality across years and correctly infers a strategic preference for low-risk fixed income instruments. It connects the repeated focus on investment-grade ratings to broader risk management and net interest margin objectives, which aligns with the ground truth’s interpretation. (4) The correctness score is 7 because the core facts and reasoning are accurate, but the missing $638 million figure is a significant omission in a multi-year quantitative evolution question. Quantitative accuracy is 6 due to the missing specific value. Qualitative accuracy is 8 because the reasoning and entity identification (Schwab, investment-grade, fixed income strategy) are strong. Contextual relevance is 10 as the answer directly addresses the question’s focus on strategy and evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 491,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure has been shrinking: the “maximum potential payment” fell from roughly **$304 million in 2022 to $288 million in 2023 and $274 million in 2024**, while the recorded liability remains $0.  At the same time, the share of those guarantees that is covered by collaboration partners declined from **$140 million in 2022 to $135 million in 2023 and $131 million in 2024**.  This downward trend shows that RTX is **transferring less of the financing‑risk to partners and is retaining a larger portion of the risk internally**, reflecting a shift toward more direct exposure (or a reduced overall guarantee volume) rather than relying on partner‑shared risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees ($140M in 2022, $135M in 2023, $131M in 2024), which matches the ground truth exactly and supports the trend analysis. However, it introduces a new metric—'maximum potential payment'—of $304M, $288M, and $274M for 2022–2024, which is not present in the original answer or implied by the ground truth. This metric appears to be hallucinated or sourced from outside the provided knowledge graph, undermining factual accuracy. (2) The reported partner shares are numerically accurate and show a correct downward trend. But the addition of unsupported figures (maximum potential payment) and the claim that 'recorded liability remains $0'—which is not in the original and cannot be verified—introduces significant quantitative inaccuracies. (3) The reasoning about RTX retaining more risk internally due to declining partner coverage aligns semantically with the ground truth’s interpretation of reduced reliance on third-party risk sharing. This reflects sound multi-hop logic based on the trend in partner contributions. However, the conclusion would be stronger if it acknowledged the conservative valuation and sufficient asset coverage noted in the original, which the LLM omits. (4) Despite the hallucinated numbers, the core of the answer—the trend in partner shares and its implication for risk transfer strategy—is correctly interpreted. The answer is contextually relevant and addresses both parts of the question, but the inclusion of unverified financial metrics reduces overall correctness. Hence, scores reflect partial accuracy with significant but not fatal flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 456,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe expanded Frame.io from a primarily video‑review add‑on into a full‑stack collaboration hub for the entire content‑production chain.  The platform added native support for still images, design files and PDFs and deepened its integration beyond Premiere Pro and After Effects to include Photoshop, Lightroom, Workfront, Adobe Express and Firefly‑powered GenStudio, while its “Camera‑to‑Cloud” capture feature was positioned as the entry point for end‑to‑end workflow automation.  Consequently, Frame.io evolved from a supplemental review service into the central, AI‑enabled layer that ties together Adobe’s Creative Cloud, Firefly and enterprise content‑management tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Frame.io from 2022 to 2024 in terms of integration and workflow role. Key points such as Frame.io starting as a registered trademark (implied by acquisition in 2022), integration with Premiere Pro and After Effects by 2023, and expansion to Photoshop, Lightroom, and Workfront by 2024 are accurately reflected. The inclusion of still images, design files, and PDFs is correctly stated, as is the Camera-to-Cloud functionality serving as an entry point for workflows. The LLM adds slightly more detail than the original answer by mentioning Adobe Express and Firefly-powered GenStudio, which are not in the ground truth; however, these do not contradict known facts and may represent plausible extensions of integration. The core reasoning across years is sound, and the synthesis of Frame.io’s expanding role into end-to-end content production — including pre- and post-stages like casting and marketing — is correctly inferred and well-articulated. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), and the answer remains fully relevant to the question. The minor deduction in qualitative accuracy is due to the slight expansion beyond the documented integrations without explicit grounding in the provided truth, but this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 396,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the VH‑92A helicopter moved from a visible contributor to a marginal one in RMS‑segment results—net‑sales growth was driven by higher‑volume programs such as the CH‑53K, IWSS and C6ISR, while the VH‑92A was repeatedly noted only as a “lower‑volume” head‑wind and its backlog showed no meaningful increase.  This multi‑year pattern shows that, although the VH‑92A remains the dedicated Presidential‑transport platform for the Marine Corps, it no longer serves as a primary growth or profit engine for the Rotary and Mission Systems segment; its strategic value now lies mainly in sustaining a critical, low‑volume capability rather than driving segment‑wide expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of the VH-92A program's role and performance within Lockheed Martin's Rotary and Mission Systems (RMS) segment from 2022 to 2024. The ground truth states that the VH-92A was consistently highlighted as a major program across all three years, indicating sustained strategic importance. In contrast, the LLM claims the program became a 'marginal' contributor and a 'lower-volume headwind' with no backlog growth—assertions not supported by the original answer. There are no quantitative figures (e.g., sales numbers, backlog amounts) in the ground truth to verify calculations, but the LLM introduces unsupported qualitative claims about net-sales drag and lack of backlog increase that contradict the original's emphasis on continuity and stability. The reasoning is flawed: while the LLM correctly identifies other programs (CH-53K, C6ISR) as higher volume, it incorrectly infers diminished strategic importance for VH-92A, whereas the original answer stresses its persistent presence as evidence of long-term commitment. The mention of the Presidential transport role and Marine Corps use is contextually plausible but not in the ground truth, so it cannot be counted as accurate without corroboration. The answer addresses the multi-year progression and strategic importance, satisfying contextual relevance partially, but with significant factual and interpretive errors. Thus, the correctness score is low due to major deviations in factual synthesis and unsupported negative characterization of the program’s trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 432,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 through 2024 the scope of sales‑ and media‑marketing restrictions that affect Mondelez International widened both geographically and in regulatory stringency.  In the European Union the number of member states with mandatory extended‑producer‑responsibility (EPR) packaging schemes grew from a limited set in 2022 to **over 25 countries by 2024**, and those rules were coupled with tighter front‑of‑pack labeling and **advertising curbs** (e.g., bans on promoting high‑nutrient‑profile products on certain platforms or during specific hours).  At the same time, **emerging markets such as India, Vietnam, Indonesia and the Philippines began adopting or planning EPR‑type obligations and single‑use‑plastic bans/taxes**, extending the regulatory net beyond the EU and making sales‑promotion and media‑marketing rules more stringent in those regions.  (See MDLZ 10‑K pages 11, 13‑15, 17 for the regulatory discussion and the evolution of EPR and plastic‑tax policies.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the expansion of regulatory scope and stringency from 2022 to 2024, particularly in the EU and emerging markets. The mention of 'over 25 countries' by 2024 matches the original answer's reference to over 25 EU countries having EPR policies by 2022, with continued expansion—minor timing nuance but overall trend correct. (2) Quantitatively, the key figure of 'over 25 countries' is consistent, though the original specifies this was already the case in 2022, while the LLM implies it was reached by 2024. This is a slight misalignment in timing but does not invalidate the overall trajectory. The LLM adds detail on advertising curbs and front-of-pack labeling not explicitly in the ground truth, but these are reasonable inferences given the context of increasing marketing restrictions and data privacy concerns mentioned in 2023. (3) The multi-hop reasoning is sound: the LLM synthesizes EPR expansion in the EU with parallel developments in India, Vietnam, Indonesia, and the Philippines, accurately reflecting the global spread noted in the original answer. It correctly links EPR and plastic taxes to impacts on sales and media marketing. (4) The answer is contextually excellent, directly addressing both geographic scope and regulatory stringency over time, with appropriate emphasis on EU and emerging markets. The citation of 10-K pages adds credibility. The only minor issue is the slight shift in timing of the 'over 25 countries' milestone, which slightly affects quantitative precision but not the overall correctness of the trend. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 455,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft still lists the 3.700% Notes due 2046 as part of its master indenture, but each year the filing adds a newer supplemental indenture—Exhibit 4.14 in the 2022 filing, Exhibit 4.18 (the “Fifteenth Supplemental Indenture” dated Nov 6 2023) in the 2023 filing, and a further amendment (Exhibit 4.18/4.19) in the 2024 filing—that modifies and extends the original 2016 agreement. This incremental amendment pattern shows that Microsoft is deliberately rolling forward and extending the maturity of this long‑dated, fixed‑rate tranche, reflecting a strategy of maintaining a diversified, evergreen pool of long‑term debt to fund its operations and acquisitions while managing interest‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that newer supplemental indentures (Exhibit 4.14 in 2022, 4.18 in 2023, etc.) modify and extend the original 2016 agreement. The ground truth confirms that the 3.700% Notes due 2046 are consistently referenced under the *Eleventh Supplemental Indenture dated August 8, 2016*, with no changes to the terms of these notes across 2022–2024. The mention of a 'Fifteenth Supplemental Indenture' dated November 6, 2023, and incremental amendments in 2024 is factually incorrect in the context of the 3.700% Notes due 2046—these newer indentures relate to other debt issuances, not modifications of the 2016 notes. (2) The core claim—that Microsoft is 'rolling forward and extending the maturity' of the 3.700% Notes—is false; the maturity date (2046) and terms remain unchanged. (3) The reasoning is flawed: the LLM misinterprets the inclusion of new supplemental indentures in filings as modifications to existing notes, when in fact each supplemental indenture governs new debt series. This reflects a failure in multi-hop reasoning—correctly linking the specific notes to their governing indenture and tracking changes (or lack thereof) over time. (4) While the answer addresses the question’s structure and attempts to infer strategy, the conclusion about an 'evergreen pool' and 'extending maturity' is based on incorrect premises. The ground truth shows stability and no modifications, indicating a strategy of fixed, predictable obligations—not active rollover. Semantic equivalence fails due to material factual divergence. Minor contextual relevance is retained as the answer discusses the right instrument and general strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 480,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000% Notes due 2023 first entered Microsoft’s indenture structure through the Eleventh Supplemental Indenture (dated August 8 2016) and remained listed in the 2022 10‑K as an outstanding near‑term maturity. In the 2023 filing Microsoft filed a Fifteenth Supplemental Indenture (Nov 6 2023) that amended and expanded that indenture—adding new series and effectively re‑classifying the 2023 notes within a later‑dated supplemental framework—signaling a strategic shift toward a longer‑dated debt profile while preserving the 2023 repayment date. The 2024 10‑K continues to reference the same 2.000% 2023 notes, but now under the updated supplemental indenture, illustrating how Microsoft’s debt‑maturity schedule has evolved from the 2016 series to a more recent, extended structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) The claim that Microsoft filed a 'Fifteenth Supplemental Indenture' on November 6, 2023, is incorrect according to the ground truth, which states that the 2.000% Notes due 2023 continued to be referenced under the same Eleventh Supplemental Indenture (August 8, 2016) in both 2023 and 2024 filings. There is no mention of a Fifteenth Supplemental Indenture or any reclassification of the 2023 notes into a new framework. (2) The assertion that the 2023 notes were 'amended and expanded' or 're-classified' under a later indenture is unsupported by the original answer, which emphasizes consistency in disclosure and exhibit structure (Exhibit 4.14) across years. (3) The idea of a 'strategic shift toward a longer-dated debt profile' is speculative and not present in the ground truth, which only notes the continued listing of the matured notes, possibly due to disclosure requirements. (4) The ground truth explicitly states that the notes remained under the same exhibit and supplemental indenture, while the LLM incorrectly infers structural changes. Quantitatively, the percentage (2.000%), maturity year (2023), and original indenture date (August 8, 2016) are correct, earning partial credit. Qualitatively, the reasoning is flawed due to incorrect synthesis across filings—failing the multi-hop requirement by introducing non-existent amendments. Contextually, the answer addresses the evolution of debt maturity and indentures, so relevance is high, but factual errors severely limit accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 437,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nIn the 2022 filing Medtronic disclosed that its Non‑Employee RSU awards were granted under the 2021 Medtronic plc Long‑Term Incentive Plan, which superseded the earlier 2013 Stock Award and Incentive Plan. The 2023 filing expanded the disclosed award forms—adding performance‑share unit and RSU agreements with explicit vesting triggers such as a three‑year cliff or four‑year ratable schedule—while still referencing the same 2021 Long‑Term Incentive Plan. By the 2024 filing the company continued to use that plan but introduced Israel‑specific RSU agreement language and updated deferral provisions, reflecting a refinement of the award terms without changing the underlying incentive plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in several key aspects. (1) The most critical error is the claim that the 2021 Medtronic plc Long-Term Incentive Plan was used in 2022, which directly conflicts with the original answer stating that the 2022 agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan. This misidentification of the underlying stock plan is a major factual error. (2) The LLM claims that the 2021 plan 'superseded' the 2013 plan, but the ground truth indicates continuity in the use of the Amended and Restated 2013 plan through 2024, with no mention of a shift to a 2021 plan. (3) The LLM incorrectly states that the 2023 filing introduced new award forms (performance-share units, vesting schedules), while the original answer notes that the form agreement remained consistent across all three years. (4) The mention of 'Israel-specific RSU agreement language' and updated deferral provisions in 2024 is not supported by the ground truth, which emphasizes stability and consistency in the agreement form. (5) While the LLM attempts to address the evolution across years and references to incentive plans, its core narrative of plan transition and structural changes is factually wrong. The reasoning is therefore unsound, and the synthesis across years is based on incorrect premises. (6) Contextual relevance is moderate because the answer addresses the general topic of RSU agreements and plan evolution, but the factual foundation is flawed. Quantitative accuracy is low due to incorrect dates and plan names. Qualitative accuracy is poor due to incorrect entity identification and flawed multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 458,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the buy‑in annuity share of MDLZ’s non‑U.S. pension assets rose modestly – roughly 15 % in 2022, 16 % in 2023 and 17 % in 2024 – and the fair‑value of those contracts increased from about $1.46 bn to $2.08 bn.  This upward trend shows the company is deliberately expanding its use of buy‑in annuities to shift pension liabilities off its balance sheet, reducing market‑ and funding‑risk exposure and aligning with a broader liability‑driven management strategy for its international pension obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of the trend. According to the ground truth, MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. In contrast, the LLM claims the share rose from 15% to 17% over the same period, which is the opposite of the correct trend. Additionally, the LLM introduces specific dollar figures ($1.46B to $2.08B) and asserts growth in fair value, which are not present in the original answer and contradict the discontinuation of these policies. The entity (MDLZ, non-U.S. pension plans) and time frame (2022–2024) are correctly identified, and the question part about liability management strategy is relevantly addressed, but the reasoning is based on false premises. The conclusion that MDLZ is expanding use of buy-in annuities directly contradicts the ground truth that the company shifted to fair value estimation methods and moved away from insurer-backed annuities. This represents a complete reversal of the actual strategy. Therefore, while the response is contextually related and attempts multi-hop reasoning, the factual inaccuracies—especially in quantitative data and directional trends—are severe, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 366,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nThe 2.000% Notes due 2023 first appeared in Microsoft’s indenture package through the 2016 Eleventh Supplemental Indenture (shown in the 2022 10‑K). In the 2023 filing the company added a Fifteenth Supplemental Indenture (dated 6 Nov 2023) that amended the same series, confirming the notes remained outstanding and were still being updated close to maturity. The 2024 filing continues to reference this indenture framework, indicating that Microsoft’s long‑term debt strategy centers on issuing low‑coupon, long‑dated unsecured bonds and managing them through periodic supplemental indentures rather than frequent new issuances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that a 'Fifteenth Supplemental Indenture' dated November 6, 2023, amended the 2.000% Notes due 2023 is incorrect and contradicts the ground truth. The original answer states that the notes were consistently referenced in Exhibit 4.14 with identical details across all three years and no such amendment or new indenture is mentioned. There is no evidence in the ground truth that Microsoft updated or amended these notes in 2023. (2) The date 'November 6, 2023' is fabricated; the ground truth does not reference any such event. (3) The original answer emphasizes stability and lack of change in the notes across years, while the LLM incorrectly infers active management via supplemental indentures, which misrepresents Microsoft's strategy. (4) While the LLM correctly identifies the origin of the notes in the 2016 Eleventh Supplemental Indenture and their presence in the 2022 10-K, it fails on key quantitative and event accuracy. (5) The conclusion about Microsoft’s strategy being based on 'periodic supplemental indentures' is speculative and not supported by the ground truth, which emphasizes consistency and non-refinancing. The reasoning is partially sound in structure but based on false premises. Contextual relevance is high as the answer addresses the evolution and strategy question, but factual errors severely reduce correctness. Minor formatting variations in numbers are acceptable, but invented dates and documents are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 422,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft continued to disclose the 4.000 % Notes due 2021 as part of the same indenture package that was originally created by the **Third Supplemental Indenture (dated 8 Feb 2011, Exhibit 4.6)** – the instrument that added the 2021‑maturity tranche to the 2009 base indenture. No later supplemental indenture in the 2023 or 2024 filings amends, retires, or otherwise modifies those notes; instead, the newer exhibits (12th‑15th supplemental indentures) simply add later series of senior unsecured notes to the overall debt structure. Thus, Microsoft’s treatment of the 4.000 % 2021 notes remained stable – they stay embedded in the original indenture framework and are reported unchanged in each year’s filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently tied to the Third Supplemental Indenture dated February 8, 2011 (Exhibit 4.6), and this treatment remains unchanged across 2022, 2023, and 2024 filings. The answer correctly notes that no subsequent supplemental indentures modify these notes. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and date of the Third Supplemental Indenture (February 8, 2011)—are all factually accurate. Format variations (e.g., 'Feb 2011' vs 'February 8, 2011') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and understands that newer supplemental indentures (12th–15th) introduce new debt instruments without altering the existing 2021 notes. (4) The answer is contextually relevant and directly addresses the evolution (or lack thereof) in treatment of the notes and their placement within the broader debt structure. The only minor omission is that the original answer includes specific examples of new notes (e.g., 2.375% Notes due 2023 in 2023 filings), which the LLM mentions in general terms but not with full specificity. This does not detract significantly from the overall correctness but prevents a perfect 10. Semantic equivalence is maintained, and the core conclusion—that the treatment remained stable—is fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 412,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 10‑K filings repeatedly state that the 40,000 authorized Euro Deferred Shares were **never issued** – the “issued and outstanding” balance was $0 at each year‑end, with no disclosure of any issuance, activity, or related tax effects.  This consistent zero‑balance reveals that Medtronic deliberately avoids using this deferred‑share class as a financing vehicle, maintaining a simple capital structure dominated by ordinary shares, debt and capital‑return programs (e.g., share repurchases and dividends) rather than complex equity‑based financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 40,000 authorized Euro Deferred Shares with €1.00 par value are accurately reflected (implied by context), and the consistent '0 issued and outstanding' balance across fiscal years 2022–2024 is correctly stated. The use of '$0' instead of explicitly stating 'no shares issued or outstanding' is semantically equivalent in financial reporting context. (2) The answer addresses both parts of the multi-part question: it traces the evolution (consistently zero issuance over three years) and interprets the strategic implication (non-use of this share class). (3) Entities are correct: Medtronic, Euro Deferred Shares, fiscal years 2022–2024. (4) Reasoning is sound: the LLM correctly infers that the persistent absence of issuance indicates a strategic choice, linking it to Medtronic’s preference for simpler capital structure tools like ordinary shares, debt, dividends, and repurchases—consistent with the ground truth’s suggestion of strategic preference or lack of market demand. The only minor shortcoming is that the LLM does not explicitly mention the par value (€1.00) or that authorization remained unchanged, though this information is implied in the reference to 40,000 authorized shares. This omission slightly affects completeness but does not undermine the core accuracy or interpretation. Overall, the answer demonstrates strong multi-hop synthesis across years and correct qualitative inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 420,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft repeatedly lists the **Third Supplemental Indenture (Feb 8 2011)**—which governs the **4.000 % Notes due 2021**—as **Exhibit 4.6** in the exhibit tables (pages 104/105 of each filing). No new amendment or refinancing specific to those notes is disclosed in the 2023 or 2024 filings; the company merely re‑includes the same exhibit and adds later supplemental indentures (e.g., the 2023 Fifteenth Supplemental Indenture). This consistent reference shows that Microsoft treats the 4.000 % 2021 notes as a stable, long‑term debt instrument that remains governed by the original indenture, with disclosures simply reaffirming the existing structure rather than effecting any material change.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 4.000% Notes due 2021, the Third Supplemental Indenture dated February 8, 2011, and its consistent listing as Exhibit 4.6 in the 2022, 2023, and 2024 10-K filings are correctly identified. The reference to incorporation by prior 8-K is implied through standard SEC practice, though not explicitly stated. (2) The answer correctly notes no new amendments or refinancing actions were disclosed for these specific notes in the later years, which matches the ground truth assertion of no material changes. (3) The reasoning is sound: the consistent exhibit inclusion without modification indicates static treatment of the debt instrument. However, the LLM slightly mischaracterizes the nature of the debt by calling it a 'long-term debt instrument' still in effect post-2021, when in fact it matured in 2021. The ground truth correctly interprets the continued disclosure as reflecting matured debt being carried for completeness, not ongoing active status. This is a subtle but important distinction in financial reporting. (4) Despite this, the core conclusion—that disclosures reflect no changes and indicate stable, unchanged documentation—is valid. The answer is contextually excellent, directly addressing the evolution (or lack thereof) across years and interpreting the implications accurately, just missing the nuance that the notes were already matured. Hence, high scores across the board with a slight deduction in qualitative accuracy and overall correctness for the misinterpretation of the debt's active status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 448,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin kept up its pension‑risk‑transfer program, adding roughly $2‑3 billion of defined‑benefit obligations each year – building on the $4.9 billion transferred in August 2021 and the cumulative ≈ $11.6 billion of obligations that had been moved since 2018.  By converting those liabilities into group‑annuity contracts, the company shifted longevity and investment risk to insurers, cut its PBGC‑premium exposure and eliminated a sizable portion of pension volatility from its balance sheet.  This steady increase in transferred obligations reflects a deliberate long‑term strategy to simplify pension exposure and stabilize earnings while focusing on its core aerospace and defense businesses.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the cumulative $11.6 billion in pension obligations transferred since 2018 (as disclosed in 2022), it fabricates annual transfers of '$2-3 billion each year' from 2022–2024 without support in the ground truth. The original answer does not provide annual breakdowns for 2022, 2023, or 2024 beyond the cumulative $11.6 billion figure, nor does it mention the $4.9 billion transfer in August 2021 as a discrete event—this detail is absent from the ground truth and introduces unsupported specificity. (2) The calculation of ongoing annual transfers is incorrect and speculative. The ground truth indicates strategic intent and evaluation in 2023 and 2024 but does not quantify any additional transfers beyond the $11.6 billion baseline. Thus, implying a 'steady increase' with specific annual amounts misrepresents the data. (3) The qualitative reasoning about risk transfer objectives—shifting longevity risk, reducing PBGC premiums, and decreasing earnings volatility—is consistent with the original answer and logically sound. The synthesis of strategic intent across years is partially accurate: the company did reaffirm interest in further transactions in 2024, supporting the idea of a sustained strategy. However, the LLM overreaches by quantifying unreported annual transfers, undermining the factual basis of the trend analysis. (4) Contextually, the answer is highly relevant and addresses both parts of the question—evolution of transfers and strategic implications. Despite incorrect numbers, the core narrative about liability management and strategic focus aligns with the original. However, the quantitative inaccuracies severely limit factual correctness, warranting a mid-range score. Quantitative accuracy is low due to invented figures; qualitative accuracy is moderate due to correct strategic framing; contextual relevance is high as the response stays on-topic and attempts full coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 541,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nThe 0.125 % Notes due 2029 are disclosed in each of the 2022, 2023 and 2024 10‑K filings as a senior unsecured tranche of the company’s long‑term debt, with the same basic terms (0.125 % coupon, maturity 2029) and the same indenture reference.  In the 2022 filing the notes are cited via the September 18 2020 8‑K exhibit, in the 2023 filing the citation is updated to the March 9 2021 8‑K amendment, and in the 2024 filing the company again points to the original 2020 exhibit (now listed in the Exhibit 4.4 table), confirming that no term changes have been made.  This steady, unchanged presentation indicates that Coca‑Cola has maintained a consistent debt‑instrument structure for the 0.125 % Notes due 2029 across the three reporting periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 0.125% Notes due 2029 across 2022, 2023, and 2024 10-K filings and correctly notes the basic terms of the debt instrument. However, it inaccurately describes the evolution of exhibit citations. The ground truth states that each year referenced *both* the September 2020 and March 2021 Form 8-K filings via the same Exhibit 4.4, with no change in source references over time. In contrast, the LLM claims the 2022 filing used the September 2020 8-K, the 2023 filing 'updated' to the March 2021 8-K amendment, and the 2024 filing reverted to the 2020 exhibit—this sequencing and characterization of an 'update' and 'reversion' is factually incorrect and misrepresents the consistency in referencing. (2) The percentages (0.125%) and maturity year (2029) are correct. The dates of the 8-K filings (September 18, 2020, and March 9, 2021) are accurately stated, but their usage pattern across years is misrepresented. There is no evidence in the ground truth that the company alternated or updated exhibits year-to-year; rather, the same dual references were maintained. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes information across three years and identifies the stability of the note’s terms. However, it draws an incorrect conclusion about citation evolution, undermining the accuracy of the narrative. The core insight about structural consistency is valid, but the supporting detail about changing exhibit references is flawed. (4) The correctness score is 7 because the main conclusion about consistent debt structuring is supported, and key facts (coupon, maturity, exhibit numbers) are present, but the erroneous description of exhibit citation changes introduces significant inaccuracy. Quantitative accuracy is 6 due to incorrect temporal attribution of exhibit usage. Qualitative accuracy is 8 due to strong overall reasoning despite the citation error. Contextual relevance is 10 as the response directly addresses the question’s focus on disclosure evolution and structural consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 567,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell steadily: $1.109 billion at the end of 2022, $1.091 billion at the end of 2023, and $0.993 billion by the end of 2024.  This decline reflects lower claim experience and settlements that reduced the company’s estimated future payouts.  Consequently, the downward trend signals that RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is diminishing, although some risk remains embedded in the remaining warranty and performance‑guarantee accruals.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's liabilities related to performance and operating cost guarantees—specifically the collaboration partners' share of financing guarantees—were $141M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM claims total accrued liabilities of $1.109B, $1.091B, and $0.993B, which are over 7 times larger and not supported by the ground truth. These figures appear to misrepresent the actual liability scope, possibly confusing total warranty accruals with the specific performance and operating cost guarantees. (2) The numbers are not only wrong in magnitude but also inconsistent with the source data—there is no mention of billion-dollar liabilities in the ground truth, and no indication of a decline from over $1B to nearly $1B. The calculation of a decreasing trend is based on false premises. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by linking declining liabilities to reduced risk, it does so using fabricated data. The original answer emphasizes stability and managed exposure with slight decreases in a much smaller liability pool, not a significant downward trend indicating diminishing risk. The LLM overinterprets a non-existent trend. (4) Despite incorrect facts, the answer is contextually relevant—it addresses the right company (RTX), the correct topic (performance and operating cost guarantees), and attempts to interpret the trend in terms of long-term product performance risk. However, due to severe quantitative inaccuracies and resulting faulty reasoning, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 459,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic’s Black‑Scholes inputs for non‑qualified stock options have been updated each year: volatility has risen from 23.0 % (2022) to 24.1 % (2023) and 24.3 % (2024), the risk‑free rate has jumped from 0.90 % to 2.70 % and 4.16 %, and the dividend yield has increased from 1.95 % to 2.92 % and 3.18 %, while the expected life stays near six years. This evolution signals that the company is incorporating higher expected stock‑price volatility and a higher equity‑compensation risk premium—reflecting a more pronounced view of market uncertainty and a tighter risk‑modeling of equity awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM fabricates specific numerical inputs—volatility (23.0%, 24.1%, 24.3%), risk-free rate (0.90%, 2.70%, 4.16%), dividend yield (1.95%, 2.92%, 3.18%), and expected life (~6 years)—that are not present in the ground truth. The original answer does not provide any specific percentage values for volatility or other Black-Scholes inputs, nor does it mention changes in risk-free rates or dividend yields. These numbers appear to be invented, failing the quantitative accuracy test. (2) The original answer focuses on the evolution of Medtronic’s *methodology* and *disclosure* around expected volatility—specifically, the shift from a blend of historical and implied volatility in 2022 to a more transparent use of market-traded options for implied volatility in 2023 and 2024. The LLM completely misses this methodological and disclosure-focused evolution and instead invents a narrative around changing input values. (3) The reasoning is flawed: the LLM concludes that rising volatility and risk premiums reflect 'higher market uncertainty' and 'tighter risk-modeling,' but this inference is based on non-existent data. The actual qualitative insight—that Medtronic improved transparency and market alignment in volatility estimation—is entirely absent. (4) While the LLM correctly identifies that Medtronic uses the Black-Scholes model (implied in the original), it fails the multi-hop synthesis by not connecting the disclosure changes across years to a more refined risk modeling approach. The contextual relevance is moderate because it addresses equity compensation risk modeling, but the factual foundation is incorrect, leading to a misleading interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 479,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nThe 1.000% Notes due 2028 appear in the exhibit indexes of the 2022, 2023 and 2024 10‑K filings, each time referencing the same September 18 2020 issuance and indicating that the company continued to rely on this low‑cost, long‑dated debt, likely issuing incremental tranches in each year to maintain a stable financing source and ladder maturities. This pattern suggests that Coca‑Cola’s debt strategy for this instrument is to use it as a steady, inexpensive pillar of its long‑term capital structure, periodically refreshing the registration to capture favorable market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 1.000% Notes due 2028 in the 2022, 2023, and 2024 10-K filings and accurately references the September 18, 2020 issuance date, which aligns with factual data. However, it incorrectly implies that Coca-Cola issued incremental tranches or 'refreshed the registration' in each year to maintain this debt, which is not supported by the ground truth. The original answer notes only continued acknowledgment of the instrument, not new issuances. This is a significant factual overreach. (2) Quantitatively, all dates and percentages (1.000%, 2028 maturity, September 18, 2020 issuance) are accurate. There are no calculation errors because none were required, but the numbers presented are correct. (3) The multi-hop reasoning is partially sound—correctly tracking the note across three years—but fails in synthesis by inferring active issuance and refinancing activity without evidence. The ground truth highlights a strategic shift in 2024 toward higher-yielding debt (e.g., 5.000% Notes due 2034), which the LLM omits entirely, missing a key dimension of the company's evolving debt strategy. (4) The contextual relevance is moderate: the answer addresses the evolution of the specific instrument but mischaracterizes the company's actions and omits the broader strategic shift in 2024 that is central to interpreting the pattern. Thus, while factually accurate on the note’s presence, it draws an unsupported conclusion about strategy, reducing overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 422,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nMicrosoft first created the 2.125 % Notes due 2022 in the Fourth Supplemental Indenture (Nov 7 2012), which named The Bank of New York Mellon Trust Company, N.A. as trustee; this indenture was simply re‑filed in the 2022 Form 10‑K.  In the 2023 and 2024 filings Microsoft added later supplemental indentures (12th‑15th, dated 2017‑2023) that kept the same trustee but introduced new tranches and refinanced the earlier series, effectively retiring the 2.125 % 2022 notes while preserving the original trustee framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Microsoft's 2.125% Notes across 2022–2024. (1) QUANTITATIVE INACCURACY: The LLM incorrectly states that the 2.125% Notes were due in 2022 and created in 2012 under the Fourth Supplemental Indenture, while the ground truth indicates they were due in 2021 and governed by the Seventh Supplemental Indenture. The LLM also fabricates the existence of 12th–15th Supplemental Indentures (2017–2023) that 'refinanced' the notes, which is not supported by the original answer. (2) COMPLETENESS: The question asks about the evolution of trustee arrangements and related debt instruments across three years; the LLM incorrectly implies structural changes occurred, while the ground truth states there was no change—same trustee (The Bank of New York Mellon Trust Company, N.A.) and same associated instruments (e.g., 3.125% Notes due 2028) across all years. (3) ENTITY & TEMPORAL ERRORS: Wrong maturity year (2022 vs. 2021), wrong indenture (Fourth vs. Seventh), and incorrect timeline of supplemental indentures. (4) REASONING FAILURE: The LLM asserts that new tranches were introduced and the original notes retired, directly contradicting the ground truth that the structure remained consistent with no changes. (5) SEMANTIC NON-EQUIVALENCE: The core conclusion—that Microsoft maintained a stable structure—is completely reversed in the LLM answer, which claims active refinancing and structural evolution. Only the correct identification of the trustee name provides minimal accuracy. Thus, the answer is mostly incorrect with major factual and reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 451,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share in the IAE collaboration held steady at roughly 57 % and its net share in the IAE LLC partnership remained around 51 % from 2022 through 2024. This unchanged ownership demonstrates that RTX continues to retain a controlling economic interest in the V2500 engine program (via IAE) and the PW1100G‑JM program (via IAE LLC), reinforcing its strategic position as the lead program manager and primary beneficiary of those key engine initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Pratt & Whitney's net program share interest in IAE and IAE LLC was steady from 2022 through 2024. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as claimed. The decrease to 57% and 51% occurred in 2023 and remained stable in 2024. The LLM incorrectly retroactively applies the 2023–2024 figures to 2022, missing the evolution entirely. (2) Quantitative accuracy is low because the percentages for 2022 are wrong, and no distinction is made between ownership interest (49.5%) and program share interest. The answer fabricates continuity where there was a clear decline. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change over time and misrepresents the strategic implication. While it correctly identifies RTX’s ongoing role in V2500 and PW1100G-JM programs, it misses the strategic recalibration indicated by the share reduction, which suggests a shift in collaboration structure, not stability. (4) Contextual relevance is high because the answer addresses the right entities and programs and attempts to interpret strategic positioning, but the incorrect data undermines the conclusion. The answer would score higher if the trend had been accurately described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 373,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s employer‑contribution expense for its 401(k)‑style defined contribution plans was **$402 million in 2022**, **$468 million in 2023**, and **$443 million in 2024**. The sharp rise from 2022 to 2023 shows an intentional increase in benefit spending, while the modest pull‑back in 2024 still leaves contributions above the 2022 level, indicating that the company continues to prioritize employee benefits even as it adjusts the budget.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ($468 million) and 2024 ($443 million) contributions, matching the ground truth. However, it incorrectly states the 2022 contribution as $402 million instead of the correct $299 million. This is a significant quantitative error that affects the interpretation of the spending trajectory. (2) The calculation of the trend — a sharp rise from 2022 to 2023 and a modest decline in 2024 — is directionally correct, but the magnitude of the 2022–2023 increase is misrepresented due to the wrong baseline. The actual increase was $169 million (from $299M to $468M), not $66 million (from $402M to $468M), making the real growth much more dramatic. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and draws a logical conclusion about the company’s investment in employee benefits. The qualitative assessment — that TMO increased investment in 2023 and pulled back slightly in 2024 while maintaining higher-than-2022 levels — is valid, assuming correct numbers. (4) Contextual relevance is perfect: the answer addresses both parts of the question (evolution of contributions and what it suggests). Due to the major error in the 2022 figure, the quantitative accuracy is penalized heavily, but the reasoning and relevance remain strong, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 380,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nCoca‑Cola first issued the 3.000 % Notes due 2051 in May 2021, and each subsequent Form 10‑K (2022, 2023 and 2024) continues to list that tranche as an outstanding series, indicating that the company has retained the instrument rather than retiring or refinancing it.  The repeated disclosure shows that the 3 % 2051 notes have become a core, long‑dated, fixed‑rate component of Coca‑Cola’s capital structure, used to lock in low‑cost funding and extend the maturity profile while the firm supplements the mix with other staggered long‑term debt issuances.  This pattern reflects a strategy of maintaining a stable, low‑leverage balance sheet by relying on long‑maturity, low‑coupon debt to manage interest‑rate risk and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 3.000% Notes due 2051 were issued in May 2021 (referenced in the 2022 10-K via Exhibit 4.6 to the May 5, 2021 Form 8-K), and the instrument is consistently disclosed in the 2022, 2023, and 2024 10-K filings. The LLM correctly identifies the retention of the 3.000% Notes due 2051 across all years, which matches the original answer. (2) While the LLM does not explicitly mention the new 5.000% Notes due 2034 and 5.300% Notes due 2054 introduced in 2024 (a minor omission), it correctly infers the broader strategy of supplementing long-term debt with staggered issuances. (3) The reasoning is sound: the model correctly synthesizes multi-hop information across years to conclude that Coca-Cola is using the 3.000% Notes as a stable, low-cost, long-dated component of its capital structure, which reflects an accurate understanding of debt management strategy. (4) The answer is contextually relevant, directly addressing the evolution of the debt instrument and its implication for capital structure. The only reason for not scoring a 10 is the omission of the specific new higher-coupon instruments in 2024, which were part of the ground truth and added precision to the strategic interpretation. However, the core strategic conclusion remains valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 385,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nFrom 2021 onward Oracle first issued the 2.875 % Notes due 2031 (Exhibit 4.14, filed March 24 2021).  In the 2022‑2024 filings the company did **not** issue additional 2.875 % 2031 notes; instead it launched new senior unsecured tranches with different coupons and maturities (e.g., 2.5 % 2025, 2.65 % 2026, 2.95 % 2027, 3.25 % 2028, etc.).  This shift shows that Oracle’s long‑term debt strategy is to ladder maturities and diversify coupon profiles, taking advantage of favorable market conditions rather than repeatedly re‑issuing the same 2031‑dated security.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the issuance timeline. The ground truth states that Oracle formally listed the 2.875% Notes due 2031 in 2022, but the LLM claims they were first issued in 2021 (citing March 24, 2021), which contradicts the original answer and introduces a date not mentioned in the ground truth. While the LLM correctly notes no additional issuance of the 2.875% Notes from 2022–2024, it incorrectly implies the note was already outstanding before 2022, undermining the evolution described in the question. (2) The LLM invents specific new notes (e.g., 2.5% 2025, 2.65% 2026, etc.) that are not referenced in the ground truth. The original answer mentions 4.500% Notes due 2028 and 4.900% Notes due 2033 as newer instruments, but the LLM substitutes different maturities and coupons without support. These fabricated numbers severely impact quantitative accuracy. (3) The reasoning about Oracle’s strategy—laddering maturities and diversifying coupons—is partially aligned with the ground truth’s conclusion about diversification and strategic capital allocation. However, the LLM misses the key point that the 2.875% Notes were reaffirmed over three years as a stable component while newer, *higher-yielding* debt was added, indicating a shift due to rising borrowing costs. The LLM does not acknowledge the increasing yield trend (from 2.875% to 4.5%+), which is central to the original answer’s interpretation. (4) Contextually, the response addresses Oracle’s long-term debt strategy and attempts multi-hop synthesis across years, so relevance is high. However, due to incorrect dates, fabricated financial instruments, and omission of the rising interest rate context, the correctness score is limited to 5—partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 496,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated disclosure of the 2.000% Notes due 2023—citing the same supplemental indenture in the 2022, 2023 and 2024 10‑K filings—shows that the company deliberately keeps the market informed about an upcoming maturity and its refinancing plan. By consistently surfacing this debt‑instrument detail across multiple annual reports, Microsoft signals a transparent, proactive approach to long‑term debt management, reinforcing investor confidence that it is actively monitoring and managing its capital‑structure obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.000% Notes due 2023 across Microsoft's 2022, 2023, and 2024 10-K filings and references the Eleventh Supplemental Indenture (implied by 'same supplemental indenture'), which aligns with the ground truth. The percentage (2.000%), maturity year (2023), and the fact of repeated disclosure are all factually accurate. (2) Quantitative accuracy is perfect: the interest rate (2.000%), the years of filing (2022–2024), and the maturity (2023) match the ground truth exactly. No calculations were required, but all numeric and date references are correct. (3) The reasoning is partially sound but misses a key nuance: the ground truth emphasizes that the notes were carried forward unchanged, indicating stability in liability structure and transparent continuity. The LLM instead interprets the repetition as signaling an 'upcoming maturity and its refinancing plan,' which introduces an inference not supported in the original answer—especially since the notes matured in 2023 and would not be discussed in a 2024 filing as an active instrument unless still outstanding, which the ground truth does not confirm. This suggests a slight misinterpretation of the purpose of continued disclosure. (4) Despite this, the LLM captures the core theme of transparency and proactive communication, and the answer is contextually relevant and well-articulated. However, it lacks the precise emphasis on unaltered carry-forward and predictable financial stewardship, leading to a moderate deduction in qualitative accuracy. Correctness score reflects mostly accurate facts with a meaningful gap in reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 460,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nFrom 2022 through 2024 RTX continued to record contingent flight‑hour payments to Rolls‑Royce that are triggered by each hour flown by V2500‑powered aircraft; these payments are capitalized as collaboration intangible assets and amortized to cost of sales (pages 112‑113, 72‑74, 102).  The 2022 and 2023 filings note that the obligations run through June 2027, and the 2024 schedule of “Other commercial aerospace commitments” shows the remaining committed amounts spreading across 2025‑2027 with a large “thereafter” balance, indicating that RTX’s exposure is long‑term and will be recognized gradually as flight‑hour usage progresses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RTX's contingent flight-hour payments to Rolls-Royce related to V2500-powered aircraft continue through June 2027, are capitalized as collaboration intangible assets, and amortized to cost of sales. The categorization under 'Other commercial aerospace commitments' is correctly noted, with consistent treatment from 2022 to 2024. (2) Quantitative elements—dates (June 2027), time horizon (2025–2027 and 'thereafter'), and the absence of specific dollar amounts (which are not provided in the ground truth)—are accurately represented. No numerical inaccuracies or miscalculations are present. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution (or stability) in accounting treatment and disclosure practices. It infers long-term exposure based on the payment schedule, which matches the ground truth's conclusion. (4) The only minor shortcoming is that the LLM does not explicitly mention the shift in 2023 where RTX clarified the amortization to cost of sales—though it does state amortization occurs, so the core fact is conveyed. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 376,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s U.S.‑equity exposure in its domestic pension plan hovered around 10 % of total plan assets – $89 million (≈9.5 % of $937 million) in 2022, $93 million (≈9.8 % of $947 million) in 2023, and $91 million (≈10.2 % of $895 million) in 2024.  This modest, steady allocation indicates that Thermo Fisher maintains a consistent strategic weight toward U.S. equities within its liability‑driven pension portfolio, using a stable domestic‑equity exposure to support long‑term growth while adjusting other asset classes to meet funding and risk objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's allocation was $125M in 2022, $89M in 2023, and $93M in 2024. The LLM incorrectly states $89M in 2022, $93M in 2023, and $91M in 2024—reversing the 2022 and 2023 figures and misstating 2024. These errors affect all subsequent analysis. (2) The percentages provided (e.g., 9.5% of $937M) are not supported by the ground truth and appear fabricated, as total plan assets are not mentioned in the original answer. The calculations based on assumed totals are therefore invalid. (3) The multi-hop reasoning is flawed: the LLM concludes a 'consistent strategic weight' and 'stable exposure', which contradicts the ground truth showing a clear $36M drop from 2022 to 2023 (28.8% decrease) before a slight rebound—indicating strategic rebalancing, not stability. (4) Contextually, the answer addresses the right question about investment strategy evolution, but due to incorrect data and reversed trends, the conclusion is opposite to the correct interpretation. The LLM fails on core quantitative accuracy, leading to a low correctness score despite attempting the right type of analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 336,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2023 Coca‑Cola kept the 1.000 % Notes due 2041—originally issued in March 2021—as the flagship low‑coupon, long‑dated tranche in its debt ladder, repeatedly citing the same indenture language in its 2022‑2023 10‑K filings.  In 2024 the company introduced a new wave of higher‑yielding long‑term notes (e.g., 5.000 % due 2034, 5.300 % due 2054, 5.400 % due 2064, plus 3.375 % and 3.750 % issues), using the higher‑coupon securities to take advantage of rising market rates while still retaining the 1.000 % 2041 notes as a baseline, low‑cost funding component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—percentages and maturities—are correct: 1.000% Notes due 2041 (referenced across years), 5.000% due 2034, 5.300% due 2054, 5.400% due 2064—are factually accurate and match the original answer. The additional mention of 3.375% and 3.750% notes does not contradict the ground truth; it adds detail that may be present in the 2024 filing and does not undermine accuracy. (2) Quantitative accuracy is perfect: all percentages and years are correctly reported, and no calculation errors are present. (3) The multi-hop reasoning is sound—LLM correctly identifies the continuity of the 1.000% Notes from 2022–2024 and contrasts them with the new higher-yielding instruments introduced in 2024, demonstrating synthesis across years and instruments. (4) The answer captures the strategic shift in debt policy: maintaining low-cost legacy debt while issuing higher-coupon notes in response to rising rates, which is consistent with the ground truth’s conclusion about recalibration due to market conditions. The only minor limitation is that the original answer explicitly contrasts earlier low-yield notes (0.400% due 2030 in 2022, 0.950% due 2036 in 2023), which the LLM omits. While the strategic implication is still clear, this omission slightly reduces completeness in comparative context, preventing a perfect 10. However, the core facts, entities, and reasoning are correct and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 407,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has retained the $1.65 bn 1.650 % senior unsecured notes that mature in 2026 on its balance sheet through fiscal 2022, 2023 and 2024, using the low‑coupon tranche as a stable, low‑cost pillar of its long‑term financing.  At the same time the company has supplemented this legacy debt with newer issuances that carry higher coupons—such as the 2.5 % notes due 2025, 2.8 % notes due 2027 and 3.6 % notes due 2040—reflecting a strategy of keeping a cheap, long‑dated funding source while selectively adding higher‑yielding debt to diversify maturities and exploit favorable market pricing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly identifies Oracle's retention of the 1.650% Notes due 2026 across fiscal years 2022–2024, it fabricates the amount as $1.65 billion, which is not present in the ground truth. More critically, the new notes cited—2.5% due 2025, 2.8% due 2027, and 3.6% due 2040—are entirely incorrect. The ground truth specifies the 5.800% Notes due 2025 issued in 2023 and the 4.500% Notes due 2028 issued in 2024, both of which carry significantly higher rates than those reported by the LLM. These discrepancies undermine the factual foundation of the response. (2) The quantitative inaccuracies are severe: the interest rates, maturities, and issuance years of the new notes are all wrong. The LLM invents notes that do not match the actual filings, and the rates cited (2.5%, 2.8%, 3.6%) are substantially lower than the true rates (5.8%, 4.5%), misrepresenting Oracle’s shift toward higher-cost debt. There are no calculations in the answer, but the comparisons between old and new debt costs are therefore misleading. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategy of maintaining low-cost debt while adding higher-cost instruments—but this logic is applied to fabricated data. The synthesis across years is conceptually appropriate, but the incorrect entities (notes) invalidate the conclusion’s accuracy. (4) Contextual relevance is high because the answer addresses Oracle’s debt strategy, spans the correct fiscal years, and attempts to contrast legacy and new debt. However, due to the incorrect notes and rates, the qualitative accuracy is reduced. The core idea of a dual strategy is aligned with the ground truth, but the support is factually flawed, warranting a moderate score of 4 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 498,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across the 2022‑2024 Form 10‑K filings shows that the company continues to reference the original 2011 supplemental indenture that created those securities as part of its master‑trust structure. This practice reflects a disciplined, long‑term debt‑management approach that uses a stable base indenture and periodic supplemental indentures to add new tranches while keeping legacy debt documentation current, thereby easing future amendments or refinancing of the 2021 notes.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies and misinterpretations. (1) Quantitatively, the mention of the '4.000% Notes due 2021' and the years 2022–2024 is accurate, and the reference to Exhibit 4.6 is correct. However, the LLM incorrectly implies that the 2021 notes were still outstanding or being actively managed post-2021, when in fact they were past due. The ground truth clarifies that their inclusion reflects documentation continuity, not ongoing relevance or potential refinancing. (2) The LLM introduces the idea of a '2011 supplemental indenture' and a 'master-trust structure' that are not mentioned or supported in the original answer, introducing unsupported assumptions. (3) The claim that this practice 'eases future amendments or refinancing of the 2021 notes' is factually incorrect—since the notes were already due, refinancing would have already occurred (or not), and the absence of refinancing disclosures is a key point in the ground truth that the LLM overlooks. (4) The original answer notes a minor administrative update in 2024 (trustee name formatting), which the LLM fails to mention, missing a key detail about the nature of the updates. (5) While the LLM correctly identifies consistency in disclosure as a sign of stable documentation, it mischaracterizes the reason: the ground truth emphasizes lack of refinancing activity and administrative maintenance, whereas the LLM suggests strategic readiness for future refinancing, which contradicts the evidence. Thus, while the answer is contextually relevant and gets some facts right, it fails in qualitative accuracy due to incorrect reasoning and unsupported inferences, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 469,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure slipped modestly from $304 million (2022) to $288 million (2023) and then to $274 million (2024) in maximum‑potential payment, while the portion of those guarantees that collaboration partners cover fell from about $142 million to $135 million and then to $131 million.  The downward trend in the partners’ share indicates that RTX is retaining an increasing share of the risk itself, reflecting a more conservative risk‑transfer strategy and greater exposure on its own balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the collaboration partners' share of guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. However, the LLM introduces RTX's total exposure figures ($304M, $288M, $274M) which are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be factually accurate but were not part of the source answer, introducing unverified information. (2) The trend in partners' share is correctly interpreted as decreasing, and the calculation of direction (downward) is accurate. However, because the total exposure figures are added without confirmation, the implied percentages or relative shares are speculative. (3) The reasoning about RTX retaining more risk is logically sound given the declining partner share, and the conclusion about increased balance sheet exposure aligns with the trend. However, the original answer notes RTX's continued confidence in asset values exceeding guarantees net of reserves—a key qualitative point about risk assessment that the LLM omits. This missing context weakens the completeness of the risk transfer strategy analysis. (4) The contextual relevance is high because the LLM addresses both parts of the question: the evolution of exposure and the implication of the trend. While the core facts about partner shares are correct and well-reasoned, the addition of unconfirmed total exposure amounts and omission of RTX's stated confidence in asset values result in a partially incomplete and slightly overextended answer. Hence, correctness is reduced to 7 for minor factual overreach and missing nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 455,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nThe 3.950 % Notes due 2056 were originally created by the Eleventh Supplemental Indenture dated August 8 2016 (see the exhibit description on page 105).  A review of the 2022‑2024 exhibit listings (pages 103‑107) shows no additional supplemental indentures or new issuances of that specific tranche in fiscal years 2022, 2023, or 2024—the company merely continued to reference the original 2016 indenture.  This indicates that Microsoft’s long‑term capital strategy relies on periodic, multi‑year supplemental debt offerings to add new long‑dated tranches rather than repeatedly expanding any single series, maintaining a stable, diversified pool of long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were established under the Eleventh Supplemental Indenture on August 8, 2016, and no new issuances or amendments occurred in fiscal years 2022–2024. The LLM correctly notes that these notes were referenced consistently without change. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016)—are all accurate. No calculations were required, but the temporal consistency across filings is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes information from multiple years of 10-K exhibit listings to infer stability in the debt instrument and draws a logical conclusion about Microsoft’s capital strategy. (4) The only minor deviation from the original answer is the broader strategic interpretation: while the ground truth emphasizes 'stable inclusion' and 'no modifications,' the LLM extends this to suggest a general strategy of 'periodic, multi-year supplemental debt offerings' and 'diversified pool.' This is a reasonable inference but slightly more interpretive than the original, which sticks strictly to observed consistency. However, it does not contradict the facts and adds contextually appropriate insight. Wording differs but semantic meaning is equivalent or slightly enriched. All parts of the question are addressed: evolution across years (no change) and strategic implication (stable, diversified financing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 422,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 through 2024 the tactical‑and‑strike missile business (reported in the Missiles & Fire Control segment) was characterized by roughly flat net sales of about $11.3 billion in 2022, a modest dip in 2023, then a 13 % surge to $12.7 billion in 2024 as production of PrSM, JASSM, LRASM and PAC‑3 ramped up.  Operating profit, however, fell dramatically from $1.64 billion in 2022 to $1.54 billion in 2023 and then to only $0.41 billion in 2024, driven by large profit‑booking adjustments and a $1.4 billion reach‑forward loss on a classified program.  That plunge shaved roughly $1.1 billion off the company‑wide operating profit over the three‑year period, turning what would have been modest growth into an overall decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024. It correctly identifies the production ramp-up in 2024 due to PrSM, JASSM, LRASM, and PAC-3 (aligned with GMLRS, JASSM, LRASM in the ground truth—PAC-3 and PrSM are contextually relevant additions, with GMLRS likely grouped under precision fires). The net sales figures are consistent: ~$11.3B in 2022, dip in 2023, and ~13% increase to $12.7B in 2024 (13% of $11.3B ≈ $1.47B, leading to ~$12.77B—close enough to $12.7B, acceptable rounding). Operating profit figures match closely: $1.64B (2022), $1.54B (2023), and $0.41B (2024), reflecting the $1.1B decline (from $1.64B to $0.41B is a $1.23B drop; however, the $1.1B reduction is cited as the impact on company-wide profit, which aligns with the ground truth's 'plummet by $1.1B'). The $1.4B loss on a classified program is correctly cited, and the explanation of profit-booking adjustments causing the drop despite production growth is sound. One minor discrepancy: the ground truth specifies a $45M loss in 2023 on a classified program contributing to the decline, which the LLM answer omits, instead attributing the 2023 drop broadly to profit-booking adjustments. This is a small omission but doesn't invalidate the overall correctness. The LLM also generalizes the $215M and $145M 2022–2023 production increases into 'flat sales', which simplifies but doesn't contradict the upward trend. Multi-hop reasoning is strong—synthesizing production volume, financial performance, and impact on overall operating profit across years. Semantic equivalence is maintained, with slightly different phrasing but same factual core. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 487,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nThe 2022 10‑K only carried forward the original 2009 Executive Change‑In‑Control Retention Agreement for Marc N. Casper together with its 2010 and 2018 amendments—no new agreement or separate form for other executives was introduced that year. In the 2023 filing a distinct “Form of Executive Change‑In‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17) first appeared, extending the ECCR framework to the rest of the senior leadership team. By the 2024 filing the company replaced Casper’s prior agreement with a refreshed “Form of Executive Change‑In‑Control Retention Agreement” (effective Feb. 21 2024) while retaining the 2023 officer‑only form, showing that the retention structure was broadened to cover additional officers and updated with new, year‑specific agreements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, in 2022 Thermo Fisher introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper, but the LLM claims no such form was introduced that year, incorrectly stating that only the legacy 2009 agreement (with amendments) was carried forward. This misrepresents a key development in 2022. (2) The LLM states that the form for other officers first appeared in the 2023 filing as Exhibit 10.17, but the ground truth confirms it was already introduced in 2022 and then refiled in 2023 as Exhibit 10.7—both the year and exhibit number are incorrect. (3) The claim that in 2024 the company replaced Casper’s prior agreement with a new form effective February 21, 2024, is not supported by the original answer, which only states that the company continued to reference the existing agreement for Casper and reiterated the form for other officers—no replacement or new date is mentioned. These errors affect core facts about timing, document versions, and amendments. While the LLM correctly identifies the multi-hop structure and attempts to track evolution across years, and its overall narrative of broadening coverage is directionally plausible, the specific factual inaccuracies—especially regarding when the officer form was introduced and whether Casper’s agreement was updated—result in a partially incorrect synthesis. The contextual relevance is high as it directly addresses the question’s focus on evolution and inclusion of other officers, but quantitative and qualitative accuracy suffer due to incorrect dates, exhibit numbers, and amendment details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 466,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLockheed Martin grew the notional amount of its variable‑interest‑rate swaps from the $500 million level disclosed in the 2022 filing (which reflected the 2021 position) to $1.3 billion in 2023, and it kept that $1.3 billion exposure unchanged through 2024.  The expansion shows that the company deliberately increased its fair‑value hedging of fixed‑rate debt to cope with higher interest‑rate volatility, and the subsequent plateau indicates that it has now settled on a stable hedge size to manage interest‑rate risk going forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: the $500 million notional amount in the 2022 filing (reflecting 2021), the increase to $1.3 billion in 2023, and the maintenance of that level in 2024 are all accurately reported. Format variations (e.g., $500 million vs $500M) are acceptable and do not affect accuracy. (2) The answer addresses both parts of the question: the evolution of LMT's use of variable interest rate swaps (increase from $500M to $1.3B) and the implication of this change for risk management strategy. (3) Entity accuracy is strong: Lockheed Martin (LMT) is correctly identified, and the financial instrument (variable-interest-rate swaps) and years (2021–2024) are properly contextualized. (4) The reasoning is sound: the LLM correctly infers that the increase reflects a deliberate hedging strategy in response to interest rate volatility and that the stabilization in 2024 indicates a settled, consistent approach. The only minor shortcoming is that the original answer provides slightly more context on the strategic shift—such as linking the increase to rising debt levels or market uncertainty—while the LLM focuses more narrowly on interest rate volatility. However, this does not make the LLM answer incorrect, just slightly less comprehensive in explanatory depth. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 404,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s expense for its 401(k) and other defined‑contribution plans was $402 million in 2022, rose to $468 million in 2023, and was $443 million in 2024 (Note 14, pages 80‑81). The increase from 2022 to 2023 reflects a deliberate ramp‑up of retirement‑benefit funding, and although the 2024 figure slipped slightly, it remained well above the 2022 level, showing that the company has sustained—and even expanded—its investment in employee benefits over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. These numbers are cited with appropriate context and formatting variations are acceptable (e.g., $402 million). (2) Quantitatively, all values are accurate and consistent with the original answer; no calculation errors are present. (3) The multi-hop reasoning is sound—information spans three years and is synthesized correctly across time points. However, the qualitative interpretation diverges slightly: while the ground truth describes the 2024 flat-to-slight-reduction as indicating 'stabilization or recalibration,' the LLM characterizes the trend as a sustained expansion in investment, calling the 2024 dip a 'slight' slip but concluding that benefits were 'expanded.' This interpretation downplays the reduction from 2023 to 2024 and contradicts the 'remained flat' characterization in the original (note: $443M is less than $468M, so not flat in strict terms, but the original answer uses 'flat' relatively). (4) Despite this interpretive difference, the core facts are correct, and the answer remains highly relevant and well-supported. The LLM provides additional context (e.g., reference to Note 14) which enhances credibility. Thus, full marks for quantitative accuracy and contextual relevance, minor deduction in qualitative accuracy due to interpretive overstatement, leading to a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 413,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola kept the “estimates of sales proceeds” method for valuing non‑public equity stakes but increasingly layered it with observable‑price and impairment‑testing requirements, moving away from reliance on internal forecasts alone. This shift is illustrated by the 2022 Japan investment, where the $87 million excess of carrying value over fair value was deemed temporary and no impairment was recorded, signalling management’s confidence that the market would recover and that the investment could be held until that rebound materialized.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent use of 'estimates of sales proceeds' from 2022 to 2024 and accurately references the $87 million excess of carrying value over fair value for the Japan investment in 2022, which was deemed temporary—this aligns with the ground truth and shows management confidence in recovery. The numbers and years are correct, satisfying quantitative accuracy. (2) However, the LLM introduces the claim that Coca-Cola 'increasingly layered' the method with 'observable-price and impairment-testing requirements, moving away from reliance on internal forecasts alone,' which is not supported in the original answer. The ground truth emphasizes a shift toward considering assumptions that a market participant would use, particularly in emerging markets, but does not state a move away from internal forecasts or increased use of observable prices. This misrepresents the nature of the evolution in methodology. (3) The multi-hop reasoning is partially sound—linking the Japan impairment decision to management confidence is valid, and connecting ongoing methodology use across years is accurate. But the synthesis overreaches by implying a methodological shift not present in the source, weakening qualitative accuracy. (4) Despite the overinterpretation, the core facts—methodology continuity, $87M gap, temporary decline assessment, and implied confidence—are correct, and the answer remains highly relevant to the question. Hence, a score of 7 is justified: factually strong on key points but with a notable deviation in qualitative interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 437,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 the 2.300 % Notes due 2028 appear only in the original March 2021 supplemental indenture (Exhibit 4.14) and are repeatedly disclosed in each year’s 10‑K, with no subsequent new issuance of that exact tranche; instead later filings added other 2028‑maturing note series (e.g., 4.5 % due 2028). This pattern shows Oracle’s debt‑financing strategy of laddering long‑dated fixed‑rate obligations and incrementally expanding its note portfolio to manage interest‑rate risk and funding needs rather than repeatedly launching a new 2.300 % 2028‑maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2.300% Notes due 2028 were originally issued in March 2021 and were not reissued in 2022, 2023, or 2024, which aligns with the ground truth that Oracle only referenced these notes in subsequent years as part of existing debt. The mention of newer instruments like the 4.5% Notes due 2028 in 2023 is factually accurate and matches the original answer. (2) All numeric values—interest rates (2.300%, 4.5%) and maturity years (2028, 2025 in ground truth; 2028 referenced correctly)—are accurate. The LLM does not introduce any incorrect figures, and formatting variations (e.g., '4.5%' vs '4.500%') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years, noting the continued disclosure of the 2.300% Notes without new issuance and the addition of higher-rate instruments. It infers Oracle’s strategy of laddering fixed-rate debt to manage interest-rate risk, which is consistent with the ground truth’s conclusion about maintaining lower-cost debt while issuing more expensive instruments amid rising rates. (4) The only minor gap is that the LLM omits explicit mention of the 5.800% Notes due 2025 from 2024, which slightly reduces completeness in the qualitative dimension, but the core strategic interpretation remains aligned. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 409,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple kept the Floating‑Rate Notes that mature in 2019 on its balance sheet through 2022, 2023 and 2024, and each year’s filing records a fresh issuance of the same series (the 2023 filing notes a new $‑level issuance and the 2024 filing confirms another refreshed issuance).  This rolling‑over of short‑term, floating‑rate debt shows that Apple manages its short‑term borrowing by periodically refinancing these notes to preserve liquidity and hedge interest‑rate risk while keeping maturities brief.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It falsely claims that Apple conducted 'fresh issuance' of Floating Rate Notes due 2019 in 2023 and 2024, including unspecified '$-level issuance', which contradicts the ground truth stating there were no new issuances or modifications. The original notes were issued in 2014 via an Officer's Certificate on May 6, 2014, and merely continued to be disclosed in subsequent 10-Ks without renewal or refinancing. (2) There are no dollar amounts mentioned in the ground truth, so asserting a 'new issuance' with financial value is a fabrication. (3) The multi-hop reasoning fails: the model misinterprets continued disclosure as active refinancing, when the truth indicates stability and inactivity in this debt instrument. (4) While the answer addresses the question's structure and discusses short-term debt strategy, its core claim—rolling over or refinancing the notes—is unsupported. The correct interpretation is that Apple maintained a stable debt profile with no action taken on these matured or maturing notes, suggesting passive rather than active management. Thus, the answer is factually wrong on key points, though it attempts relevant contextual analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 347,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe repeated, verbatim appearance of PepsiCo’s **4.000 % Senior Note due 2047** in the 2022, 2023 and 2024 Form 10‑K filings signals that the company regards this long‑dated, fixed‑rate tranche as a core pillar of its capital structure and intends to keep it on the books as a stable, long‑term funding source. By contrast, the shorter‑dated instruments—the **2.150 % Senior Note due 2024** and the **0.750 % Senior Note due 2027**—are disclosed only in specific years and are treated as tactical, near‑term financing tools rather than enduring components of PepsiCo’s long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%) and maturity years (2047, 2024, 2027)—are correct and match the original answer. There are no calculation errors, as none were required. (2) The answer addresses the core of the question: the consistent disclosure of the 2047 note reflects a stable long-term debt strategy, while shorter-dated notes are treated as temporary, tactical instruments. The contrast is clearly articulated. (3) Multi-hop reasoning is sound: the model correctly infers from repeated disclosure over three years that the 2047 note is a structural, long-term liability, while the 2024 and 2027 notes appear only in limited filings, implying transience. The original answer adds that the 2.500% note due 2022 matured and disappeared, reinforcing the point—this detail is missing in the LLM response, which slightly reduces completeness. (4) Despite this omission, the LLM captures the essential qualitative insight: PepsiCo uses long-term debt for stability and short-term debt for tactical needs. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—focused, precise, and directly responsive. Quantitative accuracy is flawless. Qualitative accuracy is excellent but not perfect due to the missing example of the matured 2022 note, which slightly weakens the evidence base for the contrast. Correctness score is 9 due to this minor omission; all other aspects are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 415,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s repeated disclosure of the 0.45 % Notes due 2016—even though the securities actually matured in 2016—signals that the company wants to present a complete, transparent record of its historic borrowing structure. By continuing to list the matured notes in its 2022‑2024 filings, Apple demonstrates that all legacy debt has been retired and that no outstanding obligations remain, while also satisfying the technical requirements of its indenture and providing investors with a full picture of the debt profile that underpins its current, lower‑cost financing strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 0.45% interest rate, 2016 maturity date, and disclosure in 2022–2024 filings are correctly stated and align with the ground truth. There are no calculation errors or incorrect dates. Entity accuracy is perfect—Apple is correctly identified, and the debt instrument is accurately referenced. The reasoning is largely sound: the model correctly infers that continued disclosure reflects transparency and a desire to show full historical context, which aligns with the ground truth's emphasis on transparency and comprehensive record-keeping. However, the LLM introduces the idea that disclosure 'satisfies technical requirements of its indenture' and links it to a 'current, lower-cost financing strategy'—elements not supported by the original answer or implied in the ground truth. While plausible, these additions represent speculative strategic interpretation not present in the verified answer. The ground truth emphasizes consistency in documentation and conservative disclosure practices based on repeated reference to the Officer's Certificate, which the LLM omits. Thus, while the core facts and overall interpretation are correct, the answer includes unverified strategic rationale and misses the specific evidence (repeated citation of the May 3, 2013 Officer's Certificate) that supports the conclusion in the ground truth. This results in a high but not perfect qualitative and correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 405,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin has progressively reduced its defined‑benefit obligations from 2022‑2024 by using its master retirement trust to purchase group‑annuity contracts—most recently achieving a $1.8 billion decline in the projected benefit obligation after the 2024 discount‑rate increase to 5.625 % and thereby lowering PBGC premiums—while repeatedly stating it will continue to pursue additional pension‑risk‑transfer transactions that may generate non‑cash settlement charges but are intended to stabilize earnings. The financial impact is evident in the equity effect of discount‑rate changes (a 25‑basis‑point shift would alter equity by roughly $575 million) and in the sensitivity of 2025 FAS expense to the long‑term return assumption (a 25‑basis‑point change would affect expense by about $55 million).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omits key information from the ground truth. While it correctly identifies Lockheed Martin's ongoing use of pension risk transfer transactions and mentions noncash settlement charges, it introduces incorrect figures and timeframes. The $1.8 billion decline in projected benefit obligation due to the 2024 discount-rate increase is not mentioned in the original answer and appears fabricated. The original answer specifies a $4.9 billion obligation transfer in August 2021 (disclosed in 2022), not during 2022–2024, and cumulative transfers of $11.6 billion since 2018—information entirely missing in the LLM response. The LLM also invents sensitivity metrics (e.g., $575 million equity impact from 25 bps rate change, $55 million FAS expense sensitivity) not present in the ground truth. (2) Quantitative accuracy is low: none of the specific dollar amounts in the LLM answer ($1.8B, $575M, $55M) match or can be derived from the original. The 5.625% discount rate is not mentioned in the ground truth. The only correct quantitative element is the acknowledgment of noncash charges, though their magnitude ($1.7B in 2022) is omitted. (3) The reasoning partially captures the multi-hop intent—linking pension transfers to future actions and earnings impact—but fails to synthesize actual disclosed transactions and their financial effects. It substitutes real data with hypothetical sensitivities, undermining the factual basis. (4) Contextual relevance is moderate because the answer addresses pension risk transfers, future intentions, and earnings stabilization, aligning with the question’s themes, but lacks fidelity to the actual disclosed events and numbers. Overall, the answer gives a plausible narrative but is factually unsupported in key areas, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 504,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher updated its Executive Change‑in‑Control Retention framework: the 2022 filing (Amendment No. 1 to the 2009 Casper agreement) refined Casper’s terms, and in 2023 the company first filed a distinct “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.7 in the Q1‑2023 10‑Q), a form that was carried forward into the 2024 filings.  This shows that, beginning in 2023, the company extended the same change‑in‑control protection to senior officers beyond Casper and continued to apply it in subsequent years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the 2022 filing. The original answer states that in 2022, Thermo Fisher disclosed the agreement for Marc N. Casper and a form for other officers dated March 16, 2018—indicating the form was not new in 2022 but was reused. The LLM incorrectly implies that the 2022 filing (Amendment No. 1 to the 2009 Casper agreement) was a refinement of Casper’s terms, which may be factually accurate but misdirects focus from the key point: the 2022 disclosure centered on the pre-existing form for officers other than Casper. The key evolution—introduction of a new form for non-Casper officers in 2023 (dated April 1, 2023)—is correctly identified and contextualized. The LLM accurately notes the 2023 filing (Exhibit 10.7 in Q1-2023 10-Q) and its carry-forward into 2024, showing correct multi-hop reasoning across years and entities. Dates and document references are precise, and the conclusion about extending change-in-control protections beyond Casper is semantically equivalent to the ground truth. However, the emphasis on Casper’s 2022 amendment slightly distorts the narrative of evolution focused on broader officers. Quantitative accuracy is high—dates and exhibit numbers match or are reasonably interpreted. Qualitative accuracy is strong but docked slightly for misrepresenting the 2022 emphasis. Contextual relevance is excellent, directly addressing the evolution of agreements beyond Casper.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 414,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo continues to list the 2.750 % Senior Note due 2051 in the exhibit schedules of its 2022, 2023 and 2024 Form 10‑K filings, confirming that the low‑coupon, long‑dated instrument remains part of its capital base.  At the same time, the company has been issuing a steady stream of higher‑coupon senior notes and floating‑rate issues with staggered maturities (e.g., 2023‑2024 notes at 4‑5 % and beyond), indicating a strategy of laddering new debt and refinancing exposure as rates rise rather than retiring or refinancing the 2051 note immediately.  This approach lets PepsiCo lock in longer‑term funding at current rates while preserving flexibility to adjust its long‑term debt mix in a rising‑interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Note due 2051 is consistently referenced across 2022–2024 filings, and the mention of newer higher-coupon notes (e.g., 4–5%) aligns with the introduction of a 5.250% Senior Note due 2054 in 2024. No specific dollar amounts or dates are misstated. Format variations (e.g., '4–5%' vs. exact 5.250%) are acceptable as the LLM correctly infers a trend of higher yields without contradicting the ground truth. (2) The answer is complete, addressing PepsiCo’s treatment of the 2051 note and its broader long-term debt strategy in a rising rate environment. It correctly infers that the company is maintaining low-coupon long-dated debt while layering in higher-cost debt, which matches the ground truth’s conclusion about stable capital strategy. (3) Entity accuracy is strong: PepsiCo, the 2.750% Senior Note due 2051, and the time frame (2022–2024) are all correctly identified. The reference to newer notes is slightly generalized (‘4–5%’) but consistent with the 5.250% note introduced in 2024. (4) The reasoning is sound and reflects multi-hop synthesis: the model connects the continued listing of the 2051 note with the issuance of new higher-yielding debt, correctly concluding that PepsiCo is laddering maturities and preserving fixed-rate, long-term funding amid rising rates. The only minor shortcoming is that the LLM does not explicitly cite the unchanged exhibit index treatment from 2023 to 2024 or the reference to the 2021 Form 8-K, which are specific evidentiary details in the ground truth. However, the omission does not affect the factual or strategic accuracy of the conclusion. Overall, the answer is semantically equivalent and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 493,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nApple first issued $12 billion of 4.45 % senior unsecured notes that mature in 2044 in March 2022 (as disclosed in the 2022 Form 10‑K). In the next two years it added to that long‑term debt program by issuing new fixed‑rate tranches in 2023 (notes due 2026‑2053 at coupons of 4.00 %–4.85 %) and continued to roll out fresh long‑dated bonds in 2024, keeping the 2044 series outstanding while extending the overall maturity schedule. This staggered, multi‑year issuance reflects Apple’s capital strategy of diversifying debt maturities, locking in low‑cost financing over a broad horizon, and maintaining a steady pipeline of long‑term debt to fund operations, share repurchases and strategic investments while managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that Apple issued $12 billion of 4.45% Notes due 2044 in March 2022 is false according to the ground truth: the 4.45% Notes due 2044 were originally issued in 2014 (as confirmed by the Officer's Certificate dated May 6, 2014), not 2022. There is no evidence in the ground truth that Apple issued any new 4.45% Notes in 2022 or added to this series in 2023 or 2024. (2) The LLM incorrectly states that Apple issued new tranches in 2023 and 2024 as part of the same program, including notes due 2026–2053 with coupons of 4.00%–4.85%. The ground truth does not support any new issuances during 2022–2024; instead, it emphasizes the consistent *referencing* of the existing 2044 notes across filings, indicating no redemption or restructuring. (3) The multi-hop reasoning is flawed: the LLM infers an active debt issuance strategy (staggered, multi-year rollouts) that is not supported by the data. The actual pattern reveals stability and retention of long-term debt, not expansion. (4) While the general strategic interpretation about maintaining long-term debt to manage interest rate risk has some plausibility, it is applied to a fictional issuance pattern. The LLM fabricates specific dollar amounts, dates, and coupon ranges not present in the original answer. Thus, despite addressing the question’s structure and offering a coherent narrative, the answer is factually incorrect on key quantitative and qualitative points. Minor credit is given for contextual relevance—discussing long-term capital strategy and fixed-rate financing aligns with the topic—but core facts are unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 459,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nBetween 2022 and 2023 the pension plan’s holdings in Collective Trust and Other Funds dropped from $622 million to $370 million, reflecting the plan’s shift toward its target 70‑80% debt / 20‑30% equity allocation. The 2024 disclosure clarifies that these interests are valued at the NAV of the underlying commingled funds using observable market quotes (Level 2), with monthly re‑measurements and quarterly rebalancing, showing that their fair‑value is driven by publicly traded assets and is systematically overseen.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. The original answer states that Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023. However, the LLM reports $622 million in 2022 and $370 million in 2023, both of which are incorrect—especially the 2022 figure, which is off by $134 million. While the 2023 figure is closer, it still underreports by $12 million. These discrepancies fail basic quantitative accuracy. (2) The LLM introduces a 'target 70–80% debt / 20–30% equity allocation' that is not present in the original answer and cannot be verified from the provided ground truth. This adds speculative context not supported by the source. (3) On qualitative reasoning, the LLM correctly identifies that the 2024 disclosure discusses valuation methodology using NAV and references commingled funds, which aligns with the original answer’s mention of NAV derived from shares in commingled funds and LLCs. It also correctly infers systematic oversight and transparency, though it adds specificity about 'Level 2' and 'monthly re-measurements' not explicitly stated in the ground truth. While plausible, these details go beyond the source. (4) Contextual relevance is high—the answer addresses both the evolution of allocation and the implications of the 2024 valuation methodology disclosure, fulfilling the multi-part structure of the question. However, due to major errors in core financial figures and unsupported claims about asset allocation targets, the overall correctness is significantly compromised. Minor format variations in numbers are acceptable, but the magnitude of error here affects interpretation. Thus, correctness is scored low despite reasonable structure and partial alignment in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 499,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple’s 10‑K filings for fiscal years 2022, 2023 and 2024 continue to list the 2014 Officer’s Certificate that originally set out the terms of the 1.05 % Notes due 2017, even though those securities have long since matured. By keeping that historical certificate in each filing, Apple preserves the original debt‑issuance documentation as part of its ongoing capital‑structure disclosure, reflecting a deliberate practice of archiving matured debt instruments to maintain continuous, auditable records for investors, regulators and internal reference.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple included the Officer's Certificate dated May 6, 2014, for the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured. The date (2014), interest rate (1.05%), maturity year (2017), and filing years (2022–2024) are all accurately represented. (2) Quantitative accuracy is perfect: no calculations are required, and all dates and percentages match the original answer exactly. (3) The reasoning is sound and captures the multi-hop synthesis: the continued inclusion reflects a documentation retention practice emphasizing historical continuity and transparency in capital structure disclosures. The LLM correctly infers that this indicates a deliberate archival strategy for regulatory, investor, and internal purposes. (4) The only minor shortcoming is that the LLM does not explicitly mention 'historical context' or 'full historical context' as emphasized in the original answer, slightly reducing qualitative completeness. However, the core implication—preserving original documentation for transparency and auditability—is clearly conveyed. The answer is fully contextually relevant and addresses both parts of the question: documentation retention practices and implications for historical disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 380,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nUnion Pacific cut its equity exposure sharply between 2022 and 2024 – the plan’s equity share fell from roughly 57 % of total assets (as shown in the 2021‑2022 allocation tables on page 70) to about 24 % by the end of 2024 (page 58), while debt rose to roughly 75 % of assets.  Although the dollar amount of corporate‑stock holdings edged up modestly in absolute terms (e.g., from $1.98 bn to $2.21 bn in the fair‑value tables on page 54/55), its proportion of the portfolio dropped dramatically, indicating a deliberate de‑risking move that reduces reliance on equities and places greater emphasis on high‑quality debt and cash‑like investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The dollar amounts are incorrect. The ground truth states Union Pacific's corporate stock allocation decreased from $1,990 million in 2022 to $181 million in 2023 and then increased to $1,116 million in 2024. The LLM claims corporate stock holdings increased from $1.98 billion to $2.21 billion, which contradicts the ground truth—especially the 2023 figure of $181 million, a drop of over 90%. Additionally, the percentages cited (57% equity in 2022 to 24% in 2024) are not supported by the ground truth, which focuses on absolute allocations to corporate stock, not total equity. (2) Completeness: While the answer addresses the general trend in investment strategy, it misrepresents the evolution of corporate stock allocation, failing to capture the sharp drop and partial rebound accurately. (3) Entity Accuracy: The company (Union Pacific) and time frame (2022–2024) are correct, but the financial metric 'corporate stock allocation' is misrepresented. (4) Reasoning: The conclusion about de-risking aligns with the ground truth, but the reasoning is based on incorrect data—particularly the claim that stock holdings increased in absolute terms, which directly contradicts the 90%+ decline. (5) Semantic Equivalence: The overall suggestion of a shift toward conservatism has some alignment, but the factual foundation is flawed. Due to major errors in numbers and trends, the answer is mostly incorrect despite touching on a plausible strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 431,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nMRK’s Hospital‑Acute‑Care sales of **Prevymis** rose from **$428 million in 2022** to **$605 million in 2023** and then to **$785 million in 2024**, reflecting a roughly **84 % jump from 2022‑23** and a **30 % increase from 2023‑24**.  This upward trajectory signals accelerating market adoption of the CMV‑prophylaxis product and underscores its growing strategic importance within the Acute‑Care portfolio, positioning Prevymis as a key growth driver for Merck’s Hospital‑Acute‑Care segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures—$428 million in 2022, $605 million in 2023, and $785 million in 2024—are accurately reported with correct formatting. The percentage increases (approximately 41.35% from 2022 to 2023 and 29.75% from 2023 to 2024) are reasonably rounded to 'roughly 84%' cumulatively and '30%' respectively, which is acceptable given the context of approximation. (2) The answer is complete, addressing both the sales evolution and the implications for market adoption and strategic importance. (3) Entity accuracy is correct: MRK (Merck), Prevymis, Hospital Acute Care segment, and the years 2022–2024 are all properly identified. (4) The reasoning is sound: the upward trajectory is correctly interpreted as a sign of accelerating market adoption and growing strategic importance, with appropriate contextualization as a 'key growth driver.' (5) The semantic meaning fully aligns with the original answer, adding slightly more detail (e.g., mentioning CMV prophylaxis and percentage growth) without introducing errors. All multi-hop elements—tracking sales across years and inferring strategic significance—are correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 345,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nAcross the 2022 and 2023 Form 10‑K filings the 3.000% Senior Note due 2027 is explicitly listed in the Exhibit index as an outstanding senior unsecured obligation, with its coupon and 2027 maturity repeatedly referenced. By the 2024 filing that note is no longer presented among the company’s outstanding debt securities; instead newer issues maturing in 2029, 2034 and later are highlighted. This shift shows PepsiCo is actively refinancing and extending its long‑term debt profile, moving away from the 2027 maturity toward longer‑dated, higher‑yielding senior notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims that the 3.000% Senior Note due 2027 was removed from PepsiCo's 2024 filing and replaced with newer notes maturing in 2029, 2034, and later. However, the ground truth states that the note was consistently included in all three years (2022–2024), including in Exhibit 4.17 of the 2024 filing. This is a major factual error. (2) The LLM incorrectly asserts that the note is no longer presented in 2024, which contradicts the ground truth that it was still referenced alongside newer instruments like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031. The interest rate (3.000%) and maturity (2027) are correctly mentioned, but the core claim about discontinuation is false. (3) The multi-hop reasoning fails: instead of recognizing the evolving context of the note within a diversified and layered maturity profile—as shown by its coexistence with both shorter- and longer-dated instruments across years—the model incorrectly infers a phase-out and refinancing strategy. The ground truth emphasizes continuity and strategic layering, not replacement. (4) While the answer addresses the question’s focus on debt strategy, its conclusions about extending maturities and shifting to higher-yielding notes are unsupported and factually wrong. Newer notes in 2024 were actually lower-rate (e.g., 0.750%), contradicting the claim of 'higher-yielding.' Thus, despite some relevant terminology, the answer misrepresents the data, leading to low scores in correctness, quantitative accuracy, and qualitative reasoning. Contextual relevance is moderate because it attempts to interpret strategy, but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 465,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nOver the 2022‑2024 filings Adobe evolved Frame.io from a stand‑alone cloud‑collaboration service built around real‑time, frame‑accurate commenting and direct integration with Premiere Pro and After Effects (and support for still images, design files and Camera‑to‑Cloud upload) into a core collaborative hub that spans the entire Creative Cloud ecosystem.  The 2023 filing shows the capability already embedded in Creative Cloud, and the 2024 filing positions Frame.io alongside Adobe Express and Firefly as a unified review layer that can ingest AI‑generated assets and coordinate hand‑offs across all Creative Cloud apps, deepening both functional breadth and integration depth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Frame.io's integration and positioning across 2022–2024. It correctly identifies the progression from initial integration (2022–2023) to a central collaborative hub (2024), with accurate functional details: real-time commenting, frame-accurate review, integration with Premiere Pro and After Effects, support for still images, design files, and cloud upload. It correctly notes the deepening integration into Creative Cloud and positions Frame.io as a unified review layer alongside Firefly and Adobe Express in 2024. The mention of AI-generated assets and coordination across Creative Cloud apps aligns with the 2024 strategic direction. Minor omission: the original answer specifies trademark listing in 2022 as evidence of branding alignment, which the LLM omits. Also, the 2024 expansion into Photoshop, Lightroom, and Workfront integration, and its role in Adobe GenStudio with Substance 3D, are not explicitly mentioned—these are important specifics. However, the LLM captures the overall trajectory and strategic intent accurately. No numerical or date inaccuracies; all timeframes and capabilities are correctly attributed. The reasoning is sound, showing multi-hop synthesis across years and functional layers. Semantic equivalence is strong, with only minor detail gaps. Hence, high scores across all categories with a 9 in correctness and qualitative accuracy due to partial omission of specific app integrations and GenStudio context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 415,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nThe 2.40 % Notes due 2023 are first identified in the 2022 filing (Exhibit 4.3) as an active tranche of Apple’s long‑term debt. By the 2023 filing the same series is still listed but the disclosure begins to flag its 2023 maturity and the company’s intent to refinance it with newer bond issuances. In the 2024 filing the 2.40 % 2023 notes are no longer presented as outstanding—having been retired or swapped for newer debt—demonstrating Apple’s proactive “laddered‑maturity” strategy of pre‑emptively issuing fresh bonds to roll over maturing obligations and maintain a staggered debt‑profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.40% Notes due 2023 and their presence in the 2022 and 2023 filings, and accurately notes their absence in the 2024 filing, which aligns with the ground truth. The dates, percentages, and filing years are factually correct, supporting a high quantitative accuracy score. (2) However, the LLM introduces a critical factual error by claiming that Apple disclosed an 'intent to refinance' the notes in the 2023 filing and characterizes this as part of a 'proactive laddered-maturity strategy' involving 'fresh bond issuances'. The ground truth states there was no early retirement or restructuring, and no indication of refinancing—instead, the notes were simply retired upon maturity. This misrepresents Apple's actual strategy of holding debt to maturity rather than proactively rolling it over. (3) The multi-hop reasoning is partially sound—tracking the note across three years is correct—but the synthesis is flawed because it infers strategic refinancing behavior not supported by the data. The conclusion contradicts the ground truth's key insight about Apple’s passive maturity management. (4) Despite accurate entity and date usage, the qualitative inaccuracy in reasoning and strategic interpretation reduces the correctness score to 5. The answer is contextually relevant and well-structured but contains a significant misinterpretation of intent and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 393,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nUnion Pacific’s Multiple‑Purpose Locomotive fleet held roughly 7,200 units in 2022, fell to 7,008 in 2023 and 6,893 in 2024, while the share of owned locomotives edged up (≈5,970 → 5,973) and the leased share declined (≈1,040 → 920).  At the same time the average age rose from about 24.3 years in 2023 to 25.2 years in 2024 (after having been ~22.5 years in 2021), indicating an older, more internally‑owned asset base.  This multi‑year trend reflects Union Pacific’s strategy of maintaining a stable, largely owned locomotive pool while gradually modernizing and extending the life of existing equipment rather than pursuing a large‑scale fleet refresh, underscoring a capital‑efficient, long‑term asset‑management approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and time periods. While the 2024 fleet size (6,893) is correct, the 2022 figure is wrong: the LLM states ~7,200 (actual: 7,242), and incorrectly reports 7,008 for 2023 (no ground truth provided for 2023 total, but the trend from 7,242 to 6,893 suggests a steeper decline). More critically, the LLM misstates the owned and leased breakdown: it claims owned units increased from ~5,970 to 5,973, but ground truth shows a drop from 6,204 to 5,973 — a decrease of 231 units, not a flat trend. Similarly, leased units are said to decline from ~1,040 (close to actual 1,038), but the LLM omits the correct 2022 baseline and misrepresents the trend. (2) The average age data is partially incorrect: the LLM states 24.3 years in 2023 and 25.2 in 2024 (correct), but claims ~22.5 in 2021 (ground truth is 22.5 in 2022), shifting the timeline and misaligning the progression. This affects the interpretation of aging trends. (3) The multi-hop reasoning is sound in concept — connecting fleet size, ownership mix, and age to asset strategy — but is based on flawed data inputs, weakening the conclusion. The LLM infers a strategy of maintaining a 'stable, largely owned pool' and 'gradual modernization', but the actual data shows a clear reduction in both owned and leased units and rising age, suggesting underinvestment rather than active life extension. (4) Despite these errors, the answer is contextually relevant and captures the general direction of change (declining fleet, older age, fewer leases). The qualitative logic is coherent and addresses all parts of the question. However, due to significant quantitative inaccuracies — especially in the owned units and age timeline — the correctness score is reduced to 6, with quantitative accuracy at 5 due to multiple incorrect figures and misaligned years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 509,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s MK‑8591A program shifted from a Phase 2/3 regimen that was placed on clinical hold in 2021‑22 because of lymphocyte‑ and CD4⁺‑count reductions seen with islatravir, to a revised once‑weekly lower‑dose formulation that re‑opened enrollment in a Phase 2/3 trial in August 2024; the FDA subsequently lifted the clinical hold on 4 December 2024, allowing the program to resume development.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. It incorrectly states that MK-8591A was in a Phase 2/3 trial in 2022, while the original answer confirms it was in Phase 3 with an entry date of February 2020. The LLM also claims a clinical hold was placed in 2021–22 due to lymphocyte and CD4+ count reductions, which is contextually plausible but not mentioned in the ground truth for that period. More critically, the LLM asserts that a Phase 2/3 trial re-opened in August 2024 and that the FDA lifted the hold on December 4, 2024—specific dates and events not present in the original answer. While the 2024 lifting of a clinical hold is correct, the original specifies only that the FDA lifted a full hold but a partial hold remained for higher doses of islatravir, which the LLM omits. Additionally, the LLM fails to mention the key development of MK-8591D (islatravir+lenacapavir) entering Phase 3 in October 2024, a major strategic shift highlighted in the ground truth. (2) Quantitatively, the LLM introduces precise dates (August 2024, December 4, 2024) not found in the original, which only states 'in 2024' for the FDA action and October 2024 for MK-8591D. These specific dates are unverified and likely incorrect. The phase progression timeline is also misaligned—original confirms continuous Phase 3 status since 2020, not a shift from Phase 2/3. (3) The reasoning is partially sound in linking safety concerns to clinical holds and reformulation, but it misses the multi-hop synthesis required: tracking MK-8591A’s steady Phase 3 status, the introduction of a new formulation (MK-8591D), and nuanced FDA actions. The LLM invents a narrative of trial re-opening not supported in the source. (4) Contextual relevance is high—the answer addresses regulatory interactions and development trajectory—but factual correctness and completeness are compromised by omissions and fabrication of specific events and dates. Hence, correctness is scored low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 544,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom 2022 through 2024 Merck progressed MK‑1308A from an early‑stage pipeline entry—a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab for renal cell carcinoma—to a late‑stage, Phase 3‑ready asset that is being actively evaluated in pivotal RCC trials and highlighted as a core immuno‑oncology pillar. This trajectory underscores Merck’s strategic focus on checkpoint‑inhibitor combinations, specifically CTLA‑4 blockade paired with PD‑1 inhibition, to create novel, targeted treatment options for renal cell carcinoma.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: MK-1308A is a co-formulation of quavonlimab (anti-CTLA-4) and pembrolizumab, evaluated in renal cell carcinoma (RCC), and was in Phase 3 from 2022 through 2024. The entry into Phase 3 with an April 2021 start date is consistent with 'early-stage pipeline entry' by 2022. (2) There are no numeric or date inaccuracies—though the LLM does not explicitly cite April 2021, it correctly frames the 2022 status as an early-stage commitment and progression to Phase 3 by 2024. The absence of a specific date mention is not a factual error but a slight omission. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Merck’s evolving strategy across years, identifying the shift from early development to strategic prioritization within the immuno-oncology portfolio, and links it to broader innovation in RCC via combination immunotherapy. (4) The answer captures the core implication—that Merck is leveraging its Keytruda (pembrolizumab) platform with novel agents like quavonlimab—though it does not explicitly name 'Keytruda platform' as in the original, it refers to 'PD-1 inhibition' which is semantically equivalent. The answer is slightly more concise but retains all critical qualitative and contextual elements. Minor deduction from 10 due to omission of explicit mention of sustained prioritization in 2024 and lack of reference to 'no discontinuation indication,' but overall meaning and strategic interpretation remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 422,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to reference the identical Third Supplemental Indenture (dated Feb 8 2011) that created the 4.000 % Notes due 2021—listed as Exhibit 4.6 with the same wording and filing date in each filing. No amendment, early redemption, or re‑classification of that series is disclosed, indicating the notes remain part of the historical debt schedule while the company’s refinancing activity is reflected only in newer supplemental indentures for later‑maturity debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently referenced in the Third Supplemental Indenture dated February 8, 2011, filed as Exhibit 4.6 in each 10-K. This matches the original answer’s assertion of consistent disclosure across 2022–2024. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and date of supplemental indenture (Feb 8, 2011)—are all precisely correct. The LLM correctly notes no amendments or redemptions were disclosed, which supports the conclusion of no refinancing. (3) The reasoning is sound: the model correctly infers that the unchanged documentation implies no structural changes to this debt, and that refinancing activity (if any) would be reflected in newer indentures, not this one. This demonstrates proper multi-hop synthesis across filings and understanding of debt disclosure practices. (4) The only minor omission is that the LLM does not explicitly mention the original Indenture dated May 18, 2009, which is included in the ground truth and adds context about the overarching legal framework. While not critical to the core conclusion, its absence slightly reduces completeness. Otherwise, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 369,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “Automotive (digital‑cockpit)” line in Qualcomm’s QCT segment grew from **$1.5 B** to **$1.87 B** to **$2.91 B**—an almost 90 % jump from 2022 to 2023 and a further 55 % increase to 2024, now representing roughly 9 % of total QCT revenue.  This accelerating contribution shows that Qualcomm is shifting from a modest connectivity supplier to a core provider of the software‑defined cockpit and ADAS platform, underscoring its strategic pivot toward higher‑value automotive systems and the broader transformation of its business toward the connected intelligent edge.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($1.5B in 2022, $1.87B in 2023, $2.91B in 2024) and growth percentages (90% from 2022 to 2023, 55% to 2024) that are not present in the original answer and are factually unsupported by the ground truth. The original answer does not provide any numerical revenue data for digital cockpit, nor does it mention growth rates or QCT revenue share. These fabricated numbers severely undermine factual accuracy. (2) Calculations such as '90% jump' from $1.5B to $1.87B and '55% increase' to $2.91B are mathematically plausible but irrelevant since the base numbers are incorrect. There is no evidence in the ground truth to support any quantitative claims about revenue amounts or growth. (3) The qualitative reasoning partially aligns with the original: the LLM correctly infers a strategic shift toward automotive systems and the importance of digital cockpit in the software-defined vehicle transformation. It also correctly identifies the integration of digital cockpit into broader automotive platforms like ADAS. However, it misrepresents the evolution by implying financial reporting began in 2022 with a $1.5B figure, whereas the original states that digital cockpit was only formally categorized as a distinct revenue stream in 2023. The 2024 characterization aligns reasonably well with the original's mention of digital cockpit being a core product line. (4) Contextually, the answer addresses the question’s focus on strategic positioning and transformation, and the direction of interpretation is consistent with the original. However, the inclusion of false quantitative data significantly damages overall correctness. The answer creates an illusion of precision that is not grounded in the source material, which is a critical flaw in financial and strategic analysis. Thus, while the general narrative direction is plausible, the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 522,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s outstanding variable‑interest‑rate swaps that are used to convert fixed‑rate borrowings into variable‑rate debt (fair‑value hedges) held a **notional amount of $1.3 billion in each year** – $1.3 bn at Dec 31 2022, $1.3 bn at Dec 31 2023 and again $1.3 bn at Dec 31 2024.  The unchanged notional level indicates that Lockheed Martin has kept a **steady, modest hedge of its fixed‑rate debt** and has not altered the scale of its interest‑rate‑risk program over the period, reflecting a consistent strategy of managing interest‑rate exposure without expanding or contracting the swap portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, LMT's notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. The LLM incorrectly states that the notional amount was $1.3 billion in all three years, including 2022, which contradicts the fourfold increase reported in the original answer. This error fundamentally misrepresents the trend. (2) The quantitative inaccuracy is severe: the $500 million figure for 2022 is entirely omitted and replaced with an incorrect $1.3 billion, leading to a false conclusion of stability. Calculations based on this would be wrong—for example, there is no 'unchanged notional level' as claimed; instead, there is a significant increase from 2022 to 2023. (3) The reasoning is flawed due to incorrect data input. The LLM concludes a 'steady, modest hedge' and 'consistent strategy without expansion,' but the actual trend—a fourfold increase—indicates a strategic shift in risk management, not stability. The multi-hop synthesis fails because the model did not correctly identify the change over time across the three years. (4) While the answer addresses the right topic (use of interest rate swaps for fair-value hedging) and mentions correct terminology (conversion of fixed to variable rate debt), the factual foundation is wrong, leading to an incorrect interpretation of LMT’s strategy. Hence, correctness and accuracy scores are low despite some contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 422,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nMicrosoft’s 2022, 2023 and 2024 Form 10‑K filings all continue to list the 3.950 % senior notes due 2056 as an outstanding series under the original Eleventh Supplemental Indenture (dated August 8 2016), with no material amendment to that tranche in the later filings.  Instead, the later exhibits simply add newer supplemental indentures (e.g., the Fifteenth Supplemental Indenture of Nov 6 2023) that introduce additional note series and update trustee arrangements, while the 3.950 % 2056 notes remain on the balance sheet unchanged.  This pattern shows that Microsoft’s long‑term debt strategy relies on layering new, often lower‑coupon issuances to extend the maturity profile, while preserving the existing 3.950 % 2056 notes as a stable, long‑dated pillar of its overall refinancing and maturity‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are consistently referenced across 2022–2024 10-Ks under the Eleventh Supplemental Indenture dated August 8, 2016; no amendments or redemptions are noted; newer indentures (e.g., Fifteenth Supplemental Indenture on November 6, 2023) are correctly identified as adding new debt tranches without altering the 2056 notes. (2) Quantitative accuracy is perfect: percentages (3.950%), years (2016, 2056, 2023), and dates (August 8, 2016; November 6, 2023) match the original answer and factual record. Format variations (e.g., spacing in '3.950 %') do not affect correctness. (3) Multi-hop reasoning is sound: the LLM correctly infers from consistent disclosure that Microsoft maintains long-term debt stability by preserving long-dated liabilities while layering in new issuances, which reflects a strategic maturity management approach. It appropriately contrasts this with refinancing of shorter-term instruments (implied by mentioning new lower-coupon notes), though it does not explicitly name the 2.000% Notes due 2023 or 2.400% Notes due 2026 as in the original answer. This omission is minor and does not detract from the core insight. (4) The answer is contextually relevant and directly addresses the question about Microsoft’s long-term debt maturity and refinancing strategy. The conclusion about using the 3.950% Notes as a 'stable, long-dated pillar' is semantically equivalent to the ground truth’s claim of 'strategic prioritization of long-dated liabilities.' Only a 9 is awarded because the LLM does not explicitly contrast the treatment of the 2056 notes with the maturity/refinancing of shorter-term instruments as clearly as the original, slightly weakening the comparative analysis that strengthens the multi-hop logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 503,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft’s repeated citation of the Eleventh Supplemental Indenture — dated August 8, 2016 and governing the 3.700 % Notes due 2046 — in its 2022, 2023 and 2024 filings signals that the indenture remains the legal foundation for those securities and that no subsequent amendment has altered its core terms. By continuing to reference it, the company underscores a stable, long‑term debt framework anchored to a single master agreement and the same trustee, reinforcing consistency and predictability in its financing obligations for investors and rating agencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016, and governs the 3.700% Notes due 2046; the references in the 2022, 2023, and 2024 filings are accurately noted. (2) Quantitative elements—dates, percentages, and years—are all factually correct with no discrepancies. (3) The reasoning is sound: the repeated reference to the indenture across filings correctly implies ongoing obligations and stability in Microsoft's long-term debt structure. The LLM correctly infers that no material amendments occurred and that the legal framework remains intact. (4) While the LLM captures the core significance—consistency, predictability, and stability in debt management—it omits a minor but relevant point from the original answer: the connection of this indenture to the broader base Indenture dated May 18, 2009, and the layered structure of supplemental indentures. This contextual layering strengthens the multi-hop synthesis slightly in the original answer. However, the LLM still conveys the essential meaning and implications accurately. Wording differences are acceptable under semantic equivalence. No calculation errors. The answer is fully relevant and addresses all parts of the question with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 370,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nIn the FY 2022 Form 10‑K the 2.125 % Notes due 2021 still appeared in the exhibit list of supplemental indentures and were shown as a senior unsecured tranche that would mature in 2021, so the company classified the remaining balance as a current liability.  By the FY 2023 and FY 2024 filings the notes no longer appear in the debt schedule, indicating they had been fully retired before those years.  This reflects Microsoft’s practice of proactively refinancing maturing senior notes—repaying the 2021 issue and replacing it with newer, longer‑dated unsecured debt to keep its overall debt maturity profile aligned with its liquidity and capital‑management objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It claims that the 2.125% Notes due 2021 no longer appear in the debt schedules for FY 2023 and FY 2024, stating they were 'fully retired.' However, the ground truth confirms that the notes were still referenced in Exhibit 4.1 of both the 2023 and 2024 10-K filings (page 104 in each), indicating continued disclosure. (2) The LLM incorrectly asserts that Microsoft classified the notes as a current liability in FY 2022 and then removed them in subsequent years, implying repayment or refinancing. The original answer notes no such removal and instead raises questions about why a matured instrument remains listed—possibly due to reporting lags, extensions, or disclosure requirements. (3) The reasoning about refinancing is speculative and unsupported by the evidence provided; the ground truth does not confirm refinancing or retirement but highlights the anomaly of continued listing post-maturity. (4) While the LLM correctly identifies the note's interest rate (2.125%) and maturity year (2021), and references the FY 2022 filing, it fails on core facts regarding the continuity of disclosure in 2023 and 2024. This undermines both quantitative accuracy (dates, presence in filings) and qualitative accuracy (synthesis across years, correct interpretation of exhibit data). The contextual relevance is moderate because the answer addresses debt management strategy, but the conclusion is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 414,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nMicrosoft’s 2.000% senior notes due 2023 remained on the books through FY 2022, but the company updated the governing indenture in FY 2023 with a Fifteenth Supplemental Indenture (Nov 6 2023) and again in FY 2024 with a further amendment, each time adding new tranches and extending the maturity schedule. This incremental, multi‑year amendment pattern reflects Microsoft’s active debt‑management strategy of staggering maturities and adjusting terms to control funding costs and preserve flexibility in its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in multiple key aspects. (1) Quantitatively, the LLM claims Microsoft issued a 'Fifteenth Supplemental Indenture' on November 6, 2023, and another amendment in FY 2024, which is factually wrong—the original answer confirms the debt was governed by the 'Eleventh Supplemental Indenture dated August 8, 2016' and consistently referenced without updates or new tranches. There is no mention of new amendments in 2023 or 2024 in the ground truth. (2) The LLM incorrectly states that Microsoft 'updated the governing indenture' and 'extended the maturity schedule,' but the 2.000% Notes were due in 2023 and not extended; the continued reference in 2024 filings likely reflects disclosure of recently matured debt, not an extension. (3) Entity accuracy fails: the LLM fabricates a 'Fifteenth Supplemental Indenture' and misrepresents the timeline and structure of Microsoft’s debt instruments. (4) Reasoning is flawed: the LLM interprets amendments and extensions as evidence of an 'active debt-management strategy,' whereas the ground truth indicates a stable, long-term approach with no changes to this instrument—opposite conclusions. (5) While the question asks about evolution and strategy, the LLM invents a narrative unsupported by data, failing multi-hop synthesis. The contextual relevance is moderate because it addresses debt management strategy, but the factual foundation is entirely incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 412,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin has transferred roughly $11.6 billion of defined‑benefit pension obligations—including a $4.9 billion block in August 2021 and additional blocks in later years—covering about 95,000 retirees, with each transfer recorded as a non‑cash settlement charge (e.g., the $1.7 billion charge in 2021) while cash contributions were modest (≈ $990 million in 2024) and largely recovered through CAS pension‑cost recoveries of ≈ $1.7 billion annually, building prepayment credits of more than $2 billion.  \nThe company’s stated strategy is to continue using pension‑risk‑transfer transactions—purchasing group annuity contracts with plan assets—to shrink the size and volatility of its defined‑benefit liabilities, acknowledging that future transfers may generate material non‑cash earnings charges but will ultimately lower long‑term pension expense and improve cash‑flow predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states the $11.6 billion in total pension obligations transferred since December 2018 and identifies the $4.9 billion transfer in August 2021, which triggered a $1.7 billion noncash settlement charge—consistent with the original answer. It adds contextual detail not in the ground truth but plausibly derived (e.g., ≈$990 million in 2024 cash contributions and $1.7 billion in annual CAS recoveries), which do not contradict known data and reflect Lockheed Martin’s typical cost recovery mechanisms. The mention of 95,000 retirees and prepayment credits over $2 billion is additional detail not present in the ground truth; while not verifiable from the provided answer, it does not appear inconsistent and may reflect synthesis from other filings. (2) The timeline is slightly misaligned—the $4.9 billion transfer occurred in August 2021, referenced in the 2022 filing, but the LLM implies it occurred during the 2022–2024 window, which is a minor inaccuracy in temporal framing. However, this does not distort the overall trend. (3) The qualitative reasoning is sound: the LLM correctly identifies the use of group annuity contracts (GACs), the strategic intent to reduce pension liability volatility, and the trade-off involving noncash charges for long-term financial stability. It synthesizes multi-hop information across years and financial impacts, correctly linking risk transfers to reduced PBGC premiums (implied via liability reduction) and improved cash-flow predictability. (4) The answer fully addresses all parts of the question: scale of obligations, financial impact (charges, cash flows, recoveries), and future strategy. Wording differs but semantic meaning matches. Minor deduction in quantitative accuracy due to the slight misplacement of the 2021 transaction within the 2022–2024 period and inclusion of unverified specifics (e.g., retiree count), but overall factual integrity is preserved. Contextual relevance is perfect—directly responsive and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 559,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated citation of “Floating Rate Notes due 2019” in Apple’s 2022‑2024 filings shows that the company had a legacy floating‑rate tranche that originally matured in 2019 and that it continues to reference this instrument even after its maturity.  This signals that Apple is actively rolling that debt into newer floating‑rate issuances (or swapping it for other floating‑rate securities) to maintain a flexible, interest‑rate‑sensitive capital structure and to manage its long‑term refinancing needs.  In short, the consistent mention reflects a deliberate strategy of laddering and refinancing floating‑rate debt rather than leaving a static, legacy tranche on the books.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Apple, Floating Rate Notes due 2019, and the 2022–2024 filing period are accurately referenced. There are no numerical values requiring calculation, but the dates (2019 maturity, 2022–2024 filings) are correctly used. (2) The answer correctly interprets the continued disclosure of a matured debt instrument as indicative of an ongoing refinancing or rollover strategy, which matches the ground truth’s assertion of a disciplined capital structure approach. (3) The multi-hop reasoning—linking post-maturity disclosure to refinancing behavior and strategic debt management—is sound and logically inferred from the pattern in filings. (4) The LLM emphasizes 'rolling that debt into newer floating-rate issuances' and 'laddering and refinancing,' which captures the essence of Apple’s strategy, though it slightly omits the transparency aspect mentioned in the original answer. However, this does not detract from the core factual and inferential accuracy. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy for not explicitly acknowledging possible disclosure practices around historical instruments, but overall reasoning is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 356,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nIn the 2022 10‑K the 4.000% Notes due 2021 are disclosed as a separate tranche under the original 2009 indenture; by the 2023 filing they are mentioned only as part of the Fourteenth Supplemental Indenture (dated March 17 2021) and are described as having been refinanced, with the remaining balance now shown as a current portion of long‑term debt; and in the 2024 filing the notes no longer appear as a distinct line item but are aggregated into the broader “4% senior notes” disclosure, underscoring that this debt series continues to be a material component of Microsoft’s capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The claim that in the 2023 filing the notes were 'refinanced' and described as part of the Fourteenth Supplemental Indenture is not supported by the original answer, which states the notes were consistently referenced across all years without mention of refinancing or structural changes. (2) The assertion that in the 2024 filing the notes 'no longer appear as a distinct line item' but are aggregated into '4% senior notes' contradicts the ground truth, which emphasizes consistent inclusion in Exhibit 4.6 across all three years—indicating ongoing formal linkage. (3) The original answer highlights that the continued reference post-maturity suggests ongoing legal or structural relevance (e.g., covenants or indentures still in effect), whereas the LLM implies an evolution toward aggregation and refinancing, suggesting decreasing relevance, which is the opposite of the truth. (4) Quantitatively, while the 4.000% rate and 2021 maturity are correctly noted, the LLM fabricates specific details like the 'Fourteenth Supplemental Indenture (dated March 17, 2021)' and changes in disclosure format not present in the ground truth. These are precise-sounding but unverified and incorrect. (5) The multi-hop reasoning is flawed: instead of recognizing the consistency of disclosure as a sign of ongoing relevance, the LLM constructs a narrative of phasing out, which misrepresents the intent and content of the filings. (6) Contextually, the answer addresses the question’s structure—discussing each year—and attempts to interpret capital structure relevance, so it maintains moderate relevance despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 465,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 UPS continued to treat its $276 million 7.620 % debentures as long‑term debt maturing on 1 April 2030, with redemption at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a Treasury yield plus 5 basis points, plus accrued interest; interest is paid semi‑annually in April and October and the notes are not subject to a sinking‑fund requirement.  The redemption mechanics and interest‑payment structure are unchanged across the three filings, but the 2024 Form 10‑K adds a current carrying‑value of about $280 million and places the debentures within a much larger long‑term debt balance (≈ $20 billion), highlighting that they now represent only a small, stable portion of UPS’s overall debt position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $276 million principal, 7.620% interest rate, maturity date of April 1, 2030, unchanged redemption terms (greater of principal plus accrued interest or present value discounted at Treasury yield plus 5 bps), and semi-annual interest payments in April and October. The carrying value of $280 million in 2024 is correctly reported. (2) Quantitative accuracy is perfect—dollar amounts, percentages, dates, and the redemption formula match the original answer. Format variations (e.g., $276 million vs $276 million) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes consistent treatment over 2022–2024, notes the stable redemption and payment structure, and identifies the shift in disclosure emphasis by 2024 toward integration within a broader debt portfolio (≈$20 billion). While the original answer emphasizes a progression from historical interest rate context (8.375% pre-2020) to structural and international comparative framing, this detail is only partially reflected—the LLM mentions the current rate but not the historical shift, which is a minor omission. (4) Contextual relevance is excellent: the answer directly addresses redemption terms, interest structure, and overall debt positioning, with appropriate emphasis on the debentures’ small, stable role in the larger capital structure. The omission of the explicit historical rate change (8.375% to 7.620%) prevents a perfect 10, but all other elements are factually and semantically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 442,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar moved beyond its original schizophrenia/bipolar indications to a rapidly expanding neuroscience platform—most notably with the 2023 FDA approval of Vraylar as an adjunctive therapy for major‑depressive disorder and subsequent pediatric/liquid‑formulation approvals that broadened its addressable market.  This drove a 35 % year‑over‑year sales jump to **$2.76 billion in 2023** (up from $2.04 billion in 2022) and sustained double‑digit growth into 2024, making Vraylar the fastest‑growing component of AbbVie’s neuroscience segment and a key contributor to overall net‑revenue expansion.  Consequently, Vraylar has become a strategic cornerstone of AbbVie’s portfolio, offsetting the loss of exclusivity for legacy immunology products and positioning the company for continued growth in high‑value CNS indications.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Vraylar's expansion into MDD and its strategic role in AbbVie's neuroscience portfolio, aligning with the ground truth. It accurately reports the 35.4% year-over-year revenue growth (rounded to 35%) and the $2.76 billion revenue in 2023 (matching the ground truth $2,759 million). However, the LLM introduces a specific 2022 revenue figure of $2.04 billion, which is not present in the original answer and cannot be verified from the provided ground truth—this is an unsupported inference. Additionally, the mention of '2023 FDA approval' and 'pediatric/liquid-formulation approvals' adds detail not confirmed in the ground truth, which only notes that by 2024 Vraylar was established with MDD as an adjunctive indication. (2) The revenue figure of $2.76 billion is correctly derived from $2,759 million (rounding is acceptable), and the 35% growth is a reasonable approximation of 35.4%. However, the implied calculation of 2022 revenue as $2.04 billion based on that growth rate is not explicitly supported in the original data and introduces a potential error in quantitative chain reasoning. (3) The multi-hop reasoning is strong: the LLM connects clinical development (MDD approval), commercial performance (sales growth), and strategic portfolio implications (offsetting immunology LOE), which reflects sound synthesis across domains. The trajectory from clinical asset to revenue driver is correctly interpreted. (4) The answer is highly contextually relevant, addressing development, commercialization, financial performance, and strategic importance. The core facts are correct, but the addition of unverified specifics (exact 2022 revenue, pediatric approvals) slightly undermines quantitative accuracy, warranting a score of 8 for correctness—core facts are right, but with minor overprecision and unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 509,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe repeated appearance of the “0.45 % Notes due 2016” in the registration‑statement exhibits for 2022, 2023 and 2024 shows that Apple continues to treat that tranche as a living part of its capital‑structure disclosures, even though the issue is several years old.  By keeping the legacy notes in the same “Description of Securities” section each year, Apple signals that it wants investors and regulators to be reminded of all outstanding debt—both new and legacy—so that its long‑term debt profile appears stable and fully transparent, and to preserve a consistent legal‑filing framework for any future refinancing or amendment of those older instruments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across 2022, 2023, and 2024, and accurately references the relevant time frame and instrument. The percentage (0.45%) and maturity year (2016) are factually correct, and the years of disclosure (2022–2024) match the ground truth. Thus, quantitative accuracy is perfect. (2) However, the LLM mischaracterizes the reason for inclusion by suggesting these notes are still part of Apple’s 'living' capital structure and implies they may be relevant for future refinancing or amendment. This is incorrect: the notes matured in 2016 and are included only as a historical exhibit (Exhibit 4.3, Officer’s Certificate from 2013), not because they remain active or legally relevant for future use. The ground truth emphasizes transparency and record-keeping, not ongoing legal or financial utility. (3) The multi-hop reasoning is partially sound—linking repeated disclosure to transparency—but fails in the final inference: the LLM incorrectly infers strategic signaling and potential reactivation, which is not supported by the data. The original answer correctly frames this as a documentation practice, not a financial strategy. (4) While the LLM captures the surface-level pattern and uses accurate entities and numbers, it introduces speculative and incorrect reasoning about Apple’s intent, undermining qualitative accuracy. The answer remains contextually relevant and addresses the core question about disclosure strategy, but with significant factual overreach in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 439,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, **UPS SurePost remained positioned inside the U.S. Domestic Package segment as the residential‑ground service for non‑urgent, lightweight shipments**, with UPS handling pickup, line‑haul and network‑wide consolidation while **final‑mile delivery was still subcontracted to the United States Postal Service**.  The company used this arrangement to offer a low‑cost, time‑definite option that complemented its core ground network and supported growing e‑commerce and returns volumes, and it continued to expand the Access Point and return‑service ecosystem to increase visibility and convenience.  **In early 2025 (announced in the 2024 filings) UPS began insourcing SurePost’s final delivery**, signaling a strategic shift to retain full control of the last‑mile segment and to capture higher‑yielding residential volume within its own network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS SurePost remained a residential ground service for non-urgent, lightweight shipments from 2022–2024; final delivery was handled by USPS during this period; and in 2024, UPS announced it would insource final delivery starting January 1, 2025. The LLM correctly notes this shift was announced in 2024 filings and represents a strategic move to gain full control over last-mile delivery. (2) Quantitative accuracy is perfect: no numerical errors, and the date (January 1, 2025) is correctly referenced as the start of the insourcing, even though the change begins in 2025—the announcement timing in 2024 is properly contextualized. (3) Multi-hop reasoning is sound: the model synthesizes information across years and correctly infers the strategic implication of the shift from USPS partnership to insourcing. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'early 2025' rather than specifying 'effective January 1, 2025, as announced in 2024'—a nuance present in the original. However, this does not affect factual correctness. Wording differences are acceptable under semantic equivalence. The answer fully addresses delivery methodology evolution and strategic positioning within U.S. Domestic Package business.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 375,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nApple first issued the 4.45 % Notes due 2044 in 2014, and the 2022‑2024 Form 10‑K filings show that the same series remains outstanding, with only periodic updates to the officer’s certificate and no new tranche added. This consistent, multi‑year presence demonstrates Apple’s deliberate strategy of using long‑dated, fixed‑rate debt as a stable, low‑cost pillar of its capital structure to fund growth and shareholder returns while preserving cash‑flow flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were originally issued in 2014 (referencing the Officer's Certificate dated May 6, 2014, as in the original answer), and remained outstanding through 2022–2024 with no new tranches or early redemption. The LLM correctly notes the absence of new issuances and only periodic administrative updates. (2) Quantitative accuracy is perfect: the interest rate (4.45%), maturity year (2044), and original issuance year (2014) are all correct. No calculations were required, but temporal and numerical consistency is maintained. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a strategic pattern—Apple’s continued reliance on long-term fixed-rate debt. The conclusion about using such debt for shareholder returns and financial flexibility is a reasonable interpretation consistent with the original answer’s claim about 'financial flexibility' and 'interest rate risk management.' (4) The only minor shortcoming is that the LLM does not explicitly mention the Officer's Certificate by date (May 6, 2014), which is a specific detail included in the ground truth and supports the continuity claim. While the LLM refers to 'periodic updates to the officer’s certificate,' the absence of the exact date slightly reduces qualitative precision. However, the semantic meaning and strategic interpretation remain equivalent. Overall, the answer is highly accurate, relevant, and correctly infers Apple's long-term capital strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 438,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings Oracle continues to disclose the 2.875 % Notes due 2031 inside the same Exhibit 4.14, listing the identical “Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028, 2.875 % Notes due 2031, 3.650 % Notes due 2041, 3.950 % Notes due 2051 and 4.100 % Notes due 2061” (with the March 24 2021 Officers’ Certificate) in each filing.  By retaining this series under the fixed Exhibit 4.14 label, Oracle signals a stable, long‑dated senior‑unsecured debt tranche that is systematically catalogued and easily traceable, reflecting a disciplined capital‑structure strategy that emphasizes predictable, staggered maturities and consistent transparency for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (2.875%, 1.650%, etc.), maturity years (2026, 2028, 2031, etc.), and the March 24, 2021 Officers’ Certificate—are correctly stated. There are no calculation errors, and the exhibit number (4.14) is accurately cited across all years. (2) The answer addresses both parts of the multi-hop question: it traces the consistent positioning of the 2.875% Notes due 2031 as Exhibit 4.14 across 2022–2024 and interprets this as evidence of Oracle’s stable capital structure and disciplined debt strategy. (3) The reasoning is sound: the LLM correctly infers that unchanged exhibit labeling and disclosure reflect a deliberate, transparent, and consistent approach to debt management, emphasizing long-term stability and investor transparency. (4) While the LLM adds slightly more detail about other notes in the exhibit (e.g., 4.100% due 2061), this does not detract from accuracy and may enhance context. The only minor shortcoming is that it does not explicitly state that no modifications to the terms were indicated in the filings—a point emphasized in the ground truth—though this is implied by the description of consistent disclosure. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 367,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 Teamsters five‑year national master agreement granted wage and benefit increases that were built into the accrual assumptions for the UPS/IBT Full‑Time Employee Pension Plan, raising the plan’s projected benefit obligation and net periodic pension cost (as noted in the 2023 10‑K, page 82). The 2024 disclosures reflect this by showing a higher discount rate and a larger pension‑benefit liability—e.g., a one‑basis‑point rise in the discount rate would reduce the projected obligation by roughly $57 million—demonstrating that the agreement has materially increased UPS’s long‑term pension obligations and the funding required to sustain them.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2023 Teamsters agreement included wage and benefit increases that impacted pension accruals and were factored into the plan's assumptions, aligning with the ground truth. It also correctly notes that these changes increased UPS's long-term pension obligations. However, the LLM introduces specific quantitative claims not present in the original answer or verifiable from the context provided—specifically, the $57 million sensitivity figure for a one-basis-point change in the discount rate and the explicit mention of 'net periodic pension cost' and 'page 82 of the 2023 10-K'—which are not supported by the ground truth knowledge graph. These details, while plausible, are not confirmed and represent overprecision. (2) The dollar amount ($57 million) and page reference cannot be verified against the original answer, which contains no such figures or citations. The ground truth does not include any numerical sensitivity analysis or specific financial statement line items, making these additions unsupported. (3) The multi-hop reasoning is generally sound: the model connects the 2023 agreement to changes in pension accrual assumptions, links those to updated liabilities in 2024 disclosures, and infers ongoing defined benefit commitments. This reflects appropriate synthesis across time and documents. (4) The correctness score is 7 because the core qualitative facts—impact of the 2023 agreement on benefit accruals and implications for long-term obligations—are accurate and contextually relevant. However, the unsupported quantitative claims reduce confidence and prevent a higher score. The qualitative accuracy is high due to correct entity identification (UPS, Teamsters, UPS/IBT Full-Time Employee Pension Plan, 2023 agreement) and logical reasoning. Contextual relevance is strong as the answer directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 518,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each continue to list the identical “Officer’s Certificate dated May 6 2014” (Exhibit 4.4) as the governing document for the 1.05 % Notes due 2017, with no amendment or new certificate introduced in any of the three filings. This steady reference shows that Apple treats the 1.05 % notes as part of the original 2014 debt‑issuance program and manages them under the same master certificate, underscoring a deliberate, long‑term approach to short‑term financing that relies on a stable legal framework rather than periodic new authorizations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 are consistently tied to the Officer’s Certificate dated May 6, 2014, across the 2022, 2023, and 2024 10-K filings. The exhibit number (4.4) is an additional detail not in the ground truth but does not contradict it. (2) Quantitative elements—interest rate (1.05%), maturity year (2017), and date of the Officer’s Certificate (May 6, 2014)—are all accurate and match the original answer. (3) The reasoning is sound: the LLM correctly infers from the unchanged disclosure that Apple maintained the same legal framework for this debt, indicating a stable, long-term management approach. While the original answer emphasizes a 'passive management approach' and 'stability in capital structure,' the LLM frames it as a 'deliberate, long-term approach' and 'stable legal framework'—a slightly more positive spin but semantically consistent. (4) The answer fully addresses the question’s multi-hop nature: it tracks disclosure evolution (or lack thereof) across three years and interprets what that continuity implies about Apple’s debt management strategy. The only minor difference is tone—'passive' vs. 'deliberate'—but the core conclusion about non-intervention and reliance on the original 2014 structure is preserved. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 393,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple first disclosed the 2.40 % Notes due 2023 in the 2022 10‑K (Exhibit 4.3, the 2013 indenture), and the same reference was retained in the 2023 filing, indicating that the tranche was still outstanding but scheduled to mature in 2023.  By the 2024 10‑K the company’s Exhibit 4.28 (the May 10 2023 Officer’s Certificate) no longer lists the 2.40 % 2023 notes—instead it adds newer series (e.g., 4.421 % Notes due 2026) and reflects the repayment or refinancing of the 2023 tranche.  \n\nThis three‑year trajectory shows Apple’s long‑term debt strategy is to “ladder” its borrowings, continuously issuing new fixed‑rate bonds ahead of existing maturities and retiring older tranches, thereby extending the average maturity profile and maintaining a flexible, low‑cost funding base.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, Apple consistently disclosed the 2.40% Notes due 2023 in its 2022, 2023, and 2024 10-K filings with no changes, indicating the debt was carried through to maturity as originally structured. However, the LLM claims that by the 2024 10-K, the notes were no longer listed—implying repayment or refinancing—and cites Exhibit 4.28 and a May 10, 2023 Officer’s Certificate, which contradicts the ground truth stating the same disclosure (from the May 3, 2013 Officer’s Certificate) was carried forward in all three years. This misrepresentation of the filing content leads to an incorrect conclusion about Apple refinancing or retiring the tranche ahead of schedule. The claim about newer notes (e.g., 4.421% due 2026) is unsupported by the provided ground truth. While the concept of a 'laddering' strategy is plausible, the reasoning is based on false premises rather than the actual multi-year consistency in disclosures. The answer is contextually relevant in addressing Apple’s debt strategy but fails on quantitative accuracy (wrong dates, exhibits, and instrument status) and qualitative accuracy (incorrect synthesis across years). Minor formatting variations like '2.40%' vs '2.40 %' are acceptable, but the core facts about the presence or absence of the notes in the 2024 filing are wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 398,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nBetween 2022 and 2023 Vraylar’s U.S. sales surged from $951 million to $1.73 billion (+ ≈ 81 %) and worldwide revenue rose from roughly $2.04 billion to $2.76 billion (+ ≈ 35 %).  The jump was driven by the 2023 FDA approval of Vraylar as an adjunctive therapy for major‑depressive disorder and by continued market‑share gains in its existing schizophrenia and bipolar indications, positioning the drug as the fastest‑growing pillar of AbbVie’s neuroscience portfolio alongside Botox Therapeutic, Duodopa and Qulipta.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states U.S. sales increased from $951 million in 2022 to $1.73 billion in 2023, but the ground truth reports U.S. sales of $2,037 million in 2022 and $2,755 million in 2023. The LLM underreports 2022 U.S. sales by over $1 billion and 2023 sales by ~$1 billion. The worldwide revenue figures are closer but still incorrect: LLM reports $2.04B in 2022 (vs. actual $2,759M total sales in 2023, not 2022), creating a temporal mismatch. The 35% growth estimate is directionally correct (actual: 35.2%), but the base numbers are wrong. (2) The LLM incorrectly implies the 2023 FDA approval drove growth, but the original answer notes that in 2022, one Phase 3 trial succeeded and another was numerically positive but non-significant—indicating approval was not yet granted in 2023. The actual 2024 positioning reflects the culmination of clinical development, suggesting approval likely came later. Thus, attributing the 2023 revenue jump to FDA approval is factually premature. (3) The qualitative reasoning partially captures the therapeutic positioning, mentioning schizophrenia and bipolar, but omits the formal 2024 expansion to include adjunctive MDD treatment as a key strategic milestone. It also incorrectly lists Duodopa and Qulipta as part of AbbVie’s neuroscience portfolio alongside Vraylar—Duodopa is not a core AbbVie asset, and Qulipta is for migraine, weakening entity accuracy. (4) Despite these issues, the answer correctly identifies Vraylar as a growing revenue driver and part of AbbVie’s neuroscience portfolio, with directional accuracy on growth trends and indications. The contextual relevance is high as it addresses clinical development, revenue, and portfolio role, but factual errors in numbers and timing reduce overall correctness. Quantitative accuracy is low due to major dollar amount discrepancies; qualitative accuracy is moderate due to correct general trajectory but flawed reasoning and entity references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 543,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nIBM has long listed “client relationships and trust” among its core competitive methods, but the wording in its 10‑K filings shows a clear evolution from 2022 through 2024. In the 2022 filing the reference to trust is a generic differentiator, while the 2023 and 2024 filings explicitly tie that trust to the company’s hybrid‑cloud and AI strategy—framing it as the foundation for winning clients in those growth markets and for “accelerated growth now with hybrid cloud and AI.”  \n\nThis multi‑year progression demonstrates that IBM is deliberately leveraging its reputation and deep‑rooted client relationships to anchor and differentiate its pivot toward hybrid cloud and AI, positioning the firm as a trusted partner essential for capturing the next wave of enterprise transformation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of IBM's emphasis on trust and client relationships from 2022 to 2024. It correctly identifies that in 2022, trust was presented more generically, while in 2023 and 2024 it became more strategically tied to hybrid cloud and AI—this matches the original answer's timeline. The LLM accurately captures the strategic intent: positioning IBM as a trusted partner in enterprise transformation, which reflects the deepening of trust as an enabler of innovation. However, the LLM omits specific details about the role of strategic partnerships and the ecosystem in 2023 and 2024 that are emphasized in the ground truth, particularly the expansion into end-to-end solutions via alliances and the integration of a broad partner ecosystem in the go-to-market strategy. These omissions are notable but do not undermine the core accuracy of the response. There are no numerical values in this question, so quantitative accuracy is scored based on correct use of years (2022–2024), which are accurate. The reasoning is sound and reflects multi-hop synthesis across years, though slightly less detailed than the original. The answer remains contextually relevant and effectively addresses the strategic progression. Thus, the correctness score is reduced slightly for incompleteness in capturing the full strategic framing around partnerships, but remains high due to accurate core messaging and evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 409,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM kept the 1.250 % Notes due 2027 in the “Notes due 2027” line of its securities table, but the way it was presented grew more explicit.  In the 2022 filing the notes were merely listed and referenced an earlier 2019 Form 8‑K that defined their rights; by the 2024 filing IBM had filed a new indenture (Feb. 2 2024) and highlighted that the 1.250 % Notes are unsecured senior obligations that sit alongside the 6.22 % Debentures due 2027, underscoring their strategic role in diversifying the company’s debt portfolio and managing interest‑rate exposure.  Thus, disclosure shifted from a simple tabular mention to a clearer articulation of the notes’ seniority, indenture amendment, and financing purpose within IBM’s overall debt structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it claims that IBM filed a new indenture on February 2, 2024, which is not supported by the ground truth and contradicts the original answer, which notes no such 2024 indenture filing—only increased disclosure with a trading symbol (IBM27B). Additionally, the mention of '6.22% Debentures due 2027' is not present in the ground truth and appears to be fabricated or misattributed. The ground truth emphasizes evolving disclosure practices and recognition via a trading symbol, while the LLM shifts focus to seniority and indenture amendments not mentioned in the original. (2) Quantitative accuracy is partially correct: the 1.250% interest rate and 2027 maturity are accurate, and the reference to the 2019 Form 8-K aligns with the original. However, the February 2, 2024, indenture date is incorrect (ground truth cites no such event), and the 6.22% debenture figure has no basis in the provided data. (3) The reasoning is partially sound in identifying a trend toward more explicit disclosure, but the multi-hop synthesis is flawed. The LLM incorrectly infers structural changes (new indenture, senior obligation framing) rather than the actual evolution—increased transparency via formal listing with a trading symbol. It fails to mention the key detail from 2024: the assignment of trading symbol IBM27B, which is central to the ground truth’s conclusion about the note becoming a recognized, traded instrument. (4) Contextual relevance is high—the answer addresses disclosure evolution and the note’s role in the debt portfolio—but correctness is undermined by fabricated details and missed key evidence. The core trajectory (increasing disclosure) is plausible, but execution lacks factual fidelity, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 496,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nIBM’s 10‑K filings from 2022 through 2024 all identify the 6.50 % Debentures due 2028 by the identical citation—“Exhibit 2 to the Form 8‑K filed on January 8 1998”—and incorporate it by reference; the exhibit number and filing date have not changed across the three years.  What does evolve is the surrounding debt‑instrument section, which expands the exhibit table to list newer indentures and supplemental indentures (e.g., the February 2 2024 indenture), but the reference to the 6.50 % Debentures remains consistently unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as 'Exhibit 2 to Form 8-K filed on January 8, 1998' across 2022–2024, which matches the original answer exactly. The date, percentage, exhibit number, and filing type are all factually correct. (2) Quantitative accuracy is perfect—no calculations are required, but all dates and percentages are correctly reported without error. (3) The multi-hop reasoning is sound: the model correctly identifies both the consistency in exhibit referencing and the evolving context of broader debt disclosures, noting the inclusion of newer indentures (e.g., February 2, 2024) in later filings. This reflects an accurate synthesis across years and instruments. (4) While the LLM captures the core evolution—consistent exhibit reference amid expanding disclosure context—it omits some specific details present in the ground truth, such as the mention of the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, which provide richer context about IBM’s long-term debt strategy. This minor omission prevents a perfect score but does not detract significantly from overall correctness. The answer remains semantically equivalent in intent and factual substance, with excellent contextual relevance to the question about exhibit consistency and disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 390,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 through 2024, FedEx International Connect Plus grew its cross‑border e‑commerce footprint from “nearly 60 origin countries to over 190 destination countries” and, bolstered by the 2024 Tricolor network redesign and the DRIVE transformation, extended day‑definite delivery to an even wider set of markets.  This expansion reflects FedEx’s strategic shift toward building a dedicated, data‑driven logistics channel for online retail, positioning International Connect Plus as a core growth engine in its global e‑commerce network.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that in 2022, FedEx International Connect Plus started from 'nearly 60 origin countries to over 190 destination countries,' which is factually wrong. According to the ground truth, in 2022 the service was available from nearly 50 origin countries to over 130 destination countries. The correct expansion occurred by 2023, not 2022. The LLM also fails to mention that the geographic reach stabilized in 2024 (no further expansion), instead implying continued growth with 'extended day-definite delivery to an even wider set of markets,' which is unsupported by the original data. (2) Quantitative inaccuracies are significant: the origin and destination country counts for 2022 are misstated, and there is no acknowledgment of the 2024 plateau. While the 2023 figures (nearly 60 origins, over 190 destinations) are correct, attributing them to 2022 distorts the timeline and growth pattern. (3) The reasoning is partially sound in linking the expansion to FedEx's e-commerce strategy, and correctly identifying International Connect Plus as a strategic growth engine. However, it misses the key insight that the stabilization in 2024 suggests a completion of a major deployment phase, which is a critical part of the strategic trajectory. The mention of the 'Tricolor network redesign' and 'DRIVE transformation' is contextually relevant but not present in the original answer and not directly tied to the geographic data provided, introducing unsupported details. (4) The contextual relevance is high because the answer addresses the strategic focus on e-commerce logistics and attempts to interpret the expansion meaningfully. However, due to major factual errors in the quantitative timeline and incorrect portrayal of ongoing expansion, the overall correctness score is low. The qualitative accuracy is moderate because the strategic interpretation is plausible but based on incorrect data. Quantitative accuracy is poor due to misstated figures and timeline confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 544,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm linked its human‑capital advancement goals—namely the 2025 targets to lift women in leadership + 15%, under‑represented minorities in leadership + 15% and overall URM representation + 20%—to executive compensation. The HR and Compensation Committee treats progress on these diversity objectives as a non‑financial performance modifier that can adjust the annual bonus payout by a multiplier of 0.9 to 1.1; this bonus‑adjustment mechanism was first applied to fiscal 2022 bonuses and remained in effect for fiscal 2024 (and continues to be used for subsequent periods).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase for women in leadership, 15% for underrepresented minorities (URM) in leadership, and 20% for overall URM representation—all tied to 2025 goals. It correctly states that these diversity goals are linked to executive compensation via a non-financial performance modifier adjusting bonuses by a factor of 0.9 to 1.1, and that this mechanism was applied starting in fiscal 2022 and remained in place through 2024. These details match the ground truth exactly, with no numerical or temporal inaccuracies, earning a perfect score on quantitative accuracy. The qualitative accuracy is slightly docked by one point because the LLM omits mention of the Reboot Representation Tech Coalition and the increased emphasis on external partnerships in 2023–2024, which is a minor but relevant contextual detail from the original answer regarding expanding initiatives. However, this does not undermine the core reasoning or synthesis, as the LLM correctly identifies the continuity and stability of the strategic framework. The multi-hop reasoning—linking human capital goals to compensation over time across fiscal years—is sound and well-articulated. Contextual relevance is full, as every part of the question (evolution over time, diversity targets, bonus mechanisms) is directly addressed with precise, pertinent information. Minor omission prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 410,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s 2022‑2024 filings keep the Floating‑Rate Notes due 2019 listed among its outstanding debt, indicating that the company still relies on this short‑term, floating‑rate tranche as a flexible funding source. By using a floating‑rate instrument that resets with market rates, Apple can hedge short‑term interest‑rate exposure, keep borrowing costs aligned with prevailing rates, and maintain a readily refinancable liquidity buffer that supports its cash‑management and capital‑allocation strategy. This repeated disclosure reflects a deliberate approach to managing interest‑rate risk while preserving liquidity through a low‑cost, market‑responsive short‑term debt position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024, which reflects its ongoing reliance on these instruments for managing short-term interest rate risk and liquidity. The dates (2019 maturity, disclosures in 2022–2024) are correctly stated, and no numerical inaccuracies exist. (2) Quantitative accuracy is perfect: the years and timeframes match the original answer, and there are no calculations required beyond correct identification of the period and instrument. (3) The multi-hop reasoning is sound—linking the continued disclosure of an older debt instrument to Apple’s broader strategy of interest rate risk management and liquidity planning is logically supported by the data. The LLM correctly infers that maintaining these notes implies ongoing exposure to variable rates and a strategic choice to avoid issuing new floating-rate debt, which matches the ground truth’s interpretation. (4) The only minor gap is that the LLM does not explicitly state that this consistency suggests Apple did not need to issue new short-term floating rate instruments, a nuance present in the original answer. However, the implication is conveyed through phrases like 'still relies' and 'repeated disclosure reflects a deliberate approach.' Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a high score with only a slight deduction in qualitative accuracy for the missing nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 430,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm’s automotive revenue surged from roughly **$1.5 billion to $2.9 billion**, underscoring a strategic pivot to make the **digital‑cockpit/ADAS‑AD platform a core QCT growth engine**. The company now markets its 5G‑enabled connectivity and high‑performance compute solutions for automotive as a primary revenue driver, positioning itself to capture the **industry‑wide shift toward embedded cellular connectivity**—analysts project **>70 % of new vehicles by 2028 will have cellular connectivity, with about 60 % of those using 5G**—indicating a rapidly expanding market demand that fuels Qualcomm’s focus on digital‑cockpit technology.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims. The ground truth does not mention specific automotive revenue figures for 2022 ($1.5B) or 2024 ($2.9B); these numbers are fabricated or misattributed. Additionally, the claim that >70% of new vehicles will have cellular connectivity by 2028 with ~60% using 5G misrepresents the original projection: the ground truth states that over 60% of new vehicles will have 5G connectivity by 2028, not that 60% of a 70% subset will use 5G. (2) There is no verification for the $1.5B to $2.9B revenue increase in the original answer; the ground truth only confirms that digital cockpit revenues were reported within QCT in 2023 and integrated into segment structure by 2024, but no dollar amounts are provided. Thus, all financial figures in the LLM answer fail the quantitative accuracy test. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies Qualcomm’s growing strategic focus on digital cockpit technology and its integration into QCT, and it appropriately links this to 5G and computing trends in automotive. However, it misses key milestones such as the evolution from R&D emphasis (2022), to commercial sales (2023), to formal segment integration (2024), instead framing the shift around unsupported revenue growth. The multi-hop synthesis is incomplete—while it connects market demand to strategy, it omits the structural and reporting evolution within Qualcomm. (4) Contextual relevance is high because the answer addresses the core theme of strategic evolution and market demand. However, due to significant quantitative errors and incomplete qualitative progression, the correctness score is moderate at 5. Quantitative accuracy is low (4) due to invented figures; qualitative accuracy is mid-range (6) as core concepts are present but underdeveloped; contextual relevance is strong (9) because the response stays focused on the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 539,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds fell from roughly $560 million in 2022 to $555 million in 2023 and $540 million in 2024. This steady decline signals a deliberate pull‑back from illiquid alternative assets, indicating that Abbott is de‑emphasizing such investments and shifting capital toward more liquid or higher‑return opportunities.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor inaccuracy in the 2022 unfunded commitment amount. The ground truth reports $569 million, while the LLM states 'roughly $560 million,' which, although close, is not precise and underrepresents the exact figure by $9 million. The 2023 ($555M) and 2024 ($540M) values are accurate. The year-over-year decline of $15M from 2022 to 2023 and 2023 to 2024 is correctly implied, though not explicitly calculated.\n\n2) Quantitatively, the answer is mostly accurate except for the 2022 figure. The use of 'roughly' softens the precision but still falls short of the required factual accuracy for full credit. The $15M annual decrease is consistent with the ground truth, and the direction and magnitude of the trend are correctly conveyed.\n\n3) The reasoning is sound: the downward trend is correctly interpreted as a strategic pullback from illiquid alternatives, aligning with the ground truth's 'strategic de-risking or rebalancing' interpretation. However, the LLM omits the nuance that Abbott continues long-term exposure via existing funds with liquidation periods extending to 2034, which is a relevant detail for assessing the completeness of the investment strategy analysis. This missing context slightly weakens the qualitative depth.\n\n4) The answer is highly relevant to the question, addressing both the evolution of commitments and the implied strategy. While it captures the core trend and strategic implication, it lacks the full contextual richness (e.g., ongoing long-term fund timelines) that would make it fully equivalent to the ground truth. Overall, the answer is factually strong with minor omissions and one approximate value, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 472,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nThe 0.45 % Notes due 2016 first appeared in Apple’s 2013 debt offering (Exhibit 4.3) and, by the time the 2022‑2024 Form 10‑Ks were filed, the filings no longer list any outstanding balance for that tranche—indicating the notes had been fully retired before fiscal 2022. This reflects Apple’s long‑term debt strategy of laddered, staggered maturities: it regularly retires older low‑coupon tranches and replaces them with new, longer‑dated issuances, preserving a diversified and low‑cost debt profile while extending the overall maturity horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the 0.45% Notes due 2016 were retired before fiscal 2022. The ground truth states that Apple continued to disclose these notes in its 2022, 2023, and 2024 10-K filings, indicating they were still part of the capital structure during those years. This directly contradicts the LLM's assertion that the notes were fully retired before fiscal 2022. (2) Quantitatively, the LLM misrepresents the timeline: the notes were issued in 2013 (correctly noted), but the claim that they were retired prior to 2022 is unsupported and false per the original answer. There are no numerical values (e.g., balances, amounts) provided in either answer, so exact dollar verification isn't possible, but the temporal facts (fiscal years of disclosure) are incorrect. The LLM incorrectly infers retirement from absence of balance listing, but the ground truth confirms ongoing disclosure across all three years. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent inclusion of the notes as evidence of stability, the LLM assumes absence of current balance implies retirement, which contradicts the source data. The conclusion about a 'laddered maturity' strategy, while plausible in general, is not supported by the specific evidence cited—the actual pattern (continued disclosure) suggests retention, not retirement. (4) Contextual relevance is moderate because the answer addresses Apple’s debt strategy and references the correct note (0.45% due 2016) and original issuance (2013), but the factual foundation is wrong, leading to an incorrect interpretation. The reasoning would be appropriate if the data supported retirement, but it does not. Thus, despite relevant framing, the answer fails on correctness due to critical factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 494,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nFrom 2022 to 2024 IBM’s 10‑K filings shift “client relationships and trust” from a peripheral competitive factor to a core pillar of its hybrid‑cloud and AI narrative—later editions explicitly tie trust to the adoption of IBM’s open hybrid‑cloud platform and AI solutions and to the company’s responsible‑innovation agenda. This progression shows IBM is deliberately positioning itself as the trusted, integrated partner that enterprises rely on to migrate to hybrid cloud and deploy AI, using client confidence as a differentiator to win large‑scale, mission‑critical workloads and to build an ecosystem of strategic alliances around its cloud‑AI stack.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024 as described in the ground truth. It correctly identifies the progression from a broader innovation context in 2022 to a more central, strategically integrated role by 2024, particularly in relation to hybrid cloud and AI. The LLM accurately reflects that trust became more explicitly tied to consulting, mission-critical infrastructure, and strategic partnerships over time, aligning with the ground truth's emphasis on ecosystem collaboration. While the original answer notes the increasing prominence of strategic partnerships in 2024, the LLM slightly amplifies this by stating trust shifted 'from a peripheral competitive factor to a core pillar,' which may overstate the 2022 positioning—ground truth indicates trust was already part of a core portfolio, not peripheral. However, this is a minor interpretive difference. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (IBM, hybrid cloud, AI, 2022–2024 timeframe) are correct. The reasoning is sound, showing multi-hop synthesis across years and strategic themes. The answer is semantically equivalent and contextually fully relevant, effectively addressing both the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 369,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 2022 10‑K first disclosed the 4.250 % Note due 2030 as part of the August 13 2020 pass‑through‑trust structure and its accompanying revolving‑credit agreement with BNP Paribas.  In the 2023 10‑K FedEx reported Amendment No. 1 to that revolving‑credit facility (dated May 22 2023), which revised borrowing limits, covenant language and the timing of liquidity draws, while the 2024 10‑K continues to reference the same amendment and does not note any further changes.  Together, these disclosures show that FedEx has been proactively tightening and updating the liquidity arrangements that back the 4.250 % note—evolving from the original 2020 facility to a refined, amendment‑enhanced structure—to ensure robust credit support and flexibility for the obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.250% Note due 2030 is linked to the August 13, 2020 Revolving Credit Agreement; Amendment No. 1 was filed on May 22, 2023; and no further changes were noted in 2024. The entities—BNP Paribas (correctly named), the revolving credit agreement, and the timeline—are accurately represented. (2) Quantitative elements—dates (August 13, 2020; May 22, 2023), interest rate (4.250%), and maturity year (2030)—are all precise and match the ground truth. No calculations are required, but temporal sequencing is correct. (3) The multi-hop reasoning across 2022, 2023, and 2024 filings is sound: the LLM correctly infers that the initial structure was established earlier but first disclosed in the 2022 10-K, updated in 2023, and unchanged in 2024. The conclusion that FedEx is proactively refining its liquidity support is logically supported. (4) The only minor deviation from the original answer is the characterization of the 2023 amendment as 'tightening' the arrangements—this implies a more restrictive stance, while the ground truth describes it neutrally as a 'proactive adjustment.' This slight interpretive difference does not undermine factual correctness but introduces a subtle bias not present in the ground truth. Otherwise, the answer is complete, contextually relevant, and semantically equivalent. Hence, a score of 9 is warranted for overall correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 422,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nApple’s 4.45 % Notes due 2044 first appeared in the 2022 filing (Exhibit 4.4 of the 2022 10‑K, p. 54) as part of the 2014 indenture. The 2023 10‑K (Exhibit 4.28, p. 56) and the 2024 10‑K (the same Exhibit 4.28, p. 56) keep that series listed in the indenture but do **not** add any new 4.45 % 2044 tranche; instead Apple issued fresh senior unsecured notes in 2023 (e.g., 4.421 % due 2026, 4.0 % due 2028, 4.15 % due 2030, 4.30 % due 2033, 4.85 % due 2053) and continued that pattern in 2024.  \n\nThe recurring issuance of new long‑dated, fixed‑rate notes across multiple years shows Apple’s long‑term financing strategy of **staggering maturities and diversifying coupon rates**, allowing it to lock in funding at varying market levels while maintaining a flexible, laddered debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it claims the 4.45% Notes due 2044 'first appeared in the 2022 filing,' which contradicts the ground truth stating they were issued in 2014 and consistently reported in all three annual filings (2022, 2023, 2024). This misrepresents the timeline and suggests a lack of proper multi-hop synthesis across years. However, the rest of the financial details — such as the new notes issued in 2023 (4.421% due 2026, etc.) and the absence of new 4.45% tranches — are factually accurate and align with plausible Apple financing behavior. (2) Quantitative accuracy is mostly correct: percentages and maturities for the newly issued notes in 2023 and 2024 are accurately reported, and there are no calculation errors. The only quantitative flaw is the incorrect dating of the 4.45% Notes' first appearance, which is a factual (not computational) error. (3) Multi-hop reasoning is partially sound — the model correctly infers a laddered maturity strategy from the issuance of new long-dated notes across years. However, it fails to recognize that the 4.45% Notes due 2044 were not newly introduced in 2022, undermining the validity of its analysis of the debt structure's evolution. The conclusion about Apple’s strategy of staggering maturities is reasonable but based on incomplete and slightly incorrect premises. (4) Contextual relevance is high — the response directly addresses the question about debt structure evolution and financing strategy. Despite the factual error, it provides relevant exhibit references and interprets strategic intent well. The correctness score is 6 due to the major error in temporal attribution, which affects the core of the multi-year analysis, but partial credit is given for accurate reporting of other debt issuances and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 499,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 to 2024 the FedEx International Connect Plus e‑commerce service grew from “nearly 50 origin countries to over 130 destination countries” (2022 filing) to “nearly 60 origin countries to over 190 destination countries” (2024 filing).  This expansion of both the number of origin markets and the reach of destination markets—adding dozens of new lanes and more than 60 additional country‑to‑country links—demonstrates that FedEx is deliberately scaling a day‑definite, contract‑based delivery offering to capture more cross‑border e‑commerce volume.  The trajectory signals that FedEx is positioning International Connect Plus as a core pillar of its e‑commerce logistics strategy, aiming to become a preferred, globally‑connected carrier for online retailers that need reliable, time‑definite shipping across an increasingly broad set of markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin countries to over 130 destination countries) and 2024 (nearly 60 origin countries to over 190 destination countries), matching the ground truth. It accurately reflects that the expansion occurred between 2022 and 2023, with no further change in 2024, though it does not explicitly mention 2023 as the year of expansion, instead attributing the change directly to the 2024 filing. This is a minor omission but does not distort the timeline. (2) All numeric values are correct and consistent with the ground truth; no calculations are required, but the description of 'more than 60 additional country-to-country links' is a reasonable inference from the increase in destination countries (from 130 to 190). (3) The multi-hop reasoning is sound: the model synthesizes data across years and correctly infers strategic intent from expansion patterns. It identifies the focus on cross-border e-commerce and time-definite delivery, aligning with the ground truth's emphasis on global connectivity and emerging markets. (4) The answer is contextually excellent, directly addressing both the evolution of geographic reach and the strategic implications. The only minor gap is the lack of explicit mention that the expansion was completed by 2023 and stabilized in 2024, which slightly weakens the qualitative accuracy. However, the overall factual correctness, clarity, and strategic interpretation are strong, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 428,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes that were originally due 2017 had been retired before the end of fiscal 2022, so they do not appear as an outstanding borrowing in the 2022, 2023 or 2024 Form 10‑Ks. Nevertheless, each of those filings (2022 – page 56; 2023 – page 56; 2024 – page 56) continues to list the 1.05 % Notes in the “Description of Securities”/indenture table, preserving the term‑sheet details of the retired series. This practice shows Apple’s systematic debt‑management approach: it regularly refinances maturing notes, replaces them with new issuances, and keeps the legacy indenture language in its disclosures to provide transparent, comparable information about its overall debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple continued to reference the 1.05% Notes due 2017 in its 10-K filings for 2022, 2023, and 2024, despite their maturity in 2017, which aligns with the ground truth. It accurately notes the consistent placement in the 'Description of Securities' or indenture table (Exhibit 4.4 in the original answer), and correctly infers that this reflects a standardized disclosure practice. However, the LLM incorrectly states that the notes 'do not appear as an outstanding borrowing' and that they were 'retired before the end of fiscal 2022'—this is factually inaccurate because the notes matured in 2017, not 2022, and thus had been settled five years prior. This misstatement affects factual precision. (2) Quantitatively, the percentage (1.05%) and the due year (2017) are correct. The mention of page 56 in each year is plausible but not verifiable from the ground truth provided; however, the core numeric facts (interest rate, maturity year) are accurate. The error lies in the implied timeline of retirement (fiscal 2022), which contradicts the known maturity in 2017. (3) The multi-hop reasoning is partially sound: the model correctly infers that continued disclosure serves transparency and comparability in debt management. It synthesizes across years and draws a reasonable conclusion about refinancing and documentation practices. However, it fabricates a detail (retirement timing) not present in the ground truth, weakening the reasoning chain. (4) The contextual relevance is high—the answer addresses both the status of the notes and the implications for Apple’s debt management strategy. Despite the factual error in timing, the overall interpretation of disclosure practices is consistent with the original answer’s conclusion about standardized frameworks and continuity. Hence, the correctness score is 7: core facts and interpretation are mostly right, but with a significant factual inaccuracy in the timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 534,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm deepened its 5G focus by expanding licensing of 5G‑essential patents and investing heavily in 5G‑Advanced (Releases 16‑18) and related automotive, IoT and AI applications, while using strategic investments and acquisitions to diversify into new markets. However, licensing revenue remained concentrated among a few OEMs and was jeopardized by geopolitical disruptions—especially the 2024 U.S. revocation of its export license to Huawei and broader U.S.–China trade restrictions that threaten sales to Chinese customers—as well as by the risk of key customers vertically integrating, which could erode both chip and royalty income.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's deepening strategic focus on 5G from 2022 to 2024, including expansion into automotive, IoT, and AI applications, increased R&D emphasis, and exposure to geopolitical risks such as U.S.-China trade restrictions and the Huawei export license revocation. However, it misses specific quantitative details present in the ground truth: notably, the $560 million in revenue from Huawei in fiscal 2024 prior to the ban, and the projection of over 27 billion IoT devices by 2026. These omissions affect quantitative accuracy. (2) While the LLM mentions the 2024 Huawei license revocation, it does not specify the financial impact ($560M), which is a key data point in the original answer. No incorrect numbers are stated, but important ones are missing, leading to a moderate quantitative accuracy score. (3) The multi-hop reasoning is generally sound—linking 5G licensing, strategic investments, and geopolitical risks across years—but lacks explicit connection of Huawei’s contribution before the ban, weakening the synthesis of financial exposure. The mention of 5G-Advanced and Releases 16–18 adds technical detail not in the ground truth but is plausible context. (4) Despite missing key figures, the LLM conveys the core evolution: growing commitment to 5G IP and licensing, strategic diversification, and rising geopolitical and competitive risks. Wording differs but meaning aligns semantically on most points. Contextual relevance is high as all aspects of the question (licensing revenue, investment, risks) are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 440,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 to 2024 the domestic pension plan’s holdings moved only modestly: U.S.‑equity exposure rose from $89 M (2022) to $93 M (2023) then slipped to $91 M (2024); international‑equity rose from $91 M to $93 M then fell to $89 M; and fixed‑income stayed at $739 M in 2022‑23 before dropping to $692 M in 2024.  This shows the company kept its long‑standing strategic mix of roughly 80 % fixed‑income with about 10 % each in U.S. and international equities, but it gradually reduced the fixed‑income share and modestly increased equity exposure as the plan’s funded status improved, reflecting a slight shift toward a more growth‑oriented asset allocation while still adhering to its liability‑driven framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and trends reported. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income. The LLM incorrectly states that in 2022, U.S. equity was $89M, international equity was $91M, and fixed income was $739M—these values actually correspond to 2023, not 2022. The LLM also claims fixed income dropped to $692M in 2024, which is unsupported by the ground truth (fixed income remained at $739M in 2024). Additionally, the LLM misrepresents the trend: it suggests equity exposure increased over time, while in reality, equity allocations decreased significantly from 2022 to 2023 and only slightly recovered in 2024. (2) All key numbers are incorrect for 2022, and the 2024 fixed income figure is fabricated. The total asset values are also wrong: ground truth shows total domestic pension assets fell from $1,267M in 2022 to $937M in 2023 and rose to $947M in 2024, but the LLM does not reflect this decline and recovery pattern. Calculations of percentages (e.g., 80% fixed income) are based on incorrect data and timeframes. (3) The multi-hop reasoning is flawed: the model fails to correctly align data across the three years and misattributes 2023 values to 2022, breaking the longitudinal analysis. It draws the opposite conclusion—increasing equity exposure—when the actual strategy shows a sharp reduction in equities in 2023 followed by stabilization, indicating de-risking, not growth orientation. (4) The contextual relevance is moderate because the answer addresses the structure of asset allocation and attempts to infer strategy, but due to severe factual inaccuracies and reversed trends, the qualitative interpretation is invalid. The conclusion about a 'growth-oriented shift' contradicts the ground truth of de-risking and reduced equity exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 518,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved edge‑networking from a peripheral IoT line‑item into a central growth pillar of its QCT portfolio, embedding 5G‑enabled mobile‑broadband, Wi‑Fi 6/6E/7 and on‑device AI capabilities into chipsets for enterprise, automotive and consumer edge devices.  While total IoT revenue slipped from about **$7.35 B in 2022** to **$5.42 B in 2024**, the company repeatedly highlighted edge‑networking demand—driven by hybrid‑work, mobile‑broadband and Wi‑Fi advances—as a key future revenue driver and directed R&D and capital toward edge‑focused technologies and product roadmaps.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention specific IoT revenue figures for 2022 ($7.35B) or 2024 ($5.42B), nor does it state a decline in IoT revenue. These numbers are fabricated or misattributed and directly contradict the qualitative trend in the original answer, which emphasizes growing strategic focus and revenue contribution—not a decline. There is no support in the original answer for any dollar figures related to edge networking or IoT revenue. (2) The use of precise financial data (e.g., $7.35B to $5.42B) implies a level of quantitative detail absent from the ground truth and introduces false precision. These numbers cannot be verified from the provided context and appear to be hallucinated. (3) Qualitatively, the LLM captures the general direction of Qualcomm’s strategic evolution—increased emphasis on edge networking, driven by hybrid work, 5G, and Wi-Fi advances—and correctly identifies mobile broadband and wireless access points as key areas. It also aligns with the idea of edge networking becoming a more central focus. However, it incorrectly frames this as a shift within the QCT portfolio and introduces unverified elements like 'on-device AI' and 'enterprise, automotive and consumer edge devices' that go beyond the scope of the original answer. (4) Contextual relevance is high because the answer addresses the evolution of strategic positioning, product development, and revenue contributions over time. Despite incorrect numbers, the narrative structure and focus on strategic evolution are appropriate. However, the inclusion of false financial data severely undermines factual correctness, warranting a low overall correctness score. The model fails the multi-hop reasoning test by inventing metrics instead of synthesizing only what is supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 511,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple repeatedly lists the 0.45 % Notes due 2016 in the debt‑disclosure exhibits of its 2022‑2024 Form 10‑K filings, treating the tranche as a permanent, low‑profile component of its borrowing base. By consistently referencing this fixed‑rate note across the three years, Apple signals a disciplined, transparent approach to managing its debt maturities—maintaining a predictable, small‑scale maturity schedule that supports overall capital‑structure stability and orderly refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 0.45% Notes due 2016 and their inclusion in Apple's 10-K filings from 2022 to 2024, satisfying quantitative accuracy for dates, percentages, and time periods. However, it makes a critical factual error by implying that the notes are still active or treated as part of Apple's current borrowing base ('permanent, low-profile component', 'predictable maturity schedule'), when in fact the notes matured in 2016 and are no longer outstanding. The original answer clarifies this key point: the notes are included for transparency and historical tracking, not because they are active debt instruments. This misinterpretation undermines the qualitative accuracy, as the reasoning incorrectly infers ongoing debt management strategy rather than post-maturity disclosure practice. While the LLM captures the theme of transparency and structured disclosure, it fails to recognize the retrospective nature of the reporting, leading to an incorrect conclusion about Apple's current capital structure management. The answer is contextually relevant and addresses the question's intent regarding debt maturity management, but the core reasoning is flawed due to the misunderstanding of the note's status post-2016.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 346,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nFrom 2022 to 2024 the EMD brand’s dealer network grew modestly – it reached **191 countries in 2022** and **193 countries by 2024**, an increase of two additional countries in the geographic coverage of its worldwide distribution network.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key quantitative aspects. According to the ground truth, EMD's distribution network covered 130 countries in 2022 and decreased to 109 countries by 2024 — a reduction of 21 countries. The LLM incorrectly states that the network grew from 191 countries in 2022 to 193 in 2024, which misrepresents both the baseline number and the trend. These numbers (191, 193) are entirely inconsistent with the ground truth (130, 109). (2) The calculation in the LLM answer (an increase of 2 countries) is therefore also incorrect; the actual change was a decrease of 21 countries, or ~16%. The LLM reports growth when there was a contraction. (3) The qualitative reasoning fails on multi-hop synthesis: the model should have identified that the network remained stable in 2023 (130 countries) before declining in 2024. Instead, it fabricates an upward trend with no supporting evidence. The entity identification (Caterpillar's EMD brand) and time frame (2022–2024) are correct, but the core metric (number of countries) is wrong. (4) The contextual relevance is moderate because the answer addresses the geographic reach over time as asked, but the factual foundation is entirely flawed. Due to severe quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 370,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.750% 7‑Year Senior Notes fell from $662 million at year‑end 2022 to $621 million at year‑end 2023 and stayed essentially flat at $621 million at year‑end 2024. This reduction shows that Thermo Fisher is deliberately de‑leveraging its medium‑term debt, preserving financial flexibility to fund strategic growth initiatives within the healthcare sector.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. According to the ground truth, the outstanding value of TMO's 1.750% 7-Year Senior Notes was consistently $700 million in 2022, 2023, and 2024. The LLM incorrectly reports $662 million in 2022, $621 million in 2023, and $621 million in 2024—none of which match the ground truth. These discrepancies are significant and not due to formatting differences. (2) The calculations and trends are therefore also wrong: the LLM claims a decline in debt, but the actual data shows no change, meaning the conclusion about de-leveraging is unfounded. (3) The multi-hop reasoning fails because the model did not correctly retrieve or synthesize the actual figures across the three years. It misidentifies both the values and the trend, leading to an incorrect interpretation of TMO's debt strategy. (4) While the answer attempts to address both parts of the question—evolution of debt and strategic implication—the complete inaccuracy of the numbers and resulting flawed reasoning severely undermines the response. The contextual relevance is low but not zero because the structure and intent of the answer align with the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 342,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar migrated its variable‑rate financing and related hedges from LIBOR‑based contracts to SOFR‑linked structures, creating a cross‑functional team to oversee the transition and broadening its use of currency‑hedging instruments such as forwards and swaps to guard against FX volatility. This shift demonstrates the company’s proactive, governance‑focused adaptation to global financial‑market reforms, emphasizing benchmark‑agnostic risk management and greater resilience to interest‑rate and currency fluctuations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Caterpillar's hedging strategy in response to the LIBOR phase-out and SOFR adoption. It accurately notes the transition from LIBOR to SOFR in variable-rate financing and hedges, the formation of a cross-functional team, and the continued use of currency hedging instruments like forwards and swaps. The answer correctly reflects Caterpillar's proactive adaptation to financial market reforms. However, it omits specific timeline details present in the ground truth: the 2022 acknowledgment of LIBOR cessation (especially the June 30, 2023 end date for USD LIBOR), the progressive shift in disclosures from 2022 to 2024, and the fact that by 2024 LIBOR was no longer referenced at all. These are important multi-hop details that show the phased nature of the transition. While the LLM conveys the strategic pivot, it lacks the year-by-year progression and specific regulatory references (FCA, IBA) that ground the timeline. There are no numerical inaccuracies—dates and benchmarks are correctly implied or referenced, and no incorrect entities or financial terms are used. The reasoning is sound and contextually appropriate, but the omission of specific disclosure evolution across the three years reduces completeness. Semantic equivalence is mostly preserved, but the answer condenses the timeline and misses the full depth of Caterpillar's phased risk management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 397,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher moved from CEO‑only change‑in‑control retention pacts to a single, standardized agreement that now covers all executive officers.  The uniform template was first disclosed in the 2023 Form 10‑Q (Exhibit 10.17) for officers other than the CEO and was carried forward in the 2024 filings (Exhibits 10.47‑10.58) with updated effective dates, ensuring consistent change‑in‑control definitions, severance and vesting terms across the entire leadership team.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution correctly: Thermo Fisher Scientific moved from a CEO-specific Change in Control Retention Agreement to a standardized form for other officers starting in 2023. However, there are factual inaccuracies in the quantitative and exhibit details that reduce correctness. The ground truth states that the standardized form was introduced in 2023 via Exhibit 10.17, not in a 10-Q, and was reaffirmed in 2024 with the same exhibit number (10.17), not Exhibits 10.47–10.58 as claimed. The mention of 'updated effective dates' and multiple exhibits in 2024 is unsupported by the original answer and potentially incorrect. Additionally, the original answer specifies that the 2022 agreement was only for CEO Marc N. Casper with amendments through 2018, which the LLM omits, weakening the baseline comparison. While the overall reasoning about standardization and its expansion beyond the CEO is sound and contextually relevant, the incorrect exhibit numbers and filing type (10-Q vs. likely 10-K) and the fabricated exhibit range in 2024 constitute significant quantitative errors. The LLM correctly identifies the trend and multi-hop evolution but misrepresents supporting documentation, leading to a 7 in overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 350,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a “future‑node” concept to the core of its next‑generation **Intel 18A** process (originally announced as Intel 20A).  The company positioned PowerVia as the industry’s first commercial implementation of backside power delivery, promising up to 15 % performance‑per‑watt gains and eliminating front‑side power routing—key advantages for high‑performance tiles and AI/data‑center workloads.  By integrating PowerVia into the Intel 18A roadmap and planning high‑volume production for 2025, Intel signaled that the technology is now a strategic pillar of its **IDM 2.0** strategy, underpinning the advanced‑process nodes and packaging capabilities needed to compete with external foundries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PowerVia was introduced as part of Intel 20A in 2022, remained central in the transition to Intel 18A in 2024, and is tied to high-volume manufacturing starting in 2025. The description of PowerVia as enabling backside power delivery, eliminating front-side routing, and improving performance-per-watt by up to 15% is consistent with known disclosures and adds context not in the original answer but not contradicted by it. (2) Quantitative accuracy is excellent: the 15% performance-per-watt gain, the 2025 high-volume production timeline, and correct naming of Intel 18A (and prior 20A) are all factually sound. No calculation errors. (3) Multi-hop reasoning is strong: the answer synthesizes PowerVia’s technical role, its evolution across the roadmap shift, and its strategic importance under IDM 2.0. It correctly infers that retaining PowerVia in 18A despite canceling 20A shows its strategic centrality. (4) The only minor gap is that the original answer explicitly notes Intel’s 2023 emphasis on signal transmission optimization and the broader 2025 process leadership goal, which the LLM answer omits—though it captures the overall intent. The addition of the 15% performance gain is accurate and enhances the response without contradicting the ground truth. Overall, the answer is semantically equivalent with slightly expanded, correct context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 401,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the “Exhibit 4.4” table – which lists the indenture and officer’s certificate for the 2014 debt issuance – again names the **1.05 % Notes due 2017** (along with the other series in that tranche).  The same entry appears in the exhibit index of each filing, so the note is repeatedly disclosed in essentially the same wording.  \n\nThis consistent re‑inclusion shows that Apple treats the 1.05 % 2017 notes as a continuing, fully disclosed component of its capital structure, underscoring a deliberate, transparent approach to managing and communicating its long‑term debt obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the repeated disclosure of the 1.05% Notes due 2017 in Apple's 2022, 2023, and 2024 10-K filings, accurately referencing Exhibit 4.4 and the Officer's Certificate from May 6, 2014. All numeric values—'1.05%' and 'due 2017'—are correct, and the years of the filings (2022–2024) match the ground truth. (2) Quantitative accuracy is perfect: percentages and years are correctly stated with no calculation errors. (3) However, the LLM answer misses a key inference from the ground truth: that the note was included *despite its maturity in 2017*, which raises questions about rollover or continued reporting. The LLM implies the note remains an active part of the capital structure, but does not acknowledge its post-maturity disclosure anomaly or explore the implication that Apple may have rolled over the debt. This weakens the multi-hop reasoning, as the significance of reporting a matured note is underdeveloped. (4) The answer is contextually relevant and well-structured, but lacks the depth of analysis present in the original answer regarding Apple’s debt management practices. While it notes 'deliberate, transparent approach,' it does not specifically suggest continuity via rollover or structural retention, which is central to the ground truth. Thus, qualitative accuracy is reduced due to incomplete synthesis of the implication behind the repeated disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 392,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to use the 2006 Equity Incentive Plan as its primary equity‑compensation vehicle, but the form of awards and their vesting terms were refined rather than replaced.  In 2022 the company began issuing RSUs to non‑employee directors under a new grant agreement (Exhibit 10.1.7), and it kept the existing performance‑based RSU agreements for executives (Exhibit 10.1.6), which typically vest over a three‑year performance cycle subject to continued service.  By the 2024 filing the plan itself was restated (Exhibit 10.1) and the same RSU formats remained in place, indicating that the evolution was limited to the adoption of updated grant documents and clearer performance‑vesting conditions rather than a shift to a new type of equity award.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements, such as the continued use of the 2006 Equity Incentive Plan and the issuance of RSUs to non-employee directors and executives with performance-based vesting. However, it misses key developments, particularly the 2023 amendment and restatement of the plan effective May 11, 2023, which is a critical factual point in the ground truth. The LLM incorrectly implies the restatement occurred by the 2024 filing without specifying the 2023 effective date, thus misrepresenting the timeline. (2) Quantitatively, the answer does not include specific erroneous numbers but omits the explicit mention of the May 11, 2023 amendment date, which is a factual inaccuracy by omission. The reference to '2024 filing' as when the plan was restated contradicts the ground truth stating the amendment was effective in 2023. (3) The multi-hop reasoning is partially sound—linking grant types and vesting conditions across years—but fails to correctly synthesize the evolution across 2022–2024, especially the expansion in 2023 to include retirement-vesting RSUs and the distinction between grandfathered and non-grandfathered executives. These nuances are entirely missing, weakening the qualitative accuracy. (4) The answer remains contextually relevant and uses appropriate terminology (e.g., performance-based RSUs, service conditions), but the absence of key developments like the 2023 amendment and the diversification of RSU types reduces correctness. The consolidation and streamlining in 2024 are also underdeveloped. Overall, the answer is partially correct with significant omissions in the evolution narrative, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 464,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nMedtronic’s filings for fiscal 2022, 2023 and 2024 each keep the same €1.00‑par, 40‑thousand‑share Euro Deferred Share authorization, and each year’s “Share Capital” note explicitly states that **no Euro‑Deferred Shares were issued or outstanding at year‑end**. The company therefore never tapped this reserved capital during the three‑year period. This consistent omission indicates that Medtronic’s financing strategy over 2022‑2024 has been to rely on ordinary‑share repurchases, debt and internally generated cash rather than on issuing Euro‑Deferred Shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained an authorized capacity of 40 thousand Euro Deferred Shares with €1.00 par value in fiscal years 2022–2024, and no shares were issued or outstanding each year—this is explicitly stated in both the LLM and original answers. (2) Quantitative elements (40 thousand shares, €1.00 par value) are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent absence of issuance that Medtronic did not use this instrument for financing, and appropriately links this to broader capital allocation strategy. (4) The LLM slightly expands on the original by specifying 'debt and internally generated cash' as alternative tools, which is a reasonable inference but not explicitly stated in the ground truth; this does not reduce accuracy but introduces a minor addition. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a 9/10 due to the slight expansion beyond the provided evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 315,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nBetween 2022 and 2024 Intel moved advanced‑packaging from a peripheral capability to a central pillar of its IDM 2.0 strategy, raising R&D outlays (R&D ≈ $15.2 B in 2022 → $16.5 B in 2024) and capital spending on 2.5D/3D and chiplet‑packaging technologies.  This heightened investment raised manufacturing complexity—multiple, often‑co‑optimized process nodes, EUV‑dependent equipment and disaggregated designs that must be synchronized across separate fabs—while packaging revenue grew sharply (e.g., $952 M in 2023, up $483 M from 2022) but the segment posted widening operating losses; by 2024 the company recorded a $3.1 B non‑cash impairment and accelerated‑depreciation charge tied to packaging‑related assets, illustrating the steep financial risk of the advanced‑packaging push.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's strategic positioning and execution risks around Advanced Packaging from 2022 to 2024, aligning well with the ground truth in terms of strategic intent, technical progress (e.g., chiplet designs, UCIe), and financial setbacks. However, some specific numbers lack direct support in the original answer. For example, the R&D figures ($15.2B in 2022 → $16.5B in 2024) and packaging revenue ($952M in 2023, up $483M from 2022) are not present in the ground truth and cannot be verified, making them potentially inaccurate. The $3.1B non-cash impairment is correctly cited and matches the original answer, which is a key factual anchor. (2) The quantitative accuracy is partially compromised due to the inclusion of unsourced financial figures. While the $3.1B impairment is correct, the R&D and revenue numbers appear to be fabricated or inferred beyond what the ground truth supports. The original answer does not mention revenue growth or specific R&D spending, so these additions, though plausible, reduce quantitative fidelity. (3) The multi-hop reasoning is strong: the LLM synthesizes strategic intent (IDM 2.0), technical complexity (disaggregated designs, EUV), and financial impact (impairments, losses), showing a logical progression from investment to risk. It correctly infers that increased investment led to operational complexity and financial strain, consistent with the original narrative. (4) Contextual relevance is excellent—the response directly addresses R&D investment, manufacturing complexity, and financial impact as required by the question. Despite unsupported specifics, the overall qualitative trajectory and key facts (e.g., $3.1B impairment, strategic centrality, execution risks) are accurate, warranting a high correctness score with a deduction for unverified numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 507,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIntel first introduced PowerVia in 2022 as the industry’s inaugural backside‑power‑delivery technique tied to the then‑planned Intel 20A node, touting it as a way to boost performance‑per‑watt and density by eliminating front‑side power routing. By the 2023 roadmap update the focus shifted to the Intel 18A node (replacing 20A) and highlighted PowerVia’s role in delivering roughly 10 % extra performance‑per‑watt and enabling external foundry customers, while still being prepared for high‑volume production. In 2024 Intel confirmed that PowerVia‑enabled Intel 18A will enter high‑volume manufacturing in 2025 (Panther Lake) and is already qualified in its new fabs, marking the technology’s transition from concept to a ready‑for‑production manufacturing capability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PowerVia from 2022 to 2024, including its introduction as a backside power delivery solution, the shift from Intel 20A to 18A, and the high-volume manufacturing (HVM) timeline in 2025. However, there is a discrepancy in the performance-per-watt improvement: the ground truth states 'up to 15%' for Intel 20A vs Intel 3, while the LLM claims 'roughly 10%' under Intel 18A, which is not supported by the original answer and may conflate different nodes or estimates. (2) Dates are mostly accurate—2022 introduction, 2023 roadmap update, 2024 confirmation of 2025 HVM—but the LLM incorrectly attributes the 10% figure without clarifying it was originally tied to 20A in the 2023 update. The mention of Panther Lake in 2025 and fab qualification adds contextual detail not in the original but plausibly aligns with public Intel disclosures; however, it goes beyond the ground truth without confirmation. (3) Multi-hop reasoning is strong: the model synthesizes information across three years, correctly identifies the technological shift, and explains the maturation from concept to production. The entity tracking (Intel, PowerVia, 20A, 18A) is accurate, though the conflation of performance gains between nodes shows a minor reasoning gap. (4) The answer is highly relevant and well-structured, conveying the strategic evolution effectively. The correctness score is 8 due to the accurate overall trajectory but with a notable quantitative inaccuracy in the performance-per-watt claim. Quantitative accuracy is 7 due to the incorrect percentage, qualitative accuracy is 9 for strong reasoning and entity handling, and contextual relevance is 10 as all parts of the question are addressed with appropriate depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 482,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nMedtronic has not introduced a new or substantially revised U.S.‑employee RSU agreement between FY 2022 and FY 2024; the same “Restricted Stock Unit Award Agreement” forms disclosed in the 2021 Long‑Term Incentive Plan (e.g., the 100 %‑vesting and ratable‑vesting variants listed in the 2022 and 2023 10‑K exhibits) continue to be referenced without any separate FY 2024 filing. This continuity suggests that Medtronic’s equity‑compensation strategy has remained stable, relying on the existing RSU framework rather than undertaking a major overhaul of its U.S. employee equity awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in referencing the '2021 Long-Term Incentive Plan' when the original answer and filings confirm that the RSU agreements are under the '2013 Stock Award and Incentive Plan', first filed in 2013. This is a factual error in entity identification (plan name and year), which affects qualitative accuracy. However, the core conclusion—that Medtronic did not update its U.S. employee RSU agreements from FY2022 to FY2024—is correct, and the observation about stable equity compensation strategy is logically sound and semantically equivalent to the original. The LLM correctly synthesizes multi-hop information across fiscal years and filings, noting consistent use of the same agreement forms without changes in FY2024. Quantitative elements (e.g., absence of new filings, continuity across years) are accurate, and no numerical calculations are required. Contextual relevance is strong, as the response directly addresses both parts of the question: update status and strategic implication. The error does not undermine the overall conclusion but reflects a lapse in precise document sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 334,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel broadened the performance‑based RSU component of its 2006 Equity Incentive Plan, adding grants to non‑grandfathered executives and to non‑employee directors.  The 2022 10‑K (Exhibit 10.1.6) introduced a dedicated form for performance‑based RSUs to non‑grandfathered executives, and the 2023 filing added Exhibit 10.1.7 for RSUs given to non‑employee directors—both forms appearing again in the 2024 10‑K exhibit list, showing the plan’s expanded and updated structure for executive RSU awards.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies and omits key elements from the ground truth. It correctly identifies the use of the 2006 Equity Incentive Plan and references performance-based RSUs in 2022 and 2023, but incorrectly claims that Intel 'broadened' the plan to include non-employee directors and non-grandfathered executives during 2022–2024. The original answer does not mention grants to non-employee directors at all, nor does it state that the plan was structurally broadened. Instead, the ground truth emphasizes continuity and reaffirmation of the plan, including its use for grandfathered vs. non-grandfathered executives, which the LLM misrepresents as an expansion. (2) Quantitatively, there are no explicit numerical errors (e.g., dates like May 11, 2023, and September 26, 2023, are not mentioned in the LLM response, so no conflict), but the LLM fabricates exhibit numbers (10.1.6 and 10.1.7) without verification against the original. While exhibits may exist, the specific characterization of them introducing new grant types is not supported in the ground truth. (3) The multi-hop reasoning is flawed: the LLM infers structural expansion based on the presence of separate agreements, but the original answer stresses consistency over time, not evolution or broadening. The LLM fails to mention the S-8 filing on September 26, 2023, or the May 11, 2023, amendment—key evidence of continued use rather than structural change. (4) Despite these issues, the response remains contextually relevant, addressing the right plan, time frame, and topic of performance-based RSUs. However, due to significant factual overreach and mischaracterization of the plan’s evolution, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 489,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed from establishing a packaging foundation and early design wins to scaling a dedicated advanced‑packaging business that now serves as the backbone of its disaggregated‑design strategy—evidenced by multiple AI‑focused design wins, the 2023 demonstration of the Universal Chiplet Interconnect Express, and expanded partnerships with ARM and Synopsys that enable chiplet‑based SoCs on its 18A and other nodes. This evolution shows Intel is leveraging sophisticated 2.5D/3D packaging to integrate heterogeneous components across process technologies, but the high fixed costs, technical complexity, and execution risks inherent in these technologies mean that fully capitalizing on the approach to compete in the AI‑driven semiconductor market remains uncertain. Nonetheless, the growing number of AI‑related packaging wins and ecosystem commitments indicates increasing confidence in Intel’s ability to turn advanced packaging into a competitive differentiator.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omits key factual information from the ground truth. While it correctly identifies Intel's progress in advanced packaging and mentions the 2023 UCIe demonstration, it fails to mention the significant $3.1 billion in non-cash impairment charges and accelerated depreciation in 2024 related to manufacturing assets, including the Intel 7 node. This is a major omission, as it reflects ongoing execution risks and financial pressures—a core part of the ground truth. Additionally, the LLM claims 'AI-focused design wins' and 'expanded partnerships with ARM and Synopsys' without grounding in the provided truth, which does not mention these entities or wins. (2) Quantitatively, the LLM omits the $16.5 billion R&D investment and the $3.1 billion charge in 2024—both critical figures. No incorrect numbers are stated, but the absence of these key figures severely undermines quantitative accuracy. The year 2023 is correctly cited for UCIe, but no dollar amounts or financial metrics are accurately reported. (3) The reasoning partially captures the multi-hop nature of the question—linking packaging to disaggregated design and AI competitiveness—but misrepresents the narrative by emphasizing growth and confidence without balancing it with the financial setbacks and execution risks highlighted in the ground truth. The conclusion that Intel is 'turning advanced packaging into a competitive differentiator' is overly optimistic and not supported by the 2024 impairment charges, which indicate persistent challenges. (4) Contextual relevance is high because the answer addresses the evolution of packaging, disaggregation, and AI competition. However, the lack of key financial data and introduction of unverified partnerships reduce factual reliability. The answer synthesizes plausible industry trends but diverges from the documented reality in the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 521,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three fiscal years Intel did not adopt any formal amendment to the 2006 Equity Incentive Plan itself; the 2022 Form 10‑K simply listed the plan (page 112 of the 2022 filing). In the 2023 filing the company introduced new RSU grant‑agreement exhibits (Exhibit 10.1.6 for performance‑based RSUs and Exhibit 10.1.7 for non‑employee‑director RSUs) that refined vesting and performance conditions (pages 107‑108 of the 2023 filing). The 2024 filing kept the same plan reference and the same grant‑agreement exhibits, indicating that the evolution was limited to the form of award documents rather than any substantive plan change.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, particularly regarding the 2023 amendment. The Original Answer states that Intel filed an 'amended and restated version of the plan effective May 11, 2023,' which is a key factual development. However, the LLM Answer incorrectly claims that 'Intel did not adopt any formal amendment to the 2006 Equity Incentive Plan itself,' directly contradicting the ground truth. This is a major error in both entity accuracy and qualitative reasoning, as it misrepresents a central aspect of the plan’s evolution. While the LLM correctly notes the introduction of new grant agreement exhibits in 2023 (Exhibits 10.1.6 and 10.1.7) and their continuation in 2024, these details only partially align with the ground truth’s broader narrative of formal structural updates via amendment. The LLM also omits mention of retirement vesting terms and performance-based awards in 2022, reducing completeness. Quantitatively, there are no numerical values to assess, but the dates and document references (e.g., page numbers, exhibit numbers) are plausible and contextually consistent, earning moderate scores. Contextually, the answer stays focused on the evolution of grant agreements and plan usage, so relevance is high. However, the failure to acknowledge the 2023 formal amendment constitutes a critical multi-hop reasoning failure—synthesizing across years to identify structural change—resulting in a low overall correctness score despite some accurate details about award forms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 424,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm kept wireless‑access‑point sales inside the **IoT revenue stream of its QCT segment**—the same classification used in the 2022 “IoT (including mobile broadband and wireless access points)” table and reiterated in the 2023‑2024 revenue‑by‑stream tables.  However, the **absolute size of that stream fell sharply** ( $7.35 B in 2022 → $5.94 B in 2023 → $5.42 B in 2024 ), reflecting a **strategic re‑prioritisation away from edge‑networking hardware toward higher‑growth areas such as automotive, 5G handsets and on‑device AI**, even as the company’s public narrative continued to stress edge‑networking as a key growth market.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative inaccuracy: The LLM claims IoT revenue declined from $7.35B (2022) to $5.94B (2023) to $5.42B (2024), but the original answer does not provide any revenue figures—especially not for IoT as a whole or wireless access points specifically. These numbers are fabricated or misattributed, with no support in the ground truth. (2) Entity and classification error: The LLM incorrectly states that wireless access points were classified under the 'IoT revenue stream' within the QCT segment. The ground truth explicitly states that by 2023, wireless access points were categorized under the 'edge networking' revenue segment, which includes mobile broadband and wireless access points—not IoT broadly. This misrepresents Qualcomm’s financial segmentation. (3) Reasoning and strategic interpretation: The LLM infers a 'strategic re-prioritisation away from edge-networking hardware' due to declining revenue, but the ground truth indicates a consistent and growing strategic emphasis on edge networking, tied to the projected doubling of IoT devices to over 27 billion by 2026. The LLM contradicts the ground truth by suggesting a de-emphasis, while the original answer shows sustained focus. (4) Semantic mismatch: While the LLM attempts to address revenue classification and strategic emphasis, its core claims about declining investment and reclassification are unsupported and factually incorrect. The only correct element is the mention of mobile broadband and wireless access points being grouped, but it misattributes the segment. Thus, despite addressing the question's general theme, the answer fails on factual correctness, multi-hop synthesis, and proper entity classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 483,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nPrevymis sales grew steadily from $ 428 million in 2022 to $ 605 million in 2023 and $ 785 million in 2024 (≈ 46 % year‑over‑year growth from 2022‑23 and ≈ 30 % growth from 2023‑24).  This upward trajectory signals rising clinical adoption and a strengthening market position for the product within Merck’s Hospital Acute Care segment, highlighting its expanding role as a key antiviral prophylaxis offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. According to the ground truth, Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly reports $428 million in 2022 and $605 million in 2023. Only the 2024 figure ($785 million) is correct. This misrepresentation leads to incorrect year-over-year growth calculations: the LLM claims ~46% growth from 2022–2023 and ~30% from 2023–2024, whereas the actual growth was approximately 15.7% (from $370M to $428M) in 2023 and 83.4% (from $428M to $785M) in 2024. The compound growth rate over 2022–2024 is correctly approximated as ~46% in the original answer, but the LLM incorrectly attributes this to a single year. (2) The quantitative inaccuracies are severe—two out of three sales figures are wrong, and both growth rates are miscalculated. While the final 2024 number is accurate, the trajectory is misrepresented. (3) The qualitative reasoning about increasing market adoption and strategic positioning in the Hospital Acute Care segment is sound and aligns with the trend implied by strong growth. The LLM correctly infers clinical adoption and strategic importance from rising sales, which shows valid multi-hop reasoning despite flawed inputs. (4) Contextually, the answer addresses both parts of the question—sales evolution and market positioning—and uses appropriate terminology. However, due to major numerical errors affecting the core of the response, the correctness score is low. The qualitative and contextual scores are moderate to high because the logic and framing are appropriate, but quantitative accuracy is critically flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 457,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted from a modest internal packaging capability to a deliberate, multi‑year strategic thrust that made advanced packaging a cornerstone of its IDM 2.0 agenda—evidenced by design wins on the 18A node, the expansion of the IFS accelerator ecosystem, and public commitments to 2D/3D packaging for AI‑centric chips. Nevertheless, the company’s ability to capitalize on this trajectory is constrained by ongoing process‑node delays and the heavy capital outlays required for new fabs and packaging lines, forcing Intel to depend on external financing, government grants and penalty‑bearing joint ventures to sustain its packaging investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift in Intel's advanced packaging efforts under IDM 2.0 and acknowledges execution challenges, which aligns with the ground truth. However, it omits key factual details and introduces unverified claims. For example, the ground truth specifies that in 2022, Intel cited delays in Intel 4 and increased costs in advanced packaging, while the LLM answer vaguely references a 'modest internal packaging capability' without citing 2022-specific challenges. The 2023 developments—such as UCIe being demonstrated in silicon and positioning packaging as a differentiator—are partially reflected but not explicitly mentioned. Most critically, the LLM answer includes unsupported specifics: 'design wins on the 18A node' and 'expansion of the IFS accelerator ecosystem' are not in the ground truth and cannot be verified from the provided data. Additionally, the claim about 'penalty-bearing joint ventures' is unsubstantiated. (2) Quantitative accuracy is poor: the ground truth includes specific figures such as $16.5 billion in R&D investment in 2024 and a $3.1 billion non-cash impairment in Q3 2024—none of which appear in the LLM answer. The absence of these key numbers, which are central to the capital constraints narrative, significantly undermines factual completeness. (3) Multi-hop reasoning is partially sound—the model connects advanced packaging to IDM 2.0 and infers that capital constraints affect execution—but it fails to synthesize the actual evidence (e.g., impairments, R&D spend, product delays like 4th Gen Xeon) that ground this conclusion. Instead, it relies on speculative phrasing. (4) Contextual relevance is high because the answer addresses the evolution of packaging strategy and links it to IDM 2.0 and capital issues. However, due to missing quantitative data, unverified claims, and incomplete multi-year trajectory details, the correctness score is limited to 5—partially correct but with significant gaps and inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 542,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM repeatedly cites “client relationships and trust” alongside technology innovation, performance, brand and service as a principal way it competes—first in the 2022 filing and then with the same wording in the 2023 and 2024 10‑Ks.  Over that period the language shifts from listing trust as one of several differentiators to explicitly linking it to the company’s hybrid‑cloud and AI platforms, signaling that IBM is leveraging its reputation for reliability and partnership to win enterprise clients for its integrated cloud‑and‑AI solutions and to position trust as the foundation of its growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024. It correctly identifies that IBM consistently listed 'client relationships and trust' as a competitive differentiator across all three years, which aligns with the ground truth. The answer accurately notes the shift in framing—from trust as one of several differentiators to its explicit linkage with hybrid cloud and AI platforms—reflecting IBM's strategic positioning. This demonstrates sound qualitative reasoning and correct multi-hop synthesis across the 2022–2024 filings. The only minor omission is the lack of mention of the 2024 strategic partnership with Palo Alto Networks, which the original answer includes as evidence of deepening trust-based collaboration. While this detail strengthens the ground truth's conclusion, the LLM still conveys the essential progression and strategic implication. All dates and entities (IBM, hybrid cloud, AI) are correct. No numerical data is present, so quantitative accuracy is scored based on absence of error. The answer is fully contextually relevant and semantically equivalent in substance, though slightly less detailed in supporting examples.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 345,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM moved the 0.950 % Notes due 2025 from a stand‑alone exhibit in a 2017 Form 8‑K to a regularly‑referenced item in the “Instruments defining the rights of security‑holders” tables of its annual reports – the note is listed in the 2023 10‑K (page 21) and appears directly in the securities table of the 2024 10‑K (page 1).  This shift shows that IBM is consolidating its debt disclosures into the periodic filings and treating the 0.950 % 2025 tranche as a stable, low‑cost component of a broader, laddered financing strategy that emphasizes long‑dated, low‑coupon debt and streamlined reporting of its debt‑management profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in presentation and one potential overstatement. (1) Quantitatively, all key facts are accurate: the 0.950% Notes due 2025 were indeed referenced via the 2017 Form 8-K (Exhibit 4.1) in both 2022 and 2023 disclosures, and by 2024 the notes were listed on the NYSE under IBM25B. The LLM correctly identifies the progression in disclosure format across years, including specific references to the 2023 and 2024 10-Ks and page numbers, which are consistent with actual filings. (2) The entity accuracy is strong—IBM, the note’s coupon (0.950%), maturity (2025), and relevant forms (8-K, 10-K) are all correctly identified. (3) The reasoning is sound in noting a shift toward more integrated and streamlined disclosure practices, suggesting a stable, laddered debt strategy. However, the LLM introduces the idea of a 'laddered financing strategy' and 'long-dated, low-coupon debt' as broader context not explicitly supported by the provided ground truth, which only discusses this specific note and its disclosure continuity. While plausible, this inference goes beyond the evidence in the original answer. (4) The ground truth emphasizes regulatory continuity and transparency, while the LLM emphasizes consolidation and strategic framing—both valid, but the latter adds interpretive layers. Despite this, the core multi-hop synthesis—tracking the note’s disclosure evolution and its implications for transparency and stability—is accurate. Minor wording differences are acceptable under semantic equivalence. Thus, the answer is highly accurate but slightly overreaches in strategic interpretation, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 471,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from a planned feature of the 20A node to a production‑ready element of its next‑generation 18A process.  In 2022 the company introduced PowerVia as part of the 20A roadmap and began design work; by 2023 it was slated for high‑volume manufacturing on Intel 4/Intel 3 (Ireland) and for external foundry customers under the IDM 2.0 model; and in 2024 Intel confirmed that the first high‑volume commercial implementation of backside‑power delivery (PowerVia) will be in the 18A node (Panther Lake) scheduled for 2025, backed by new fab expansions in Arizona, Ireland, Ohio and Europe and by “Smart‑Capital” investments.  This trajectory shows that Intel’s roadmap is centering on backside‑power delivery as a key differentiator for advanced nodes, aiming to boost performance‑per‑watt and density while leveraging its expanded manufacturing footprint to bring the technology to market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's PowerVia strategy and correctly identifies the shift toward backside power delivery as a key differentiator, which aligns with the question's intent. However, there are significant factual inaccuracies that reduce correctness. First, the claim that PowerVia was slated for high-volume manufacturing on Intel 4/Intel 3 in 2023 is incorrect—PowerVia is specific to Intel 20A and later Intel 18A, not Intel 4 or 3. Second, the assertion that PowerVia was planned for external foundry customers under IDM 2.0 in 2023 is not supported by the ground truth and introduces unsupported details. Third, while the 2025 timeline for 18A is correct, the association of PowerVia’s first high-volume implementation with Panther Lake is speculative and not in the original answer. The ground truth states that Intel canceled Intel 20A in favor of 18A for PowerVia deployment, but the LLM incorrectly implies continued development on 20A and misrepresents the node transition. The strategic pivot from concept to commercialization is correctly framed, but the specific entities, nodes, and timelines are partially incorrect. Quantitative accuracy is moderate: the 2025 date is correct, but incorrect node assignments (Intel 4/3) and unsupported manufacturing plans reduce precision. Qualitative accuracy suffers from these factual errors and overreach in synthesis, though the overall reasoning about strategic importance is sound. Contextual relevance is high—the answer directly addresses the evolution and roadmap implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 430,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nThe 2022‑2024 SEC exhibits repeatedly reference the same Restricted Stock Unit award forms under the 2021 Medtronic plc Long‑Term Incentive Plan (and its amended 2013 counterpart), using unchanged vesting structures—either 100 % after three years or ratable over four years—without any material redesign. This consistent use of identical RSU agreement language across multiple fiscal years demonstrates that Medtronic’s U.S. equity compensation strategy remains stable, retaining RSUs as a core, long‑term incentive vehicle for domestic employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core conclusion as the ground truth: Medtronic's U.S. equity compensation strategy demonstrated stability from 2022 to 2024 due to the consistent use of unchanged Restricted Stock Unit (RSU) award agreements. The LLM correctly identifies that the RSU forms were reused across years under the 2021 Long-Term Incentive Plan, which incorporates the 2013 plan framework, aligning with the ground truth's reference to the August 27, 2013 filing. The vesting structures (100% after three years or ratable over four years) are accurately described, though not explicitly mentioned in the original answer—this is additional but correct detail consistent with historical Medtronic practices. All entities (Medtronic, U.S. employees, RSUs, Long-Term Incentive Plan) and timeframes (2022–2024) are correct. The reasoning correctly synthesizes multi-hop information across years and documents to infer strategic stability from document consistency. The only minor gap is the absence of the specific exhibit number (Exhibit 10.54), which is present in the original answer, but this does not affect the factual or semantic accuracy of the conclusion. Quantitative elements (percentages, years) are correct. Wording differs but meaning is equivalent: 'unchanged vesting structures' and 'identical RSU agreement language' effectively communicate the same stability message as the original. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 413,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nIntel promoted advanced packaging—particularly 2D/2.5D/3D techniques and the Universal Chiplet Interconnect Express standard—as a key differentiator of its IDM 2.0 and Open System Foundry strategy, hoping to let customers assemble disaggregated chiplets from multiple process nodes.  In practice, repeated node delays, the heavy capital outlays required for new fabs, and the logistical complexity of mixing different foundry technologies caused inventory write‑downs, impairments and postponed product launches, while capital constraints and uncertain government funding limited how quickly the company could scale its packaging capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic positioning and execution challenges Intel faced with advanced packaging from 2022 to 2024, including the role of disaggregated design (chiplets), UCIe, capital constraints, node delays, and impairments. It correctly identifies advanced packaging as a strategic differentiator under IDM 2.0 and Open System Foundry, aligning with Intel's 2023 positioning. The mention of inventory write-downs, impairments, and postponed launches reflects the execution challenges noted in the ground truth. However, the LLM answer lacks specific quantitative and temporal details that are critical for full accuracy: it omits the $3.1 billion impairment charge in 2024 and does not specify that the underutilized assets were tied to the Intel 7 node. While it references 'repeated node delays' and 'capital constraints,' it fails to explicitly connect the 2022 Intel 4 (7nm) delays to product timing risks, as stated in the original answer. The answer synthesizes multi-hop information reasonably well—linking packaging tech, chiplet strategy, UCIe, and financial execution—but misses precise entity-year-metric linkages. Wording is semantically close and contextually relevant, but the absence of key figures and specific node references reduces quantitative accuracy. Thus, while the qualitative reasoning and overall relevance are strong, the lack of specific numbers and some timeline conflation prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 398,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nAccenture’s target asset mix for its defined‑benefit plans has been steadily “equity‑leaning” over the last three fiscal years.  In the non‑U.S. plans the equity allocation rose from **21 % (2022)** to **27 % (2023)** and is projected at **28 % for 2025**, while the fixed‑income share fell correspondingly from roughly **48‑50 % to about 36‑42 %**; the U.S. plans remain essentially 100 % fixed‑income but now carry a slightly lower overall debt weighting as the company allows a modest increase in equity exposure elsewhere.  This multi‑year shift signals a deliberate strategy to boost the plans’ long‑term risk‑adjusted returns—by modestly increasing exposure to higher‑return equities while still maintaining a liability‑driven, duration‑matched core of fixed‑income assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ORIGINAL ANSWER states that Accenture maintained a balanced, diversified strategy across fixed income and equities with evolving flexibility in allocation, but does not provide specific percentage allocations. In contrast, the LLM answer asserts precise figures (e.g., 21% equity in 2022 rising to 28% in 2025, fixed income falling from 48-50% to 36-42%) and makes a strong claim about an 'equity-leaning' shift, which is not supported by the ground truth. The ground truth does not mention any such numerical changes or a trend toward higher equity exposure. Additionally, the LLM introduces a distinction between U.S. and non-U.S. plans and claims U.S. plans are '100% fixed-income,' which is absent from the original. These specific percentages and structural claims represent a fabrication or misrepresentation of data. While the LLM correctly identifies the general themes of balancing fixed income and equities, liability matching, and risk-adjusted returns, and attempts multi-hop reasoning about strategic evolution, the reliance on unsupported numbers undermines factual correctness. The reasoning about strategic intent (boosting long-term returns while managing risk) is plausible but based on incorrect data, reducing qualitative accuracy. Contextually, the answer addresses the right topic and time frame, so relevance is moderate. However, the core failure is quantitative inaccuracy, which leads to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 420,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated citation of the 1.05% Notes due 2017 in its 2022‑2024 10‑K filings shows that it treats legacy‑debt disclosures as permanent elements of its filing package, preserving a complete audit trail of every debt security it has ever issued rather than removing them once they mature. This reveals a deliberately exhaustive and risk‑averse disclosure stance, even as Apple’s active financing strategy shifts toward issuing larger, longer‑dated fixed‑rate senior notes (e.g., 4.4%–4.8% notes due 2026‑2053) to refinance maturing obligations and fund its operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates and interest rates for Apple's debt instruments. The ground truth references specific notes issued between 2022–2024, including Floating Rate Notes due 2020 (still referenced), 2.15% Notes due 2022, and 3.45% Notes due 2024. However, the LLM incorrectly states that Apple issued 4.4%–4.8% notes due 2026–2053 during this period, which is not supported by the original answer or implied knowledge. These are material quantitative errors. (2) The mention of '1.05% Notes due 2017' being referenced in 2022–2024 filings aligns with the original answer and is factually consistent; however, the characterization of Apple’s broader issuance strategy misrepresents the actual instruments cited. There is no mention in the ground truth of notes due as far as 2053 or in the 4.4%–4.8% range, making these fabricated details. (3) The multi-hop reasoning is partially sound: the model correctly infers that continued disclosure of a matured note suggests a policy of comprehensive historical reporting. It also attempts to contrast legacy disclosures with active debt management, which matches the intent of the original answer. However, the synthesis fails because it invents newer debt instruments not present in the source, undermining the validity of the comparison. (4) While the conceptual interpretation of Apple's disclosure philosophy is reasonable and contextually relevant—emphasizing transparency and audit trails—the inclusion of incorrect debt instruments severely impacts quantitative accuracy. The answer gets credit for structure and logical framing but loses points for key factual mismatches. Thus, correctness is partially compromised despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 483,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nAccenture repurchased $4.1 billion of Class A shares in fiscal 2022, and after a $3 billion board‑approved increase its open‑market repurchase authority stood at $6.13 billion; by the end of fiscal 2023 the remaining authorized amount had slipped to roughly $2.7 billion as the company continued to execute purchases. In fiscal 2024 the board added $4 billion of authority, raising total outstanding capacity to $6.69 billion, and the company spent about $4.5 billion on share purchases during the year. This multi‑year trend demonstrates a disciplined, scalable capital‑return framework—periodically expanding repurchase authorization and consistently using open‑market purchases to deploy surplus cash while maintaining a strong dividend policy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Accenture did not repurchase $4.1 billion in fiscal 2022—this number is entirely fabricated. The original answer states only that Accenture had $3.13 billion in available authorization in fiscal 2022, with no disclosure of actual repurchase volume for that year. Similarly, the claim that Accenture spent $4.5 billion on share purchases in fiscal 2024 is incorrect; the ground truth reports only $605 million in purchases during that year. The LLM also misstates the remaining authorization at the end of fiscal 2023 as $2.7 billion, while the original answer does not provide a specific number for 2023 but implies continuity with 2024 disclosures, which show $2.69 billion available after new authorization. (2) The calculation of total outstanding authority in fiscal 2024 is partially correct: $2.69 billion remaining + $4.0 billion new = $6.69 billion, which matches the ground truth. However, the LLM incorrectly implies that the $6.13 billion authority after fiscal 2022 was due to a $3 billion increase, which is not supported by the original answer. (3) The multi-hop reasoning is flawed: the model invents repurchase amounts for 2022 and 2024 that are not in the source, fails to accurately track the evolution of authorization, and misrepresents the pattern of execution. While it correctly identifies the $4.0 billion new authorization in 2024 and the concept of ongoing repurchases, the synthesis is undermined by fabricated data. (4) Despite these errors, the LLM captures the general strategic theme—consistent, measured capital returns with periodic authorization increases—so the contextual relevance and qualitative reasoning receive moderate scores. However, the severe quantitative inaccuracies drastically reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 509,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were first issued in November 2019 (Exhibit 4jj).  In each of the following years BMS filed a new supplemental indenture – the Thirteenth (March 2022), the Fourteenth (November 2023) and the Fifteenth (February 2024) – that added fresh tranches of senior unsecured notes with later maturities and varying coupons, but left the original 4.350 % 2047 notes unchanged and still outstanding.  This staggered, incremental approach demonstrates that BMS is deliberately constructing a laddered, long‑dated debt profile, using low‑cost fixed‑rate senior notes to lock in financing for an extended horizon while diversifying maturities and managing interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic insight correctly—that BMY (BMS) is maintaining a laddered, diversified long-term debt structure with the 4.350% Senior Notes due 2047 remaining outstanding across 2022–2024. However, there are key factual inaccuracies affecting quantitative accuracy. First, the LLM incorrectly states that new supplemental indentures were filed in March 2022 (Thirteenth), November 2023 (Fourteenth), and February 2024 (Fifteenth), whereas the ground truth specifies that the 4.350% 2047 notes were issued under the Eleventh Supplemental Indenture in November 2019 and were simply carried forward in subsequent years without new tranches being added via these later indentures. The LLM implies active restructuring or new tranches in each year, which is not supported by the original answer. Additionally, the LLM references 'Exhibit 4jj' and specific new indentures not mentioned in the ground truth, introducing unverified details. While the strategic interpretation—laddered maturities, fixed-rate financing, interest rate risk management—is semantically aligned with the original answer’s conclusion about staggered maturities and stable capital structure, the incorrect dating and structuring of indentures undermines factual precision. The company name is referred to as 'BMS' (common shorthand for Bristol-Myers Squibb, ticker BMY), which is acceptable but slightly less precise. No dollar amounts or interest rates are misstated (the 4.350% coupon is correctly noted), but the erroneous timeline and legal mechanics of the indentures reduce quantitative and qualitative accuracy. The answer remains contextually relevant and correctly synthesizes the multi-year pattern into a coherent financing strategy, earning strong marks for reasoning and relevance despite factual flaws in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 492,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.40 % Notes due 2023 were disclosed only in the generic “Description of Securities” (Exhibit 4.3) without any separate maturity or balance detail. By the 2023 filing Apple added a specific note re‑classifying the remaining principal as a current liability and explicitly stating the amount outstanding as the maturity date approached. After the notes matured, the 2024 filing removed them from long‑term debt and reported that no principal remained outstanding, concluding the disclosure cycle.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Apple's disclosure approach for the 2.40% Notes due 2023 was consistent across 2022, 2023, and 2024, with no changes in format or substance—specifically listing the notes under Exhibit 4.3 with identical descriptions referencing the Officer's Certificate dated May 3, 2013. However, the LLM claims that Apple 'added a specific note re-classifying the remaining principal as a current liability' in 2023 and 'removed them from long-term debt' in 2024, implying an evolving disclosure approach, which is factually wrong according to the ground truth. (2) There are no numeric values (e.g., dollar amounts, interest rates beyond the note description) in either answer that conflict directly, but the LLM fabricates changes in accounting treatment and disclosure structure that did not occur, undermining quantitative accuracy despite correct mention of the 2.40% rate and 2023 maturity. (3) The multi-hop reasoning fails because the LLM incorrectly infers changes in disclosure practices over time when the knowledge graph confirms stability. It introduces unverified details like reclassification as a current liability and explicit outstanding balance reporting, which are not supported. (4) While the LLM stays on topic and discusses the relevant notes and filings across the correct years, its core conclusion about evolving disclosure contradicts the ground truth, resulting in low correctness and qualitative accuracy. Contextual relevance is moderate because it addresses the right instrument and time frame but draws false inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 447,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe Amended 2010 SIP authorized 127 million Class A ordinary shares in fiscal 2022; the same 127 million level was retained through fiscal 2023, and the plan was expanded to 141 million authorized shares for fiscal 2024 (as disclosed in the 2024 filing).  This upward step‑up in the share‑authorisation ceiling signals that Accenture is deliberately enlarging its equity‑incentive pool, indicating a long‑term strategy to maintain ample shares for future grants and to continue using share‑based compensation as a core tool for attracting, retaining and aligning employee interests with shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative progression of authorized shares. According to the ground truth, the number increased from 127,000,000 in fiscal 2022 to 141,000,000 in fiscal 2023 and remained at that level in 2024. However, the LLM incorrectly states that the 127 million level was retained through fiscal 2023 and only increased to 141 million in fiscal 2024. This misrepresents the timing of the increase, which is a critical factual error. (2) The numbers themselves (127 million and 141 million) are correct in value but assigned to the wrong fiscal years. There are no calculation errors per se, but the misattribution undermines the accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the increase indicates a long-term strategy to maintain equity incentives for employee retention and alignment with shareholders. This interpretation aligns with the ground truth’s implication of strategic expansion followed by stabilization. However, because the timeline is wrong, the reasoning about 'stabilization' in 2024 is based on incorrect premises—the plan did not change in 2024, but the LLM implies it did. (4) The contextual relevance is high as the answer addresses both the numerical evolution and strategic implication. Qualitative reasoning is logical but built on faulty data. Quantitative accuracy is low due to incorrect year assignments. Correctness score is 6 because core facts (values) are correct, but their temporal sequence—key to answering 'how it evolved'—is flawed, leading to an incomplete and partially misleading picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 449,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned feature of the postponed **Intel 20A** node to the core breakthrough of its next‑generation **Intel 18A** process.  The company described PowerVia as the industry‑first implementation of backside power delivery that, together with RibbonFET, would give **up to ~15 % performance‑per‑watt improvement** over the Intel 3 node and is now slated for high‑volume manufacturing in 2025 (Panther Lake) — a key part of Intel’s IDM 2.0 roadmap and future nodes such as **Intel 14A**.  This progression shows that PowerVia has become a strategic pillar of Intel’s advanced‑process technology, essential for boosting performance, density and foundry competitiveness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Intel's PowerVia technology from 2022 to 2024. (1) All key facts are correct: PowerVia was introduced alongside RibbonFET, positioned for Intel 20A in 2022–2023, then transitioned to Intel 18A after 20A's productization was canceled. It is set for high-volume manufacturing in 2025 with Panther Lake. (2) Quantitative accuracy is excellent: the ~15% performance-per-watt improvement over Intel 3 is correctly cited and aligns with Intel's public disclosures; dates (2025 HVM) and node names (Intel 18A, 14A) are accurate. (3) Multi-hop reasoning is sound—LLM correctly synthesizes PowerVia’s strategic elevation from a roadmap concept to a foundational technology across process node transitions. (4) Minor omission: the original answer notes PowerVia enables optimization by eliminating front-side power routing, which explains *why* it improves performance-per-watt; this technical rationale is missing in the LLM response, slightly reducing qualitative completeness. However, the strategic importance and roadmap integration are well conveyed. Wording differs but semantic meaning matches. No factual errors—only slight depth difference in explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 342,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s defined‑benefit pension assets held **$239.3 million** in mutual‑fund equity securities as of August 31 2022 (page 87), **$196.2 million** as of August 31 2023 (page 98), and **$273.7 million** as of August 31 2024 (page 96). The allocation dipped in fiscal 2023 before rebounding sharply in fiscal 2024, indicating that the company temporarily reduced equity exposure—likely to de‑risk the portfolio—but then deliberately increased its equity‑based holdings again, underscoring a strategic shift to re‑emphasize growth‑oriented, equity investments while still aligning assets with long‑term liability‑matching objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Accenture's allocation to mutual fund equity securities decreased from $239,293 million in FY2022 to $196,226 million in FY2023 and remained flat in FY2024. However, the LLM states the amount was $239.3 million, $196.2 million, and $273.7 million—off by a factor of 1,000 (millions vs. thousands). This is a critical quantitative error. Additionally, the LLM claims an increase to $273.7 million in FY2024, which directly contradicts the ground truth of no change. (2) The numbers are not only incorrect in magnitude but also misrepresent the trend: the ground truth shows a consistent reduction and stabilization, while the LLM reports a dip followed by a rebound—exactly the opposite trajectory. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize data across the three fiscal years. It incorrectly identifies a strategic re-emphasis on equity investments, while the actual trajectory indicates a strategic reduction. (4) Despite the incorrect data and reasoning, the answer is contextually relevant—addressing the right company, metric, and time frame, and attempting to interpret strategic intent—hence a moderate contextual relevance score. However, due to severe factual and numerical inaccuracies, the correctness, quantitative, and qualitative scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 404,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid’s finite‑life intangible on the books at roughly **$145 million net** (page 115 of the 2022 10‑K) and continued to amortize it without any impairment charge being reported; the company’s IPR&D‑impairment disclosures reference only nemtabrutinib and COVID‑19 vaccine assets, not Dificid.  At the same time, therapeutic positioning was reinforced as a narrow‑spectrum, first‑line treatment for C. difficile, and sales data from the segment‑reporting tables (pages 129‑130 of the 2023 and 2024 10‑Ks) show Dificid revenue climbing from **$263 million in 2022 to $302 million in 2023 to $340 million in 2024**, with growing shares in both U.S. and international markets.  Consequently, Dificid’s contribution to total pharmaceutical sales rose modestly, while its asset valuation remained stable absent any impairment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its qualitative assessment of Dificid's strategic evolution and financial treatment, but contains a significant quantitative inaccuracy regarding 2022 revenue. The ground truth states that Dificid was valued as a $145 million intangible asset in 2022, which the LLM correctly reports. However, the LLM claims Dificid generated $263 million in global sales in 2022, while the ground truth does not provide 2022 revenue and only specifies $340 million in 2024 (with $303M U.S., $37M international). There is no mention in the original answer of 2022 or 2023 revenue figures, so the LLM's inclusion of $263M (2022) and $302M (2023) is unsupported by the ground truth and introduces fabricated data. This is a major error in quantitative accuracy. (2) The LLM correctly identifies the stable $145M asset valuation and lack of impairment, aligning with the original answer’s point about Dificid being a modest intangible asset. It also correctly notes the 2024 revenue of $340M, matching the ground truth exactly. However, the incremental revenue figures for 2022 and 2023 are not present in the original and cannot be verified against it, undermining the quantitative accuracy. (3) The multi-hop reasoning is sound in structure—tying asset valuation, therapeutic positioning, and revenue trends across years—but relies on extraneous data not in the ground truth. The LLM correctly infers growing strategic importance through segment reporting and therapeutic emphasis, which aligns with the original answer’s claim about Dificid becoming a 'strategically recognized product.' (4) Despite the incorrect insertion of 2022 and 2023 sales numbers, the overall narrative of Dificid’s rising strategic profile and stable valuation is consistent with the ground truth. The contextual relevance is perfect—it directly addresses all three dimensions of the question (valuation, positioning, revenue). Due to the significant but isolated numerical inaccuracy, the correctness score is reduced to 7, with a lower quantitative accuracy score of 6, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 573,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel kept packaging‑related R&D at roughly $16‑$17 billion a year (about 30 % of revenue, $16.0 B in 2023 and $16.5 B in 2024, down slightly from the $17.5 B spent in 2022 – see pages 32 & 39), but its execution faltered: repeated delays in key process/package nodes (the 10 nm rollout, the Intel 4/7 nm “Intel 4” delay, and the 7 nm defect mode) and the complexity of a disaggregated‑design approach slowed time‑to‑market and forced the company to record a $3.1 billion non‑cash impairment and accelerated‑depreciation charge in Q3 2024 tied to the Intel 7 node (page 34).  These execution gaps, together with the $952 million packaging‑revenue increase in 2023 (up $483 million from 2022) and the resulting rise in operating losses, drove higher spending, inventory write‑downs and reliance on prepayments and third‑party foundries, exposing Intel to substantial financial risk through sustained losses, excess capacity and costly capital commitments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While the $3.1 billion impairment charge in 2024 is correctly cited and aligns with the ground truth, the R&D investment figures are not supported by the original answer or typical SEC filing data. The claim that Intel spent $16–17 billion annually on packaging-related R&D (30% of revenue) is unsubstantiated; the original answer does not specify exact R&D amounts tied solely to packaging, only that R&D costs increased due to complexity. The breakdown of $16.0B in 2023 and $16.5B in 2024 (down from $17.5B in 2022) misrepresents the data—these appear to be total R&D figures, not packaging-specific, and are presented as if they are directly tied to packaging, which is a critical error. Additionally, the $952 million packaging-revenue increase in 2023 and $483 million prior-year figure are not mentioned in the ground truth and appear fabricated. (2) The mention of 'pages 32, 34, 39' implies specific document references not provided in the context, raising concerns about hallucination. The execution delays (Intel 4/7nm, 10nm rollout, defect modes) are plausible but not explicitly detailed in the original answer, which only refers to 'delays' generally. (3) The multi-hop reasoning is partially sound—Intel’s strategic focus, execution challenges, and financial risks are addressed, and the synthesis of R&D, delays, and financial exposure follows a logical chain. However, the reasoning is undermined by incorrect numerical grounding. (4) Despite the incorrect numbers, the LLM captures the overall trajectory from strategic emphasis to operational strain and correctly identifies the $3.1B impairment as a key financial risk. The contextual relevance is high because it directly addresses R&D, delays, and financial exposure across 2022–2024. However, the quantitative inaccuracies severely reduce factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 531,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nBetween 2022 and 2024, MK‑8591A (doravirine + islatravir) progressed from early‑phase testing to a pivotal Phase 2/3 trial that opened in August 2024, while the FDA’s clinical hold first imposed in December 2021 remained active and was refined with a partial hold in December 2024; the regimen was listed under “Under Review” in Merck’s 2024 pipeline, signaling an imminent regulatory filing. This trajectory reflects Merck’s long‑term strategy of building durable, long‑acting HIV regimens—both for treatment and for pre‑exposure prophylaxis—to create convenient, once‑daily or once‑weekly options that can expand the company’s presence in a high‑growth therapeutic area.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it incorrectly states that MK-8591A progressed to a 'pivotal Phase 2/3 trial that opened in August 2024'—this contradicts the ground truth, which states the drug entered Phase 3 in February 2020 and remained in Phase 3 through 2024. The LLM also misrepresents the regulatory timeline: it claims the FDA clinical hold 'first imposed in December 2021' was still active, but the ground truth indicates the hold was *lifted* on December 4, 2024, with only a partial hold remaining for higher doses. The LLM incorrectly implies an imminent regulatory filing by stating the regimen was 'Under Review' in 2024, while the original answer notes no submission had occurred by 2024. (2) These errors reflect flawed multi-hop reasoning: the model fails to correctly track the compound’s development stage over time, incorrectly suggesting progression into late-stage trials during 2022–2024 when it was already in Phase 3 by 2020. (3) While the LLM correctly identifies Merck’s long-term strategy in HIV therapeutics—developing long-acting, convenient regimens—the strategic interpretation is based on incorrect developmental and regulatory facts, weakening the qualitative accuracy. (4) Contextually, the answer addresses the question’s scope and attempts to infer strategy, earning moderate relevance, but the factual foundation is too flawed to support a higher score. Overall, major errors in dates, trial phases, and regulatory status severely reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 427,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nFrom 2022 through 2024 Merck broadened MK‑1308A’s clinical focus from a single‑tumor (renal‑cell‑carcinoma) program to a pan‑tumor immuno‑oncology strategy, evaluating the quavonlimab + pembrolizumab co‑formulation in multiple advanced solid tumours—including colorectal, hepatocellular, melanoma and small‑cell lung cancers—while continuing to test it as a pembrolizumab‑based combination.  The effort remained in Phase 2/3 testing with no new regulatory approvals, but the program kept up active FDA interactions and stayed eligible for expedited‑review pathways.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MK-1308A maintained a consistent focus on renal cell carcinoma (RCC) from 2022 to 2024, but the LLM claims Merck broadened the clinical focus to a 'pan-tumor immuno-oncology strategy' across multiple cancers (colorectal, hepatocellular, melanoma, small-cell lung cancer), which is not supported by the original answer. This misrepresents the clinical focus evolution. Additionally, while the LLM correctly notes that MK-1308A is a combination of quavonlimab and pembrolizumab, this detail only emerged in 2023 per the ground truth, not as an ongoing strategy from 2022. The claim about 'active FDA interactions' and 'expedited-review pathways' is not mentioned in the original answer and thus unsupported. (2) There are no specific numbers (e.g., dollar amounts, percentages, patient counts) in either answer, so quantitative accuracy cannot be faulted for numerical errors, but the misrepresentation of trial scope (Phase 2/3 vs. consistently Phase 3 in ground truth) is a critical error—original specifies Phase 3 only, while LLM says Phase 2/3. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the continuity of RCC focus and instead infers expansion, contradicting the ground truth's emphasis on increasing specificity. It also incorrectly attributes broader combination therapy testing beyond pembrolizumab, while the original confirms it is always in combination with pembrolizumab. (4) Correctness is low due to major factual errors in clinical focus and development phase. Qualitative accuracy is low due to incorrect reasoning and unsupported claims. Quantitative accuracy is low due to incorrect phase designation. Contextual relevance is moderate because the answer addresses the right drug, company, and general timeline, and correctly notes lack of approval and ongoing development, but misrepresents key strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 531,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture repurchased roughly 12.2 million shares for $4.1 bn in FY 2022, then continued net buybacks of about $4.5 bn in FY 2023 and a similar‑scale $4.5‑$6 bn of purchases in FY 2024, while the Board repeatedly expanded its repurchase authority—from $3.1 bn available at the end of FY 2022 to $6.1 bn after a September 2022 increase and to $6.7 bn after a September 2024 increase, leaving about $2.7 bn of authority unused at the close of FY 2024. This stepped‑up, continually enlarged share‑buyback program—combined with regular dividend increases—demonstrates that Accenture’s capital‑return strategy is to consistently deploy excess cash through a disciplined, growing share‑repurchase framework that reinforces shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, Accenture did not repurchase $4.1 billion in FY 2022; the available authorization was $3.13 billion, but no actual repurchase amount for FY 2022 is provided. The LLM fabricates a $4.1B repurchase in FY 2022 and $4.5B in FY 2023, which are not supported by the data. In reality, only FY 2024 repurchase activity is specified: $605 million for 2,000,308 shares. The LLM incorrectly states that repurchases were in the $4.5–6B range in FY 2024, which is over 7x higher than the actual $605M. (2) The authorization timeline is also wrong: the LLM claims increases in September 2022 and September 2024, but the ground truth only mentions a September 2024 approval of $4,000 million. The starting authorization in FY 2022 was $3.13B, not $3.1B 'available at the end'—and the LLM incorrectly implies growth in authorization over time due to multiple increases, while only one new authorization (in 2024) is documented. The remaining authority at the end of FY 2024 was $2.694B, which the LLM approximates as $2.7B—this one number is correct. (3) Multi-hop reasoning is flawed: the LLM invents a pattern of large annual repurchases and repeated authorizations without evidence from the provided data. It fails to note that the 2023 filing contains forward-looking disclosure about 2024 activity, which is a key nuance in the original answer. (4) Despite these major errors, the LLM captures the general strategic direction—Accenture maintains a sustained capital return strategy with share buybacks and dividend increases—and correctly infers that replenishing authorization indicates a long-term, flexible approach. This qualitative insight saves it from a 0, but the severe quantitative inaccuracies severely undermine the answer's reliability. Thus, correctness is scored low at 3/10, quantitative accuracy at 2/10, qualitative reasoning at 4/10, and contextual relevance at 7/10 for addressing the right topic with flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 551,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million 2.350 % Notes due 2040 are repeatedly listed in the capital‑structure exhibits of the 2022, 2023 and 2024 Form 10‑K filings (e.g., Exhibit 4.6 in the 2020 8‑K and again in the exhibit tables on pages 134 and 138 of the 2022‑2024 filings).  This persistence shows that BMS treats the 2040 tranche as a permanent, low‑cost pillar of its long‑term debt, using it to lock in fixed‑rate financing, diversify its maturity profile and maintain a stable interest‑expense base while preserving flexibility to manage other debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the dollar amount ($750 million), interest rate (2.350%), maturity year (2040), and the years of filing (2022–2024) are accurately reported. Minor formatting differences (e.g., $750 million vs $750,000,000) are acceptable and semantically equivalent. (2) The answer correctly identifies the persistence of the notes across the three years’ Form 10-K filings and references specific exhibit details (e.g., Exhibit 4.6, page numbers), which supports verifiability. (3) The reasoning is sound: the LLM correctly infers that the continued inclusion reflects a strategic choice to maintain fixed-rate debt for stability, cost predictability, and maturity diversification—consistent with the ground truth’s emphasis on interest rate risk management and stable interest expenses. (4) The only minor shortcoming is that the LLM does not explicitly state that the note was *not refinanced or retired*, which is a key point in the original answer highlighting strategic retention despite market changes. However, the implication is present through 'repeatedly listed' and 'persistence'. The mention of 'low-cost pillar' and 'flexibility to manage other obligations' adds slight interpretive depth without overreaching. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop synthesis across filings and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 402,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company continues to reference the same $1 bn 4.350 % Senior Notes due 2047 that were originally issued in November 2019, with no amendment or new interest‑rate terms disclosed. This consistent reference shows that BMS has kept a stable, long‑dated fixed‑rate debt instrument on its balance sheet, using the 4.350 % note to lock in low‑cost capital for the long term and reflecting a strategic preference for long‑term, fixed‑rate financing rather than frequent refinancing or rate adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.350% Senior Notes due 2047 and their consistent interest rate across recent filings, aligning with the ground truth. It accurately notes the notes were issued in November 2019 and reaffirms the stability of the rate. However, it adds a $1 billion amount, which, while plausible and commonly associated with such notes, is not present in the original ground truth and thus introduces unverified quantitative detail. (2) The percentage (4.350%) and year (2047) are correct; the reference to November 2019 issuance matches the Form 8-K filing date mentioned in the ground truth. The $1 billion figure is not confirmed in the original answer and lacks corroboration across the provided truth data, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosure across multiple years (2022–2024) and infers a strategic preference for fixed-rate, long-term financing, which is a valid interpretation of the pattern. It correctly identifies the absence of rate changes or amendments as evidence of stability. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of the interest rate commitment and what it reveals about debt strategy. Despite the minor addition of the unverified $1B amount, the core facts, reasoning, and conclusion are factually aligned with the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 405,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Nike’s discussion of FlyEase shifted from a brief mention in the “product‑research” list to an explicit reference that ties the platform to its global supply chain; the 2024 filing notes that FlyEase‑enabled footwear is produced at dedicated Air‑Manufacturing‑Innovation sites (Vietnam and Missouri) and that the contract manufacturers making those shoes account for a large share of total output—four footwear contract manufacturers together generate roughly 57 % of Nike Brand footwear and operate 96 factories in 11 countries, with Vietnam, Indonesia and China supplying 50 %, 27 % and 18 % of that production. This quantitative detail demonstrates that FlyEase is now manufactured at scale and integrated into Nike’s worldwide manufacturing network.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Nike's reporting on FlyEase from fiscal 2022 to 2024, noting its progression from a minor mention to integration with global manufacturing. However, it introduces details not present in the ground truth: specifically, the claim that FlyEase-enabled footwear is produced at 'dedicated Air-Manufacturing-Innovation sites (Vietnam and Missouri)' and that it is tied to four contract manufacturers accounting for 57% of output. These specific claims (57%, Missouri, Air-Manufacturing-Innovation sites) are not supported by the original answer and appear to be hallucinated or inferred beyond the provided data. The geographic production shares (50%, 27%, 18% for Vietnam, Indonesia, China) are correctly reported and match the ground truth, which is a key quantitative strength. (2) The numbers for country-level manufacturing distribution are accurate and properly cited, but the additional 57% figure and factory count (96 factories in 11 countries) are not in the original answer and cannot be verified against the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking FlyEase to global manufacturing via shared production geography is valid inference, but the leap to specific contract manufacturers and dedicated innovation sites goes beyond the evidence provided in the ground truth. The original answer only states that FlyEase is integrated into the broader manufacturing footprint, not that it is tied to specific sites or manufacturers. (4) Despite the hallucinated details, the core message—that FlyEase has achieved scale and integration into global operations by 2024—is consistent with the original. The answer addresses both parts of the question (evolution over time and quantitative evidence), but the inclusion of unsupported specifics lowers correctness and quantitative accuracy. Hence, a score of 7 is justified for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 530,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nThe RedCard‑related penetration rate fell steadily over the three fiscal years – it was about **20.5 % of purchases in 2022, 19.8 % in 2023 and 18.6 % in 2024**.  This downward trend signals that Target’s loyalty‑driven payment incentive (the 5 % discount for using a RedCard) is losing its ability to attract or retain card usage, suggesting the current RedCard‑centric strategy is becoming less effective at driving incremental sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in RedCard penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, introducing a factual error in the final and most recent data point. This discrepancy affects the quantitative accuracy significantly, though the general trend direction (declining) is preserved. (2) The numbers for 2022 and 2023 are accurate; the 2024 figure is off by 0.8 percentage points, which is non-trivial in the context of year-over-year changes in penetration rates. No calculations (e.g., differences or ratios) are explicitly requested, but the trend interpretation relies on accurate data points. (3) The multi-hop reasoning is sound: the model correctly synthesizes a three-year trend and draws a logical conclusion about the weakening effectiveness of Target's loyalty-driven payment strategy. The interpretation aligns with the ground truth, noting reduced effectiveness in driving customer behavior. (4) Contextual relevance is perfect—the answer addresses both parts of the question: the evolution of penetration rates and the strategic implication. The qualitative reasoning is strong and semantically equivalent to the ground truth, despite the numerical inaccuracy in the 2024 figure. The conclusion is reasonable given the data presented, even if one data point is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 395,
        "total_tokens": 1624
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.24,
    "average_quantitative_accuracy": 6.7,
    "average_qualitative_accuracy": 6.58,
    "average_contextual_relevance": 8.54,
    "score_distribution": {
      "excellent": 246,
      "good": 160,
      "fair": 232,
      "poor": 162
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 31246.22,
    "timestamp": "2026-02-03T00:21:11.966186"
  }
}